<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>CEREB Medicine - Combined Tests</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
</style>
  <style>
  body {
    font-family: Arial, sans-serif;
    padding: 0;
    margin: 0;
  }

  button {
    margin: 5px;
    padding: 10px 15px;
    background: #ffffff;
    border: 1px solid #2d3748;
    border-radius: 4px;
    cursor: pointer;
    color: #000000;
    position: relative;
    top: 5px;
    font-size: 14px;
    transition: background 0.2s ease, color 0.2s ease, transform 0.1s ease;
  }

  button:hover {
    background: #f3f4f6;
    color: #000000;
    transform: translateY(-1px);
  }

  body, html {
            margin: 0;
            padding: 0;
            height: 100%;
            overflow: hidden;
        }
        .iframe-container {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            overflow: auto;
            -webkit-overflow-scrolling: touch;
        }
        .iframe-container iframe {
            width: 100%;
            height: 100%;
            border: none;
            display: block;
        }
    
    /* Mobile optimization */
    

  /* Dropdown styling */
  .dropdown-wrapper {
    position: absolute;
    top: 20px;
    right: 20px;
    z-index: 1100;
  }

  .dropdown-toggle {
    background: #2c5281;
    color: white;
    border: none;
    font-size: 14px;
    padding: 10px 18px;
    border-radius: 6px;
    font-weight: bold;
    letter-spacing: 0.5px;
  }

  .dropdown-toggle:hover {
    background: #24466c;
  }

  .dropdown-menu {
  display: none;
  position: absolute;
  right: 0;              /* keep aligned to right edge of toggle */
  margin-top: 6px;
  background: white;
  border: 1px solid #cbd5e0;
  border-radius: 8px;
  max-height: 350px;
  overflow-y: auto;
  box-shadow: 0 6px 16px rgba(0, 0, 0, 0.15);
  min-width: 250px;
  max-width: 90vw;       /* prevent it from going outside screen */
  word-wrap: break-word; /* wrap long names */
  white-space: normal;   /* allow text to wrap */
  animation: fadeIn 0.2s ease-in-out;
}

.dropdown-menu button {
  display: block;
  width: 100%;
  text-align: left;
  margin: 0;
  padding: 10px 15px;
  border-radius: 0;
  background: transparent;
  color: #2d3748;
  border: none;
  border-bottom: 1px solid #edf2f7;
  font-size: 13px;
  white-space: normal;   /* allow wrapping inside button */
  word-break: break-word;
}


  img {
    max-width: 100%;
    max-height: 400px;
    width: auto;
    height: auto;
    display: block;
    margin: 10px auto;
  }

  body > section:last-child {
    margin-bottom: 0 !important;
  }
  
</style>
  <script>
  function showTest(id) {
    document.querySelectorAll('.iframe-container').forEach(div => div.style.display = 'none');
    document.getElementById(id).style.display = 'block';
    document.getElementById('dropdownMenu').style.display = 'none';
    window.scrollTo(0, 0);
  }

  function toggleDropdown() {
    const menu = document.getElementById('dropdownMenu');
    menu.style.display = menu.style.display === 'block' ? 'none' : 'block';
  }

  document.addEventListener('click', function (event) {
    const toggle = document.getElementById('dropdownToggle');
    const menu = document.getElementById('dropdownMenu');
    if (!toggle.contains(event.target) && !menu.contains(event.target)) {
      menu.style.display = 'none';
    }
  });
</script>
<script src="../../../access-control.js"></script>
  <script src="../../../block.js"></script>
  <script src="../../../error-handler/link-checker.js"></script>
  <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5920367457745298"
     crossorigin="anonymous"></script>
</head>
<body>
<script>
      // Initialize access control for protected page
      if (!accessControl.initProtectedPage()) {
        throw new Error('Access denied - redirecting to index.html');
      }
    </script>
  <button onclick="history.back()" style="position: absolute; top: 20px; left: 20px; background: transparent; color: white; border: none; padding: 10px; cursor: pointer; z-index: 1001; font-size: 20px;">
  <i class="fas fa-arrow-left"></i>
</button>

<div class="dropdown-wrapper">
  <button class="dropdown-toggle" id="dropdownToggle" onclick="toggleDropdown()">â˜° INDEX</button>
  <div class="dropdown-menu" id="dropdownMenu">
<button onclick="showTest('test1')">Cardiology</button>
<button onclick="showTest('test2')">Endocrinology</button>
<button onclick="showTest('test3')">Extra Advantage Series</button>
<button onclick="showTest('test4')">Gastroenterology</button>
<button onclick="showTest('test5')">Hematology & Tranfusion</button>
<button onclick="showTest('test6')">Medical Oncology</button>
<button onclick="showTest('test7')">Nephrology</button>
<button onclick="showTest('test8')">Neurology</button>
<button onclick="showTest('test9')">Pulmonary Medicine & Critical Care</button>
<button onclick="showTest('test10')">Rheumatology</button>
</div>
  </div>
  
<div id="test1" class="iframe-container" style="display:block;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Cardiology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Cardiology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                179 Questions | 716 Total Marks | 189 min Duration | ~63.35 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 60-year-old woman with a recent type B aortic dissection presents with abdominal pain and lower limb ischemia with diminished femoral and popliteal pulses. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add intravenous enalaprilat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase nitroprusside infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repair the descending aorta&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch nitroprusside to amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Repair the descending aorta&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Repair the descending aorta&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enalaprilat: Although used for blood pressure control, it doesn&#x27;t address the underlying issue of malperfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enalaprilat:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increasing nitroprusside: May help with blood pressure control but doesn&#x27;t solve the urgent need for revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increasing nitroprusside:&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Switching to amlodipine: Not appropriate in an acute setting requiring immediate intervention.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Switching to amlodipine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the signs of complicated type B aortic dissection (malperfusion syndromes) and the need for immediate surgical/endovascular repair.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with Marfan syndrome has an ascending aortic diameter of 4.3 cm, which has increased by 0.6 cm in the past year. Her mother had an aortic dissection. She is considering pregnancy. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aortic repair before pregnancy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proceed with pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aortic repair before pregnancy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aortic repair before pregnancy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atorvastatin: Statins are not indicated for aortic disease management in this context and are contraindicated in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atorvastatin:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Losartan: Contraindicated in pregnancy due to fetal toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Losartan:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proceeding with pregnancy without aortic repair would be dangerous due to the high risk of dissection.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with Marfan syndrome have an increased risk for pregnancy-related aortic dissection and rupture; aortic repair surgery is recommended before conception to reduce this risk in those with an ascending aortic diameter greater than 4.0 cm and who have risk factors for aortic dissection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with acute chest pain. ECG shows multifocal ST depressions. His BP is 170/100 mm Hg on the right arm and 140/90 mm Hg in the left arm. He also has a diastolic murmur at the left sternal border. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary Angiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Invasive aortography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Magnetic resonance angiography (MRA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CT Angiography&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CT Angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Coronary angiography: Relatively contraindicated in suspected aortic dissection.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Coronary angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Invasive aortography: Less commonly used compared to CTA for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  MRA: Time consuming and unnecessary in an emergency like in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  MRA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected aortic dissection, perform TTE and CT angiography promptly for diagnosis and to guide management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old woman with extensive cardiovascular disease and poorly controlled hypertension is evaluated for acute-onset ripping chest pain that radiates to her back. Chest radiograph is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute coronary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic dissection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stress-induced cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aortic dissection&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/untitled-3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The most likely diagnosis is acute aortic dissection. This patient&#x27;s chest radiograph shows a widened superior mediastinum and a right pleural effusion consistent with aortic dissection, although these findings are not diagnostic. The diagnosis of aortic dissection can be established with transesophageal echocardiography, CT angiography, or MR angiography, all of which have similar sensitivity and specificity for acute thoracic aortic disease. Because of its wide availability and short image acquisition time, CT angiography has become the primary diagnostic test for acute thoracic aortic disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man with peripheral artery disease (PAD) and persistent claudication despite exercise and optimal medical therapy (aspirin, statin, enalapril). What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cilostazol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Evolocumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pentoxifylline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cilostazol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clopidogrel : Dual antiplatelet therapy is not routinely recommended for PAD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ Option C. Evolocumab : PCSK9 inhibitors are for patients with high LDL cholesterol despite statin therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Evolocumab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pentoxifylline : Not proven effective for claudication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pentoxifylline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with peripheral artery disease and intermittent claudication, cilostazol is recommended to improve limb symptoms in addition to smoking cessation, aspirin, statin therapy, and supervised exercise.&lt;/li&gt;&lt;li&gt;âž¤ Cilostazol is contraindicated in patients with heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with acute chest pain for the last 3 hours. Aspirin and clopidogrel was given in the ambulance. ECG is taken in ER and shown below. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tirofiban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emergent coronary angiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enoxaparin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171044.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reteplase : This is a thrombolytic agent used in STEMI and not in NSTE-ACS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reteplase&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tirofiban : GpIIb/IIIa inhibitor used primarily during PCI under special circumstances.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tirofiban&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emergent Coronary angiography : While angiography is crucial to confirm the diagnosis and guide further management, immediate anticoagulation with enoxaparin should be initiated first. In this patient with ST depression (a high risk factor), URGENT coronary angiography is optimal (&amp;lt; 24h) rather than immediate (&amp;lt; 2h).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emergent Coronary angiography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected NSTE-ACS, early administration of enoxaparin is crucial to prevent further thrombus formation while awaiting coronary angiography.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with exertional chest pain and a positive stress test undergoes angiography revealing complex multivessel coronary artery disease (CAD) involving the left main. He has a left ventricular ejection fraction (LVEF) of 42%. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary artery bypass grafting (CABG)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medical therapy without revascularization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myocardial viability testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Percutaneous coronary intervention (PCI)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Coronary artery bypass grafting (CABG)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Medical therapy : Insufficient for complex CAD and reduced LVEF, carries a higher risk of adverse events.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Medical therapy&lt;/li&gt;&lt;li&gt;â€¢ Option C. Viability testing : Not necessary before revascularization in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Viability testing&lt;/li&gt;&lt;li&gt;â€¢ Option D. PCI : Less favorable than CABG for complex multivessel disease, especially with left main involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PCI&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with multivessel coronary artery disease, coronary artery bypass grafting is associated with enhanced survival compared with medical therapy alone.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of hypertension and coronary artery disease presents with acute decompensated heart failure. He is dyspneic at rest and has bibasilar crackles on lung auscultation. Which of the following medications is NOT appropriate for initial&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nitroglycerin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CPAP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Verapamil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Furosemide : Loop diuretic, cornerstone of therapy in ADHF to reduce fluid overload.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Furosemide&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nitroglycerin : Vasodilator, used to reduce preload and afterload, improving cardiac function in ADHF.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nitroglycerin&lt;/li&gt;&lt;li&gt;â€¢ Option D. CPAP : Non-invasive ventilation, often used in ADHF to improve oxygenation and decrease the work of breathing.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CPAP&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Non-dihydropyridine calcium channel blockers (like verapamil) are C/I in acute decompensated heart failure due to their negative inotropic effects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with stable angina and aspirin allergy is undergoing lifestyle counseling and antianginal therapy. What is the most appropriate cardioprotective treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low-dose aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ticagrelor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clopidogrel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low-dose aspirin : Contraindicated due to aspirin allergy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low-dose aspirin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prasugrel and Option D. Ticagrelor : More potent antiplatelet agents, typically used in acute coronary syndrome or after PCI, not as monotherapy for stable angina.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prasugrel&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Ticagrelor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ All patients with stable ischemic heart disease should receive guideline-directed therapies consisting of lifestyle modification, cardioprotective therapy, and antianginal medication. Patients with stable ischemic heart disease should receive antiplatelet therapy (low-dose aspirin or clopidogrel in aspirin-intolerant patients) for secondary prevention of cardiovascular events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with decompensated heart failure is hospitalized and treated with a maximal dose of IV furosemide. He has minimal urine output and persistent signs of volume overload. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add intravenous milrinone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add intravenous nitroglycerin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start CVVH (Continuous venovenous hemofiltration)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Start CVVH (Continuous venovenous hemofiltration)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Add intravenous milrinone: Milrinone is an inotrope used to improve cardiac contractility. While it may help with cardiac output, it doesn&#x27;t directly address the volume overload and can worsen renal function.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Add intravenous milrinone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add intravenous nitroglycerin: Nitroglycerin is a vasodilator that can reduce preload and afterload, but it&#x27;s not the primary treatment for volume overload when diuretics fail.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add intravenous nitroglycerin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase furosemide: The patient is already on the maximal dose of furosemide, so further increases would not be effective and could lead to adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase furosemide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with ADHF who are unresponsive to maximal diuretic therapy, CVVH is a crucial intervention to manage volume overload and prevent further complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old woman 3 months postpartum presents with recurrent exertional chest pain. Cardiac catheterization shows normal coronary arteries, and cardiac MRI reveals diffuse perfusion abnormalities. What is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary vasospasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Microvascular dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peripartum cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spontaneous coronary artery dissection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Microvascular dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary vasospasm : This would cause transient ST-elevation on ECG.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary vasospasm&lt;/li&gt;&lt;li&gt;â€¢ Option C. Peripartum cardiomyopathy : Presents with heart failure symptoms, not typically isolated chest pain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Peripartum cardiomyopathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spontaneous coronary artery dissection : More common in the peripartum period but would typically have abnormal coronary angiography findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spontaneous coronary artery dissection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Consider microvascular dysfunction as a potential cause of angina in women with normal coronary arteries on angiography.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with diabetes mellitus received a drug-eluting stent for non-ST elevation acute coronary syndrome (NSTE-ACS). She was started on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. What is the recommended minimum duration of her antiplatelet therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 month&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;6 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;12 months&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 12 months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1 month: This duration is too short and would significantly increase the risk of stent thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1 month:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 3 months: While some studies suggest shorter durations may be safe in select patients, the standard recommendation for patients with diabetes is 12 months.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 3 months:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 6 months: This is the minimum duration for patients without diabetes who have received a drug-eluting stent for ACS.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. 6 months:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the recommended duration of dual antiplatelet therapy in patients with diabetes who have undergone percutaneous coronary intervention (PCI) with drug-eluting stents for acute coronary syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old man with persistent angina despite maximally tolerated antianginal therapy. He has orthostatic hypotension and current BP and PR are 100/60 mm Hg and 54/min respectively. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addition of clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Addition of isosorbide mononitrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exercise echocardiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Coronary angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Addition of Clopidogrel : Not indicated for stable angina without recent revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Addition of Clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ Option B. Addition of Isosorbide mononitrate : Adding more antianginal medication may not be helpful if the patient is already on maximally tolerated doses. Addition of nitrate in this patient may worsen orthostatic hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Addition of Isosorbide mononitrate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise echocardiography : May provide prognostic information but doesn&#x27;t identify lesions for revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise echocardiography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In the setting of persistent symptoms despite maximally tolerated medical therapy, invasive imaging for revascularization assessment is appropriate to improve symptom status and quality of life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a 6.1 cm abdominal aortic aneurysm (AAA) detected on routine USG screening. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abdominal aortography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ACE inhibitor therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CT angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Open abdominal aortic aneurysm repair&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CT angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal aortography : Invasive and less commonly used for AAA evaluation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal aortography&lt;/li&gt;&lt;li&gt;â€¢ Option B. ACE inhibitor therapy : Doesn&#x27;t address the need for repair of a large AAA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ACE inhibitor therapy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Open AAA repair : Premature before confirming the location and suitability for repair with CTA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Open AAA repair&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The U.S. Preventive Services Task Force recommends one-time screening with duplex ultrasonography in all men aged 65 to 75 years who have smoked at least 100 cigarettes in their lifetime and selective screening in men in this age group who have never smoked.&lt;/li&gt;&lt;li&gt;âž¤ CT angiography or magnetic resonance angiography is the imaging procedure of choice to identify the exact location of an abdominal aneurysm and plan operative repair.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with Alzheimer&#x27;s disease, on donepezil, presents with somnolence, hypotension (70/40 mmHg), and sinus bradycardia (30/min). What is the next treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chest compressions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous atropine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isoproterenol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous atropine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone : Antiarrhythmic drug, not indicated for bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chest compressions : Not indicated if the patient has a pulse.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chest compressions&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isoproterenol : Second-line chronotropic agent, considered if atropine is ineffective.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isoproterenol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The treatment of hemodynamically unstable bradycardia with a pulse is intravenous atropine.&lt;/li&gt;&lt;li&gt;âž¤ The most common extrinsic cause of sinus bradycardia is medication use (Î²-blockers, donepezil, neostigmine, pyridostigmine).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with a history of atrial fibrillation, diabetes, and peripheral artery disease presents with acute left leg pain, absent pulses, and cold, mottled skin. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apixaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unfractionated heparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venous duplex ultrasonography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Unfractionated heparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Angiography : Essential for diagnosis and planning revascularization, but anticoagulation should be started first.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Angiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Apixaban : Oral anticoagulant, not appropriate in the acute setting of ALI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Apixaban&lt;/li&gt;&lt;li&gt;â€¢ Option D. Venous duplex ultrasonography : Not indicated for ALI, which is an arterial problem.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Venous duplex ultrasonography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Treat acute limb ischemia with anticoagulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with no medical history presents with frequent, bothersome palpitations that subside with exercise and in the nights. ECG is shown. Echo and baseline lab tests including CBC and TFT are normal. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reassurance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-172502.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone : Antiarrhythmic drug with potential toxicity, not first-line for simple PVCs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG : Not helpful for diagnosing PVCs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reassurance : Not sufficient for bothersome symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reassurance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Beta-blockers are the first-line treatment for symptomatic PVCs in patients without structural heart disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 71-year-old man with a history of coronary artery bypass graft (CABG) presents with worsening exertional chest pain. He is on aspirin, metoprolol, sublingual nitroglycerin, and rosuvastatin. ECG shows LBBB. Which is the most appropriate test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dobutamine echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exercise single-photon emission CT (SPECT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vasodilator myocardial perfusion imaging (MPI)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vasodilator myocardial perfusion imaging (MPI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dobutamine echocardiography : Not ideal due to the presence of LBBB, which can hinder image interpretation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dobutamine echocardiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG : LBBB limits the interpretability of exercise ECG for ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise SPECT : Exercise increases heart rate which can worsen artefacts due to LBBB.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise SPECT&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In the evaluation of patients with chest pain, vasodilator myocardial perfusion imaging with adenosine, regadenoson, or dipyridamole minimizes septal abnormalities frequently seen with exercise or dobutamine myocardial perfusion imaging.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with recurrent chest pain and elevated troponin. ECG is shown. remains in pain despite aspirin, clopidogrel, heparin, and nitroglycerin. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eplerenone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen per nasal cannula&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urgent coronary angiography&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Urgent coronary angiography&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-173300.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Echocardiography : May be helpful, but not the immediate priority.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Echocardiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eplerenone : Indicated in certain post-MI patients, but not the immediate priority for refractory angina.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eplerenone&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oxygen per nasal cannula : Indicated only if the patient is hypoxic.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oxygen per nasal cannula&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Urgent or immediate diagnostic angiography with intent to perform revascularization is indicated in patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with a history of radiation therapy for Hodgkin lymphoma presents with exertional dyspnea and a burning sensation in her throat. She has no history of hypertension, hyperlipidemia, or diabetes and she is a non-smoker. Physical examination and chest X-ray are normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary artery disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Coronary artery disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis : Valvular diseases are possible after radiation but less likely given the normal physical exam.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option B . Constrictive pericarditis and Option D . Restrictive cardiomyopathy : These can occur after radiation but typically present with additional signs like elevated JVP, edema, or diastolic dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Constrictive pericarditis&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Restrictive cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Cancer survivors who received chest radiotherapy are at risk for the late development of cardiovascular complications, including pericardial constriction, valvular heart disease, restrictive cardiomyopathy, and coronary artery disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with type 2 diabetes, hypertension, hyperlipidemia, and aortofemoral bypass surgery 2 years ago has an HbA1c of 7.1%. His current medications are metformin, atenolol, ramipril, amlodipine, aspirin, rivaroxaban, and atorvastatin. Which medication is most appropriate to add for cardiovascular risk reduction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Niacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pramlintide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liraglutide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Clopidogrel : Patient is already on rivaroxaban and aspirin. Addition of clopidogrel would not provide any additional benefit and only increase the bleeding risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ Option C. Niacin : No longer recommended for routine use due to lack of benefit and side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Niacin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pramlintide : Amylin analog used for glycemic control, no proven cardiovascular benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pramlintide&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with type 2 diabetes mellitus, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists are associated with reduced rates of adverse cardiovascular events, including stroke, myocardial infarction, and cardiovascular death, compared with placebo.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old woman 6-month history of right shoulder pain on exertion and it is relieved by rest. Her ECG shows LBBB. She has no known comorbidities and not on any regular medications. What is the most appropriate test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pharmacologic myocardial perfusion imaging&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further testing is required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pharmacologic myocardial perfusion imaging&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary angiography : Not the initial test for stable angina. It should be reserved for patients with a high pretest likelihood of CAD and unstable symptoms, or for those in whom optimal medical therapy has been ineffective.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary angiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG : LBBB limits interpretation of ECG changes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG&lt;/li&gt;&lt;li&gt;â€¢ Option D. No further testing: Inappropriate as the patient has exertional chest pain.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No further testing:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ S tress testing with imaging is indicated in patients with an inability to exercise, baseline ECG abnormalities that limit interpretation of the exercise ECG, or indeterminate findings on the exercise ECG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man with type 2 diabetes and a history of stroke is on aspirin, metformin, olmesartan, and rosuvastatin. His LDL-C is 66 mg/dL, HDL-C is 28 mg/dL and HbA1c is 6.8%. What additional medication should be considered for CV risk reduction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Niacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No changes in management&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ezetimibe : Not indicated as LDL cholesterol is already well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Option C. Niacin : Can increase HDL but no longer recommended for routine use due to lack of benefit and side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Niacin&lt;/li&gt;&lt;li&gt;â€¢ Option D. No changes in management : Inadequate as SGLT2 inhibitors provide additional CV benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No changes in management&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Consider adding SGLT2 inhibitors to the treatment regimen for patients with type 2 diabetes and established ASCVD to reduce CV risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man presents with severe chest pain and diaphoresis. His ECG is shown below. His cardiac troponins were elevated and he was started on aspirin, ticagrelor and UFH. He experiences recurrent chest pain, hypotension and hence coronary angiogram was done which was normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary plaque rupture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary vasospasm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stress cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Coronary vasospasm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-174059.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary plaque rupture : Would be visible on angiography.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary plaque rupture&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism : Usually presents with pleuritic chest pain and dyspnea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stress cardiomyopathy : More common in elderly women and usually triggered by stress.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stress cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Coronary vasospasm can mimic ACS and may present with recurrent chest pain, ECG changes, and even troponin elevation, despite normal coronary arteries.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with CAD and diabetes mellitus experiences worsening angina. He is currently on ramipril, diltiazem, metformin, atorvastatin and isosorbide mononitrate twice daily. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease lisinopril dosage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduce isosorbide mononitrate dosage to once daily&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repeat coronary angiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduce isosorbide mononitrate dosage to once daily&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adding amlodipine : Not the first-line option when nitrate tolerance is suspected.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adding amlodipine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreasing lisinopril : Not indicated as blood pressure is controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreasing lisinopril&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat coronary angiography : Not necessary unless there is a suspicion of new coronary lesions or progression of existing ones.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat coronary angiography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Long-acting nitrates provide a constant level of vasodilation and symptom relief throughout the day, but a nitrate-free interval is required to avoid tolerance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old man with diabetes, hypertension, and hyperlipidemia presents with a 6-week history of resting foot pain and a non-healing ulcer. His ankle-brachial index (ABI) is 0.44 on the right and 0.62 on the left. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperbaric oxygen treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Invasive angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary below-the-knee amputation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Invasive angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT angiography : Can be helpful but is not the first step for patients with CLTI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperbaric oxygen treatment : Not a primary treatment for CLTI, but may be adjunctive.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperbaric oxygen treatment&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary amputation : Not the initial approach in patients with potentially salvageable limbs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary amputation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Chronic limb-threatening ischemia (CLTI) is characterized by more than 2 weeks of ischemic rest pain, nonhealing wound/ulcers, or gangrene in one or both legs that is attributable to objectively proven peripheral artery disease.&lt;/li&gt;&lt;li&gt;âž¤ In patients with CLTI, immediate invasive angiography with endovascular revascularization is often the most effective strategy to preserve tissue viability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old woman with chest pain over 24 hours and it is worsening despite multiple doses of NTG. She is known case of hypertension and dyslipidaemia and on enalapril and rosuvastatin. Her ECG 3 months ago was normal and her current ECG in the ER is shown. Her initial troponin is normal. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary artery calcium scoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Invasive coronary angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Invasive coronary angiography&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-174508.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary artery calcium scoring : No use in patients who are already receiving statins and not helpful in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary artery calcium scoring&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary CT angiography : May be considered, but invasive angiography is preferred for immediate diagnosis and potential intervention.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise ECG : C/I in the context of acute/ongoing ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise ECG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Invasive coronary angiography is the preferred diagnostic test in patients with refractory angina to assess coronary anatomy and guide potential revascularization.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man presents with inferior STEMI and he is successfully treated with PCI. He has a history of paroxysmal AF and was taking flecainide. He was also started on rivaroxaban, metoprolol, and ramipril post PCI. He is currently asymptomatic and now planned for discharge from the hospital. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ambulatory ECG monitoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Discontinue flecainide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discontinue metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exercise stress testing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Discontinue flecainide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ambulatory ECG monitoring : Helpful for assessing AF burden but doesn&#x27;t address the contraindication of flecainide.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ambulatory ECG monitoring&lt;/li&gt;&lt;li&gt;â€¢ Option C. Discontinue metoprolol : Not ideal as it&#x27;s essential for managing ischemic heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Discontinue metoprolol&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise stress testing : Not recommended immediately post-MI, especially with existing conduction abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise stress testing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Class IC antiarrhythmics like flecainide are C/I in patients with ischemic heart disease due to an increased risk of ventricular arrhythmias and death.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with stable angina has persistent symptoms despite maximally tolerated medical therapy. Coronary Angiogram shows 70% proximal RCA stenosis and 80% obtuse marginal artery stenosis. What benefit can the patient expect from CABG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discontinuation of cardioprotective medications&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Improvement in symptoms&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased survival&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reduced risk for myocardial infarction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Improvement in symptoms&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinuation of medications : Not recommended after CABG.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinuation of medications&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased survival : Less likely in this patient without multivessel or left main disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased survival&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reduced risk of MI : Possible, but not the primary goal in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reduced risk of MI&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Primary goal of revascularization instable angina is symptom relief.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old woman is evaluated for atypical chest pain. Exercise stress testing is performed. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophic cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ischemic coronary artery disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal test result&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rate-dependent conduction defect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ischemic coronary artery disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-174936.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old man with a history of hypertension and hypercholesterolemia has chronic stable angina. Which of the following medications have been shown to reduce mortality and risk of myocardial infarction (MI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î²-Blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nitrates&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aspirin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ranolazine: Ranolazine is a newer anti-anginal medication that works by reducing myocardial oxygen demand. While it is effective in relieving angina symptoms, it has not been shown to reduce mortality or MI risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ranolazine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Î²-Blockers: Beta-blockers are first-line therapy for chronic stable angina. They reduce myocardial oxygen demand by decreasing heart rate and contractility. While they are effective in controlling angina symptoms and improving exercise tolerance, their impact on mortality is less clear.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Î²-Blockers:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nitrates: Nitrates are potent vasodilators that improve myocardial blood flow and reduce angina symptoms. They are primarily used for symptom relief and do not have a significant impact on mortality or MI risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nitrates:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Aspirin reduces mortality and MI risk in patients with chronic stable angina.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old man with a history of hypertension and CAD presents with recurrent atrial flutter. He is on dabigatran, metoprolol, ramipril, aspirin, and atorvastatin. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardioversion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Catheter ablation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Catheter ablation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone : Antiarrhythmic drug with potential for toxicity, not the first-line treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac catheterization : Not needed for treating atrial flutter at this point.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac catheterization&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardioversion : May provide temporary relief but is not definitive treatment in this case where the patient is experiencing recurrence.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardioversion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Catheter ablation is the best treatment for recurrent typical atrial flutter.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old woman with ischemic cardiomyopathy presents with progressive dyspnea, edema and confusion. Her medications include low-dose aspirin, furosemide, carvedilol, ramipril, digoxin, and spironolactone. Her BP is 84/52 mm Hg, PR is 118/min, RR is 28/min and SpO2 is 95 in room air. Her reports are shown below. ALT - 172 U/L, AST - 163 U/L, S. Creatinine - 2.9 mg/dL , S. K - 4.7 mEq/L, S. Na - 132 mEq/L &amp;amp; S. Digoxin - 0.3 ng/mL. What is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start Noradrenaline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Start Noradrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase carvedilol : Beta-blockers are contraindicated in cardiogenic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase carvedilol&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase digoxin : Not effective in cardiogenic shock and potentially harmful with AKI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase digoxin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase lisinopril : Afterload reduction may be considered later, but inotropic support is the priority in this patient with cardiogenic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase lisinopril&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ In patients with cardiogenic shock, inotropes such as Noradrenaline, dobutamine or milrinone may be considered to improve cardiac function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old asymptomatic woman with CAD, diabetes and hypertension presents with palpitations. ECG shows AF. She is on metoprolol, telmisartan, aspirin, and atorvastatin. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add oral anticoagulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discontinue aspirin and begin oral anticoagulation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No change in therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Discontinue aspirin and begin oral anticoagulation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adding clopidogrel : Not indicated, as the patient has no recent ACS or stent.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adding clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adding oral anticoagulation without discontinuing aspirin : Increases bleeding risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adding oral anticoagulation without discontinuing aspirin&lt;/li&gt;&lt;li&gt;â€¢ Option D. No change in therapy : Inadequate as the patient needs anticoagulation for stroke prevention.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No change in therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ For most patients with high-risk atrial fibrillation and stable coronary artery disease, oral anticoagulation therapy without an antiplatelet agent is sufficient for prevention of both acute coronary syndromes and thromboembolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old man with a history of peripheral artery disease (PAD) presents with acute right leg pain. On examination, the right foot is cool and pedal pulses are absent. Sensation and muscle strength are normal. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arterial duplex ultrasonography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Emergent right leg amputation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate Heparin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Initiate Heparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arterial duplex ultrasonography: While useful for diagnosing PAD, it is not the immediate priority in acute limb ischemia. Revascularization should be initiated before obtaining imaging studies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arterial duplex ultrasonography:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CT angiography: This can provide a detailed view of the arterial anatomy and identify the location of the occlusion, but it should not delay revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CT angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Emergent right leg amputation: This is a last resort if revascularization fails or is not possible. Amputation should not be considered until all revascularization options have been exhausted.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Emergent right leg amputation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Prompt initiation of anticoagulation with heparin in ALI to prevent further thrombus formation and limb loss.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with diabetes and PAD has a right foot ulcer and feeble pulses. Ankle Brachial Index (ABI) on the right is 1.65. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exercise ankle-brachial index (ABI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lower extremity CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Toe-brachial index (TBI)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venous duplex ultrasonography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Toe-brachial index (TBI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ABI : Not useful when resting ABI is uninterpretable.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ABI&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower Extremity CT angiography : Helpful for planning revascularization, but TBI is the more appropriate initial test in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower Extremity CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option D. Venous duplex ultrasonography : Evaluates for venous disease, not arterial.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Venous duplex ultrasonography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Toe-brachial index (TBI) is useful in diagnosing PAD when ankle-brachial index (ABI) is uninterpretable due to non-compressible vessels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;52-year-old woman complains of chest tightness after walking for 2-3 km and relieved with rest. Her resting ECG is normal. She is known case of hypertension and dyslipidemia and currently taking ramipril and atorvastatin. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenosine single-photon emission CT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary artery calcium scoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exercise electrocardiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stress echocardiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Exercise electrocardiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine single-photon emission CT : Reserved for patients who cannot exercise or have uninterpretable ECGs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine single-photon emission CT&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary artery calcium scoring : Used for risk stratification in asymptomatic patients especially to know the need for a statin. The patient is already on atorvastatin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary artery calcium scoring&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stress echocardiography : Can be considered if exercise ECG is inconclusive.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stress echocardiography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Exercise ECG is the first-line test for evaluating suspected CAD in patients with typical angina and a normal resting ECG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with ischemic cardiomyopathy (EF 20%) and NYHA class III heart failure is on maximally tolerated doses of ACE inhibitor, furosemide, and empagliflozin. ECG shows LBBB with a QRS duration of 130 ms. What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add carvedilol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CRT-D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Add carvedilol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add Ivabradine : Indicated only after maximally tolerated beta-blocker dose.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add Ivabradine&lt;/li&gt;&lt;li&gt;â€¢ Option D. CRT-D : Considered if LVEF remains â‰¤35%, QRS duration â‰¥150 ms, and NYHA class II-IV symptoms despite optimal medical therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CRT-D&lt;/li&gt;&lt;li&gt;â€¢ Option C. Add digoxin : Considered for primary prevention of sudden cardiac death in patients with LVEF â‰¤35% despite optimal medical therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Add digoxin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Initiate beta-blocker therapy in patients with HFrEF who are not already on it, as part of guideline-directed medical therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old woman presents with acute type B aortic dissection involving the descending thoracic aorta with a maximal aortic diameter of 6.8 cm. Her BP is 173/99 mm Hg and PR is 90/min. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate endovascular stenting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immediate open surgical repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV labetalol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repeat CT angiography in 12 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV labetalol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate endovascular stenting: Endovascular stenting can be used to treat patients with descending aortic aneurysms; however, there is scant evidence to support this as an initial treatment option for aneurysm with dissection. After medical stabilization, thoracic endovascular aortic repair (TEVAR) with stent grafting can be used; typical indications include descending aortic aneurysm diameter greater than 6.0 cm, rapid growth (&amp;gt;0.5 cm/year), or end-organ damage. TEVAR has the advantage over surgical operation of lower morbidity and shorter hospital stay, although there may be complications, including stroke, spinal ischemia, and aortic graft endoleaks. This patient should be treated with stent implantation only after medical stabilization.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate endovascular stenting:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate open surgical repair: Open surgical repair of the descending aorta is not recommended in patients with uncomplicated type B aortic dissection because of high rates of morbidity (such as paraplegia) and mortality. This patient has no signs or symptoms of complications that would prompt immediate surgical repair.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate open surgical repair:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat CT angiography in 12 hours: Repeat CT angiography at 12 hours is not indicated unless the patient does not stabilize with medical therapy. Serial imaging (usually magnetic resonance angiography) is typically performed in asymptomatic patients at the time of discharge and then periodically in patients who do not have an indication for aneurysmal repair to screen for extension or recurrence of the dissection, aneurysm formation, and leakage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat CT angiography in 12 hours:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Patients with uncomplicated type B aortic dissection may be initially treated with medical therapy, including Î²-blockers, sodium nitroprusside, and opioids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 81-year-old woman had a drug-eluting stent (DES) for chronic stable angina 1 month ago. She is currently on aspirin and clopidogrel. She is a known case of hypertension, dyslipidaemia, CKD and peptic ulcer disease and was on medications for the same. She wants to minimize DAPT in view of her age and comorbidities. How long should she continue DAPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discontinue clopidogrel now&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Discontinue clopidogrel in 5 months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discontinue clopidogrel in 11 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Discontinue clopidogrel and aspirin in 11 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Discontinue clopidogrel in 5 months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinuing clopidogrel in 1 month can be done in case of bare metal stents (BMS) and not DES.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 12 months of DAPT is recommended in patient with ACS.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D . Aspirin should be continued indefinitely in patients with CAD.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Dual antiplatelet therapy is recommended for at least 6 months after drug-eluting stent placement for treatment of stable angina.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with recent post-CABG (coronary artery bypass graft) status presents with chest pain. On arrival, his blood pressure is 60/30 mmHg with a heart rate of 30/min. The ECG shows a narrow complex arrhythmia. The patient has already received three boluses of IV atropine. While awaiting transcutaneous pacing, which of the following is the next appropriate step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Another bolus of atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Norepinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dopamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV Dopamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Another bolus of atropine: As per ACLS guidelines, a maximum of three boluses of atropine are recommended for symptomatic bradycardia. Further doses are unlikely to be effective.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Another bolus of atropine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV Norepinephrine: While norepinephrine is a potent vasopressor, it can also worsen bradycardia due to its reflex bradycardia effect (baroreceptor response).&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV Norepinephrine:&lt;/li&gt;&lt;li&gt;â€¢ Opion D. IV Dobutamine: Dobutamine primarily acts on beta-1 receptors, increasing heart rate and contractility, but it can also cause vasodilation (beta-2 effects), potentially worsening hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Opion D. IV Dobutamine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Chronotropic drugs like dopamine can be tried while awaiting pacing in symptomatic bradycardia with hypotension, especially when atropine has been ineffective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following non-invasive tests has the best accuracy in detecting coronary stenosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac magnetic resonance perfusion scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary CT angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SPECT MPI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exercise echocardiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Coronary CT angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091702.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CMR perfusion have high sensitivity, but their specificity is not as high as Coronary CTA, meaning they might produce more false-positive results.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CMR perfusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise echocardiography and Option C. SPECT MPI have lower sensitivity and specificity than Coronary CTA, indicating a higher chance of both false negatives and false positives.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise echocardiography&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. SPECT MPI&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Coronary CTA is a highly accurate non-invasive test for detecting coronary stenosis due to its excellent sensitivity and specificity. It is a valuable tool for diagnosing and evaluating CAD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Xavier, a 72-year-old retired judge, experiences increased fatigue during walking. His physical exam, vitals, baseline ECG and 2D Echo are normal. Exercise ECG shows a peak heart rate of 96 beats/min with no ST changes. What is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronotropic incompetence&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HFpEF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal aging&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronotropic incompetence&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. HFpEF : Unlikely given the normal echocardiogram, especially the normal atrial size.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HFpEF&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lung disease : Unlikely given the normal chest X-ray and absence of respiratory symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal aging : While aging can cause some decline in exercise tolerance, this patient&#x27;s significant fatigue suggests a pathological cause.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal aging&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Predicted maximal HR âˆ¼ 220-Age&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Venkatesh, a 40-year-old man with hypertension treated with hydrochlorothiazide and metoprolol, presents with fatigue. His physical exam is normal except for a heart rate of 40 beats/min. ECG shows sinus bradycardia. Lab tests, including thyroid function and hemoglobin, are normal. What is the most reasonable next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dual-chamber pacemaker implantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exercise ECG test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start isoprenaline 10mg TID&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stop metoprolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Stop metoprolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dual chamber Pacemaker implantation : This may be indicated later if the bradycardia persists or is symptomatic after discontinuing the beta-blocker.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dual chamber Pacemaker implantation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG test : This may be helpful to assess the chronotropic response, but the priority is to address the potential medication-induced bradycardia first.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise ECG test&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start isoprenaline 10mg TID : This is a pure beta agonist with chronotropic effects and is not a first-line treatment for bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start isoprenaline 10mg TID&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers and calcium channel blockers increase sinus node recovery time and can cause severe sinus bradycardia in some individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old man with bacterial pneumonia experiences a sudden lightheadedness. His BP is stable, and the rhythm strip is shown. Which of the following is most likely to lead to sustained improvement in heart rate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenosine 6 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carotid body massage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol 5 mg IV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valsalva maneuver&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metoprolol 5 mg IV&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-182921.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine 6 mg IV : Primarily used for supraventricular tachycardia (SVT) and may not be effective in FAT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine 6 mg IV&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carotid body massage : A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carotid body massage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Valsalva maneuver : A vagal maneuver that may temporarily slow the heart rate but is not a definitive treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Valsalva maneuver&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Focal atrial tachycardia is not dependent on the AV node and beta-blockers or non-dihydropyridine CCBs are the preferred treatment options for rate control.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are called to the ER for a young patient in cardiac arrest during exercise. ECG showed bidirectional VT and it was cardioverted immediately. ECG post-cardioversion is normal. 2D Echo and cardiac MRI are also normal. Mutations in which protein are responsible for this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium ryanodine receptor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desmosomal proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Potassium channel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sarcomere proteins&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Calcium ryanodine receptor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Desmosomal proteins: Mutations in desmosomal proteins cause arrhythmogenic right ventricular cardiomyopathy (ARVC), which is a structural heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Desmosomal proteins:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Potassium channel: Mutations in potassium channels can cause long QT syndrome. In this case resting ECG would have showed long QTc.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Potassium channel:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sarcomere proteins: Mutations in sarcomere proteins cause hypertrophic cardiomyopathy (HCM), which would have resulted in structural heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sarcomere proteins:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize bidirectional VT as a hallmark of CPVT, an inherited arrhythmia syndrome caused by mutations in the cardiac ryanodine receptor (RyR2).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Vadivel, a 5-year post-heart transplant patient with no prior rejection episodes, presents with progressive exertional dyspnea and chest discomfort. He is on tacrolimus, mycophenolate mofetil, and low-dose prednisolone. 2D Echo shows normal LV function and no valvular abnormalities. What is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-mediated rejection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cellular rejection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary artery disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endocarditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Coronary artery disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibody-mediated rejection : Rare this far out from transplant, especially without prior rejection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibody-mediated rejection&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cellular rejection : Unlikely with normal LV function and no arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cellular rejection&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endocarditis : Less likely without fever or new murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endocarditis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize that coronary artery disease is a major cause of late mortality in heart transplant recipients, even in the absence of typical risk factors or angina.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cardiac allograft vasculopathy (CAV) is different from atherosclerotic CAD. Which of the following regarding CAV is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eccentric lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Minimal calcification&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Poor collaterals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Microvasculature affected&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Eccentric lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-183458.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Minimal calcification: CAV lesions often have minimal calcification, particularly in the early stages, which can make them difficult to detect on standard coronary angiography.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Minimal calcification:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Poor collaterals: The development of collateral vessels is often impaired in CAV, making the heart more vulnerable to ischemia and infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Poor collaterals:&lt;/li&gt;&lt;li&gt;â€¢ Option d. Microvasculature affected: CAV can affect both the epicardial coronary arteries and the microvasculature, leading to diffuse myocardial dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ d. Microvasculature affected:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ CAV is different from CAD and difficult to treat.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with a history of hypertension and hyperlipidemia presents with severe chest pain. His ECG shows ST-segment depression and his initial troponin level is elevated. He is currently taking aspirin, amlodipine, simvastatin, and tadalafil. Which of the following medications should NOT be administered?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nitroglycerin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nitroglycerin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Clopidogrel : P2Y12 inhibitor, indicated in NSTEMI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ Option B. Heparin IV : Anticoagulation, indicated in NSTEMI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Heparin IV&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol IV : Beta-blocker, indicated in NSTEMI unless contraindicated (e.g., heart failure).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol IV&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Be aware of the contraindication of nitroglycerin in patients taking phosphodiesterase-5 inhibitors due to the risk of severe hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 75-year-old man admitted for non-ST-elevation myocardial infarction. He has a history of CAD and takes daily aspirin. He&#x27;s had multiple angina episodes in the past few days, has ST-segment depression on ECG, and elevated troponin. Which of the following details does NOT confer increased risk of poor outcomes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Two anginal episode in 24 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Age.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Daily aspirin use.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above confer increased risk.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above confer increased risk.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Two anginal episode in 24 hours : High risk indicating loss of ischemic preconditioning and an active/ongoing ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Two anginal episode in 24 hours&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age : Advanced age is the SINGLE most important risk factor in ACS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age&lt;/li&gt;&lt;li&gt;â€¢ Option C. Daily aspirin use : While aspirin is cardioprotective, ACS despite use of aspirin indicates high thrombus burden and hence, high risk.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Daily aspirin use&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ TIMI score for NSTE-ACS is important!&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman experiences recurrent chest pain with transient ST elevations during episodes. Angiography shows normal coronary arteries, but pain is worse during hyperventilation. Which of the following is NOT a reasonable treatment for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Long-acting oral nitrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aspirin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amlodipine &amp;amp; Option D. Diltiazem (calcium channel blockers): These relax the smooth muscle in the coronary arteries, preventing or reversing vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amlodipine &amp;amp; Option D. Diltiazem&lt;/li&gt;&lt;li&gt;â€¢ Option C. Long-acting oral nitrates: These medications help to dilate the coronary arteries and reduce the frequency of vasospastic episodes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Long-acting oral nitrates:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Aspirin is C/I in Prinzmetal&#x27;s angina due to its potential to worsen vasospasm.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Sengutuvel, a 57-year-old man with risk factors for CAD, presents with crushing chest pain, diaphoresis, and shortness of breath. Which diagnostic test will most rapidly guide therapeutic management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ECG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary CT Angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum troponin I level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ECG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-184050.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary CT angiography : Coronary CT angiography is not warranted in a patient having active ischemic pain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option C. Echocardiogram : Can show wall motion abnormalities but cannot differentiate between STEMI and NSTEMI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Echocardiogram&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum troponin I level : A key biomarker for MI, but it takes time to elevate, and ECG is crucial for immediate decision-making.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum troponin I level&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected ACS, a 12-lead ECG is the most rapid and crucial test to guide immediate management decisions, especially regarding the need for urgent reperfusion therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of smoking presents with progressive bilateral calf pain that worsens with walking and improves with rest. He has normal resting ankle-brachial index (ABI) values. What is the most appropriate next test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exercise ankle-brachial index (ABI) testing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Invasive angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Magnetic resonance angiography (MRA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Segmental lower extremity blood pressure testing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Exercise ankle-brachial index (ABI) testing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Invasive angiography : Not the initial test, reserved for patients with severe PAD or when revascularization is planned.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Invasive angiography&lt;/li&gt;&lt;li&gt;â€¢ Option C. MRA : Another option for anatomic imaging, but exercise ABI is a less invasive first step.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MRA&lt;/li&gt;&lt;li&gt;â€¢ Option D. Segmental lower extremity blood pressure testing : Used to localize PAD, but not necessary as the initial test when the ABI is normal.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Segmental lower extremity blood pressure testing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 25% of patients with typical claudication symptoms have a normal or borderline ankle-brachial index.&lt;/li&gt;&lt;li&gt;âž¤ Exercise ABI testing is useful to evaluate for peripheral artery disease in patients with normal ABI values (&amp;gt;0.90 and â‰¤1.40) and high suspicion of PAD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man is evaluated one month after atherectomy and stenting of the right superficial femoral artery for severe claudication. He is now asymptomatic and on guideline-directed medical therapy (GDMT) for peripheral artery disease (PAD). Lab results show total cholesterol 120 mg/dL, LDL 50 mg/dL, and HDL 48 mg/dL. What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cilostazol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Evolocumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ticagrelor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional treatment&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No additional treatment&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cilostazol : Used to improve walking distance in patients with claudication, but not necessary for asymptomatic patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cilostazol&lt;/li&gt;&lt;li&gt;â€¢ Option B. Evolocumab : A PCSK9 inhibitor used to further lower LDL cholesterol in high-risk patients. Not indicated in this patient with well-controlled LDL.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Evolocumab&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ticagrelor : A more potent antiplatelet agent, not routinely recommended for PAD in addition to aspirin. May be added in high risk PAD (e.g., if associated CAD).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ticagrelor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Guideline-directed medical therapy for peripheral artery disease includes exercise; an antiplatelet agent; and aggressive management of atherosclerotic risk factors, including smoking, hypertension, diabetes mellitus, and dyslipidemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with hyperlipidemia, prediabetes, and a significant smoking history is seeking cardiovascular risk reduction. Which intervention is most likely to have the greatest impact on his risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Depression screening and treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low-dose aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Smoking cessation counseling and varenicline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Weight loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Smoking cessation counseling and varenicline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Depression screening and treatment : Important, but smoking cessation has a more immediate and significant impact on cardiovascular risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Depression screening and treatment&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low-dose aspirin : Controversial and not routinely recommended for primary prevention in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low-dose aspirin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Weight loss : Beneficial for cardiovascular health but less impactful than smoking cessation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Weight loss&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Smoking cessation substantially reduces cardiovascular risk within 2 years, with risk returning to the level of a nonsmoker after âˆ¼ 15 years.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with a history of atrial fibrillation, diabetes, and peripheral artery disease presents with acute left leg pain, absent pulses, and cold, mottled skin. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apixaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unfractionated heparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venous duplex ultrasonography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Unfractionated heparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Angiography: Essential for diagnosis and planning revascularization, but anticoagulation should be started first.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Apixaban : Oral anticoagulant, not appropriate in the acute setting of ALI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Apixaban&lt;/li&gt;&lt;li&gt;â€¢ Option D. Venous duplex ultrasonography : Not indicated for ALI, which is an arterial problem.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Venous duplex ultrasonography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Treat acute limb ischemia with anticoagulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with peripheral artery disease (PAD) was prescribed atorvastatin. He has read in a newspaper that statins can cause muscle aches and stopped taking atorvastatin after he developed worsening leg pain upon walking. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colestipol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Icosapent ethyl&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atorvastatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colestipol (bile acid resin): Not a first-line agent for PAD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colestipol&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ezetimibe (cholesterol absorption inhibitor): Monotherapy with ezetimibe is NOT a substitute for statin therapy. Can be used as an add on if LDL-C is not adequately reduced.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Option D. Icosapent ethyl (fish oil): Used for triglyceride lowering, which may be considered in addition to statins to lower CV risk (in patients with triglycerides of 135-499 mg/dL).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Icosapent ethyl&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Peripheral artery disease is considered a clinical atherosclerotic cardiovascular disease.&lt;/li&gt;&lt;li&gt;âž¤ Statin therapy is recommended for secondary prevention of atherosclerotic cardiovascular disease in patients with peripheral artery disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a recent non-ST-elevation myocardial infarction (NSTEMI) and peripheral artery disease (PAD) is on dual antiplatelet therapy (DAPT), an ACE inhibitor, a statin, and a beta-blocker. He is asymptomatic. His resting ankle-brachial index (ABI) is low bilaterally. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exercise ABI testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lower extremity CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Toe-brachial index testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional testing&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No additional testing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ABI testing : Indicated for symptomatic patients with normal or borderline resting ABI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ABI testing&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower extremity CT angiography : Considered if revascularization is planned.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower extremity CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option C. Toe-brachial index testing : Used when ABI is unreliable due to non-compressible arteries.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Toe-brachial index testing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The American College of Cardiology recommends resting ankle-brachial index testing in patients with history or physical examination findings suggestive of peripheral artery disease.&lt;/li&gt;&lt;li&gt;âž¤ Patients with both coronary artery disease and peripheral artery disease are at higher risk for major adverse cardiovascular events.&lt;/li&gt;&lt;li&gt;âž¤ Also, avoid unnecessary testing in a patient with asymptomatic peripheral artery disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with a history of hypertension, hyperlipidemia, and CAD presents with a 3-month history of progressive left calf discomfort exacerbated by walking stairs but absent at rest. He is a smoker and he is currently on aspirin, rosuvastatin, metoprolol, and amlodipine. His left ABI is 0.68. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pentoxifylline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Revascularization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Supervised exercise training&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Supervised exercise training&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT angiography : While CT angiography is used for diagnosis and pre-procedural planning in PAD, it is not the first-line treatment for claudication.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pentoxifylline : Not recommended for PAD treatment as it lacks evidence of benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pentoxifylline&lt;/li&gt;&lt;li&gt;â€¢ Option C. Revascularization : Revascularization (either surgical or endovascular) may be considered if symptoms are refractory to exercise and medical therapy. However, it&#x27;s not the initial step in management.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Revascularization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Supervised exercise training is the most effective initial treatment to increase walking distance for patients with intermittent claudication due to PAD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman with peripheral artery disease (PAD) has persistent claudication despite supervised exercise and optimal medical therapy. Her current medications are aspirin, metformin, canagliflozin, cilostazol, atorvastatin, and olmesartan. CT angiogram reveals an 80% stenosis in the left iliac artery. What is the best treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pentoxifylline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Revascularization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch olmesartan to ramipril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Revascularization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pentoxifylline : Not recommended for PAD treatment due to lack of efficacy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pentoxifylline&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stop canagliflozin : SGLT2 inhibitors should be used with caution in PAD but not discontinued unless there are specific complications.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stop canagliflozin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Switching to a different antihypertensive : ACEi or ARBs can provide survival benefit in ASCVD but unlikely to significantly improve symptoms which is the priority in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Switching to a different antihypertensive&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man is evaluated for right leg tiredness and cramping when walking 25 yards. His feet are shown following elevation (left) and during dependent positioning (right). Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inferior vena cava thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Livedo reticularis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peripheral artery disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venous insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Peripheral artery disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-094723.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Diagnose peripheral artery disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with recurrent fevers, night sweats, weight loss, and a transient ischemic attack (TIA). ECG is normal and echo is shown in the video. CT head is normal as well. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer a direct oral anticoagulant (DOAC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer intravenous thrombolytic therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obtain blood cultures and begin empiric antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urgent surgical excision&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Urgent surgical excision&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. DOAC : Anticoagulation may be considered temporarily before surgery (or if the patient has atrial fibrillation) but is not definitive treatment in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. DOAC&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombolytic therapy : Not indicated for TIA caused by a cardiac tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombolytic therapy&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blood cultures and antibiotics : Not appropriate for a cardiac myxoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Blood cultures and antibiotics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Patients with a myxoma may present with valvular occlusive symptoms, such as dyspnea and syncope; embolic phenomena, including stroke or transient ischemic events; and/or constitutional symptoms, such as fever, anorexia, and weight loss.&lt;/li&gt;&lt;li&gt;âž¤ In patients with atrial myxoma and a central nervous system embolic event, urgent cardiac surgical evaluation and excision are indicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with normal blood pressure and no significant medical history has a lipid profile showing total cholesterol of 241 mg/dL, HDL of 49 mg/dL, LDL of 116 mg/dL, and triglycerides of 128 mg/dL. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Begin high-intensity statin therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Begin high-intensity statin therapy and ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calculate 10-year risk for ASCVD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repeat lipid profile while fasting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Calculate 10-year risk for ASCVD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Begin high-intensity statin therapy and Option B. Begin high-intensity statin therapy and ezetimibe : Starting statin therapy (with or without ezetimibe) is premature without assessing risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Begin high-intensity statin therapy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Begin high-intensity statin therapy and ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat lipid profile while fasting : While fasting lipid profile is preferred, the non-fasting results do not warrant immediate repeat testing before risk assessment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat lipid profile while fasting&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Cardiovascular risk scores can be used to assess a patient&#x27;s future risk for major cardiovascular events and to identify preventive interventions.&lt;/li&gt;&lt;li&gt;âž¤ The American College of Cardiology/American Heart Association Pooled Cohort Equations are commonly used to calculate the 10-year risk for atherosclerotic cardiovascular disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old woman undergoes successful primary percutaneous coronary intervention (PCI) for an acute anterior STEMI and cardiogenic shock. Angiography reveals a 100% occlusion of mid LAD and a 70% stenosis of mid-right coronary artery (RCA). What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PCI to LAD and RCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PCI to LAD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PCI to RCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urgent CABG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PCI to LAD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. PCI to LAD and RCA : While both lesions need to be addressed, the priority is to revascularize the culprit lesion (LAD) first to stabilize the patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. PCI to LAD and RCA&lt;/li&gt;&lt;li&gt;â€¢ Option C. PCI to RCA : The RCA is not the infarct-related artery and should not be prioritized over the LAD in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C. PCI to RCA&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urgent CABG : CABG is an option for multivessel disease, but PCI of the culprit lesion is the immediate priority in a patient with cardiogenic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urgent CABG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In STEMI with cardiogenic shock, the immediate priority is to restore blood flow to the infarct-related artery with primary PCI. Non-culprit lesions can be addressed later in a staged procedure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman 2 weeks postpartum presents with chest pain, ST-segment elevation in anterior leads, and elevated troponin. She has no risk factors for atherosclerosis. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atherosclerotic plaque rupture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peripartum cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spontaneous coronary artery dissection (SCAD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stress-induced (takotsubo) cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spontaneous coronary artery dissection (SCAD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atherosclerotic plaque rupture : Unlikely in a young woman with no risk factors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atherosclerotic plaque rupture&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peripartum cardiomyopathy : Presents with heart failure symptoms and global LV dysfunction, not ST-elevation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peripartum cardiomyopathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Takotsubo cardiomyopathy : Typically triggered by stress, often presents with apical ballooning on echo. Common in post-menopausal women (not young women).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Takotsubo cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous coronary artery dissection is the most common cause of pregnancy-associated myocardial infarction and occurs most commonly in the first month postpartum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old man presents with a 3-hour history of chest pain. His BP is 80/50 mmHg, HR is 120/min and has elevated JVP and clear lungs. ECG is shown. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intra-aortic balloon pump placement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous 0.9% saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous 0.9% saline&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-101859.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intra-aortic balloon pump : Indicated in cardiogenic shock with LV dysfunction, but not the first-line treatment for RV infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intra-aortic balloon pump&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous dobutamine: Inotrope may be considered if fluids are ineffective, but not the initial management.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous dobutamine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral metoprolol : Beta-blockers can worsen hypotension and should be avoided in RV infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral metoprolol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ A patient with an inferior myocardial infarction with right ventricular involvement and hypotension should receive intravenous fluids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman 2 weeks postpartum presents with chest pain, ST-segment elevation in anterior leads, and elevated troponin. She has no risk factors for atherosclerosis. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atherosclerotic plaque rupture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peripartum cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spontaneous coronary artery dissection (SCAD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stress-induced (takotsubo) cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spontaneous coronary artery dissection (SCAD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atherosclerotic plaque rupture : Unlikely in a young woman with no risk factors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atherosclerotic plaque rupture&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peripartum cardiomyopathy : Presents with heart failure symptoms and global LV dysfunction, not ST-elevation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peripartum cardiomyopathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Takotsubo cardiomyopathy : Typically triggered by stress, often presents with apical ballooning on echo. Common in post menopausal women (not young women).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Takotsubo cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous coronary artery dissection is the most common cause of pregnancy-associated myocardial infarction and occurs most commonly in the first month postpartum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of CABG presents with progressive fatigue, dyspnea, elevated jugular venous pressure with Kussmaul&#x27;s sign, and a pericardial knock. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic liver disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Constrictive pericarditis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac tamponade : Would not present with Kussmaul&#x27;s sign or pericardial knock.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac tamponade&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic liver disease : Can cause ascites and edema but not the other findings.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic liver disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Restrictive cardiomyopathy : Can mimic constrictive pericarditis, but the history of CABG makes the latter more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Restrictive cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Kussmaul sign and pericardial knock, if present, are helpful clues to the presence of constrictive pericarditis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man presents with an chest pain, nausea and diaphoresis. ECG is shown. The nearest tertiary care center is 140 minutes away. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thrombolysis and admission to a telemetry bed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombolysis and transfer to a PCI center&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transfer to a tertiary care center&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thrombolysis and transfer to a PCI center&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102708.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT angiography : Delays reperfusion therapy, which is crucial in STEMI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT angiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombolyse and admit : Does not allow for timely angiography and potential rescue PCI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombolyse and admit&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transfer to tertiary care center : Delays reperfusion and worsens outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transfer to tertiary care center&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ For patients with STEMI, thrombolytic therapy is recommended if symptom onset is within 12 hours and PPCI is not available within 120 minutes of FMC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old woman presents with severe chest pain for the last 3 hours. She is diaphoretic and appears drowsy. Her BP is 80/60 mm Hg and PR is 60/min. ECG is shown below. She was started on aspirin, clopidogrel and heparin. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tenecteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary Angioplasty&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Temporary pacing&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Temporary pacing&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-102907.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atropine: Atropine may be useful for bradycardia but is unlikely to be effective in the setting of high-grade AV block. Additionally, it does not address the underlying myocardial ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atropine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tenecteplase: While fibrinolysis with tenecteplase may be considered in some STEMI cases, it is not the first-line therapy in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tenecteplase:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary Angioplasty: Primary PCI is the preferred reperfusion strategy for STEMI, but it should be performed after stabilizing the patient&#x27;s hemodynamics with temporary pacing.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary Angioplasty:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Anterior MI related bradyarrhythmias are inherently unstable and need temporary pacing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with subacute pericarditis, fever, pulsus paradoxus, and pericardial friction rub. ECG shows diffuse ST-segment elevation. Echocardiogram shows a small pericardial effusion. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discharge on ibuprofen and colchicine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Discharge on prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hospitalize and begin ibuprofen and colchicine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hospitalize and begin methylprednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hospitalize and begin ibuprofen and colchicine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Outpatient treatment : Not appropriate for high-risk pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Outpatient treatment&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisone : Reserved for recurrent or refractory pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisone&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methylprednisolone : High-dose steroids are not first-line for initial treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methylprednisolone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Hospitalize patients with acute pericarditis and high-risk features for initial treatment and monitoring.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 71-year-old woman presents with cardiogenic shock. ECG showed ST depressions in multiple leads and her Troponins were elevated. PCI was performed successfully but she continues to be in cardiogenic shock and she is on aspirin, prasugrel and norepinephrine. Which of the following is the most appropriate additional management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intra-aortic balloon pump (IABP) placement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urgent cardiac transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intra-aortic balloon pump (IABP) placement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin : Weak inotrope, unlikely to be effective in cardiogenic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol : Beta-blocker, contraindicated in cardiogenic shock due to negative inotropic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urgent cardiac transplantation : Not feasible in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urgent cardiac transplantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ IABP is a mechanical circulatory support device that can temporarily improve hemodynamics in patients with cardiogenic shock after MI by reducing afterload and improving coronary perfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 77-year-old woman with COPD and prior stroke presents with intermittent chest pain. She is on aspirin, atorvastatin, MDI salbutamol and MDI tiotropium. ECG is taken and shown. Initial troponin is elevated and she was started on enoxaparin. What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tirofiban&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clopidogrel&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-105337.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prasugrel : Absolutely C/I in patients with prior stroke and have to be carefully used in elderly patients who are aged &amp;gt; 75.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prasugrel&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reteplase : Thrombolytic therapy, not indicated for NSTE-ACS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reteplase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tirofiban : Gp IIb/IIIa inhibitor, typically used during PCI under special circumstances.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tirofiban&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ All patients with nonâ€“ST-elevation acute coronary syndrome should be treated with aspirin and a P2Y12 inhibitor regardless of reperfusion strategy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old woman with a history of NSTEMI and AF underwent a successful PCI with a drug eluting stent. What is the most appropriate management of her antithrombotic therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin plus clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspirin plus ticagrelor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aspirin plus rivaroxaban plus ticagrelor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rivaroxaban plus ticagrelor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rivaroxaban plus ticagrelor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin plus clopidogrel: This is traditional dual antiplatelet therapy (DAPT) and does not address the need for anticoagulation in AF.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin plus clopidogrel:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aspirin plus ticagrelor: Similar to option a, it lacks anticoagulation for AF.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aspirin plus ticagrelor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aspirin plus rivaroxaban plus ticagrelor: Triple therapy is no longer recommended as it increases bleeding risk without significant additional benefit compared to dual therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aspirin plus rivaroxaban plus ticagrelor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Among patients with atrial fibrillation who have undergone percutaneous coronary intervention for acute coronary syndrome, double therapy with clopidogrel or ticagrelor plus a direct oral anticoagulant is recommended over triple therapy with an oral anticoagulant, aspirin, and P2Y12 inhibitor to reduce the risk for bleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman is evaluated for a 6-week history of persistent fatigue and occasional exertional dyspnea. ECG is shown. Which of the following abnormalities best describes the findings on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Completed anterior myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Completed inferior myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Completed lateral myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Completed posterior myocardial infarction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Completed lateral myocardial infarction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-110228.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ This ECG shows a completed lateral myocardial infarction, with initial deep Q waves in leads I, aVL, and V6. There is also an inverted T wave in these leads.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true when comparing ST-segment elevation myocardial infarctions (STEMI) versus nonâ€“ST-segment elevation myocardial infarctions (NSTEMI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;There is a greater chance of finding an occlusive thrombus in a NSTEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients with STEMI have more developed coronary collateral networks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A person with a STEMI is more likely to have single-vessel disease than a person with a NSTEMI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The thrombus in STEMI is more platelet-rich compared to that of NSTEMI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A person with a STEMI is more likely to have single-vessel disease than a person with a NSTEMI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. There is a greater chance of finding an occlusive thrombus in a NSTEMI: This is incorrect. STEMI is caused by a complete occlusive thrombus, while NSTEMI may have partial or intermittent occlusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. There is a greater chance of finding an occlusive thrombus in a NSTEMI:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Patients with STEMI have more developed coronary collateral networks: This is incorrect. Collateral circulation is more likely to develop in patients with chronic ischemia, such as those with chronic stable angina or NSTEMI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Patients with STEMI have more developed coronary collateral networks:&lt;/li&gt;&lt;li&gt;â€¢ Option D. The thrombus in STEMI is more platelet-rich compared to that of NSTEMI: Thrombus in STEMI is more fibrin rich and the thrombus in NSTEMI is more platelet rich.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The thrombus in STEMI is more platelet-rich compared to that of NSTEMI:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand that while both STEMI and NSTEMI involve myocardial infarction, STEMI is more often associated with single-vessel disease and complete coronary artery occlusion, while NSTEMI is often associated with multi-vessel disease or less severe occlusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 51-year-old male presents with chest pain, 4 days after he was diagnosed with an ST elevation myocardial infarction (STEMI). It is severe, central chest pain with radiation to the trapezius and worse with deep inspiration. The pain woke him from sleep and has improved slightly after getting up out of bed. His Troponin levels were unchanged and ECG showed new saddle-shaped ST elevations in inferior and lateral leads. What is the likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Recurrent MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early Pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dressler&#x27;s Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe GERD due to aspirin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Early Pericarditis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Recurrent MI: While possible, the unchanged troponin and the specific characteristics of the chest pain make it less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Recurrent MI:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dressler&#x27;s Syndrome: This is a post-MI syndrome occurring weeks to months after the infarction, characterized by fever, pericarditis, pleuritis, and leukocytosis. It is too early for this diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dressler&#x27;s Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Severe GERD due to aspirin: GERD can cause chest pain, but the pain is typically burning and not pleuritic. Additionally, the ECG changes are not consistent with GERD.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Severe GERD due to aspirin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Early pericarditis is a common complication of STEMI that typically occurs in the first week after MI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman experiences shortness of breath after a recent MI that was treated with a drug-eluting stent. Her current medications are aspirin, ticagrelor, enalapril, metoprolol, and atorvastatin. Her physical examination, chest X-ray, and ECG are normal. Which of the following is the most likely cause of her dyspnea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stent thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ticagrelor side effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal rupture&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ticagrelor side effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart failure : Unlikely given the normal physical exam and imaging findings.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart failure&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stent thrombosis : Usually presents with acute coronary syndrome symptoms and ECG changes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stent thrombosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal rupture : Rare complication of MI, usually presents with shock and a new murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal rupture&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Dyspnea is a well-recognized and often self-limited side effect of ticagrelor therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with hypertension and type 2 diabetes mellitus presents to the ER with acute chest pain and diaphoresis. Her BP is 100/60 mm Hg and PR is. ECG is shown. Troponins are elevated. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Permanent pacemaker implantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Temporary pacing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac catheterization&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111130.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Echocardiography : While useful for assessing LV function and complications of MI, it does not address the underlying cause of the arrhythmia (ischemia).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Echocardiography&lt;/li&gt;&lt;li&gt;â€¢ Option C. Permanent pacemaker implantation : May be required if the conduction disturbance is persistent after revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Permanent pacemaker implantation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Temporary pacing : This could be considered if the patient becomes hemodynamically unstable or of there is a high grade AV block.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Temporary pacing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with acute inferior MI, Mobitz type I block and sinus bradycardia can be managed without pacing and the immediate treatment of choice would be reperfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Thiru is admitted after an anterior MI. In the ICU, he has frequent premature ventricular contractions (PVCs) and lab results show S. K of 2.9 mEq/L and S. Mg of 1 mg/dL. Which of the following is NOT indicated in this setting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV lidocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Magnesium repletion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potassium repletion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV lidocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Magnesium repletion : Indicated to correct hypomagnesemia, which can trigger arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Magnesium repletion&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol : Beta-blocker, reduces myocardial oxygen demand and helps prevent arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol&lt;/li&gt;&lt;li&gt;â€¢ Option D. Potassium repletion : Indicated to correct hypokalemia, which can also trigger arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Potassium repletion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Beta-blockers and correction of electrolyte imbalances re essential in preventing arrhythmias and reducing mortality in acute MI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications should be avoided in patients with an acute ST-elevation myocardial infarction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucocorticoids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucocorticoids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin: Aspirin is an antiplatelet medication that is beneficial in STEMI. It helps prevent further clot formation and reduces the risk of complications.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colchicine: Colchicine is an anti-inflammatory medication that can be used in certain cases of pericarditis, but it is not contraindicated in STEMI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colchicine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol: Metoprolol is a beta-blocker that reduces heart rate and blood pressure, decreasing the workload on the heart. It is beneficial in STEMI unless there are specific contraindications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ NSAIDs (except aspirin) and glucocorticoids are absolutely C/I in STEMI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Approximately how long should patients with STEMI be advised to maintain bed rest after revascularization?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;6-12 hours&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;24 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;48 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;72 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 6-12 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. 24 hours, Option C. 48 hours and Option D. 72 hours: These durations are too long for bed rest after revascularization. Prolonged bed rest can lead to complications like deconditioning, deep vein thrombosis, and pneumonia. Early mobilization is encouraged to promote recovery and prevent these complications.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 24 hours, Option C. 48 hours&lt;/li&gt;&lt;li&gt;â€¢ Option D. 72 hours:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with STEMI should be advised to maintain bed rest for 6-12h after revascularization, followed by early mobilization to promote recovery and prevent complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mrs. Hinduja, a 64-year-old woman, had a drug-eluting (everolimus) stent placed one month ago for a recent MI. She is on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel. Her ophthalmologist wants to know if these can be stopped for a cataract surgery next week. What is the most appropriate advice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discontinue both aspirin and clopidogrel and proceed with cataract surgery.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postpone the surgery for 6 months.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Postpone the surgery for 6 months.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery, Option B. Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery and Option C. Discontinue both aspirin and clopidogrel and proceed with cataract surgery : Stopping either or both antiplatelet medications prematurely increases the risk of stent thrombosis and is not recommended.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinue aspirin, continue clopidogrel, and proceed with cataract surgery, Option B. Discontinue clopidogrel, continue aspirin, and proceed with cataract surgery&lt;/li&gt;&lt;li&gt;â€¢ Option C. Discontinue both aspirin and clopidogrel and proceed with cataract surgery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Stopping DES in the first 6 months is associated with increased risk of in-stent thrombosis and hence, elective surgeries must be postponed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman with stable heart failure with reduced ejection fraction (HFrEF) is on maximum doses of lisinopril, among other medications. Which treatment is most appropriate to further reduce HF hospitalizations and mortality?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase carvedilol dosage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch lisinopril to valsartan-sacubitril&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Switch lisinopril to valsartan-sacubitril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: While it can reduce HF hospitalizations, it does not improve mortality.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ivabradine: Used for patients with HFrEF in sinus rhythm and a high heart rate despite beta-blocker therapy. Not applicable here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ivabradine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increasing carvedilol: Might not be tolerated well and has not shown the same mortality benefit as valsartan-sacubitril.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increasing carvedilol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Valsartan-sacubitril significantly reduces heart failure hospitalizations and mortality in patients with symptomatic heart failure with reduced ejection fraction and is recommended in preference to an ACE inhibitor or angiotensin receptor blocker.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old athlete experiences cardiac arrest during a race and is successfully resuscitated. Resting ECG is shown. Echocardiogram shows normal LV function but RV dilation and dysfunction. What is the most appropriate management before discharge?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Genetic testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Implantable cardioverter-defibrillator (ICD)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115610.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone: Antiarrhythmic medication, but not as effective as ICD for preventing sudden death.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Genetic testing: Important for diagnosis and family screening, but not the immediate priority before discharge.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Genetic testing:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lisinopril: ACE inhibitor for LV dysfunction, not indicated in this case with normal LV function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lisinopril:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with sustained ventricular arrhythmias (&amp;gt;30 seconds) or cardiac arrest without a reversible cause have a class 1 recommendation for secondary prevention with implantable cardioverter-defibrillator placement.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presents with ascites, pedal edema and elevated JVP. ECG showed low voltage complexes and echo showed increased LV wall thickness. He also has a history of carpal tunnel syndrome. What is the most appropriate test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exercise echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right and left heart catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum Î±-galactosidase level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac MRI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise echocardiography: Primarily used to diagnose coronary artery disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exercise echocardiography:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right and left heart catheterization: Invasive and not the first-line test for infiltrative cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right and left heart catheterization:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum Î±-galactosidase level: Used to diagnose Fabry disease, which usually causes Hypertrophic Cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum Î±-galactosidase level:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac magnetic resonance imaging with gadolinium is highly sensitive and specific for cardiac amyloidosis, but it does not distinguish between AL (immunoglobulin light-chain) amyloidosis and transthyretin amyloidosis.&lt;/li&gt;&lt;li&gt;âž¤ In patients with cardiac magnetic resonance imaging findings consistent with cardiac amyloidosis, an abnormal 99m-technetium pyrophosphate scan would confirm transthyretin amyloidosis without the need for a biopsy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old man with heart failure with mildly reduced ejection fraction (HFmrEF) and type 2 diabetes mellitus is asymptomatic and on appropriate medications. Which additional treatment is most appropriate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Empagliflozin (SGLT2 inhibitor)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Empagliflozin (SGLT2 inhibitor)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: Reduces HF hospitalizations but not mortality, and this patient is asymptomatic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Furosemide: Loop diuretic, indicated for volume overload which is not present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Furosemide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ivabradine: Used for HF with reduced ejection fraction (HFrEF) with high heart rates despite beta-blockers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ivabradine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A sodium-glucose cotransporter 2 inhibitor is recommended to reduce risk for worsening heart failure and cardiovascular death in patients with type 2 diabetes mellitus and established heart failure with reduced ejection fraction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-day postpartum woman presents with acute heart failure symptoms. Echocardiogram shows LV dilation and hypokinesis with an ejection fraction of 38%.RV is normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ascending aortic dissection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peripartum cardiomyopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spontaneous coronary artery dissection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Peripartum cardiomyopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute pulmonary embolism : Less likely given normal right heart function on echocardiogram.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ascending aortic dissection: Usually presents with acute chest pain, and echo would show aortic abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Ascending aortic dissection:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spontaneous coronary artery dissection: Typically presents with chest pain and ECG changes indicative of ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Spontaneous coronary artery dissection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Peripartum cardiomyopathy is left ventricular systolic dysfunction with onset toward the end of pregnancy or in the months after delivery in the absence of another identifiable cause; patients often present with features of heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with decompensated heart failure is hospitalized and treated with a maximal dose of IV furosemide. He has minimal urine output and persistent signs of volume overload. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add intravenous milrinone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add intravenous nitroglycerin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start CVVH (Continuous venovenous hemofiltration)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Start CVVH (Continuous venovenous hemofiltration)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Add intravenous milrinone: Milrinone is an inotrope used to improve cardiac contractility. While it may help with cardiac output, it doesn&#x27;t directly address the volume overload and can worsen renal function.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Add intravenous milrinone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add intravenous nitroglycerin: Nitroglycerin is a vasodilator that can reduce preload and afterload, but it&#x27;s not the primary treatment for volume overload when diuretics fail.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add intravenous nitroglycerin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase furosemide: The patient is already on the maximal dose of furosemide, so further increases would not be effective and could lead to adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase furosemide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with ADHF who are unresponsive to maximal diuretic therapy, CVVH is a crucial intervention to manage volume overload and prevent further complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with ischemic cardiomyopathy (EF 20%) is on maximally tolerated heart failure medications and experiencing significant functional decline. He wishes to pursue care that will restore functionality. What is the most appropriate long-term treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heart transplantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left ventricular assist device (LVAD) placement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tolvaptan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Heart transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: Although it can reduce hospitalizations, it does not improve survival or functional capacity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. LVAD placement: LVADs are a bridge to transplantation or destination therapy for those who are not transplant candidates. This patient may be eligible for transplant.&lt;/li&gt;&lt;li&gt;â€¢ Option C. LVAD placement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tolvaptan: Used for hyponatremia, but not a primary treatment for advanced heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tolvaptan:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with persistent severe heart failure symptoms despite maximal medical therapy are candidates for advanced treatment; acceptable candidates for cardiac transplantation are generally younger than 65 to 70 years with no medical contraindications and have good social support and adherence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man with a history of HFrEF and AF, presents for follow-up with stable NYHA class III symptoms. He is currently on losartan, carvedilol, empagliflozin, furosemide, and apixaban. He has a history of ACE inhibitor-induced angioedema and spironolactone-induced gynecomastia. Which medication is the most appropriate addition to his current regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add eplerenone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Switch carvedilol to metoprolol succinate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch losartan to valsartan-sacubitril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Add eplerenone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ivabradine: Not indicated in patients with atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Ivabradine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switch carvedilol to metoprolol succinate: Not necessary, as there is no evidence of benefit in switching between beta-blockers in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Switch carvedilol to metoprolol succinate:&lt;/li&gt;&lt;li&gt;â€¢ benefit in switching between beta-blockers in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Switch losartan to valsartan-sacubitril: Contraindicated due to the history of ACE inhibitor-induced angioedema.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Switch losartan to valsartan-sacubitril:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aldosterone antagonist therapy (spironolactone, eplerenone) is indicated in all patients with symptomatic heart failure with reduced ejection fraction and normal kidney function to improve survival.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man with hypertrophic cardiomyopathy (HCM) diagnosed at age 38 presents with exertional dyspnea. He is on metoprolol and disopyramide. Echocardiogram shows asymmetric septal hypertrophy, systolic anterior motion of the mitral valve (SAM), and a resting LVOT gradient of 64 mmHg. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addition of valsartan-sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD) therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Replacement of metoprolol with carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Septal reduction therapy (SRT)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Septal reduction therapy (SRT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Valsartan-sacubitril: This medication is contraindicated in HCM due to the risk of worsening LVOT obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Valsartan-sacubitril:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ICD therapy: Indicated for primary prevention of sudden cardiac death in high-risk HCM patients but not the primary treatment for symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. ICD therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Replacement of metoprolol with carvedilol: Unlikely to be beneficial as both are beta-blockers.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Replacement of metoprolol with carvedilol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Septal reduction therapy is indicated for symptomatic HCM patients with a significant LVOT gradient despite optimal medical therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman presents with acute substernal chest discomfort and dyspnea after seeing her dog being attacked and killed by another dog. Her echocardiogram shows apical and mid-ventricular hypokinesis with preserved basal function, and coronary angiography is normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ascending aortic dissection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary artery dissection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary artery embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Takotsubo cardiomyopathy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Takotsubo cardiomyopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Ascending aortic dissection: This would typically present with severe tearing chest pain radiating to the back.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.  Ascending aortic dissection:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary artery dissection: This would show abnormalities on angiography.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Coronary artery dissection:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary artery embolism: This would also cause regional wall motion abnormalities on echocardiogram.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Coronary artery embolism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Takotsubo cardiomyopathy is a syndrome characterized by transient regional systolic ventricular dysfunction mimicking myocardial infarction in the absence of angiographic evidence of obstructive coronary artery disease.&lt;/li&gt;&lt;li&gt;âž¤ Treatment of takotsubo cardiomyopathy is similar to that for heart failure of other causes; most patients recover cardiac function over several months.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with restrictive cardiomyopathy and atrial fibrillation presents with refractory heart failure symptoms despite optimal medical therapy. Echo shows an EF of 50%, severe biatrial enlargement and pulmonary hypertension. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac resynchronization therapy (CRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac transplantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary vein isolation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cardiac transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CRT: Not indicated in patients with preserved EF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. CRT:&lt;/li&gt;&lt;li&gt;â€¢ Option C. ICD: Not indicated for primary prevention in a patient with preserved EF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. ICD:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary vein isolation: May not be effective in patients with severe atrial enlargement and underlying restrictive cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Pulmonary vein isolation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Heart transplantation is an effective therapy for select patients with end-stage restrictive cardiomyopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old woman, 6 days postpartum, presents with acute heart failure symptoms (orthopnea, paroxysmal nocturnal dyspnea, elevated JVP, S3, crackles, edema). Echocardiogram shows an ejection fraction (EF) of 20% and diffuse hypokinesis. She is currently on furosemide and bilevel positive airway pressure (BiPAP). What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bisoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enalapril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bisoprolol (beta-blocker): While beneficial in HFrEF, it should be initiated cautiously after volume status is optimized in acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Bisoprolol (beta-blocker):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diltiazem (non-dihydropyridine calcium channel blocker): Contraindicated in HFrEF due to negative inotropic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Diltiazem (non-dihydropyridine calcium channel blocker):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ivabradine: Used in HFrEF patients with sinus rhythm and elevated heart rate despite optimal beta-blocker therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Ivabradine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors reduce morbidity and mortality in patients with heart failure with reduced ejection fraction and should be used in both symptomatic and asymptomatic patients.&lt;/li&gt;&lt;li&gt;âž¤ Metoprolol, carvedilol, and bisoprolol reduce mortality in patients with heart failure with reduced ejection fraction, but treatment should be delayed in patients with volume overload until the patient is closer to being euvolemic.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old man with no prior medical history undergoes a pre-participation sports examination. ECG shows sinus bradycardia and voltage criteria for left ventricular (LV) hypertrophy. Echocardiogram shows mild LV dilation and symmetric LV hypertrophy with a normal LV ejection fraction and diastolic function. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Athlete&#x27;s heart&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fabry disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertensive heart disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonobstructive hypertrophic cardiomyopathy (HCM)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Athlete&#x27;s heart&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fabry disease: A lysosomal storage disorder that can cause LV hypertrophy but is also associated with other systemic manifestations like angiokeratomas and renal dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fabry disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertensive heart disease: Usually occurs in older individuals with a history of hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Hypertensive heart disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonobstructive HCM: A genetic disorder that causes asymmetric LV hypertrophy and often has impaired diastolic function.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Nonobstructive HCM:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increased left ventricular (LV) wall thickness and LV cavity dilatation may be normal findings in highly trained athletes; symmetric wall thickness of 13 mm or less and normal diastolic filling favor the diagnosis of athlete heart over the diagnosis of HCM.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man who is a known case of HFrEF presents with persistent NYHA III symptoms despite optimal medical therapy. ECG shows LBBB and echo shows an EF of 25%. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac resynchronization therapy-defibrillator (CRT-D)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Implantable pulmonary artery pressure sensor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wearable cardioverter-defibrillator&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac resynchronization therapy-defibrillator (CRT-D)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ICD: May be indicated for primary prevention of sudden cardiac death but doesn&#x27;t address the LBBB and dyssynchrony.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. ICD:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Implantable pulmonary artery pressure sensor: Used for monitoring, not for treating heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Implantable pulmonary artery pressure sensor:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Wearable cardioverter-defibrillator: Temporary measure, not appropriate for long-term management of heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Wearable cardioverter-defibrillator:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac resynchronization therapy is indicated in patients with New York Heart Association functional class II to IV symptoms despite guideline-directed medical therapy who have an ejection fraction of 35% or less, sinus rhythm, and left bundle branch block with a QRS duration of 150 ms or longer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman with hypertension and paroxysmal AF presents with a 6-month history of exertional dyspnea. She has normal vital signs, clear lungs, and a normal JVP. Echocardiography shows an ejection fraction of 55%, increased left ventricular wall thickness, and an enlarged left atrium. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heart failure with preserved ejection fraction (HFpEF)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-output heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HOCM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HFrEF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Heart failure with preserved ejection fraction (HFpEF)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. High-output heart failure: This is associated with an elevated cardiac index, which is not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. High-output heart failure:&lt;/li&gt;&lt;li&gt;â€¢ Option C. HOCM: This would show LV outflow tract obstruction, which is absent in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. HOCM:&lt;/li&gt;&lt;li&gt;â€¢ Option D. HFrEF: Unlikley given the normal EF in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. HFrEF:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HFpEF should be suspected in patients who meet the following three criteria: symptoms of heart failure, left ventricular ejection fraction of 50% or greater, and no other apparent cause of HF symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with hypertrophic cardiomyopathy (HCM) experiences an episode of syncope and was admitted. 2D Echo revealed a maximum LV wall thickness of 30 mm and a dynamic LVOT obstruction. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disopyramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Septal reduction therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Implantable cardioverter-defibrillator (ICD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Disopyramide: Primarily used for treating HF symptoms in HCM (in case if Î²B or CCB therapy is ineffective)&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Disopyramide:&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Septal reduction therapy: Indicated for symptomatic patients with significant LVOT obstruction, but not for primary prevention of SCD.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.  Septal reduction therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Verapamil: Used for symptom relief in HCM, but not for SCD prevention.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Verapamil:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Consider ICD therapy for primary prevention of SCD in patients with HCM and high-risk features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man presents with progressive fatigue, dyspnea and edema. He has a history of ischemic cardiomyopathy with an EF of 10% and had 4 hospitalizations in the last 6 months. He is currently on sacubitril-valsartan, carvedilol, eplerenone, furosemide and empagliflozin. Labs reveal a S. creatinine of 1.7 mg/dL and S. Na of 128 mEq/L. What is the most reasonable next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heart transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ECMO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left ventricular assist device (LVAD) placement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add H-ISDN&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Left ventricular assist device (LVAD) placement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart transplant: This patient is not a candidate for heart transplant based on his age and recent colon cancer. Most centers have an age cutoff of 65 years (but variable). With the exception of skin cancer, most programs require that a patient be cancer-free for at least 5 years before being considered for heart transplant.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Heart transplant:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ecmo: Ecmo is a short-term life support option and is not suitable for long-term management of heart failure. it is typically reserved for refractory acute heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Ecmo:&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Add H-ISDN: Adding another medication would not be expected to provide significant benefit in this case of severe heart failure with maximized GDMT. Typically, H-ISDN is used for patients who are not able to tolerate ARNi/ACEi and ARB.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.  Add H-ISDN:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Left ventricular assist devices, either as a bridge to heart transplant or as primary therapy, are reasonable in patients with advanced heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with paroxysmal AF and HFrEF (EF 45%) has recurrent hospitalizations due to acute heart failure. She is currently on apixaban, metoprolol, furosemide, and telmisartan. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrioventricular (AV) node ablation with permanent pacemaker implantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD) placement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left atrial appendage occlusion (LAAO)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rhythm control&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rhythm control&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. AV node ablation: Considered only if rate and rhythm control fails to control tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. AV node ablation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ICD: Indicated for primary prevention of sudden cardiac death in certain patients, but not the primary treatment for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ICD:&lt;/li&gt;&lt;li&gt;â€¢ Option C. LAAO: Used for stroke prevention in patients who have C/I for anticoagulation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. LAAO:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aggressive efforts to achieve rhythm control in patients with atrial fibrillation and concomitant heart failure decrease morbidity and mortality.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old woman with ischemic cardiomyopathy (EF 38%) and type 2 diabetes mellitus has well-controlled blood pressure and glycemic control. She is on aspirin, atorvastatin, valsartan-sacubitril, metoprolol succinate, and metformin. Her BNP. What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glimepiride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dapagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Saxagliptin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dapagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glimepiride (sulfonylurea): No proven cardiovascular benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glimepiride (sulfonylurea):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Liraglutide: Shown to reduce CV events in T2DM but not specifically in HFrEF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Liraglutide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Saxagliptin: Not recommended in HFrEF due to the potential for increased hospitalizations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Saxagliptin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Consider adding SGLT2 inhibitors in patients with HFrEF, even if their diabetes is well-controlled, to reduce CV morbidity and mortality.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old woman is evaluated in the emergency department for a 1-week history of progressive exertional dyspnea and orthopnea. Vital signs are normal. Focused point-of-care cardiac ultrasonography is performed and done and as shown below. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heart failure with reduced ejection fraction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Large pericardial effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Heart failure with reduced ejection fraction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/supawork-e53ff9bb04dd417abdf7b818ed4326bc.gif&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Heart failure with reduced ejection fraction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis : Aortic stenosis typically presents with symptoms such as chest pain, syncope, and heart failure. However, the ultrasound findings do not suggest aortic valve pathology or significant left ventricular outflow obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac tamponade : Cardiac tamponade would present with findings such as hypotension, jugular venous distension, and pulsus paradoxus. The ultrasound in tamponade typically shows a large pericardial effusion with diastolic collapse of the right atrium or right ventricle. These findings are not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac tamponade&lt;/li&gt;&lt;li&gt;â€¢ Option D. Large pericardial effusion : A large pericardial effusion would show a significant fluid accumulation around the heart on ultrasound, often leading to tamponade physiology. This is not observed in the provided ultrasound image.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Large pericardial effusion&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Recognize the clinical presentation of heart failure with reduced ejection fraction (HFrEF) and correlate it with echocardiographic findings, emphasizing the importance of identifying left ventricular systolic dysfunction in patients presenting with symptoms of heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man is evaluated in the emergency department for acute worsening of dyspnea. Chest radiograph is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eosinophilic pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphangioleiomyomatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary edema&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary edema&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115748.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac tamponade : While cardiomegaly can be seen in cardiac tamponade, which is a condition where fluid accumulates in the sac surrounding the heart, leading to compression of the heart, diffuse alveolar infiltrates are not a feature of cardiac tamponade. Therefore, this diagnosis is unlikely based on the radiographic findings.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac tamponade&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eosinophilic pneumonia : Eosinophilic pneumonia is characterized by the presence of eosinophils (a type of white blood cell) in the lung tissue, which typically presents with bilateral infiltrates on a chest radiograph. However, this condition does not usually present with cardiomegaly or pleural effusion, making this option less likely given the findings on the radiograph.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eosinophilic pneumonia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphangioleiomyomatosis: Lymphangioleiomyomatosis is a rare lung disease that affects the lungs and lymphatic system, leading to cystic lung disease. The chest radiograph for this condition would typically show diffuse thin-walled cysts rather than cardiomegaly, alveolar infiltrates, or pleural effusion. Thus, this diagnosis is inconsistent with the radiographic findings in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Lymphangioleiomyomatosis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary edema is characterized by cardiomegaly and bilateral perihilar alveolar infiltrates on a chest radiograph, often associated with pleural effusion and fluid in the minor fissure, especially in the context of heart failure. This is a key diagnostic feature that must be remembered.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a past medical history of coronary artery disease develops a myocardial infarction. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. Repeat Echo after 3 months shows the same findings. What is this patientâ€™s heart failure stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stage A: Patients in Stage A have risk factors for HF but no structural heart disease or symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stage A:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stage C: Patients in Stage C have structural heart disease and current or prior symptoms of HF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stage C:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage D: Patients in Stage D have refractory HF requiring specialized interventions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage D:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ACC/AHA staging system for heart failure, categorizes patients based on the presence or absence of structural heart disease and symptoms of heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old woman with a history of recurrent heart failure hospitalizations presents with ascites and edema. Her JVP was elevated and there was no change with inspiration. On examination, she has an audible low-pitched late diastolic sound with a pansystolic murmur in the left sternal border. Echo shows diastolic dysfunction with mildly increased LV wall thickness. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fabry disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dilated Cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Restrictive cardiomyopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Constrictive pericarditis: While this can also cause elevated JVP and diastolic dysfunction, it usually does not present with a pansystolic murmur or S3 gallop. Pericardial knock is more characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Constrictive pericarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fabry disease: This is a rare genetic disorder that can cause RCM, but it is less likely than other causes in this patient without a specific family history or other suggestive features.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fabry disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dilated cardiomyopathy: This presents with systolic dysfunction (reduced ejection fraction) and a dilated left ventricle, which are not seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dilated cardiomyopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Restrictive cardiomyopathy presents with features of right heart failure, Kussmaul&#x27;s sign, S3/S4 gallop, diastolic dysfunction, and associated findings like TR.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with a history HF and HCM presents with NYHA class III dyspnea. She is currently on metoprolol and disopyramide. Echocardiogram shows an EF of 78% and LVOT gradient of 64 mmHg at rest. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addition of valsartan-sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD) therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Replacement of metoprolol with carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Septal reduction therapy (SRT)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Septal reduction therapy (SRT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Valsartan-sacubitril: Contraindicated in HCM as it can worsen LVOT obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Valsartan-sacubitril:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  ICD: Indicated for primary prevention of sudden cardiac death in high-risk HCM patients, but not for symptomatic relief of LVOT obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.  ICD:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Replacing metoprolol with carvedilol: Unlikely to be beneficial, as both are beta-blockers.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Replacing metoprolol with carvedilol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Septal reduction therapy is the treatment of choice for symptomatic patients with HCM and a high LVOT gradient despite optimal medical therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents with dyspnea on exertion. His resting ECG is normal. 2D echo revealed diastolic dysfunction, mild concentric LVH, and an LV EF of 65%. His BNP levels were elevated. Which of the following will maximally increase survival in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sacubitril-Valsartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. None of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sacubitril-Valsartan: This is an angiotensin receptor-neprilysin inhibitor (ARNI) indicated for HFrEF, not HFpEF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Sacubitril-Valsartan:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Empagliflozin: This is an SGLT2 inhibitor shown to benefit patients with HFrEF and may reduce hospitalizations in HFpEF, but not proven to improve survival.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Empagliflozin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spironolactone: While this mineralocorticoid receptor antagonist may improve symptoms and reduce hospitalizations in HFpEF, it has not been shown to reduce mortality.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Spironolactone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ There are no medications currently proven to significantly improve survival in HFpEF. Management primarily focuses on symptom management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Circumferential subendocardial late-gadolinium enhancement (LGE) is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic heart disease (IHD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amyloidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/untitled-2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis: Sarcoidosis typically shows a patchy or focal pattern of LGE, often in the mid-myocardial or subepicardial layers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myocarditis: Myocarditis can have various patterns of LGE, including patchy, focal, or epicardial, depending on the extent and distribution of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myocarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic heart disease (IHD): IHD typically shows subendocardial or transmural LGE in a coronary artery distribution, corresponding to areas of infarction or ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic heart disease (IHD):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Circumferential subendocardial late-gadolinium enhancement (LGE) on cardiac MRI is a hallmark feature of cardiac amyloidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Proportion of sudden cardiac death (SCD) in heart failure is maximum among which of the following NYHA classes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proportion of deaths due to SCD is highest in NYHA Class II.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ms. Kalavathy, a 35-year-old Anglo-Indian from Ireland, experienced cardiac arrest due to monomorphic VT with a LBBB morphology. Coronary angiogram and echocardiogram were normal. Echo is shown. Which protein mutation is most likely responsible for her presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Potassium channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desmosomal proteins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sarcomere proteins&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Desmosomal proteins&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-124018.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Potassium channels: Mutations in these channels cause long QT syndrome, characterized by a prolonged QT interval on ECG and syncope.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Potassium channels:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium channel: Mutations in these channels cause Brugada syndrome, characterized by a specific ECG pattern and increased risk of sudden cardiac death.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Sodium channel:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Sarcomere proteins: Mutations in these proteins cause hypertrophic cardiomyopathy, which would show LV hypertrophy on echocardiogram.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ . Sarcomere proteins:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ARVC is a rare genetic disorder most commonly due to mutations in genes encoding cardiac desmosomal proteins. Approximately 50% have a familial transmission with autosomal dominant inheritance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a history of MI and HF is comfortable at rest. However, when walking to his car, he develops dyspnea, fatigue, and sometimes palpitations. He must rest for several minutes before these symptoms resolve. Which of the following is his NYHA classification?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Class III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I: No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath), or angina.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Class II:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In the NYHA classification, Class III heart failure is defined by marked limitation of physical activity where patients are comfortable at rest, but less than ordinary activity (e.g., walking short distances) causes symptoms such as dyspnea, fatigue, and palpitations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a symptom of heart failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Confusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early hunger&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nocturia without polyuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right upper quadrant pain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Early hunger&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Early hunger&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Confusion: This can occur in HF, particularly in older adults or those with severe HF. It is often due to decreased cerebral perfusion caused by reduced cardiac output.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Confusion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nocturia without polyuria: This is a common symptom of HF, especially in the early stages. It is caused by redistribution of fluid from the legs to the central circulation when lying down.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nocturia without polyuria:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right upper quadrant pain: This can be caused by liver congestion due to right heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right upper quadrant pain:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the various symptoms of heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are a risk factor for development of peripartum cardiomyopathy EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced maternal age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malnutrition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primiparous&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Twin pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Primiparous&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Advanced maternal age: Advanced maternal age is a recognized risk factor for peripartum cardiomyopathy due to the increased cardiovascular strain and the higher likelihood of pre-existing heart conditions in older pregnant women.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Advanced maternal age:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malnutrition: Malnutrition is another risk factor because inadequate nutrition can impair the heart muscle&#x27;s ability to function properly, thereby increasing the risk of developing cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Malnutrition:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Twin pregnancy: A twin pregnancy significantly increases the workload on the heart, making it a well-documented risk factor for peripartum cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Twin pregnancy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Primiparous status (first pregnancy) is not a risk factor for peripartum cardiomyopathy, whereas advanced maternal age, malnutrition, and twin pregnancy are significant risk factors for the development of this condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You admit a 19-year-old with acute HF and LV dysfunction. After assessment, you suspect acute viral myocarditis, which is confirmed on endomyocardial biopsy. Which of the following therapies is recommended for treatment for acute viral myocarditis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ibuprofen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ramipril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oseltamivir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ramipril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ramipril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ibuprofen: Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID). Although it is commonly used to reduce inflammation and pain, its use is generally avoided in viral myocarditis. This is because NSAIDs can potentially increase the risk of adverse outcomes by inhibiting prostaglandin synthesis, which is essential for maintaining renal function and controlling inflammatory responses. Furthermore, NSAIDs might increase viral replication, leading to worsening of the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ibuprofen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oseltamivir: Oseltamivir is an antiviral medication primarily used to treat influenza. It is not effective for treating viral myocarditis because it specifically targets the influenza virus and has not been studied for cardiac involvement. Therefore, it is not recommended for the treatment of viral myocarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oseltamivir:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisone: Prednisone is a corticosteroid with potent anti-inflammatory effects. However, the use of immunosuppressive therapies, including corticosteroids like prednisone, is generally avoided in the acute phase of viral myocarditis because they may increase the risk of viral replication and myocardial injury. Current evidence does not support the use of prednisone in acute viral myocarditis, and large trials have shown negative results in treating myocarditis with immunosuppressive therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisone:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In the management of acute viral myocarditis, Ramipril (an ACE inhibitor) is recommended to manage heart failure symptoms and improve cardiac function, while anti-inflammatory, immunosuppressive, and specific antiviral therapies are generally not recommended.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of hypertension and hyperlipidemia presents with acute chest pain radiating to the left arm and jaw. ECG is shown. Which coronary artery is most likely occluded?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left anterior descending (LAD) artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left circumflex (LCx) artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right coronary artery (RCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left main coronary artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right coronary artery (RCA)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-174647.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left anterior descending (LAD) artery : Occlusion of the LAD artery typically causes ST-segment elevation in anterior leads.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left anterior descending (LAD) artery&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left circumflex (LCx) artery : Occlusion of the LCx artery typically causes ST-segment elevation in lateral leads.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left circumflex (LCx) artery&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left main coronary artery : Occlusion of the left main coronary artery typically causes widespread ST-segment elevation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left main coronary artery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the ECG findings of an inferior myocardial infarction and its association with RCA occlusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with recurrent palpitations and near-syncope. ECG during the episode is shown. His BP is 130/84 mm Hg and PR is 154/min. Vagal manoeuvrers and IV adenosine (6mg) administration do not terminate the tachycardia. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Synchronized cardioversion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Repeat adenosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoptolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Repeat adenosine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175001.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175104.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Synchronized cardioversion: This is typically reserved for hemodynamically unstable patients or those who fail medical therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Synchronized cardioversion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol: Beta-blockers like metoprolol (and calcium channel blockers) are used if initial therapy with vagal manoeuvres and adenosine fail.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metoprolol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amiodarone: This is an antiarrhythmic drug that can be used if AV nodal blockers fail.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amiodarone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Step wise management of regular narrow complex tachycardia (like AVNRT):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old intern presents with recurrent episodes of syncope after hearing ambulance siren in the ER. She also experiences light-headedness and dizziness early morning once she wakes up hearing alarms. The ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congenital long QT syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Wolff-Parkinson-White syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertrophic cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Congenital long QT syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180215.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brugada syndrome: This is associated with a specific ECG pattern (ST-elevation in V1-V3) and sudden cardiac death, not typically triggered by sounds.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brugada syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Wolff-Parkinson-White syndrome: This involves an accessory pathway, causing a short PR interval and delta wave, and is not typically associated with syncope triggered by sound.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Wolff-Parkinson-White syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypertrophic cardiomyopathy: This is characterized by left ventricular hypertrophy, which may or may not have a prolonged QT interval and is not typically triggered by sound.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypertrophic cardiomyopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Syncope triggered by auditory stimuli, combined with a prolonged QT interval on ECG, is highly suggestive of congenital long QT syndrome, particularly LQT2.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman presents with abrupt-onset palpitations that she can terminate by coughing. ECG is shown. What is the most likely rhythm diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrioventricular nodal reentrant tachycardia (AVNRT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atrioventricular nodal reentrant tachycardia (AVNRT)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180707.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180802.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation: Irregular rhythm with no discernible P waves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial tachycardia: Typically slower than AVNRT and less likely to be terminated by vagal maneuvers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular tachycardia: Wide QRS complex tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular tachycardia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ ECG findings of AVNRT = narrow QRS complex tachycardia, pseudo r&#x27; wave in V1, and responsiveness to vagal maneuvers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 41-year-old man is evaluated for daily palpitations lasting minutes at a time. What is the most appropriate initial test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;30-day event monitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;12-lead resting ECG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;24-hour ambulatory ECG monitor (Holter monitor)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 12-lead resting ECG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ECG: Used to assess for exercise-induced arrhythmias or ischemia, not the initial test for palpitations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ECG:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 30-day event monitor: Used for infrequent symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 30-day event monitor:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 24-hour Holter monitor: Indicated if the resting ECG is normal but suspicion for arrhythmia remains high.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 24-hour Holter monitor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The initial test in patients with a history of palpitations, presyncope, or syncope is 12-lead resting ECG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old woman with hypertension and hyperlipidemia is starting trastuzumab therapy for early-stage breast cancer. What is the most appropriate cardiac surveillance for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multigated acquisition (MUGA) scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No surveillance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Echocardiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI: More expensive and not routinely needed for initial surveillance.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI:&lt;/li&gt;&lt;li&gt;â€¢ Option C. MUGA scan: Less commonly used for surveillance than echocardiography.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MUGA scan:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No surveillance: Inappropriate given the risk of cardiotoxicity with trastuzumab.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No surveillance:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients receiving trastuzumab therapy at high risk for cardiac dysfunction, periodic echocardiographic surveillance is recommended.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman with HFrEF (EF 25%) presents with NYHA class III symptoms. She is currently receiving valsartan-sacubitril, carvedilol, spironolactone, empagliflozin, and furosemide. In view of persistent symptoms, she is planned for CRT. Which of the following is the most useful investigation in predicting the usefulness of CRT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ECG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TEE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SPECT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ECG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. TEE (transesophageal echocardiography): While TEE can provide valuable information about cardiac structure and function, it is not the most reliable predictor of CRT response.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TEE (transesophageal echocardiography):&lt;/li&gt;&lt;li&gt;â€¢ Option C. SPECT (single-photon emission computed tomography): SPECT can assess myocardial perfusion and viability but does not directly predict CRT response.&lt;/li&gt;&lt;li&gt;â€¢ Option C. SPECT (single-photon emission computed tomography):&lt;/li&gt;&lt;li&gt;â€¢ Option D. PET (positron emission tomography): PET is also used for myocardial viability assessment and is not the primary tool for predicting CRT response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PET (positron emission tomography):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand that a 12-lead ECG demonstrating a wide QRS complex with LBBB morphology is the most useful investigation in predicting the potential benefits of CRT in patients with HFrEF.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with chest pain that worsens with physical activity and improves with rest. Her resting ECG shows left ventricular hypertrophy (LVH) with a strain pattern. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dobutamine echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dobutamine myocardial perfusion imaging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exercise myocardial perfusion imaging&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Exercise myocardial perfusion imaging&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dobutamine echocardiography: May be considered if the patient cannot exercise, but exercise is preferred.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dobutamine echocardiography:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dobutamine myocardial perfusion imaging : Can be used, but exercise is preferred if possible.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dobutamine myocardial perfusion imaging&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise ECG: Less sensitive for detecting ischemia in patients with LVH due to baseline ECG changes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise ECG:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Exercise myocardial perfusion imaging is the preferred stress test for assessing myocardial ischemia in patients with LVH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old woman is admitted to the ICU with respiratory failure. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multifocal atrial tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinus tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Multifocal atrial tachycardia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-181657.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation: Has no P waves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial tachycardia: Usually a regular rhythm and has single â€˜Pâ€™ wave morphology&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sinus tachycardia: Usually a regular rhythm and has single â€˜Pâ€™ wave morphology&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sinus tachycardia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 61-year-old man is evaluated following the recent diagnosis of hypertension. ECG is shown. Which of the following abnormalities is seen on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Accelerated idioventricular rhythm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left bundle branch block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Old inferior myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right bundle branch block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Left bundle branch block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-181851.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman is evaluated prior to an elective total hip arthroplasty. ECG is shown. Which of the following abnormalities is seen on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute anterior myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nonacute inferior myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute lateral myocardial infarction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nonacute inferior myocardial infarction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182109.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ There are no ECG changes consistent with an anterior or lateral infarction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man is evaluated following a transient ischemic attack. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial flutter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrioventricular nodal reentrant tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atrioventricular reciprocating tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atrial fibrillation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182316.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old man with a newly diagnosed ischemic stroke is evaluated in the emergency department. ECG is shown. Which of the following abnormalities is seen on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left bundle branch block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left ventricular hypertrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myocardial ischemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonspecific intraventricular conduction delay&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Left ventricular hypertrophy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182500.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman is evaluated for palpitations. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial flutter&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrial tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinus tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Atrial flutter&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182715.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 49-year-old man is evaluated for symptoms of dyspnea, peripheral edema, and exercise intolerance. Echocardiography shows biventricular increased wall thickness. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infiltrative cardiomyopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pericardial effusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stress-related cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Infiltrative cardiomyopathy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182906.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old man is evaluated for nonanginal chest pain. ECG is shown. Which of the following is shown on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intraventricular conduction delay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left bundle branch block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right bundle branch block&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Right bundle branch block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183058.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man is evaluated for the acute onset of severe chest pain. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arrhythmogenic right ventricular cardiomyopathy/dysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pericarditis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183237.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man is evaluated for palpations and light headedness. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antidromic atrioventricular reentrant tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrioventricular nodal reentrant tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinus tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atrioventricular nodal reentrant tachycardia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183439.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Karthik, is admitted to CCU after being diagnosed with STEMI. He received Reteplase an hour ago and currently he is asymptomatic and stable. The CCU staff nurse is concerned about the rhythm (shown below) in the monitor and informs you. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer amiodarone 300mg mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer flecainide 400 mg orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administer metoprolol 5 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Continue observation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Continue observation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183627.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer amiodarone 300mg mg IV : Would be appropriate therapy if this was ventricular tachycardia or perhaps supraventricular tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer amiodarone 300mg mg IV&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer flecainide 400 mg orally : Class IC antiarrhythmic, contraindicated in post-MI patients due to increased mortality risk (CAST trial).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer flecainide 400 mg orally&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administer metoprolol 5 mg IV : Beta-blocker, may be used for rate control in certain SVTs but not indicated for AIVR.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administer metoprolol 5 mg IV&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Accelerated idioventricular rhythm, which commonly arises after reperfusion, is generally benign and transient. The slow rate is a major difference between accelerated idioventricular rhythm and ventricular tachycardia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man is evaluated for bradycardia prior to cataract surgery. He is asymptomatic. ECG is shown. Which of the following ECG findings is present?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mobitz type 1 second-degree atrioventricular block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mobitz type 2 second-degree atrioventricular block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sinus arrest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinus bradycardia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sinus bradycardia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184015.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman with sarcoidosis is evaluated for an irregular pulse, a sensation of pounding in the neck, and an episode of syncope. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Junctional rhythm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Monomorphic ventricular tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polymorphic ventricular tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular fibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Monomorphic ventricular tachycardia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184202.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman is evaluated for unexplained right heart enlargement and a history of paroxysmal atrial fibrillation. Physical examination reveals a parasternal impulse, fixed splitting of S2, mitral regurgitation, and a pulmonary outflow murmur. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ostium primum atrial septal defect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patent foramen ovale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ostium primum atrial septal defect&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184317.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old woman is evaluated in the emergency department following an episode of syncope. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial tachycardia with 2:1 block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complete heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Junctional rhythm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mobitz type 2 second-degree atrioventricular block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Junctional rhythm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184453.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man is evaluated in the emergency department for rapid heart rate and dizziness. He was recently started on levofloxacin for community-acquired pneumonia. A telemetry rhythm strip is shown. Which of the following abnormalities is seen on this patient&#x27;s telemetry rhythm strip?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monomorphic ventricular tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right bundle branch block with aberrancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Torsades de pointes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular fibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Torsades de pointes&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184630.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman is evaluated for dyspnea associated with nausea and diaphoresis. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early repolarization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inferior myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nonâ€“ST-elevation myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pericarditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inferior myocardial infarction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184819.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman is evaluated for a â€œracing heartâ€ sensation. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrioventricular nodal reentrant tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrioventricular reciprocating tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinus tachycardia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sinus tachycardia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185004.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old woman is evaluated for recurrent episodes of syncope. She is otherwise well and takes no medications. ECG is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertrophic cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Long QT syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurocardiogenic syncope&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Long QT syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185143.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 79-year-old woman is evaluated for fatigue and bradycardia. ECG is shown. Which of the following abnormalities is seen on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idioventricular rhythm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mobitz type 2 second-degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sinus bradycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Third-degree heart block&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Third-degree heart block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185318.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old woman is evaluated for episodes of palpitations. ECG is shown. Which of the following abnormalities or underlying conditions is responsible for the changes on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial septal defect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lown-Ganong-Levine pattern&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patent foramen ovale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wolff-Parkinson-White pattern&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Wolff-Parkinson-White pattern&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185505.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 51-year-old man is evaluated for syncope after prolonged standing in a warm environment. ECG is shown. Which of the following ECG findings is shown?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First-degree atrioventricular block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Normal sinus rhythm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sick sinus syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinoatrial nodal exit block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. First-degree atrioventricular block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185636.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old woman with peripheral artery disease is evaluated prior to elective cholecystectomy. ECG is shown. Which of the following is the most likely electrocardiographic diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bifascicular block conduction delay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left anterior fascicular block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left posterior fascicular block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right bundle branch block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Left posterior fascicular block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185806.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following conditions is demonstrated on this electrocardiogram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute posterior myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brugada pattern&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left ventricular hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right ventricular hypertrophy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Right ventricular hypertrophy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185926.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most likely cause of the findings on this electrocardiogram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypocalcemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothermia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypocalcemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190037.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman experiences intermittent palpitations, shortness of breath, and light headedness. ECG is shown. Echocardiogram is normal. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electrophysiology (EP) study&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flecainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Electrophysiology (EP) study&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190157.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Options A. Atenolol and D. Verapamil (AV nodal blockers): These medications are atrioventricular nodal blockers and may be unsafe if the patient has anterograde conduction down the accessory pathway during atrial fibrillation. These drugs promote rapid 1:1 conduction from the atria to the ventricles over the accessory pathway during atrial fibrillation, which can lead to very rapid ventricular rates and ventricular fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Options A. Atenolol and D. Verapamil (AV nodal blockers):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Flecainide: It is an antiarrhythmic drug that is frequently used to treat paroxysmal atrial fibrillation and other arrhythmias. Flecainide is not indicated in this patient because the type and mechanism of the arrhythmia are unknown. This patient requires risk stratification, which can be accomplished with an electrophysiology study.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Flecainide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected WPW syndrome, an EP study is indicated to assess arrhythmia risk and consider ablation of the accessory pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 81-year-old man with a history of hypertension and osteoarthritis is scheduled for elective hip arthroplasty. He is asymptomatic and has no history of cardiovascular disease. His ECG is shown. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dobutamine echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prophylactic pacemaker insertion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further testing or intervention&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No further testing or intervention&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190419.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dobutamine echocardiography: Not indicated as there are no signs or symptoms of heart failure or ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dobutamine echocardiography:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Echocardiography: Not necessary as the ECG findings are not suggestive of structural heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Echocardiography:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prophylactic pacemaker insertion: Not indicated in asymptomatic patients with bifascicular block and first-degree AV block.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prophylactic pacemaker insertion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Asymptomatic Tri-fascicular block does not require pacemaker implantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 84-year-old man presents with fatigue and loss of energy. His ECG is shown. Upon vigorous exercise his heart rate reaches a maximum of 72/min. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hospital admission&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pacemaker implantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Switch lisinopril to amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reassurance and clinical monitoring&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pacemaker implantation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091643.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hospital admission: Not necessary unless the patient is hemodynamically unstable.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hospital admission:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switching medications: Unlikely to address the underlying bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switching medications:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reassurance and monitoring: Inadequate for symptomatic bradycardia with potential for adverse outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reassurance and monitoring:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Treat a patient with symptomatic bradycardia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with history of hypertension and stroke has been diagnosed with mildly symptomatic paroxysmal AF. He is currently taking rivaroxaban and metoprolol. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left atrial appendage occlusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pacemaker implantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rhythm control&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rhythm control&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left atrial appendage occlusion: Indicated for stroke prevention in non-valvular AF but not the primary treatment for rhythm control.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left atrial appendage occlusion:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pacemaker implantation: Not indicated for paroxysmal AF without symptomatic bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pacemaker implantation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No additional therapy: Early rhythm control is recommended for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No additional therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with recently diagnosed atrial fibrillation and concomitant cardiovascular conditions, early rhythm control (antiarrhythmic drugs or ablation) reduces the primary composite end point of cardiovascular death, stroke, or hospitalization for heart failure or acute coronary syndrome compared with usual care.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with hypertension presents with acute shortness of breath, hypotension and palpitations. He has jugular venous distention and pulmonary crackles. ECG was done and is shown below. After successful cardioversion, what is the best treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Catheter ablation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flecainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Catheter ablation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091936.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone: Antiarrhythmic drug that can be used for atrial flutter, but catheter ablation is more definitive.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Flecainide: Another antiarrhythmic drug, but catheter ablation is preferred.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Flecainide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol: Beta-blocker, primarily used for rate control, not as effective for rhythm control in atrial flutter.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Catheter ablation is the definitive treatment for typical atrial flutter due to its high success rate and low complication rate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old woman presents with recurrent palpitations lasting 5-15 minutes, occue a few times per month and relieved by rest or deep breathing. The resting ECG is normal. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exercise ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Implantable loop recorder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Holter Monitoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;30-day event monitor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 30-day event monitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ECG: Not indicated for evaluating palpitations occurring at rest.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exercise ECG:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Implantable loop recorder: Reserved for very infrequent or unexplained syncope (which prevents the patient from triggering the devices). Records symptomatic and asymptomatic events (brady/tachy) over a very long period (months to years).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Implantable loop recorder:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Holter monitoring :  Usually records electrical activity continuously for 24-28 hours and most suited for patients with more frequent symptoms (e.g., daily).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Holter monitoring&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A 30-day event monitor is most appropriate for evaluating patients with palpitations who have symptoms that occur less than daily but frequently over the course of a month.&lt;/li&gt;&lt;li&gt;âž¤ An implantable looping event recorder is most appropriate for infrequent or highly symptomatic arrhythmias in which the symptoms might preclude a patient from activating the device, such as syncope.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents with recurrent syncope without prodrome. His father died suddenly at age 45. ECG is shown. Physical examination and 2D Echo is normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary artery disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Long QT syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vasovagal syncope&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Brugada syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092311.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary artery disease: Unlikely in a young patient with no risk factors and normal ECG findings.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coronary artery disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Long QT syndrome: ECG would show a prolonged QT interval, not the Brugada pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Long QT syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vasovagal syncope: Typically has prodromal symptoms (lightheadedness, nausea) and normal ECG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vasovagal syncope:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiovascular syncopal events often occur suddenly and usually without a significant prodrome, although chest pain and palpitations may be present.&lt;/li&gt;&lt;li&gt;âž¤ Causes of cardiovascular syncope include cardiac arrhythmia; coronary artery disease; and structural and obstructive disease, including aortic and pulmonary valve stenosis, obstructive hypertrophic cardiomyopathy, aortic dissection, and cardiac tamponade.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman presents with palpitations. Her ECG is shown. She is a known diabetic and hypertensive and currently taking metformin and metoprolol. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase metoprolol dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate oral anticoagulation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reassurance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Initiate oral anticoagulation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092619.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin: Insufficient for stroke prevention in high-risk patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase metoprolol dosage: Not necessary as the ventricular rate is controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase metoprolol dosage:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reassurance: Inappropriate as the patient is at high risk for stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reassurance:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In stable patients with atrial fibrillation, the primary goals of therapy are to (1) prevent stroke, (2) control heart rate, (3) minimize or eliminate symptoms, and (4) modify underlying risk factors.&lt;/li&gt;&lt;li&gt;âž¤ Anticoagulation is indicated for stroke prevention in patients with nonvalvular atrial fibrillation who have a CHA2DS2-VASc score of 2 or greater in men or 3 or greater in women.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man presents with palpitations and lightheadedness. He was having significant work pressure over the last 2 weeks and he has not been sleeping well. ECG showed VT and he is successfully cardioverted in the ER. Echocardiogram is normal. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac MRI with stress perfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electrophysiology (EP) study&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Implantable cardioverter-defibrillator (ICD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Implantable loop recorder (ILR)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac MRI with stress perfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. EP study: May be indicated later if diagnosis of sustained VT is in doubt or if ablation is being considered (to localize the arrhythmogenic focus).&lt;/li&gt;&lt;li&gt;â€¢ Option B. EP study:&lt;/li&gt;&lt;li&gt;â€¢ Option C. ICD: May be considered if there is VT + structural heart disease or HF with EF â‰¤ 35%. In idiopathic VT, it is unnecessary.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ICD:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ILR: It would be premature to consider ILR placement before assessment for structural heart disease. An ILR may be valuable to assess rare recurrences of arrhythmia and/or to assess symptoms, but further evaluation is needed first.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ILR:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac MRI with stress perfusion is a valuable tool for evaluating the underlying cause of VT in patients with structurally normal hearts on echocardiography.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old man is evaluated in the emergency department for an irregular heart rhythm. He is otherwise asymptomatic. A representative sample from an ECG rhythm strip is shown. Which of the following abnormalities is seen on this patient&#x27;s ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-grade atrioventricular block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mobitz type 1 second-degree atrioventricular block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mobitz type 2 second-degree atrioventricular block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mobitz type 1 second-degree atrioventricular block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092929.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This ECG demonstrates Mobitz type 1 second-degree (Wenckebach) atrioventricular block, which is characterized electrocardiographically by a PR interval that progressively prolongs until, eventually, the beat is dropped. In the tracing shown, the PR interval widens over the first six beats and no ventricular complex follows the seventh atrial beat.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 81-year-old man is evaluated in the emergency department for chest pain. During the evaluation, he becomes unresponsive and pulseless. ECG is shown. what is the next best step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer 100% oxygen by NRBM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer procainamide IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administer 1 g calcium gluconate IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unsynchronized defibrillation with 200 J&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unsynchronized defibrillation with 200 J&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093042.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient is in ventricular fibrillation. Immediate defibrillation  is required and treatment should proceed along advanced cardiac life support protocol. Defibrillation in this case should precede administration of oxygen. Medications will not be effective in the absence of circulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following disorders could account for the findings on the rhythm strip of a homeless man who was found unresponsive on the street?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypocalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypophosphatemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothermia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypothermia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093143.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093206.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hypothermia most likely accounts for the findings shown on this electrocardiogram. In hypothermia, all of the electrocardiographic intervals are prolonged, including the PR interval, the QRS complex, the QT interval, and the R-R interval, owing to slowed impulse conduction through potassium channels. In addition, the J point is elevated, producing a characteristic J wave (Osborn wave) that represents distortion of the earliest phase of membrane repolarization. These changes are most prominent in the precordial leads V2 through V5. This electrocardiogram demonstrates Osborn waves (arrows).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diagnoses is most consistent with the radiographic findings shown?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dual chamber Pacemaker&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Single chamber pacemaker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CRT device&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Swan Ganz catheter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Dual chamber Pacemaker&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-112453.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Single chamber pacemaker: A single chamber pacemaker has only one lead, typically in the RV.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Single chamber pacemaker:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CRT device: A CRT device would include an additional lead positioned to pace the left ventricle via the coronary sinus, which is not seen in this image.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CRT device:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Swan Ganz catheter: A Swan-Ganz catheter, used for measuring hemodynamic parameters, is not an implantable device and would appear as a different configuration on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Swan Ganz catheter:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A dual chamber pacemaker has leads placed in both the right atrium and right ventricle. This device is used to maintain coordinated atrial and ventricular pacing in patients with specific types of heart block or other cardiac rhythm disturbances.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old gentleman presents with complaints of dizziness and one episode of syncope. On examination, you notice a pulse rate of around 38/min and blood pressure of approximately 88/56 mmHg. What will be your next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urgent transcutaneous pacing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urgent transvenous pacing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine 0.5 mg IV push&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emergency defibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atropine 0.5 mg IV push&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Urgent transcutaneous pacing: While TCP may be necessary if atropine is ineffective or if the bradycardia is due to complete heart block, it is not the initial treatment of choice in this situation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Urgent transcutaneous pacing:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urgent transvenous pacing: Similar to TCP, transvenous pacing is a more definitive treatment but is not the immediate priority in an unstable patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urgent transvenous pacing:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emergency defibrillation: Defibrillation is indicated for ventricular fibrillation or pulseless ventricular tachycardia, not for bradycardia with a pulse.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emergency defibrillation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Symptomatic bradycardia with hemodynamic instability is a medical emergency. Initial treatment as per ACLS protocol is atropine administration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are true regarding Mobitz II block except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PR varying&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wide QRS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bundle branch block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defect lies below AV node&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PR varying&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wide QRS: This is often present in Mobitz II due to the block occurring below the AV node, affecting the His-Purkinje system.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wide QRS:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bundle branch block: Mobitz II is frequently associated with bundle branch block as the block occurs within the bundle branches or more distally in the conduction system.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bundle branch block:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Defect lies below AV node: The conduction defect in Mobitz II is located below the AV node, typically in the His-Purkinje system.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Defect lies below AV node:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mobitz II second-degree block is associated with a constant PR interval, wide QRS complex and bundle branch block due to the conduction defect located below the AV node.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with palpitations and giddiness for 2 hours. On arrival, BP is 80/60 mmHg. ECG is shown. What is the next step in management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carotid sinus massage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardioversion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardioversion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093714.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carotid sinus massage: This maneuver can sometimes terminate AVNRT, but it is not recommended in the setting of hemodynamic instability due to the risk of further complications.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carotid sinus massage:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine: Adenosine is a first-line agent for stable AVNRT, but it is contraindicated in patients with asthma or bronchospasm and may not be effective in cases of hemodynamic instability.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV metoprolol: Beta-blockers like metoprolol are used for rate control in AVNRT, but they should not be the initial treatment in hemodynamically unstable patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV metoprolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ â€˜ If the patient is in shock, shock the patient !â€™&lt;/li&gt;&lt;li&gt;âž¤ â€˜&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant lady G2P1L1 currently 37 weeks POG (period of gestation) presented with worsening headache, blurring of vision, reduced perception of fetal movements. On arrival, BP was 200/100 mmHg. ECG is shown. Which of the following is the best management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV MgSO4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV MgSO4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093914.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV lignocaine: While lidocaine is an antiarrhythmic, it is not effective in PMVT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV amiodarone: Amiodarone is effective for monomorphic VT but can prolong QTc interval and potentially can trigger PMVT.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Defibrillation: Can be tried in case of unstable PMVT or if the patient is in cardiac arrest.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Defibrillation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IV MgSO4 is the treatment of choice for stable PMVT.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old patient with HCM presents with palpitations over the last 1 week. ECG showed AF. His CHA2DS2-Vasc score is 0. What is the treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No anticoagulation required&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin for 4 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Long term Warfarin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anticoagulation is contraindicated&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Long term Warfarin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. No anticoagulation required: This is incorrect as anticoagulation is strongly recommended for HCM patients with AF.&lt;/li&gt;&lt;li&gt;â€¢ Option A. No anticoagulation required:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warfarin for 4 weeks: This is insufficient duration. Long-term anticoagulation is necessary for stroke prevention in HCM patients with AF.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warfarin for 4 weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anticoagulation contraindicated: This is incorrect. Anticoagulation is indicated for stroke prevention in HCM patients with AF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anticoagulation contraindicated:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF), long-term anticoagulation is recommended regardless of their CHA2DS2-VASc score due to the increased risk of thromboembolic events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 71-year-old man with a pacemaker presents with malaise, fatigue, and localized discomfort at the pacemaker site and the appearance is shown in the image. He has no fever, chills, or weight loss. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood cultures&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Empiric therapy with cephalexin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pacemaker pocket aspiration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET/CT scanning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Blood cultures&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094129.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Empiric therapy with cephalexin: Premature before confirming infection and identifying the causative organism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Empiric therapy with cephalexin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pacemaker pocket aspiration: Not recommended as it can introduce infection into a previously sterile pocket.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pacemaker pocket aspiration:&lt;/li&gt;&lt;li&gt;â€¢ Option D. PET/CT scanning: May be helpful later if the diagnosis is unclear, but blood cultures are the priority.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PET/CT scanning:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In all patients suspected of having infection of a cardiac implanted electronic device, a minimum of two blood cultures should be drawn from separate sites.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old patient with long-standing atrial fibrillation (AF) received a VVIR pacemaker. After a few months, he presents with dizziness, fatigue, and visible pulsations in the neck. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sick sinus syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pacemaker syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lead displacement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pacemaker syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sick sinus syndrome: Would not be associated with elevated JVP or cannon â€˜aâ€™ waves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sick sinus syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lead displacement: Lead displacement would likely cause pacing failure or erratic pacing, not the specific symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lead displacement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular tachycardia: This would present with a rapid, regular heart rhythm and different symptoms (palpitations, chest pain, syncope).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular tachycardia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pacemaker syndrome is a potential complication of single-chamber ventricular pacing (usually VVIR), and presents with dizziness and syncope due to AV dissociation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common mechanism of digitalis-induced ventricular arrhythmias?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Re-entry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Delayed afterdepolarizations (DADs)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Early afterdepolarizations (EADs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enhanced automaticity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Delayed afterdepolarizations (DADs)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Re-entry: While re-entry is the most common mechanism for arrhythmias in general, it&#x27;s not the primary mechanism for digitalis-induced ventricular arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Re-entry:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Early afterdepolarizations (EADs): EADs are associated with prolonged repolarization (long QT syndrome), which is not a direct effect of digitalis toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Early afterdepolarizations (EADs):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enhanced automaticity: Although digitalis can increase automaticity, it&#x27;s not the predominant mechanism; DADs caused by calcium overload play a more significant role.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enhanced automaticity:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the primary mechanism of digitalis-induced ventricular arrhythmias is delayed afterdepolarizations (DADs) caused by intracellular calcium overload.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following describes the AV node accurately?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decremental response&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sodium-dependent conduction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased gap junctions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Speed of conduction is 1-2 m/s&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Decremental response&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodium-dependent conduction: The action potential upstroke in the AV node is dependent on the smaller and slower inward Ca2+ current, which is the reason why the upstroke velocity of the action potential is lowâ€”one of the factors responsible for the slow conduction velocity in the AV node.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodium-dependent conduction:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased gap junctions: The AV node actually has fewer gap junctions than other parts of the conduction system, contributing to its slower conduction speed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased gap junctions:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Speed of conduction is 1-2 m/s: The conduction speed in the AV node is much slower, around 0.05 m/s (50 mm/s).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Speed of conduction is 1-2 m/s:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AV node acts as a â€˜gatekeeperâ€™ to the ventricles.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing Mr. Aravind, a 24-year-old previously healthy athlete, for his routine physical examination. Which of the following rhythms is demonstrated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First-degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mobitz type I, second-degree heart block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mobitz type II, second-degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Complete Heart Block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mobitz type I, second-degree heart block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094521.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. First-degree heart block: This has a prolonged but constant PR interval.&lt;/li&gt;&lt;li&gt;â€¢ Option A. First-degree heart block:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mobitz type II, second-degree heart block: This has a constant PR interval with occasional dropped QRS complexes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mobitz type II, second-degree heart block:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type III heart block (complete heart block): This has complete dissociation between the atria and ventricles, with no relationship between P waves and QRS complexes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type III heart block (complete heart block):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mobitz type I second-degree heart block (Wenckebach) is a relatively benign rhythm often seen in athletes due to high vagal tone.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT indicative of high risk in Wolff-Parkinson-White (WPW) syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple pathways&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Refractory period &amp;gt; 240 ms&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inducible AF or AVRT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Accessory pathway in the posteroseptal region&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Refractory period &gt; 240 ms&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple pathways: The presence of multiple accessory pathways increases the risk of arrhythmias and is a high-risk feature.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple pathways:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inducible AF or AVRT: The ability to induce AF or AV reentrant tachycardia (AVRT) during electrophysiology study indicates a higher risk of spontaneous arrhythmias and is a high-risk feature.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inducible AF or AVRT:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Accessory pathway in the posteroseptal region: Poster septal accessory pathways are associated with a higher risk of sudden cardiac death due to their potential to conduct rapidly during AF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Accessory pathway in the posteroseptal region:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High risk in WPW = multiple accessory pathways, accessory pathway refractory period &amp;lt; 240ms, inducible AVRT or AF in EPS &amp;amp; shortest RR in AF â‰¤ 250ms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman with a history of hypertension, COPD, diabetes and osteoporosis presents to the emergency department after a fall, with intense left hip pain, dry mucous membranes, and tachycardia. Her ECG is shown. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenosine 6 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Synchronized DCC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Verapamil 5 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pain control and IV hydration&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pain control and IV hydration&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095717.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine 6 mg IV: Primarily used for supraventricular tachycardia (SVT), not MAT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine 6 mg IV:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Synchronized DCC: Not effective for MAT and it is C/I.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Synchronized DCC:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Verapamil 5 mg IV: Verapamil may be in helpful in some patients with MAT (for rate control) but often unnecessary as treatment of underlying cause is sufficient and the most important.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Verapamil 5 mg IV:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The initial management of MAT should focus on addressing the underlying causes, such as pain and dehydration in this case.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding the most common form of paroxysmal supraventricular tachycardia (PSVT)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is usually life-threatening.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It relies on enhanced automaticity as a mechanism.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It relies on multiple pathways for conduction from the atrium into the AV node.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It requires systemic anticoagulation for thromboembolic prophylaxis.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It relies on multiple pathways for conduction from the atrium into the AV node.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is usually life-threatening: AVNRT is usually not life-threatening, though it can cause significant symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is usually life-threatening:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It relies on enhanced automaticity as a mechanism: AVNRT is a re-entry tachycardia, not caused by enhanced automaticity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It relies on enhanced automaticity as a mechanism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. It requires systemic anticoagulation for thromboembolic prophylaxis: Anticoagulation is not typically required for AVNRT unless there are additional risk factors for thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It requires systemic anticoagulation for thromboembolic prophylaxis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common form of PSVT is AVNRT, which is caused by re-entry circuits involving multiple pathways within the AV node.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are in the emergency department when a 19-year-old woman, Ms. Vidhya, arrives after collapsing during a Sunday marathon. She is unresponsive and pulseless. ECG is shown. Which of the following rhythms is the cause of her cardiac arrest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AF with pre-excitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AF with LBBB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monomorphic VT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Torsades de pointes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. AF with pre-excitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095925.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrioventricular nodal reentrant tachycardia: This is usually a narrow-complex tachycardia, unlike the wide-complex seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrioventricular nodal reentrant tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Monomorphic ventricular tachycardia: This has a regular rhythm with similar QRS complexes, unlike the irregular pattern seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Monomorphic ventricular tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Torsades de pointes: Difficult to differentiate but the given ECG does not have the twisting morphology to consider it as Torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Torsades de pointes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AF with preexcitation presents with rapid irregular wide-complex tachycardia and it is lethal.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding the below rhythm is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Catheter ablation has a high success rate in common atrial flutter.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is dependent on the cavotricuspid isthmus for conduction.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The wave of depolarization propagates anti-clockwise&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100045.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100137.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Catheter ablation has a high success rate in common atrial flutter: True. It has &amp;gt; 95% success.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Catheter ablation has a high success rate in common atrial flutter:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is dependent on the cavotricuspid isthmus for conduction: True. Since the wavefront passes in the cavotricuspid isthmus, where it is susceptible to interruption by catheter ablation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is dependent on the cavotricuspid isthmus for conduction:&lt;/li&gt;&lt;li&gt;â€¢ Option D. The wave of depolarization propagates anti-clockwise: The circuit most commonly revolves in a counterclockwise direction (as viewed looking toward the tricuspid annulus from the ventricular apex), which produces the characteristic negative sawtooth flutter waves in leads II, III, and aVF and positive P waves in lead V1.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The wave of depolarization propagates anti-clockwise:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Catheter ablation is a highly effective treatment for typical atrial flutter, offering high success rates and a low risk of complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Sarabesh presents with palpitations. His ECG is shown. Which of the following is false regarding the rhythm?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Incidence increases with age.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;More common in women than in men.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is associated with an increased risk of mortality.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. More common in women than in men.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100253.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. True. The incidence of AF increases with age.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. True. AF is associated with an increased risk of mortality.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Not all of the above statements are false. Option A and C are true.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atrial fibrillation is the most common sustained arrhythmia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a history of pacemaker insertion presents to you for routine review. You notice the pacemaker site like what is shown in the image. What is the most appropriate additional management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspiration of the device pocket&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pacemaker extraction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topical mupirocin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clinical observation and reassessment&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pacemaker extraction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092200.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspiration: Not recommended for diagnostic purposes and can worsen infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspiration:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Topical mupirocin: Ineffective for deep pocket infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Topical mupirocin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation: Inappropriate as the infection can worsen and lead to serious complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prompt device removal and antibiotic therapy is required in cases of suspected or confirmed cardiac device infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ms. Kavitha, a 22-year-old woman with rheumatic mitral stenosis develops atrial fibrillation. Her CHAâ‚‚DSâ‚‚-VASc is 1. Which of the following is the correct approach to stroke prevention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No anticoagulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate aspirin 325 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate apixaban 5 mg twice daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate warfarin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Initiate warfarin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. No anticoagulation: Incorrect, since AF increases the risk of stroke by 20-25x in patients with mitral stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. No anticoagulation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate aspirin 325 mg daily: Insufficient for stroke prevention in patients with AF and high risk factors like rheumatic mitral stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate aspirin 325 mg daily:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate apixaban 5 mg twice daily: DOACs are not recommended in patients with rheumatic mitral stenosis due to limited data.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate apixaban 5 mg twice daily:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Warfarin is the recommended anticoagulant for stroke prevention in patients with AF and rheumatic mitral stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 189 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test2" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Endocrinology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Endocrinology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                36 Questions | 144 Total Marks | 46 min Duration | ~76.67 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;True about insulinoma is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha cell tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Most of them are malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C-peptide level is elevated&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not associated with MEN 1 syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. C-peptide level is elevated&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) C-peptide level is elevated&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha cell tumor: This is incorrect; insulinomas arise from beta cells of the pancreas , which are responsible for the production of insulin.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Alpha cell tumor:&lt;/li&gt;&lt;li&gt;â€¢ insulinomas arise from beta cells&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option B: Most of them are malignant: The majority of insulinomas are benign ; only a small percentage are malignant.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Most of them are malignant:&lt;/li&gt;&lt;li&gt;â€¢ majority of insulinomas are benign&lt;/li&gt;&lt;li&gt;â€¢ Option D: It is not associated with MEN 1 syndrome : This is incorrect; insulinomas can be associated with Multiple Endocrine Neoplasia Type 1 .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ It is not associated with MEN 1 syndrome&lt;/li&gt;&lt;li&gt;â€¢ insulinomas&lt;/li&gt;&lt;li&gt;â€¢ Multiple Endocrine Neoplasia Type 1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Insulinomas are beta-cell tumors , most of which are benign and can present with hypoglycemia and elevated levels of insulin and C-peptide in the blood . They may also be associated with MEN 1 syndrome .&lt;/li&gt;&lt;li&gt;âž¤ Insulinomas&lt;/li&gt;&lt;li&gt;âž¤ beta-cell tumors&lt;/li&gt;&lt;li&gt;âž¤ benign&lt;/li&gt;&lt;li&gt;âž¤ present with hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of insulin&lt;/li&gt;&lt;li&gt;âž¤ C-peptide in the blood&lt;/li&gt;&lt;li&gt;âž¤ MEN 1 syndrome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1124&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1124&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Fine needle aspiration cytology is not able to detect which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hashimoto thyroiditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Follicular cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medullary cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Follicular cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Follicular cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma: FNAC is usually diagnostic for papillary carcinoma due to its distinctive cytological features , including nuclear grooves and psammoma bodies .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ diagnostic for papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ distinctive cytological features&lt;/li&gt;&lt;li&gt;â€¢ nuclear grooves&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hashimoto thyroiditis: FNAC can suggest this diagnosis when lymphocytes and Hurthle cells are present , indicating an autoimmune process .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Hashimoto thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ diagnosis when lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ Hurthle cells are present&lt;/li&gt;&lt;li&gt;â€¢ autoimmune process&lt;/li&gt;&lt;li&gt;â€¢ Option D: Medullary cancer: FNAC can suggest medullary carcinoma by demonstrating amyloid and calcitonin in cells , but a definitive diagnosis often requires additional tests such as serum calcitonin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Medullary cancer:&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ medullary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ demonstrating amyloid&lt;/li&gt;&lt;li&gt;â€¢ calcitonin in cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While FNAC is a useful tool in the initial assessment of thyroid nodules, it cannot distinguish between follicular adenoma and follicular carcinoma due to the necessity of examining capsular and vascular invasion histologically.&lt;/li&gt;&lt;li&gt;âž¤ FNAC is a useful tool&lt;/li&gt;&lt;li&gt;âž¤ initial assessment of thyroid nodules,&lt;/li&gt;&lt;li&gt;âž¤ cannot distinguish between follicular adenoma&lt;/li&gt;&lt;li&gt;âž¤ follicular carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Psammoma bodies are seen in all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma of thyroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenocarcinoma of colon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Papillary cancer of the ovary&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adenocarcinoma of colon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Adenocarcinoma of colon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma of thyroid: It is known to frequently have psammoma bodies , which are calcified concentric structures found within the tumor tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Papillary carcinoma of thyroid:&lt;/li&gt;&lt;li&gt;â€¢ frequently have psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ calcified concentric structures&lt;/li&gt;&lt;li&gt;â€¢ Option C: Meningioma: This benign brain tumor often contains psammoma bodies , contributing to its classic histological appearance .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Meningioma:&lt;/li&gt;&lt;li&gt;â€¢ benign brain tumor&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ classic histological appearance&lt;/li&gt;&lt;li&gt;â€¢ Option D: Papillary cancer of the ovary (serous cystadenoma of the ovary): Similar to papillary thyroid carcinoma , ovarian papillary tumors can also exhibit psammoma bodies .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Papillary cancer of the ovary (serous cystadenoma of the ovary):&lt;/li&gt;&lt;li&gt;â€¢ papillary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ ovarian papillary tumors&lt;/li&gt;&lt;li&gt;â€¢ exhibit psammoma bodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Psammoma bodies are calcified structures often found in certain neoplasms such as papillary carcinoma of the thyroid, meningioma , and papillary cancer of the ovary (serous cystadenoma of the ovary) but are not typically seen in adenocarcinoma of the colon .&lt;/li&gt;&lt;li&gt;âž¤ Psammoma bodies&lt;/li&gt;&lt;li&gt;âž¤ calcified structures&lt;/li&gt;&lt;li&gt;âž¤ found in certain neoplasms&lt;/li&gt;&lt;li&gt;âž¤ papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid, meningioma&lt;/li&gt;&lt;li&gt;âž¤ papillary cancer of the ovary&lt;/li&gt;&lt;li&gt;âž¤ adenocarcinoma of the colon&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1098&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1098&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Necrobiosis lipoidica is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lyme disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Simmonds disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diabetes mellitus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/21/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diabetes mellitus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes insipidus: This is a condition characterized by polyuria and polydipsia due to issues with vasopressin (ADH); it is not associated with skin changes like necrobiosis lipoidica.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes insipidus:&lt;/li&gt;&lt;li&gt;â€¢ polyuria and polydipsia&lt;/li&gt;&lt;li&gt;â€¢ issues with vasopressin&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lyme disease : Caused by Borrelia burgdorferi and transmitted by ticks , Lyme disease can present with a variety of symptoms including erythema migrans, but not necrobiosis lipoidica.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lyme disease&lt;/li&gt;&lt;li&gt;â€¢ Borrelia burgdorferi&lt;/li&gt;&lt;li&gt;â€¢ transmitted by ticks&lt;/li&gt;&lt;li&gt;â€¢ Lyme disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: Simmonds disease: Also known as Sheehan&#x27;s syndrome , is postpartum hypopituitarism , not associated with necrobiosis lipoidica.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Simmonds disease:&lt;/li&gt;&lt;li&gt;â€¢ Sheehan&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ postpartum hypopituitarism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Necrobiosis lipoidica is a skin condition primarily associated with diabetes mellitus , presenting as well-circumscribed, waxy plaques typically on the shins with a yellowish center and telangiectatic borders .&lt;/li&gt;&lt;li&gt;âž¤ Necrobiosis lipoidica&lt;/li&gt;&lt;li&gt;âž¤ skin condition&lt;/li&gt;&lt;li&gt;âž¤ diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ well-circumscribed, waxy plaques&lt;/li&gt;&lt;li&gt;âž¤ shins&lt;/li&gt;&lt;li&gt;âž¤ yellowish center&lt;/li&gt;&lt;li&gt;âž¤ telangiectatic borders&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mauriacâ€™s syndrome is characterized by all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dwarfism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiomegaly&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiomegaly&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiomegaly&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes: Mauriac&#x27;s syndrome is specifically associated with poorly controlled type 1 diabetes mellitus in children .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diabetes:&lt;/li&gt;&lt;li&gt;â€¢ Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ poorly controlled type 1 diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ Option B: Obesity: Despite being a sign of poor glycemic control , obesity is not a characteristic of Mauriac&#x27;s syndrome . Instead, patients may present with Cushingoid features.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Obesity:&lt;/li&gt;&lt;li&gt;â€¢ sign of poor glycemic control&lt;/li&gt;&lt;li&gt;â€¢ obesity&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dwarfism: Growth impairment or stunted growth is a classical component of Mauriac&#x27;s syndrome due to chronic hyperglycemia and its metabolic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dwarfism:&lt;/li&gt;&lt;li&gt;â€¢ Growth impairment&lt;/li&gt;&lt;li&gt;â€¢ stunted growth&lt;/li&gt;&lt;li&gt;â€¢ classical component of Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ chronic hyperglycemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mauriac&#x27;s syndrome is associated with type 1 diabetes mellitus in children and presents with hepatomegaly , growth retardation , and Cushingoid features , but not with cardiomegaly.&lt;/li&gt;&lt;li&gt;âž¤ Mauriac&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ type 1 diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ children&lt;/li&gt;&lt;li&gt;âž¤ hepatomegaly&lt;/li&gt;&lt;li&gt;âž¤ growth retardation&lt;/li&gt;&lt;li&gt;âž¤ Cushingoid features&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the primary contributor to insulin resistance in liver disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased insulin release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Steatosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatocyte dysfunction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased â€˜Câ€™ peptide level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Steatosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Steatosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Decreased insulin release: This refers to a problem with insulin secretion from the pancreas , not resistance at the level of hepatic or peripheral tissues and does not directly relate to liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Decreased insulin release:&lt;/li&gt;&lt;li&gt;â€¢ problem with insulin secretion&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hepatocyte dysfunction: While hepatocyte dysfunction can contribute to metabolic disturbances , it is a broader term that includes various liver impairments, not specific to insulin resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Hepatocyte dysfunction:&lt;/li&gt;&lt;li&gt;â€¢ hepatocyte dysfunction&lt;/li&gt;&lt;li&gt;â€¢ metabolic disturbances&lt;/li&gt;&lt;li&gt;â€¢ Option D: Decreased â€˜Câ€™ peptide level: C-peptide is a byproduct of insulin production . Lower levels may indicate reduced insulin secretion but are not a direct cause of insulin resistance in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Decreased â€˜Câ€™ peptide level:&lt;/li&gt;&lt;li&gt;â€¢ C-peptide&lt;/li&gt;&lt;li&gt;â€¢ byproduct of insulin production&lt;/li&gt;&lt;li&gt;â€¢ Lower levels&lt;/li&gt;&lt;li&gt;â€¢ reduced insulin secretion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hepatic steatosis , or fatty liver disease , is a significant contributor to insulin resistance , which impairs both the liver&#x27;s response to insulin and the peripheral action of insulin .&lt;/li&gt;&lt;li&gt;âž¤ Hepatic steatosis&lt;/li&gt;&lt;li&gt;âž¤ fatty liver disease&lt;/li&gt;&lt;li&gt;âž¤ contributor to insulin resistance&lt;/li&gt;&lt;li&gt;âž¤ impairs both the liver&#x27;s response&lt;/li&gt;&lt;li&gt;âž¤ insulin&lt;/li&gt;&lt;li&gt;âž¤ peripheral action of insulin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbin 10th/ 1140, Joslinâ€™s Diabetes Mellitus 14/e p436&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbin 10th/ 1140, Joslinâ€™s Diabetes Mellitus 14/e p436&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to ADA guidelines, the diagnosis of diabetes is made when the fasting blood glucose is more than?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;126 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;100 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;140 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;200 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 126 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 126 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: 100 mg/dL: This is considered the upper limit of normal for fasting glucose , with levels between 100 mg/dL and 125 mg/dL indicating impaired fasting glucose or prediabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ 100 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ upper limit of normal for fasting glucose&lt;/li&gt;&lt;li&gt;â€¢ levels between 100 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ 125 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ impaired fasting glucose&lt;/li&gt;&lt;li&gt;â€¢ Option C: 140 mg/dL: This level is above the diagnostic criteria for diabetes when measured fasting and may also indicate diabetes if it is a 2-hour postprandial or oral glucose tolerance test (OGTT) value.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ 140 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ above the diagnostic criteria&lt;/li&gt;&lt;li&gt;â€¢ diabetes&lt;/li&gt;&lt;li&gt;â€¢ measured fasting&lt;/li&gt;&lt;li&gt;â€¢ indicate diabetes&lt;/li&gt;&lt;li&gt;â€¢ Option D: 200 mg/dL: A level of 200 mg/dL or higher may indicate diabetes if it is from a random plasma glucose test accompanied by classic symptoms of hyperglycemia or hyperglycemic crisis, or during an OGTT.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ 200 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ level of 200 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ diabetes&lt;/li&gt;&lt;li&gt;â€¢ random plasma glucose test&lt;/li&gt;&lt;li&gt;â€¢ classic symptoms&lt;/li&gt;&lt;li&gt;â€¢ hyperglycemia&lt;/li&gt;&lt;li&gt;â€¢ hyperglycemic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A fasting blood glucose level of 126 mg/dL or higher is diagnostic for diabetes mellitus according to ADA guidelines .&lt;/li&gt;&lt;li&gt;âž¤ fasting blood glucose level of 126 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ higher&lt;/li&gt;&lt;li&gt;âž¤ diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ ADA guidelines&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th /1110&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th /1110&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common association in MEN I is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lipoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucagonoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gastrinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gastrinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Insulinoma: Insulinomas are also associated with MEN I and result in hypoglycemia due to unregulated insulin secretion , but they are less common compared to gastrinomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Insulinoma:&lt;/li&gt;&lt;li&gt;â€¢ associated with MEN I&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ unregulated insulin secretion&lt;/li&gt;&lt;li&gt;â€¢ less common&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lipoma : While patients with MEN I may develop non-endocrine tumors like lipomas , these are not as commonly associated with the syndrome as endocrine tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Lipoma&lt;/li&gt;&lt;li&gt;â€¢ MEN I may develop non-endocrine tumors&lt;/li&gt;&lt;li&gt;â€¢ lipomas&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glucagonoma : Glucagonomas, which secrete glucagon , are rare pancreatic endocrine tumors and are less commonly associated with MEN I than gastrinomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Glucagonoma&lt;/li&gt;&lt;li&gt;â€¢ secrete glucagon&lt;/li&gt;&lt;li&gt;â€¢ rare pancreatic endocrine tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of MEN I , gastrinomas are the most commonly associated functional pancreatic endocrine tumors , often leading to Zollinger-Ellison syndrome , characterized by peptic ulcer disease , gastroesophageal reflux , and diarrhea due to hypergastrinemia .&lt;/li&gt;&lt;li&gt;âž¤ MEN I&lt;/li&gt;&lt;li&gt;âž¤ gastrinomas&lt;/li&gt;&lt;li&gt;âž¤ most commonly associated functional pancreatic endocrine tumors&lt;/li&gt;&lt;li&gt;âž¤ Zollinger-Ellison syndrome&lt;/li&gt;&lt;li&gt;âž¤ peptic ulcer disease&lt;/li&gt;&lt;li&gt;âž¤ gastroesophageal reflux&lt;/li&gt;&lt;li&gt;âž¤ diarrhea&lt;/li&gt;&lt;li&gt;âž¤ hypergastrinemia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1140&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1140&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What marker is indicative of a non-functional pancreatic neuroendocrine tumor (PNET)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromogranin-A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD100&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CEA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PSA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chromogranin-A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chromogranin-A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: CD100: CD100 is not a recognized marker for PNETs . CD markers are generally used in the characterization of lymphocytes and other cells of the immune system.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ CD100:&lt;/li&gt;&lt;li&gt;â€¢ not a recognized marker for PNETs&lt;/li&gt;&lt;li&gt;â€¢ Option C: CEA: Carcinoembryonic antigen (CEA) is a tumor marker associated with colorectal cancer and some other adenocarcinomas, not specifically with PNETs.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ CEA:&lt;/li&gt;&lt;li&gt;â€¢ tumor marker associated with colorectal cancer&lt;/li&gt;&lt;li&gt;â€¢ Option D: PSA: Prostate-specific antigen (PSA) is used as a marker for prostate cancer . It has no relevance in the diagnosis of PNETs.&lt;/li&gt;&lt;li&gt;â€¢ Option D: PSA:&lt;/li&gt;&lt;li&gt;â€¢ marker for prostate cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chromogranin A is a marker for pancreatic non-functional neuroendocrine tumours .&lt;/li&gt;&lt;li&gt;âž¤ Chromogranin A&lt;/li&gt;&lt;li&gt;âž¤ marker for pancreatic non-functional neuroendocrine tumours&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 720&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 720&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents to the clinic with complaints of bilateral lower extremity swelling and fatigue for the past several months. He has a past medical history significant for poorly controlled diabetes mellitus, hypertension, and obesity. Laboratory investigations reveal elevated serum creatinine and proteinuria. A renal biopsy is performed, which demonstrates deposition of amyloid proteins in the glomeruli. Which of the following types of diabetes mellitus is most commonly associated with this renal complication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Maturity onset DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type I DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type II DM&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type II DM&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type II DM&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Maturity onset diabetes of the young (MODY) is characterized by monogenic defects of Î²-cell function but is not typically associated with amyloid deposition in the islets.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Maturity onset diabetes of the young&lt;/li&gt;&lt;li&gt;â€¢ monogenic defects of Î²-cell function&lt;/li&gt;&lt;li&gt;â€¢ Option B: Type I DM is an autoimmune disorder leading to Î²-cell destruction and does not typically involve amyloid deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Type I DM&lt;/li&gt;&lt;li&gt;â€¢ autoimmune disorder&lt;/li&gt;&lt;li&gt;â€¢ Î²-cell destruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amyloid deposition in the islets of Langerhans is a feature specifically associated with Type II diabetes mellitus , which can contribute to the dysfunction of insulin-secreting pancreatic Î²-cells .&lt;/li&gt;&lt;li&gt;âž¤ Amyloid deposition&lt;/li&gt;&lt;li&gt;âž¤ islets of Langerhans&lt;/li&gt;&lt;li&gt;âž¤ Type II diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ dysfunction of insulin-secreting pancreatic Î²-cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 261&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 261&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following thyroid carcinoma variants is not associated with aggressiveness?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Follicular variant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Unencapsulated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tall cell variant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxyphilic (Hurthle) cell type&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Follicular variant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Follicular variant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Unencapsulated: Lack of encapsulation is a feature associated with increased aggressiveness in papillary carcinoma . Encapsulation can help contain the tumor and prevent its spread . So, this option matches the criteria for aggressiveness.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Unencapsulated:&lt;/li&gt;&lt;li&gt;â€¢ Lack of encapsulation&lt;/li&gt;&lt;li&gt;â€¢ increased aggressiveness in papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Encapsulation&lt;/li&gt;&lt;li&gt;â€¢ contain the tumor&lt;/li&gt;&lt;li&gt;â€¢ prevent its spread&lt;/li&gt;&lt;li&gt;â€¢ Option C: Tall cell variant: The tall cell variant of papillary carcinoma is associated with a more aggressive behavior compared to classical papillary carcinoma . Therefore, this option matches the criteria for aggressiveness.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Tall cell variant:&lt;/li&gt;&lt;li&gt;â€¢ papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ more aggressive behavior&lt;/li&gt;&lt;li&gt;â€¢ classical papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D: Oxyphilic (Hurthle) cell type: Hurthle cell carcinoma, a variant of follicular thyroid carcinoma , is generally considered more aggressive than papillary carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Oxyphilic (Hurthle) cell type:&lt;/li&gt;&lt;li&gt;â€¢ variant of follicular thyroid carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The f ollicular variant of papillary carcinoma tends to have a better prognosis compared to classical papillary carcinoma as it is less aggressive in its behavior .&lt;/li&gt;&lt;li&gt;âž¤ f&lt;/li&gt;&lt;li&gt;âž¤ ollicular variant of papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ better prognosis&lt;/li&gt;&lt;li&gt;âž¤ classical papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ less aggressive in its behavior&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1091&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1091&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following thyroid carcinomas originates from C-cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Medullary carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Medullary carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular carcinoma: This carcinoma arises from follicular cells , which are responsible for synthesizing and secreting thyroid hormones , not calcitonin.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Follicular carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ carcinoma arises from follicular cells&lt;/li&gt;&lt;li&gt;â€¢ synthesizing&lt;/li&gt;&lt;li&gt;â€¢ secreting thyroid hormones&lt;/li&gt;&lt;li&gt;â€¢ Option C: Papillary carcinoma: The most common type of thyroid cancer , also derived from follicular cells , and not from C-cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ common type of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ follicular cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma: A rare and highly aggressive thyroid cancer that arises from follicular cells and has a poor prognosis ; it does not originate from C-cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Anaplastic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ rare and highly aggressive thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ arises from follicular cells&lt;/li&gt;&lt;li&gt;â€¢ has a poor prognosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary carcinoma of the thyroid is derived from C-cells , which are distinct from follicular cells that give rise to the more common papillary and follicular thyroid carcinomas . Medullary thyroid carcinoma is characterized by the production of calcitonin and may be associated with multiple endocrine neoplasia type 2 (MEN2).&lt;/li&gt;&lt;li&gt;âž¤ Medullary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid is derived from C-cells&lt;/li&gt;&lt;li&gt;âž¤ distinct from follicular cells&lt;/li&gt;&lt;li&gt;âž¤ rise to the more common papillary&lt;/li&gt;&lt;li&gt;âž¤ follicular thyroid carcinomas&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ production of calcitonin&lt;/li&gt;&lt;li&gt;âž¤ multiple endocrine neoplasia type 2&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1095&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1095&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hurthle cell tumor is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ionizing radiation in early decades is a major risk factor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Follicular carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma â€“ This is the most common type of thyroid carcinoma , but Hurthle cell tumors are not classified as papillary carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Papillary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Hurthle cell tumors&lt;/li&gt;&lt;li&gt;â€¢ papillary carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medullary carcinoma â€“ This type arises from parafollicular C cells , which is not related to the follicular cells that give rise to Hurthle cell tumors .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Medullary carcinoma&lt;/li&gt;&lt;li&gt;â€¢ arises from parafollicular C cells&lt;/li&gt;&lt;li&gt;â€¢ not related to the follicular cells&lt;/li&gt;&lt;li&gt;â€¢ Hurthle cell tumors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ionizing radiation in early decades is a major risk factor â€“ While exposure to ionizing radiation is a known risk factor for thyroid carcinoma , it is not specifically tied to the pathogenesis of Hurthle cell tumors, which are a variant of follicular carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Ionizing radiation in early decades is a major risk factor&lt;/li&gt;&lt;li&gt;â€¢ exposure to ionizing radiation&lt;/li&gt;&lt;li&gt;â€¢ risk factor&lt;/li&gt;&lt;li&gt;â€¢ thyroid carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hurthle cell tumors are a variant of follicular thyroid carcinoma , which are characterized by distinctive large cells with abundant granular cytoplasm and are encapsulated . They differ from papillary and medullary thyroid carcinomas both in terms of their origin and histological appearance.&lt;/li&gt;&lt;li&gt;âž¤ Hurthle cell tumors&lt;/li&gt;&lt;li&gt;âž¤ variant of follicular thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ distinctive large cells&lt;/li&gt;&lt;li&gt;âž¤ abundant granular cytoplasm&lt;/li&gt;&lt;li&gt;âž¤ encapsulated&lt;/li&gt;&lt;li&gt;âž¤ differ from papillary&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;About papillary carcinoma of thyroid, all are true except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prognosis better&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psammoma body present in 50% cases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Early metastasis with poor prognosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spreads by the lymphatic route&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Early metastasis with poor prognosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Early metastasis with poor prognosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Prognosis better: This is true . Papillary carcinoma of the thyroid generally has an excellent prognosis, especially when diagnosed early and in younger patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Prognosis better:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B: Psammoma body present in 50% cases: Psammoma bodies are calcifications that are often found in papillary thyroid carcinoma but may not be present in as many as 50% of cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Psammoma body present in 50% cases:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Spreads by the lymphatic route: This is true . Papillary thyroid carcinoma commonly spreads to regional lymph nodes via lymphatics.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Spreads by the lymphatic route:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Papillary carcinoma of the thyroid typically has a favorable prognosis , even with early lymphatic spread , contrasting with other cancers where early metastasis often correlates with a poor prognosis .&lt;/li&gt;&lt;li&gt;âž¤ Papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid&lt;/li&gt;&lt;li&gt;âž¤ favorable prognosis&lt;/li&gt;&lt;li&gt;âž¤ early lymphatic spread&lt;/li&gt;&lt;li&gt;âž¤ contrasting&lt;/li&gt;&lt;li&gt;âž¤ cancers&lt;/li&gt;&lt;li&gt;âž¤ early metastasis&lt;/li&gt;&lt;li&gt;âž¤ poor prognosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1086&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1086&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 51-year-old man Sonu with a history of recurrent calcium-containing renal stones presents to the emergency room with excruciating flank pain and blood in the urine. This patient is likely to have which of the following underlying disorders?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Proteus infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperaldosteronism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Anemia of chronic disease â€“ This condition is associated with long-standing , chronic illnesses that lead to alterations in iron metabolism and erythropoiesis but is not directly related to calcium stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Anemia of chronic disease&lt;/li&gt;&lt;li&gt;â€¢ long-standing&lt;/li&gt;&lt;li&gt;â€¢ chronic illnesses&lt;/li&gt;&lt;li&gt;â€¢ alterations in iron metabolism&lt;/li&gt;&lt;li&gt;â€¢ erythropoiesis&lt;/li&gt;&lt;li&gt;â€¢ Option B: Chronic Proteus infection â€“ While Proteus bacteria can increase the risk for struvite stone formation due to urease production , it is not typically associated with calcium stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Chronic Proteus infection&lt;/li&gt;&lt;li&gt;â€¢ Proteus bacteria&lt;/li&gt;&lt;li&gt;â€¢ increase the risk for struvite stone formation&lt;/li&gt;&lt;li&gt;â€¢ urease production&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyperaldosteronism â€“ This condition leads to hypertension and hypokalemia due to excess aldosterone and is not typically associated with calcium-containing renal stone disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hyperaldosteronism&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ hypokalemia&lt;/li&gt;&lt;li&gt;â€¢ excess aldosterone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recurrent calcium-containing renal stones may suggest an underlying disorder of calcium metabolism, such as hyperparathyroidism , due to its association with increased PTH levels , hypercalcemia , and hypercalciuria .&lt;/li&gt;&lt;li&gt;âž¤ Recurrent calcium-containing renal stones&lt;/li&gt;&lt;li&gt;âž¤ underlying disorder of calcium metabolism,&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ increased PTH levels&lt;/li&gt;&lt;li&gt;âž¤ hypercalcemia&lt;/li&gt;&lt;li&gt;âž¤ hypercalciuria&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 9/e p1103&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 9/e p1103&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common thyroid cancer after radiation exposure is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medullary cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Follicular cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Papillary cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Papillary cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medullary cancer: Medullary thyroid cancer arises from parafollicular C-cells and is typically associated with genetic mutations in the RET proto-oncogene , not with radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medullary cancer:&lt;/li&gt;&lt;li&gt;â€¢ arises from parafollicular C-cells&lt;/li&gt;&lt;li&gt;â€¢ genetic mutations in the RET proto-oncogene&lt;/li&gt;&lt;li&gt;â€¢ Option C: Follicular cancer: While not associated with radiation exposure , the incidence of follicular carcinoma is higher in areas with iodine deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Follicular cancer:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ radiation exposure&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic cancer: Anaplastic thyroid cancer is a rare and aggressive form of thyroid cancer that generally occurs in the elderly population and is not associated with radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Anaplastic cancer:&lt;/li&gt;&lt;li&gt;â€¢ rare and aggressive form of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ occurs in the elderly population&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Papillary thyroid carcinoma is the most common thyroid cancer associated with childhood exposure to ionizing radiation , which can significantly increase the risk of this cancer .&lt;/li&gt;&lt;li&gt;âž¤ Papillary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ most common thyroid cancer&lt;/li&gt;&lt;li&gt;âž¤ childhood exposure&lt;/li&gt;&lt;li&gt;âž¤ ionizing radiation&lt;/li&gt;&lt;li&gt;âž¤ increase the risk of this cancer&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1086&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1086&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Orphan Annie eye nuclei appearance is characteristic of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma thyroid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carcinoma pituitary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paraganglioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Papillary carcinoma thyroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-094905.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Papillary carcinoma thyroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ &#x27;Orphan Annie eye&#x27; nuclei is a distinctive cytological feature of papillary carcinoma of the thyroid , which is important for diagnosis and distinguishing it from other neoplasms.&lt;/li&gt;&lt;li&gt;âž¤ &#x27;Orphan Annie eye&#x27; nuclei&lt;/li&gt;&lt;li&gt;âž¤ distinctive cytological feature&lt;/li&gt;&lt;li&gt;âž¤ papillary carcinoma&lt;/li&gt;&lt;li&gt;âž¤ thyroid&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1087&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1087&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The laboratory screening test which suggests normal thyroid function is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TSH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Free T4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Free T3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. TSH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) TSH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Free T4: Free T4 measurement reflects the biologically active portion of thyroxine and can be normal in early or mild forms of thyroid dysfunction .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Free T4:&lt;/li&gt;&lt;li&gt;â€¢ Free T4 measurement reflects&lt;/li&gt;&lt;li&gt;â€¢ biologically active portion of thyroxine&lt;/li&gt;&lt;li&gt;â€¢ normal in early or mild forms&lt;/li&gt;&lt;li&gt;â€¢ thyroid dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Option C: T3: Total T3 levels can be affected by factors that influence binding proteins and are not the first line of screening; they are more helpful in diagnosing hyperthyroidism or in certain clinical situations like T3 toxicosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ T3:&lt;/li&gt;&lt;li&gt;â€¢ affected by factors&lt;/li&gt;&lt;li&gt;â€¢ influence binding proteins&lt;/li&gt;&lt;li&gt;â€¢ not the first line of screening;&lt;/li&gt;&lt;li&gt;â€¢ Option D: Free T3: Similar to T3, Free T3 is not the first line of screening but rather used for specific clinical indications and is less commonly measured than TSH or Free T4.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Free T3:&lt;/li&gt;&lt;li&gt;â€¢ Free T3 is not the first line of screening&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TSH is the most sensitive initial screening test for evaluating thyroid function because it reflects the pituitary&#x27;s response to the serum concentration of free thyroid hormones , particularly free T4.&lt;/li&gt;&lt;li&gt;âž¤ TSH&lt;/li&gt;&lt;li&gt;âž¤ most sensitive initial screening test&lt;/li&gt;&lt;li&gt;âž¤ evaluating thyroid function&lt;/li&gt;&lt;li&gt;âž¤ reflects the pituitary&#x27;s response&lt;/li&gt;&lt;li&gt;âž¤ serum concentration&lt;/li&gt;&lt;li&gt;âž¤ free thyroid hormones&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1083&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1083&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Medullary carcinoma of the thyroid is associated with which of the following syndrome:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MEN I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MEN II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fraumeni syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hashimotoâ€™s thyroiditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MEN II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MEN II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: MEN I â€“ Incorrect. MEN I typically involves tumors of the parathyroid glands , pituitary gland , and pancreas , not medullary thyroid carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ MEN I â€“ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ tumors of the parathyroid glands&lt;/li&gt;&lt;li&gt;â€¢ pituitary gland&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option C: Li-Fraumeni syndrome â€“ Incorrect. This is a hereditary cancer syndrome associated with a variety of cancers , including sarcomas, breast cancer, and brain tumors, but not specifically medullary thyroid carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Li-Fraumeni syndrome â€“ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ hereditary cancer syndrome&lt;/li&gt;&lt;li&gt;â€¢ variety of cancers&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hashimotoâ€™s thyroiditis â€“ Incorrect. This is an autoimmune disease of the thyroid gland and is not directly associated with medullary thyroid carcinoma , although thyroid cancer can occur more frequently in the setting of Hashimoto&#x27;s thyroiditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hashimotoâ€™s thyroiditis â€“ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ autoimmune disease&lt;/li&gt;&lt;li&gt;â€¢ thyroid gland&lt;/li&gt;&lt;li&gt;â€¢ medullary thyroid carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma is commonly associated with Multiple Endocrine Neoplasia type II (MEN II), which includes two subtypes , MEN IIA and MEN IIB , both characterized by the occurrence of medullary thyroid carcinoma and p heochromocytomas . MEN IIA also includes parathyroid adenomas or hyperplasia.&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Multiple Endocrine Neoplasia type II&lt;/li&gt;&lt;li&gt;âž¤ two subtypes&lt;/li&gt;&lt;li&gt;âž¤ MEN IIA&lt;/li&gt;&lt;li&gt;âž¤ MEN IIB&lt;/li&gt;&lt;li&gt;âž¤ occurrence of medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ heochromocytomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1129&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1129&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a family history of endocrine neoplasia presents with a thyroid nodule. Histological examination of the nodule after fine-needle aspiration biopsy reveals amyloid deposition. Which of the following types of thyroid carcinoma is the woman most likely to have?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Medullary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Medullary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma: This is the most common type of thyroid cancer and is characterized by branching papillae and often presents with psammoma bodies . It is not typically associated with amyloid deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ most common type of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ branching papillae&lt;/li&gt;&lt;li&gt;â€¢ psammoma bodies&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular carcinoma : It does not characteristically involve amyloid deposition .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Follicular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ involve amyloid deposition&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma: This is a highly aggressive and undifferentiated form of thyroid cancer . Amyloid is not a feature of anaplastic thyroid carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ highly aggressive&lt;/li&gt;&lt;li&gt;â€¢ undifferentiated form of thyroid cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma is unique among thyroid cancers as it originates from parafollicular C-cells and is associated with amyloid deposition within the tumor , which can be identified histologically. This type of carcinoma can occur sporadically or as part of the multiple endocrine neoplasia type 2 syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ unique&lt;/li&gt;&lt;li&gt;âž¤ thyroid cancers&lt;/li&gt;&lt;li&gt;âž¤ originates from parafollicular C-cells&lt;/li&gt;&lt;li&gt;âž¤ amyloid deposition&lt;/li&gt;&lt;li&gt;âž¤ tumor&lt;/li&gt;&lt;li&gt;âž¤ type of carcinoma&lt;/li&gt;&lt;li&gt;âž¤ sporadically&lt;/li&gt;&lt;li&gt;âž¤ part of the multiple endocrine neoplasia type 2 syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1091&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1091&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is not seen in MEN I:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parathyroid adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pancreatic cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolactinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medullary carcinoma thyroid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Medullary carcinoma thyroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Medullary carcinoma thyroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Multiple Endocrine Neoplasia type I (MEN I) is characterized by the presence of tumors in parathyroid glands , anterior pituitary, and pancreatic islets , and does not commonly include medullary carcinoma of the thyroid, which is associated with MEN II.&lt;/li&gt;&lt;li&gt;âž¤ Multiple Endocrine Neoplasia type I&lt;/li&gt;&lt;li&gt;âž¤ presence of tumors in parathyroid glands&lt;/li&gt;&lt;li&gt;âž¤ anterior pituitary,&lt;/li&gt;&lt;li&gt;âž¤ pancreatic islets&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1091&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1091&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman presents with a solitary thyroid nodule. Fine needle aspiration cytology (FNAC) is performed, and the pathologist reports that the distinction between a benign and a malignant lesion cannot be made with certainty. Which type of thyroid nodule is most notorious for requiring histologic examination beyond FNAC to establish a definitive diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma of thyroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carcinoma breast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenocarcinoma lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Follicular carcinoma of thyroid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Follicular carcinoma of thyroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Follicular carcinoma of thyroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma of thyroid : Papillary carcinoma typically shows distinctive nuclear features on FNAC which are usually diagnostic, making it sufficient for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma of thyroid&lt;/li&gt;&lt;li&gt;â€¢ distinctive nuclear features on FNAC&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carcinoma breast : FNAC can be diagnostic for breast carcinoma, showing malignant cells , but a core biopsy is often preferred for additional architectural and immunohistochemical information.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carcinoma breast&lt;/li&gt;&lt;li&gt;â€¢ diagnostic for breast carcinoma,&lt;/li&gt;&lt;li&gt;â€¢ malignant cells&lt;/li&gt;&lt;li&gt;â€¢ Option C: Adenocarcinoma lung : While FNAC can suggest adenocarcinoma of the lung by demonstrating malignant glandular cells, a core biopsy is usually required for complete characterization.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Adenocarcinoma lung&lt;/li&gt;&lt;li&gt;â€¢ FNAC&lt;/li&gt;&lt;li&gt;â€¢ adenocarcinoma of the lung&lt;/li&gt;&lt;li&gt;â€¢ malignant glandular cells,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While FNAC can suggest follicular neoplasm , it cannot differentiate follicular carcinoma from follicular adenoma as the latter requires the identification of capsular or vascular invasion, which necessitates histological examination of the entire surgical specimen.&lt;/li&gt;&lt;li&gt;âž¤ FNAC&lt;/li&gt;&lt;li&gt;âž¤ follicular neoplasm&lt;/li&gt;&lt;li&gt;âž¤ cannot differentiate follicular carcinoma&lt;/li&gt;&lt;li&gt;âž¤ follicular adenoma&lt;/li&gt;&lt;li&gt;âž¤ latter requires the identification of capsular&lt;/li&gt;&lt;li&gt;âž¤ vascular invasion,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old female presents to her primary care physician with a history of a progressively enlarging neck mass over the past several years. She reports no symptoms of dysphagia, dyspnea, or hoarseness. Physical examination reveals a palpable, non-tender, firm mass in the anterior neck consistent with a long-standing goitre. Which malignancy develops in long standing goitre?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papillary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follicular carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaplastic carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Follicular carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Follicular carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma: This is the most common thyroid malignancy and can occur with or without a preceding goiter . It has a distinctive histological appearance but is not particularly associated with iodine deficiency or long-standing goiters.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Papillary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ most common thyroid malignancy&lt;/li&gt;&lt;li&gt;â€¢ with or without a preceding goiter&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medullary carcinoma: This type of cancer arises from parafollicular C cells producing calcitonin and is commonly associated with genetic syndromes like MEN 2, rather than long-standing goiters.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Medullary carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ cancer arises from parafollicular C cells&lt;/li&gt;&lt;li&gt;â€¢ calcitonin&lt;/li&gt;&lt;li&gt;â€¢ genetic syndromes like MEN 2,&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma: This is a very aggressive form of thyroid cancer that can arise de novo or from existing well-differentiated tumors but isn&#x27;t specifically linked to long-standing goiters.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Anaplastic carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ very aggressive form of thyroid cancer&lt;/li&gt;&lt;li&gt;â€¢ arise de novo&lt;/li&gt;&lt;li&gt;â€¢ existing well-differentiated tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Follicular carcinoma of the thyroid is associated with iodine deficiency and is more likely to develop in the setting of a long-standing goiter . This malignancy is notorious for hematogenous spread and requires thorough histological examination to differentiate it from benign conditions.&lt;/li&gt;&lt;li&gt;âž¤ thyroid is associated with iodine deficiency&lt;/li&gt;&lt;li&gt;âž¤ develop in the setting of a long-standing goiter&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ notorious for hematogenous spread&lt;/li&gt;&lt;li&gt;âž¤ histological examination&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1089&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1089&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old patient presents with symptoms of hypercalcemia, peptic ulcer disease, and a pituitary mass on imaging. Given these clinical features, which of the following conditions is least likely to be part of the patient&#x27;s underlying syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Foregut carcinoid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior pituitary tumors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic neuroendocrine tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parathyroid hyperplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Posterior pituitary tumors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Posterior pituitary tumors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Foregut carcinoid - Foregut carcinoids (including those found in the thymus, lung, and stomach) are part of the spectrum of MEN-1 syndrome , although less common compared to other manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Foregut carcinoid&lt;/li&gt;&lt;li&gt;â€¢ part of the spectrum of MEN-1 syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: Pancreatic neuroendocrine tumors - These tumors are a hallmark of MEN-1 and can produce a variety of symptoms depending on the hormone they secrete (e.g., gastrin, insulin).&lt;/li&gt;&lt;li&gt;â€¢ Option C: Pancreatic neuroendocrine tumors&lt;/li&gt;&lt;li&gt;â€¢ hallmark of MEN-1&lt;/li&gt;&lt;li&gt;â€¢ produce a variety of symptoms&lt;/li&gt;&lt;li&gt;â€¢ hormone they secrete&lt;/li&gt;&lt;li&gt;â€¢ Option D: Parathyroid hyperplasia - Primary hyperparathyroidism due to parathyroid hyperplasia is the most common feature of MEN-1 syndrome, causing hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Parathyroid hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ Primary hyperparathyroidism&lt;/li&gt;&lt;li&gt;â€¢ parathyroid hyperplasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MEN-1 syndrome, also known as Wermer syndrome, is characterized by anterior pituitary tumors, pancreatic neuroendocrine tumors , and parathyroid hyperplasia, but not by tumors of the posterior pituitary.&lt;/li&gt;&lt;li&gt;âž¤ MEN-1 syndrome,&lt;/li&gt;&lt;li&gt;âž¤ Wermer syndrome,&lt;/li&gt;&lt;li&gt;âž¤ anterior pituitary tumors,&lt;/li&gt;&lt;li&gt;âž¤ pancreatic neuroendocrine tumors&lt;/li&gt;&lt;li&gt;âž¤ parathyroid hyperplasia,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1129&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1129&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are feature of granulomatous thyroiditis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Painless&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Giant cell on histological examination&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Painless&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Painless&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: In the initial phase of granulomatous (subacute) thyroiditis , there may be a transient hyperthyroid phase due to the inflammatory destruction of thyroid follicles leading to the release of preformed thyroid hormones into circulation .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ initial phase of granulomatous&lt;/li&gt;&lt;li&gt;â€¢ thyroiditis&lt;/li&gt;&lt;li&gt;â€¢ transient hyperthyroid phase&lt;/li&gt;&lt;li&gt;â€¢ inflammatory destruction of thyroid follicles&lt;/li&gt;&lt;li&gt;â€¢ release of preformed thyroid hormones into circulation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Following the hyperthyroid phase of granulomatous thyroiditis, there is a hypothyroid phase as the damaged thyroid may be temporarily unable to produce sufficient hormones . This is usually self-limited, and normal thyroid function often returns, but some patients may develop permanent hypothyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ hyperthyroid phase&lt;/li&gt;&lt;li&gt;â€¢ granulomatous thyroiditis,&lt;/li&gt;&lt;li&gt;â€¢ hypothyroid phase&lt;/li&gt;&lt;li&gt;â€¢ damaged thyroid&lt;/li&gt;&lt;li&gt;â€¢ temporarily unable to produce sufficient hormones&lt;/li&gt;&lt;li&gt;â€¢ Option D: Granulomatous thyroiditis is characterized histologically by granuloma formation with giant cells . These multinucleated giant cells are part of the body&#x27;s response to inflammation and are involved in the degradation of thyroglobulin, which is released during the follicular destruction.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Granulomatous thyroiditis&lt;/li&gt;&lt;li&gt;â€¢ histologically&lt;/li&gt;&lt;li&gt;â€¢ granuloma formation with giant cells&lt;/li&gt;&lt;li&gt;â€¢ multinucleated giant cells&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s response to inflammation&lt;/li&gt;&lt;li&gt;â€¢ degradation of thyroglobulin,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Granulomatous thyroiditis is the most common cause of thyroid pain, not a painless condition.&lt;/li&gt;&lt;li&gt;âž¤ Granulomatous thyroiditis&lt;/li&gt;&lt;li&gt;âž¤ thyroid pain,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1093&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1093&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Brown tumour is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoparathyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-101457.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brown tumors are associated with hyperparathyroidism and represent a severe manifestation of osteitis fibrosa cystica , where excessive bone resorption leads to fibrous and cystic bone changes .&lt;/li&gt;&lt;li&gt;âž¤ Brown tumors&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ represent a severe manifestation&lt;/li&gt;&lt;li&gt;âž¤ osteitis fibrosa cystica&lt;/li&gt;&lt;li&gt;âž¤ excessive bone resorption&lt;/li&gt;&lt;li&gt;âž¤ fibrous&lt;/li&gt;&lt;li&gt;âž¤ cystic bone changes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common cause of Cushingâ€™s syndrome is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exogenous corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pituitary tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenal adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Exogenous corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Exogenous corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: A pituitary adenoma that secretes adrenocorticotropic hormone (ACTH) can cause Cushing&#x27;s disease , which is a subset of Cushing&#x27;s syndrome. This is the most common cause of endogenous Cushing&#x27;s syndrome , but overall less common than the exogenous form caused by taking corticosteroid medications.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ pituitary adenoma&lt;/li&gt;&lt;li&gt;â€¢ secretes adrenocorticotropic hormone&lt;/li&gt;&lt;li&gt;â€¢ Cushing&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ common cause of endogenous Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C: An adrenal adenoma is a benign tumor of the adrenal gland that can autonomously secrete cortisol . It&#x27;s a less common cause of Cushing&#x27;s syndrome compared to exogenous steroid use and pituitary tumors but should be considered, especially when ACTH levels are low.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ adrenal adenoma&lt;/li&gt;&lt;li&gt;â€¢ benign tumor&lt;/li&gt;&lt;li&gt;â€¢ adrenal gland&lt;/li&gt;&lt;li&gt;â€¢ autonomously secrete cortisol&lt;/li&gt;&lt;li&gt;â€¢ less common cause of Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ exogenous steroid use&lt;/li&gt;&lt;li&gt;â€¢ pituitary tumors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Adrenal carcinomas are rare but can also cause Cushing&#x27;s syndrome by secreting excessive amounts of cortisol . They are more aggressive than adenomas and can be associated with a worse prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Adrenal carcinomas&lt;/li&gt;&lt;li&gt;â€¢ rare&lt;/li&gt;&lt;li&gt;â€¢ cause Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ secreting excessive amounts of cortisol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Exogenous corticosteroids are the most common cause of Cushing&#x27;s syndrome , primarily due to the widespread use of corticosteroid medications for a variety of medical conditions.&lt;/li&gt;&lt;li&gt;âž¤ Exogenous corticosteroids&lt;/li&gt;&lt;li&gt;âž¤ most common cause of Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ widespread use of corticosteroid medications&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1115&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1115&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Submucosal neuroma is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MEN I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MEN II A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MEN II B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MEN II B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) MEN II B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Multiple Endocrine Neoplasia type I (MEN I) is a syndrome characterized by the presence of tumors in the parathyroid glands , pancreatic islet cells , and the anterior pituitary gland . Submucosal neuromas are not typically associated with MEN I.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Multiple Endocrine Neoplasia type I (MEN I)&lt;/li&gt;&lt;li&gt;â€¢ syndrome&lt;/li&gt;&lt;li&gt;â€¢ presence of tumors&lt;/li&gt;&lt;li&gt;â€¢ parathyroid glands&lt;/li&gt;&lt;li&gt;â€¢ pancreatic islet cells&lt;/li&gt;&lt;li&gt;â€¢ anterior pituitary gland&lt;/li&gt;&lt;li&gt;â€¢ Option B: Multiple Endocrine Neoplasia type II A (MEN II A) is a syndrome that includes medullary thyroid carcinoma , pheochromocytoma , and primary hyperparathyroidism . It does not typically present with submucosal neuromas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Multiple Endocrine Neoplasia type II A (MEN II A)&lt;/li&gt;&lt;li&gt;â€¢ syndrome&lt;/li&gt;&lt;li&gt;â€¢ includes medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ primary hyperparathyroidism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Submucosal neuromas are associated with MEN II B and can contribute to the diagnosis of this syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Submucosal neuromas&lt;/li&gt;&lt;li&gt;âž¤ MEN II B&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th 1130&lt;/li&gt;&lt;li&gt;âž¤ Ref: Robbins 10 th 1130&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common site of pheochromocytoma after adrenal gland is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hilum of kidney&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Organs of Zuckerkandl&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neck&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary bladder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Organs of Zuckerkandl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Organs of Zuckerkandl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: The hilum of the kidney is an area where the renal artery enters and the renal vein and ureter exit . While it is close to the adrenal glands , it is not a common site for extra-adrenal pheochromocytomas , which are tumors that arise from chromaffin cells typically found in the adrenal medulla.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ hilum of the kidney&lt;/li&gt;&lt;li&gt;â€¢ area where the renal artery enters&lt;/li&gt;&lt;li&gt;â€¢ renal vein and ureter exit&lt;/li&gt;&lt;li&gt;â€¢ close to the adrenal glands&lt;/li&gt;&lt;li&gt;â€¢ not a common site for extra-adrenal pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ Option C: While chromaffin tissue can be found along the sympathetic chain in the neck , pheochromocytomas are not commonly found in this location.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ chromaffin tissue&lt;/li&gt;&lt;li&gt;â€¢ found along&lt;/li&gt;&lt;li&gt;â€¢ sympathetic chain in the neck&lt;/li&gt;&lt;li&gt;â€¢ Option D: Pheochromocytomas can occur in the urinary bladder , but it is an uncommon site . When they do occur in this location, they can cause symptoms such as hypertension, palpitations, and headache during micturition.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ urinary bladder&lt;/li&gt;&lt;li&gt;â€¢ uncommon site&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Organs of Zuckerkandl are the most common extra-adrenal pheochromocytoma .&lt;/li&gt;&lt;li&gt;âž¤ Organs of Zuckerkandl&lt;/li&gt;&lt;li&gt;âž¤ most common extra-adrenal pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1130&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1130&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True about adrenal pheochromocytoma is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromaffin negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mostly malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral in 10% of cases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unilateral in 10% of cases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bilateral in 10% of cases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bilateral in 10% of cases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Adrenal pheochromocytomas are typically chromaffin positive , meaning they stain positively for chromaffin , which is indicative of catecholamine-secreting cells . These tumors arise from chromaffin cells in the adrenal medulla.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Adrenal pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ chromaffin positive&lt;/li&gt;&lt;li&gt;â€¢ stain positively for chromaffin&lt;/li&gt;&lt;li&gt;â€¢ catecholamine-secreting cells&lt;/li&gt;&lt;li&gt;â€¢ Option B: While pheochromocytomas can be malignant , most are benign . The malignancy rate is estimated to be about 10% in adrenal pheochromocytomas. Malignancy is usually determined by the presence of metastasis rather than histological features.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytomas can be malignant&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ malignancy rate&lt;/li&gt;&lt;li&gt;â€¢ about 10% in adrenal pheochromocytomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D: This statement is incorrect because unilateral pheochromocytomas are much more common than 10%. The majority of pheochromocytomas are unilateral.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ unilateral pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ much more common than 10%.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While most adrenal pheochromocytomas are benign and unilateral, they can be bilateral in 10% of cases , especially in hereditary syndromes .&lt;/li&gt;&lt;li&gt;âž¤ adrenal pheochromocytomas are benign and unilateral,&lt;/li&gt;&lt;li&gt;âž¤ bilateral in 10% of cases&lt;/li&gt;&lt;li&gt;âž¤ hereditary syndromes&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents to the emergency department with complaints of episodic headaches, palpitations, and sweating. Physical examination reveals elevated blood pressure and a palpable abdominal mass. Which of the following tumors is most likely to exhibit the \&quot;rule of 10\&quot; characteristic?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oncocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal cell carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pheochromocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pheochromocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Oncocytomas are benign renal epithelial tumors that typically do not follow the \&quot;rule of 10s\&quot;. They are usually asymptomatic and are often found incidentally during imaging for other conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Oncocytomas&lt;/li&gt;&lt;li&gt;â€¢ benign renal epithelial tumors&lt;/li&gt;&lt;li&gt;â€¢ do not follow the \&quot;rule of 10s\&quot;.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lymphomas are cancers of the lymphatic system and do not follow the \&quot;rule of 10s\&quot;. They have various subtypes with differing presentations and prognoses.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Lymphomas&lt;/li&gt;&lt;li&gt;â€¢ cancers of the lymphatic system&lt;/li&gt;&lt;li&gt;â€¢ do not follow the \&quot;rule of 10s\&quot;.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults and does not adhere to the \&quot;rule of 10s\&quot;. RCC has different subtypes with varying clinical behaviors and genetic associations.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Renal cell carcinoma (RCC)&lt;/li&gt;&lt;li&gt;â€¢ most common type of kidney cancer&lt;/li&gt;&lt;li&gt;â€¢ adults&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pheochromocytoma is classically described by the \&quot;rule of 10s\&quot;, which can be helpful in remembering the characteristics of this tumor for diagnosis and management decisions .&lt;/li&gt;&lt;li&gt;âž¤ Pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ \&quot;rule of 10s\&quot;,&lt;/li&gt;&lt;li&gt;âž¤ helpful in remembering&lt;/li&gt;&lt;li&gt;âž¤ tumor for diagnosis&lt;/li&gt;&lt;li&gt;âž¤ management decisions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is not seen in pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Episodic palpitations&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Weight loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diarrhea&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diarrhea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diarrhea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hypertension is a hallmark sign of pheochromocytoma and can be sustained or paroxysmal due to episodic catecholamine secretion by the tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Hypertension&lt;/li&gt;&lt;li&gt;â€¢ hallmark sign of pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ Option B: Episodic palpitations are a common symptom of pheochromocytoma due to episodic release of catecholamines , particularly norepinephrine , which stimulates the heart and causes increased contractility and heart rate.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Episodic palpitations&lt;/li&gt;&lt;li&gt;â€¢ common symptom of pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ episodic release of catecholamines&lt;/li&gt;&lt;li&gt;â€¢ norepinephrine&lt;/li&gt;&lt;li&gt;â€¢ Option C: Weight loss is frequently seen in pheochromocytoma patients . The excess catecholamines can increase metabolism and cause a hyperadrenergic state , leading to weight loss even in the presence of a good appetite.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Weight loss&lt;/li&gt;&lt;li&gt;â€¢ seen in pheochromocytoma patients&lt;/li&gt;&lt;li&gt;â€¢ excess catecholamines&lt;/li&gt;&lt;li&gt;â€¢ increase metabolism&lt;/li&gt;&lt;li&gt;â€¢ hyperadrenergic state&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While hypertension , episodic palpitations , and weight loss are common in pheochromocytoma , diarrhea is not typically associated with this condition.&lt;/li&gt;&lt;li&gt;âž¤ hypertension&lt;/li&gt;&lt;li&gt;âž¤ episodic palpitations&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mitotic figures and giant cells are seen in which of the following tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benign and malignant thyroid cancers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Benign and malignant pheochromocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Benign and malignant liver tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benign and malignant renal tumors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Benign and malignant pheochromocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Benign and malignant pheochromocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thyroid cancers can indeed present with mitotic figures , especially in more aggressive forms such as anaplastic thyroid carcinoma . However, giant cells are particularly characteristic of certain inflammatory conditions such as subacute thyroiditis, rather than thyroid neoplasms.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Thyroid cancers&lt;/li&gt;&lt;li&gt;â€¢ present with mitotic figures&lt;/li&gt;&lt;li&gt;â€¢ more aggressive forms&lt;/li&gt;&lt;li&gt;â€¢ anaplastic thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option C: Benign and malignant liver tumors \\ such as hepatocellular carcinoma can show mitotic figures , indicating a high proliferative rate . However, giant cells are more typical of specific liver pathologies such as giant cell hepatitis, not necessarily of benign or malignant liver tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Benign and malignant liver tumors&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ show mitotic figures&lt;/li&gt;&lt;li&gt;â€¢ high proliferative rate&lt;/li&gt;&lt;li&gt;â€¢ Option D: In renal tumors , mitotic figures are also indicative of a higher grade of malignancy , especially in clear cell renal carcinoma . Giant cells are not a characteristic feature of common benign or malignant renal tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ renal tumors&lt;/li&gt;&lt;li&gt;â€¢ mitotic figures&lt;/li&gt;&lt;li&gt;â€¢ higher grade of malignancy&lt;/li&gt;&lt;li&gt;â€¢ clear cell renal carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The histological presence of mitotic figures and giant cells in pheochromocytomas is not indicative of malignancy ; instead, malignancy is confirmed by the presence of metastatic disease .&lt;/li&gt;&lt;li&gt;âž¤ histological presence&lt;/li&gt;&lt;li&gt;âž¤ mitotic figures&lt;/li&gt;&lt;li&gt;âž¤ giant cells in pheochromocytomas&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ malignancy&lt;/li&gt;&lt;li&gt;âž¤ presence of metastatic disease&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Homer wright rosettes are seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuroblastoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephroblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ependymoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Neuroblastoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Neuroblastoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Also known as Wilms&#x27; tumor , nephroblastoma is a kidney tumor usually found in children . It can show other types of rosette formations, but not typically Homer Wright rosettes.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Wilms&#x27; tumor&lt;/li&gt;&lt;li&gt;â€¢ nephroblastoma&lt;/li&gt;&lt;li&gt;â€¢ kidney tumor&lt;/li&gt;&lt;li&gt;â€¢ found in children&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hepatoma , or hepatocellular carcinoma , is a liver tumor and does not feature the presence of Homer Wright rosettes. Its pathology is markedly different from that of neuroblastic tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Hepatoma&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ liver tumor&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ependymomas are glial cell tumors that can form rosettes known as perivascular rosettes or ependymal rosettes , which are distinct from Homer Wright rosettes.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Ependymomas&lt;/li&gt;&lt;li&gt;â€¢ glial cell tumors&lt;/li&gt;&lt;li&gt;â€¢ form rosettes&lt;/li&gt;&lt;li&gt;â€¢ perivascular rosettes&lt;/li&gt;&lt;li&gt;â€¢ ependymal rosettes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Homer wright rosettes are seen in Neuroblastoma.&lt;/li&gt;&lt;li&gt;âž¤ Homer wright rosettes&lt;/li&gt;&lt;li&gt;âž¤ Neuroblastoma.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 480&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 480&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not part of the â€œrule of 10â€ in pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10% are bilateral&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10% are malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;10% are extra adrenal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10% are symptomatic&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 10% are symptomatic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 10% are symptomatic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: In the context of pheochromocytoma , approximately 10% of tumors can be found bilaterally , often associated with hereditary conditions such as Multiple Endocrine Neoplasia types 2A and 2B , von Hippel-Lindau disease , and neurofibromatosis type 1 .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ approximately 10% of tumors&lt;/li&gt;&lt;li&gt;â€¢ bilaterally&lt;/li&gt;&lt;li&gt;â€¢ hereditary conditions&lt;/li&gt;&lt;li&gt;â€¢ Multiple Endocrine Neoplasia types 2A&lt;/li&gt;&lt;li&gt;â€¢ 2B&lt;/li&gt;&lt;li&gt;â€¢ von Hippel-Lindau disease&lt;/li&gt;&lt;li&gt;â€¢ neurofibromatosis type 1&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pheochromocytomas are usually benign , but about 10% can be malignant . Malignancy is determined by the presence of metastases rather than the histological appearance of the primary tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ 10% can be malignant&lt;/li&gt;&lt;li&gt;â€¢ Option C: Around 10% of pheochromocytomas are located outside of the adrenal glands , commonly in the abdomen in locations like the organ of Zuckerkandl . These are termed paragangliomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ 10% of pheochromocytomas&lt;/li&gt;&lt;li&gt;â€¢ located outside of the adrenal glands&lt;/li&gt;&lt;li&gt;â€¢ abdomen&lt;/li&gt;&lt;li&gt;â€¢ organ of Zuckerkandl&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;rule of 10\&quot; in pheochromocytoma refers to the observation that approximately:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;rule of 10\&quot;&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ observation&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are extra-adrenal. 10% of pheochromocytomas are bilateral, affecting both adrenal glands. 10% of pheochromocytomas are malignant.&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are extra-adrenal.&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are bilateral, affecting both adrenal glands.&lt;/li&gt;&lt;li&gt;âž¤ 10% of pheochromocytomas are malignant.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a feature of Sipple Syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medullary carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperthyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hyperthyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pheochromocytoma is a characteristic feature of MEN 2A and presents as a catecholamine-secreting tumor typically originating in the adrenal medulla.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Pheochromocytoma&lt;/li&gt;&lt;li&gt;â€¢ feature of MEN 2A&lt;/li&gt;&lt;li&gt;â€¢ catecholamine-secreting tumor&lt;/li&gt;&lt;li&gt;â€¢ Option B: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor of the thyroid and a principal feature of MEN 2A . It arises from the parafollicular C-cells of the thyroid gland and secretes calcitonin.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;â€¢ neuroendocrine tumor&lt;/li&gt;&lt;li&gt;â€¢ thyroid&lt;/li&gt;&lt;li&gt;â€¢ principal feature of MEN 2A&lt;/li&gt;&lt;li&gt;â€¢ Option D: Primary hyperparathyroidism is part of the MEN 2A syndrome and is due to hyperplasia or adenoma of the parathyroid glands leading to excessive secretion of parathyroid hormone (PTH).&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Primary hyperparathyroidism&lt;/li&gt;&lt;li&gt;â€¢ part of the MEN 2A syndrome&lt;/li&gt;&lt;li&gt;â€¢ due to hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ adenoma of the parathyroid glands&lt;/li&gt;&lt;li&gt;â€¢ excessive secretion of parathyroid hormone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While pheochromocytoma , medullary thyroid carcinoma , and hyperparathyroidism are part of the Sipple syndrome , hyperthyroidism is not.&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ Sipple syndrome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Robbins 10 th 1130&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Robbins 10 th 1130&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 46 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test3" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Extra Advantage Series&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Extra Advantage Series&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                188 Questions | 752 Total Marks | 198 min Duration | ~63.19 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 78-year-old woman presents with exertional dyspnea, and chest pain. Echo was done and showed severe aortic stenosis, He has hypertension, chronic kidney disease (stage G4), hyperlipidemia, severe COPD, and atrial fibrillation. What is the most appropriate next step in treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Balloon aortic valvuloplasty&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continued medical therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical aortic valve replacement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transcatheter aortic valve implantation (TAVI)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Transcatheter aortic valve implantation (TAVI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transcatheter aortic valve implantation is recommended in preference to surgical aortic valve replacement for symptomatic patients with severe aortic stenosis who are older than 80 years or younger patients with a life expectancy less than 10 years.&lt;/li&gt;&lt;li&gt;âž¤ Transcatheter aortic valve implantation is recommended for symptomatic patients of any age with severe aortic stenosis and a high or prohibitive surgical risk if predicted post procedure survival is more than 12 months with an acceptable quality of life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman presents with progressive dyspnea on exertion and fatigue. Physical examination reveals an early diastolic murmur at the left lower sternal border that increases with inspiration. ECG shows right axis deviation and right atrial enlargement. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tricuspid stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic regurgitation: Presents with a diastolic murmur at the left sternal border but decreases with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral stenosis: Presents with a diastolic murmur at the apex and does not increase with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary regurgitation: Presents with a diastolic murmur at the left sternal border but decreases with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical presentation of tricuspid stenosis, including the characteristic murmur and ECG findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with fatigue and near-syncope with exertion. He has a 3/6 systolic ejection murmur along the right upper sternal border that increases with squatting. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bicuspid aortic valve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertrophic cardiomyopathy (HCM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Restrictive membranous ventricular septal defect (VSD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ruptured sinus of Valsalva aneurysm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bicuspid aortic valve&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertrophic cardiomyopathy (HCM): The murmur of HCM is typically heard best at the left lower sternal border and decreases with squatting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertrophic cardiomyopathy (HCM):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Restrictive membranous ventricular septal defect (VSD): VSDs typically present with a holosystolic murmur, not a systolic ejection murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Restrictive membranous ventricular septal defect (VSD):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ruptured sinus of Valsalva aneurysm: This typically presents with a continuous murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ruptured sinus of Valsalva aneurysm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Systolic ejection murmur along the right upper sternal border that increases with squatting as a classic finding of a bicuspid aortic valve.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with non-ischemic dilated cardiomyopathy and severe secondary mitral regurgitation (MR) is on maximally tolerated guideline-directed medical therapy (GDMT) and is now asymptomatic. What is the most appropriate additional management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac magnetic resonance imaging (MRI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac resynchronization therapy (CRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical mitral valve repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional therapy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No additional therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac magnetic resonance imaging ( MRI): Unnecessary if the mechanism and severity of MR are already well-established.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac magnetic resonance imaging ( MRI):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac resynchronization therapy (CRT): Indicated for patients with LVEF â‰¤35%, QRS duration â‰¥150 ms, and NYHA class II-IV symptoms despite GDMT. Not applicable here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac resynchronization therapy (CRT):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical mitral valve repair: Considered if the patient remains symptomatic despite optimal GDMT or if there is progressive LV enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical mitral valve repair:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In asymptomatic patients with severe secondary MR due to LV dysfunction, optimal GDMT is the first-line therapy and usually sufficient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 49-year-old woman with no medical problems presents with a diminished S1, an aortic ejection click, and a grade 2/6 early diastolic murmur at the left sternal border that is accentuated when leaning forward. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac magnetic resonance imaging (MRI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transthoracic echocardiography (TTE)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Transthoracic echocardiography (TTE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization: Invasive and not the initial step for a new murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac magnetic resonance imaging (MRI): More expensive and not routinely used as the first-line investigation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac magnetic resonance imaging (MRI):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transesophageal echocardiography (TEE): More invasive than TTE and reserved for cases where TTE is inconclusive or there is a high suspicion of endocarditis or other valvular pathology.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transesophageal echocardiography (TEE):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transthoracic echocardiography (TTE) is the initial diagnostic test of choice for evaluating a new cardiac murmur.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old man presents with a 3 hour history of chest pain. His BP is 80/50 mmHg, HR is 120/min and has elevated JVP and clear lungs. ECG is shown. What is the most appropriate treatment ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intra-aortic balloon pump placement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous 0.9% saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous 0.9% saline&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-135849.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intra-aortic balloon pump placement: Indicated in cardiogenic shock with LV dysfunction, but not the first-line treatment for RV infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intra-aortic balloon pump placement:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous dobutamine: Inotrope may be considered if fluids are ineffective, but not the initial management.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous dobutamine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral metoprolol: Beta-blockers can worsen hypotension and should be avoided in RV infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral metoprolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A patient with an inferior myocardial infarction with right ventricular involvement and hypotension should receive intravenous fluids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with atrial fibrillation and severe primary mitral regurgitation (MR) due to mitral valve prolapse has an LVEF of 55% and LV end-systolic dimension of 60 mm. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac magnetic resonance imaging (MRI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Surgical mitral valve repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transcatheter mitral valve repair (TMVR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Surgical mitral valve repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac magnetic resonance imaging (MRI): Unnecessary if the mechanism and severity of MR are already established by TTE.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac magnetic resonance imaging (MRI):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transcatheter mitral valve repair (TMVR): Considered in patients with favourable anatomy and high risk for surgical repair.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transcatheter mitral valve repair (TMVR):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transesophageal echocardiography (TEE): May be helpful if TTE is inconclusive, but not necessary in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transesophageal echocardiography (TEE):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Surgery for chronic primary severe mitral regurgitation is indicated in the presence of symptoms, left ventricular dilation, or reduced ejection fraction.&lt;/li&gt;&lt;li&gt;âž¤ Surgical mitral valve repair is first-line therapy for patients with primary severe mitral regurgitation meeting indications for intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with a mechanical mitral valve prosthesis is planning pregnancy. She is currently on warfarin 4mg with a stable INR of 3.0. What is the most appropriate anticoagulation strategy during the first trimester?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stop warfarin and start bivalirudin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stop warfarin and start dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop warfarin and start subcutaneous dose-adjusted unfractionated heparin (UFH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Continue warfarin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Continue warfarin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stop warfarin and start Bivalirudin: Not recommended for long-term anticoagulation in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stop warfarin and start Bivalirudin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stop warfarin and start Dabigatran : Direct oral anticoagulants (DOACs) are not recommended in pregnancy due to limited safety data.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stop warfarin and start Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stop warfarin and start subcutaneous dose-adjusted unfractionated heparin UFH: Can be considered if warfarin dose is &amp;gt;5 mg/d or if the patient prefers to avoid warfarin during the first trimester.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stop warfarin and start subcutaneous dose-adjusted unfractionated heparin&lt;/li&gt;&lt;li&gt;â€¢ UFH:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Warfarin is the preferred anticoagulant for pregnant women with mechanical heart valves if the dose is â‰¤5 mg/d.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man with a history of aortic valve replacement and end-stage renal disease on hemodialysis presents with progressive fatigue, fever, shortness of breath and bilateral basal crackles. ECG shows first degree AV block. Echocardiogram shows a vegetation on the aortic valve bioprosthesis with severe aortic regurgitation. After blood cultures and empiric antibiotics are initiated, what is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early surgical aortic valve replacement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Placement of a temporary pacemaker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No change in therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Early surgical aortic valve replacement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization: Can be done in selected patients at the time of surgery to determine the need of coronary artery bypass grafting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Placement of a temporary pacemaker: Not the most important step at this point.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Placement of a temporary pacemaker:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No change in therapy: Inadequate as surgery is required for definitive management of PVE with complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No change in therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Early surgical valve replacement is indicated in patients with IE and heart failure, annular or aortic abscess, or destructive penetrating lesions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man with a history of hypertension and hyperlipidemia presents with exertional dyspnea and elevated BNP. 2D Echo shows EF of 45% and low-flow, low-gradient severe aortic stenosis. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dobutamine stress echocardiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical aortic valve replacement (SAVR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transcatheter aortic valve implantation (TAVI)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dobutamine stress echocardiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization: In this patient who likely has low cardiac output, direct measurement of the aortic valve gradient by cardiac catheterization (Option A) would result in low gradients that underestimate the severity of the AS, similar to gradient and velocity values on resting echocardiography. Dobutamine catheterization may be performed in lieu of dobutamine echocardiography in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization:&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;amp; option D. Surgical aortic valve replacement  (SAVR) or Transcatheter aortic valve implantation (TAVI): Proceeding to surgical or transcatheter aortic valve implantation is inappropriate at this time; the resting echo does not adequately differentiate between pseudosevere AS due to insufficient stroke volume and low-flow, low-gradient severe AS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;amp; option D.&lt;/li&gt;&lt;li&gt;â€¢ Surgical aortic valve replacement  (SAVR) or Transcatheter aortic valve implantation (TAVI):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diagnose low-flow, low-gradient severe symptomatic aortic stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with nonischemic dilated cardiomyopathy, diabetes mellitus, and severe aortic stenosis undergoes coronary angiography, revealing diffuse coronary artery disease requiring CABG. Her ascending aorta measures 5.6 cm in diameter. What additional intervention is most appropriate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic valve replacement (AVR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AVR and aortic repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transcatheter aortic valve implantation (TAVI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional intervention&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AVR and aortic repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic valve replacement (AVR): Does not address the TAA, which has a high risk of rupture.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic valve replacement (AVR):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transcatheter aortic valve implantation (TAVI): Contraindicated in patients with concomitant significant CAD and TAA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transcatheter aortic valve implantation (TAVI):&lt;/li&gt;&lt;li&gt;â€¢ Option D. No intervention: This would leave the patient at risk for aortic dissection or rupture.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No intervention:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with an ascending aorta or aortic root larger than 4.5 cm in diameter who require surgery for CAD or valve pathology, aortic repair should be performed at the time of cardiac surgery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man had a mechanical mitral valve replacement 1 year ago. He is currently on warfarin and his INR is 3.4. He now presents with easy bruising and scattered ecchymoses. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue current warfarin dosage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease warfarin dosage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discontinue warfarin and start aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Discontinue warfarin and start dabigatran&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Continue current warfarin dosage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreasing warfarin dosage: Would increase the risk of thromboembolic events.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreasing warfarin dosage:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Discontinue warfarin and start aspirin: Not sufficient for anticoagulation in patients with mechanical valves.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Discontinue warfarin and start aspirin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Discontinue warfarin and start dabigatran : DOACs are not recommended for patients with mechanical valves (based on the data from Re-ALIGN trial).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Discontinue warfarin and start dabigatran&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with a prosthetic cardiac valve, the appropriate INR goal varies by type of valve and valve position, with a goal INR of 3.0 (range 2.5-3.5) for a mechanical valve in the mitral position. Dabigatran is associated with excess bleeding and thrombosis, and the safety of other direct oral anticoagulants has not been assessed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with exertional dyspnea and syncope has echocardiographic findings of severe aortic stenosis (AS) and a bicuspid aortic valve. What is the most next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT angiography of the thoracic aorta&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exercise treadmill stress testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transcatheter aortic valve implantation (TAVI)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CT angiography of the thoracic aorta&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization: May be needed to evaluate coronaries if intermediate to high pre-test probability. If low pre-test probability, CTA of the coronaries can be along with CTA of the aorta.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac catheterization:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise treadmill stress testing: C/I in symptomatic severe AS due to the risk of adverse events.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise treadmill stress testing:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transcatheter aortic valve implantation (TAVI): Not appropriate before assessing the aorta, as aortic pathology might influence the choice of intervention.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transcatheter aortic valve implantation (TAVI):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with bicuspid aortic valve and suspected aortic stenosis, evaluate the thoracic aorta before proceeding with any intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old asymptomatic man has severe aortic regurgitation (AR) with normal left ventricular (LV) ejection fraction (EF) and elevated LV end-systolic dimension (45 mm). What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Repeat evaluation in 6 months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Surgical aortic valve replacement (SAVR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transcatheter aortic valve implantation (TAVI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Repeat evaluation in 6 months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Surgical aortic valve replacement (SAVR): Not indicated yet due to lack of symptoms and only mild LV enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Surgical aortic valve replacement (SAVR):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transcatheter aortic valve implantation (TAVI): Not recommended for isolated severe AR in patients who are candidates for surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transcatheter aortic valve implantation (TAVI):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transesophageal echocardiography (TEE): May be helpful if TTE image quality is poor, but not necessary in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transesophageal echocardiography (TEE):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In symptomatic patients with severe aortic regurgitation, aortic valve surgery is indicated regardless of left ventricular systolic function.&lt;/li&gt;&lt;li&gt;âž¤ In asymptomatic patients with chronic severe aortic regurgitation and left ventricular systolic dysfunction (EF â‰¤55%), aortic valve surgery is indicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man is evaluated for exertional dyspnea and a sensation of pounding in the neck that has progressed over the last year. Blood pressure is 150/60 mm Hg, and pulse rate is 60/min. The following murmur is heard over the left sternal edge. Identify the cause.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aortic regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis: Is a systolic murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis: Produces a low-frequency diastolic murmur heard best at the apex.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid regurgitation: The murmur of tricuspid regurgitation is also heard during systole, and the intensity may increase with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman is evaluated for exertional dyspnea. She was previously asymptomatic, but 4 months ago she began having shortness of breath during moderate activity. Blood pressure is 132/80 mm Hg, pulse rate is 80/min, and respiration rate is 22/min. Auscultation is performed at the upper right sternal border. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aortic stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation: Produces a higher-pitched, holosystolic murmur that is loudest at the apex.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonic stenosis: The murmur of pulmonic stenosis is heard best at the left upper sternal border and may increase in intensity with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonic stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ventricular septal defect: A small ventricular septal defect without pulmonary hypertension presents with a loud and often palpable holosystolic murmur located at the left sternal border that may obliterate the S2. Progressive pulmonary hypertension results in shortening of the murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ventricular septal defect:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman is evaluated in the emergency department for an 8-hour history of acute-onset, sharp, and persistent chest pain. Blood pressure is 130/70 mm Hg, and pulse rate is 60/min. Auscultation is performed with the diaphragm at the left sternal border. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pericardial rub&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pericardial rub&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic regurgitation: Aortic regurgitation is a high-pitched diastolic murmur heard best along the mid-left upper sternal border.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis: The murmur of aortic stenosis is a harsh crescendo-decrescendo systolic murmur loudest at the upper right sternal edge.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patent ductus arteriosus: A continuous murmur of patent ductus arteriosus begins in systole and extends without interruption into diastole.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patent ductus arteriosus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman is evaluated for an 18-month history of progressive fatigue and dyspnea. Blood pressure is 112/72 mm Hg, pulse rate is 76/min, and respiration rate is normal. The apical impulse is slightly sustained but not displaced. Auscultation is performed at the cardiac apex. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonic regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mitral stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic regurgitation: Aortic regurgitation produces a high-pitched diastolic murmur heard best along the mid left sternal border.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation: Mitral regurgitation produces a high-pitched holosystolic murmur loudest at the cardiac apex.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonic regurgitation: The murmur of pulmonic regurgitation is early diastolic, best heard over the left second and third interspaces and increases in intensity with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonic regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman is evaluated for a heart murmur. Blood pressure is 140/70 mm Hg, and pulse rate is 60/min. Auscultation is performed with firm pressure on the diaphragm at the cardiac apex. Which of the following findings accounts for the auscultatory findings at the apex?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitral regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis: Aortic stenosis produces a harsh, systolic crescendo-decrescendo murmur that is loudest at the right upper sternal edge.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis: The murmur of mitral stenosis is heard during diastole at the cardiac apex. A pericardial friction rub may consist of one to three components and may be heard in systole, diastole, or both systole and diastole.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid regurgitation: The holosystolic murmur of tricuspid regurgitation is heard loudest at the lower left sternal edge, and the intensity may increase with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Loud S1 in mitral stenosis (MS) is lost in all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First-degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic Regurgitation (AR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calcified valve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mild MS&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mild MS&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. First-degree heart block: A classic cause of soft S1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. First-degree heart block:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic Regurgitation (AR): Can cause volume overload of the LV and soft S1.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic Regurgitation (AR):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Calcified valve: Calcification of the mitral valve leaflets leads to reduced mobility and a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Calcified valve:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mitral stenosis is typically associated with a loud S1, this characteristic finding can be lost or diminished in cases of calcified valves.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman came for a routine health check-up. She has no symptoms, and on examination, she has a grade 4/6 holosystolic murmur at the apex. 2D Echo demonstrates severe Mitral regurgitation with LVEF of 50%. The left ventricle is moderately dilated with an LV end-systolic dimension (LVESD) of 42 mm. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serial clinical and echocardiographic evaluations&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Surgical mitral valve repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical mitral valve replacement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transcatheter mitral valve repair&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Surgical mitral valve repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serial clinical and echocardiographic evaluations: While monitoring is important, it is not the most appropriate next step in this case of severe MR with LV dilatation. Delaying surgery can lead to irreversible LV damage and worsening of symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serial clinical and echocardiographic evaluations:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical mitral valve replacement: Replacement is considered if repair is not feasible or if the mitral valve is severely damaged. However, repair is the preferred option whenever possible.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical mitral valve replacement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transcatheter mitral valve repair: This is a less invasive option but is currently recommended for patients who are high-risk surgical candidates. This patient is asymptomatic and otherwise healthy, making her a good candidate for surgical repair.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transcatheter mitral valve repair:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Indications for surgical mitral valve repair in asymptomatic patients include severe primary MR and LV dilatation (ESD â‰¥ 40mm and/or EF â‰¤ 60%).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old man presents with recurrent chest pain and dyspnea. He has a history of hypertension and hyperlipidemia. Physical exam reveals elevated JVP, crackles, and a soft early systolic murmur with an S3 gallop. ECG is shown. Chest X-ray shows pulmonary congestion. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mitral regurgitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-180925.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis: While this can cause heart failure, it would present with a harsh systolic murmur radiating to the carotids, not a soft early systolic murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac tamponade: This can cause elevated JVP and distant heart sounds, but it would not typically present with a new murmur or ECG changes of MI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac tamponade:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid regurgitation: This would cause a holosystolic murmur that increases with inspiration, not the early systolic murmur described in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute MR usually occurs in association with inferior MI and it is due to rupture of posteromedial papillary muscle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following indicate severe mitral stenosis except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Soft S1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased duration of MDM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Long A2-OS gap&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Palpable P2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Long A2-OS gap&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Soft S1: In severe MS, the mitral valve leaflets become thickened and calcified, resulting in a softer first heart sound (S1).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Soft S1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased duration of MDM: As the severity of mitral stenosis increases, the mid-diastolic murmur (MDM) becomes longer due to the prolonged flow of blood across the narrowed valve.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased duration of MDM:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Palpable P2: In severe MS, pulmonary hypertension often develops, leading to accentuated pulmonary component of the second heart sound (P2), which can be palpable.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Palpable P2:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Short A2-OS gap is a marker of severe mitral stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are causes of a soft first heart sound except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcified valves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sepsis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcified valves: Calcification of the mitral valve leaflets can make them rigid and less mobile, leading to a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcified valves:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation: In some cases of mitral regurgitation, the mitral valve may not close completely, resulting in a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heart failure: Reduced left ventricular contractility in heart failure can lead to less forceful closure of the mitral valve and a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heart failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperdynamic states are associated with loud S1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 21-year-old woman with a history of connective tissue disease presents with acute shortness of breath and pulmonary edema. Examination reveals severe aortic regurgitation due to a right coronary cusp avulsion. She is in cardiogenic shock. What intervention is most likely to maintain end-organ perfusion until surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Esmolol continuous IV infusion titrated to a heart rate of 60â€“70 beats/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intra-aortic balloon pump&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV nitroprusside&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV norepinephrine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV nitroprusside&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Esmolol (beta-blocker) continuous IV infusion titrated to a heart rate of 60â€“70 beats/min: Slowing the heart rate increases diastolic time, worsening regurgitation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Esmolol (beta-blocker) continuous IV infusion titrated to a heart rate of 60â€“70 beats/min:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intra-aortic balloon pump: Contraindicated in severe aortic regurgitation, as it inflates during diastole, further increasing regurgitation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intra-aortic balloon pump:&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV norepinephrine : IV norepinephrine and E. Vasopressin: These are vasopressors that increase afterload, which would worsen aortic regurgitation.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ IV norepinephrine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In acute severe aortic regurgitation with cardiogenic shock, IV nitroprusside can be used as a bridge to surgery by reducing afterload and improving forward flow.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mrs. Vinitha, a 24-year-old woman with severe mitral stenosis, presents with acute dyspnea and fatigue. On exam, her BP is 110/70 mm Hg and her HR is 50/min. She has bilateral crackles on auscultation. Which of the following interventions would NOT be beneficial?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Percutaneous balloon mitral valvotomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transvenous pacemaker placement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transvenous pacemaker placement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. IV furosemide: Lowers left atrial pressure and it is beneficial in mitral stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IV furosemide:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Percutaneous balloon mitral valvotomy (PBMV): Lowers LA-LV pressure gradient by opening up the stenosed valve and hence it is beneficial in mitral stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Percutaneous balloon mitral valvotomy (PBMV):&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above: This is incorrect, as pacing can be associated with worsening of pulmonary congestion in mitral stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sinus bradycardia is advantageous in the setting of mitral stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding mitral valve prolapse (MVP) is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MVP is more common in connective tissue diseases such as Marfan syndrome.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MVP occurs more commonly in women than in men.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The anterior leaflet is usually more affected than the posterior leaflet.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The click and murmur of MVP will occur early with the initiation phase of Valsalva.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The anterior leaflet is usually more affected than the posterior leaflet.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In most patients with MVP, the cause is unknown. MVP is a frequent finding in patients with heritable disorders of connective tissue, including Marfan syndrome, osteogenesis imperfecta, and Ehlers- Danlos syndrome. The posterior mitral leaflet is usually more affected than the anterior, and the mitral valve annulus is often dilated. MVP is more common in women and occurs most frequently between the ages of 15 and 30 years; the clinical course is most often benign. A frequent physical examination finding is the mid or late (nonejection) systolic click, followed by a highpitched, mid-late systolic crescendo-decrescendo murmur and is heard best at the apex. Radiation of the murmur will depend on the involved leaflet. With posterior leaflet prolapse, the jet of mitral regurgitation (MR) is directed anteriorly and the murmur will radiate to the base of the heart. With anterior leaflet involvement, the jet of MR is directed posteriorly and the murmur will radiate to the axilla and back. The click and murmur occur earlier with standing, during the strain phase of the Valsalva maneuver, and with any intervention that decreases left ventricular (LV) volume (preload), exaggerating the propensity of mitral leaflet prolapse. Conversely, squatting and isometric exercises, which increase LV volume, diminish MVP; the click-murmur omplex is delayed, moves away from S1, and may even disappear.&lt;/li&gt;&lt;li&gt;â€¢ In most patients with MVP, the cause is unknown.&lt;/li&gt;&lt;li&gt;â€¢ MVP is a frequent finding in patients with heritable disorders of connective tissue, including Marfan syndrome, osteogenesis imperfecta, and Ehlers- Danlos syndrome.&lt;/li&gt;&lt;li&gt;â€¢ The posterior mitral leaflet is usually more affected than the anterior, and the mitral valve annulus is often dilated.&lt;/li&gt;&lt;li&gt;â€¢ MVP is more common in women and occurs most frequently between the ages of 15 and 30 years; the clinical course is most often benign.&lt;/li&gt;&lt;li&gt;â€¢ A frequent physical examination finding is the mid or late (nonejection) systolic click, followed by a highpitched, mid-late systolic crescendo-decrescendo murmur and is heard best at the apex.&lt;/li&gt;&lt;li&gt;â€¢ Radiation of the murmur will depend on the involved leaflet. With posterior leaflet prolapse, the jet of mitral regurgitation (MR) is directed anteriorly and the murmur will radiate to the base of the heart. With anterior leaflet involvement, the jet of MR is directed posteriorly and the murmur will radiate to the axilla and back.&lt;/li&gt;&lt;li&gt;â€¢ The click and murmur occur earlier with standing, during the strain phase of the Valsalva maneuver, and with any intervention that decreases left ventricular (LV) volume (preload), exaggerating the propensity of mitral leaflet prolapse. Conversely, squatting and isometric exercises, which increase LV volume, diminish MVP; the click-murmur omplex is delayed, moves away from S1, and may even disappear.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MVP is more common in women and occurs most frequently between the ages of 15 and 30 years; the clinical course is most often benign.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old female presented with fatigue. Cardiac catheterization is done and it is demonstrated below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mitral stenosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140418.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis : This would show a pressure gradient between the left ventricle and the aorta during systole.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation : This would show a high-pressure V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation : This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ LA-LV gradient during diastole is characteristic of mitral stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old female presented with palpitations and generalized tiredness. Cardiac catheterization is done, and the results are shown in the image. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mitral regurgitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140450.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mitral regurgitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitral stenosis : In mitral stenosis, there would be a pressure gradient between the left atrium and left ventricle during diastole, leading to an elevated LA pressure throughout diastole, not just during systole.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitral stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis : This would show a pressure gradient between the left ventricle and the aorta during systole.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation : This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Large â€˜vâ€™ wave in LA pressure tracing during ventricular systole is characteristic of mitral regurgitation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presented with chest pain. Cardiac catheterization is done and it is demonstrated below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aortic stenosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140521.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitral stenosis : This would show a pressure gradient between the left atrium and left ventricle during diastole.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitral stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation : This would show a high-pressure V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation : This would show an elevated left ventricular diastolic pressure and a rapid decline in aortic pressure during diastole.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The pressure gradient between the LV and the aorta during systole is hallmark of LVOT obstruction (like aortic stenosis).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female presented with palpitations and chest pain. Cardiac catheterization is done, and the results are shown in the image. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aortic regurgitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-140552.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitral stenosis: This would cause a pressure gradient between the left atrium and left ventricle during diastole, leading to an elevated left atrial pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitral stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis : This would show a pressure gradient between the left ventricle and the aorta during systole, causing the aortic pressure to rise more slowly and not reach as high a peak.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation : This would show a prominent V wave in the left atrial pressure tracing during systole, due to blood regurgitating back into the left atrium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Low diastolic blood pressure in aorta and elevated LV diastolic pressure are hallmarks of aortic regurgitation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old asymptomatic man is found to have a patent ductus arteriosus (PDA) with left- atrial and ventricular enlargement on echocardiogram. The estimated right ventricular systolic pressure is 30 mmHg and RV is normal in size. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PDA device closure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serial echocardiographic monitoring&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PDA device closure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI : While it can provide detailed information, echocardiography is sufficient to confirm the diagnosis and indication for closure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option B. Indomethacin : Used to close PDA in premature infants, not effective in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Indomethacin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serial echocardiographic monitoring : Not recommended when closure is already indicated due to left heart enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serial echocardiographic monitoring&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ PDA closure is indicated in patients with left-sided cardiac chamber enlargement even in the absence of symptoms, as long as PA systolic pressure is &amp;lt; 50% of systemic.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man presents with transient right-sided weakness. Evaluation reveals a small ischemic stroke and a patent foramen ovale (PFO) with right-to-left shunt. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PFO device closure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PFO device closure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin : Antiplatelet therapy alone is less effective than PFO closure in preventing recurrent stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Warfarin : Anticoagulation may be considered in older patients or those with contraindications to PFO closure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Warfarin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation : Not appropriate due to the high risk of recurrent stroke in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ PFO closure is recommended for younger patients (&amp;lt; 60y) with cryptogenic stroke and PFO to reduce the risk of recurrent stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old man is evaluated for exertional dyspnea. Physical exam reveals a continuous murmur beneath the left clavicle, fixed splitting of S2, and right axis deviation on ECG. Echocardiogram shows a 1.5-cm ostium secundum atrial septal defect (ASD) with moderate right heart enlargement. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial septal defect closure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiopulmonary exercise testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Echocardiographic surveillance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atrial septal defect closure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiopulmonary exercise testing : Not necessary as the cause of dyspnea (ASD) is already established.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiopulmonary exercise testing&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography : Not indicated in this patient with a congenital heart defect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiographic surveillance : Not sufficient, as the ASD requires closure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiographic surveillance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Atrial septal defect closure is indicated for symptomatic patients or those with right heart enlargement to prevent long-term complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old woman with Eisenmenger syndrome due to PDA presents with heavy menstrual periods and fatigue. Prior to onset of symptoms her Hb was 18g/dL and now her Hb is 14.7 g/dL. Her serum ferritin levels were low. She is receiving bosentan for pulmonary hypertension. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hysterectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral iron therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phlebotomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Supplemental oxygen therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oral iron therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hysterectomy : Surgical interventions are better avoided in Eisenmengerâ€™s syndrome owing to increased peri-operative risk. If menorrhagia is presumed to be the cause of anemia, can try endometrial ablation, intrauterine device placement, and, rarely, hysterectomy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hysterectomy&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phlebotomy : Indicated for symptomatic hyperviscosity (especially if Hb &amp;gt; 20g/dL and/or Hct &amp;gt; 65% in the absence of dehydration).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phlebotomy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Supplemental oxygen : Not the primary treatment in this patient (if used, do not use SpO2 targets, rather target symptomatic relief in patients with Eisenmenger syndrome).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Supplemental oxygen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Correction of iron deficiency is associated with increased exercise capacity and improved quality of life in patients with cyanotic congenital heart disease.&lt;/li&gt;&lt;li&gt;âž¤ Adaptive erythrocytosis is well tolerated in patients with cyanotic congenital heart disease, and therapeutic phlebotomy is not indicated until Hb &amp;gt; 20 g/dL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old man with a history of repaired tetralogy of Fallot presents for routine follow up. On exam, he has a grade 1/6 early systolic murmur localized to the left second intercostal space and a grade 2/6 diastolic murmur best heard in the left second and third intercostal spaces, that increases with inspiration.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic coarctation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary regurgitation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic coarctation : Usually presents with upper extremity hypertension and a systolic murmur in the left infraclavicular area.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic coarctation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic regurgitation : Diastolic murmur at the left sternal border that does not increase with inspiration (it rather increases with expiration).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic regurgitation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis : Diastolic rumble at the apex, not associated with TOF repair.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Severe PR causes a diastolic murmur heard at the left sternal border that increases in intensity with inspiration, a parasternal lift, and a soft systolic pulmonary outflow murmur.&lt;/li&gt;&lt;li&gt;âž¤ PR is the most common postoperative sequela of TOF repair .&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man presents with progressive dyspnea, a systolic murmur at the left second intercostal space, a diastolic flow rumble over the tricuspid valve, and fixed splitting of the second heart sound (S2). ECG is shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial septal defect (ASD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bicuspid aortic valve with aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect (VSD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atrial septal defect (ASD)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-133706.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bicuspid aortic valve with AR : Would have a diastolic murmur at the left sternal border.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bicuspid aortic valve with AR&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis : Would have a diastolic murmur at the apex.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. VSD : Typically presents with a holosystolic murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. VSD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical and ECG findings suggestive of an ASD.&lt;/li&gt;&lt;li&gt;âž¤ as amyloidosis, should be considered. Serum protein electrophoresis/urine protein electrophoresis and free light-chain analysis may help identify immunoglobulin light-chain amyloidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man is evaluated for exertional dyspnea. On physical examination, a parasternal impulse is noted at the left sternal border. A grade 2/6 systolic murmur is heard at the second left intercostal space with fixed splitting of the S2. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coarctation of the aorta&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ostium secundum atrial septal defect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ostium secundum atrial septal defect&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-140334.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man is evaluated for hypertension. He is asymptomatic. A systolic murmur is heard in the left infraclavicular region. Blood pressure is 168/90 mm Hg in both arms. Chest radiograph is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic coarctation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibromuscular dysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Giant cell arteritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aortic coarctation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-140350.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-140402.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old asymptomatic man has a continuous \&quot;machinery\&quot; murmur beneath the left clavicle that envelops the second heart sound. What is the most likely cause of this murmur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bicuspid aortic valve with aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus (PDA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect (VSD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Patent ductus arteriosus (PDA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bicuspid aortic valve with AR : This would typically cause a diastolic murmur, not a continuous murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bicuspid aortic valve with AR&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary regurgitation : This would cause a diastolic murmur along the left sternal border that increases with inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary regurgitation&lt;/li&gt;&lt;li&gt;â€¢ Option D. VSD: This would cause a holosystolic murmur, not a continuous murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. VSD:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Continuous \&quot;machinery\&quot; murmur is seen in PDA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old man presents with palpitations and syncope. On examination, he has a systolic click with a pansystolic murmur in the left lower sternal border and an elevated JVP. He also complains of intermittent bluish discoloration of face during exercise since childhood. ECG is shown. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ASD (Atrial Septal Defect)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;VSD (Ventricular Septal Defect)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ebstein&#x27;s Anomaly&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TOF (Tetralogy of Fallot)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ebstein&#x27;s Anomaly&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-140431.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ASD: While ASD can be present in Ebstein&#x27;s anomaly, it alone does not explain all the clinical features in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. ASD:&lt;/li&gt;&lt;li&gt;â€¢ Option B. VSD: VSD presents with a harsh holosystolic murmur but not the other findings in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. VSD:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TOF: TOF is a cyanotic congenital heart defect with a different murmur pattern (harsh systolic ejection murmur) and ECG findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TOF:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Very tall (Himalayan) P waves are a hallmark of Ebsteinâ€™s anomaly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-year-old boy from a rural area in tamilnadu presents with fatigue during physical activity, clubbing, and cyanosis in his feet. His hands appear normal. What is the most likely congenital abnormality?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial septal defect with shunt reversal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D-transposition of the great arteries&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus with shunt reversal&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect with shunt reversal&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Patent ductus arteriosus with shunt reversal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial septal defect with shunt reversal: While ASDs can lead to Eisenmenger syndrome, the cyanosis would be central, affecting both upper and lower extremities.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial septal defect with shunt reversal:&lt;/li&gt;&lt;li&gt;â€¢ Option B. D-transposition of the great arteries: This typically presents with severe central cyanosis (nit differential) shortly after birth, not later in childhood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. D-transposition of the great arteries:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal defect with shunt reversal: Similar to ASD, VSDs can lead to Eisenmenger syndrome, but cyanosis would be central, not differential.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal defect with shunt reversal:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Differential cyanosis (lower extremity cyanosis with sparing of the upper extremities) is a hallmark of a PDA with Eisenmenger syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are performing a right heart catheterization in a 45-year-old man with suspected pulmonary hypertension. You do indeed note elevated pulmonary arterial pressures, with a mean pulmonary arterial pressure of 45 mmHg. The patient is not hypoxemic. However, you also note the following oxygen saturations from each cardiac chamber: Superior vena cavaâ€”61% Inferior vena cavaâ€”65% Right atriumâ€”85% Right ventricleâ€”84% Pulmonary arteryâ€”84% You suspect which of the following based on this data?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial septal defect with left-to-right shunting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventricular septal defect with left-to-right shunting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect with right-to-left shunting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atrial septal defect with left-to-right shunting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Patent ductus arteriosus: This would cause a step-up in the pulmonary artery saturation, not the right atrium.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Patent ductus arteriosus:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ventricular septal defect with left-to-right shunting: This would cause a step-up in the right ventricle, not the right atrium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ventricular septal defect with left-to-right shunting:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal defect with right-to-left shunting: This would not cause a step-up in oxygen saturation in any right heart chamber.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal defect with right-to-left shunting:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ A step-up in oxygen saturation between the vena cavae and the right atrium during right heart catheterization is indicative of ASD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements regarding bicuspid aortic valve (BAV) disease are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A mutation in the NOTCH1 gene is responsible for BAV in some families.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ascending aortic aneurysm formation occurs commonly among patients with BAV disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BAV has a female to male predominance.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;BAV is the most common congenital heart abnormality.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. BAV has a female to male predominance.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A . Mutations in NOTCH1 have been linked to some familial cases of BAV.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option B . Aortopathy, including ascending aortic aneurysm formation, is a common association with BAV.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option D . BAV is the most common congenital heart abnormality, affecting about 0.5-1.4% of the population.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ BAV is the most common congenital heart valve defect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following congenital cardiovascular abnormalities would provide the highest maternal risk in the setting of pregnancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bicuspid aortic valve with aortic diameter &amp;lt;45 mm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Partial anomalous pulmonary venous return without pulmonary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Severe native aortic coarctation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systemic right ventricle&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Severe native aortic coarctation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bicuspid aortic valve with aortic diameter &amp;lt;45 mm : While a bicuspid aortic valve can be associated with aortic dilation, the risk is lower if the aortic diameter is less than 45 mm.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bicuspid aortic valve with aortic diameter &amp;lt;45 mm&lt;/li&gt;&lt;li&gt;â€¢ Option B. Partial anomalous pulmonary venous return without pulmonary hypertension : This condition is generally well-tolerated and poses a lower risk in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Partial anomalous pulmonary venous return without pulmonary hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic right ventricle : While this can be associated with complex congenital heart disease, it does not carry the same immediate risk of aortic complications as severe coarctation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic right ventricle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Severe aortic coarctation is a high-risk condition in pregnancy due to the increased risk of aortic dissection or rupture.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are reading an 2D Echo on a 26-year-old with dyspnea and a murmur. You note a mid-septal VSD. You also expect to find dilation of which of the following cardiac chambers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary sinus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left ventricle&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right atrium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right ventricle&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Left ventricle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Left ventricle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Left to right shunts below tricuspid valve usually causes LV dilatation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old non-smoker presents with dyspnea, chest pain, and pulsus paradoxus. Echocardiogram shows a large pericardial effusion and a right atrial mass. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial myxoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma with cardiac metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiac angiosarcoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Papillary fibroelastoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiac angiosarcoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial myxoma : More common in the left atrium, less likely to cause bloody effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial myxoma&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchogenic carcinoma : Less likely in a non-smoker, and presentation is not typical.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchogenic carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Papillary fibroelastoma : Usually found on heart valves, not associated with pericardial effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Papillary fibroelastoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac angiosarcomas are rare malignant cardiac tumors that typically arise within the right atrium and are commonly associated with sanguinous pericardial effusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man with hypertension presents with acute chest pain, unequal blood pressures in the arms, a diastolic murmur, and a widened mediastinum on chest X-ray. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroprusside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Open aortic repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thoracic endovascular aortic repair&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Open aortic repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary angiography : Not the priority in this acute setting. CT Angiography would have been more appropriate though.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary angiography&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous nitroprusside : Used for blood pressure control after the diagnosis is confirmed, but not the definitive treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous nitroprusside&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thoracic endovascular aortic repair (TEVAR): Typically used for uncomplicated type B dissections, not type A.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thoracic endovascular aortic repair&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with ascending aortic dissection, immediate open aortic repair is imperative to improve survival and reduce morbidity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old smoker presents with dyspnea, pedal edema and exertional chest pain. He is a known diabetic and hypertensive and on medications for the same. ECG shows LBBB on ECG has an EF of 25% in 2D Echo. What is the most appropriate test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac catheterization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiac PET&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Technetium-99m pyrophosphate scintigraphy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac catheterization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac MRI : Can be helpful after CAD is ruled out or for assessing myocardial viability.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardiac PET : Can aid in assessing LV function and evaluating for ischemia. However, given this patient&#x27;s high likelihood of CAD, cardiac catheterization is the most direct and appropriate modality to assess for CAD.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardiac PET&lt;/li&gt;&lt;li&gt;â€¢ Option D. Technetium-99m pyrophosphate scintigraphy : Used for diagnosing transthyretin amyloid cardiomyopathy, not the most likely diagnosis in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Technetium-99m pyrophosphate scintigraphy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with new-onset heart failure and a high likelihood of coronary artery disease should be evaluated with cardiac catheterization.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old man is evaluated for sudden-onset dyspnea. Blood pressure is 198/120 mm Hg. Cardiopulmonary examination reveals aortic regurgitation and pulmonary crackles. Emergency chest CT with contrast is performed. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic aneurysm rupture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic hematoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aortic ulcer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type A aortic dissection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Type A aortic dissection&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134152.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134205.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The most likely diagnosis is type A aortic dissection. The CT scan with contrast shows a dissection plane extending through the aortic arch (arrow). Type A aortic dissection classically presents with the sudden onset of chest or back pain that has a tearing or ripping quality; however, not all patients will have this symptom. Patients may present with hypertension, syncope, a murmur of aortic regurgitation, or heart failure in the setting of sudden aortic insufficiency. The findings of asymmetric blood pressures in the upper extremities, asymmetric pulses, or pulsus paradoxus should all raise suspicion for acute aortic dissection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man is evaluated during a routine examination. Blood pressure is 100/70 mm Hg, and pulse rate is 60/min. Auscultation is performed with firm pressure on the diaphragm at the upper left sternal border. Which of the following best describes the second sound?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No splitting with respiration (single)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Persistent inspiratory/expiratory splitting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splitting in expiration (paradoxic)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Splitting in inspiration (normal)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Splitting in inspiration (normal)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ In this patient, auscultation reveals normal splitting of S2 during inspiration. Both components of a split S2 are high-frequency sounds heard best with the diaphragm in the second left intercostal space.&lt;/li&gt;&lt;li&gt;â€¢ Splitting of S2 represents asynchronous closure of the aortic and pulmonic valves. In the normal adult, splitting varies with the respiratory cycle and is perceived as a single S2 during expiration and a double S2 during inspiration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man is evaluated for hypotension and orthopnea. The neck veins are examined with the patient in a semirecumbent position. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient&#x27;s neck examination reveals jugular venous distention, reflecting increased right atrial pressure, which is most likely caused by left-sided heart failure. Other causes of jugular venous distension include cardiac tamponade, right ventricular failure, and massive pulmonary embolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman is evaluated for exertional dyspnea and orthopnea. Blood pressure is 110/80 mm Hg, and pulse rate is 60/min. Auscultation over the apical impulse is performed with light pressure on the bell. Which of the following best describes the acoustic events at the apex?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;S1 + paradoxical splitting of S2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S1 + physiological splitting of S2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;S1 + S2 + S3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;S1 + S2 + S4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. S1 + S2 + S3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) S1 + S2 + S3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The acoustic events at the apex are best described as S1 + S2 + S3. An S3 is heard in this patient. An S3 is a low-frequency, early diastolic sound best heard with the bell of the stethoscope at the cardiac apex. It may be perceived as a double S2. Positioning the patient in the left lateral decubitus position will facilitate the identification of an S3. An S3 is often heard in heart failure with reduced ejection fraction but can also be present in volume overload states, such as valvular regurgitation, shunt lesions, or late pregnancy. An S3 can also represent a normal finding in children or highly trained athletes.&lt;/li&gt;&lt;li&gt;â€¢ An S4 is also a low-frequency diastolic sound, but it occurs in late diastole and thus may be perceived as a double S1.&lt;/li&gt;&lt;li&gt;â€¢ Both components of a split S2 are high-frequency sounds heard best with the diaphragm in the second left intercostal space. Splitting of the S2 represents asynchronous closure of the aortic and pulmonic valves. In the normal adult, splitting varies with the respiratory cycle and is perceived as a single S2 during expiration and a double S2 during inspiration. Paradoxical splitting of S2 is characterized by audible splitting during expiration and a single S2 during inspiration. It is often associated with aortic stenosis but does not differentiate mild from severe aortic stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following conditions is seen on this CT angiogram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Penetrating atherosclerotic ulcer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thoracic aortic aneurysm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type A aortic dissection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type B aortic dissection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Type B aortic dissection&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134222.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The CT angiogram shows a Stanford type B aortic dissection arising immediately distal to the take-off of the left subclavian artery and extending to the level of the common iliac arteries. Type B aortic dissections are usually treated with medical therapy that controls blood pressure. Î²-Blockers are the initial agents of choice. Invasive treatment for type B aortic dissections is reserved for patients with occlusion of a major aortic branch with visceral or limb ischemia, progressive dilation or expansion on medical therapy, or a large penetrating atherosclerotic ulcer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following clinical manifestations is most likely associated with the findings seen on this CT angiogram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bitemporal hemianopia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Erythema nodosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Livedo reticularis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sclerodactyly&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Livedo reticularis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134238.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The findings seen on this CT angiogram are most likely associated with livedo reticularis. Livedo reticularis is a subtle, lacy network of faintly pink or bluish red vessels, usually seen on the lower legs due to altered blood flow through cutaneous vessels. This CT angiogram shows extensive atherosclerotic disease scattered throughout the central vasculature. Plaques are heavily concentrated in the proximal descending aorta, causing visible narrowing. Aortic atherosclerotic plaques are a significant source of systemic emboli. Emboli from aortic plaques may be thrombotic or atheromatous. Thromboembolism occurs when an atherosclerotic plaque becomes unstable and ruptures, exposing thrombogenic factors that lead to clot formation. Thromboemboli that arise from plaques tend to be single and lodge in small or medium arteries, causing transient ischemic attack, stroke, kidney infarction, intestinal ischemia, or limb ischemia. Atheroemboli result from release of fragments of plaque (such as cholesterol crystals) that tend to lodge more diffusely in smaller arterial beds in different organs; they may result in conditions such as livedo reticularis, â€œblue toeâ€ syndrome, and retinal or kidney ischemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the strongest predictor of Cardiovascular disease (CVD) incidence and subsequent mortality due to CVD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TC/HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;hs-CRP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. LDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. TC/HDL (Total Cholesterol to HDL ratio): While this ratio provides some information about cardiovascular risk, it is not as strong a predictor as LDL cholesterol alone.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TC/HDL (Total Cholesterol to HDL ratio):&lt;/li&gt;&lt;li&gt;â€¢ Option B. hs-CRP (High-sensitivity C-reactive protein): hs-CRP is a marker of inflammation, which can contribute to the development of CVD. However, it is not as directly linked to CVD risk as LDL cholesterol. It has a high negative predictive value with regards to CVD but can be elevated in inflammatory states, hence not very specific.&lt;/li&gt;&lt;li&gt;â€¢ Option B. hs-CRP (High-sensitivity C-reactive protein):&lt;/li&gt;&lt;li&gt;â€¢ Option D. HDL (High-density lipoprotein cholesterol): Higher levels of HDL are protective, but they are not as strong a predictor of risk as LDL cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Option D. HDL (High-density lipoprotein cholesterol):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LDL cholesterol is the primary target for lipid-lowering therapy in the prevention and management of CVD due to its strong association with CVD incidence and mortality.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following imaging modalities is best for assessing coronary plaque morphology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IVUS (Intravascular Ultrasound)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;OCT (Optical Coherence Tomography)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary Angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CT Coronary Calcium Scoring&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. OCT (Optical Coherence Tomography)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. IVUS (Intravascular Ultrasound): While IVUS provides valuable information about plaque burden and vessel size, its resolution is not as high as OCT, limiting its ability to characterize plaque morphology in detail.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IVUS (Intravascular Ultrasound):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary Angiography: Angiography is a luminal imaging technique that only shows the outline of the vessel lumen. It cannot visualize plaque components within the vessel wall.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary Angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CT Coronary Calcium Scoring: This non-invasive technique quantifies the amount of calcium in coronary arteries, a marker of atherosclerosis. However, it does not provide detailed information about plaque morphology or composition.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. CT Coronary Calcium Scoring:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ OCT is the gold standard imaging modality for assessing coronary plaque morphology due to its superior resolution, which allows for detailed visualization of plaque components and aids in risk assessment and treatment planning.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old gentleman is brought into your emergency department after a syncopal episode. ECG shows a regular broad complex tachycardia with no apparent P waves. With regard to the JVP waveform, which of these features would you expect to see?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant v waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon a waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent x descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Slow y descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon a waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Giant v waves: Seen in tricuspid regurgitation, not VT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Giant v waves:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prominent x descent: This is a normal finding in the JVP waveform.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prominent x descent:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Slow y descent: Seen in constrictive pericarditis or cardiac tamponade.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Slow y descent:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Irregular cannon a waves in the JVP is a sign of AV dissociation, which is commonly seen in ventricular tachycardia and complete&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old high school student has a syncopal episode while playing basketball. On physical examination, he has a rapid carotid upstroke and a loud systolic murmur at the left lower sternal border. ECG and 2D echo showed LVH. What maneuver is expected to decrease the murmur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Squat-to-stand maneuver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hand grip&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valsalva maneuver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amyl nitrate inhalation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hand grip&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Squat-to-stand maneuver: This maneuver increases preload (the volume of blood returning to the heart). In HCM, increased preload can worsen the outflow tract obstruction, leading to an increase in the murmur&#x27;s intensity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Squat-to-stand maneuver:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Valsalva maneuver: This maneuver decreases preload. In HCM, this can initially worsen the outflow tract obstruction, leading to a louder murmur. However, in later phases of the maneuver, the murmur may decrease due to decreased left ventricular volume.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Valsalva maneuver:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amyl nitrate inhalation: This maneuver primarily decreases afterload. While it can decrease the intensity of the murmur in HCM, it is not as effective as the hand grip maneuver.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amyl nitrate inhalation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HCM has a dynamic LVOT obstruction and the murmur correlates with the degree of LVOT obstruction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of hypertension and hyperlipidemia comes for a routine follow-up visit. His physical examination is normal, but an echocardiogram reveals a 1-cm mass attached to the mitral valve with a stalk. The mass is independently mobile. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bacterial endocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left atrial myxoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nonbacterial thrombotic endocarditis (NBTE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Papillary fibroelastoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Papillary fibroelastoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bacterial endocarditis : Usually presents with fever, chills, and a new or changing murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bacterial endocarditis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left atrial myxoma : Larger and usually attached to the atrial septum, not the valve.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left atrial myxoma&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nonbacterial thrombotic endocarditis (NBTE): Associated with malignancy or hypercoagulable states, not the typical appearance of PFEs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nonbacterial thrombotic endocarditis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Typical presentation of papillary fibroelastoma on echocardiography â†’ a small, mobile mass attached to a valve by a stalk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old asymptomatic basketball player has come for routine evaluation. On examination he has a brisk carotid upstroke and grade 3/6 systolic murmur in the left sternal border. Echocardiogram showing asymmetric septal hypertrophy (18mm), systolic anterior motion (SAM) of the mitral valve, and a resting LVOT gradient of 30 mmHg. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advise the patient that he should not play basketball&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Begin beta-blocker therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Refer for alcohol septal ablation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Refer for implantable cardioverter-defibrillator (ICD) placement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Advise the patient that he should not play basketball&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Beta-blockers : May be used to treat symptoms of HF in HCM, but do not eliminate the risk of sudden cardiac death in athletes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alcohol septal ablation : Considered for symptomatic patients with severe LVOT obstruction and have failed initial medical therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alcohol septal ablation&lt;/li&gt;&lt;li&gt;â€¢ Option D. ICD placement : Patients with HCM should be considered for implantable cardioverter-defibrillator therapy if they have any of the following risk factors for sudden cardiac death: (1) massive myocardial hypertrophy (wall thickness â‰¥30 mm), (2) previous cardiac arrest due to ventricular arrhythmia, (3) blunted blood pressure response or hypotension during exercise, (4) unexplained syncope, (5) nonsustained ventricular tachycardia on ambulatory ECG and (6) family history of sudden death due to HCM.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ICD placement&lt;/li&gt;&lt;li&gt;â€¢ An ICD should not be placed solely for the purpose of allowing a patient to participate in high-intensity sports.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Athletes with a probable or unequivocal diagnosis of hypertrophic cardiomyopathy may participate in competitive sports that are considered static and low intensity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old asymptomatic woman comes for a routine health check-up. On examination she has a grade 2/6 midsystolic murmur localized to the left sternal border that diminishes with standing. Other reports including ECG and chest xray were normal. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac magnetic resonance imaging (MRI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transthoracic echocardiography (TTE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Routine clinical follow-up without imaging&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Routine clinical follow-up without imaging&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134307.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI : Unnecessary for an asymptomatic patient with a benign murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option B. TEE : Invasive and not warranted in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TEE&lt;/li&gt;&lt;li&gt;â€¢ Option C. TTE : Not necessary unless the murmur is associated with other symptoms or abnormalities on physical examination.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TTE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Short, soft systolic murmurs (grade &amp;lt;3) that are well localized to the left sternal border and are not associated with symptoms often do not require further investigation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old man with short stature, hypertelorism, and neck webbing has a loud systolic murmur at the left upper sternal border and a click that is heard better with expiration. Which genetic disorder is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Down syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Marfan syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Noonan syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Turner syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Noonan syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Down syndrome : More commonly associated with atrioventricular septal defects.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Down syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. Marfan syndrome : Associated with aortic root dilation and other skeletal abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Marfan syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Turner syndrome : Sex chromosome disorder seen in females, not males.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Turner syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Noonan syndrome is commonly associated with congenital cardiac lesions, including pulmonary stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Falsely low BNP (B-type natriuretic peptide) values can be seen in which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Female gender&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Obesity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Advanced age: BNP levels tend to increase with age, so falsely low values are less likely in older individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Advanced age:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Female gender: While there may be slight gender differences in BNP levels, it is not a major factor in causing falsely low values.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Female gender:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoking: Smoking is not known to significantly affect BNP levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoking:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obesity, constrictive pericarditis, cardiac tamponade and rarely flash pulmonary edema may be associated with lower than expected BNP levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with the following rhythm. His BP is 120/80 mm Hg and his pulse rate is 150/min. The following manoeuvre is performed. What is the manoeuvre?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Standard Valsalva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;REVERT manoeuvre&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Castellâ€™s manoeuvre&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Modified squat manoeuvre&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. REVERT manoeuvre&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134324.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Standard Valsalva: The standard Valsalva manoeuvre alone is less effective than the REVERT manoeuvre in terminating SVTs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Standard Valsalva:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Castellâ€™s manoeuvre: Used fir splenic percussion and not related to cardiology.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Castellâ€™s manoeuvre:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Modified squat manoeuvre: There is no such manoeuvre.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Modified squat manoeuvre:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ REVERT manoeuvre is more effective in terminating paroxysmal SVTs compared to standard Valsalva manoeuvre.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic heart failure presents with dyspnea on exertion and fatigue. You ask the patient to do Valsalva and you notice the blood pressure tracing as shown below. Which of the following is the most likely underlying cause of this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased sympathetic nervous system activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Impaired systolic function&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased parasympathetic nervous system activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Impaired diastolic function&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Impaired systolic function&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134337.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134353.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased sympathetic nervous system activity: This would typically lead to an exaggerated overshoot response.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased sympathetic nervous system activity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased parasympathetic nervous system activity: This would result in a more pronounced decrease in blood pressure during the strain phase but not necessarily affect the overshoot.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased parasympathetic nervous system activity:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Impaired diastolic function: Usually results in a square wave response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Impaired diastolic function:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the normal physiological response to the Valsalva maneuver and recognize the absence of the overshoot response as a potential sign of impaired systolic function in heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient presents with dyspnea, fatigue, and peripheral edema. On examination, you observe the JVP as shown in the video and a pansystolic murmur in the left sternal border. This finding is called as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lancisi sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bernheim effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muller&#x27;s sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brockenbrough effect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lancisi sign&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bernheim effect: This refers to the displacement of the interventricular septum towards the left ventricle in patients with right ventricular hypertrophy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bernheim effect:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Muller&#x27;s sign: This is the systolic pulsation of the uvula seen in severe aortic regurgitation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Muller&#x27;s sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brockenbrough effect: This refers to the paradoxical decrease in pulse pressure in the Post-VPC impulse, seen in HOCM.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brockenbrough effect:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize Lancisi&#x27;s sign as a clinical manifestation of tricuspid regurgitation, characterized by a giant cv wave in the JVP coinciding with ventricular systole.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with palpitations. You examine his JVP and you see as what is shown in the video below. His pulse rate is 150/min. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Supraventricular tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventricular tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WPW syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ventricular tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete heart block: This would typically cause bradycardia (slow heart rate) and irregular cannon a waves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete heart block:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Supraventricular tachycardia (SVT): SVTs (like AVNRT) tend to produce regular cannon â€˜aâ€™ waves.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Supraventricular tachycardia (SVT):&lt;/li&gt;&lt;li&gt;â€¢ Option D. WPW syndrome: WPW can cause SVTs (like AVRT) which sometimes can produce regular cannon â€˜aâ€™ waves.&lt;/li&gt;&lt;li&gt;â€¢ Option D. WPW syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Irregular cannon â€˜aâ€™ waves in the JVP is a hallmark of AV dissociation and it is commonly seen in complete heart block and VT.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old lady presents with ascites, elevated JVP, and pedal edema. Her JVP is shown in the video. All of the following can be the cause except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atrial myxoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Atrial myxoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Constrictive pericarditis: The rigid pericardium restricts ventricular filling, leading to right heart failure and Kussmaul&#x27;s sign. Classic cause of Kussmaulâ€™s sign.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Constrictive pericarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Restrictive cardiomyopathy: The stiff ventricles in this condition also impair filling, causing right heart failure and Kussmaul&#x27;s sign.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Restrictive cardiomyopathy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tricuspid stenosis: This directly obstructs blood flow from the right atrium to the right ventricle, leading to elevated right atrial pressure, JVP elevation, and Kussmaul&#x27;s sign.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tricuspid stenosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Kussmaul&#x27;s sign (increased JVP with inspiration) is a specific finding in conditions that impair right ventricular filling, such as constrictive pericarditis, restrictive cardiomyopathy, and tricuspid stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following can cause paradoxical splitting of the second heart sound except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LBBB (Left Bundle Branch Block)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonic stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RV pacing (Right Ventricular Pacing)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HOCM (Hypertrophic Obstructive Cardiomyopathy)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pulmonic stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. LBBB (Left Bundle Branch Block): Delays left ventricular activation and thus aortic valve closure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. LBBB (Left Bundle Branch Block):&lt;/li&gt;&lt;li&gt;â€¢ Option C. RV pacing: Delays right ventricular activation and thus pulmonic valve closure, leading to A2 preceding P2 on expiration (similar to paradoxical splitting).&lt;/li&gt;&lt;li&gt;â€¢ Option C. RV pacing:&lt;/li&gt;&lt;li&gt;â€¢ Option D. HOCM (Hypertrophic Obstructive Cardiomyopathy): Can cause delayed left ventricular emptying and aortic valve closure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. HOCM (Hypertrophic Obstructive Cardiomyopathy):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Classic causes of paradoxical splitting are LBBB, severe AS/HOCM and RV pacing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with pounding sensation in the chest for the last 1 hour. On examination you notice the JVP to be elevated and it shown in the video below. Which of the following is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ventricular ectopics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AVNRT (Atrioventricular Nodal Reentrant Tachycardia)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Complete heart block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AVNRT (Atrioventricular Nodal Reentrant Tachycardia)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ventricular ectopics: Ventricular ectopics can cause irregular cannon a waves but not regular ones.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ventricular ectopics:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tricuspid regurgitation: While tricuspid regurgitation can cause prominent v waves in the JVP, it does not typically cause cannon a waves.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tricuspid regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Complete heart block: Complete heart block usually causes irregular cannon a waves due to AV dissociation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Complete heart block:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical significance of regular cannon a waves in the JVP and their association with AVNRT.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the diagnosis based on the pressure tracing shown in the image.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HOCM&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. HOCM&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134415.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis: Gradient decreases with Valsalva and post VPC.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation: Does not exhibit bronckenbrough effect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mitral regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation: Does not exhibit bronckenbrough effect.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brockenbrough effect is a hallmark of HOCM.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the likely diagnosis based on the pulse waveform shown below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ventricular Bigeminy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HOCM&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HOCM&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134431.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134445.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134459.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ventricular Bigeminy: Associated with pulsus bigeminy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ventricular Bigeminy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic Regurgitation: Usually associated with bounding and collapsing (water hammer) pulse. Sometimes can produce pulsus bisferians (in severe cases) but does not have the spike and dome appearance like that of HOCM.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic Regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic Stenosis: Aortic stenosis typically presents with a slow-rising and delayed pulse (pulsus parvus et tardus).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic Stenosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulsus bisferians can be seen in HOCM, AR and sometimes AS + AR but the spike and dome appearance is typical of HOCM.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a history of recently diagnosed lymphoma presents with dyspnea and diaphoresis. Blood pressure is 70/60 mm Hg, heart rate is 110 beats/min, and her radial pulse becomes difficult to palpate at times, especially during inspiration. You see the monitor and notice the rhythm as shown in the video. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;COPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiac tamponade&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute anterior myocardial infarction: While MI can cause hypotension and tachycardia, it is less likely to cause pulsus paradoxus or electrical alternans.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute anterior myocardial infarction:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic obstructive pulmonary disease exacerbation: COPD exacerbation can cause dyspnea and tachycardia, but not the other findings in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic obstructive pulmonary disease exacerbation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myocardial amyloidosis: Amyloidosis can cause restrictive cardiomyopathy, but it is a less likely cause of acute tamponade in this patient with a recent lymphoma diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myocardial amyloidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Classic clinical presentation of cardiac tamponade is hypotension, tachycardia, pulsus paradoxus, and electrical alternans in ECG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with severe shortness of breath. You are attending him and notice the pulse and ECG tracing as shown in the image below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Severe LV failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac Tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Septic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Digitalis toxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Severe LV failure&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134518.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac Tamponade: Cardiac tamponade can cause pulsus paradoxus and electrical alternans (not pulsus alternans).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac Tamponade:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Septic shock: Septic shock usually results in a bounding pulse. Sometimes, it is associated with a. dicrotic pulse.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Septic shock:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Digitalis toxicity: Digitalis toxicity causes pulsus bigeminy and not alternans.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Digitalis toxicity:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize pulsus alternans as a clinical sign of severe left ventricular systolic dysfunction and understand its underlying pathophysiology.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with a history of hypertension, now with a new diagnosis of diabetes mellitus, presents with elevated blood pressure (140/90 mmHg), total cholesterol (250 mg/dL), and hemoglobin A1c (6.6%). Which risk factor confers the highest risk for atherosclerotic cardiovascular disease (ASCVD) in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diastolic blood pressure of 90 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HDL cholesterol level of 30 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Total cholesterol level of 250 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Diabetes mellitus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B, C, D : A diastolic blood pressure of 90 mm Hg, HDL cholesterol level of 30 mg/dL (0.78 mmol/L) and total cholesterol level of 250 mg/dL (6.47 mmol/L) have a relatively small effect on 10-year ASCVD risk compared with the presence of diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option B, C, D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with diabetes mellitus have a 2-4x increased risk for CV disease, with more than two thirds of patients with diabetes eventually dying of heart disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following can produce the murmur depicted in the video except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lutembacher syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ruptured sinus of Valsalva aneurysm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aortic regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patent ductus arteriosus (PDA): This is a persistent connection between the aorta and pulmonary artery, leading to a continuous left-to-right shunt and a continuous \&quot;machinery murmur.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patent ductus arteriosus (PDA):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lutemacher syndrome: This is a combination of an atrial septal defect (ASD) and mitral stenosis creating a continuous increase in LA â†’ RA pressure gradient resulting in a continuous murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lutemacher syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ruptured sinus of Valsalva aneurysm: This can create a fistula between the aorta and right heart chambers, leading to a continuous shunt and murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ruptured sinus of Valsalva aneurysm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aortic regurgitation typically results in an early diastolic murmur.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are causes of a soft first heart sound except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcified valves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sepsis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcified valves: Calcification of the mitral valve leaflets can make them rigid and less mobile, leading to a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcified valves:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation: In some cases of mitral regurgitation, the mitral valve may not close completely, resulting in a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heart failure: Reduced left ventricular contractility in heart failure can lead to less forceful closure of the mitral valve and a softer S1.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heart failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperdynamic states are associated with loud S1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following can result in mid-diastolic murmur except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute rheumatic fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary regurgitation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete heart block: Can result in a mid-diastolic murmur (called Rytandâ€™s murmur)&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete heart block:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic regurgitation: Severe aortic regurgitation can cause a mid-diastolic murmur known as the Austin Flint murmur. This occurs due to the regurgitant jet striking the anterior leaflet of the mitral valve, causing it to vibrate and create turbulence.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute rheumatic fever: Can result in mitral valvulitis resulting in turbulent blood flow and a mid-diastolic murmur (Carey Coombâ€™s murmur).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute rheumatic fever:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary regurgitation is associated with an early diastolic murmur.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old asymptomatic man is found to have a grade II diastolic murmur on routine physical examination. His ECG and chest X-ray are normal. What is the next best step in evaluation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carotid ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further workup required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Echocardiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134547.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI : Offers excellent visualization but is typically reserved for more complex cases or when echocardiography is inconclusive.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carotid ultrasound : Not relevant for the evaluation of a cardiac murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carotid ultrasound&lt;/li&gt;&lt;li&gt;â€¢ Option C. No further workup : A diastolic murmur always requires further investigation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. No further workup&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A diastolic murmur is always pathological and should be evaluated with echocardiography to assess for underlying structural heart disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Tamilvanan, a 67-year-old man, presents with symptoms of heart failure. You are assessing his volume status using JVP examination. Which statement is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The vertical distance between the top of the jugular venous pulsation and the sternal angle accurately measures central venous pressure (CVP).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The angle of inclination is irrelevant when measuring JVP.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normally, JVP rises with inspiration due to increased right heart filling.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venous pulsations above the clavicle in the sitting position are abnormal.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Venous pulsations above the clavicle in the sitting position are abnormal.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . The vertical distance between the top of the JVP and the sternal angle underestimates CVP, and the measurement is affected by body size and patient position.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option B. The angle of inclination is important, as it affects the hydrostatic pressure in the jugular veins.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normally, the JVP falls with inspiration due to decreased intrathoracic pressure. A rise in JVP with inspiration (Kussmaul&#x27;s sign) is seen in constrictive pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Jugular venous pulsations above the clavicle in the sitting position are abnormal and indicative of elevated central venous pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding blood pressure measurements?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SBP increases and DBP decreases when measured in more distal arteries.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SBP in the legs are usually as much as 20 mmHg lower than arm blood pressures.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The difference in blood pressure measured in both arms should be less than 20 mmHg.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Using a BP cuff that is too small will result in a marked underestimation of the true BP.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SBP increases and DBP decreases when measured in more distal arteries.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Systolic leg blood pressures are actually higher than arm pressures, not lower.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C . The difference in blood pressure between arms should be less than 10 mmHg, not 20 mmHg.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D . Using a too-small cuff leads to overestimation of blood pressure, not underestimation.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ So many things have to be considered while taking BP recordings!&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the cardiac axis marked by â€˜?â€™ in the image below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right Axis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Northwest Axis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal Axis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left Axis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Left Axis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134607.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-134622.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right Axis: From +90Â° to 180 Â°&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right Axis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Northwest Axis: -90 Â° to 180 Â°&lt;/li&gt;&lt;li&gt;â€¢ Option B. Northwest Axis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal Axis: -30 Â° to 90 Â° (or 100 Â° )&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal Axis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Axis determination is important in exams!&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following diseases are associated with the development of cardiac conduction disease EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lyme disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Syphilis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hyperthyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lyme disease: Cardiac involvement in Lyme disease can lead to AV block.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lyme disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Syphilis: This can lead to aortitis and subsequent damage to the conducting system.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Syphilis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic lupus erythematosus: This autoimmune disease can cause inflammation in the heart, including the conduction system.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic lupus erythematosus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypothyroidism (not hyperthyroidism) causes conduction system abnormalities. Hyperthyroidism is associated with sinus tachycardia and AF.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ms. Anitha, a 24-year-old woman, presents with postural light-headedness and palpitations after a recent upper respiratory illness. Upon standing for 2 minutes, her heart rate increases to 135 beats/min with no change in blood pressure. Which of the following is a reasonable therapeutic option for her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Upright Yoga&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodium chloride tablets&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sodium chloride tablets&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluid restriction: This would worsen the hypovolemia and exacerbate the symptoms of POTS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluid restriction:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Upright Yoga: While exercise can be beneficial in the long term, it may initially worsen symptoms in POTS patients due to increased demands on the cardiovascular system.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Upright Yoga:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Furosemide: This is a diuretic that would further decrease blood volume and worsen symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Furosemide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ POTS is characterized by symptomatic sinus tachycardia that occurs with postural change from a supine position to standing. The sinus rate increases by 30 beats/min or to &amp;gt;120 beats/min within 10 minutes of standing and in the absence of hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After a common heart transplant operation, a portion of which donor heart chamber will remain in the donor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary sinus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left atrium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right ventricle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right atrium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Left atrium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The most common contemporary cardiac transplant operation is referred to as a â€œbicavalâ€ orthotopic cardiac transplant that mimics the natural anatomic position. In this operation, the donor and recipient SVC and IVC are connected as are the aortic and pulmonary great vessels. The left atrium of the recipient retains its roof, including the draining pulmonary veins, and the donor left atrium is then sutured to the retained atrial tissue. This technique maintains function of the donor right atrium, which is important for governing early postoperative right heart output, and may prevent atrial arrhythmias.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a standard heart transplantation procedure, the left atrium of the recipient retains its roof, including the draining pulmonary veins, and the donor left atrium is then sutured to the retained atrial tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT an early diastolic sound?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;S3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Opening Snap&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pericardial knock&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. S3: Early diastolic sound.&lt;/li&gt;&lt;li&gt;â€¢ Option A. S3:&lt;/li&gt;&lt;li&gt;â€¢ Option C. OS: Early diastolic sound.&lt;/li&gt;&lt;li&gt;â€¢ Option C. OS:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pericardial knock: Early diastolic sound.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pericardial knock:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ S3, OS, pericardial knock and tumour plop (seen in atrial myxoma) are early diastolic sounds, while S4 is a late diastolic sound.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Farooq, a 45-year-old man, presents with progressive dyspnea. PFT and CT chest are normal. Echo shows features of pulmonary hypertension and his LVEF is 65%. His cardiac catheterization reports are shown. RA pressure- 10 mmHg PA pressure - 55/35 (mean = 42) mmHg PCWP - 34 mmHg LVEDP - 34 mmHg Cardiac output - 4.5 L/min PVR - 1.8 Wood unit What is the most likely cause of his pulmonary hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HFpEF&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary arterial hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HFpEF&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Chronic lung disease : Normal PFT and CT chest make chronic lung disease unlikely.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Chronic lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral stenosis : Elevated LVEDP is unlikely in mitral stenosis. Also, mitral stenosis patients have a gradient between LVEDP and PCWP. Identical LVEDP and PCWP rules out mitral stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral stenosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Idiopathic pulmonary arterial hypertension: The elevated PCWP rules out idiopathic pulmonary arterial hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Idiopathic pulmonary arterial hypertension:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In the presence of elevated PCWP equal to LVEDP and normal LV systolic function, consider HFpEF as the cause of pulmonary hypertension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are assessing a patient with an aortic aneurysm. You observe hypertelorism, a bifid uvula, and \&quot;corkscrew\&quot; carotids on imaging. You suspect Loeys-Dietz syndrome. Which protein&#x27;s gene mutation is responsible for the syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFTR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibrillin-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;STK11 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TGF-Î² receptor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TGF-Î² receptor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cystic fibrosis transmembrane conductance regulator : Mutations in this gene cause cystic fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cystic fibrosis transmembrane conductance regulator&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrillin-1 : Mutations in this gene cause Marfan syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrillin-1&lt;/li&gt;&lt;li&gt;â€¢ Option C. STK11 gene : Mutations in this gene cause Peutz-Jeghers syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. STK11 gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Loeys-Dietz syndrome is caused by mutations in the genes encoding TGF-Î²r.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following rheumatologic diseases is associated with a risk for aortic aneurysms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psoriatic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Various rheumatologic diseases have increased risk of aortic aneurysms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are appropriate therapeutic steps for varicose veins EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Avoid prolonged standing.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Frequent elevation of the lower extremities.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Graduated compression stockings.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aspirin.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Avoid prolonged standing: Prolonged standing increases pressure in the veins of the legs, worsening varicose veins.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Avoid prolonged standing:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Frequent elevation of the lower extremities: Elevating the legs helps reduce pressure in the veins and improves blood flow back to the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Frequent elevation of the lower extremities:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Graduated compression stockings: These stockings apply pressure to the legs, helping to improve blood flow and reduce swelling.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Graduated compression stockings:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Aspirin is not a standard treatment for varicose veins.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are reasonable therapeutic options for chronic lymphedema EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diuretic therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Frequent leg elevation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intermittent pneumatic compression devices&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liposuction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Diuretic therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Frequent leg elevation: Elevating the affected limb helps reduce swelling by promoting lymphatic drainage.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Frequent leg elevation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intermittent pneumatic compression devices: These devices use air pressure to massage the limb and promote lymphatic flow.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intermittent pneumatic compression devices:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liposuction: In some cases, liposuction can be used to remove excess fat and reduce the size of the affected limb. Liposuction may be particularly useful in post-mastectomy lymphedema.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liposuction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diuretic therapy is ineffective and contraindicated in lymphedema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the statements regarding chronic venous disease is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;More men than women suffer from varicose veins.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;More men than women suffer from chronic venous insufficiency with edema.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;More than 50% of patients over 70 years old have chronic venous insufficiency.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most patients with chronic venous insufficiency will develop venous ulcers.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. More men than women suffer from chronic venous insufficiency with edema.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. More men than women suffer from varicose veins: This is incorrect; varicose veins are more common in women.&lt;/li&gt;&lt;li&gt;â€¢ Option A. More men than women suffer from varicose veins:&lt;/li&gt;&lt;li&gt;â€¢ Option C. More than 50% of patients over 70 years old have chronic venous insufficiency: The prevalence in this age group is closer to 10%.&lt;/li&gt;&lt;li&gt;â€¢ Option C. More than 50% of patients over 70 years old have chronic venous insufficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Most patients with chronic venous insufficiency will develop venous ulcers: Only about 20% of patients with chronic venous insufficiency develop venous ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Most patients with chronic venous insufficiency will develop venous ulcers:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Varicose veins are more common in women than in men.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with bacterial endocarditis, which of the following echocardiographic lesions is most likely to lead to embolization?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5-mm mitral valve vegetation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;11-mm tricuspid valve vegetation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;11-mm aortic valve vegetation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;11-mm mitral valve vegetation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 11-mm mitral valve vegetation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 11-mm mitral valve vegetation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Although any valvular vegetation can embolize, vegetations located on the mitral valve and vegetations &amp;gt;10 mm are at greatest risk of embolizing. Of the choices, options B, C, and D are large enough to increase the risk of embolization.&lt;/li&gt;&lt;li&gt;â€¢ Hematogenously seeded infection from an embolized vegetation may involve any organ, but particularly affects those organs with the highest blood flow. They are seen in up to 50% of patients with endocarditis. Tricuspid lesions will lead to pulmonary septic emboli, which is common in injection drug users. Mitral and aortic lesions can lead to embolic infections in the skin, spleen, kidneys, meninges, and skeletal system. A dreaded neurologic complication is mycotic aneurysm, focal dilations of arteries at points in the arterial wall that have been weakened by infection in the vasa vasorum or septic emboli, leading to hemorrhage.&lt;/li&gt;&lt;li&gt;â€¢ Education Objective :&lt;/li&gt;&lt;li&gt;â€¢ Education Objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Mitral vegetations &amp;gt;10 mm are at greatest risk of embolization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with a history of bioprosthetic aortic valve replacement presents with intermittent fever and dyspnea 3 years after the procedure. TTE is normal. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac CT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further testing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transesophageal echocardiography (TEE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac CT : Less sensitive than TEE for detecting vegetations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac CT&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac MRI : Not the first-line imaging modality for PVE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option D. No further testing : Inappropriate given the suspicion for PVE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No further testing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected infective endocarditis, transthoracic echocardiography is recommended as the initial imaging choice in most clinical situations.&lt;/li&gt;&lt;li&gt;âž¤ TEE is the preferred imaging modality to evaluate for PVE when TTE is inconclusive or if complications have developed or are clinically suspected or if intracardiac device leads are present, transesophageal echocardiography is recommended.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man is evaluated for recurrent pericarditis. He has had two prior episodes, both successfully treated with ibuprofen and colchicine. His current symptoms include fever, pulsus paradoxus, a pericardial friction rub, and widespread ST-segment elevation on ECG. Echocardiogram shows a small pericardial effusion without tamponade. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anakinra&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colchicine and intravenous immune globulin (IVIG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ibuprofen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ibuprofen, colchicine, and prednisone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ibuprofen, colchicine, and prednisone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anakinra : This is an interleukin-1 receptor antagonist used for refractory cases of recurrent pericarditis that have not responded to other treatments.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anakinra&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colchicine and IVIG : This combination is also used for refractory cases, but glucocorticoids should be added first.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colchicine and IVIG&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ibuprofen alone : Unlikely to be effective for recurrent pericarditis, especially since it has been used previously.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ibuprofen alone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with recurrent pericarditis initially treated with both colchicine and an NSAID, the addition of a glucocorticoid should be considered.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man had an atrial septal defect (ASD) closure one year ago. He is now scheduled for tooth extraction and periodontal cleaning. The dentist recommended a nil per oral (NPO) 8 hours prior to the procedure. What is the choice for IE prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral Azithromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No endocarditis prophylaxis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No endocarditis prophylaxis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A), B), C): These are antibiotics used for endocarditis prophylaxis but are not indicated in this case.&lt;/li&gt;&lt;li&gt;â€¢ A), B), C):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Endocarditis prophylaxis is not routinely recommended for dental procedures in patients with repaired ASDs unless there are specific high-risk features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman presents with progressive dyspnea, cough, weight loss, and pulsus paradoxus. Physical exam reveals jugular venous distention, distant heart sounds, and crackles. Chest X-ray shows a large right upper lobe mass and an enlarged cardiac silhouette. What is the next test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT-guided needle biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fiberoptic bronchoscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PET/CT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transthoracic echocardiography (TTE)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Transthoracic echocardiography (TTE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT-guided needle biopsy : May be needed later to assess the lung mass, but not the immediate priority.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT-guided needle biopsy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fiberoptic bronchoscopy : May be useful for evaluating the lung mass, but not the priority in this unstable patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fiberoptic bronchoscopy&lt;/li&gt;&lt;li&gt;â€¢ Option C. PET/CT : May be useful for staging malignancy, but not the immediate priority.&lt;/li&gt;&lt;li&gt;â€¢ Option C. PET/CT&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Findings suggesting cardiac tamponade include pulsus paradoxus, tachycardia, distant heart sounds, and occasionally an enlarged silhouette on CXR.&lt;/li&gt;&lt;li&gt;âž¤ Echocardiography is an essential tool in the diagnosis of cardiac tamponade because it defines the presence, distribution, and relative volume of pericardial fluid.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient evaluated for cough is found to have an enlarged cardiac silhouette on chest radiography. He is suspected of having pericardial effusion. Ultrasonography is performed with the probe placed in the subxiphoid area. The results are shown. Which of the following is the most likely interpretation of this study?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Large pericardial effusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;No pericardial effusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LV dilatation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Indeterminate study&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Large pericardial effusion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202024-12-14%20at%2009.53.39.jpeg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. No pericardial effusion: This option is incorrect because the ultrasound clearly demonstrates the presence of a significant anechoic space around the heart, indicating a pericardial effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. No pericardial effusion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. LV dilatation: Left ventricular (LV) dilatation is not indicated by the findings described in this scenario. The primary abnormality is the pericardial effusion, not an intrinsic abnormality of the left ventricle.&lt;/li&gt;&lt;li&gt;â€¢ Option C. LV dilatation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Indeterminate study : This option is incorrect because the ultrasound findings are definitive for a large pericardial effusion. There is no indication that the study is inconclusive or indeterminate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Indeterminate study&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A large pericardial effusion is characterized by the accumulation of fluid around the heart, visible as an anechoic space on ultrasound. It can lead to cardiac tamponade, a life-threatening condition that requires prompt recognition and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with SLE presents with progressive dyspnea, fatigue, chest fullness, and bilateral peripheral edema. She is febrile and her JVP is elevated. ECG is shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac tamponade&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-124716.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Constrictive pericarditis : Although it can present with similar symptoms, it usually has a more insidious onset and does not typically cause electrical alternans on ECG.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Constrictive pericarditis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism : Can cause dyspnea and elevated JVP, but it would not typically present with electrical alternans.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary hypertension : Less likely in the absence of lung disease or right heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary hypertension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Electrical alternans is a hallmark of cardiac tamponade.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man is evaluated for a 2-week history of fever and malaise. Nail findings show splinter hemorrhages. Which of the following is the next appropriate step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood cultures&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urine cultures&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CT scan of the chest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CSF analysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Blood cultures&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-150655.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urine cultures: While urine cultures may be helpful in identifying a urinary tract infection, they are not the primary diagnostic test for suspected IE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urine cultures:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CT scan of the chest: A CT scan might be helpful in later stages to assess for complications of IE, such as embolic events, but blood cultures are the first step.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CT scan of the chest:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CSF analysis: CSF analysis is used to diagnose infections of the central nervous system, not IE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CSF analysis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Splinter hemorrhages in the setting of fever and malaise raise the suspicion of infective endocarditis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man is evaluated for a 2-day history of fever, malaise, and heart murmur. Today, crops of nonpainful cutaneous lesions have appeared on his feet as shown. Given the diagnosis, the patient is at risk of all of the following except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intracranial hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic dissection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aortic dissection&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184301.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intracranial hemorrhage: Septic emboli from IE can lodge in the brain, causing intracranial hemorrhage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intracranial hemorrhage:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke: Septic emboli can also cause ischemic stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heart failure: Valve damage from IE can lead to heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heart failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Aortic complications are uncommon in endocarditis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man is evaluated for chronic right-sided heart failure. Chest radiographs are shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic thromboembolic pulmonary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Constrictive pericarditis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184320.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic thromboembolic pulmonary hypertension: This condition involves pulmonary artery obstruction due to organized clots, leading to increased pulmonary artery pressure and right-sided heart failure. However, it would not typically present with pericardial calcification on chest radiographs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic thromboembolic pulmonary hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary hyperparathyroidism: While primary hyperparathyroidism can cause hypercalcemia and possibly lead to calcifications in various tissues, it is not typically associated with pericardial calcification or the symptoms of chronic right-sided heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary hyperparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Restrictive cardiomyopathy : Restrictive cardiomyopathy causes diastolic dysfunction due to myocardial stiffness but does not involve pericardial calcification. The imaging findings and clinical presentation are more consistent with constrictive pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Restrictive cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Constrictive pericarditis is characterized by pericardial thickening and calcification that leads to impaired cardiac filling and chronic right-sided heart failure. Radiographic evidence of pericardial calcification is a key diagnostic clue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man is evaluated for a 2-week history of subjective fever and malaise. A grade 2/6 holosystolic murmur that increases with inspiration is present at the left mid-sternal border. A new, painful skin lesion is shown. Which of the following is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are associated with infective endocarditis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They are typically painless.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are caused by immune complex deposition.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They can be found on the fingertips and toes.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. They are typically painless.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184332.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) They are typically painless.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are associated with infective endocarditis : This is true. Osler&#x27;s nodes are a cutaneous manifestation of infective endocarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are associated with infective endocarditis&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are caused by immune complex deposition: This is true. The pathogenesis of Osler&#x27;s nodes involves the deposition of immune complexes in the skin, leading to inflammation and the formation of the nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are caused by immune complex deposition:&lt;/li&gt;&lt;li&gt;â€¢ Option D. They can be found on the fingertips and toes: This is true. Osler&#x27;s nodes are most commonly found on the pads of the fingers and toes, but they can also occur on other parts of the hands and feet.&lt;/li&gt;&lt;li&gt;â€¢ Option D. They can be found on the fingertips and toes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Osler&#x27;s nodes as a painful, cutaneous manifestation of infective endocarditis caused by immune complex deposition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 77-year-old man is evaluated for a 10-day history of fever and fatigue. Two years ago, he underwent dual-chamber pacemaker implantation. He reports tenderness at the site of his pacemaker, as shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cutaneous squamous cell carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Device-associated infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyoderma gangrenosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyogenic granuloma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Device-associated infection&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184347.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cutaneous squamous cell carcinoma: Cutaneous squamous cell carcinoma typically presents as a persistent, non-healing ulcer or nodule with a rough or scaly surface. It would not be associated with the systemic symptoms (fever, fatigue) described here, nor with tenderness at the site of a previously implanted device.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cutaneous squamous cell carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyoderma gangrenosum : Pyoderma gangrenosum is a rare inflammatory condition that typically presents with painful, rapidly progressing ulcers with a purulent base and violaceous borders. It is associated with systemic diseases like inflammatory bowel disease and rheumatoid arthritis, not with pacemaker implantation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyoderma gangrenosum&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyogenic granuloma : Pyogenic granuloma is a benign vascular lesion that typically appears as a small, red, rapidly growing nodule or mass, often after minor trauma. It would not typically present with systemic symptoms like fever or tenderness at a pacemaker site.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyogenic granuloma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A device-associated infection can occur after implantation of devices like pacemakers and may present with systemic symptoms such as fever, along with local signs like tenderness, erythema, and even erosion of the device through the skin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man presents with edema and ascites. On examination, he has elevated JVP with no respiratory variation. His BP is 110/70 mmHg and decreases to 80/60 mmHg with inspiration. 2D echo revealed a large pericardial effusion. Pericardiocentesis was performed, but intracardiac pressures remain elevated. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Effusive-constrictive pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dilated cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Effusive-constrictive pericarditis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Constrictive pericarditis: This would present with elevated intracardiac pressures, but there wouldn&#x27;t be a significant pericardial effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Constrictive pericarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac tamponade: This would also present with elevated intracardiac pressures, but these pressures would normalize after pericardiocentesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac tamponade:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dilated cardiomyopathy: This presents with a dilated left ventricle and reduced ejection fraction, and typically does not have elevated intracardiac pressures or pericardial effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dilated cardiomyopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Effusive-constrictive pericarditis is a combination of pericardial effusion and constrictive pericarditis, characterized by persistently elevated intracardiac pressures even after drainage of the effusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with chronic kidney disease shortness of breath and diaphoresis. BP is 90/60 mm Hg and it decreases to 70/50 during inspiration. On examination, his JVP is elevated, has pitting pedal edema and heart sounds were faint. What is the next management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemodialysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroglycerin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pericardiocentesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right heart catheterization&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pericardiocentesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemodialysis : May worsen the situation by reducing the right sided filling pressures without affecting the increased intra-pericardiac pressure in tamponade.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemodialysis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous nitroglycerin : May reduce right heart filling and may worsen hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous nitroglycerin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right heart catheterization : May be useful for diagnosis but does not treat tamponade.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right heart catheterization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Definitive treatment of cardiac tamponade is pericardiocentesis or surgical pericardial drainage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old patient presents with edema and elevated jugular venous pressure (JVP). The JVP pressure tracing is shown below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Constrictive pericarditis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184409.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac tamponade: In cardiac tamponade, the x descent is typically absent or minimal, and the y descent is blunted or slow.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac tamponade:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tricuspid regurgitation: This would cause a prominent v wave in the JVP tracing, not a prominent x descent.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tricuspid regurgitation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid stenosis: Tricuspid stenosis would cause a slow y descent, but the x descent would be normal or blunted.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tricuspid stenosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Prominent x and y descent is characteristic of constrictive pericarditis. The prominent â€˜yâ€™ descent of constrictive pericarditis is also called as â€˜friedrich signâ€™.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man with hypertension and hyperlipidemia presents with acute chest pain, elevated CRP, and normal troponin levels. ECG is shown. Echocardiogram reveals a small pericardial effusion. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Echocardiographic-guided pericardiocentesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emergent cardiac catheterization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exercise treadmill stress testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose aspirin and colchicine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. High-dose aspirin and colchicine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184426.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Echocardiographic-guided pericardiocentesis : Indicated for large effusions or tamponade, neither of which is present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Echocardiographic-guided pericardiocentesis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Emergent cardiac catheterization : Not necessary as the ECG findings are not consistent with ST-elevation myocardial infarction, and troponin levels are normal.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Emergent cardiac catheterization&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise treadmill stress testing : Contraindicated in acute pericarditis due to the risk of exacerbating inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exercise treadmill stress testing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with acute pericarditis, first-line treatment is high-dose aspirin or NSAIDs and adjuvant colchicine therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with pleuritic chest pain, fever, and malaise two weeks after a myocardial infarction (MI). On auscultation, you hear a multiphasic rub. His CRP levels are elevated, and troponin levels are slightly elevated but unchanged compared to previous values. ECG shows new ST elevations. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dressler&#x27;s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recurrent MI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dressler&#x27;s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute pericarditis: Less likely given the recent MI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute pericarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism: Unlikely with unchanged troponin and ECG findings.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recurrent MI: Unlikely with unchanged troponin and ECG findings suggestive of pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recurrent MI:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Dressler&#x27;s syndrome is a post-MI pericarditis that occurs after 1-2 weeks.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old homeless man presents with TIA, fever, chills, tender splenomegaly, new painful nodules on fingers, and nits on clothes. Blood cultures are negative, but echo reveals aortic valve vegetation. What test should be sent to confirm the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bartonella serology&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Epstein-Barr virus heterophile antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV polymerase chain reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Q fever serology&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bartonella serology&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Epstein-Barr virus heterophile antibody: EBV does not typically cause endocarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Epstein-Barr virus heterophile antibody:&lt;/li&gt;&lt;li&gt;â€¢ Option C. HIV polymerase chain reaction: HIV does not cause endocarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HIV polymerase chain reaction:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Q fever serology: While Q fever can cause culture-negative endocarditis, the patient&#x27;s history and presentation are more consistent with Bartonella infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Q fever serology:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Two most common pathogens responsible for culture negative endocarditis re&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old man with substance use disorder is evaluated for 3 weeks of fever and malaise and a new heart murmur. Funduscopic findings are shown. Which of the following about the finding is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are retinal hemorrhages with pale centers.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They are NOT pathognomonic for infective endocarditis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are usually asymptomatic.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are due to septic emboli to the retina.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. They are due to septic emboli to the retina.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-10-184442.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are retinal hemorrhages with pale centers: This is the classic description of Roth spots. The pale center is thought to represent fibrin or inflammatory cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are retinal hemorrhages with pale centers:&lt;/li&gt;&lt;li&gt;â€¢ Option B. They are not pathognomonic for infective endocarditis: While Roth spots are strongly associated with infective endocarditis, they can also occur in other conditions like leukemia, HIV, anemia, diabetic/hypertensive retinopathy and vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. They are not pathognomonic for infective endocarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are usually asymptomatic: Roth spots themselves do not usually cause any sympotms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are usually asymptomatic:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Roth spots are examples of immunological manifestations of endocarditis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old African American male presents with nephrotic syndrome and progressive renal failure. Renal biopsy reveals focal segmental glomerulosclerosis (FSGS). Which of the following genetic polymorphisms is most likely associated with his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NPHS1 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NPHS2 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TRPC6 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;APOL1 polymorphism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. APOL1 polymorphism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) APOL1 polymorphism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;amp; B. NPHS1 and NPHS2: Mutations are associated with congenital nephrotic syndrome, not FSGS in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;amp; B. NPHS1 and NPHS2:&lt;/li&gt;&lt;li&gt;â€¢ Option C. TRPC6 mutations: Can cause FSGS, but they are less common than APOL1 variants in African Americans.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TRPC6 mutations:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ APOL1 gene variants are a significant risk factor for focal segmental glomerulosclerosis (FSGS) and other forms of non-diabetic kidney disease in individuals of African descent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common cause of nephrotic syndrome in adults?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Minimal change disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Focal segmental glomerulosclerosis (FSGS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Membranous nephropathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetic nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Membranous nephropathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Membranous nephropathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Minimal change disease: This is a common cause of nephrotic syndrome in children, but less frequent in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Minimal change disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Focal segmental glomerulosclerosis (FSGS): FSGS can cause nephrotic syndrome, but it&#x27;s less common than membranous nephropathy in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Focal segmental glomerulosclerosis (FSGS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetic nephropathy: This is a leading cause of chronic kidney disease, but it typically presents with proteinuria in the absence of the full-blown nephrotic syndrome (edema, hyperlipidemia, hypoalbuminemia).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetic nephropathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Membranous nephropathy is the most common cause of nephrotic syndrome in adults, especially in Caucasian populations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old obese woman with controlled hypertension has nephrotic-range proteinuria and mild edema. Renal biopsy reveals segmental scarring in 60% of glomeruli, mainly at the corticomedullary junction. Which diagnosis is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Focal segmental glomerulosclerosis (FSGS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertensive nephrosclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Minimal change disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Crescentic glomerulonephritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Focal segmental glomerulosclerosis (FSGS)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-163558.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Focal segmental glomerulosclerosis (FSGS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertensive nephrosclerosis: While the patient has hypertension, the biopsy findings do not fit the typical pattern of nephrosclerosis (arteriolosclerosis and global glomerulosclerosis).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertensive nephrosclerosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Minimal change disease: This would usually present with less severe proteinuria and no glomerular scarring on biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Minimal change disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Crescentic glomerulonephritis: This is a rapidly progressive form of glomerulonephritis with crescents (proliferations of cells) on biopsy, not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Crescentic glomerulonephritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Focal segmental glomerulosclerosis (FSGS) is characterized by segmental scarring in a subset of glomeruli, often associated with obesity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical feature of post-streptococcal glomerulonephritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hematuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proteinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A, B &amp;amp; C : These are classic features of PSGN.&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A, B &amp;amp; C&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-streptococcal glomerulonephritis (PSGN) typically presents with hematuria, proteinuria and hypertension, but not hypokalemia. The usual timeframe for PSGN development after impetigo is 2-6 weeks.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy presents with hematuria and edema, three weeks after a confirmed case of impetigo. Which of the following is the most appropriate time frame for the development of post-streptococcal glomerulonephritis (PSGN) following impetigo?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-3 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2-6 weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3-8 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2-6 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 2-6 weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 2-6 weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1-3 weeks: This time frame is too short for PSGN to develop after a streptococcal infection like impetigo.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1-3 weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 3-8 weeks: While PSGN can occasionally present slightly later, the most typical window is within the first 2-6 weeks.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 3-8 weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 2-6 days: This time frame is far too short. PSGN takes weeks, not days, to manifest.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 2-6 days:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-streptococcal glomerulonephritis (PSGN) is an immune-mediated complication that can occur after a streptococcal infection. The classic presentation includes hematuria (blood in the urine), edema (swelling) and hypertension. The most common time frame for the development of PSGN following a streptococcal infection is 2-6 weeks . Recognizing this typical time frame is crucial for timely diagnosis and management of PSGN.&lt;/li&gt;&lt;li&gt;âž¤ 2-6 weeks&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with systemic lupus erythematosus (SLE) presents with proteinuria, edema and a normal serum creatinine. Renal biopsy reveals Thickened basement membranes with diffuse sub-epithelial immune deposit . Which of the following complications is she at increased risk of developing?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute kidney injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal vein thrombosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nephritic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypocomplementemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Renal vein thrombosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Renal vein thrombosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute kidney injury: While possible in SLE, it&#x27;s less common with class V lupus nephritis, which typically has a more insidious onset.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute kidney injury:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nephritic syndrome: This is characterized by hematuria and hypertension, which are not prominent features of class V lupus nephritis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nephritic syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypocomplementemia: While common in other classes of lupus nephritis, it&#x27;s not always present in class V, which is often associated with normal complement levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypocomplementemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lupus nephritis class V (membranous lupus nephritis) carries an increased risk of renal vein thrombosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with hemoptysis (coughing up blood), shortness of breath and hematuria. His serum creatinine is elevated. A renal biopsy is taken and immunofluorescence is shown below. Given the likely diagnosis, what would be the immunofluorescence findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mesangial cell proliferation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linear IgG deposits along the glomerular basement membrane&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subepithelial immune complex deposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mesangial IgA deposits&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Linear IgG deposits along the glomerular basement membrane&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-164723_IdSR2Ar.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Linear IgG deposits along the glomerular basement membrane&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mesangial cell proliferation: Is seen in IgA nephropathy and other conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mesangial cell proliferation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subepithelial immune complex deposits: Are characteristic of membranous nephropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subepithelial immune complex deposits:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mesangial IgA deposits: Are seen in IgA nephropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mesangial IgA deposits:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Linear IgG deposits along the glomerular basement membrane on immunofluorescence are characteristic of Goodpasture syndrome (anti-GBM disease).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following demographic groups is MOST likely to be affected by IgA nephropathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elderly women&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Young men&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Children under 5 years old&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;African American individuals&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Young men&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Young men&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elderly women: IgA nephropathy is less common in elderly individuals and slightly more common in men than women.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elderly women:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Children under 5 years old: While IgA nephropathy can occur in children, it is more typically diagnosed in adolescents and young adults.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Children under 5 years old:&lt;/li&gt;&lt;li&gt;â€¢ Option D. African American individuals: IgA nephropathy is less prevalent in individuals of African descent compared to those of Caucasian or Asian descent.&lt;/li&gt;&lt;li&gt;â€¢ Option D. African American individuals:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgA nephropathy, also known as Berger&#x27;s disease, primarily affects young men, particularly those in their teens to late 30s. While it can affect individuals of any age, gender or race, certain demographic factors increase the risk of developing this condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical feature of ANCA-associated vasculitis (AAV)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Palpable purpura&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mononeuritis multiplex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hematuria and proteinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypocomplementemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypocomplementemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypocomplementemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Palpable purpura: Is a common skin manifestation of AAV.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Palpable purpura:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mononeuritis multiplex: (asymmetric peripheral neuropathy) is also a classic finding.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mononeuritis multiplex:&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hematuria and proteinuria: Are common due to glomerulonephritis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hematuria and proteinuria:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ANCA-associated vasculitis (AAV) does not typically present with hypocomplementemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What percentage of Alport syndrome cases are inherited in an autosomal recessive pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;15%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;85%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 15%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 15%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5%: This is the approximate percentage for the less common autosomal dominant form.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5%:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 50%: This is the probability of inheritance for each child if one parent has the X-linked dominant form.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 50%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 85%: This is the approximate percentage for the most common X-linked dominant form.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 85%:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alport syndrome is a genetic disorder primarily affecting the kidneys, hearing, and vision. While most cases (around 80-85%) are inherited in an X-linked pattern, approximately 15% of cases are inherited in an autosomal recessive pattern. This means that both parents must carry a mutated gene for their child to be affected&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy presents with recurrent hematuria and a family history of kidney disease, on further questioning he has difficulty in hearing since childhood. A renal biopsy reveals thin glomerular basement membranes (GBMs) on electron microscopy. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thin basement membrane nephropathy (TBMN)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alport syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Minimal change disease (MCD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alport syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alport syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . IgA nephropathy: Presents with mesangial IgA deposits.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ IgA nephropathy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thin basement membrane nephropathy ( TBMN) : This is a benign condition with persistent thin GBM, but no progression to multilamellation or other Alport features.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thin basement membrane nephropathy&lt;/li&gt;&lt;li&gt;â€¢ TBMN)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Minimal change disease ( MCD): Does not cause thinning of the GBM.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Minimal change disease (&lt;/li&gt;&lt;li&gt;â€¢ MCD):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Alport syndrome is primarily inherited in an X-linked dominant pattern (approximately 85%), but 15% of cases follow an autosomal recessive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Alport syndrome is primarily inherited in an X-linked dominant pattern (approximately 85%), but 15% of cases follow an autosomal recessive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Thin glomerular basement membranes (GBMs) on electron microscopy, combined with recurrent hematuria and a family history of kidney disease and hearing loss, are suggestive of Alport syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Thin glomerular basement membranes (GBMs) on electron microscopy, combined with recurrent hematuria and a family history of kidney disease and hearing loss, are suggestive of Alport syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old boy presents with asymptomatic microscopic hematuria and a family history of similar findings. Renal function is normal. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alport syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Benign familial hematuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Post-streptococcal glomerulonephritis (PSGN)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Benign familial hematuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alport syndrome: Usually has proteinuria and progressive kidney disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alport syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IgA nephropathy: Presents with episodic gross hematuria, often after infections.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IgA nephropathy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Post-streptococcal glomerulonephritis (PSGN): Occurs after streptococcal infection, with edema and hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option D. Post-streptococcal glomerulonephritis (PSGN):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Benign familial hematuria (thin basement membrane nephropathy) is the most likely diagnosis in a child with asymptomatic microscopic hematuria and a positive family history. It is a benign condition with normal renal function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with nephrotic syndrome is at increased risk of developing which of the following complications?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thromboembolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute kidney injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thromboembolism: Nephrotic syndrome leads to the loss of proteins involved in blood clotting, increasing the risk of blood clots.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thromboembolism:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Infection: Loss of immunoglobulins (antibodies) in the urine makes individuals more susceptible to infections.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Infection:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute kidney injury: The underlying kidney disease causing nephrotic syndrome can worsen, leading to acute kidney injury&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute kidney injury:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nephrotic syndrome increases the risk of blood clots, infections, and kidney failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical feature of nephrotic syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proteinuria &amp;gt; 3.5 g/day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoalbuminemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperlipidemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hyperkalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Proteinuria &amp;gt; 3.5 g/day: This is a hallmark of nephrotic syndrome. The excessive loss of protein in the urine is a defining characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Proteinuria &amp;gt; 3.5 g/day:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypoalbuminemia: This occurs due to the significant loss of albumin (a protein) in the urine, leading to low albumin levels in the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypoalbuminemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperlipidemia: The liver tries to compensate for the protein loss by increasing the production of lipids (fats), leading to high levels of cholesterol and triglycerides in the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperlipidemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nephrotic syndrome is characterized by a constellation of findings, including heavy proteinuria, low albumin levels, and elevated lipids. Hyperkalemia (high potassium) is not typically associated with nephrotic syndrome; in fact, hypokalemia (low potassium) is more common due to urinary losses.&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old boy presents with generalized edema, massive proteinuria, and hypoalbuminemia. Given the likely diagnosis, what would be electron microscopic findings would be present in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sub-endothelial immune complex deposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mesangial electron-dense deposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thinning of the glomerular basement membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Effacement of podocyte foot processes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Effacement of podocyte foot processes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sub-endothelial immune complex deposits: This is typically seen in lupus nephritis and other immune-complex mediated glomerulonephritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sub-endothelial immune complex deposits:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mesangial electron-dense deposits: This is characteristic of IgA nephropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mesangial electron-dense deposits:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thinning of the glomerular basement membrane: This is seen in thin basement membrane nephropathy, a benign condition with minimal proteinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thinning of the glomerular basement membrane:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation strongly suggests minimal change disease (MCD) , which is the most common cause of nephrotic syndrome in children. The hallmark electron microscopic finding in MCD is the effacement (flattening or fusion) of podocyte foot processes . These foot processes are crucial for the filtration barrier in the glomerulus and their damage leads to the massive proteinuria seen in nephrotic syndrome.&lt;/li&gt;&lt;li&gt;âž¤ minimal change disease (MCD)&lt;/li&gt;&lt;li&gt;âž¤ effacement (flattening or fusion) of podocyte foot processes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In children diagnosed with minimal change disease (MCD), what percentage is expected to achieve spontaneous remission without specific treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;30%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;75%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 10%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 10%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 30%, Option C. 50% &amp;amp; Option D. 75%: These percentages are too high. While spontaneous remission can happen in MCD, it&#x27;s not the norm. Most children require treatment with corticosteroids to achieve remission.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 30%, Option C. 50% &amp;amp; Option D. 75%:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Minimal change disease (MCD) is the most common cause of nephrotic syndrome in children. The hallmark of MCD on electron microscopy is the effacement of podocyte foot processes. Spontaneous remission occurs in a minority of children with MCD (approximately 10%), while the majority respond well to corticosteroid therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old obese man with a history of hypertension presents with proteinuria, edema and hypoalbuminemia. Renal biopsy reveals focal segmental glomerulosclerosis (FSGS). Which of the following would be the LEAST appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Weight loss and blood pressure control&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ACEi/ARBs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodium restriction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A, B &amp;amp; D: These are all appropriate initial interventions for secondary FSGS.&lt;/li&gt;&lt;li&gt;â€¢ Options A, B &amp;amp; D:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Secondary FSGS, often due to obesity and hypertension, usually doesn&#x27;t respond to corticosteroids. Treatment focuses on addressing the underlying cause and using renoprotective agents (ACEi/ARBs).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with obesity-related FSGS is started on a weight loss program and an ACE inhibitor. After 6 months, their proteinuria has significantly decreased. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue current therapy and monitor closely.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add a corticosteroid.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Consider renal biopsy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate dialysis.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Continue current therapy and monitor closely.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add a corticosteroid: Corticosteroids are typically used for other forms of FSGS, not primarily obesity-related. Adding them unnecessarily could expose the patient to potential side effects without a clear benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Add a corticosteroid:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Consider renal biopsy: A renal biopsy is typically performed at the initial diagnosis to confirm FSGS and exclude other causes. If the patient is responding well to therapy, a repeat biopsy is usually not indicated.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Consider renal biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate dialysis: Dialysis is indicated in cases of end-stage renal disease (ESRD) when the kidneys are no longer functioning adequately. This patient is responding to therapy and does not show signs of ESRD.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate dialysis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ If a patient with obesity-related FSGS responds well to initial therapy (weight loss and ACEi/ARB), continued monitoring is usually sufficient. Further intervention isn&#x27;t immediately necessary.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is associated with â€œtram-trackâ€ appearance of renal biopsy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MPGN type I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MPGN type II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MPGN type III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alport syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. MPGN type I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. MPGN type II: Shows dense deposits within the GBM, not the tram-track appearance.&lt;/li&gt;&lt;li&gt;â€¢ Option B. MPGN type II:&lt;/li&gt;&lt;li&gt;â€¢ Option C. MPGN type III: Is similar to type I but with less prominent mesangial interposition.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MPGN type III:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alport syndrome: Shows splitting and lamellation of the GBM.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alport syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;tram-track\&quot; appearance on renal biopsy is a hallmark of MPGN type I due to the characteristic mesangial interposition. This distinctive finding helps differentiate MPGN type I from other glomerular diseases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient is newly diagnosed with idiopathic membranoproliferative glomerulonephritis (MPGN) type I. Which of the following statements regarding their prognosis is MOST accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The majority of patients will experience spontaneous remission within 5 years.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal function typically remains stable for at least 20 years after diagnosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Approximately 50% of patients will develop end-stage renal disease (ESRD) within 10 years.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Early treatment with corticosteroids can prevent progression to ESRD in most cases.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Approximately 50% of patients will develop end-stage renal disease (ESRD) within 10 years.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The majority of patients will experience spontaneous remission within 5 years :  Spontaneous remission is rare in MPGN type I.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ The majority of patients will experience spontaneous remission within 5 years&lt;/li&gt;&lt;li&gt;â€¢ Option B. Renal function typically remains stable for at least 20 years after diagnosis: Renal function typically declines over time, with 90% of patients developing renal insufficiency within 20 years.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Renal function typically remains stable for at least 20 years after diagnosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Early treatment with corticosteroids can prevent progression to ESRD in most cases: While corticosteroids may be beneficial in some cases, they do not guarantee prevention of ESRD.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Early treatment with corticosteroids can prevent progression to ESRD in most cases:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MPGN type I is a progressive disease with a poor prognosis. Approximately half of the patients progress to ESRD within 10 years, emphasizing the need for early diagnosis and management to potentially slow disease progression. While treatments like corticosteroids may be used, they do not guarantee prevention of ESRD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the risk of urothelial malignancy in patients with analgesic nephropathy-related ESRD is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The risk is lower than in patients with other causes of ESRD.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The risk is the same as in patients with other causes of ESRD.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The risk is higher than in patients with other causes of ESRD.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;There is no association between analgesic nephropathy and urothelial malignancy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The risk is higher than in patients with other causes of ESRD.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The risk is lower than in patients with other causes of ESRD: This is incorrect. The association between analgesic nephropathy and urothelial malignancy increases the risk compared to other ESRD causes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The risk is lower than in patients with other causes of ESRD:&lt;/li&gt;&lt;li&gt;â€¢ Option B. The risk is the same as in patients with other causes of ESRD: While patients with ESRD generally have a higher risk of certain malignancies, the risk of urothelial malignancy is specifically elevated in those with analgesic nephropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The risk is the same as in patients with other causes of ESRD:&lt;/li&gt;&lt;li&gt;â€¢ Option D. There is no association between analgesic nephropathy and urothelial malignancy: Extensive research has established a clear link between prolonged analgesic use, analgesic nephropathy, and the increased risk of developing urothelial cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. There is no association between analgesic nephropathy and urothelial malignancy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with end-stage renal disease (ESRD) caused by analgesic nephropathy are at an increased risk of developing urothelial malignancies (cancers of the urinary tract) compared to individuals with ESRD from other causes.&lt;/li&gt;&lt;li&gt;âž¤ increased risk&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with weight loss, heat intolerance, and palpitations. Her TSH is normal, and free T4 is elevated. Which of the following is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Graves&#x27; disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Toxic multinodular goiter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute thyroiditis (de Quervain&#x27;s thyroiditis)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TSH-secreting pituitary adenoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TSH-secreting pituitary adenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) TSH-secreting pituitary adenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Graves&#x27; disease: TSH would be suppressed as it is a primary hyperthyroidism. RAIU will show diffuse increase in uptake of Iodine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Graves&#x27; disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Toxic multinodular goiter: TSH would be suppressed as it is a primary hyperthyroidism. RAIU will show patchy multi-focal increased uptake of Iodine.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Toxic multinodular goiter:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subacute thyroiditis (de Quervain&#x27;s thyroiditis): TSH would be suppressed as it is a primary hyperthyroidism. RAIU will show decreased uptake.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subacute thyroiditis (de Quervain&#x27;s thyroiditis):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A TSH-secreting pituitary adenoma is indicated by the combination of normal TSH and elevated free T4, consistent with central hyperthyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male presents with congestive heart failure and sepsis. Thyroid function tests (TFT) reveal a low total T3, normal free T4 and normal TSH. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Give Levothyroxine 200Âµg IV STAT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Give Hydrocortisone 100mg IV STAT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give Levothyroxine 200Âµg and 100mg Hydrocortisone IV STAT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation and repeat TFT after discharge&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Observation and repeat TFT after discharge&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Observation and repeat TFT after discharge&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Give Levothyroxine 200Âµg IV STAT: Levothyroxine replacement is not indicated in SES and may even be harmful.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Give Levothyroxine 200Âµg IV STAT:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Give Hydrocortisone 100mg IV STAT: This could be appropriate for suspected adrenal insufficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Give Hydrocortisone 100mg IV STAT:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Give Levothyroxine 200Âµg and 100mg Hydrocortisone IV STAT: This could be an appropriate treatment for myxedema coma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Give Levothyroxine 200Âµg and 100mg Hydrocortisone IV STAT:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with sick euthyroid syndrome, characterized by low total T3, normal free T4, and normal TSH in the context of critical illness, observation and repeat TFTs after recovery is the appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy presents with growth retardation, delayed bone age, and normal intellect. His thyroid function tests reveal elevated T3, T4, and normal TSH levels. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Refetoff syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TSH-secreting pituitary adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;McCune-Albright syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Graves&#x27; disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Refetoff syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Refetoff syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. TSH-secreting pituitary adenoma: This would result in elevated TSH and T4 levels, but the patient would likely exhibit symptoms of hyperthyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TSH-secreting pituitary adenoma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. McCune-Albright syndrome: This syndrome is associated with precocious puberty, bone lesions, and cafÃ©-au-lait spots.&lt;/li&gt;&lt;li&gt;â€¢ Option C. McCune-Albright syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Graves&#x27; disease: This autoimmune disorder causes clinical hyperthyroidism with elevated T4 and suppressed TSH levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Graves&#x27; disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Refetoff syndrome, or resistance to thyroid hormone (RTH), presents with elevated T3 and T4, normal TSH levels, growth retardation, and delayed bone age, with the patient usually being clinically euthyroid or hypothyroid.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with a 2-week history of palpitations and excessive sweating. Physical examination reveals a non-tender thyroid gland. Thyroid function tests show an elevated free T4 and suppressed TSH. Radioactive iodine uptake (RAIU) scan is shown. Thyroglobulin levels are low. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Graves disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyrotoxicosis factitia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Toxic Multinodular Goiter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroiditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Thyrotoxicosis factitia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-133042_3j62nY0.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Thyrotoxicosis factitia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Graves&#x27; disease: Graves&#x27; disease is an autoimmune condition causing hyperthyroidism. It typically presents with a diffuse goiter, increased RAIU, and high thyroglobulin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Graves&#x27; disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Toxic Multinodular Goiter: This condition also has an increased RAIU and increased thyroglobulin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Toxic Multinodular Goiter:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroiditis: RAIU can be suppressed but thyroglobulin levels are usually elevated in thyroiditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroiditis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyrotoxicosis factitia is characterized by low radioactive iodine uptake (RAIU) and low thyroglobulin levels, indicating exogenous thyroid hormone use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents with a 3-month history of fatigue and constipation. Thyroid function tests show reduced free T4 and increased TSH levels. Which of the following symptoms or signs is LEAST likely to be associated with her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alopecia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amenorrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carpal tunnel syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiac tamponade&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiac tamponade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alopecia: Hypothyroidism can cause hair loss due to slowed metabolism and decreased hair growth.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alopecia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amenorrhea: Hypothyroidism can disrupt menstrual cycles (Menorrhagia initially and oligo/amenorrhea in long standing disease).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amenorrhea:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carpal tunnel syndrome: Hypothyroidism can cause fluid retention and swelling, which can compress the median nerve in the wrist, leading to carpal tunnel syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carpal tunnel syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac tamponade is the least likely symptom associated with primary hypothyroidism, despite pericardial effusion being relatively common.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is false regarding congenital hypothyroidism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid dyshormonogenesis is the most common cause.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Most infants appear normal at birth.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The recommended initial dose of levothyroxine is 10-15 Âµg/kg/day.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Early treatment can significantly improve neurodevelopmental outcomes.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroid dyshormonogenesis is the most common cause.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Thyroid dyshormonogenesis is the most common cause.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Most infants appear normal at birth: The majority of infants appear normal at birth (but classic features are prolonged jaundice, poor feeding, hypotonia, macroglossia, delayed bone maturation, and umbilical hernia).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Most infants appear normal at birth:&lt;/li&gt;&lt;li&gt;â€¢ Option C. The recommended initial dose of levothyroxine is 10-15 Âµg/kg/day: When the diagnosis is confirmed, T4 is instituted at a dose of 10â€“15 Î¼g/kg/day and the dose is adjusted by close monitoring of TSH levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The recommended initial dose of levothyroxine is 10-15 Âµg/kg/day:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Early treatment can significantly improve neurodevelopmental outcomes: Early treatment with T4 results in normal IQ levels, but subtle neurodevelopmental abnormalities may occur in those with the most severe hypothyroidism at diagnosis or when treatment is delayed or suboptimal.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Early treatment can significantly improve neurodevelopmental outcomes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid gland dysgenesis, not thyroid dyshormonogenesis, is the most common cause of congenital hypothyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old hypothyroid patient calls your OPD and informs that she has missed her thyroxine tablet the previous day and asks what to do about it. What will be your advice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ask her to review immediately to the hospital&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ask her to take 2 tablets today&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Skip the missed dose and resume from today&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ask her to take TFT and review&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ask her to take 2 tablets today&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ask her to take 2 tablets today&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ All others are incorrect by default.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Advise hypothyroid patients who miss a dose of thyroxine to take two doses the next day due to the long half-life of T4.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-iv, B-iii, C-ii, D-i&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-iv, B-iii, C-i,D-ii&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-iii, B-iv, C-i,D-ii&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-iii, B-iv, C-ii,D-i&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A-iv, B-iii, C-ii, D-i&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/whatsapp-image-2024-08-17-at-121458-pm.jpeg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A-iv, B-iii, C-ii, D-i&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ If there is no residual thyroid function, the daily replacement dose of LT4 is usually 1.6 Î¼g/kg body weight (typically 100â€“150 Î¼g/d) Adult patients under 60 years old without evidence of heart disease may be started on 50â€“100 Î¼g of LT4 daily. For adults with indications to treat in a subclinical hypothyroidism treatment is administered by starting with a low dose of LT4 (25â€“50 Î¼g/d). In the elderly, especially patients with known coronary artery disease, the starting dose of LT4 is 12.5â€“25 Î¼g/d.&lt;/li&gt;&lt;li&gt;â€¢ If there is no residual thyroid function, the daily replacement dose of LT4 is usually 1.6 Î¼g/kg body weight (typically 100â€“150 Î¼g/d)&lt;/li&gt;&lt;li&gt;â€¢ Adult patients under 60 years old without evidence of heart disease may be started on 50â€“100 Î¼g of LT4 daily.&lt;/li&gt;&lt;li&gt;â€¢ For adults with indications to treat in a subclinical hypothyroidism treatment is administered by starting with a low dose of LT4 (25â€“50 Î¼g/d).&lt;/li&gt;&lt;li&gt;â€¢ In the elderly, especially patients with known coronary artery disease, the starting dose of LT4 is 12.5â€“25 Î¼g/d.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Standard Adult: 50-100 Âµg/day Post thyroidectomy: 100-150 Âµg/day Coronary Artery Disease: 12.5-25 Âµg/day Subclinical Hypothyroidism: 25-50 Âµg/day&lt;/li&gt;&lt;li&gt;âž¤ Standard Adult: 50-100 Âµg/day&lt;/li&gt;&lt;li&gt;âž¤ Post thyroidectomy: 100-150 Âµg/day&lt;/li&gt;&lt;li&gt;âž¤ Coronary Artery Disease: 12.5-25 Âµg/day&lt;/li&gt;&lt;li&gt;âž¤ Subclinical Hypothyroidism: 25-50 Âµg/day&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a history of Hashimoto&#x27;s thyroiditis is brought to the emergency department with altered mental status, hypothermia (35Â°C), bradycardia (45 bpm), and hypotension (80/50 mmHg). Her skin is dry and doughy, and she has non-pitting edema in her extremities. Which of the following is the NOT indicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Levothyroxine 200 Î¼g IV bolus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Hydrocortisone 50mg 6 th hourly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV broad spectrum Antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;External Rewarming&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. External Rewarming&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) External Rewarming&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Levothyroxine 200 Î¼g IV bolus: LT4 single IV bolus of 200â€“400 Î¼g (loading dose) is the preferred initial treatment in myxedema coma (alternate if no IV avaialble: NG tube LT4).&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Levothyroxine 200&lt;/li&gt;&lt;li&gt;â€¢ Î¼g IV bolus:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV Hydrocortisone 50mg 6 th hourly: Parenteral hydrocortisone (50 mg every 6 h) should be administered because there is impaired adrenal reserve in profound hypothyroidism&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV Hydrocortisone 50mg 6 th hourly:&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV broad spectrum Antibiotics: Sepsis is an important precipitating cause of myxedema coma. Early use of broad-spectrum antibiotics is warranted until infection is excluded.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV broad spectrum Antibiotics:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ External (active) rewarming is not indicated for myxedema coma unless the temperature is below 30Â°C, as it can result in cardiovascular collapse.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with a history of Graves&#x27; disease presents to the emergency department with fever, tachycardia, agitation, and vomiting. She recently underwent a dental procedure. Which of the following is the most appropriate initial treatment for her suspected condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propylthiouracil (PTU)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radioactive iodine (RAI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrocortisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Propylthiouracil (PTU)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Propylthiouracil (PTU)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Propranolol (A): Can be used for cardio-protection but not immediately required.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Propranolol (A):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radioactive iodine (C) : Not suitable for acute management of thyrotoxic crisis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radioactive iodine (C)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrocortisone (D) : Adjunctive therapy in thyroid storm, can be added later.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrocortisone (D)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propylthiouracil (PTU) is the most appropriate initial treatment for thyrotoxic crisis (thyroid storm) due to its rapid onset of action and ability to inhibit peripheral conversion of T4 to T3.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of thyrotoxicosis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sinus Tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polyuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypocalciuria&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypocalciuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypocalciuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sinus Tachycardia: The most common CV manifestation in thyrotoxicosis is sinus tachycardia.  Atrial fibrillation is more common in patients &amp;gt;50 years of age.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sinus Tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyuria : Probably due to increased renal blood flow and hypercalciuria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyuria&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypercalcemia: This is due to the effect of thyroid hormones causing bone resorption.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypercalcemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypercalciuria, not hypocalciuria, is a common feature of thyrotoxicosis due to the effect of thyroid hormones on bone resorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with thyrotoxicosis develops atrial fibrillation. Which of the following statements regarding their management is CORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age &amp;lt; 50 is a risk factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Long-term anticoagulation is unnecessary&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Digoxin sensitivity is increased&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Warfarin sensitivity is decreased&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Long-term anticoagulation is unnecessary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Long-term anticoagulation is unnecessary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age &amp;lt; 50 is a risk factor: Elderly patients (Age &amp;gt;50) are at increased risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age &amp;lt; 50 is a risk factor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Digoxin sensitivity is increased: Digoxin sensitivity is decreased because of increased renal clearance and increased number of Na-K ATPse.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Digoxin sensitivity is increased:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Warfarin sensitivity is decreased: Warfarin sensitivity is increased as production of vitamin K dependent clotting factors are reduced.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Warfarin sensitivity is decreased:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Long-term anticoagulation is generally unnecessary in patients with atrial fibrillation and thyrotoxicosis, as spontaneous reversion to sinus rhythm often occurs with control of hyperthyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old male smoker with a history of Graves&#x27; disease presents with weight loss and loss of appetite. He is on carbimazole 5mg per day, and his recent free T4 levels (done a week ago) were normal. He has mild orbitopathy but no dermopathy. On examination, you notice clubbing; otherwise, he is vitally stable. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI of the orbit&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;X-ray of hands with wrist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CT of the chest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repeat TFT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CT of the chest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CT of the chest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI of the orbit: It not the primary concern given the new symptoms and clubbing.&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI of the orbit:&lt;/li&gt;&lt;li&gt;â€¢ Option B. X-ray of hands with wrist: May be useful in thyroid acropachy (It refers to a form of clubbing found in &amp;lt; 1% of patients with Gravesâ€™ disease. It is so strongly associated with thyroid dermopathy that an alternative cause of clubbing should be sought in a Gravesâ€™ patient without coincident skin and orbital involvement).&lt;/li&gt;&lt;li&gt;â€¢ Option B. X-ray of hands with wrist:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat TFT: Repeating thyroid function tests is unlikely to yield new information.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat TFT:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a smoker with Graves&#x27; disease presenting with clubbing, weight loss, and loss of appetite, a CT of the chest is indicated to rule out an underlying lung malignancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following should be avoided in children with Graves disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methimazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radioactive Iodine Ablation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroidectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Propylthiouracil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Propylthiouracil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methimazole: Preferred treatment in children with Graves disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methimazole:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radioactive Iodine Ablation: Usually reserved for refractory/severe Graves disease in children.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radioactive Iodine Ablation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroidectomy: Usually reserved for refractory/severe Graves disease in children.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroidectomy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propylthiouracil should be avoided in children with Graves&#x27; disease due to the risk of hepatitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is unlikely in a case of neonatal thyrotoxicosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Poor intrauterine growth&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fetal tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced Bone Age&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fetal goiter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced Bone Age&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduced Bone Age&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Poor intrauterine growth: Common feature due to increased basal metabolic rate in the fetus with thyrotoxicosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Poor intrauterine growth:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fetal tachycardia: HR &amp;gt; 160/min is commin in the fetus with thyrotoxicosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fetal tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fetal goiter: Common due to trophic effects of antibodies on the thyroid gland.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fetal goiter:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neonatal thyrotoxicosis is associated with advanced bone age, not reduced bone age.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with Graves&#x27; disease undergoes RAI therapy. Two months later, she complains of persistent palpitations and heat intolerance. Which of the following is the most likely explanation for her persistent symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RAI therapy is ineffective in young patients.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The patient is experiencing a relapse of Graves&#x27; disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The patient is developing hypothyroidism.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The full effect of RAI therapy takes 2-3 months to manifest.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The full effect of RAI therapy takes 2-3 months to manifest.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The full effect of RAI therapy takes 2-3 months to manifest.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . RAI therapy is ineffective in young patients: RAI is effective in all age groups.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ RAI therapy is ineffective in young patients:&lt;/li&gt;&lt;li&gt;â€¢ Option B . The patient is experiencing a relapse of Graves&#x27; disease: Relapse is possible, but less likely within two months.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ The patient is experiencing a relapse of Graves&#x27; disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C . The patient is developing hypothyroidism: Hypothyroidism is a later complication of RAI.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ The patient is developing hypothyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Summary of RAIA in Graves:&lt;/li&gt;&lt;li&gt;â€¢ Summary of RAIA in Graves:&lt;/li&gt;&lt;li&gt;â€¢ Indication : Initial treatment or for relapses after antithyroid drugs. Tracer used: I131. Emits Î² &amp;amp; Î³. t1/2 âˆ¼ 8 days. Elderly/Cardiac Patients: Consider pretreatment with antithyroid drugs and beta-blockers (because of small, increased risk of Thyrotoxic Crisis) Carbimazole/Methimazole: Stop 2-3 days before and restart 3-7 days after RAI. PTU: Prolonged radioprotective effect, requires longer discontinuation or higher RAI dose. Persistence of Hyperthyroidism: Can persist for 2-3 months, managed with beta-blockers or antithyroid drugs. Safety Precautions: Avoid close contact with children and pregnant women for 5-7 days. Complications: Radiation Thyroiditis: Mild pain may occur 1-2 weeks after treatment. Flare of Orbitopathy: Especially in smokers. Consider prednisone pre-treatment. Permanent Hypothyroidism: Risk is 10-20% in the first year, 5% per year thereafter, requiring lifelong LT4 replacement. Possibly a small increased lifetime risk of solid cancers. Contraindications: Pregnancy, breastfeeding and suspected thyroid cancer.&lt;/li&gt;&lt;li&gt;â€¢ Indication : Initial treatment or for relapses after antithyroid drugs.&lt;/li&gt;&lt;li&gt;â€¢ Indication&lt;/li&gt;&lt;li&gt;â€¢ Tracer used: I131. Emits Î² &amp;amp; Î³. t1/2 âˆ¼ 8 days.&lt;/li&gt;&lt;li&gt;â€¢ Tracer used:&lt;/li&gt;&lt;li&gt;â€¢ Elderly/Cardiac Patients: Consider pretreatment with antithyroid drugs and beta-blockers (because of small, increased risk of Thyrotoxic Crisis) Carbimazole/Methimazole: Stop 2-3 days before and restart 3-7 days after RAI. PTU: Prolonged radioprotective effect, requires longer discontinuation or higher RAI dose.&lt;/li&gt;&lt;li&gt;â€¢ Elderly/Cardiac Patients:&lt;/li&gt;&lt;li&gt;â€¢ Carbimazole/Methimazole: Stop 2-3 days before and restart 3-7 days after RAI. PTU: Prolonged radioprotective effect, requires longer discontinuation or higher RAI dose.&lt;/li&gt;&lt;li&gt;â€¢ Carbimazole/Methimazole: Stop 2-3 days before and restart 3-7 days after RAI.&lt;/li&gt;&lt;li&gt;â€¢ PTU: Prolonged radioprotective effect, requires longer discontinuation or higher RAI dose.&lt;/li&gt;&lt;li&gt;â€¢ Persistence of Hyperthyroidism: Can persist for 2-3 months, managed with beta-blockers or antithyroid drugs.&lt;/li&gt;&lt;li&gt;â€¢ Persistence of Hyperthyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Safety Precautions: Avoid close contact with children and pregnant women for 5-7 days.&lt;/li&gt;&lt;li&gt;â€¢ Safety Precautions:&lt;/li&gt;&lt;li&gt;â€¢ Complications: Radiation Thyroiditis: Mild pain may occur 1-2 weeks after treatment. Flare of Orbitopathy: Especially in smokers. Consider prednisone pre-treatment. Permanent Hypothyroidism: Risk is 10-20% in the first year, 5% per year thereafter, requiring lifelong LT4 replacement. Possibly a small increased lifetime risk of solid cancers.&lt;/li&gt;&lt;li&gt;â€¢ Complications:&lt;/li&gt;&lt;li&gt;â€¢ Radiation Thyroiditis: Mild pain may occur 1-2 weeks after treatment. Flare of Orbitopathy: Especially in smokers. Consider prednisone pre-treatment. Permanent Hypothyroidism: Risk is 10-20% in the first year, 5% per year thereafter, requiring lifelong LT4 replacement. Possibly a small increased lifetime risk of solid cancers.&lt;/li&gt;&lt;li&gt;â€¢ Radiation Thyroiditis: Mild pain may occur 1-2 weeks after treatment.&lt;/li&gt;&lt;li&gt;â€¢ Flare of Orbitopathy: Especially in smokers. Consider prednisone pre-treatment.&lt;/li&gt;&lt;li&gt;â€¢ Permanent Hypothyroidism: Risk is 10-20% in the first year, 5% per year thereafter, requiring lifelong LT4 replacement.&lt;/li&gt;&lt;li&gt;â€¢ Possibly a small increased lifetime risk of solid cancers.&lt;/li&gt;&lt;li&gt;â€¢ Contraindications: Pregnancy, breastfeeding and suspected thyroid cancer.&lt;/li&gt;&lt;li&gt;â€¢ Contraindications:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The full effect of RAI therapy for Graves&#x27; disease takes 2-3 months to manifest, which can explain persistent symptoms shortly after treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents with progressive confusion, memory loss, and seizures. She also has a history of hypothyroidism and she is on Levothyroxine 75 Âµg/d. Her records suggest a high anti TPO antibodies and MRI of the brain reveals diffuse white matter hyperintensities. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Progressive multifocal leukoencephalopathy (PML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hashimoto&#x27;s encephalopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurosarcoidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hashimoto&#x27;s encephalopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hashimoto&#x27;s encephalopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple sclerosis (MS): MS follows dissemination in space and time and it is not associated with anti TPO antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple sclerosis (MS):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Progressive multifocal leukoencephalopathy (PML): It is caused by JC virus and is usually seen in immunocompromised individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Progressive multifocal leukoencephalopathy (PML):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neurosarcoidosis: The clinical features are NOT compatible with the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neurosarcoidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hashimoto&#x27;s encephalopathy, also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is characterized by progressive confusion, memory loss, seizures, high anti-TPO antibodies, and diffuse white matter hyperintensities on MRI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is false regarding Hashimotoâ€™s thyroiditis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TPO and Tg antibodies in the mother can cause fetal hypothyroidism.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High Iodine intake increases the risk.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thyroid destruction is primarily mediated by the CD8+ cytotoxic T cells.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alcohol intake is protective.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. TPO and Tg antibodies in the mother can cause fetal hypothyroidism.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) TPO and Tg antibodies in the mother can cause fetal hypothyroidism.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. High Iodine intake increases the risk: A high iodine or low selenium intake and decreased exposure to microorganisms in childhood increases risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B. High Iodine intake increases the risk:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thyroid destruction is primarily mediated by the CD8+ cytotoxic T cells: True. Pathogenic effect of antibodies is restricted to a secondary role in amplifying an ongoing autoimmune response.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thyroid destruction is primarily mediated by the CD8+ cytotoxic T cells:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alcohol intake is protective: Smoking cessation transiently increases incidence, whereas alcohol intake seems protective.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alcohol intake is protective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transplacental passage of Tg or TPO antibodies has no effect on the fetal thyroid, whereas TSH-R blocking antibodies may induce transient neonatal hypothyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with severe fatigue. Thyroid function tests reveal low free T4, high TSH, and elevated anti-TPO antibodies. Which of the following statements regarding the histopathological findings in her thyroid gland is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphocytic infiltration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrophy of thyroid follicles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absence of fibrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Goiter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Absence of fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Absence of fibrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lymphocytic infiltration: Hallmark of Hashimotoâ€™s thyroiditis and can form germinal centres within the gland.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lymphocytic infiltration:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrophy of thyroid follicles: The destruction of thyroid follicles by the immune system leads to their shrinkage and atrophy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrophy of thyroid follicles:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Goiter: In the early stages of Hashimoto&#x27;s, the thyroid gland may become enlarged (goiter) due to inflammation. However, as the disease progresses, the gland can shrink due to atrophy. Atrophy is especially common in Asians.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Goiter:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hashimoto&#x27;s thyroiditis histopathology includes lymphocytic infiltration, atrophy of thyroid follicles, and fibrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with a one-week history of fever, neck pain, and fatigue. On physical examination, her thyroid gland is tender. Thyroid function tests reveal elevated free T4 and suppressed TSH. Which of the following statements regarding her underlying condition is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Associated with URI.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated ESR.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Positive anti-TPO.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Giant cells in biopsy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Positive anti-TPO.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Positive anti-TPO.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Associated with URI: This is a true statement, as De Quervainâ€™s thyroiditis is often triggered by a viral infection.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Associated with URI:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated ESR: This is also true due to the inflammatory process.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated ESR:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Giant cells in biopsy: This is the characteristic histological finding due to the presence of granulomas in De Quervainâ€™s thyroiditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Giant cells in biopsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid peroxidase (TPO) antibodies are usually negative in subacute (De Quervainâ€™s) thyroiditis, which is associated with an elevated ESR and giant cells in biopsy following an upper respiratory infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents to her primary care physician 6 months after delivery with complaints of fatigue, cold intolerance, and weight gain for the last 3 weeks. She also reports feeling depressed and having difficulty concentrating. Her thyroid function tests reveal elevated TSH and low free T4 levels and positive anti-TPO antibodies. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;De Quervain&#x27;s thyroiditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subacute lymphocytic thyroiditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Riedel&#x27;s thyroiditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hashimoto&#x27;s thyroiditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subacute lymphocytic thyroiditis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Subacute lymphocytic thyroiditis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. De Quervain&#x27;s thyroiditis: This is a painful form of thyroiditis and they have an elevated ESR. Anti TPO antibodies are rarely positive in De Quervainâ€™s.&lt;/li&gt;&lt;li&gt;â€¢ Option A. De Quervain&#x27;s thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Riedel&#x27;s thyroiditis: This is a rare fibrotic thyroiditis with a hard, fixed goiter.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Riedel&#x27;s thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hashimoto&#x27;s thyroiditis: While also autoimmune, Hashimoto&#x27;s typically presents with a gradual (chronic) onset of hypothyroidism and is less likely to occur postpartum.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hashimoto&#x27;s thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ Summary of post-partum thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ Summary of post-partum thyroiditis:&lt;/li&gt;&lt;li&gt;â€¢ Similar to De Quervainâ€™s thyroiditis, but painless and have normal ESR. Occurs in 5% of women 3-6 months postpartum, termed postpartum thyroiditis. Associated with TPO antibodies antepartum, 3x more common in type 1 diabetes. Recovery is the rule. Annual follow-up recommended as some develop permanent hypothyroidism. May recur in subsequent pregnancies.&lt;/li&gt;&lt;li&gt;â€¢ Similar to De Quervainâ€™s thyroiditis, but painless and have normal ESR.&lt;/li&gt;&lt;li&gt;â€¢ Occurs in 5% of women 3-6 months postpartum, termed postpartum thyroiditis.&lt;/li&gt;&lt;li&gt;â€¢ Associated with TPO antibodies antepartum, 3x more common in type 1 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Recovery is the rule. Annual follow-up recommended as some develop permanent hypothyroidism. May recur in subsequent pregnancies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Subacute lymphocytic thyroiditis, also known as painless thyroiditis, often presents postpartum with a hypothyroid phase and positive anti-TPO antibodies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with a firm, non-tender, fixed goiter and complaints of difficulty swallowing and hoarseness. Fine needle aspiration is inconclusive. Which of the following is the most appropriate next step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start treatment with levothyroxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate radioactive iodine therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform open biopsy for definitive diagnosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Begin glucocorticoid therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Perform open biopsy for definitive diagnosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Perform open biopsy for definitive diagnosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start treatment with levothyroxine: Levothyroxine is used to treat hypothyroidism, which is uncommon (TFT is often normal) in Riedel&#x27;s thyroiditis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start treatment with levothyroxine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate radioactive iodine therapy: Radioactive iodine therapy is used to treat hyperthyroidism, not indicated in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate radioactive iodine therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Begin glucocorticoid therapy: Glucocorticoids may be considered after a definitive diagnosis of Riedel&#x27;s thyroiditis is established, but not as the initial step.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Begin glucocorticoid therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Perform an open biopsy for a definitive diagnosis in a patient with a firm, non-tender, fixed goiter and compressive symptoms, as this presentation is highly suggestive of Riedel&#x27;s thyroiditis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of atrial fibrillation treated with amiodarone presents with weight loss, palpitations, and heat intolerance. Thyroid function tests reveal suppressed TSH and elevated free T4. Thyroid USG shows decreased vascularity. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Potassium perchlorate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-dose antithyroid drugs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucocorticoids (prednisone)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroidectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucocorticoids (prednisone)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Glucocorticoids (prednisone)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Potassium perchlorate: Used in type 1 AIT (increases synthesis, increased vascularity).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Potassium perchlorate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. High-dose antithyroid drugs: Also used in type 1 AIT, ineffective in type 2 due to the release of preformed hormone.&lt;/li&gt;&lt;li&gt;â€¢ Option B. High-dose antithyroid drugs:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroidectomy: Reserved for severe, unresponsive cases, not the initial approach.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroidectomy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucocorticoids (prednisone) are the first-line treatment for amiodarone-induced thyrotoxicosis (AIT) type 2, characterized by destructive thyroiditis and decreased vascularity on ultrasound.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with a palpable thyroid nodule and has normal TSH levels. USG reveals a hypoechoic solid nodule with microcalcifications. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Observation and repeat USG in 6 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fine needle aspiration biopsy (FNA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radioiodine scanning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroid lobectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fine needle aspiration biopsy (FNA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-142646_s0moNWZ.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fine needle aspiration biopsy (FNA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Observation and repeat USG in 6 months: This approach is suitable for smaller or less suspicious nodules but not for those with high-risk features like microcalcifications. Delayed diagnosis could lead to potential complications if the nodule is malignant.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Observation and repeat USG in 6 months:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radioiodine scanning: Useful only if hyperthyroid on TFTs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radioiodine scanning:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroid lobectomy: Surgery is usually reserved for confirmed malignancy or large symptomatic nodules. FNA is required for diagnosis before considering surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thyroid lobectomy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Papillary thyroid cancer generally has a good prognosis, and its presence is not associated with a poor prognosis compared to other types of thyroid cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old male presents with a rapidly enlarging neck mass and hoarseness. Fine needle aspiration biopsy reveals thyroid cancer. Which of the following factors is NOT associated with a poor prognosis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Male gender&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Age &amp;gt; 65 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Papillary histology&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;p53 mutations&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Papillary histology&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Papillary histology&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Male gender: Male gender is associated with a worse prognosis in thyroid cancer compared to female gender.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Male gender:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age &amp;gt; 65 years: Older age at diagnosis is a significant risk factor for poorer outcomes in thyroid cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age &amp;gt; 65 years:&lt;/li&gt;&lt;li&gt;â€¢ Option D. p53 mutations: p53 mutations are associated with a more aggressive tumor behavior and a poorer prognosis in thyroid cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. p53 mutations:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Papillary histology in thyroid cancer is not associated with a poor prognosis and generally indicates a good outcome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man is diagnosed with papillary thyroid carcinoma (PTC). Which of the following statements is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BRAF mutation is the most common genetic alteration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lymph node micrometastases indicates poor prognosis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It has a propensity to spread via the lymphatic system.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PTC is present in up to 25% of thyroid glands at autopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lymph node micrometastases indicates poor prognosis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lymph node micrometastases indicates poor prognosis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRAF mutation is the most common genetic alteration: True. a. BRAF V600E mutations reduce uptake of RAI and increase risk of recurrence (but effect on overall outcomes in unclear).&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRAF mutation is the most common genetic alteration:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It has a propensity to spread via the lymphatic system: This is true. PTC has a tendency to spread to the lymph nodes in the neck.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It has a propensity to spread via the lymphatic system:&lt;/li&gt;&lt;li&gt;â€¢ Option D. PTC is present in up to 25% of thyroid glands at autopsy: This is also true. Many people have small, microscopic PTCs that never cause any problems.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PTC is present in up to 25% of thyroid glands at autopsy:&lt;/li&gt;&lt;li&gt;â€¢ Summary if important thyroid cancers:&lt;/li&gt;&lt;li&gt;â€¢ Summary if important thyroid cancers:&lt;/li&gt;&lt;li&gt;â€¢ PTC: Most common type of thyroid cancer (80-85% of differentiated thyroid cancers) Genetics: RET/PTC rearrangements (20-40%), BRAF V600E mutation (most common), RAS mutations (20-30%).&lt;/li&gt;&lt;li&gt;â€¢ PTC: Most common type of thyroid cancer (80-85% of differentiated thyroid cancers) Genetics: RET/PTC rearrangements (20-40%), BRAF V600E mutation (most common), RAS mutations (20-30%).&lt;/li&gt;&lt;li&gt;â€¢ PTC:&lt;/li&gt;&lt;li&gt;â€¢ Genetics: RET/PTC rearrangements (20-40%), BRAF V600E mutation (most common), RAS mutations (20-30%).&lt;/li&gt;&lt;li&gt;â€¢ Genetics: RET/PTC rearrangements (20-40%), BRAF V600E mutation (most common), RAS mutations (20-30%).&lt;/li&gt;&lt;li&gt;â€¢ BRAF V600E mutations reduce uptake of RAI and increase risk of recurrence (but effect on overall outcomes in unclear).&lt;/li&gt;&lt;li&gt;â€¢ BRAF V600E mutations reduce uptake of RAI and increase risk of recurrence (but effect on overall outcomes in unclear).&lt;/li&gt;&lt;li&gt;â€¢ Microscopic PTC is found in âˆ¼ 25% of autopsy thyroids (clinically insignificant). Characteristic cytological features: Orphan Annie eye appearance with Nuclear grooves and Prominent nucleoli. Tall cell, columnar cell, hobnail, poorly differentiated â€“ aggressive variants. Can be multifocal &amp;amp; invade locally within the thyroid gland/ adjacent structures. Usually Spreads primarily via lymphatic system. Slow growth can lead to a significant burden of pulmonary metastases with few symptoms. Lymph node involvement is prognostic but micro metastases (&amp;lt; 2 mm) does not alter prognosis. Most PTCs are identified in early stages (I or II) with excellent prognosis. Stage IV disease has markedly increased mortality but is rare (~1%).&lt;/li&gt;&lt;li&gt;â€¢ Microscopic PTC is found in âˆ¼ 25% of autopsy thyroids (clinically insignificant).&lt;/li&gt;&lt;li&gt;â€¢ Characteristic cytological features: Orphan Annie eye appearance with Nuclear grooves and Prominent nucleoli.&lt;/li&gt;&lt;li&gt;â€¢ Tall cell, columnar cell, hobnail, poorly differentiated â€“ aggressive variants.&lt;/li&gt;&lt;li&gt;â€¢ Can be multifocal &amp;amp; invade locally within the thyroid gland/ adjacent structures.&lt;/li&gt;&lt;li&gt;â€¢ Usually Spreads primarily via lymphatic system.&lt;/li&gt;&lt;li&gt;â€¢ Slow growth can lead to a significant burden of pulmonary metastases with few symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Lymph node involvement is prognostic but micro metastases (&amp;lt; 2 mm) does not alter prognosis. Most PTCs are identified in early stages (I or II) with excellent prognosis. Stage IV disease has markedly increased mortality but is rare (~1%).&lt;/li&gt;&lt;li&gt;â€¢ FTC: more common in iodine-deficient regions. Genetics: RAS mutations, PAX8-PPARÎ³1 rearrangement. Diagnosis: Difficult by FNA alone, requires Bx to assess capsular/vascular invasion. Prognosis:&lt;/li&gt;&lt;li&gt;â€¢ FTC: more common in iodine-deficient regions. Genetics: RAS mutations, PAX8-PPARÎ³1 rearrangement. Diagnosis: Difficult by FNA alone, requires Bx to assess capsular/vascular invasion. Prognosis:&lt;/li&gt;&lt;li&gt;â€¢ FTC:&lt;/li&gt;&lt;li&gt;â€¢ Genetics: RAS mutations, PAX8-PPARÎ³1 rearrangement. Diagnosis: Difficult by FNA alone, requires Bx to assess capsular/vascular invasion. Prognosis:&lt;/li&gt;&lt;li&gt;â€¢ Genetics: RAS mutations, PAX8-PPARÎ³1 rearrangement.&lt;/li&gt;&lt;li&gt;â€¢ Diagnosis: Difficult by FNA alone, requires Bx to assess capsular/vascular invasion.&lt;/li&gt;&lt;li&gt;â€¢ Prognosis:&lt;/li&gt;&lt;li&gt;â€¢ Capsular invasion only: Low risk of metastasis, lobectomy suffices. Angioinvasive FTC: More aggressive, can metastasize to bone, lung, and CNS.&lt;/li&gt;&lt;li&gt;â€¢ Capsular invasion only: Low risk of metastasis, lobectomy suffices.&lt;/li&gt;&lt;li&gt;â€¢ Angioinvasive FTC: More aggressive, can metastasize to bone, lung, and CNS.&lt;/li&gt;&lt;li&gt;â€¢ Higher mortality than PTC, partly due to more frequent stage IV presentation. Poor Prognostic Factors: Distant metastases, age &amp;gt;55 years, primary tumor size &amp;gt;4 cm, marked vascular invasion.&lt;/li&gt;&lt;li&gt;â€¢ Higher mortality than PTC, partly due to more frequent stage IV presentation.&lt;/li&gt;&lt;li&gt;â€¢ Poor Prognostic Factors: Distant metastases, age &amp;gt;55 years, primary tumor size &amp;gt;4 cm, marked vascular invasion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lymph node micrometastases (&amp;lt;2 mm) in papillary thyroid carcinoma (PTC) do not alter prognosis, even though lymph node involvement is prognostic.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is false regarding thyroid cancer treatment after thyroidectomy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;S. Tg is a sensitive marker post-surgery.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Universal Target TSH post-surgery is 0.5-2 mIU/L.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patient should follow low Iodine diet for 1-2 weeks prior to I131 therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TSH &amp;gt; 25 is required at the time of I 131 therapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Universal Target TSH post-surgery is 0.5-2 mIU/L.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Universal Target TSH post-surgery is 0.5-2 mIU/L.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. S. Tg is a sensitive marker post-surgery: This is true. Serum thyroglobulin (Tg) is a useful tumor marker for monitoring patients with papillary and follicular thyroid cancers after thyroidectomy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. S. Tg is a sensitive marker post-surgery:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patient should follow low Iodine diet for 1-2 weeks prior to I131 therapy: This is also true. A low iodine diet is recommended before radioactive iodine (RAI) therapy to enhance the uptake of iodine by any remaining thyroid tissue or cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patient should follow low Iodine diet for 1-2 weeks prior to I131 therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TSH &amp;gt; 25 is required at the time of I131 therapy: This is generally true for patients with high-risk thyroid cancer. A higher TSH level helps stimulate the uptake of RAI by thyroid cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TSH &amp;gt; 25 is required at the time of I131 therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The target TSH level post-surgery for thyroid cancer patients is based on the risk of recurrence, not universally 0.5-2 mIU/L. It ranges from 0.5-2.0 mIU/L for low risk, 0.1-0.5 mIU/L for intermediate risk, to &amp;lt;0.1 mIU/L for high risk or metastatic disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with chronic kidney disease presents with muscle cramps and tingling in her fingers. Her serum calcium is 7.7 mg/dL (normal: 8.5-10.5 mg/dL) and serum albumin is 3.0 g/dL (normal range: 3.5-5.0 g/dL). What is her corrected calcium level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;8.0 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;8.3 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;8.5 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;9.0 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 8.5 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 8.5 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Corrected calcium is calculated using the following formula:&lt;/li&gt;&lt;li&gt;â€¢ Corrected calcium (mg/dL) = Measured calcium (mg/dL) + 0.8 x (4.0 - Albumin [g/dL])&lt;/li&gt;&lt;li&gt;â€¢ In this case:&lt;/li&gt;&lt;li&gt;â€¢ Corrected calcium = 7.5 + 0.8 x (4.0 - 3.0) = 7.7 + 0.8 = 8.5 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the patient&#x27;s corrected calcium level is 8.5 mg/dL, which is within the normal range.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To calculate the corrected calcium level in patients with low serum albumin, use the formula:&lt;/li&gt;&lt;li&gt;âž¤ Corrected calcium (mg/dL) = Measured calcium (mg/dL) + 0.8 x (4.0 - Albumin [g/dL])&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding calcium homeostasis is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced S. Ig levels can increase total serum calcium levels.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DCT is the major site for active calcium reabsorption in the kidney.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CaSR in the cortical TAL in the kidney works independent of Vit D and PTH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Passive intestinal absorption is non saturable.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Reduced S. Ig levels can increase total serum calcium levels.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Reduced S. Ig levels can increase total serum calcium levels.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . DCT is the major site for active calcium reabsorption in the kidney: True. Via TRPV5.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ DCT is the major site for active calcium reabsorption in the kidney:&lt;/li&gt;&lt;li&gt;â€¢ Option C . CaSR in the cortical TAL in the kidney works independent of Vit D and PTH: CaSR senses only Ca and Mg . PTH or Vit D does NOT exert control on CaSR.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ CaSR in the cortical TAL in the kidney works independent of Vit D and&lt;/li&gt;&lt;li&gt;â€¢ PTH:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Passive intestinal absorption is non saturable: True. Main reason for hypercalcemia with large intakes of calcium (e.g., Milk Alkali Syndrome).&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Passive intestinal absorption is non saturable:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alterations in serum protein concentrations, such as albumin and immunoglobulin (Ig) levels, directly affect the total serum calcium concentration but do not change the ionized calcium levels. Corrected calcium should be calculated in relation to albumin and Ig concentrations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding Phosphorus homeostasis is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Majority of phosphorus absorption in intestine is Vitamin D dependent.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum levels are best measured in fasting state.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PTH and FGF23 increase Na-Pi transporter activity in the PCT.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Concentration of phosphorus is more in ECF compared to ICF.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum levels are best measured in fasting state.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum levels are best measured in fasting state.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Majority of phosphorus absorption in intestine is Vitamin D dependent: Phosphorus is absorbed efficiently (65%) even without vitamin D. Vit D increases absorption to 85-90%.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Majority of phosphorus absorption in intestine is Vitamin D dependent:&lt;/li&gt;&lt;li&gt;â€¢ Option C. PTH and FGF23 increase Na-Pi transporter activity in the PCT: PTH and FGF23 reduce Na-Pi levels, increasing phosphate excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. PTH and FGF23 increase Na-Pi transporter activity in the PCT:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Concentration of phosphorus is more in ICF compared to ECF: Phosphorus is the most abundant intracellular anion. ECF concentrations and amount are generally lower.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Concentration of phosphorus is more in ICF compared to ECF:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum phosphorus levels are best measured in the fasting state due to variations caused by food intake and circadian rhythms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with chronic alcoholism was started in IV dextrose. He develops cardiac arrhythmias, seizures, and rhabdomyolysis. Which of the following electrolyte disturbances is most likely responsible for her clinical deterioration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypocalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypophosphatemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypophosphatemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypophosphatemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypernatremia: Hypernatremia (high sodium) is not a typical feature of refeeding syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypernatremia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypocalcemia: Hypocalcemia (low calcium) can occur in refeeding syndrome, but it is less common and less severe than hypophosphatemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypocalcemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperphosphatemia: Hyperphosphatemia (high phosphate) is the opposite of what is seen in refeeding syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperphosphatemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Refeeding syndrome, commonly occurring in severely malnourished individuals after reintroducing nutrition, is characterized by hypophosphatemia, which can lead to cardiac arrhythmias, seizures, and rhabdomyolysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old chronic alcoholic developed refeeding syndrome and is about to get IV phosphate replacement. Which of the following is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phosphate cannot be administered IV.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypocalcemia, if present must be corrected first.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase dose of phosphate if hypercalcemic.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperglycemia is common.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypocalcemia, if present must be corrected first.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypocalcemia, if present must be corrected first&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phosphate cannot be administered IV: Phosphate can be administered IV, usually as sodium or potassium phosphate salts. Less severe hypophosphatemia (1.5â€“2.5 mg/dL) can be treated with oral phosphate (750â€“2000 mg/d as elemental phosphorus) but higher doses can cause bloating and diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phosphate cannot be administered IV:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase the dose of phosphate if hypercalcemic: Reduce dose of phosphate by 50% if the patient is hypercalcemic (serum Ca-PO4 product must be &amp;lt;50 mg2/dL2 to reduce the risk of heterotopic calcification).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase the dose of phosphate if hypercalcemic:&lt;/li&gt;&lt;li&gt;â€¢ Reduction of dose is also recommended in patients with renal dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperglycemia is common: Hypoglycemia is common due to increased glucose entry and utilization by tissues. Hence concurrent dextrose administration can be considered (especially in those at risk of hypoglycemia).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperglycemia is common:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In refeeding syndrome, hypocalcemia, if present, must be corrected before administering IV phosphate to prevent further hypocalcemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following monoclonal antibodies has been approved for X-linked hypophosphatemia (XLH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Burosumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teprotumumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Burosumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Burosumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Teplizumab: This monoclonal antibody (CD3) is used in the treatment of type 1 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Teplizumab:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Teprotumumab: This monoclonal antibody (IGF-1r) is used in the treatment of thyroid eye disease (Graves&#x27; ophthalmopathy).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Teprotumumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atezolizumab: This monoclonal antibody (PD-L1) is used in the treatment of certain types of cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atezolizumab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Burosumab is a monoclonal antibody approved for X-linked hypophosphatemia (XLH).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding Magnesium (Mg) homeostasis is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mg is primarily absorbed in the jejunum.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin D can increase Mg absorption.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Majority of Mg is reabsorbed in the PCT.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mg reabsorption is inhibited by hypercalcemia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Majority of Mg is reabsorbed in the PCT.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Majority of Mg is reabsorbed in the PCT.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mg is primarily absorbed in the jejunum: This is true, although some absorption also occurs in the ileum. Usual absorption is 30-40% but can increase to 70% during deficiency states.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mg is primarily absorbed in the jejunum:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin D can increase Mg absorption: This is true, although the mechanism is not fully understood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin D can increase Mg absorption:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mg reabsorption is inhibited by hypercalcemia: This is also true. Magnesium reabsorption in the cTAL is increased by PTH but inhibited by hypercalcemia or hypermagnesemia, both of which activate the CaSR in this nephron segment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mg reabsorption is inhibited by hypercalcemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The majority of magnesium is reabsorbed in the cortical thick ascending limb (cTAL) of the kidney.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old man who is a known case of Gitelmanâ€™s syndrome presents with tetany. On evaluation his serum Mg level is 0.6 g/dL (normal: 1.7-2.4 mg/dL). Which of the following is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Protective against Digitalis toxicity.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Co-existent hypocalcemia is common.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IM MgSO4 is as effective as IV MgSO4.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin D deficiency, if present should be corrected with calcitriol.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Co-existent hypocalcemia is common.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Co-existent hypocalcemia is common.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Protective against Digitalis toxicity: Hypomagnesemia actually increases the risk of digitalis toxicity (ECG abnormalities in hypomagnesemia: Prolonged PR or QT intervals, T-wave flattening or inversion, and ST straightening).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Protective against Digitalis toxicity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. IM MgSO4 is as effective as IV MgSO4: For IV use, MgCl2 is generally preferred. IV MgSO4 is inferior because sulfate anions may bind calcium in serum and urine and aggravate hypocalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IM MgSO4 is as effective as IV MgSO4:&lt;/li&gt;&lt;li&gt;â€¢ Use of IM MgSO4 is discouraged - the injections are painful and provide relatively little magnesium (2 mL of 50% MgSO4 supplies only 4 mmol).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin D deficiency, if present, should be corrected with calcitriol: Vitamin D deficiency frequently coexists with hypomagnesemia and should be treated with calcidiol (but not with calcitriol, which may impair tubular magnesium reabsorption, possibly via PTH suppression by acting on VDR in the parathyroid gland).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin D deficiency, if present, should be corrected with calcitriol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Co-existent hypocalcemia is common in patients with severe hypomagnesemia, such as in Gitelman&#x27;s syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of following drugs is most likely to cause hypomagnesemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cetuximab.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ustekinumab.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Burosumab.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cetuximab.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cetuximab.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rituximab: Targets CD20 on B cells and is not associated with hypomagnesemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rituximab:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ustekinumab: Targets interleukin-12 and -23 and is not associated with hypomagnesemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ustekinumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Burosumab: Targets FGF23 and is used to treat X-linked hypophosphatemia; it does not cause hypomagnesemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Burosumab:&lt;/li&gt;&lt;li&gt;â€¢ Summary: Important causes of hypomagnesemia â€“&lt;/li&gt;&lt;li&gt;â€¢ Summary:&lt;/li&gt;&lt;li&gt;â€¢ Impaired absorption: Vit D deficiency, PPIs, malabsorption, TRPM6 mutations (rare). Increases intestinal losses: Vomiting, diarrhea, fistulas. Impaired renal absorption: Syndromes (Barrtterâ€™s, Gitelmanâ€™s), TIN, drugs (diuretics, cisplatin, cyclosporine, aminoglycosides, foscarnet, pentamidine &amp;amp; cetuximab ) &amp;amp; others (hypercalcemia, severe hypophosphatemia) ECF to ICF : Refeeding , insulin, catecholamines.&lt;/li&gt;&lt;li&gt;â€¢ Impaired absorption: Vit D deficiency, PPIs, malabsorption, TRPM6 mutations (rare).&lt;/li&gt;&lt;li&gt;â€¢ Impaired absorption:&lt;/li&gt;&lt;li&gt;â€¢ Increases intestinal losses: Vomiting, diarrhea, fistulas.&lt;/li&gt;&lt;li&gt;â€¢ Increases intestinal losses:&lt;/li&gt;&lt;li&gt;â€¢ Impaired renal absorption: Syndromes (Barrtterâ€™s, Gitelmanâ€™s), TIN, drugs (diuretics, cisplatin, cyclosporine, aminoglycosides, foscarnet, pentamidine &amp;amp; cetuximab ) &amp;amp; others (hypercalcemia, severe hypophosphatemia)&lt;/li&gt;&lt;li&gt;â€¢ Impaired renal absorption:&lt;/li&gt;&lt;li&gt;â€¢ ECF to ICF : Refeeding , insulin, catecholamines.&lt;/li&gt;&lt;li&gt;â€¢ ECF to ICF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cetuximab is most likely to cause hypomagnesemia among the listed drugs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following stimulates the production of 1,25(OH)2D (Calcitriol) by activating 1Î±-hydroxylase in the kidneys?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PTH (Parathyroid Hormone)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calcium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FGF-23 (Fibroblast Growth Factor 23)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,25 (OH)2D (Calcitriol)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PTH (Parathyroid Hormone)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) PTH (Parathyroid Hormone)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcium: High calcium levels actually suppress 1Î±-hydroxylase activity, decreasing calcitriol production.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcium:&lt;/li&gt;&lt;li&gt;â€¢ Option C. FGF-23: FGF-23 also suppresses 1Î±-hydroxylase activity and reduces calcitriol levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FGF-23:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1,25 (OH)2D (Calcitriol): Calcitriol acts through a negative feedback loop to inhibit its own production by suppressing 1Î±-hydroxylase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1,25 (OH)2D (Calcitriol):&lt;/li&gt;&lt;li&gt;â€¢ Summary:&lt;/li&gt;&lt;li&gt;â€¢ Summary:&lt;/li&gt;&lt;li&gt;â€¢ Vitamin D basics:&lt;/li&gt;&lt;li&gt;â€¢ Vitamin D basics:&lt;/li&gt;&lt;li&gt;â€¢ Cutaneous production of cholecalciferol is reduced by melanin and sunblocks. 25 (OH)D [calcidiol] is the major circulating form (formed in the liver by 25 hydroxylase). t1/2 âˆ¼ 2-3 weeks (88% of 25 (OH)D is bound to Vitamin D binding protein) 2nd hydroxylation occurs in kidney (PCT) by 1Î±-hydroxylase forming 1,25 (OH)2D (Calcitriol) â€“ the active from. 1Î±-hydroxylase is hormonally regulated â€“ Stimulated by: PTH and low phosphate. Inhibited by: Ca, FGF-23 &amp;amp; 1,25 (OH)2D (Calcitriol). 1Î±-hydroxylase is also present in other cells (keratinocytes, placenta, macrophages), but not hormonally regulated. Inactivation of vitamin D metabolites occurs through 24-hydroxylation.&lt;/li&gt;&lt;li&gt;â€¢ Cutaneous production of cholecalciferol is reduced by melanin and sunblocks.&lt;/li&gt;&lt;li&gt;â€¢ 25 (OH)D [calcidiol] is the major circulating form (formed in the liver by 25 hydroxylase). t1/2 âˆ¼ 2-3 weeks (88% of 25 (OH)D is bound to Vitamin D binding protein)&lt;/li&gt;&lt;li&gt;â€¢ 2nd hydroxylation occurs in kidney (PCT) by 1Î±-hydroxylase forming 1,25 (OH)2D (Calcitriol) â€“ the active from. 1Î±-hydroxylase is hormonally regulated â€“ Stimulated by: PTH and low phosphate. Inhibited by: Ca, FGF-23 &amp;amp; 1,25 (OH)2D (Calcitriol).&lt;/li&gt;&lt;li&gt;â€¢ Stimulated by: PTH and low phosphate. Inhibited by: Ca, FGF-23 &amp;amp; 1,25 (OH)2D (Calcitriol).&lt;/li&gt;&lt;li&gt;â€¢ Stimulated by: PTH and low phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Inhibited by: Ca, FGF-23 &amp;amp; 1,25 (OH)2D (Calcitriol).&lt;/li&gt;&lt;li&gt;â€¢ 1Î±-hydroxylase is also present in other cells (keratinocytes, placenta, macrophages), but not hormonally regulated.&lt;/li&gt;&lt;li&gt;â€¢ Inactivation of vitamin D metabolites occurs through 24-hydroxylation.&lt;/li&gt;&lt;li&gt;â€¢ Actions of 1,25(OH)2D [calcitriol]:&lt;/li&gt;&lt;li&gt;â€¢ Actions of 1,25(OH)2D [calcitriol]:&lt;/li&gt;&lt;li&gt;â€¢ VDR forms heterodimer with retinoid X receptor, inducing target gene expression. VDR is expressed in various cells and tissues. Effects of VDR - Intestine: Increased calcium absorption by inducing calbindin 9K, TRPV5, TRPV6. Bone: Regulates osteoblasts (increases osteocalcin, osteopontin, RANKL and FGF23). Parathyroid: Reduces PTH production. Others: Antiproliferative effects (keratinocytes, breast ca cells, prostate ca cells). Effects of VDR on hair follicle is ligand (Vitamin D) independent!!&lt;/li&gt;&lt;li&gt;â€¢ VDR forms heterodimer with retinoid X receptor, inducing target gene expression.&lt;/li&gt;&lt;li&gt;â€¢ VDR is expressed in various cells and tissues. Effects of VDR - Intestine: Increased calcium absorption by inducing calbindin 9K, TRPV5, TRPV6. Bone: Regulates osteoblasts (increases osteocalcin, osteopontin, RANKL and FGF23). Parathyroid: Reduces PTH production. Others: Antiproliferative effects (keratinocytes, breast ca cells, prostate ca cells). Effects of VDR on hair follicle is ligand (Vitamin D) independent!!&lt;/li&gt;&lt;li&gt;â€¢ Intestine: Increased calcium absorption by inducing calbindin 9K, TRPV5, TRPV6. Bone: Regulates osteoblasts (increases osteocalcin, osteopontin, RANKL and FGF23). Parathyroid: Reduces PTH production. Others: Antiproliferative effects (keratinocytes, breast ca cells, prostate ca cells). Effects of VDR on hair follicle is ligand (Vitamin D) independent!!&lt;/li&gt;&lt;li&gt;â€¢ Intestine: Increased calcium absorption by inducing calbindin 9K, TRPV5, TRPV6.&lt;/li&gt;&lt;li&gt;â€¢ Bone: Regulates osteoblasts (increases osteocalcin, osteopontin, RANKL and FGF23).&lt;/li&gt;&lt;li&gt;â€¢ Parathyroid: Reduces PTH production.&lt;/li&gt;&lt;li&gt;â€¢ Others: Antiproliferative effects (keratinocytes, breast ca cells, prostate ca cells).&lt;/li&gt;&lt;li&gt;â€¢ Effects of VDR on hair follicle is ligand (Vitamin D) independent!!&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PTH (Parathyroid Hormone) stimulates the production of 1,25(OH)2D (Calcitriol) by activating 1Î±-hydroxylase in the kidneys.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with fatigue and bone pain. Laboratory findings reveal low serum calcium, elevated parathyroid hormone (PTH), and low 25-hydroxyvitamin D [calcidiol] levels. Which of the following statements regarding this patient&#x27;s condition is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1,25 (OH)2 D [calcitriol] levels are often normal.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Expansion of the proliferating zone is seen in rickets.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Looser&#x27;s zones seen in osteomalacia occur near large arteries.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proximal myopathy can occur.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Expansion of the proliferating zone is seen in rickets.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Expansion of the proliferating zone is seen in rickets.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1,25 (OH)2 D (calcitriol) levels are often normal: In severe vitamin D deficiency, there is a compensatory increase in PTH, which stimulates 1Î±-hydroxylase activity and can maintain normal calcitriol levels despite the deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1,25 (OH)2 D (calcitriol) levels are often normal:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Looser&#x27;s zones seen in osteomalacia occur near large arteries: These radiolucent lines, also known as pseudofractures, are characteristic of osteomalacia and are often found adjacent to large arteries. These are often long, but only a few mm wide and common in scapula, pelvis and femoral neck.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Looser&#x27;s zones seen in osteomalacia occur near large arteries:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proximal myopathy can occur: Muscle weakness, particularly in the proximal muscles, is a common symptom of severe vitamin D deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proximal myopathy can occur:&lt;/li&gt;&lt;li&gt;â€¢ Summary: Vitamin D deficiency â€“&lt;/li&gt;&lt;li&gt;â€¢ Summary: Vitamin D deficiency â€“&lt;/li&gt;&lt;li&gt;â€¢ Causes: Poor sunlight exposure, poor intake/malabsorption, increased demand (barbiturates, phenytoin, rifampin, nephrotic syndrome), impaired activation (liver or kidney disease, hypoparathyroidism, FGF23 excess) or resistance (VDR mutations). Genetic causes: VDDR type I (1Î±-hydroxylase mutations, can be responsive to calcitriol) &amp;amp; VDDR type 2 (VDR mutations, has alopecia and resistant to calcitriol). Clinical Manifestations: â†“ S.Ca, â†‘ PTH (leading to â†“PO4 and â†‘ALP), proximal myopathy, and increased CV mortality. Rickets in children before epiphyseal fusion. Osteomalacia in adults. Diagnosis: Serum 25(OH)D level â€“ best screening test. Vitamin D sufficiency is defined as &amp;gt;50 nmol/L (&amp;gt;20 ng/mL). &amp;lt;37 nmol/L (&amp;lt;15 ng/mL) â€“ can lead to â†‘ PTH &amp;amp; â†‘ ALP. Treatment: RDA: 600 IU/d (1-70 years) and 800 IU/d (&amp;gt;70 years). But up to 40000 IU/d is safe ! Severe deficiency: Repletion (50000 IU/week for 3-12 weeks) followed by maintenance therapy (800 IU/d). If 1Î±-hydroxylation is defective, use metabolites not requiring activation (calcitriol, doxercalciferol, alfacalcidol). Monitor treatment with serum and urinary calcium measurements. Target 24-h urinary Ca = 100â€“250 mg/d (&amp;gt; 250mg/d should lead to reduction in dosage).&lt;/li&gt;&lt;li&gt;â€¢ Causes: Poor sunlight exposure, poor intake/malabsorption, increased demand (barbiturates, phenytoin, rifampin, nephrotic syndrome), impaired activation (liver or kidney disease, hypoparathyroidism, FGF23 excess) or resistance (VDR mutations). Genetic causes: VDDR type I (1Î±-hydroxylase mutations, can be responsive to calcitriol) &amp;amp; VDDR type 2 (VDR mutations, has alopecia and resistant to calcitriol).&lt;/li&gt;&lt;li&gt;â€¢ Causes:&lt;/li&gt;&lt;li&gt;â€¢ Genetic causes: VDDR type I (1Î±-hydroxylase mutations, can be responsive to calcitriol) &amp;amp; VDDR type 2 (VDR mutations, has alopecia and resistant to calcitriol).&lt;/li&gt;&lt;li&gt;â€¢ Genetic causes: VDDR type I (1Î±-hydroxylase mutations, can be responsive to calcitriol) &amp;amp; VDDR type 2 (VDR mutations, has alopecia and resistant to calcitriol).&lt;/li&gt;&lt;li&gt;â€¢ Clinical Manifestations: â†“ S.Ca, â†‘ PTH (leading to â†“PO4 and â†‘ALP), proximal myopathy, and increased CV mortality. Rickets in children before epiphyseal fusion. Osteomalacia in adults.&lt;/li&gt;&lt;li&gt;â€¢ Clinical Manifestations:&lt;/li&gt;&lt;li&gt;â€¢ Rickets in children before epiphyseal fusion. Osteomalacia in adults.&lt;/li&gt;&lt;li&gt;â€¢ Rickets in children before epiphyseal fusion.&lt;/li&gt;&lt;li&gt;â€¢ Osteomalacia in adults.&lt;/li&gt;&lt;li&gt;â€¢ Diagnosis: Serum 25(OH)D level â€“ best screening test. Vitamin D sufficiency is defined as &amp;gt;50 nmol/L (&amp;gt;20 ng/mL). &amp;lt;37 nmol/L (&amp;lt;15 ng/mL) â€“ can lead to â†‘ PTH &amp;amp; â†‘ ALP.&lt;/li&gt;&lt;li&gt;â€¢ Diagnosis:&lt;/li&gt;&lt;li&gt;â€¢ Vitamin D sufficiency is defined as &amp;gt;50 nmol/L (&amp;gt;20 ng/mL). &amp;lt;37 nmol/L (&amp;lt;15 ng/mL) â€“ can lead to â†‘ PTH &amp;amp; â†‘ ALP.&lt;/li&gt;&lt;li&gt;â€¢ Vitamin D sufficiency is defined as &amp;gt;50 nmol/L (&amp;gt;20 ng/mL).&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;37 nmol/L (&amp;lt;15 ng/mL) â€“ can lead to â†‘ PTH &amp;amp; â†‘ ALP.&lt;/li&gt;&lt;li&gt;â€¢ Treatment: RDA: 600 IU/d (1-70 years) and 800 IU/d (&amp;gt;70 years). But up to 40000 IU/d is safe ! Severe deficiency: Repletion (50000 IU/week for 3-12 weeks) followed by maintenance therapy (800 IU/d). If 1Î±-hydroxylation is defective, use metabolites not requiring activation (calcitriol, doxercalciferol, alfacalcidol). Monitor treatment with serum and urinary calcium measurements. Target 24-h urinary Ca = 100â€“250 mg/d (&amp;gt; 250mg/d should lead to reduction in dosage).&lt;/li&gt;&lt;li&gt;â€¢ Treatment:&lt;/li&gt;&lt;li&gt;â€¢ RDA: 600 IU/d (1-70 years) and 800 IU/d (&amp;gt;70 years). But up to 40000 IU/d is safe ! Severe deficiency: Repletion (50000 IU/week for 3-12 weeks) followed by maintenance therapy (800 IU/d). If 1Î±-hydroxylation is defective, use metabolites not requiring activation (calcitriol, doxercalciferol, alfacalcidol). Monitor treatment with serum and urinary calcium measurements. Target 24-h urinary Ca = 100â€“250 mg/d (&amp;gt; 250mg/d should lead to reduction in dosage).&lt;/li&gt;&lt;li&gt;â€¢ RDA: 600 IU/d (1-70 years) and 800 IU/d (&amp;gt;70 years). But up to 40000 IU/d is safe !&lt;/li&gt;&lt;li&gt;â€¢ Severe deficiency: Repletion (50000 IU/week for 3-12 weeks) followed by maintenance therapy (800 IU/d).&lt;/li&gt;&lt;li&gt;â€¢ If 1Î±-hydroxylation is defective, use metabolites not requiring activation (calcitriol, doxercalciferol, alfacalcidol).&lt;/li&gt;&lt;li&gt;â€¢ Monitor treatment with serum and urinary calcium measurements. Target 24-h urinary Ca = 100â€“250 mg/d (&amp;gt; 250mg/d should lead to reduction in dosage).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Expansion of the proliferating zone is not seen in rickets; it is the hypertrophic zone that is expanded.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the incorrect statement among the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intermittent PTH increases bone mass.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PTHR1 is the principal receptor for PTH and PTHrP.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PTHrP acts primarily via autocrine/paracrine pathways.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recombinant human calcitonin is useful in hypercalcemic states.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Recombinant human calcitonin is useful in hypercalcemic states.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Recombinant human calcitonin is useful in hypercalcemic states.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intermittent PTH increases bone mass: This is true and is the basis for the use of PTH analogs (teriparatide and abaloparatide) in the treatment of osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intermittent PTH increases bone mass:&lt;/li&gt;&lt;li&gt;â€¢ Option B. PTHR1 is the principal receptor for PTH and PTHrP: Both hormones share the same receptor, which explains their similar physiological effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PTHR1 is the principal receptor for PTH and PTHrP:&lt;/li&gt;&lt;li&gt;â€¢ Option C. PTHrP acts primarily via autocrine/paracrine pathways: PTHrP mainly acts locally on the cells that produce it or on nearby cells, rather than having systemic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. PTHrP acts primarily via autocrine/paracrine pathways:&lt;/li&gt;&lt;li&gt;â€¢ Summary:&lt;/li&gt;&lt;li&gt;â€¢ Summary:&lt;/li&gt;&lt;li&gt;â€¢ PTH Structure and Physiology: 84-amino-acid peptide (first 34 amino acids being crucial for its function). Acts on bone, kidney, and indirectly on the intestine to â†‘ serum calcium. Regulation: PTH release inhibited by calcium and vitamin D (and vice versa). Continuous exposure to high PTH leads to bone resorption, while intermittent administration increases bone mass. PTH acts on osteoblasts, which indirectly activate osteoclasts (via RANKL) for bone resorption. PTH assays should ideally measure only the full-length, biologically active form. PTHrP Structure and Physiology: PTHrP and PTH share structural and functional homology and bind to PTHR1 (activating mutations of PTHR1 results in Jansenâ€™s disease â€“ hypercalcemia, short limbed dwarfism and cystic bone lesions with undetectable PTH) It is produced in many cell types and mainly acts as a paracrine factor. PTHrP is important for bone development and other functions. PTHrP and its role in calcium homeostasis is limited to disease states (especially in humoral hypercalcemia of malignancy (HHM). Calcitonin: â†“ bone resorption and â†‘ renal calcium clearance. It is of limited physiologic significance in humans. Used as a tumor marker (MTC) and treatment for hypercalcemia and Paget&#x27;s disease. Calcitonin from salmon is 10â€“100x more potent than mammalian forms â€“ is used therapeutically to lower serum calcium in hypercalcemic states.&lt;/li&gt;&lt;li&gt;â€¢ PTH Structure and Physiology: 84-amino-acid peptide (first 34 amino acids being crucial for its function). Acts on bone, kidney, and indirectly on the intestine to â†‘ serum calcium. Regulation: PTH release inhibited by calcium and vitamin D (and vice versa). Continuous exposure to high PTH leads to bone resorption, while intermittent administration increases bone mass. PTH acts on osteoblasts, which indirectly activate osteoclasts (via RANKL) for bone resorption. PTH assays should ideally measure only the full-length, biologically active form.&lt;/li&gt;&lt;li&gt;â€¢ PTH Structure and Physiology:&lt;/li&gt;&lt;li&gt;â€¢ 84-amino-acid peptide (first 34 amino acids being crucial for its function). Acts on bone, kidney, and indirectly on the intestine to â†‘ serum calcium. Regulation: PTH release inhibited by calcium and vitamin D (and vice versa). Continuous exposure to high PTH leads to bone resorption, while intermittent administration increases bone mass. PTH acts on osteoblasts, which indirectly activate osteoclasts (via RANKL) for bone resorption. PTH assays should ideally measure only the full-length, biologically active form.&lt;/li&gt;&lt;li&gt;â€¢ 84-amino-acid peptide (first 34 amino acids being crucial for its function).&lt;/li&gt;&lt;li&gt;â€¢ Acts on bone, kidney, and indirectly on the intestine to â†‘ serum calcium.&lt;/li&gt;&lt;li&gt;â€¢ Regulation: PTH release inhibited by calcium and vitamin D (and vice versa).&lt;/li&gt;&lt;li&gt;â€¢ Continuous exposure to high PTH leads to bone resorption, while intermittent administration increases bone mass.&lt;/li&gt;&lt;li&gt;â€¢ PTH acts on osteoblasts, which indirectly activate osteoclasts (via RANKL) for bone resorption.&lt;/li&gt;&lt;li&gt;â€¢ PTH assays should ideally measure only the full-length, biologically active form.&lt;/li&gt;&lt;li&gt;â€¢ PTHrP Structure and Physiology: PTHrP and PTH share structural and functional homology and bind to PTHR1 (activating mutations of PTHR1 results in Jansenâ€™s disease â€“ hypercalcemia, short limbed dwarfism and cystic bone lesions with undetectable PTH) It is produced in many cell types and mainly acts as a paracrine factor. PTHrP is important for bone development and other functions. PTHrP and its role in calcium homeostasis is limited to disease states (especially in humoral hypercalcemia of malignancy (HHM).&lt;/li&gt;&lt;li&gt;â€¢ PTHrP Structure and Physiology:&lt;/li&gt;&lt;li&gt;â€¢ PTHrP and PTH share structural and functional homology and bind to PTHR1 (activating mutations of PTHR1 results in Jansenâ€™s disease â€“ hypercalcemia, short limbed dwarfism and cystic bone lesions with undetectable PTH) It is produced in many cell types and mainly acts as a paracrine factor. PTHrP is important for bone development and other functions. PTHrP and its role in calcium homeostasis is limited to disease states (especially in humoral hypercalcemia of malignancy (HHM).&lt;/li&gt;&lt;li&gt;â€¢ PTHrP and PTH share structural and functional homology and bind to PTHR1 (activating mutations of PTHR1 results in Jansenâ€™s disease â€“ hypercalcemia, short limbed dwarfism and cystic bone lesions with undetectable PTH)&lt;/li&gt;&lt;li&gt;â€¢ It is produced in many cell types and mainly acts as a paracrine factor. PTHrP is important for bone development and other functions.&lt;/li&gt;&lt;li&gt;â€¢ PTHrP and its role in calcium homeostasis is limited to disease states (especially in humoral hypercalcemia of malignancy (HHM).&lt;/li&gt;&lt;li&gt;â€¢ Calcitonin: â†“ bone resorption and â†‘ renal calcium clearance. It is of limited physiologic significance in humans. Used as a tumor marker (MTC) and treatment for hypercalcemia and Paget&#x27;s disease. Calcitonin from salmon is 10â€“100x more potent than mammalian forms â€“ is used therapeutically to lower serum calcium in hypercalcemic states.&lt;/li&gt;&lt;li&gt;â€¢ Calcitonin:&lt;/li&gt;&lt;li&gt;â€¢ â†“ bone resorption and â†‘ renal calcium clearance. It is of limited physiologic significance in humans. Used as a tumor marker (MTC) and treatment for hypercalcemia and Paget&#x27;s disease. Calcitonin from salmon is 10â€“100x more potent than mammalian forms â€“ is used therapeutically to lower serum calcium in hypercalcemic states.&lt;/li&gt;&lt;li&gt;â€¢ â†“ bone resorption and â†‘ renal calcium clearance.&lt;/li&gt;&lt;li&gt;â€¢ It is of limited physiologic significance in humans.&lt;/li&gt;&lt;li&gt;â€¢ Used as a tumor marker (MTC) and treatment for hypercalcemia and Paget&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Calcitonin from salmon is 10â€“100x more potent than mammalian forms â€“ is used therapeutically to lower serum calcium in hypercalcemic states.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recombinant human calcitonin is not useful in hypercalcemic states; salmon calcitonin is used therapeutically.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic mutations is usually associated with parathyroid carcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MEN1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HRPT2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CASR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GCM2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. HRPT2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) HRPT2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. MEN1: Mutations in this gene are associated with multiple endocrine neoplasia type 1 (MEN1), a syndrome that can include parathyroid adenomas but rarely carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option A. MEN1:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CASR: Mutations in this gene cause familial hypocalciuric hypercalcemia (FHH), a benign condition unrelated to parathyroid cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CASR:&lt;/li&gt;&lt;li&gt;â€¢ Option D. GCM2: Mutations in this gene are associated with non-syndromic familial isolated hyperparathyroidism (FIHP), which is characterized by benign parathyroid tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GCM2:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HRPT2 mutations are usually associated with parathyroid carcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with CKD stage 4 presents with persistent hypercalcemia and elevated PTH levels despite treatment with vitamin D analogs. Which of the following is the most likely cause of his persistent hyperparathyroidism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parathyroid carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple endocrine neoplasia type 1 (MEN1)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monoclonal outgrowth within hyperplastic parathyroid glands&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin D resistance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Monoclonal outgrowth within hyperplastic parathyroid glands&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Monoclonal outgrowth within hyperplastic parathyroid glands&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Parathyroid carcinoma: Although possible, parathyroid carcinoma is less likely in this scenario as it is relatively rare.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Parathyroid carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple endocrine neoplasia type 1 (MEN1): MEN1 is a hereditary syndrome that can cause primary hyperparathyroidism (PHPT).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple endocrine neoplasia type 1 (MEN1):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin D resistance: Can cause SHPT, but unlikely in the given clinical context.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin D resistance:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Monoclonal outgrowth within hyperplastic parathyroid glands is the most likely cause of persistent hyperparathyroidism in a CKD patient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old male presents with a serum calcium of 11.2 mg/dL (normal 8.5-10.5) and a parathyroid hormone (PTH) level of 110 pg/mL (normal 15-70 pg/mL). He is otherwise asymptomatic, has normal renal function, and his dual-energy X-ray absorptiometry (DXA) scan is within normal limits. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parathyroidectomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cinacalcet&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bisphosphonates&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Parathyroidectomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Parathyroidectomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Observation: While observation might be considered in elderly patients with mild PHPT, it is not appropriate for a young, asymptomatic patient with elevated S.Ca levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Observation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cinacalcet: Cinacalcet is a calcimimetic that can lower PTH and calcium levels. However, it is not a first-line treatment for PHPT and is generally reserved for patients who are not surgical candidates or who have persistent PHPT post-surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cinacalcet:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bisphosphonates: Bisphosphonates can help to prevent bone loss but do not address the underlying cause of hyperparathyroidism, which is excessive PTH secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bisphosphonates:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most appropriate management for a 43-year-old male with primary hyperparathyroidism (PHPT), elevated serum calcium, and PTH levels is parathyroidectomy .&lt;/li&gt;&lt;li&gt;âž¤ parathyroidectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old female with PHPT underwent parathyroidectomy. On POD 4, she experiences persistent hypocalcemia with low PTH levels, requiring continuous IV calcium infusion to maintain S.Ca. Which of the following is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neck exploration under general anesthesia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Check Mg levels.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neck Ultrasound to look for parathyroids.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add Cinacalcet.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Check Mg levels.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Check Mg levels.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neck exploration under general anesthesia: This is invasive and usually done if there is persistent hyperparathyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neck exploration under general anesthesia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neck Ultrasound to look for parathyroids: Will not be providing any useful information in a post-op patient with hypoparathyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neck Ultrasound to look for parathyroids:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Add Cinacalcet: Cinacalcet is a calcimimetic that lowers PTH, which is already low in this patient. It would be inappropriate and potentially worsen hypocalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Add Cinacalcet:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient who has persistent hypocalcemia and low PTH levels post-parathyroidectomy, the most appropriate next step is to check magnesium levels .&lt;/li&gt;&lt;li&gt;âž¤ check magnesium levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 71-year-old male with abdominal pain underwent an ultrasound (USG) that showed renal stones. His serum calcium (S.Ca) is 12.3 mg/dL (normal 8.5-10.5) and his parathyroid hormone (PTH) is 135 pg/mL (normal 15-70). What should be done next?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tc99m Sestamibi SPECT.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;24-hour urinary calcium.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DXA spine and femur.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bisphosphonates.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tc99m Sestamibi SPECT.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tc99m Sestamibi SPECT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 24-hour urinary calcium: While this can help assess calcium metabolism, it is not the immediate next step in diagnosing the cause of the patient&#x27;s hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 24-hour urinary calcium:&lt;/li&gt;&lt;li&gt;â€¢ Option C. DXA spine and femur: DXA scans assess bone density and can reveal osteoporosis, a potential complication of PHPT. However, the priority is to confirm the diagnosis of PHPT and localize the parathyroid adenoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. DXA spine and femur:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bisphosphonates: Bisphosphonates are used to treat osteoporosis, a potential consequence of PHPT, but not the primary hyperparathyroidism itself. They are not indicated at this stage of diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bisphosphonates:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a 71-year-old male with suspected primary hyperparathyroidism and renal stones, the next step is Tc99m Sestamibi SPECT to localize the parathyroid adenoma.&lt;/li&gt;&lt;li&gt;âž¤ Tc99m Sestamibi SPECT&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following conditions causing hypercalcemia is least likely to respond to glucocorticoid therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin D intoxication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin A intoxication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-small cell lung cancer (NSCLC)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Non-small cell lung cancer (NSCLC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Non-small cell lung cancer (NSCLC)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin D intoxication: Glucocorticoids are a standard treatment for this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin D intoxication:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin A intoxication: Glucocorticoids are effective in treating hypercalcemia related to vitamin A intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin A intoxication:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis: Glucocorticoids are a first-line treatment for hypercalcemia caused by sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The condition causing hypercalcemia that is least likely to respond to glucocorticoid therapy is non-small cell lung cancer (NSCLC) .&lt;/li&gt;&lt;li&gt;âž¤ non-small cell lung cancer (NSCLC)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with breast cancer presents with dehydration and a serum calcium of 17 mg/dL. Which of the following is not a useful therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Fluids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;s.c Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Zoledronic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Calcitonin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IV Calcitonin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-184606.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-184633.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) IV Calcitonin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. IV Fluids: Aggressive hydration with isotonic saline is essential to restore intravascular volume and promote renal calcium excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IV Fluids:&lt;/li&gt;&lt;li&gt;â€¢ Option B. s.c Denosumab: Denosumab, a monoclonal antibody targeting RANKL, is a potent inhibitor of osteoclast activity and bone resorption, making it effective in malignancy-associated hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. s.c Denosumab:&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV Zoledronic Acid: Zoledronic acid, a bisphosphonate, is another potent inhibitor of bone resorption and is commonly used in the management of hypercalcemia of malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV Zoledronic Acid:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with severe hypercalcemia due to malignancy, IV Calcitonin is not as useful due to its transient effect and development of tachyphylaxis.&lt;/li&gt;&lt;li&gt;âž¤ IV Calcitonin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a history of osteoporosis presents with fatigue, nausea, and polyuria. Labs reveal hypercalcemia, metabolic alkalosis, and elevated creatinine. Which of the following is the most likely cause of her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Milk-alkali syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin D intoxication&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Milk-alkali syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Milk-alkali syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary hyperparathyroidism: While it can cause hypercalcemia, it is not typically associated with metabolic alkalosis and renal impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary hyperparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis: Can cause hypercalcemia but is usually associated with granulomatous inflammation and elevated 1,25-dihydroxyvitamin D levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin D intoxication: While it can cause hypercalcemia, it is not usually associated with metabolic alkalosis and renal impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin D intoxication:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most likely cause of hypercalcemia, metabolic alkalosis, and renal impairment in an elderly woman with osteoporosis is milk-alkali syndrome .&lt;/li&gt;&lt;li&gt;âž¤ milk-alkali syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with perioral numbness and tingling one day after total thyroidectomy. Which of the following is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start IV Zoledronate.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start Calcium and calcitriol supplements.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV fluids and forced diuresis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Administer IV sodium bicarbonate.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Start Calcium and calcitriol supplements.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Start Calcium and calcitriol supplements.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start IV Zoledronate: Zoledronic acid is a bisphosphonate used to treat hypercalcemia by inhibiting bone resorption. It would worsen hypocalcemia in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start IV Zoledronate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV fluids and forced diuresis: This is used to treat hypercalcemia, not hypocalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV fluids and forced diuresis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer IV sodium bicarbonate: Sodium bicarbonate is used to correct metabolic acidosis and has no role in treating hypocalcemia. In fact it can worsen hypokalemia by causing alkalosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer IV sodium bicarbonate:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most appropriate management for hypocalcemia presenting with perioral numbness and tingling post-thyroidectomy is starting calcium and calcitriol supplements .&lt;/li&gt;&lt;li&gt;âž¤ starting calcium and calcitriol supplements&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old child presents with short stature, round face, obesity, shortened fourth and fifth metacarpals, hypocalcemia, and hyperphosphatemia. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pseudopseudohypoparathyroidism (PPHP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pseudohypoparathyroidism type 1A (PHP1A)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudohypoparathyroidism type 1B (PHP1B)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pseudohypoparathyroidism type 2 (PHP2)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pseudohypoparathyroidism type 1A (PHP1A)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-190718.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pseudohypoparathyroidism type 1A (PHP1A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pseudopseudohypoparathyroidism (PPHP): Individuals with PPHP have AHO features but normal calcium, phosphate, and PTH levels. They do not exhibit hormone resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pseudopseudohypoparathyroidism (PPHP):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudohypoparathyroidism type 1B (PHP1B): While PHP1B also presents with hypocalcemia and hyperphosphatemia, it is less likely to be associated with the full spectrum of AHO features.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudohypoparathyroidism type 1B (PHP1B):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pseudohypoparathyroidism type 2 (PHP2): PHP2 is characterized by hypocalcemia and hyperphosphatemia with normal urinary cAMP response to PTH, but it does not typically present with AHO features.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pseudohypoparathyroidism type 2 (PHP2):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The child&#x27;s presentation with short stature, round face, obesity, shortened fourth and fifth metacarpals, hypocalcemia, and hyperphosphatemia is characteristic of Albright&#x27;s hereditary osteodystrophy (AHO), which is associated with PHP1A.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is false regarding McCune Albright Syndrome ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polyostotic fibrous dysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CafÃ©-au-lait spots&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypofunctioning endocrinopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased FGF23&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypofunctioning endocrinopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypofunctioning endocrinopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polyostotic fibrous dysplasia: This is a hallmark of MAS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polyostotic fibrous dysplasia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CafÃ©-au-lait spots: These are another characteristic feature of MAS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CafÃ©-au-lait spots:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased FGF23: Polyostotic lesions can lead to elevated FGF23 levels, contributing to phosphate wasting and hypophosphatemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased FGF23:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ McCune Albright Syndrome (MAS) is characterized by hyperfunctioning endocrinopathy, not hypofunctioning. It includes polyostotic fibrous dysplasia, cafÃ©-au-lait spots, and increased FGF23.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with osteoporosis and a history of peptic ulcer disease is considering treatment with oral bisphosphonates. Which of the following is most suitable for him?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alendronate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Risedronate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ibandronate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Zoledronic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Risedronate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Risedronate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alendronate: Requires administration on an empty stomach with water, which could be problematic for someone with peptic ulcer disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alendronate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ibandronate: Also requires administration on an empty stomach and may not be well-tolerated in patients with a history of gastrointestinal issues.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ibandronate:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Zoledronic acid: This is an intravenous bisphosphonate and does not address the specific concern of oral administration in a patient with peptic ulcer disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Zoledronic acid:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risedronate can be taken after breakfast, which is beneficial for patients with a history of peptic ulcer disease, avoiding exacerbation of symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient had a hip fracture and was started on a bone protective agent. However, after 3 years of use, the patient lost follow-up and stopped therapy. Within 3 months of stopping treatment, the patient developed a new vertebral fracture. What is the drug that was likely given initially and stopped?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zoledronate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alendronate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Denosumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Denosumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Zoledronate and Option B. Alendronate: These are bisphosphonates, which have a longer-lasting effect on bone remodeling than denosumab. While there can be a gradual loss of bone density after discontinuing bisphosphonates, it is not as rapid or dramatic as the rebound effect seen with denosumab.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Zoledronate and Option B. Alendronate:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Raloxifene: This is a selective estrogen receptor modulator (SERM) with a milder effect on bone density compared to bisphosphonates and denosumab. Its discontinuation is not typically associated with a rapid increase in fracture risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Raloxifene:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Denosumab is associated with a rapid rebound increase in bone turnover and risk of fractures upon discontinuation, which explains the new vertebral fracture within three months of stopping the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old lady presented with a Colles&#x27; fracture. She has diabetes and suffered from an MI 2 years ago and a stroke a year ago. Which of the following drugs would be the most appropriate for her osteoporosis treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alendronate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Romosozumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alendronate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-192229.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alendronate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Strontium ranelate: Not available in the US and has a potential risk of cardiovascular events, which would be a concern in this patient with a history of MI and stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Strontium ranelate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Romosozumab: While effective in reducing fractures, it has a higher cost and is usually reserved for patients with severe osteoporosis who have failed other treatments. Its safety profile in patients with cardiovascular disease is not yet fully established.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Romosozumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Raloxifene: Raloxifene is a SERM that is primarily effective in reducing vertebral fractures and has limited data on preventing non-vertebral fractures like Colles&#x27; fractures. Additionally, it carries a risk of thromboembolic events which might be a concern in this patient (but note that Raloxifene does not increase CV risk like HRT).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Raloxifene:&lt;/li&gt;&lt;li&gt;â€¢ Fracture reduction data:&lt;/li&gt;&lt;li&gt;â€¢ Fracture reduction data:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alendronate is effective for reducing the risk of fractures and is generally well-tolerated, making it the most appropriate choice for a patient with a history of cardiovascular events and a Colles&#x27; fracture.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following bone protective drugs with their recommended durations of use:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;a-iii, b-iv,c-i, d-ii, e-v&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;a-iv, b-i,c-ii, d-v, e-iii&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;a-ii, b-i,c-iv, d-v, e-iii&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;a-iii, b-iv,c-i, d-v, e-ii&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. a-iv, b-i,c-ii, d-v, e-iii&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-192447.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Alendronate (a): Typically used for up to 5 years (iv) .&lt;/li&gt;&lt;li&gt;â€¢ Alendronate (a):&lt;/li&gt;&lt;li&gt;â€¢ 5 years (iv)&lt;/li&gt;&lt;li&gt;â€¢ Zoledronate (b): Typically used for up to 3 years (i) .&lt;/li&gt;&lt;li&gt;â€¢ Zoledronate (b):&lt;/li&gt;&lt;li&gt;â€¢ 3 years (i)&lt;/li&gt;&lt;li&gt;â€¢ Denosumab (c): Used continuously, with long-term data supporting use for up to 10 years (ii) .&lt;/li&gt;&lt;li&gt;â€¢ Denosumab (c):&lt;/li&gt;&lt;li&gt;â€¢ 10 years (ii)&lt;/li&gt;&lt;li&gt;â€¢ Romosozumab (d): Approved for use for up to 1 year (v) .&lt;/li&gt;&lt;li&gt;â€¢ Romosozumab (d):&lt;/li&gt;&lt;li&gt;â€¢ 1 year (v)&lt;/li&gt;&lt;li&gt;â€¢ Abaloparatide (e): Approved for up to 2 years (iii) .&lt;/li&gt;&lt;li&gt;â€¢ Abaloparatide (e):&lt;/li&gt;&lt;li&gt;â€¢ 2 years (iii)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medications approved for use :&lt;/li&gt;&lt;li&gt;âž¤ Medications approved for use :&lt;/li&gt;&lt;li&gt;âž¤ Alendronate (a): up to 5 years. Zoledronate (b): up to 3 years. Denosumab (c): up to 10 years. Romosozumab (d): up to 1 year. Abaloparatide (e): up to 2 years.&lt;/li&gt;&lt;li&gt;âž¤ Alendronate (a): up to 5 years.&lt;/li&gt;&lt;li&gt;âž¤ Zoledronate (b): up to 3 years.&lt;/li&gt;&lt;li&gt;âž¤ Denosumab (c): up to 10 years.&lt;/li&gt;&lt;li&gt;âž¤ Romosozumab (d): up to 1 year.&lt;/li&gt;&lt;li&gt;âž¤ Abaloparatide (e): up to 2 years.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old depressed woman presents with a T-score of -2.8 on DEXA scan and severe hot flashes. She has a past history of hysterectomy 6 years ago. Which of the following would be the most suitable treatment for this patient to prevent fractures?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transdermal estrogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Equine estrogen with medroxyprogesterone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Transdermal estrogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/17/screenshot-2024-08-17-192756.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Transdermal estrogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Equine estrogen with medroxyprogesterone: While this combination therapy is effective for osteoporosis and hot flashes, it is not necessary for women who have had a hysterectomy as it includes progestin, which is used to protect the endometrium in women with a uterus. Addition of progestin can potentially increase the risk of breast cancer as well.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Equine estrogen with medroxyprogesterone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Raloxifene: Raloxifene is a selective estrogen receptor modulator (SERM) that can be used to prevent osteoporosis. However, it can worsen hot flashes and is not the ideal choice for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Raloxifene:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Teriparatide: Teriparatide is an anabolic agent that stimulates bone formation. While effective for osteoporosis, it does not address menopausal symptoms and is generally reserved for patients with severe osteoporosis who have failed other treatments.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Teriparatide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transdermal estrogen is effective for both osteoporosis and severe hot flashes, and since the patient has had a hysterectomy, she does not need progestin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 198 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test4" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Gastroenterology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Gastroenterology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                140 Questions | 560 Total Marks | 150 min Duration | ~64.29 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following clinical features is most indicative of advanced cirrhosis with portal hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Easy bruising&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spider nevi&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Caput medusae&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Caput medusae&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-140329.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Caput medusae&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Jaundice: Jaundice is a sign of liver dysfunction but is not specific to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Jaundice:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Easy bruising: Easy bruising can indicate liver dysfunction due to decreased production of clotting factors but, like jaundice, is not specific to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Easy bruising:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spider nevi: Spider nevi are associated with liver disease but are less specific for portal hypertension compared to caput medusae.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spider nevi:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Caput medusae is a clinical feature indicative of portal hypertension in the setting of advanced cirrhosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with a history of cirrhosis due to chronic hepatitis B infection presents with altered mental status. On examination, he exhibits asterixis. Which of the following best describes this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatic encephalopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal pressure hydrocephalus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hepatic encephalopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hepatic encephalopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute stroke: Typically presents with sudden onset neurological deficits such as weakness or numbness on one side of the body, difficulty speaking, or facial drooping, which are not described in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alzheimer&#x27;s disease: Is a progressive neurodegenerative disorder characterized by gradual memory loss, cognitive decline, and changes in behavior, but it does not typically present with acute changes or asterixis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alzheimer&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal pressure hydrocephalus: Is characterized by the triad of gait disturbance, urinary incontinence, and cognitive decline, but the acute onset and presence of asterixis are more indicative of hepatic encephalopathy in the context of known liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal pressure hydrocephalus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hepatic encephalopathy&#x27;s characteristic presentation in a patient with underlying liver disease, includes altered mental status, confusion, difficulty with tasks, and asterixis, which highlights liver function in neuropsychiatric status.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following parameters is NOT included in the Child-Turcotte-Pugh (CTP) score to assess the severity of liver disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum albumin level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;International normalized ratio (INR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum sodium level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ascites&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serum sodium level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Serum sodium level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum albumin level: Is included in the CTP score as a measure of the liver&#x27;s synthetic function.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum albumin level:&lt;/li&gt;&lt;li&gt;â€¢ Option B. International normalized ratio: INR is included to assess the liver&#x27;s ability to synthesize clotting factors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. International normalized ratio:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ascites: The presence and severity of ascites are used to evaluate the liver&#x27;s synthetic function and portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ascites:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To recognize the components of the Child-Turcotte-Pugh score and understand that serum sodium level is not included in this assessment of liver disease severity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic liver disease has a Child-Pugh score of 8. Which Child-Pugh class does this score fall into?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Child-Pugh class A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Child-Pugh class B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Child-Pugh class C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Child-Pugh class D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Child-Pugh class B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Child-Pugh class A: Is for scores of 5-6, representing mild liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Child-Pugh class A:&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Child-Pugh class C: Is for scores of 10-15, representing severe liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Child-Pugh class C:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Child-Pugh class D: There is no Child-Pugh class D in the classification system.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Child-Pugh class D:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Child-Pugh score of 8 categorizes a patient with chronic liver disease into Class B, indicating moderate severity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate pharmacological treatment to add for persistent ascites in cirrhotic patients after dietary sodium restriction ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonselective beta-blockers&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oral spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oral spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous albumin: Intravenous albumin is used primarily in the management of large-volume paracentesis or in specific cases like spontaneous bacterial peritonitis, not as a first-line treatment for moderate ascites.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous albumin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral antibiotics: Oral antibiotics are used for the treatment or prevention of spontaneous bacterial peritonitis, not for the direct management of ascites.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral antibiotics:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonselective beta-blockers: Nonselective beta-blockers are used for variceal bleeding prophylaxis and can worsen ascites in some cirrhotic patients by reducing renal perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonselective beta-blockers:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Oral spironolactone is the first-line pharmacological treatment for cirrhotic patients with persistent ascites despite dietary sodium restriction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old male with known cirrhosis presents to the emergency department with hematemesis. He is hypotensive and tachycardic. After initial resuscitation with IV fluids, what is the most appropriate next step in the management of suspected variceal bleeding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral proton pump inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endoscopic band ligation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous octreotide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immediate liver transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous octreotide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intravenous octreotide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral proton pump inhibitors: Oral proton pump inhibitors are used in the management of peptic ulcer disease bleeding, not variceal bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral proton pump inhibitors:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Endoscopic band ligation: Endoscopic band ligation is a definitive treatment for variceal bleeding but may not be immediately available and should be preceded by pharmacological therapy to control the bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Endoscopic band ligation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immediate liver transplantation: Immediate liver transplantation is not a practical immediate step in the acute management of variceal bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immediate liver transplantation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Intravenous octreotide is a critical component of the initial management of acute variceal bleeding in cirrhotic patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Child-Pugh score of 8 comes under ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Child-Pugh class A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Child-Pugh class B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Child-Pugh class C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Child-Pugh class D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Child-Pugh class B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Child-Pugh class B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man who recently underwent total knee replacement surgery presents with sudden onset of shortness of breath and pleuritic chest pain. His ECG shows sinus tachycardia and the D-dimer test is elevated. Which of the following is the most appropriate next step in diagnosing this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arterial blood gas analysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary function tests&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Computed tomography pulmonary angiography (CTPA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transthoracic echocardiogram&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Computed tomography pulmonary angiography (CTPA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arterial blood gas analysis: Arterial blood gas analysis can show hypoxemia and hypocapnia in the case of PE, but these findings are nonspecific and cannot confirm the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arterial blood gas analysis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pulmonary function tests: Pulmonary function tests are not useful in the acute setting of suspected PE as they are primarily used to evaluate chronic respiratory conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pulmonary function tests:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transthoracic Echocardiogram: A transthoracic echocardiogram can be helpful in assessing right ventricular function in the setting of PE and may show signs of right heart strain, but it cannot diagnose PE directly. It is more useful in risk stratification and management rather than initial diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transthoracic Echocardiogram:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The computed tomography pulmonary angiography (CTPA) is the most appropriate diagnostic test for a patient with suspected pulmonary embolism, especially in the context of recent surgery and elevated D-dimer levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with a history of chronic obstructive pulmonary disease (COPD) presents to the clinic with increased shortness of breath, wheezing, and productive cough for the past 2 days. She uses a short-acting bronchodilator as needed. Which of the following is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start systemic corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prescribe a long-acting muscarinic antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate antibiotic therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase the dose of the short-acting bronchodilator&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Start systemic corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prescribing a long-acting muscarinic antagonist: Prescribing a long-acting muscarinic antagonist (LAMA) is a good option for long-term management of COPD to improve symptoms and reduce exacerbations, but it is not the first choice for treating an acute exacerbation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prescribing a long-acting muscarinic antagonist:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate antibiotic therapy: Antibiotic therapy may be indicated if there is a strong suspicion or evidence of a bacterial infection contributing to the exacerbation, such as increased sputum purulence, but it is not the standard initial treatment for all acute COPD exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate antibiotic therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase the dose of the short-acting bronchodilator: Increasing the dose of a short-acting bronchodilator can provide symptomatic relief and is often part of the management of acute exacerbations, but it may not be sufficient on its own without addressing the inflammation with corticosteroids.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase the dose of the short-acting bronchodilator:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Systemic corticosteroids are an appropriate initial treatment for an acute exacerbation of COPD, as they address the underlying airway inflammation and can improve symptoms and lung function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man is brought to the emergency department after a motor vehicle accident. He is tachypneic, hypotensive, and has decreased breath sounds on the left side with tracheal deviation to the right. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rib fracture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tension pneumothorax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary contusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tension pneumothorax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tension pneumothorax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemothorax: Hemothorax involves the accumulation of blood in the pleural space and can present with similar symptoms, but tracheal deviation is more specifically associated with tension pneumothorax due to the significant shift in mediastinal structures.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemothorax:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rib fractures: Rib fractures can cause pain and lead to shallow breathing, potentially causing or contributing to a pneumothorax, but the clinical presentation described is more consistent with a tension pneumothorax.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rib fractures:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary contusion: Pulmonary contusion involves injury to the lung tissue itself and can lead to respiratory distress, but it does not cause tracheal deviation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary contusion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation of a tension pneumothorax, includes tachypnea, hypotension, decreased breath sounds on the affected side, and contralateral tracheal deviation, as a life-threatening condition that requires immediate intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate diagnostic test to confirm cirrhosis in a patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abdominal ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver biopsy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum albumin level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Upper gastrointestinal endoscopy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liver biopsy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Liver biopsy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal ultrasound: Can suggest cirrhosis by showing a nodular liver surface, ascites, or signs of portal hypertension but cannot definitively diagnose cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal ultrasound:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum albumin level: Can indicate liver function but is not a diagnostic test for cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum albumin level:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Upper gastrointestinal endoscopy: Is useful for identifying complications of portal hypertension such as esophageal varices, not for diagnosing cirrhosis itself.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Upper gastrointestinal endoscopy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Liver biopsy is the gold standard diagnostic test for confirming cirrhosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old woman with end-stage liver disease is being evaluated for liver transplantation. Her recent laboratory tests include serum bilirubin, serum creatinine, and INR. Which additional parameter is essential to calculate her Model for End-Stage Liver Disease (MELD) score?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum albumin level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum sodium level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platelet count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemoglobin level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum sodium level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum sodium level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum albumin level: Serum albumin level is not included in the MELD score calculation, although it is an important parameter in assessing liver function and nutritional status.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum albumin level:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platelet count: Platelet count is not part of the MELD score calculation but is often used in assessing the degree of portal hypertension and hypersplenism in liver disease patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platelet count:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemoglobin level: Hemoglobin level is also not included in the MELD score calculation and is not directly related to liver function, although anemia can be a complication of end-stage liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemoglobin level:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum sodium level, in addition to serum bilirubin, serum creatinine, and INR, is essential for calculating the MELD score, which is used to assess the severity and prognosis of end-stage liver disease for transplantation prioritization.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of alcohol use disorder presents with new-onset ascites. Paracentesis is performed, and the serum-ascites albumin gradient (SAAG) is calculated to be 1.8 g/dL. Which of the following is the most likely cause of his ascites?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tuberculous peritonitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic ascites&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nephrotic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculous peritonitis: Tuberculous peritonitis typically presents with a low SAAG, suggesting that the ascites is not due to portal hypertension but to peritoneal inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculous peritonitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancreatic ascites: Pancreatic ascites is usually due to leakage of pancreatic enzymes causing inflammation and ascites with a low SAAG, indicating that the cause is not related to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancreatic ascites:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nephrotic syndrome: Nephrotic syndrome can cause ascites due to hypoalbuminemia leading to reduced oncotic pressure, but it typically results in a low SAAG, as the ascites is not due to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nephrotic syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A high serum-ascites albumin gradient (SAAG) of 1.1 g/dL or greater is indicative of portal hypertension, with cirrhosis being a common cause, especially in patients with a history of alcohol use disorder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with no significant medical history presents with abdominal swelling and discomfort. A diagnostic paracentesis shows a SAAG of 0.9 g/dL. Which of the following conditions is most likely associated with her ascites?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Budd-Chiari syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congestive heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malignant ascites&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatic venous outflow obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Malignant ascites&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Budd-Chiari syndrome and D. Hepatic venous outflow obstruction : Both typically lead to portal hypertension and would more likely present with a SAAG greater than 1.1 g/dL.&lt;/li&gt;&lt;li&gt;â€¢ Options A. Budd-Chiari syndrome and D. Hepatic venous outflow obstruction&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure: Can cause ascites due to increased hydrostatic pressure in the systemic and portal venous systems, typically resulting in a SAAG greater than 1.1 g/dL, indicating that the ascites is due to portal hypertension secondary to heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A SAAG lower than 1.1 g/dL suggests the ascites is not due to portal hypertension and that malignant ascites is caused by the direct spread of cancer in the peritoneal cavity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male with a history of chronic heart failure presents with progressive abdominal distension. Paracentesis reveals a SAAG of 1.3 g/dL. Which of the following is the most likely cause of his ascites?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peritoneal carcinomatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcoholic cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Congestive heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreatic ascites&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Congestive heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peritoneal carcinomatosis: Peritoneal carcinomatosis typically leads to exudative ascites with a low SAAG, as the ascites formation is due to peritoneal involvement by malignant cells rather than portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peritoneal carcinomatosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholic cirrhosis: Alcoholic cirrhosis could also present with a high SAAG due to portal hypertension; however, the patient&#x27;s history of chronic heart failure makes congestive heart failure a more likely cause in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholic cirrhosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreatic ascites: Pancreatic ascites usually results from the leakage of pancreatic enzymes, leading to inflammation and exudative ascites with a low SAAG, not related to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreatic ascites:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A high SAAG (â‰¥1.1 g/dL) in a patient with chronic heart failure is indicative of ascites due to congestive heart failure, reflecting portal hypertension secondary to increased venous pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of cirrhosis due to chronic hepatitis C infection presents with new-onset ascites. What is the most appropriate initial step in the management of his ascites?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the dose of his current diuretic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start antibiotic prophylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform a large-volume paracentesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrict dietary sodium&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Restrict dietary sodium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Restrict dietary sodium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of his current diuretic: Increasing the dose of his current diuretic without first attempting dietary modifications may lead to electrolyte imbalances and kidney injury.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of his current diuretic:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start antibiotic prophylaxis: Antibiotic prophylaxis is indicated in specific situations, such as prior episodes of spontaneous bacterial peritonitis (SBP), but not as an initial step for all cases of ascites.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start antibiotic prophylaxis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perform a large-volume paracentesis: Large-volume paracentesis is typically reserved for tense ascites causing respiratory discomfort or as a diagnostic procedure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perform a large-volume paracentesis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dietary sodium restriction is the initial management strategy for patients with cirrhosis presenting with ascites.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with cirrhosis is evaluated in the clinic. She is oriented to person, place, and time but demonstrates poor concentration and mild confusion about recent events. She has no asterixis or other focal neurological signs. According to the West Haven Criteria, how would her hepatic encephalopathy be graded?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Grade I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Grade II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Grade III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Grade IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Grade I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Grade I&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Grade II: Hepatic encephalopathy is characterized by increased confusion, disorientation to time, obvious personality changes, inappropriate behavior, and asterixis (flapping tremor).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Grade II:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Grade III: Involves a somnolent but arousable state, profound confusion, disorientation to time and place, and more pronounced asterixis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Grade III:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Grade IV: Is characterized by coma with or without response to painful stimuli.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Grade IV:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Grade I is characterized by mild confusion and poor concentration without more severe neurological signs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate long-term treatment to prevent further episodes of hepatic encephalopathy in a patient with advanced cirrhosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral lactulose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose vitamin K&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oral lactulose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oral lactulose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous albumin: Intravenous albumin is used in the management of patients with cirrhosis and complications such as spontaneous bacterial peritonitis or hepatorenal syndrome, but it is not a standard treatment for preventing hepatic encephalopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous albumin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral propranolol: Oral propranolol is used for primary prophylaxis of variceal bleeding in cirrhotic patients by reducing portal hypertension, not for preventing hepatic encephalopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral propranolol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose vitamin K: High-dose vitamin K is sometimes used in cirrhotic patients to correct coagulopathy, but it does not play a role in the prevention of hepatic encephalopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose vitamin K:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oral lactulose is the most appropriate long-term treatment for preventing recurrent episodes of hepatic encephalopathy in patients with advanced cirrhosis, due to its mechanism of reducing blood ammonia levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of alcohol abuse and chronic hepatitis B infection is found to have an elevated alpha-fetoprotein (AFP) level during routine screening making him vulnerable for ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Renal cell carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatocellular carcinoma (HCC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic adenocarcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Colorectal adenocarcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hepatocellular carcinoma (HCC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Renal cell carcinoma: Renal cell carcinoma is not typically associated with alcohol abuse, hepatitis B infection, or elevated AFP levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Renal cell carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancreatic adenocarcinoma: Pancreatic adenocarcinoma is also not directly linked to alcohol abuse, hepatitis B infection, or elevated AFP levels as specific risk factors or biomarkers.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancreatic adenocarcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colorectal adenocarcinoma: Colorectal adenocarcinoma, while alcohol consumption may be a risk factor, is not directly associated with hepatitis B infection or elevated AFP levels as a specific biomarker.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colorectal adenocarcinoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alcohol abuse and chronic hepatitis B infection, combined with an elevated alpha-fetoprotein (AFP) level, significantly increases the likelihood of developing hepatocellular carcinoma (HCC).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with a history of non-alcoholic steatohepatitis (NASH) presents with worsening fatigue and abdominal distension. An abdominal ultrasound reveals a nodular liver and ascites. Which additional finding would most suggest the presence of hepatocellular carcinoma (HCC)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated alpha-fetoprotein (AFP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyponatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoalbuminemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Elevated alpha-fetoprotein (AFP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Elevated alpha-fetoprotein (AFP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoglycemia: Hypoglycemia can occur in advanced liver disease due to the liver&#x27;s impaired gluconeogenesis, but it is not specific for HCC.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoglycemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyponatremia: Hyponatremia is common in advanced liver disease, particularly with the development of ascites and portal hypertension, but it is not specific for HCC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyponatremia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypoalbuminemia: Hypoalbuminemia is indicative of liver dysfunction and is a common feature of cirrhosis and advanced liver disease but does not specifically suggest HCC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypoalbuminemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An elevated alpha-fetoprotein (AFP) level, particularly in a patient with risk factors and liver disease such as NASH, is suggestive of hepatocellular carcinoma (HCC).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which imaging characteristic on contrast-enhanced computed tomography (CECT) is most indicative of hepatocellular carcinoma (HCC)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early arterial enhancement with washout in the venous phase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continuous enhancement in both arterial and venous phases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lack of enhancement in all phases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Late venous enhancement without arterial enhancement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Early arterial enhancement with washout in the venous phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Early arterial enhancement with washout in the venous phase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Continuous enhancement in both arterial and venous phases: It  is not typical for HCC and may suggest other types of lesions or benign vascular processes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Continuous enhancement in both arterial and venous phases:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lack of enhancement in all phases: It is not characteristic of HCC. HCC typically shows some degree of contrast enhancement due to its arterial supply.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lack of enhancement in all phases:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Late venous enhancement without arterial enhancement: It is not a typical feature of HCC and may be seen in other types of liver lesions or vascular abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Late venous enhancement without arterial enhancement:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Early arterial enhancement with washout in the venous phase on contrast-enhanced computed tomography (CECT) is a key imaging characteristic indicative of hepatocellular carcinoma (HCC) in patients with liver disease, such as cirrhosis due to chronic hepatitis C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most appropriate first-line treatment option for early-stage hepatocellular carcinoma (HCC) and well-preserved liver function?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic chemotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver transplantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radiofrequency ablation (RFA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Palliative care&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Radiofrequency ablation (RFA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Radiofrequency ablation (RFA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic chemotherapy: Systemic chemotherapy is generally not the first-line treatment for early-stage HCC due to its limited efficacy and potential for systemic side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic chemotherapy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver transplantation: Liver transplantation is a potential treatment option for early-stage HCC, especially for patients with underlying cirrhosis and liver dysfunction. However, it is typically considered when other curative treatments like resection or ablation are not feasible or have failed, and the patient meets specific criteria (such as the Milan criteria).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver transplantation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Palliative care: Palliative care is an important aspect of managing advanced cancer but is not the appropriate first-line treatment for a patient with early-stage HCC and well-preserved liver function, who has potentially curative treatment options.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Palliative care:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Radiofrequency ablation (RFA) is an appropriate first-line treatment for patients with early-stage hepatocellular carcinoma (HCC) and well-preserved liver function, offering a minimally invasive approach with the potential for curative outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patterns of liver function tests (LFTs) is most consistent with acute viral hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ALT, normal AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated AST, normal ALT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ALT and AST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated alkaline phosphatase, normal ALT and AST&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated ALT and AST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in acute viral hepatitis where both enzymes are usually elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Elevated ALT, normal AST&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with acute viral hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than acute viral hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In acute viral hepatitis, both ALT and AST levels are typically elevated, reflecting hepatocellular injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patterns of liver function tests (LFTs) is most consistent with ischemic hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ALT, normal AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated AST, normal ALT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ALT and AST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated alkaline phosphatase, normal ALT and AST&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated ALT and AST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in ischemic hepatitis, where both enzymes are usually elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with ischemic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than ischemic hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Ischemic hepatitis typically presents with marked elevations in both ALT and AST levels, reflecting acute hepatocellular injury due to compromised hepatic perfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patterns of liver function tests (LFTs) is most consistent with acute fulminant Wilson&#x27;s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ALT, normal AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated AST, normal ALT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ALT and AST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated alkaline phosphatase, normal ALT and AST&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated ALT and AST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in acute fulminant Wilson&#x27;s disease, where both enzymes are usually elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with acute fulminant Wilson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than acute fulminant Wilson&#x27;s disease, as alkaline phosphatase levels are typically elevated in cholestasis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Acute fulminant Wilson&#x27;s disease presents with markedly elevated ALT and AST levels, reflecting severe hepatocellular injury and necrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patterns of liver function tests (LFTs) is most consistent with alcoholic hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ALT, normal AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated AST, normal ALT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ALT and AST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated alkaline phosphatase, normal ALT and AST&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated ALT and AST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in alcoholic hepatitis, where both enzymes are usually elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than alcoholic hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Alcoholic hepatitis typically presents with marked elevations in both ALT and AST levels, reflecting hepatocellular injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following calculations is most appropriate to assess the severity and prognosis of alcoholic hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Child-Pugh score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glasgow Alcoholic Hepatitis Score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Maddrey&#x27;s Discriminant Function&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MELD score&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Maddrey&#x27;s Discriminant Function&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Child-Pugh score : While used to assess the severity of liver disease, the Child-Pugh score may not be as specific for alcoholic hepatitis severity as Maddrey&#x27;s Discriminant Function.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Child-Pugh score&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glasgow Alcoholic Hepatitis Score : This scoring system assesses the severity of alcoholic hepatitis but does not specifically incorporate INR, which is a component of Maddrey&#x27;s Discriminant Function.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glasgow Alcoholic Hepatitis Score&lt;/li&gt;&lt;li&gt;â€¢ Option D. MELD score : The Model for End-Stage Liver Disease (MELD) score is used for liver transplant allocation and does not specifically assess the severity of alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. MELD score&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Maddrey&#x27;s Discriminant Function is a valuable tool for assessing the severity and prognosis of alcoholic hepatitis, guiding treatment decisions and predicting mortality in patients with this condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the primary pharmacological treatment for severe alcoholic hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pentoxifylline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;N-acetylcysteine (NAC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ursodeoxycholic acid (UDCA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pentoxifylline : While also used in the management of severe alcoholic hepatitis, pentoxifylline has shown less efficacy compared to prednisolone in improving short-term survival.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pentoxifylline&lt;/li&gt;&lt;li&gt;â€¢ Option C. N-acetylcysteine (NAC) : NAC is primarily used for acetaminophen overdose and does not have a significant role in the treatment of alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. N-acetylcysteine (NAC)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ursodeoxycholic acid (UDCA) : UDCA is not recommended for the treatment of alcoholic hepatitis as it may worsen outcomes in this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ursodeoxycholic acid (UDCA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Prednisolone is the primary pharmacological treatment for severe alcoholic hepatitis, improving short-term survival by reducing inflammation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old obese patient presents with fatigue, right upper quadrant abdominal pain, and hepatomegaly. Laboratory tests reveal elevated liver enzymes and imaging studies show hepatic steatosis. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-alcoholic fatty liver disease (NAFLD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcoholic liver disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute viral hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autoimmune hepatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Non-alcoholic fatty liver disease (NAFLD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholic liver disease : While alcohol consumption can also lead to fatty liver disease, the absence of significant alcohol intake in this patient makes NAFLD more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholic liver disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute viral hepatitis : The clinical presentation and imaging findings are not consistent with acute viral hepatitis, which typically presents with acute onset jaundice and viral prodrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute viral hepatitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Autoimmune hepatitis : Although autoimmune hepatitis can present with elevated liver enzymes and hepatomegaly, the association with obesity and hepatic steatosis makes NAFLD more likely in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Autoimmune hepatitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and risk factors for NAFLD, including obesity and hepatic steatosis, aids in the diagnosis and management of non-alcoholic fatty liver disease, which encompasses non-alcoholic steatohepatitis (NASH) as a progressive form.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following histological findings is characteristic of non-alcoholic steatohepatitis (NASH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Presence of Mallory-Denk bodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Periportal inflammation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bile duct proliferation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatic iron deposition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Presence of Mallory-Denk bodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Periportal inflammation : While inflammation is a feature of NASH, it typically involves the lobular region rather than periportal areas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Periportal inflammation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bile duct proliferation : Bile duct proliferation is not a typical histological finding in NASH and is more suggestive of chronic cholestatic liver diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bile duct proliferation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatic iron deposition : Hepatic iron deposition is not a characteristic histological finding in NASH and is more commonly associated with hereditary hemochromatosis or chronic liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatic iron deposition&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Characteristic histological features of NASH, such as Mallory-Denk bodies, helps in the accurate diagnosis and differentiation from other liver diseases, guiding appropriate management strategies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the primary pharmacological treatment for NASH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ursodeoxycholic acid (UDCA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pioglitazone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ursodeoxycholic acid (UDCA) : UDCA has not shown consistent efficacy in treating NASH and is not recommended as a primary pharmacological treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ursodeoxycholic acid (UDCA)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metformin : While metformin may improve insulin sensitivity, its role in treating NASH is limited and controversial.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metformin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin E : Vitamin E has shown some benefit in improving liver histology in NASH patients without diabetes but is not considered a first-line treatment option.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin E&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ NASH, such as pioglitazone, aids in the management of this progressive liver disease, particularly in patients with associated metabolic risk factors like diabetes or insulin resistance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patterns of liver function tests (LFTs) is most consistent with cholestatic liver disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ALT and AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated ALT, normal AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ALP and GGT, normal ALT and AST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated bilirubin, normal ALP and GGT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated ALP and GGT, normal ALT and AST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT and AST : This pattern is more indicative of hepatocellular injury rather than cholestasis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT and AST&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated ALT, normal AST : Elevated ALT with normal AST levels is not characteristic of cholestatic liver diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated ALT, normal AST&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated bilirubin, normal ALP and GGT : While elevated bilirubin can occur in cholestatic liver diseases, normal ALP and GGT levels are inconsistent with impaired bile flow.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated bilirubin, normal ALP and GGT&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The characteristic pattern of elevated ALP and GGT levels with normal ALT and AST helps in distinguishing cholestatic liver diseases from other causes of liver dysfunction, guiding further diagnostic evaluation and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old male presents with intermittent episodes of mild jaundice, particularly during periods of stress or fasting. Laboratory tests reveal unconjugated hyperbilirubinemia with normal liver function tests. Which of the following conditions is most likely responsible for the patient&#x27;s presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wilson&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gilbert Syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dubin-Johnson syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gilbert Syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson&#x27;s disease : Wilson&#x27;s disease presents with hepatic copper accumulation leading to liver dysfunction, neurological symptoms, and Kayser-Fleischer rings, which are not present in Gilbert Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is associated with abnormal liver function tests reflecting increased bilirubin turnover.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dubin-Johnson syndrome : Dubin-Johnson syndrome is characterized by conjugated hyperbilirubinemia due to impaired bilirubin excretion into bile, resulting in darkly pigmented liver tissue, which is not seen in Gilbert Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dubin-Johnson syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and laboratory findings of Gilbert Syndrome, includes unconjugated hyperbilirubinemia with normal liver function tests.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-week-old neonate presents with severe jaundice since birth. Laboratory tests reveal markedly elevated unconjugated bilirubin levels without evidence of hemolysis or liver dysfunction. Which of the following conditions is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gilbert Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crigler-Najjar Syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dubin-Johnson Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Crigler-Najjar Syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gilbert Syndrome : Gilbert Syndrome also presents with unconjugated hyperbilirubinemia but is milder and typically presents later in life.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gilbert Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia, but it is associated with evidence of hemolysis on laboratory tests, which is not present in Crigler-Najjar Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dubin-Johnson Syndrome : Dubin-Johnson Syndrome presents with conjugated hyperbilirubinemia and is characterized by darkly pigmented liver tissue, which is not seen in Crigler-Najjar Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dubin-Johnson Syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and laboratory findings of Crigler-Najjar Syndrome, includes severe unconjugated hyperbilirubinemia without evidence of hemolysis or liver dysfunction, is essential for early diagnosis and appropriate management, which may include phototherapy or liver transplantation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with chronic jaundice and dark-colored urine. Laboratory tests reveal elevated levels of conjugated bilirubin and normal liver function tests. Abdominal imaging shows a liver with a characteristic \&quot;black liver\&quot; appearance. Which of the following conditions is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gilbert Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crigler-Najjar Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dubin-Johnson Syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dubin-Johnson Syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-115621.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gilbert Syndrome : Gilbert Syndrome presents with unconjugated hyperbilirubinemia due to reduced activity of UDP-glucuronosyltransferase (UGT1A1), without evidence of liver dysfunction or bile pigment deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gilbert Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is not associated with conjugated hyperbilirubinemia or liver pigment deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar Syndrome : Crigler-Najjar Syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), without evidence of liver pigment deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar Syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and characteristic imaging findings of Dubin-Johnson Syndrome, including conjugated hyperbilirubinemia and a \&quot;black liver\&quot; appearance, aids in accurate diagnosis and differentiation from other causes of jaundice.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with chronic jaundice and dark urine with elevated levels of conjugated bilirubin with normal liver function tests. Abdominal imaging shows no abnormalities. Which of the following conditions is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gilbert Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crigler-Najjar Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rotor Syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rotor Syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gilbert Syndrome : Gilbert Syndrome presents with unconjugated hyperbilirubinemia due to reduced activity of UDP-glucuronosyltransferase (UGT1A1), with normal liver function tests and no evidence of conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gilbert Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia : Hemolytic anemia can cause unconjugated hyperbilirubinemia due to increased bilirubin production from hemolysis, but it is not associated with conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar Syndrome : Crigler-Najjar Syndrome is characterized by severe unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), with normal liver function tests and no evidence of conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar Syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and laboratory findings of Rotor Syndrome, includes conjugated hyperbilirubinemia with normal liver function tests and absence of liver imaging abnormalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-month-old infant presents with persistent jaundice, hepatosplenomegaly, and failure to thrive. Laboratory tests reveal elevated levels of conjugated bilirubin and liver function tests consistent with cholestasis. Abdominal imaging shows no abnormalities. Which of the following conditions is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wilson&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alagille syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crigler-Najjar syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Progressive familial intrahepatic cholestasis (PFIC)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Progressive familial intrahepatic cholestasis (PFIC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson&#x27;s disease : Wilson&#x27;s disease presents with hepatic copper accumulation leading to liver dysfunction and neurological symptoms, which are not typical features of PFIC.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alagille syndrome : Alagille syndrome presents with bile duct paucity, characteristic facial features, and cardiac abnormalities, which are not features of PFIC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alagille syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar syndrome : Crigler-Najjar syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), which is different from the cholestatic presentation seen in PFIC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and laboratory findings of progressive familial intrahepatic cholestasis (PFIC), includes cholestasis with elevated conjugated bilirubin levels and normal or mildly abnormal liver function tests.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with jaundice, pruritus, cardiac murmur and characteristic facial features as below. Laboratory tests show elevated levels of conjugated bilirubin and liver function tests consistent with cholestasis. Which of the following conditions is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wilson&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Progressive familial intrahepatic cholestasis (PFIC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crigler-Najjar syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alagille syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Alagille syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-130600.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-130600_Lr5LzCE.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson&#x27;s disease : Wilson&#x27;s disease presents with hepatic copper accumulation leading to liver dysfunction and neurological symptoms, which are not typical features of Alagille syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Progressive familial intrahepatic cholestasis (PFIC) : PFIC is characterized by defects in hepatobiliary transport proteins, leading to cholestasis, but it does not typically present with the characteristic facial features seen in Alagille syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Progressive familial intrahepatic cholestasis (PFIC)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar syndrome : Crigler-Najjar syndrome is characterized by unconjugated hyperbilirubinemia due to deficient activity of UDP-glucuronosyltransferase (UGT1A1), which is different from the cholestatic presentation seen in Alagille syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crigler-Najjar syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and characteristic facial features of Alagille syndrome, along with laboratory findings consistent with cholestasis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following manifestations is a rare but severe complication most likely associated with acute hepatitis B infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic liver cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatocellular carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fulminant hepatic failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic hepatitis B infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Fulminant hepatic failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic liver cirrhosis : Chronic liver cirrhosis is a long-term complication of chronic hepatitis B infection, not typically seen in the acute phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic liver cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatocellular carcinoma : Hepatocellular carcinoma is a long-term complication of chronic hepatitis B infection and is not associated with the acute phase of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic hepatitis B infection : Chronic hepatitis B infection is characterized by persistent HBsAg positivity for more than six months and is not typically associated with acute manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic hepatitis B infection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The manifestations of acute hepatitis B infection, includes fulminant hepatic failure which is a severe complication, aids in prompt diagnosis and management, preventing progression to life-threatening complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female presents for routine health screening. Laboratory tests reveal positive serology for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), with elevated liver enzymes. Which of the following best describes the patient&#x27;s hepatitis B virus (HBV) infection status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune tolerance phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immune clearance phase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune control phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune escape phase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immune clearance phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune tolerance phase : In the immune tolerance phase, patients have high viral loads, normal liver enzymes, and positive HBeAg. There is minimal liver inflammation despite active viral replication.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune tolerance phase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase : In the immune control phase, patients have low viral loads, normal liver enzymes, and negative HBeAg. There is minimal liver inflammation due to effective immune control of the virus.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune escape phase : The immune escape phase refers to the development of HBV mutants that evade immune recognition, typically occurring in chronic infection and associated with disease progression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune escape phase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The different phases of hepatitis B virus (HBV) infection, includes the immune clearance phase characterized by active viral replication and elevated liver enzymes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes a patient&#x27;s hepatitis B virus (HBV) infection status if he has positive serology for hepatitis B surface antigen (HBsAg) , who has come for a routine check up ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic hepatitis B infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute hepatitis B infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune control phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resolved hepatitis B infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronic hepatitis B infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute hepatitis B infection : Acute infection is characterized by the presence of HBsAg along with other markers such as IgM anti-HBc and HBV DNA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative HBeAg.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Resolved hepatitis B infection : Resolved infection is characterized by the presence of anti-HBs and absence of HBsAg.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Resolved hepatitis B infection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ HBsAg positivity indicates chronic hepatitis B infection that helps in appropriate management and monitoring of patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the patient&#x27;s hepatitis B virus (HBV) infection status if she has positive serology for anti-HBs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic hepatitis B infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute hepatitis B infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune control phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resolved hepatitis B infection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Resolved hepatitis B infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic hepatitis B infection : Chronic infection is characterized by persistent HBsAg positivity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute hepatitis B infection : Acute infection is characterized by the presence of HBsAg, often accompanied by IgM anti-HBc.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative HBeAg.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Anti-HBs positivity helps in indicating resolved hepatitis B infection or immunity from vaccination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the patient&#x27;s hepatitis B virus (HBV) infection status if patient shows positive serology for hepatitis B e antigen (HBeAg) ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune tolerance phase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immune clearance phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune control phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune escape phase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Immune tolerance phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immune clearance phase : In the immune clearance phase, patients have high viral loads, elevated liver enzymes, and positive HBeAg.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immune clearance phase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase : In the immune control phase, patients have low viral loads, normal liver enzymes, and negative HBeAg.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune escape phase : The immune escape phase refers to the development of HBV mutants that evade immune recognition, typically occurring in chronic infection and associated with disease progression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune escape phase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The significance of HBeAg positivity helps in indicating the immune tolerance phase of hepatitis B infection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the patient&#x27;s hepatitis B virus (HBV) infection status if laboratory tests reveal positive serology for IgM antibodies to hepatitis B core antigen (anti-HBc IgM)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic hepatitis B infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute hepatitis B infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune control phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resolved hepatitis B infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute hepatitis B infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic hepatitis B infection : Chronic infection is characterized by persistent HBsAg positivity and absence of IgM anti-HBc.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic hepatitis B infection&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase : Immune control phase is characterized by low viral load, normal liver enzymes, and negative anti-HBc IgM.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune control phase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Resolved hepatitis B infection : Resolved infection is characterized by the presence of anti-HBs and absence of HBsAg and IgM anti-HBc.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Resolved hepatitis B infection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ IgM anti-HBc positivity indicates acute hepatitis B infection that aids in prompt diagnosis and management of patients presenting with acute hepatitis symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the patient&#x27;s hepatitis B virus (HBV) infection status in a patient with chronic Hepatitis B infection and positive serology for antibodies to hepatitis B e antigen (anti-HBe)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune tolerance phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immune clearance phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune control phase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune escape phase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Immune control phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune tolerance phase : In the immune tolerance phase, patients have high viral loads, normal liver enzymes, and positive HBeAg.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune tolerance phase&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immune clearance phase : In the immune clearance phase, patients have high viral loads, elevated liver enzymes, and positive HBeAg.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immune clearance phase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune escape phase : The immune escape phase refers to the development of HBV mutants that evade immune recognition, typically occurring in chronic infection and associated with disease progression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune escape phase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Anti-HBe positivity indicates the immune control phase of hepatitis B infection that helps in understanding disease progression and guiding management strategies for patients with chronic hepatitis B.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with chronic hepatitis B infection presents with elevated liver enzymes and detectable HBV DNA levels. The patient has no evidence of cirrhosis or hepatocellular carcinoma. Which of the following is the most appropriate initial treatment according to current guidelines?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interferon-alpha&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tenofovir disoproxil fumarate (TDF)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adefovir dipivoxil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tenofovir disoproxil fumarate (TDF)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lamivudine : Lamivudine is an older nucleoside analog and is associated with high rates of resistance, making it a less preferred option for initial treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lamivudine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Interferon-alpha : Interferon-alpha is less commonly used due to its side effect profile and limited efficacy compared to nucleos(t)ide analogs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Interferon-alpha&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adefovir dipivoxil : Adefovir dipivoxil is another nucleotide analog, but it is associated with a higher rate of nephrotoxicity and resistance compared to TDF or entecavir.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adefovir dipivoxil&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The current treatment guidelines for chronic hepatitis B infection, includes the preference for nucleos(t)ide analogs such as tenofovir disoproxil fumarate (TDF) or entecavir as initial therapy that aids in appropriate management and prevention of disease progression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most appropriate interval for monitoring liver function tests and viral load during tenofovir disoproxil fumarate (TDF) therapy for chronic hepatitis B infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Every 6 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Every 12 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Every 3 months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Every 2 weeks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Every 3 months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Every 6 months : Monitoring every 6 months may not be frequent enough to detect changes in viral load or liver function tests in patients receiving antiviral therapy for chronic hepatitis B infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Every 6 months&lt;/li&gt;&lt;li&gt;â€¢ Option B. Every 12 months : Monitoring every 12 months is too infrequent for patients on antiviral therapy, as changes in viral load or liver function may occur earlier and require intervention.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Every 12 months&lt;/li&gt;&lt;li&gt;â€¢ Option D. Every 2 weeks : Monitoring every 2 weeks is too frequent and may not be necessary for stable patients on antiviral therapy for chronic hepatitis B infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Every 2 weeks&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The appropriate monitoring intervals for patients on antiviral therapy for chronic hepatitis B infection, includes regular assessments of liver function tests and viral load every 3 months and ensuring effective management and timely adjustment of treatment as needed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following are confirmatory tests for active HCV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HCV RNA PCR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HCV core antigen assay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HCV genotyping&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. HCV RNA PCR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. The HCV core antigen assay can be used as an alternative to HCV RNA PCR in some cases to confirm active infection, but HCV RNA PCR remains the gold standard for confirming active HCV replication.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HCV genotyping is important for determining the genotype of the HCV virus, which can influence treatment decisions. However, it is not the initial confirmatory test for active infection; it is typically done after confirming active infection with HCV RNA PCR.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver biopsy is an invasive procedure used to assess liver damage and is not used as a confirmatory test for active HCV infection. It may be used in certain clinical scenarios to assess the extent of liver fibrosis or cirrhosis but is not necessary for the initial diagnosis of HCV.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ HCV RNA PCR is the confirmatory test for active infection following positive anti-HCV antibody serology that aids in accurate diagnosis and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient with a history of blood transfusion 20 years ago tests positive for anti-HCV antibodies and elevated liver enzymes. Which of the following best describes the patient&#x27;s HCV infection status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute HCV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic HCV infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Resolved HCV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reinfection with HCV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chronic HCV infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute HCV infection typically refers to the initial 6 months following exposure to the virus. The history of a blood transfusion 20 years ago and the current presentation suggest a time frame beyond the acute phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Resolved HCV infection would be suggested by the presence of anti-HCV antibodies without detectable viral RNA and without elevated liver enzymes, indicating that the patient&#x27;s immune system cleared the infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reinfection with HCV implies that the patient had previously cleared the virus (either spontaneously or with treatment) and then was exposed to the virus again. This scenario would also require evidence of viral RNA to confirm ongoing infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The presence of anti-HCV antibodies along with elevated liver enzymes in a patient with a risk factor for HCV exposure suggests chronic HCV infection, particularly when the exposure occurred more than 6 months prior.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient presents tests positive for anti-HCV antibodies and elevated liver enzymes. Which of the following statements regarding HCV serology is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-HCV antibodies indicate active HCV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HCV RNA PCR is not necessary if anti-HCV antibodies are positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Resolved HCV infection is characterized by positive HCV RNA PCR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HCV core antigen assay is used to detect prior HCV exposure&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HCV core antigen assay is used to detect prior HCV exposure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-HCV antibodies indicate exposure to the HCV virus but do not differentiate between active and resolved infections. The presence of antibodies alone cannot confirm active HCV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option B . HCV RNA PCR testing is necessary to confirm active HCV infection even if anti-HCV antibodies are positive. This is because anti-HCV antibodies can be present in both active and resolved infections.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C. Resolved HCV infection is characterized by the presence of anti-HCV antibodies without detectable HCV RNA. The absence of HCV RNA indicates that the virus is not currently replicating in the patient&#x27;s body.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ HCV core antigen assay helps to detect prior HCV exposure, that aids in accurate diagnosis and management of hepatitis C virus (HCV) infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with history of intravenous drug use tests positive for anti-HCV antibodies and a confirmatory HCV RNA PCR test indicates active infection. Genotyping shows genotype 1a HCV. His liver function tests are mildly elevated. There is no evidence of cirrhosis on imaging. What is the most appropriate next step in managing this patient&#x27;s HCV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiate treatment with pegylated interferon and ribavirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform a liver biopsy to assess the degree of liver fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start direct-acting antiviral (DAA) therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recommend abstinence from alcohol and re-evaluate in 6 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Start direct-acting antiviral (DAA) therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pegylated interferon and ribavirin were used in the past but are now largely replaced by DAAs due to the latter&#x27;s superior efficacy and safety profile.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver biopsy to assess fibrosis is less commonly performed now due to the availability of non-invasive methods for assessing liver damage and the universal treatment recommendation for HCV regardless of fibrosis stage.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option D. While recommending abstinence from alcohol is important for liver health, it is not a substitute for antiviral treatment in patients with active HCV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The management of chronic HCV infection with direct-acting antivirals is the standard of care. It emphasizes the shift away from older treatments like pegylated interferon and ribavirin to DAAs, which offer better efficacy, safety, and a shorter treatment duration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For a 55-year-old female with chronic HCV infection genotype 2, without cirrhosis, what is the most appropriate treatment regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ledipasvir/Sofosbuvir for 12 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sofosbuvir/Velpatasvir for 12 weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elbasvir/Grazoprevir for 12 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sofosbuvir and ribavirin for 24 weeks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sofosbuvir/Velpatasvir for 12 weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ledipasvir/sofosbuvir is highly effective in treating HCV genotype 1 infections but is not the first choice for genotype 2.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elbasvir/grazoprevir is primarily used for HCV genotype 1 and 4 infections, and thus not the optimal choice for genotype 2.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sofosbuvir and ribavirin for 24 weeks is an older regimen that may be considered in certain contexts for genotype 2 but is less preferable due to the longer treatment duration and side effects associated with ribavirin.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The efficacy of sofosbuvir/velpatasvir for 12 weeks helps  in treating HCV genotype 2 infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with fatigue, jaundice, and abdominal discomfort for the past few weeks. Laboratory tests reveal elevated liver enzymes, hypergammaglobulinemia, and positive antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA). What is the most likely diagnosis based on these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-alcoholic fatty liver disease (NAFLD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autoimmune hepatitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary biliary cholangitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Autoimmune hepatitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic hepatitis : While alcoholic hepatitis can present with similar symptoms, it is typically associated with a history of excessive alcohol consumption and may not have the characteristic autoantibodies seen in autoimmune hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic hepatitis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-alcoholic fatty liver disease (NAFLD) : NAFLD typically presents with elevated liver enzymes and fatty infiltration of the liver but lacks the characteristic autoimmune serological markers seen in autoimmune hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-alcoholic fatty liver disease (NAFLD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary biliary cholangitis : Primary biliary cholangitis may present with similar symptoms, but it is characterized by the presence of anti-mitochondrial antibodies (AMA) and histological features of bile duct damage, which are not seen in autoimmune hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary biliary cholangitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and laboratory findings of autoimmune hepatitis, includes elevated liver enzymes, hypergammaglobulinemia, and positive autoantibodies (ANA and ASMA).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most appropriate initial treatment for autoimmune hepatitis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ursodeoxycholic acid (UDCA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ursodeoxycholic acid (UDCA): UDCA is used in primary biliary cholangitis but is not the first-line treatment for autoimmune hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ursodeoxycholic acid&lt;/li&gt;&lt;li&gt;â€¢ Option C. Azathioprine : Azathioprine is often used as a steroid-sparing agent in autoimmune hepatitis but is typically initiated after corticosteroids as maintenance therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Azathioprine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methotrexate : Methotrexate is not a first-line treatment for autoimmune hepatitis and is associated with potential hepatotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methotrexate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment approach for autoimmune hepatitis, is the use of corticosteroids to suppress inflammation and reduce immune-mediated hepatocellular injury, helps in effectively managing the disease and improving patient outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female presents with fatigue, pruritus, and right upper quadrant abdominal pain. Laboratory tests show elevated alkaline phosphatase and positive anti-mitochondrial antibodies (AMA). Abdominal imaging reveals hepatomegaly and features suggestive of intrahepatic cholestasis. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic liver disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary biliary cholangitis (PBC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autoimmune hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-alcoholic fatty liver disease (NAFLD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary biliary cholangitis (PBC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic liver disease : Alcoholic liver disease typically presents with a history of alcohol abuse and may have elevated liver enzymes but lacks the characteristic AMA positivity seen in PBC.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic liver disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Autoimmune hepatitis : Autoimmune hepatitis may present with similar symptoms but is characterized by elevated transaminases and positive antinuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA), rather than AMA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Autoimmune hepatitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-alcoholic fatty liver disease (NAFLD): NAFLD typically presents with features of metabolic syndrome and may have elevated liver enzymes, but it does not typically present with pruritus or positive AMA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-alcoholic fatty liver disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and laboratory findings of primary biliary cholangitis (PBC), includes pruritus, elevated alkaline phosphatase, and positive anti-mitochondrial antibodies (AMA).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most appropriate initial pharmacological treatment for early-stage primary biliary cholangitis (PBC)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ursodeoxycholic acid (UDCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ursodeoxycholic acid (UDCA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids : Corticosteroids are not first-line treatment for PBC and may be considered in certain cases of refractory disease or overlap syndromes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option C. Methotrexate : Methotrexate is not recommended for the treatment of PBC and is associated with potential hepatotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Azathioprine : Azathioprine may be used as an adjunctive therapy in PBC but is not typically initiated as first-line treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Azathioprine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The initial pharmacological management of primary biliary cholangitis (PBC), includes the use of ursodeoxycholic acid (UDCA) to improve liver function and slow disease progression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with fatigue, pruritus, and jaundice. Laboratory tests reveal elevated alkaline phosphatase and serum bilirubin levels. Imaging studies show multifocal strictures and dilatations of the intrahepatic and extrahepatic bile ducts. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic liver disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary sclerosing cholangitis (PSC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autoimmune hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-alcoholic fatty liver disease (NAFLD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary sclerosing cholangitis (PSC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic liver disease typically presents with a history of significant alcohol consumption and can lead to a spectrum of liver abnormalities, including steatosis, alcoholic hepatitis, and cirrhosis, but it does not typically present with the specific bile duct changes seen in PSC.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Autoimmune hepatitis is characterized by inflammation of the liver due to an autoimmune response and is often associated with elevated transaminases and positive autoimmune markers, which are not the primary findings in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-alcoholic fatty liver disease (NAFLD) is associated with metabolic risk factors such as obesity, diabetes, and hyperlipidemia and primarily affects the liver parenchyma, leading to steatosis and potentially steatohepatitis, but it does not cause the bile duct abnormalities seen in PSC.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation of fatigue, pruritus, jaundice, elevated alkaline phosphatase, and serum bilirubin levels, along with characteristic imaging findings of multifocal strictures and dilatations of bile ducts, is typical of primary sclerosing cholangitis (PSC).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What histopathological feature is characteristic of primary sclerosing cholangitis (PSC) ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Steatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mallory-Denk bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Granulomas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Onion-skinning&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Onion-skinning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-174600.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Steatosis, or the accumulation of fat within liver cells, is a feature more commonly associated with conditions like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease, not PSC.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mallory-Denk bodies are cytoplasmic inclusions found in liver cells, typically associated with alcoholic liver disease and not characteristic of PSC.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Granulomas are aggregates of macrophages and are more typically associated with conditions such as sarcoidosis or granulomatous hepatitis, not specifically characteristic of PSC.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Onion-skinning, characterized by concentric fibrosis and inflammation around bile ducts, is a characteristic histopathological feature of primary sclerosing cholangitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 17-year-old male presents with worsening academic performance, behavioral changes, slowed movements, and a slight tremor. Ophthalmological examination shows the following finding. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parkinson&#x27;s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wilson Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Juvenile Huntington&#x27;s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple Sclerosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Wilson Disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-174749.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize the presentation and classic findings of Wilson Disease, particularly the presence of Kayser-Fleischer rings and a combination of hepatic and neuropsychiatric symptoms in a young patient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the significance of the finding in the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatitis C infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Copper accumulation in Wilson Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron overload in hemochromatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bilirubin deposition in Dubin-Johnson syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Copper accumulation in Wilson Disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-175158.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hepatitis C infection can lead to liver dysfunction, but it does not cause Kayser-Fleischer rings or copper accumulation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C . Iron overload occurs in hemochromatosis, a different condition characterized by excessive iron deposition in the body, but it does not lead to Kayser-Fleischer rings.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bilirubin deposition occurs in conditions like Dubin-Johnson syndrome, which can lead to liver dysfunction and jaundice, but not Kayser-Fleischer rings.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Kayser-Fleischer rings, a greenish-brown discoloration of the cornea periphery, is indicative of copper accumulation in Wilson Disease, which can cause liver dysfunction and neuropsychiatric symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diagnostic tests is most appropriate for confirming Wilsonâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum ceruloplasmin levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum copper levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Genetic testing for ATP7B mutations&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Genetic testing for ATP7B mutations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum ceruloplasmin levels are often low in Wilson Disease, but this finding is not specific and can be seen in other conditions or in carriers of the disease without clinical manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serum copper levels can be elevated in Wilson Disease, but they can also be normal or low, making this test less reliable for diagnosis. Free copper levels (non-ceruloplasmin bound copper) can be more indicative but still lack the specificity of genetic testing.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Liver biopsy can demonstrate copper accumulation and liver damage, and it can be useful in cases where the diagnosis is unclear. However, it is invasive and carries risks, making genetic testing a more definitive and less invasive option when available.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Genetic testing for ATP7B mutations is the most definitive method for confirming a diagnosis of Wilson Disease, that directly identifies the genetic cause of the disorder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What scoring system is commonly used for the initial assessment and diagnosis of Wilson Disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Child-Pugh Score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MELD Score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nazer Score&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ranson&#x27;s Criteria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nazer Score&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A . The Child-Pugh Score is used to assess the prognosis of chronic liver disease, mainly cirrhosis, and to determine the required strength of treatment and the need for liver transplantation.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option B . The MELD Score (Model for End-Stage Liver Disease) is used to prioritize patients for liver transplantation, based on the severity of chronic liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ranson&#x27;s Criteria are used to assess the severity of acute pancreatitis and predict its outcome.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The Nazer Score is a scoring system used for the initial assessment and diagnosis of Wilson Disease, incorporating clinical, biochemical, and histological parameters relevant to the disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mainstay of treatment for Wilsonâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron chelation therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Copper chelation therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ursodeoxycholic acid (UDCA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Copper chelation therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron chelation therapy is used to treat conditions involving iron overload, such as hemochromatosis, not Wilson Disease, which involves copper accumulation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Corticosteroids are not a primary treatment for Wilson Disease; they are more commonly used in conditions involving inflammation or autoimmune processes.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ursodeoxycholic acid (UDCA) is used to improve liver function in certain liver diseases, such as primary biliary cirrhosis, but it is not a mainstay of treatment for Wilson Disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In copper chelation therapy, using agents such as penicillamine or trientine, is the mainstay of treatment for Wilson Disease to reduce copper accumulation in the body.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old non-smoking male presents with exertional dyspnea and recurrent respiratory infections. Pulmonary function tests reveal airflow obstruction that does not significantly improve with bronchodilators. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha-1 antitrypsin (AAT) deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystic fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alpha-1 antitrypsin (AAT) deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD): While COPD may present similarly to AAT deficiency, the lack of significant smoking history and the presence of recurrent respiratory infections suggest an alternative diagnosis such as AAT deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Asthma : Asthma typically presents with reversible airflow obstruction and bronchial hyperresponsiveness, which may improve with bronchodilators, unlike the non-responsiveness seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Asthma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystic fibrosis : Cystic fibrosis often presents with recurrent respiratory infections and obstructive lung disease but is associated with characteristic features such as pancreatic insufficiency and elevated sweat chloride levels, which are absent in AAT deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystic fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation of AAT deficiency, includes early-onset emphysema in non-smokers and a lack of response to bronchodilators.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male presents with a family history of early-onset emphysema. Pulmonary function tests reveal airflow obstruction that does not improve significantly with bronchodilators. What is the most appropriate initial diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha-1 antitrypsin (AAT) level measurement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High-resolution computed tomography (HRCT) scan of the chest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Genetic testing for cystic fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alpha-1 antitrypsin (AAT) level measurement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chest X-ray : While chest X-ray may reveal findings suggestive of emphysema, it is not specific for AAT deficiency and may not establish a definitive diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chest X-ray&lt;/li&gt;&lt;li&gt;â€¢ Option C. High-resolution computed tomography (HRCT) scan of the chest : HRCT may show characteristic changes of emphysema, but it is not specific for AAT deficiency and may not be necessary as an initial diagnostic test.&lt;/li&gt;&lt;li&gt;â€¢ Option C. High-resolution computed tomography (HRCT) scan of the chest&lt;/li&gt;&lt;li&gt;â€¢ Option D. Genetic testing for cystic fibrosis : Genetic testing for cystic fibrosis is not indicated in the absence of clinical features suggestive of the condition, such as pancreatic insufficiency and elevated sweat chloride levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Genetic testing for cystic fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Alpha-1 antitrypsin (AAT) level measurement is the initial diagnostic test for suspected AAT deficiency helps in establishing a timely and accurate diagnosis to guide management decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most appropriate treatment to slow disease progression in emphysema due to alpha-1 antitrypsin (AAT) deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Long-acting beta-agonists (LABAs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhaled corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha-1 antitrypsin augmentation therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxygen therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alpha-1 antitrypsin augmentation therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Long-acting beta-agonists (LABAs) : LABAs may provide symptomatic relief but do not address the underlying deficiency of AAT and do not slow disease progression.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Long-acting beta-agonists (LABAs)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inhaled corticosteroids : Inhaled corticosteroids may be used in patients with AAT deficiency and asthma or chronic bronchitis but are not effective in slowing the progression of emphysema.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inhaled corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxygen therapy : Oxygen therapy is used for symptomatic relief in patients with advanced emphysema and hypoxemia but does not address the underlying deficiency of AAT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxygen therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Alpha-1 antitrypsin (AAT) augmentation therapy helps in slowing disease progression in patients with AAT deficiency and emphysema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with fatigue, weakness, and joint pain. Physical examination reveals skin pigmentation as in the image below and hepatomegaly. Laboratory tests show elevated serum ferritin levels and increased transferrin saturation. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wilson Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemochromatosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha1 antitrypsin (A1AT) deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hemochromatosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-180615.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wilson Disease involves copper accumulation and typically presents with liver dysfunction and neuropsychiatric symptoms, not primarily iron overload symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alpha1 antitrypsin (A1AT) deficiency is a genetic disorder that can lead to liver disease and lung disease, but it is not associated with iron overload or the specific constellation of symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organ systems and cause a wide range of symptoms, but it does not cause iron overload or the specific features described here.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical features of hemochromatosis, includes fatigue, bronze skin pigmentation, hepatomegaly, and elevated serum ferritin levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What diagnostic test is most appropriate for confirming the suspected diagnosis of hemochromatosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liver biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Genetic testing for HFE mutations&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum ceruloplasmin levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abdominal ultrasound&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Genetic testing for HFE mutations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liver biopsy can be used to assess the degree of liver damage and iron accumulation but is not the first-line test for diagnosing hemochromatosis due to its invasiveness.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum ceruloplasmin levels are used in the evaluation of Wilson Disease, which involves copper metabolism, not iron.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abdominal ultrasound can evaluate liver size and structure but is not specific for diagnosing hemochromatosis. It cannot directly detect iron overload.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Genetic testing for HFE mutations is the most direct and specific diagnostic test for confirming hereditary hemochromatosis, given its association with specific gene mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mainstay of treatment for reducing iron overload in hemochromatosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phlebotomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron chelation therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver transplantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Erythropoiesis-stimulating agents&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Phlebotomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron chelation therapy is used primarily in patients who cannot undergo phlebotomy, such as those with anemia or heart complications, or in conditions of iron overload from repeated blood transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Liver transplantation may be considered in advanced cases of hemochromatosis with severe liver damage, but it is not a treatment for iron overload per se.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Erythropoiesis-stimulating agents are used to treat anemia, particularly in chronic kidney disease, and do not directly reduce iron overload.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Phlebotomy is the mainstay of treatment for reducing iron overload in patients with hemochromatosis, effectively lowering the total body iron burden through regular removal of blood.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with alcohol use disorder undergoes successful endoscopic variceal ligation after variceal hemorrhage. To reduce rebleeding risk, the most appropriate additional treatment is :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate initiation of oral beta-blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer a course of oral antibiotics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repeat endoscopic ligation in 24 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Schedule for a transjugular intrahepatic portosystemic shunt (TIPS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Administer a course of oral antibiotics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Administer a course of oral antibiotics (kindly check answer ????)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate initiation of oral beta-blockers : While beta-blockers are important in the secondary prophylaxis of variceal bleeding, their immediate initiation is not as crucial as antibiotic prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate initiation of oral beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repeat endoscopic ligation in 24 hours: Repeat endoscopic ligation is not typically performed within 24 hours unless there is evidence of rebleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repeat endoscopic ligation in 24 hours:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Schedule for a transjugular intrahepatic portosystemic shunt (TIPS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Schedule for a transjugular intrahepatic portosystemic shunt (TIPS):&lt;/li&gt;&lt;li&gt;â€¢ TIPS is reserved for patients who fail medical and endoscopic therapy and is not used as immediate prophylaxis after the first variceal bleed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antibiotic prophylaxis helps in preventing rebleeding and infections after an initial variceal hemorrhage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with dysphagia, regurgitation of undigested food, halitosis and history of recurrent aspiration pneumonia. Upper endoscopy reveals a pathology in the upper esophagus. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Achalasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Zenker&#x27;s diverticulum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Barrett&#x27;s esophagus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Zenker&#x27;s diverticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia: Achalasia is characterized by the failure of the lower esophageal sphincter to relax and by aperistalsis of the esophagus, leading to dysphagia and regurgitation, but it does not involve the formation of a diverticulum.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture : An esophageal stricture typically presents with progressive dysphagia, particularly for solid foods, and is usually caused by chronic gastroesophageal reflux disease (GERD), radiation, or ingestion of caustic substances, but it does not cause a diverticulum.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture&lt;/li&gt;&lt;li&gt;â€¢ Option D. Barrett&#x27;s esophagus: It is a condition where the lining of the esophagus is replaced by tissue similar to the lining of the intestine, usually as a result of chronic GERD. It is associated with an increased risk of esophageal adenocarcinoma but does not present with a diverticulum or the specific symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Barrett&#x27;s esophagus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zenker&#x27;s diverticulum is characterized by dysphagia, regurgitation of undigested food, halitosis, and the presence of a pulsion diverticulum just above the upper esophageal sphincter.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with dysphagia, glossitis, and iron deficiency anemia. She reports a history of chronic oral ulcerations. What condition is most likely causing her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zenker&#x27;s diverticulum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Plummer-Vinson syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Barrett&#x27;s esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mallory-Weiss tear&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Plummer-Vinson syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Plummer-Vinson syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Zenker&#x27;s diverticulum: Zenker&#x27;s diverticulum is a pharyngoesophageal diverticulum that can cause dysphagia and regurgitation of undigested food, but it is not associated with iron deficiency anemia, glossitis, or oral ulcerations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Zenker&#x27;s diverticulum:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barrett&#x27;s esophagus: Barrett&#x27;s esophagus is a condition where the lining of the esophagus changes due to chronic gastroesophageal reflux disease (GERD), leading to an increased risk of esophageal adenocarcinoma. It typically does not present with iron deficiency anemia, glossitis, or oral ulcerations.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barrett&#x27;s esophagus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mallory-Weiss tear: A Mallory-Weiss tear is a tear in the mucosa near the gastroesophageal junction, typically caused by forceful retching or vomiting, leading to bleeding. It is not associated with iron deficiency anemia, glossitis, or chronic oral ulcerations as primary symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mallory-Weiss tear:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of dysphagia, iron deficiency anemia, glossitis, and chronic oral ulcerations is indicative of Plummer-Vinson syndrome, a condition characterized by esophageal webs and increased risk for esophageal squamous cell carcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with dysphagia to solids, episodes of food impaction, a history of allergic conditions (allergic rhinitis and eczema), and upper endoscopy findings of linear furrows, white plaques, and concentric rings in the esophagus. What condition is most likely causing his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastroesophageal reflux disease (GERD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eosinophilic esophagitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Barrett&#x27;s esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infectious esophagitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Eosinophilic esophagitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastroesophageal reflux disease: Gastroesophageal reflux disease (GERD) can cause dysphagia and esophageal changes, but the specific endoscopic findings described (linear furrows, white plaques, and concentric rings) are more characteristic of eosinophilic esophagitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastroesophageal reflux disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barrett&#x27;s esophagus: Barrett&#x27;s esophagus involves changes in the esophageal lining due to chronic acid exposure from GERD, but it typically presents with metaplastic columnar epithelium rather than the findings described.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barrett&#x27;s esophagus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious esophagitis: Infectious esophagitis can cause dysphagia and might show ulcers or plaques on endoscopy, but it is more common in immunocompromised patients and does not typically present with the combination of findings seen in eosinophilic esophagitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious esophagitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Eosinophilic esophagitis is likely causing the symptoms in a young patient with dysphagia, a history of allergic conditions, and characteristic endoscopic findings of linear furrows, white plaques, and concentric rings in the esophagus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 53-year-old female presents with a one-year history of progressively worsening intermittent dysphagia to solids and liquids as well. She mentions episodes of waking up at night coughing and choking. She denies any significant weight loss. Barium swallow study reveals the following image. Esophageal manometry is most likely to show which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased lower esophageal sphincter (LES) pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Normal LES relaxation with swallowing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased LES pressure with incomplete relaxation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypercontractile esophageal peristalsis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased LES pressure with incomplete relaxation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171841.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased LES pressure: This finding is more typical of gastroesophageal reflux disease (GERD) rather than achalasia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased LES pressure:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Normal LES relaxation with swallowing: This finding would be inconsistent with achalasia, where LES relaxation is impaired.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Normal LES relaxation with swallowing:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypercontractile esophageal peristalsis: This would suggest a disorder like Jackhammer esophagus rather than achalasia, which is characterized by aperistalsis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypercontractile esophageal peristalsis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The characteristic manometry findings of achalasia include : increased LES pressure and incomplete LES relaxation upon swallowing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most likely underlying pathophysiology in Achalasia cardia ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune destruction of esophageal smooth muscle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mechanical obstruction at the gastroesophageal junction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Degeneration of the myenteric plexus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperplasia of the esophageal mucosa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Degeneration of the myenteric plexus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune destruction of esophageal smooth muscle: While some autoimmune conditions can affect the esophagus, direct autoimmune destruction of smooth muscle doesn&#x27;t typically result in achalasia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune destruction of esophageal smooth muscle:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mechanical obstruction at the gastroesophageal junction: This would suggest a condition like a tumor or stricture, not achalasia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mechanical obstruction at the gastroesophageal junction:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia of the esophageal mucosa: This is not associated with achalasia, which is a motility disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperplasia of the esophageal mucosa:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Achalasia results from the degeneration of the myenteric plexus, leading to impaired LES relaxation and aperistalsis of the esophagus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents with a burning sensation in her chest after meals, particularly when lying down. She reports occasional regurgitation of acidic fluid into her mouth and has experienced hoarseness and chronic cough. What condition is most likely causing her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peptic ulcer disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastroesophageal reflux disease (GERD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gastroesophageal reflux disease (GERD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gastroesophageal reflux disease (GERD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peptic ulcer disease: Peptic ulcer disease may present with epigastric pain, which can be exacerbated by meals, but it is less likely to cause symptoms such as regurgitation or chronic cough.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peptic ulcer disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture: Esophageal strictures are characterized by narrowing of the esophageal lumen, often due to scarring or inflammation, and may cause dysphagia, but they do not typically present with heartburn or regurgitation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal cancer: Esophageal cancer may present with dysphagia, weight loss, and other systemic symptoms, but it is less likely to cause typical GERD symptoms such as heartburn and regurgitation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The characteristic symptoms of gastroesophageal reflux disease (GERD), includes heartburn, regurgitation of acidic fluid, hoarseness, and chronic cough, particularly following meals and exacerbated by lying down.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man with 6 months of unresponsive epigastric pain, diarrhea, heartburn, no NSAID use, and mild epigastric tenderness presents with fasting serum gastrin levels of 1000 pg/mL and multiple duodenal and jejunal peptic ulcers on endoscopy. What is the most appropriate next step to confirm the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Secretin stimulation test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Helicobacter pylori stool antigen test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CT scan of the abdomen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Secretin stimulation test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Secretin stimulation test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Helicobacter pylori stool antigen test : While H. pylori infection is a common cause of peptic ulcers, the patient&#x27;s high gastrin levels and multiple ulcers in the duodenum and jejunum suggest ZES, making this test less relevant for this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Helicobacter pylori stool antigen test&lt;/li&gt;&lt;li&gt;â€¢ Option C. 24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) test : This test measures the breakdown product of serotonin and is used in the diagnosis of carcinoid syndrome, not ZES.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) test&lt;/li&gt;&lt;li&gt;â€¢ Option D. CT scan of the abdomen : Although CT can be used to localize gastrinomas, the diagnosis of ZES should be confirmed biochemically before imaging studies are performed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CT scan of the abdomen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In a patient with multiple peptic ulcers and elevated fasting serum gastrin levels, the secretin stimulation test is the most appropriate next step to confirm the diagnosis of Zollinger-Ellison Syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with a history of hypertension and diabetes is on the ventilator since 72 hours in the ICU following a severe stroke. On the fourth day, the nurse reports the presence of coffee-ground material in the nasogastric tube. Which of the following interventions is most appropriate for the prevention of further gastrointestinal bleeding in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiation of oral sucralfate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous proton pump inhibitor (PPI) therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administration of oral H2 receptor antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Placement of a transjugular intrahepatic portosystemic shunt (TIPS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous proton pump inhibitor (PPI) therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous proton pump inhibitor (PPI) therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Initiation of oral sucralfate : While sucralfate can provide a protective barrier over gastrointestinal mucosa, it is less effective than PPIs for the prevention of stress-related gastrointestinal bleeding in critically ill patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Initiation of oral sucralfate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administration of oral H2 receptor antagonist : H2 receptor antagonists reduce acid secretion and can be used for stress ulcer prophylaxis, but PPIs are generally preferred due to their superior acid suppression.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administration of oral H2 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ Option D. Placement of a transjugular intrahepatic portosystemic shunt (TIPS) : TIPS is a procedure used to reduce portal hypertension, primarily in cirrhotic patients with variceal bleeding, and is not indicated for stress ulcer bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Placement of a transjugular intrahepatic portosystemic shunt (TIPS)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In critically ill ICU patients at high risk for stress ulcers and gastrointestinal bleeding, such as those with severe neurological injuries or requiring mechanical ventilation, prophylactic intravenous PPI therapy is the most effective intervention to prevent further bleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old male with a history of dyspepsia is referred to gastroenterology for evaluation. What is the most appropriate initial test for Helicobacter pylori in the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urea breath test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serologic antibody test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stool antigen test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoscopic biopsy for histology&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Urea breath test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Urea breath test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serologic antibody test : This test can indicate past or present infection but cannot distinguish between the two, making it less useful for initial diagnosis or confirmation of eradication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serologic antibody test&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stool antigen test : Although this test is also non-invasive and has good sensitivity and specificity, the urea breath test is generally preferred due to its rapidity and convenience.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stool antigen test&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic biopsy for histology : While accurate, endoscopy is invasive and not recommended as an initial test for patients without alarm symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic biopsy for histology&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For initial testing of Helicobacter pylori in patients with dyspepsia and no alarming features, the non-invasive and accurate urea breath test is the most appropriate choice.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which test is most appropriate to diagnose H. pylori infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serologic antibody test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urea breath test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stool antigen test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoscopic biopsy for histology&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stool antigen test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Stool antigen test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serologic antibody test : It is not the best choice for diagnosis because it cannot differentiate between past and current infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serologic antibody test&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urea breath test : This test is reliable but should be avoided if the patient is on proton pump inhibitors or bismuth, which can lead to false negatives.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Urea breath test&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic biopsy for histology : While accurate, it is invasive and typically reserved for patients with alarm symptoms or those in whom endoscopy is otherwise indicated.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic biopsy for histology&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The stool antigen test is the preferred non-invasive method for diagnosing active H. pylori infection, especially in patients taking iron supplements, which do not interfere with test results.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old man presents with a six-month history of nocturnal epigastric pain relieved by eating and antacids, with no alarming symptoms. To assess for past exposure to H. pylori, which test should be performed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urea breath test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fecal antigen test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serologic antibody test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoscopic biopsy with rapid urease test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serologic antibody test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Serologic antibody test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Urea breath test : This test is used to diagnose current active infection or to confirm eradication after treatment, but it is not used to determine past exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Urea breath test&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fecal antigen test : Like the urea breath test, it is used to diagnose active infections and confirm eradication post-treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fecal antigen test&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic biopsy with rapid urease test : This is an invasive test for current infection, typically used if endoscopy is indicated for other reasons, such as alarm symptoms or failure of initial treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic biopsy with rapid urease test&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The serologic antibody test can determine past exposure to H. pylori but cannot differentiate between current and past infection. It is not the test of choice for diagnosing active infection or for confirming eradication after treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most appropriate initial treatment regimen for H. pylori infection in a patient with no prior antibiotic exposure and no contraindications is triple therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clarithromycin, amoxicillin, and omeprazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amoxicillin, ciprofloxacin, and ranitidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole, ciprofloxacin, and lansoprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clarithromycin, amoxicillin, and omeprazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Clarithromycin, amoxicillin, and omeprazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole : This quadruple therapy is an alternative, particularly in areas of high clarithromycin resistance or for patients with previous macrolide exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metronidazole, tetracycline, bismuth subsalicylate, and omeprazole&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amoxicillin, ciprofloxacin, and ranitidine : This combination is not a standard regimen for H. pylori eradication and includes a fluoroquinolone and an H2 blocker, which is less effective than a proton pump inhibitor in this setting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amoxicillin, ciprofloxacin, and ranitidine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metronidazole, ciprofloxacin, and lansoprazole : This regimen does not follow the recommended guidelines for H. pylori treatment due to the inclusion of ciprofloxacin, which is not a first-line agent for this infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metronidazole, ciprofloxacin, and lansoprazole&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment for H. pylori infection should consist of triple therapy with a proton pump inhibitor (like omeprazole) and two antibiotics (clarithromycin and amoxicillin) for 14 days to effectively eradicate the infection and promote ulcer healing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old male hiker presents with several months of progressive weakness, joint pains, unexplained weight loss, intermittent diarrhea, recent episodes of uveitis and abdominal discomfort. Examination reveals hyperpigmentation of the skin, particularly around the eyes. Laboratory tests show anemia and a low serum albumin level. Endoscopic biopsy of the small intestine reveals numerous macrophages laden with periodic acid-Schiff (PAS)-positive granules in the lamina propria. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Whipple&#x27;s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Whipple&#x27;s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-094407.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Whipple&#x27;s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sarcoidosis : This systemic granulomatous disease can cause similar systemic symptoms and hyperpigmentation, but it does not exhibit PAS-positive macrophages on intestinal biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sarcoidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphoma : While GI lymphoma may present with weight loss and abdominal pain, it does not show PAS-positive macrophages on biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amyloidosis : This condition can lead to systemic symptoms and gastrointestinal involvement, but the biopsy would show amyloid deposits, not PAS-positive macrophages.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amyloidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Whipple&#x27;s disease should be suspected in patients with systemic symptoms, including arthralgias, gastrointestinal complaints, and hyperpigmentation, especially when intestinal biopsy shows PAS-positive macrophages.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following treatments is most appropriate for this Whippleâ€™s disease ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Long-term antibiotic therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gluten-free diet&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High-dose corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chemotherapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Long-term antibiotic therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Long-term antibiotic therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gluten-free diet : This is the treatment for celiac disease, not Whipple&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gluten-free diet&lt;/li&gt;&lt;li&gt;â€¢ Option C. High-dose corticosteroids : Steroids are not the primary treatment for Whipple&#x27;s disease and are typically used for conditions with significant inflammation, like autoimmune diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. High-dose corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chemotherapy : Used for treating malignancies, not infectious diseases like Whipple&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chemotherapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The appropriate treatment for Whipple&#x27;s disease involves initial antibiotic therapy, typically with ceftriaxone or penicillin G, followed by prolonged oral therapy with trimethoprim-sulfamethoxazole to eradicate the infection and prevent relapse.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents with chronic diarrhea, abdominal bloating, and vitamin B12 deficiency. She has a history of type 2 diabetes and underwent Roux-en-Y gastric bypass surgery 5 years ago. Her symptoms are partially relieved by antibiotics. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lactose intolerance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irritable Bowel Syndrome (IBS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Small Intestinal Bacterial Overgrowth (SIBO)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Celiac disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Small Intestinal Bacterial Overgrowth (SIBO)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Small Intestinal Bacterial Overgrowth (SIBO)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lactose intolerance : Typically presents with symptoms after dairy consumption, but does not cause vitamin B12 deficiency or improve with antibiotics.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lactose intolerance&lt;/li&gt;&lt;li&gt;â€¢ Option B. Irritable Bowel Syndrome (IBS) : While IBS can cause similar symptoms, it does not lead to vitamin B12 deficiency and is not typically relieved by antibiotics.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Irritable Bowel Syndrome (IBS)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Celiac disease : Could explain the symptoms and vitamin deficiency, but the relief with antibiotics is more characteristic of SIBO.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Celiac disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In patients with chronic gastrointestinal symptoms, vitamin deficiencies, and a history that predisposes to bacterial overgrowth, SIBO should be considered, especially when symptoms improve with antibiotic therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents to the clinic with chronic diarrhea, weight loss, and fatigue following a 6-month volunteer trip to Southeast Asia. She reports a significant decrease in appetite and has noted her stools to be bulky and foul-smelling. Laboratory tests reveal iron-deficiency anemia and folate deficiency. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Celiac Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irritable Bowel Syndrome (IBS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tropical Sprue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Giardiasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tropical Sprue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tropical Sprue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Celiac Disease : While celiac disease can cause similar gastrointestinal symptoms and malabsorption, it is not typically associated with travel to tropical regions.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Celiac Disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Irritable Bowel Syndrome (IBS) : IBS primarily presents with abdominal discomfort and altered bowel habits but does not typically cause significant malabsorption or nutrient deficiencies.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Irritable Bowel Syndrome (IBS)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Giardiasis : This parasitic infection can cause diarrhea and malabsorption but is usually acute in nature and would likely resolve on its own or with appropriate treatment within a few weeks to months.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Giardiasis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Tropical Sprue should be considered in patients with chronic diarrhea, malabsorption, and nutrient deficiencies, particularly if they have a history of extended travel or residency in tropical regions and symptoms persist despite returning to a non-tropical environment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy is brought to the pediatric clinic by his parents due to concerns about poor coordination, developmental delay and chronic diarrhea since infancy. Physical examination reveals a thin child with steatorrhea and acanthocytosis on blood smear. Laboratory tests indicate very low levels of cholesterol and triglycerides, and fat-soluble vitamin deficiencies are noted. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cystic Fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Celiac Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abetalipoproteinemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreatic Insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Abetalipoproteinemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Abetalipoproteinemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cystic Fibrosis : This genetic disorder can cause malabsorption and growth delay but is more commonly associated with respiratory symptoms and does not typically present with acanthocytosis or the specific lipid profile seen in abetalipoproteinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cystic Fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Celiac Disease : While celiac disease can lead to malabsorption and growth problems, it does not cause the lipid abnormalities or acanthocytosis associated with abetalipoproteinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Celiac Disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreatic Insufficiency : This condition can lead to steatorrhea and fat-soluble vitamin deficiencies but does not cause the abnormal lipid profile or acanthocytosis seen in abetalipoproteinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreatic Insufficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In patients presenting with chronic diarrhea, failure to thrive, neurological symptoms, acanthocytosis, and very low levels of cholesterol and triglycerides, consider abetalipoproteinemia, especially if fat-soluble vitamin deficiencies are present.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During an endoscopic examination of a 59-year-old male with a history of hematemesis, an ulcer in the duodenum is found to have a flat, pigmented spot at the base. There is no active bleeding or visible vessel. How should this ulcer be classified according to the Forrest classification?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Forrest Ia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Forrest Ib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Forrest IIb&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Forrest III&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Forrest III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Forrest III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Forrest Ia: Ulcers have active spurting hemorrhage, which is not present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Forrest Ia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Forrest Ib: Ulcers have active oozing bleeding, not evident in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Forrest Ib:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Forrest IIb: Ulcers have a non-bleeding visible vessel or an adherent clot, which is different from the described flat pigmented spot.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Forrest IIb:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A duodenal ulcer with a flat pigmented spot and no active bleeding is Forrest III, which is associated with a low risk of rebleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female with a history of recurrent abdominal pain and bloody diarrhea has undergone multiple colonoscopies over the past 3 years, all showing continuous inflammation of the mucosa extending from the rectum to the transverse colon. There is no evidence of granulomas on biopsy. Which feature is most suggestive of her underlying condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Skip lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Granuloma formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Continuous mucosal involvement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transmural inflammation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Continuous mucosal involvement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Continuous mucosal involvement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Skip lesions : Characteristic of Crohn&#x27;s Disease, which involves patchy areas of inflammation separated by healthy tissue along the digestive tract.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Skip lesions&lt;/li&gt;&lt;li&gt;â€¢ Option B. Granuloma formation : Also more typical of Crohn&#x27;s Disease, where non-caseating granulomas can often be found on biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Granuloma formation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transmural inflammation : Suggestive of Crohn&#x27;s Disease, as it involves the entire thickness of the bowel wall, unlike the superficial involvement seen in Ulcerative Colitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transmural inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Continuous mucosal involvement without granulomas, especially from the rectum to more proximal parts of the colon, suggests Ulcerative Colitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman with a diagnosis of Irritable Bowel Syndrome (IBS) predominantly with constipation (IBS-C) can be prescribed which drug to alleviate constipation and abdominal discomfort. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lubiprostone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Broad-spectrum antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gluten-free diet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lubiprostone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lubiprostone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loperamide : Primarily used to manage diarrhea (IBS-D) due to its antidiarrheal effects, not suitable for IBS-C.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loperamide&lt;/li&gt;&lt;li&gt;â€¢ Option C. Broad-spectrum antibiotics : May be used in specific cases like Small Intestinal Bacterial Overgrowth (SIBO), but not typically for IBS-C without evidence of SIBO.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Broad-spectrum antibiotics&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gluten-free diet : While some patients with IBS may report sensitivity to gluten, a gluten-free diet is not a standard treatment for IBS-C and is more specific to conditions like celiac disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gluten-free diet&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For IBS-C, when dietary fiber is insufficient, medications like lubiprostone that enhance intestinal fluid secretion can be effective in managing symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which medication would be most appropriate to add in the management plan of severe IBS-D in men and women when other treatments have not been effective?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alosetron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psyllium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alosetron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alosetron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psyllium : A soluble fiber that can help manage both IBS-C and IBS-D, but might not be sufficient for severe IBS-D cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psyllium&lt;/li&gt;&lt;li&gt;â€¢ Option C. Omeprazole : A proton pump inhibitor used for acid-related disorders, not typically used for IBS-D.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Omeprazole&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metformin : Used in the management of type 2 diabetes, not IBS-D.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metformin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For patients with severe IBS-D not adequately managed by dietary modifications, alosetron can be considered under a risk management program due to its efficacy in reducing diarrhea and bowel urgency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with abdominal pain, diarrhea, and a recent onset of fever. She has a history of mouth ulcers. Imaging studies reveal thickening of the terminal ileum and the presence of a fistula. Which of the following diagnoses is most consistent with these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Crohn&#x27;s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ulcerative Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diverticulitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastroenteritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Crohn&#x27;s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Crohn&#x27;s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ulcerative Colitis : Typically involves continuous inflammation of the colon starting from the rectum, without fistulas or mouth ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ulcerative Colitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diverticulitis : Involves the inflammation or infection of diverticula in the colon, not commonly associated with terminal ileum involvement or fistula formation in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diverticulitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastroenteritis : Generally presents with acute onset of diarrhea and vomiting due to infection, not typically associated with chronic inflammation, thickening of the ileum, or fistulas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastroenteritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Terminal ileum involvement, fistula formation, and mouth ulcers strongly indicate Crohn&#x27;s Disease among inflammatory bowel diseases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old male with a diagnosis of Crohn&#x27;s Disease presents with moderate to severe flare-up symptoms despite oral corticosteroid therapy. His medical history includes a partial ileal resection. Which of the following is the most appropriate next step in his management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the dose of oral corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate 5-aminosalicylic acid (5-ASA) therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start infliximab therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgical resection of affected segments&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Start infliximab therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Start infliximab therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of oral corticosteroids : Not advisable due to the risk of steroid dependency and side effects, particularly in cases unresponsive to initial corticosteroid therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of oral corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate 5-aminosalicylic acid (5-ASA) therapy : 5-ASA is more commonly used in mild to moderate ulcerative colitis and has limited efficacy in Crohn&#x27;s Disease, especially in moderate to severe cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate 5-aminosalicylic acid (5-ASA) therapy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical resection of affected segments : Surgery may be considered for complications or disease refractory to medical therapy, but it is not the first step following corticosteroid failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical resection of affected segments&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In moderate to severe Crohn&#x27;s Disease unresponsive to corticosteroids, anti-TNF agents like infliximab are effective in inducing and maintaining remission.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old woman with Crohn&#x27;s Disease has mild ileocolic involvement controlled with budesonide. She is planning to conceive. What is the most appropriate management to maintain remission during pregnancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discontinue all medications&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Switch to oral mesalamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Continue budesonide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Continue budesonide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Continue budesonide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinue all medications : Discontinuing effective treatment could lead to a flare-up, which poses a greater risk to both the mother and the fetus than the medication itself.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinue all medications&lt;/li&gt;&lt;li&gt;â€¢ Option B. Switch to oral mesalamine : While mesalamine is generally safe in pregnancy, there&#x27;s no need to switch if budesonide is effectively controlling the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Switch to oral mesalamine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate azathioprine : Azathioprine can be used during pregnancy for IBD management, but it&#x27;s typically reserved for more severe disease or when other treatments are ineffective.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate azathioprine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Budesonide can be safely continued during pregnancy to maintain remission in patients with mild Crohn&#x27;s Disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of polycythemia vera presents with gradual onset of diffuse abdominal pain, bloating, and diarrhea over the past week. She denies any cardiac history. Laboratory tests show elevated white blood cells and lactate. CT abdomen reveals venous dilatation and edema in the bowel wall without arterial occlusion. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute mesenteric ischemia due to arterial embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic mesenteric ischemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mesenteric venous thrombosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonocclusive mesenteric ischemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mesenteric venous thrombosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mesenteric venous thrombosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute mesenteric ischemia due to arterial embolism : Typically presents suddenly with severe pain, often in patients with a cardiac source of emboli.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute mesenteric ischemia due to arterial embolism&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic mesenteric ischemia : Presents with postprandial pain and weight loss over months to years, not with acute symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic mesenteric ischemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonocclusive mesenteric ischemia : Occurs in low-flow states such as heart failure or sepsis, and is characterized by diffuse pain without a clear occlusive source on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonocclusive mesenteric ischemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Mesenteric venous thrombosis should be considered in patients with a hypercoagulable state presenting with gradual onset of abdominal pain and specific CT findings, even without arterial occlusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 82-year-old man with a history of heart failure and recent myocardial infarction is admitted to the ICU for management of cardiogenic shock. He subsequently develops diffuse abdominal pain,bloody diarrhea and hypotension. Abdominal imaging shows diffuse small bowel wall thickening with patent mesenteric vessels. What is the most likely cause of his abdominal symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute mesenteric ischemia due to arterial embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic mesenteric ischemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mesenteric venous thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonocclusive mesenteric ischemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nonocclusive mesenteric ischemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Nonocclusive mesenteric ischemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute mesenteric ischemia due to arterial embolism : Typically presents suddenly in patients with a source for emboli (e.g., atrial fibrillation), not primarily associated with low-flow states.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute mesenteric ischemia due to arterial embolism&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic mesenteric ischemia : Manifests with postprandial abdominal pain and weight loss over months to years, not acutely in the setting of cardiogenic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic mesenteric ischemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mesenteric venous thrombosis : Presents with gradual onset abdominal pain, often associated with hypercoagulable states, and would show venous occlusion on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mesenteric venous thrombosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In patients with systemic low-flow states, such as cardiogenic shock, presenting with acute abdominal symptoms and diffuse bowel wall changes without vessel occlusion, consider nonocclusive mesenteric ischemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a 52-year-old man with a history of alcohol abuse presenting with hematemesis, jaundice, ascites, palmar erythema, spider angiomata, thrombocytopenia, and prolonged PT/INR, what is the most appropriate diagnostic procedure to identify the bleeding source?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abdominal ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophagogastroduodenoscopy (EGD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Contrast-enhanced CT scan of the abdomen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Barium swallow study&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Esophagogastroduodenoscopy (EGD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Esophagogastroduodenoscopy (EGD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal ultrasound: Abdominal ultrasound is useful for evaluating the liver, spleen, and portal vein, which could help in assessing the chronic liver disease but is not the immediate test for active upper gastrointestinal bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal ultrasound:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Contrast-enhanced CT scan of the abdomen: Contrast-enhanced CT scan of the abdomen is helpful in the evaluation of abdominal structures and can provide information about the liver and spleen, but it is not the first-line diagnostic tool for an active variceal bleed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Contrast-enhanced CT scan of the abdomen:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Barium swallow study: A barium swallow study may be used to evaluate structural abnormalities of the esophagus and stomach, but it is contraindicated in the setting of an active bleed as it can interfere with endoscopic therapeutic procedures.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Barium swallow study:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ EGD is the immediate and most appropriate next step in the diagnosis and potential treatment of variceal bleeding in a patient with signs of portal hypertension and cirrhosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For a 50-year-old male with cirrhosis due to hepatitis C presenting with acute hematemesis, jaundice, ascites, and palmar erythema, who has been stabilized with IV fluids, the best immediate pharmacotherapy is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous octreotide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral omeprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous octreotide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous octreotide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral propranolol: Is used in the primary prevention of variceal bleeding, not in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral propranolol:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intravenous ceftriaxone: Is indicated for infection prophylaxis in cirrhotic patients with gastrointestinal bleeding, but it is not the primary treatment for the bleed itself.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intravenous ceftriaxone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral omeprazole: Is a proton pump inhibitor that may help with peptic ulcers but is not the first-line treatment for acute variceal bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral omeprazole:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Intravenous octreotide is the initial pharmacological treatment in the acute management of variceal bleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with cirrhosis is admitted to the hospital with a variceal bleed. He has been resuscitated and received octreotide and endoscopic band ligation. The next day, he develops melena. His hemoglobin has dropped from 8.5 g/dL on admission to 7.8 g/dL. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start a proton pump inhibitor (PPI) infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arrange for an urgent repeat endoscop&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform a tagged red blood cell scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Arrange for an urgent repeat endoscop&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Arrange for an urgent repeat endoscopy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a proton pump inhibitor (PPI) infusion: Proton pump inhibitor (PPI) infusion is adjunctive therapy for peptic ulcer disease but would not be the most appropriate next step for suspected ongoing variceal bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a proton pump inhibitor (PPI) infusion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perform a tagged red blood cell scan : A tagged red blood cell scan is a diagnostic procedure to localize sites of slow gastrointestinal bleeding but is not appropriate for acute rebleeding where endoscopy is indicated.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perform a tagged red blood cell scan&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure: A transjugular intrahepatic portosystemic shunt (TIPS) is considered if endoscopic treatment fails or is not possible; it is not the immediate next step after a drop in hemoglobin without first reassessing endoscopically.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prepare for emergent transjugular intrahepatic portosystemic shunt (TIPS) procedure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An urgent repeat endoscopy is indicated in a patient with cirrhosis who develops signs of ongoing variceal bleeding post-initial endoscopic treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old male presents with a 6-month history of bloody diarrhea, abdominal pain, and weight loss. Colonoscopy shows continuous mucosal inflammation and ulceration limited to the rectum and sigmoid colon. Biopsy findings include crypt abscesses and mucosal inflammation. Which condition do these findings most likely suggest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Crohn&#x27;s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ulcerative Colitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Infectious Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic Colitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ulcerative Colitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ulcerative Colitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Crohn&#x27;s Disease : Typically presents with transmural inflammation and can affect any part of the gastrointestinal tract from mouth to anus, often with \&quot;skip lesions.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ Option A. Crohn&#x27;s Disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infectious Colitis : Usually has a more acute onset and is associated with infectious pathogens; biopsy might show inflammation but not typically crypt abscesses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infectious Colitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic Colitis : Generally occurs in older patients and involves the splenic flexure and descending colon; histology would show ischemic changes rather than crypt abscesses.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic Colitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Continuous colonic inflammation with crypt abscesses, particularly in the rectum and sigmoid colon, suggests Ulcerative Colitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most critical diagnostic criterion for toxic megacolon ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Presence of colonic dilation &amp;gt;6 cm on imaging&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;History of constipation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fever and tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Electrolyte imbalances&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Presence of colonic dilation &gt;6 cm on imaging&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Presence of colonic dilation &amp;gt;6 cm on imaging&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of constipation: While constipation can be a symptom associated with various gastrointestinal conditions, it is not a specific or critical diagnostic criterion for toxic megacolon. Toxic megacolon is more directly identified by imaging showing colonic dilation and systemic signs of toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of constipation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fever and tachycardia: Fever and tachycardia are signs of systemic inflammation and toxicity. They can be present in toxic megacolon but are not specific to this condition. They can occur in various infectious and inflammatory diseases and are not definitive for diagnosing toxic megacolon.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fever and tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Electrolyte imbalances: Electrolyte imbalances can occur in many gastrointestinal disorders, including severe diarrhea or vomiting, and can be a consequence of toxic megacolon due to fluid shifts and systemic illness. However, they are not specific diagnostic criteria for toxic megacolon. The primary diagnostic criterion remains colonic dilation &amp;gt;6 cm on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Electrolyte imbalances:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Colonic dilation &amp;gt;6 cm on imaging is a key diagnostic criterion for toxic megacolon, especially in patients with underlying inflammatory bowel disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to the Forrest classification, a gastric ulcer on the lesser curvature of the stomach is classified as ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Forrest Ia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Forrest Ib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Forrest IIa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Forrest IIb&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Forrest IIa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Forrest IIa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Forrest Ia: Represents active arterial bleeding, which is not described in the scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Forrest Ia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Forrest Ib: Indicates an active bleed but with a slower, oozing vessel, also not described here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Forrest Ib:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Forrest IIb: It is characterized by an ulcer with an adherent clot, not a visible vessel.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Forrest IIb:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A gastric ulcer with a visible non-bleeding vessel according to the Forrest classification (Forrest IIa), indicates a high risk of rebleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with intermittent dysphagia to solids, particularly meat, which improves with swallowing water. He denies any history of heartburn or regurgitation. Upper endoscopy reveals a lesion at the gastroesophageal junction. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Achalasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schatzki ring&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mallory-Weiss tear&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Schatzki ring&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171136.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Schatzki ring&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia: Achalasia typically presents with progressive dysphagia to both solids and liquids, regurgitation of undigested food, and sometimes chest pain, due to the failure of the lower esophageal sphincter to relax and absence of esophageal peristalsis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture: An esophageal stricture usually results from chronic gastroesophageal reflux disease (GERD) and presents with gradual onset of dysphagia to solids, but it does not present as a circumferential ring at the gastroesophageal junction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mallory-Weiss tear: A Mallory-Weiss tear is a longitudinal tear in the mucosa at the gastroesophageal junction or in the stomach, usually caused by severe retching or vomiting, leading to hematemesis, not dysphagia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mallory-Weiss tear:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presentation of intermittent dysphagia to solids, particularly meat, that improves with water and the finding of a circumferential ring at the gastroesophageal junction on endoscopy, is indicative of a Schatzki ring.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female presents with dysphagia and chest pain. She describes the chest pain as intense and squeezing, radiating to her back and relieved with antacids. Esophageal manometry reveals high-amplitude peristaltic contractions with a distal esophageal spasm. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Achalasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diffuse esophageal spasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Jackhammer esophagus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nutcracker esophagus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Jackhammer esophagus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171523.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Jackhammer esophagus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia: Achalasia is characterized by the failure of the lower esophageal sphincter (LES) to relax and the absence of normal esophageal peristalsis, leading to symptoms of dysphagia and regurgitation, which is not consistent with the described manometry findings.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diffuse esophageal spasm: Diffuse esophageal spasm presents with intermittent contractions of the esophagus that are non-peristaltic, leading to chest pain and dysphagia, but the contractions are not typically described as high amplitude as in Jackhammer esophagus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diffuse esophageal spasm:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nutcracker esophagus : Nutcracker esophagus is characterized by high-amplitude peristaltic contractions in the distal esophagus, but unlike Jackhammer esophagus, the contractions maintain a normal duration, and the term \&quot;nutcracker\&quot; is used to describe the strong squeezing nature of the contractions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nutcracker esophagus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Jackhammer esophagus is characterized by high-amplitude, prolonged peristaltic contractions in the distal esophagus, as observed on esophageal manometry, leading to symptoms of dysphagia and intense chest pain that may be relieved with antacids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with heatburn and dysphagia to solids and liquids, along with regurgitation of undigested food. Barium swallow shows image as below. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastroesophageal reflux disease (GERD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Achalasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diffuse esophageal spasm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Achalasia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171654.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-171712.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastroesophageal reflux disease (GERD): GERD typically presents with heartburn and regurgitation, and may cause esophageal strictures, but it does not involve impaired esophageal sphincter relaxation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastroesophageal reflux disease (GERD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture: Esophageal strictures are characterized by narrowing of the esophageal lumen, often due to scarring or inflammation, and may present with dysphagia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diffuse esophageal spasm: Diffuse esophageal spasm presents with uncoordinated, simultaneous contractions of the esophagus, leading to chest pain and dysphagia, but it does not involve impaired lower esophageal sphincter relaxation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diffuse esophageal spasm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Achalasia is characterized by impaired relaxation of the lower esophageal sphincter and absent peristalsis in the esophageal body, leading to dysphagia and regurgitation. The classic radiographic finding on barium swallow is a dilated esophagus with a bird&#x27;s beak appearance at the gastroesophageal junction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 39-year-old woman with a history of severe recurrent peptic ulcers despite high-dose PPIs, watery diarrhea, weight loss, previous parathyroid adenoma, hypercalcemia, and elevated fasting serum gastrin levels is evaluated. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Celiac disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Zollinger-Ellison Syndrome (ZES)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crohn&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Zollinger-Ellison Syndrome (ZES)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Zollinger-Ellison Syndrome (ZES)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Celiac disease : Characterized by malabsorption and gastrointestinal symptoms due to gluten sensitivity, celiac disease can cause peptic ulcer-like symptoms but would not explain the hypercalcemia or markedly elevated gastrin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Celiac disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crohn&#x27;s disease : While Crohn&#x27;s can affect any part of the gastrointestinal tract and cause ulcerations, it does not typically present with hypergastrinemia or hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Crohn&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastric cancer : While gastric cancer can present with ulcers and weight loss, the markedly elevated gastrin levels and hypercalcemia are more indicative of ZES, especially in the context of a MEN1 syndrome background.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastric cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In a patient with recurrent peptic ulcers resistant to treatment, episodes of watery diarrhea, hypercalcemia, and a markedly elevated fasting serum gastrin level, Zollinger-Ellison Syndrome should be considered, particularly if there is a history of endocrine tumors suggestive of MEN1 syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate next step in the management of patient diagnosed with GERD who has not responded to initial treatment measures such as antacids ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start a proton pump inhibitor (PPI) trial&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform Upper Gastrointestinal Endoscopy (UGIE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Order a 24-hour esophageal pH monitoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recommend lifestyle modifications and reassess in 6 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Perform Upper Gastrointestinal Endoscopy (UGIE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Perform Upper Gastrointestinal Endoscopy (UGIE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a proton pump inhibitor (PPI) trial: Starting a PPI trial is a reasonable initial approach for suspected GERD but is less appropriate in this case because the patient has not responded to antacids, and there is a need for diagnostic evaluation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a proton pump inhibitor (PPI) trial:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 24-hour esophageal pH monitoring : 24-hour esophageal pH monitoring is the gold standard for diagnosing GERD but is typically reserved for cases where the diagnosis is unclear after endoscopy or when evaluating the efficacy of therapy in complicated cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 24-hour esophageal pH monitoring&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recommend lifestyle modifications and reassess in 6 months:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recommend lifestyle modifications and reassess in 6 months:&lt;/li&gt;&lt;li&gt;â€¢ Lifestyle modifications are recommended for all patients with GERD, but solely recommending this without further evaluation or treatment is inadequate for a patient with persistent symptoms despite over-the-counter treatments.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In patients with GERD symptoms not responding to initial treatments or presenting with alarm features, UGIE is indicated to evaluate for complications and rule out other diagnoses.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate next step to evaluate symptoms in a patient with GERD who has persistent symptoms despite optimized PPI therapy and in whom other complications have been ruled out through UGIE, 24-hour esophageal pH monitoring?Which of the following is the most appropriate next step to evaluate symptoms in a patient with GERD who has persistent symptoms despite optimized PPI therapy and in whom other complications have been ruled out through UGIE, 24-hour esophageal pH monitoring?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Order a barium swallow test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform a repeat UGIE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Order a 24-hour esophageal pH monitoring&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate a trial of H2 receptor antagonists&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Order a 24-hour esophageal pH monitoring&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Order a 24-hour esophageal pH monitoring&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Barium swallow test: A barium swallow test may be useful in evaluating anatomical abnormalities like a hiatal hernia but is less useful for assessing ongoing reflux in a patient already diagnosed with GERD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Barium swallow test:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Perform a repeat UGIE: Repeat UGIE might be considered if there were new or worsening symptoms suggesting complications, but it is not the best next step for evaluating treatment-resistant GERD without new alarm features.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Perform a repeat UGIE:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate a trial of H2 receptor antagonists: Initiating a trial of H2 receptor antagonists may be considered as an adjunctive therapy to PPIs in some cases, but it&#x27;s more appropriate to assess the current treatment&#x27;s effectiveness with pH monitoring before changing the therapeutic approach.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Initiate a trial of H2 receptor antagonists:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For patients with GERD not responding to optimized PPI therapy and without alarm features, 24-hour esophageal pH monitoring is the most appropriate next step to assess the adequacy of acid suppression and correlate symptoms with reflux events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old obese man with type 2 diabetes reports 6 months of nighttime heartburn and sour taste, worsened by spicy foods and lying down. Antacids provide temporary relief. UGIE shows mild esophagitis. What&#x27;s the best next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lifestyle modifications and a trial of proton pump inhibitors (PPIs)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immediate Nissen fundoplication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;24-hour esophageal pH monitoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose H2 receptor antagonists&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lifestyle modifications and a trial of proton pump inhibitors (PPIs)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lifestyle modifications and a trial of proton pump inhibitors (PPIs)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate Nissen fundoplication : This surgical intervention is considered in cases of GERD refractory to medical therapy or in patients who prefer surgery to long-term medication. It is not indicated as an initial step in the management of mild GERD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate Nissen fundoplication&lt;/li&gt;&lt;li&gt;â€¢ Option C. 24-hour esophageal pH monitoring : This diagnostic tool is used to confirm the diagnosis of GERD in cases where the diagnosis is uncertain, especially in patients with non-erosive reflux disease (NERD), or to assess the effectiveness of acid-suppressive therapy. It is not indicated as an initial step in the management of a patient with confirmed GERD and esophagitis on UGIE.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 24-hour esophageal pH monitoring&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose H2 receptor antagonists : While H2 receptor antagonists can reduce acid production and provide symptomatic relief in GERD, PPIs are more effective in healing esophagitis and are preferred as the initial pharmacological therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose H2 receptor antagonists&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The initial management of GERD with mild esophagitis includes lifestyle modifications and a trial of proton pump inhibitors. PPIs are preferred over H2 receptor antagonists due to their superior efficacy in healing esophagitis and relieving GERD symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with dysphagia. He has a history of atopic dermatitis and seasonal allergies. An upper endoscopy is performed as seen in the image provided. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reflux esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Herpes simplex virus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic esophagitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida esophagitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic esophagitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091804.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic esophagitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ O ption A. Reflux esophagitis : Typically shows erythema, ulceration, or erosions, not the concentric rings as seen in the image.&lt;/li&gt;&lt;li&gt;â€¢ O&lt;/li&gt;&lt;li&gt;â€¢ ption A. Reflux esophagitis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Herpes simplex virus esophagitis : Usually presents with multiple small, shallow ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Herpes simplex virus esophagitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida esophagitis : Often visible as white plaques or lesions along the esophageal mucosa.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida esophagitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The presence of esophageal concentric rings on endoscopy, especially in a patient with atopic history, is indicative of eosinophilic esophagitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old immunocompromised male presents with odynophagia and retrosternal chest pain. His symptoms began abruptly a few days ago and have progressively worsened. An upper endoscopy reveals several shallow, small ulcers in the esophagus as shown in the image. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reflux esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytomegalovirus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Herpes simplex virus esophagitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida esophagitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Herpes simplex virus esophagitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-091932.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Herpes simplex virus esophagitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reflux esophagitis : More commonly presents with linear erosions and erythema rather than discrete shallow ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reflux esophagitis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cytomegalovirus esophagitis : Typically exhibits larger, deeper ulcers on endoscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cytomegalovirus esophagitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida esophagitis : Usually visualized as white plaques or lesions along the esophageal mucosa, resembling cottage cheese.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida esophagitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In an immunocompromised patient with acute odynophagia and endoscopic findings of shallow ulcers, herpes simplex virus esophagitis is the most likely diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old male with a history of HIV/AIDS presents with dysphagia, odynophagia, and retrosternal chest pain. His CD4 count is 100 cells/mmÂ³. An endoscopy is performed and the image provided shows linear white plaques along the esophagus. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reflux esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytomegalovirus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Herpes simplex virus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida esophagitis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Candida esophagitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-092211.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Candida esophagitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reflux esophagitis : Usually presents with erythematous mucosa and linear erosions rather than white plaques.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reflux esophagitis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cytomegalovirus esophagitis : Typically presents with large superficial ulcers on endoscopy, not white plaques.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cytomegalovirus esophagitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Herpes simplex virus esophagitis : Often presents with multiple small, shallow ulcers, not white plaques.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Herpes simplex virus esophagitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In an immunocompromised patient presenting with odynophagia and dysphagia, the finding of white plaques on endoscopy is diagnostic of Candida esophagitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with chronic epigastric pain relieved by antacids and frequent NSAID use presents with sudden severe \&quot;tearing\&quot; epigastric pain radiating to the back since 4 hours. Physical exam shows epigastric tenderness. Chest X-ray is normal. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start a proton pump inhibitor and admit for observation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform an urgent endoscopy.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Order an abdominal ultrasound to assess for gallstones.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Obtain a serum amylase and lipase.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Perform an urgent endoscopy.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Perform an urgent endoscopy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a proton pump inhibitor and admit for observation : While PPIs are part of the management for peptic ulcer disease, the acute nature and severity of the patient&#x27;s symptoms warrant immediate diagnostic evaluation to rule out complications like perforation or bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a proton pump inhibitor and admit for observation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Order an abdominal ultrasound to assess for gallstones : While gallstone disease can present with epigastric pain, the patient&#x27;s history of chronic epigastric pain relieved by antacids and NSAID use strongly points towards peptic ulcer disease rather than biliary colic.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Order an abdominal ultrasound to assess for gallstones&lt;/li&gt;&lt;li&gt;â€¢ Option D. Obtain a serum amylase and lipase : These tests are useful in diagnosing pancreatitis, which can present with epigastric pain radiating to the back. However, the patient&#x27;s history and clinical presentation are more consistent with peptic ulcer disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Obtain a serum amylase and lipase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In a patient with sudden severe epigastric pain and a history suggestive of peptic ulcer disease, urgent endoscopy is critical to diagnose potential complications such as perforation or bleeding and to initiate appropriate therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents to the clinic with a 4-day history of watery diarrhea, abdominal cramps, and nausea. She reports no recent travel, antibiotic use, or sick contacts. Her stool does not contain blood or mucus. She denies any fever or significant dietary changes prior to the onset of symptoms. Laboratory studies, including stool cultures, are negative for pathogens. A stool osmotic gap calculation shows a low value. Which of the following is the most likely mechanism of her diarrhea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased absorption of nutrients due to mucosal damage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Osmotic load from unabsorbed dietary substances&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased chloride secretion in the gut&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Motility disorder causing rapid intestinal transit&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased chloride secretion in the gut&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased chloride secretion in the gut&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased absorption of nutrients due to mucosal damage : This mechanism is more typical of inflammatory diarrhea, which often presents with fever, bloody diarrhea, and evidence of inflammation on laboratory tests.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased absorption of nutrients due to mucosal damage&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osmotic load from unabsorbed dietary substances : Osmotic diarrhea occurs when non-absorbable substances in the diet draw water into the gut, characterized by a high stool osmotic gap.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osmotic load from unabsorbed dietary substances&lt;/li&gt;&lt;li&gt;â€¢ Option D. Motility disorder causing rapid intestinal transit : While rapid transit can contribute to diarrhea, it is not characterized by a low stool osmotic gap and is more commonly associated with conditions like irritable bowel syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Motility disorder causing rapid intestinal transit&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Secretory diarrhea is characterized by increased electrolyte secretion, particularly chloride, into the gut, leading to watery stools. It is identified by a low stool osmotic gap and the absence of pathogenic organisms in stool cultures.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman reports chronic diarrhea, bloating, fatigue, and unexplained weight loss, worsened by consuming gluten-containing foods. She has iron-deficiency anemia and low vitamin D levels. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Irritable Bowel Syndrome (IBS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inflammatory Bowel Disease (IBD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Celiac Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric Ulcer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Celiac Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Celiac Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Irritable Bowel Syndrome (IBS) : While IBS can cause similar gastrointestinal symptoms, it does not lead to nutrient malabsorption or the specific nutrient deficiencies seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Irritable Bowel Syndrome (IBS)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inflammatory Bowel Disease (IBD) : IBD, including Crohn&#x27;s disease and ulcerative colitis, could cause similar symptoms and anemia, but the specific worsening with gluten-containing foods and the combination of deficiencies point more towards celiac disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inflammatory Bowel Disease (IBD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastric Ulcer : A gastric ulcer might cause pain and anemia due to bleeding, but it would not typically cause the nutrient malabsorption, diarrhea, and specific dietary trigger related to gluten intake.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastric Ulcer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Chronic gastrointestinal symptoms that worsen with gluten ingestion, combined with iron-deficiency anemia and other signs of malabsorption, are suggestive of celiac disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate initial test to evaluate this patient for celiac disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-tissue transglutaminase antibody (tTG-IgA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stool fat content&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Colonoscopy with biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anti-tissue transglutaminase antibody (tTG-IgA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Anti-tissue transglutaminase antibody (tTG-IgA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum albumin : While low serum albumin can indicate malnutrition, it is not specific for celiac disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum albumin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stool fat content : Elevated stool fat content can indicate malabsorption but is not specific for celiac disease and is less commonly used as an initial test.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stool fat content&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colonoscopy with biopsy : While biopsy of the small intestine is the gold standard for diagnosing celiac disease, it is typically performed after positive serological testing.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colonoscopy with biopsy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In patients with symptoms suggestive of celiac disease, the anti-tissue transglutaminase antibody (tTG-IgA) test is the most appropriate initial investigation due to its high sensitivity and specificity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is currently approved for the treatment of celiac disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dapsone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;There are no medications approved for the treatment of celiac disease; the only effective treatment is a strict gluten-free diet.z&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. There are no medications approved for the treatment of celiac disease; the only effective treatment is a strict gluten-free diet.z&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) There are no medications approved for the treatment of celiac disease; the only effective treatment is a strict gluten-free diet.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutenase : Enzyme supplements that break down gluten, known as glutenases, have been researched but are not yet approved for the treatment of celiac disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutenase&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisone : Corticosteroids like prednisone may be used in severe cases or for refractory celiac disease, but they are not a standard treatment for typical cases of celiac disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisone&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dapsone : Dapsone is used for dermatitis herpetiformis, a skin manifestation of celiac disease, but not for treating the intestinal aspect of celiac disease itself.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dapsone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The cornerstone of managing celiac disease is a strict gluten-free diet, as there are currently no medications approved to treat the condition directly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which symptom aligns with Rome IV criteria for IBS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain relief post-bowel movement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Discomfort and bloating&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No alarming symptoms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Varied stool consistency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pain relief post-bowel movement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pain relief post-bowel movement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Discomfort and bloating : While common in IBS, these alone do not fulfill the diagnostic criteria without the specific relationship to bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Discomfort and bloating&lt;/li&gt;&lt;li&gt;â€¢ Option C. No alarming symptoms : The absence of alarming symptoms is important in IBS diagnosis but, by itself, does not confirm the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option C. No alarming symptoms&lt;/li&gt;&lt;li&gt;â€¢ Option D. Varied stool consistency : Changes in stool form and frequency are part of the criteria but need to be associated with abdominal pain for IBS diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Varied stool consistency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In diagnosing IBS, a key feature is recurrent abdominal pain that improves with defecation, per the Rome IV criteria. This distinguishes IBS from other gastrointestinal disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old woman has recurrent abdominal pain, fluctuating between diarrhea and constipation for 6 months. The pain often lessens post-defecation. No weight loss, bleeding, or anemia is present. What diagnosis fits the Rome IV criteria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nocturnal diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Food-induced pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abdominal pain with stool changes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Constipation without pain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Abdominal pain with stool changes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Abdominal pain with stool changes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nocturnal diarrhea : While diarrhea can be a symptom of IBS, nocturnal diarrhea is not specific to IBS and can be indicative of other conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nocturnal diarrhea&lt;/li&gt;&lt;li&gt;â€¢ Option B. Food-induced pain : Food can trigger symptoms in IBS, but the Rome IV criteria specifically highlight the relationship between pain and defecation or stool changes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Food-induced pain&lt;/li&gt;&lt;li&gt;â€¢ Option D. Constipation without pain : IBS requires the presence of abdominal pain; constipation alone, without associated pain, does not meet the criteria for IBS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Constipation without pain&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis of IBS according to the Rome IV criteria is based on recurrent abdominal pain associated with defecation and changes in stool frequency or form, not solely on the presence of bowel habit abnormalities like nocturnal diarrhea or constipation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following findings would be considered a \&quot;red flag\&quot; that suggests a need for further investigation beyond IBS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alternating diarrhea and constipation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abdominal bloating and gas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nocturnal bowel movements&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Response to dietary changes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nocturnal bowel movements&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nocturnal bowel movements&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alternating diarrhea and constipation : Common in IBS and not considered a red flag.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alternating diarrhea and constipation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Abdominal bloating and gas : Typical symptoms of IBS, not red flags.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Abdominal bloating and gas&lt;/li&gt;&lt;li&gt;â€¢ Option D. Response to dietary changes : Improvement with dietary changes supports an IBS diagnosis and is not a red flag.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Response to dietary changes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In the evaluation of suspected IBS, nocturnal bowel movements are a red flag warranting further investigation to exclude organic diseases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with chronic NSAID use presents with black tarry stools and vomiting bright red blood. The most immediate next diagnostic step is -&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abdominal X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophagogastroduodenoscopy (EGD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CT angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;H. pylori stool antigen test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Esophagogastroduodenoscopy (EGD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Esophagogastroduodenoscopy (EGD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal X-ray: Abdominal X-ray is not sensitive or specific for diagnosing PUD and is not indicated for acute upper GI bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abdominal X-ray:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CT angiography: CT angiography may be used when EGD does not identify the bleeding source, or if the bleeding is suspected to be from a lower GI source, which is not suggested in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CT angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option D. H. pylori stool antigen test: It is a non-invasive test to diagnose H. pylori infection, a common cause of PUD, but it is not used for acute diagnosis or management of upper GI bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. H. pylori stool antigen test:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ EGD is the critical next step in diagnosing and managing a patient with suspected PUD bleeding, particularly when presenting with melena and hematemesis, and a history of NSAID use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with peptic ulcer disease and hematemesis presents with tachycardia and low hemoglobin. After initial fluid resuscitation, the next step is to&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discontinue aspirin and start a high-dose proton pump inhibitor (PPI) infusion.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform immediate surgery to control the source of bleeding.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administer a single dose of intravenous vitamin K.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Schedule an elective esophagogastroduodenoscopy (EGD) within the next 24 hours.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Discontinue aspirin and start a high-dose proton pump inhibitor (PPI) infusion.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Discontinue aspirin and start a high-dose proton pump inhibitor (PPI) infusion.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate surgery is not the first-line treatment for PUD bleeding and is reserved for cases where endoscopic treatment fails or if the patient is hemodynamically unstable after resuscitation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vitamin K is given for reversal of vitamin K antagonist therapy or in cases of severe coagulopathy; it is not indicated as a routine initial treatment for PUD bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. While an EGD is necessary for the diagnosis and potential treatment of PUD bleeding, it should be performed urgently in a patient with active bleeding and hemodynamic instability, not electively within the next 24 hours.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The immediate management of acute PUD bleeding includes discontinuation of aspirin and initiation of a high-dose PPI infusion to reduce acid secretion and promote clot stability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old female with systemic sclerosis, chronic iron deficiency anemia, and melena has an EGD showing multiple longitudinal stripes of red mucosa alternating with normal mucosa in the stomach. The most likely diagnosis is -&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric antral vascular ectasia (GAVE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peptic ulcer disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Portal hypertensive gastropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastritis due to Helicobacter pylori infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gastric antral vascular ectasia (GAVE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-110039.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gastric antral vascular ectasia (GAVE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peptic ulcer disease: It is usually presents with focal ulcers rather than longitudinal stripes of erythema.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peptic ulcer disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Portal hypertensive gastropathy: It is associated with liver disease and portal hypertension, not systemic sclerosis, and usually does not present with the striped pattern seen on endoscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Portal hypertensive gastropathy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastritis due to Helicobacter pylori infection: It is typically diffusely erythematous and does not have the characteristic striped pattern seen in GAVE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastritis due to Helicobacter pylori infection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The endoscopic appearance of \&quot;watermelon stomach\&quot; is indicative of Gastric Antral Vascular Ectasia (GAVE), especially in patients with systemic sclerosis presenting with chronic anemia and gastrointestinal bleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with GERD and hypertension presents with hematemesis after heavy drinking and forceful retching. Examination shows mild epigastric tenderness and normal liver function tests. The most likely diagnosis is-&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Esophageal varices&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastric antral vascular ectasia (GAVE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peptic ulcer disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mallory-Weiss tear&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mallory-Weiss tear&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mallory-Weiss tear&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Esophageal varices: It could be a cause of hematemesis but are usually associated with signs of chronic liver disease, which this patient does not have.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Esophageal varices:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gastric antral vascular ectasia (GAVE) : It is typically seen as a chronic condition associated with iron deficiency anemia and is characterized by distinctive endoscopic findings, not typically related to acute episodes of retching.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gastric antral vascular ectasia (GAVE)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Peptic ulcer disease: It could present with hematemesis but is less likely in the absence of abdominal pain and a history of forceful retching.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Peptic ulcer disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mallory-Weiss tear is a cause of hematemesis in the context of heavy alcohol consumption and forceful retching, especially in the absence of chronic liver disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with severe abdominal pain, bloody diarrhea, and fever after eating at a new seafood restaurant 3 days ago. Examination shows diffuse abdominal tenderness. The most likely diagnosis is&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inflammatory Bowel Disease (IBD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infectious Colitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Irritable Bowel Syndrome (IBS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Infectious Colitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Infectious Colitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inflammatory Bowel Disease (IBD): IBD usually presents with a more prolonged history of abdominal pain and bloody diarrhea and may have systemic symptoms such as weight loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inflammatory Bowel Disease (IBD):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ischemic Colitis: Ischemic Colitis often affects older patients with known cardiovascular risks and presents with sudden onset abdominal pain and bloody diarrhea without significant preceding events.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ischemic Colitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Irritable Bowel Syndrome (IBS): IBS is characterized by chronic abdominal pain and altered bowel habits without significant fever or bloody stools, typically in the absence of an infectious trigger.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Irritable Bowel Syndrome (IBS):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Infectious colitis is characterized by acute onset of bloody diarrhea following a potential exposure to contaminated food.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old man with chronic kidney disease and aortic stenosis presents with maroon-colored stools and iron deficiency anemia. Colonoscopy shows multiple small, flat, red lesions in the cecum. The most likely diagnosis is&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colonic diverticulosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ischemic colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Angiodysplasia of the colon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Colorectal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Angiodysplasia of the colon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Angiodysplasia of the colon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Colonic diverticulosis: Colonic diverticulosis can cause bleeding but typically presents with larger, sac-like protrusions rather than flat, red lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Colonic diverticulosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ischemic colitis: Ischemic colitis usually presents with abdominal pain and bloody diarrhea, often in patients with a history of vascular disease or risk factors for ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ischemic colitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colorectal carcinoma: Colorectal carcinoma might present with iron deficiency anemia and rectal bleeding but typically shows as a mass lesion on colonoscopy, not as small, flat lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colorectal carcinoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To identify angiodysplasia of the colon in an elderly patient with chronic kidney disease and aortic stenosis, presenting with intermittent, painless rectal bleeding and iron deficiency anemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man with a history of intermittent abdominal pain and non-bloody diarrhea undergoes a colonoscopy, which shows segmental areas of inflammation interspersed with normal mucosa, primarily affecting the ileum and ascending colon. A biopsy reveals transmural inflammation and non-caseating granulomas. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Crohn&#x27;s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ulcerative Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Irritable Bowel Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Celiac Disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Crohn&#x27;s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Crohn&#x27;s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ulcerative Colitis : Characterized by continuous mucosal inflammation starting from the rectum and extending proximally, without granulomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ulcerative Colitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Irritable Bowel Syndrome : A functional gastrointestinal disorder without the inflammatory or structural changes seen in Crohn&#x27;s Disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Irritable Bowel Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Celiac Disease : Involves inflammation and villous atrophy in the small intestine triggered by gluten ingestion, not typically presenting with granulomas or segmental inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Celiac Disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The presence of \&quot;skip lesions,\&quot; transmural inflammation, and granulomas on biopsy are indicative of Crohn&#x27;s Disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Sacroiliitis is a common extraintestinal manifestation associated with ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Crohn&#x27;s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ulcerative Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both Crohn&#x27;s Disease and Ulcerative Colitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neither, this is unrelated to IBD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both Crohn&#x27;s Disease and Ulcerative Colitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Both Crohn&#x27;s Disease and Ulcerative Colitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Crohn&#x27;s Disease : While sacroiliitis can be associated with Crohn&#x27;s, it is not exclusive to this form of IBD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Crohn&#x27;s Disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ulcerative Colitis : Similarly, Ulcerative Colitis can also present with sacroiliitis, but it is not the sole IBD associated with this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ulcerative Colitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neither, this is unrelated to IBD : Incorrect, as sacroiliitis is well-documented as an extraintestinal manifestation of both Crohn&#x27;s Disease and Ulcerative Colitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neither, this is unrelated to IBD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Sacroiliitis can be an extraintestinal manifestation of both Crohn&#x27;s Disease and Ulcerative Colitis, highlighting the systemic inflammatory involvement in IBD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with mild Ulcerative Colitis limited to the rectum (ulcerative proctitis) is seeking treatment options. What is the most appropriate initial therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Topical 5-aminosalicylic acid (5-ASA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Systemic immunosuppressants&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Colectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Topical 5-aminosalicylic acid (5-ASA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Topical 5-aminosalicylic acid (5-ASA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral corticosteroids : Generally reserved for more severe or extensive disease not responsive to 5-ASA agents.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option C. Systemic immunosuppressants : Used for moderate to severe disease or in patients who do not respond to first-line therapies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Systemic immunosuppressants&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colectomy : Considered a last resort, typically for severe, refractory disease or when there&#x27;s a high risk of cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Topical 5-ASA agents are the first-line treatment for mild ulcerative proctitis due to their efficacy and safety profile.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old female with moderate to severe Ulcerative Colitis not responding to oral 5-ASA therapy is considering her treatment options. Which of the following is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiate oral prednisone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the dose of oral 5-ASA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add topical corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgical colectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Initiate oral prednisone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Initiate oral prednisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase the dose of oral 5-ASA : This approach is unlikely to be effective in moderate to severe cases not responding to initial 5-ASA therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase the dose of oral 5-ASA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Add topical corticosteroids : While useful in some cases, topical corticosteroids may not provide sufficient control for moderate to severe disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Add topical corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical colectomy : Considered in cases of refractory disease, complications, or increased cancer risk, but not typically the next step after 5-ASA failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical colectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Oral corticosteroids are the next step in management for moderate to severe Ulcerative Colitis not responding to 5-ASA therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male with a known diagnosis of Crohn&#x27;s disease is diagnosed with toxic megacolon. He is hemodynamically stable but shows signs of systemic toxicity. What is the most appropriate initial management for this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate surgical intervention&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Broad-spectrum antibiotics and bowel rest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administration of antidiarrheal agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose corticosteroids and intravenous hydration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Broad-spectrum antibiotics and bowel rest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Broad-spectrum antibiotics and bowel rest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate surgical intervention : Indicated in cases of perforation, massive bleeding, or failure of medical management.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate surgical intervention&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administration of antidiarrheal agents : Contraindicated in toxic megacolon as it may exacerbate colonic dilation and the risk of perforation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administration of antidiarrheal agents&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose corticosteroids : May be used to reduce inflammation in conjunction with other supportive measures, but not alone.&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose corticosteroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Initial management of toxic megacolon involves bowel rest, IV hydration, and broad-spectrum antibiotics, with surgical intervention reserved for complications or failure of conservative treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of atrial fibrillation presents to the emergency department with sudden onset of severe abdominal pain out of proportion to physical findings. His heart rate is irregular, and an abdominal examination reveals mild tenderness without rebound or guarding. Which of the following is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute mesenteric ischemia due to arterial embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic mesenteric ischemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mesenteric venous thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonocclusive mesenteric ischemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute mesenteric ischemia due to arterial embolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute mesenteric ischemia due to arterial embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic mesenteric ischemia : Typically presents with postprandial pain and weight loss due to fear of eating, developing over a longer time.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic mesenteric ischemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mesenteric venous thrombosis : Often has a more gradual onset and may be associated with hypercoagulable states, not sudden and severe pain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mesenteric venous thrombosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonocclusive mesenteric ischemia : Occurs in low-flow states like heart failure or sepsis, and while this patient has AFib, there&#x27;s no mention of a low-flow state.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonocclusive mesenteric ischemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Acute abdominal pain in a patient with atrial fibrillation suggests acute mesenteric ischemia due to arterial embolism, requiring prompt diagnosis and treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with COPD presents with diarrhea, abdominal cramping, and fever after recent antibiotics. His stool is watery with 5-6 bowel movements per day. What is the most appropriate diagnostic test to confirm the suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stool culture for enteric pathogens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stool enzyme immunoassay for Clostridium difficile toxins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sigmoidoscopy to visualize the colonic mucosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abdominal ultrasound&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stool enzyme immunoassay for Clostridium difficile toxins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stool culture for enteric pathogens: Is useful for identifying bacterial causes of diarrhea other than C. difficile, which is less likely given the patient&#x27;s recent antibiotic use.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stool culture for enteric pathogens:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sigmoidoscopy can visualize colonic mucosal damage: Associated with severe cases of C. difficile infection but is not a first-line diagnostic tool due to its invasiveness and the availability of less invasive tests.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sigmoidoscopy can visualize colonic mucosal damage:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abdominal ultrasound: An abdominal ultrasound is not specific for diagnosing C. difficile infection and is more useful for evaluating other causes of abdominal pain and complications of infections.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abdominal ultrasound:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Stool enzyme immunoassay for C. difficile toxins is the most appropriate initial diagnostic test.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old female with a recent history of hospitalization for urinary tract infection treated with antibiotics presents with diarrhea and abdominal pain. The presence of which of the following in stool would most likely confirm the diagnosis of Clostridium difficile colitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clostridium difficile toxin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ova and parasites&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clostridium difficile toxin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood: Blood in the stool can indicate various gastrointestinal conditions, including infections, inflammatory bowel disease, and colorectal cancer, but is not specific for C. difficile colitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leukocytes: Leukocytes in the stool suggest inflammation in the gastrointestinal tract, which can be seen in infectious colitis, inflammatory bowel disease, and other conditions, but is not specific for C. difficile infection.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leukocytes:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ova and parasites: The presence of ova and parasites in the stool indicates a parasitic infection, which is a different etiology from C. difficile colitis, typically caused by bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ova and parasites:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of Clostridium difficile toxin in stool is the key diagnostic marker for C. difficile colitis, particularly in patients with recent antibiotic use and symptoms of diarrhea and abdominal pain.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman is diagnosed with moderate Clostridium difficile colitis. She has a history of penicillin allergy. Which of the following is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metronidazole orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vancomycin orally&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fidaxomicin orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous immunoglobulin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vancomycin orally&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metronidazole orally: Metronidazole orally was previously a standard treatment for C. difficile infection but is now generally reserved for mild cases or when first-line therapies are not available, due to its lower efficacy compared to vancomycin and fidaxomicin for moderate to severe infections.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Metronidazole orally:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fidaxomicin orally: Fidaxomicin orally is another effective treatment for C. difficile colitis and could be considered a first-line therapy. However, it is often reserved for cases where there is a high risk of recurrence or for severe infections due to its higher cost.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Fidaxomicin orally:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous immunoglobulin: Intravenous immunoglobulin is used in severe, complicated cases, particularly with evidence of systemic toxicity or in recurrent infections not responding to standard therapies. It is not typically used as first-line therapy for moderate C. difficile colitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous immunoglobulin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment of choice for moderate Clostridium difficile colitis, especially in patients with a penicillin allergy, is oral vancomycin. This therapy is preferred over metronidazole due to its superior efficacy in moderate to severe infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man presents with intermittent, painless rectal bleeding and small amounts of bright red blood. His history includes hypertension and a low-fiber diet. Physical and abdominal examinations are unremarkable, with no hemorrhoidal disease noted. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemorrhoids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diverticulosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Colorectal cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diverticulosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemorrhoids: Hemorrhoids could cause painless rectal bleeding, but the absence of hemorrhoidal disease on rectal examination makes this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemorrhoids:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ischemic colitis: Ischemic colitis typically presents with abdominal pain and sometimes bloody diarrhea, not just isolated, painless rectal bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ischemic colitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colorectal cancer: Colorectal cancer could present with rectal bleeding, but it is less likely to be intermittent and painless, and other symptoms such as weight loss or a change in bowel habits are often present.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colorectal cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diverticulosis is a common cause of intermittent, painless rectal bleeding in older adults, particularly those on a low-fiber diet, in the absence of hemorrhoidal disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman presents with intermittent, painless rectal bleeding, but normal physical and rectal examination. What is the most appropriate next step to establish the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anoscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colonoscopy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Barium enema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CT scan of the abdomen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Colonoscopy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anoscopy: Is a useful tool for examining the anal canal and lower rectum but is limited in scope and would not be adequate for evaluating the entire colon, which is necessary given the patient&#x27;s symptoms and age.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anoscopy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barium enema: Is a radiographic exam used to visualize the colon and rectum. While it can detect abnormalities, it is less sensitive than colonoscopy and does not allow for biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barium enema:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CT scan of the abdomen: Can provide detailed images of the abdominal organs, but it is not the best initial test for direct evaluation of the colon&#x27;s inner lining and for performing biopsies of suspicious lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CT scan of the abdomen:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Colonoscopy is the most appropriate diagnostic test for a patient presenting with intermittent, painless rectal bleeding and a normal physical examination, allowing for comprehensive evaluation and biopsy of the colon and rectum.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with left lower quadrant abdominal pain, low-grade fever, and a change in bowel habits to loose stools. His history includes hypertension, and examination reveals tenderness and slight guarding in the left lower quadrant. What is the most likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute appendicitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diverticulitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary tract infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diverticulitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute appendicitis: Acute appendicitis typically presents with pain that starts around the umbilicus and then localizes to the right lower quadrant, not the left, and is associated with rebound tenderness, which is not described in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute appendicitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ischemic colitis: Ischemic colitis can cause abdominal pain and changes in bowel habits, but it is more often associated with risk factors such as cardiovascular disease, and the presentation can vary more widely than the classic presentation of diverticulitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ischemic colitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urinary tract infection: Urinary tract infection may cause abdominal discomfort, but it is more commonly associated with urinary symptoms such as dysuria, frequency, and urgency, and does not typically cause localized left lower quadrant pain or changes in bowel habits.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urinary tract infection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diverticulitis typically presents with left lower quadrant pain, fever, and altered bowel habits in adults, corresponding with the location of sigmoid diverticula. Top of Form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the assessment of a patient suspected to have diverticulitis, imaging reveals a localized abscess adjacent to the sigmoid colon. According to the modified Hinchey classification, how should this case of diverticulitis be classified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage Ia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage Ib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage III&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stage II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Stage II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stage Ia: Stage Ia involves mild clinical diverticulitis without the presence of an abscess or other complications.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stage Ia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stage Ib: Stage Ib is not a recognized category in the modified Hinchey classification.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stage Ib:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage III: Stage III diverticulitis is characterized by a generalized purulent peritonitis, which is a more severe condition than a localized abscess.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage III:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ According to the modified Hinchey classification for diverticulitis, Stage II is characterized by the presence of a localized abscess&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman with confirmed mild acute diverticulitis and no signs of systemic infection is stable and has no comorbidities. What is the most appropriate initial management for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous antibiotics and hospital admission&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral antibiotics and outpatient follow-up&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate surgical consultation for colectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoscopic evaluation within 24 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oral antibiotics and outpatient follow-up&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oral antibiotics and outpatient follow-up&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous antibiotics and hospital admission: Are typically reserved for patients with severe diverticulitis, signs of systemic infection, hemodynamic instability, or significant comorbidities that may complicate the course of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous antibiotics and hospital admission:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate surgical consultation for colectomy: Is generally considered in cases of complicated diverticulitis with conditions such as perforation, obstruction, fistula, or failure of medical management.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate surgical consultation for colectomy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic evaluation within 24 hours: Is not typically indicated in the acute management of diverticulitis due to the risk of perforation and is usually avoided during the acute phase of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoscopic evaluation within 24 hours:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A mild acute diverticulitis in a stable patient without comorbidities or signs of systemic infection can be initially managed with oral antibiotics and outpatient follow-up, reserving more invasive interventions for complicated cases or those with severe presentations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 150 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test5" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Hematology &amp;amp; Tranfusion&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Hematology &amp;amp; Tranfusion&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                200 Questions | 800 Total Marks | 210 min Duration | ~63.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A patient with blood type A requires a blood transfusion. Which of the following blood types could they safely receive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and AB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A and O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A, B, and AB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A and O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A and O&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and AB: Type AB blood contains B antigens, which would react with the recipient&#x27;s anti-B antibodies, leading to a transfusion reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and AB:&lt;/li&gt;&lt;li&gt;â€¢ Option C. A, B, and AB: Type B blood would also react with the recipient&#x27;s anti-B antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A, B, and AB:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only A: While type A blood is compatible, type O is also safe for transfusion to a person with type A blood.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only A:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Understanding ABO compatibility is crucial for safe blood transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic modifications on chromosome 9 leads to the formation of the B antigen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addition of N-acetylgalactosamine (GalNAc) to the H antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Addition of galactose (Gal) to the H antigen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Removal of fucose from the H antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absence of both GalNAc and Gal on the H antigen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Addition of galactose (Gal) to the H antigen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Addition of galactose (Gal) to the H antigen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Addition of N-acetylgalactosamine (GalNAc) to the H antigen: This modification results in the formation of the A antigen.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Addition of N-acetylgalactosamine (GalNAc) to the H antigen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Removal of fucose from the H antigen: While removal of fucose is a step in the formation of both A and B antigens, it&#x27;s not the final step for the B antigen.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Removal of fucose from the H antigen:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Absence of both GalNAc and Gal on the H antigen: This results in the O blood group, where neither A nor B antigens are present.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Absence of both GalNAc and Gal on the H antigen:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The A and B antigens are formed by modifications of the H antigen.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following Rh antigens is the most immunogenic, leading to the highest risk of alloimmunization in Rh-negative individuals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;E antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;c antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D antigen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. D antigen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) D antigen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. C antigen: While the C antigen can be immunogenic, it is less so than the D antigen. Anti-C antibodies are relatively common, but they usually cause milder reactions than anti-D antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. C antigen:&lt;/li&gt;&lt;li&gt;â€¢ Option B. E antigen: Similar to the C antigen, the E antigen is immunogenic but less so than the D antigen. Anti-E antibodies are less common than anti-C antibodies and generally cause less severe reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. E antigen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. c antigen: The c antigen is the most common Rh antigen (80% of the population expresses it). However, it is considered weakly immunogenic, and anti-c antibodies are relatively rare.&lt;/li&gt;&lt;li&gt;â€¢ Option C. c antigen:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The D antigen is the most immunogenic, posing the highest risk of alloimmunization in Rh-negative individuals. Understanding the Rh system and its genetic basis is crucial for safe blood transfusions and preventing complications like hemolytic disease of the newborn.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with blood type AB positive requires a plasma transfusion. Which of the following blood types could be safely used as a source of fresh frozen plasma (FFP)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Only O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Only AB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A, B, AB, and O - all types&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only A and B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Only AB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Only AB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a trauma setting where blood typing is not immediately available, which blood type is typically used for emergency transfusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AB negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;B positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;O negative&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. O negative&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) O negative&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. AB negative: AB negative blood contains both A and B antigens, which could cause a serious reaction if the recipient has antibodies against either of these antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option A. AB negative:&lt;/li&gt;&lt;li&gt;â€¢ Option B. A positive: A positive blood contains A antigens and the Rh factor, both of which could trigger a transfusion reaction in a recipient without these antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option B. A positive:&lt;/li&gt;&lt;li&gt;â€¢ Option C. B positive: B positive blood contains B antigens and the Rh factor, making it unsuitable for transfusion to individuals who lack these antigens.&lt;/li&gt;&lt;li&gt;â€¢ Option C. B positive:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ O negative blood is the universal red blood cell donor, making it the preferred choice for emergency transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with blood type B negative requires an emergency blood transfusion due to severe hemorrhage. Which of the following blood types could be safely administered?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B positive and B negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AB negative and O negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;B negative and O positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only B negative&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Only B negative&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Only B negative&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. B positive and B negative: B positive blood has the RhD antigen, which the recipient could develop antibodies against, leading to potential complications in future transfusions or pregnancies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. B positive and B negative:&lt;/li&gt;&lt;li&gt;â€¢ Option B. AB negative and O negative: AB negative blood contains A antigens, which would react with the recipient&#x27;s anti-A antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option B. AB negative and O negative:&lt;/li&gt;&lt;li&gt;â€¢ Option C. B negative and O positive: O positive blood contains the RhD antigen, which the recipient could develop antibodies against.&lt;/li&gt;&lt;li&gt;â€¢ Option C. B negative and O positive:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ It is crucial to match both ABO and Rh blood groups to ensure safe transfusions, especially in emergency situations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient experiences a delayed hemolytic transfusion reaction (DHTR) 5 days after a blood transfusion. Which of the following blood group systems is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Kell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Kidd&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MNS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Kidd&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Kidd&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Kell: While Kell antibodies can cause severe hemolytic reactions, these are typically acute rather than delayed.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Kell:&lt;/li&gt;&lt;li&gt;â€¢ Option C. MNS: MNS antibodies can cause delayed hemolytic transfusion reactions, but they are relatively rare compared to Kidd antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MNS:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewis: Lewis antibodies are naturally occurring and typically of the IgM isotype, which are generally not considered clinically significant in transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Kidd antibodies are typically IgG and can cause severe delayed reactions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following blood group antigens can be acquired by donor red blood cells (RBCs) soon after transfusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duffy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Kidd&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MNS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lewis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lewis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Duffy: Duffy antigens are also integral membrane proteins of red blood cells and are not passively acquired.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Duffy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Kidd: Kidd antigens are similarly integral membrane proteins and are not acquired from the plasma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Kidd:&lt;/li&gt;&lt;li&gt;â€¢ Option C. MNS: MNS antigens are part of the red blood cell glycophorin complex and are not acquired from the plasma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MNS:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Lewis antigens are not intrinsic to RBCs but are acquired from the plasma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antigen is resistant to P. vivax/knowlesi?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;K/k&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DARC (Duffy Antigen Receptor for Chemokines)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lewis Ag&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A antigen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. DARC (Duffy Antigen Receptor for Chemokines)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) DARC (Duffy Antigen Receptor for Chemokines)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. K/k: Kell antigens are a group of antigens found on red blood cells. They are not involved in malaria resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option A. K/k:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lewis Ag: Lewis antigens are present in body fluids and can be adsorbed onto red blood cells. They do not play a role in malaria resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lewis Ag:&lt;/li&gt;&lt;li&gt;â€¢ Option D. A antigen: The A antigen is part of the ABO blood group system and determines blood type. It has no relationship to malaria susceptibility.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A antigen:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The Duffy antigen receptor for chemokines (DARC) is essential for P. vivax and P. knowlesi malaria parasites to invade red blood cells. Individuals without this receptor are naturally resistant to these types of malaria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the primary goal of a blood crossmatch?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Determine the blood type of the donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Determine the blood type of the recipient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Detect unexpected antibodies in the recipient&#x27;s serum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ensure compatibility between donor red blood cells and recipient serum&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ensure compatibility between donor red blood cells and recipient serum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ensure compatibility between donor red blood cells and recipient serum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Determine the blood type of the donor: Blood typing is a separate test performed prior to crossmatching to determine the donor&#x27;s ABO and Rh blood group.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Determine the blood type of the donor:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Determine the blood type of the recipient: Similar to donor typing, recipient blood typing is done prior to crossmatching.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Determine the blood type of the recipient:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Detect unexpected antibodies in the recipient&#x27;s serum: While crossmatching can detect unexpected antibodies, this is primarily the purpose of an antibody screen, a separate test performed before crossmatching.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Detect unexpected antibodies in the recipient&#x27;s serum:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Crossmatching is essential for ensuring safe blood transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient&#x27;s blood sample is mixed with Anit-A/B/D and the findings are shown below. What is the patient&#x27;s blood type?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A+&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B+&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AB+&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;O-&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. B+&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/01/screenshot-2024-08-01-103344.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) B+&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient&#x27;s blood sample is mixed with Anit-A/B/D and the findings are shown below. What is the patient&#x27;s blood type?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A+&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B-&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AB-&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;O-&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. O-&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/01/screenshot-2024-08-01-103851.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) O-&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the maximum storage duration for PRBCs at 2-6Â°C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;21 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;35 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;42 days&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;56 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 42 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 42 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with acute blood loss and a hemoglobin (Hb) of 7 g/dL is in need of a blood transfusion. How many units of PRBCs should be transfused to raise the Hb to approximately 10 g/dL?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 unit&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 units&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3 units&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4 units&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 3 units&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 3 units&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient is admitted to the ICU with acute coronary syndrome (ACS) and a hemoglobin level of 8.5 g/dL. What is the most appropriate transfusion threshold for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;7 g/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;8 g/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;8-10 g/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10 g/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 8-10 g/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 8-10 g/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 7 g/dL: This is too low of a threshold for a patient with acute coronary syndrome (ACS). Transfusing at this level might not be necessary and could expose the patient to unnecessary risks associated with blood transfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 7 g/dL:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 8 g/dL: While this could be considered in some cases, it might not be optimal for all ACS patients, especially those with ongoing ischemia or hemodynamic instability.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 8 g/dL:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 10 g/dL: This is a higher threshold typically used for stable patients or those without significant cardiac comorbidities. In ACS, a slightly lower threshold is often preferred to ensure adequate oxygen delivery to the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 10 g/dL:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Transfusion thresholds for ACS patients may be individualized within a recommended range.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which blood additive provides the longest shelf life for stored red blood cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACD (Acid citrate dextrose)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CPD (Citrate phosphate dextrose)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CP2D (Citrate phosphate double dextrose)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SAGM (Saline adenine glucose mannitol)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. SAGM (Saline adenine glucose mannitol)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) SAGM (Saline adenine glucose mannitol)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACD (Acid citrate dextrose): This was one of the earliest preservatives and has a relatively short shelf life (21 days). The citrate acts as an anticoagulant, while dextrose provides energy for the red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACD (Acid citrate dextrose):&lt;/li&gt;&lt;li&gt;â€¢ Option B. CPD (Citrate phosphate dextrose): This is an improvement over ACD due to the addition of phosphate, which acts as a buffer to maintain pH. However, it still has a relatively short shelf life (21 days).&lt;/li&gt;&lt;li&gt;â€¢ Option B. CPD (Citrate phosphate dextrose):&lt;/li&gt;&lt;li&gt;â€¢ Option C. CP2D (Citrate phosphate double dextrose): This has double the amount of dextrose compared to CPD, providing more energy for the red blood cells and extending the shelf life slightly (28 days).&lt;/li&gt;&lt;li&gt;â€¢ Option C. CP2D (Citrate phosphate double dextrose):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ SAGM is the additive that provides the longest shelf life for stored red blood cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The addition of adenine to CPD (CPDA-1) results in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased red blood cell survival due to enhanced glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Improved pH buffering capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prevention of osmotic lysis of red blood cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Provision of ATP for extended red blood cell survival&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Provision of ATP for extended red blood cell survival&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Provision of ATP for extended red blood cell survival&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased red blood cell survival due to enhanced glycolysis: Adenine doesn&#x27;t directly enhance glycolysis (the breakdown of glucose for energy). Glucose in the additive solution is the primary energy source for red blood cells during storage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased red blood cell survival due to enhanced glycolysis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Improved pH buffering capacity: The phosphate in CPD and CPDA-1 acts as the primary buffer to maintain a stable pH during storage. Adenine does not have a significant buffering effect.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Improved pH buffering capacity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prevention of osmotic lysis of red blood cells: Osmotic lysis is primarily prevented by maintaining the correct balance of electrolytes and osmotic pressure in the solution, not by adenine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prevention of osmotic lysis of red blood cells:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Adenine improves the quality of stored red blood cells by providing ATP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the main advantage of single-donor platelets (SDPs) over random-donor platelets (RDPs)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lower cost&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduced risk of alloimmunization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Higher platelet increment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Longer shelf life&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Reduced risk of alloimmunization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Reduced risk of alloimmunization&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lower cost: SDPs are typically more expensive to produce than RDPs because they require apheresis, a specialized blood collection procedure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lower cost:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Higher platelet increment: While some studies have shown slightly higher platelet increments with SDPs, the difference is not always clinically significant, and the overall efficacy in preventing bleeding is similar between SDPs and RDPs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Higher platelet increment:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Longer shelf life: Both SDPs and RDPs have similar shelf lives, typically around 5 days when stored properly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Longer shelf life:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ SDPs are preferred to reduce the risk of alloimmunization in patients who may require multiple transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the Following is not a contraindication for platelet transfusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TTP (Thrombotic Thrombocytopenic Purpura)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HUS (Hemolytic Uremic Syndrome)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ITP (Immune Thrombocytopenia)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HELLP Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ITP (Immune Thrombocytopenia)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) ITP (Immune Thrombocytopenia).&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. TTP (Thrombotic Thrombocytopenic Purpura): Platelet transfusion is contraindicated in TTP because it can worsen the microvascular thrombosis, which is the primary cause of organ damage in this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TTP (Thrombotic Thrombocytopenic Purpura):&lt;/li&gt;&lt;li&gt;â€¢ Option B. HUS (Hemolytic Uremic Syndrome): Similar to TTP, platelet transfusion can exacerbate the thrombotic process in HUS and is generally avoided.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HUS (Hemolytic Uremic Syndrome):&lt;/li&gt;&lt;li&gt;â€¢ Option D. HELLP Syndrome: Platelet transfusion is typically reserved for severe thrombocytopenia (&amp;lt;20,000/ÂµL) or active bleeding in HELLP syndrome, as it doesn&#x27;t address the underlying cause of the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. HELLP Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Platelet transfusion is generally contraindicated in conditions where it could worsen thrombosis (TTP, HUS) but may be considered in specific situations like life-threatening bleeding in ITP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient receiving platelet transfusions shows a corrected count increment (CCI) of 3,500/ÂµL one hour after transfusion and 2,500/ÂµL at 20 hours. Which of the following is the most likely cause of this refractoriness?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune thrombocytopenic purpura (ITP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersplenism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Immune thrombocytopenic purpura (ITP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Immune thrombocytopenic purpura (ITP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sepsis and Option B. Fever: While sepsis and fever can cause increased platelet consumption, they typically don&#x27;t result in such a low CCI at both time points. Additionally, the patient&#x27;s clinical presentation would likely provide clues to these conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sepsis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fever:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypersplenism: Hypersplenism, an enlarged spleen, can sequester platelets, leading to thrombocytopenia. However, it usually doesn&#x27;t cause the rapid decline in platelet count seen in ITP, where active immune-mediated destruction is occurring.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypersplenism:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Platelet refractoriness with low CCI at 1 and 20 hours suggests immune-mediated platelet destruction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with severe liver disease presents with a prolonged prothrombin time (PT) and is scheduled for an invasive procedure. Which of the following is the most appropriate blood product for correcting their coagulopathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cryoprecipitate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prothrombin complex concentrate (PCC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fresh frozen plasma (FFP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet concentrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Fresh frozen plasma (FFP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Fresh frozen plasma (FFP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cryoprecipitate: While cryoprecipitate is a source of fibrinogen and factor VIII, it would not address the multiple coagulation factor deficiencies commonly seen in liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cryoprecipitate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prothrombin Complex Concentrate (PCC): PCC contains vitamin K-dependent clotting factors (II, VII, IX, and X), but patients with liver disease may also have deficiencies in other factors not included in PCC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prothrombin Complex Concentrate (PCC):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelet concentrate: Platelets are used to treat thrombocytopenia (low platelet count), not coagulation factor deficiencies. While liver disease can cause thrombocytopenia, it is not the primary concern in this scenario where the patient has a prolonged PT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelet concentrate:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ FFP is the preferred blood product for correcting coagulopathy in liver disease due to its comprehensive coagulation factor content.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the typical percentage increase in clotting factor levels expected after one unit of FFP transfusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;40%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 30%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10%: This is too low of an increase. FFP contains a significant amount of clotting factors, and a single unit typically raises levels by more than 10%.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10%:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 20%: This is also too low of an increase. The expected increase is generally closer to 30%.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 20%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 40%: This is an overestimation of the increase. While FFP does contain clotting factors, the volume transfused and the recipient&#x27;s plasma volume will affect the overall percentage increase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 40%:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ FFP provides a moderate increase in clotting factor levels and is suitable for most coagulopathies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with von Willebrand disease (vWD) is experiencing a bleeding episode. Which of the following blood products is most appropriate for managing this patient&#x27;s bleeding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fresh frozen plasma (FFP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prothrombin complex concentrate (PCC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cryoprecipitate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelets&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cryoprecipitate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cryoprecipitate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fresh frozen plasma (FFP): While FFP contains vWF and factor VIII, the concentrations are lower than in cryoprecipitate. Thus, a larger volume of FFP would be needed to achieve the same therapeutic effect, potentially increasing the risk of volume overload.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fresh frozen plasma (FFP):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prothrombin complex concentrate (PCC): PCC contains vitamin K-dependent clotting factors (II, VII, IX, and X) but does not contain vWF or factor VIII. It is not indicated for vWD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prothrombin complex concentrate (PCC):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelets: Platelets are primarily used to treat thrombocytopenia (low platelet count), not deficiencies in vWF or factor VIII. While vWD can affect platelet function, the primary defect is in vWF, which is necessary for platelet adhesion and aggregation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelets:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Cryoprecipitate is the preferred treatment for bleeding in vWD due to its high concentration of vWF and factor VIII.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the recommended minimum irradiation dose for the center of a blood product bag to prevent TA-GVHD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;15 Gy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;25 Gy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;35 Gy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;50 Gy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 25 Gy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 25 Gy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 15 Gy: This dose is insufficient to reliably inactivate all donor lymphocytes in the blood product, which is necessary to prevent TA-GVHD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 15 Gy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 35 Gy and Option D. 50 Gy: While these higher doses would effectively prevent TA-GVHD, they are unnecessary and could cause excessive damage to red blood cells, potentially compromising their functionality and lifespan.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 35 Gy&lt;/li&gt;&lt;li&gt;â€¢ Option D. 50 Gy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The irradiation dose for blood products is standardized to ensure effective prevention of TA-GVHD while minimizing damage to blood components.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the optimal timing for leukoreduction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediately before transfusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Within 3-5 days of blood collection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;After 5 days of blood collection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The timing of leukoreduction does not matter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Within 3-5 days of blood collection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Within 3-5 days of blood collection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of severe febrile non-hemolytic transfusion reactions (FNHTR) is scheduled for surgery and requires a red blood cell (RBC) transfusion. The blood bank is unable to provide leukoreduced RBCs due to limited supply. Which of the following alternative methods could be considered to potentially reduce the risk of FNHTR in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Irradiation of RBCs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Washing of RBCs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;UVB-treated RBCs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasmapheresis of RBCs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. UVB-treated RBCs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) UVB-treated RBCs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Irradiation of RBCs: Irradiation is primarily used to prevent transfusion-associated graft-versus-host disease (TA-GVHD) in immunocompromised patients. It does not specifically address the risk of FNHTR.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Irradiation of RBCs:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Washing of RBCs: Washing RBCs can remove some plasma proteins and antibodies, which may be helpful in preventing allergic reactions. However, it is not as effective as leukoreduction in preventing FNHTR, which is primarily caused by cytokines released from white blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Washing of RBCs:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Plasmapheresis of RBCs: Plasmapheresis is a procedure that separates plasma from blood cells and is not relevant to reducing the risk of FNHTR.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Plasmapheresis of RBCs:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ UVB-treated RBCs may be considered as an alternative to leukoreduced RBCs in situations where leukoreduction is not feasible or unavailable. However, the efficacy of UVB treatment in preventing FNHTR is still under investigation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents with a history of recurrent bacterial infections and is found to have low IgG levels. Which of the following is the most appropriate treatment option for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plasmapheresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous immunoglobulin (IVIG)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous immunoglobulin (IVIG)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intravenous immunoglobulin (IVIG)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plasmapheresis: This is used to remove harmful substances from blood and is not indicated in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plasmapheresis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids: While corticosteroids have immunomodulatory effects, they are not the first-line treatment for hypogammaglobulinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab: This is a monoclonal antibody targeting CD20-positive B cells and is not indicated for primary immunodeficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ IVIG is a crucial therapy for patients with primary immunodeficiencies, providing passive immunity by supplementing IgG levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with WaldenstrÃ¶m macroglobulinemia (WM) presents with hyperviscosity syndrome. Which of the following is the most appropriate initial therapeutic intervention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plasmapheresis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Splenectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Plasmapheresis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Plasmapheresis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a standard TPE procedure, what is the recommended plasma volume that has to be exchanged?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-1.5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2-3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3-5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1-1.5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1-1.5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to the Advanced Trauma Life Support (ATLS) definition, massive transfusion is defined as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transfusion of &amp;gt;5 units of packed red blood cells (PRBCs) in 24 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transfusion of &amp;gt;10 units of PRBCs in 24 hours&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transfusion of any amount of PRBCs in a patient with hemorrhagic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transfusion of PRBCs, platelets, and plasma in a 1:1:1 ratio&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Transfusion of &gt;10 units of PRBCs in 24 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Transfusion of &amp;gt;10 units of PRBCs in 24 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of liver disease receives a massive blood transfusion. Which complication should be monitored closely due to the presence of citrate in transfused blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypothermia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypocalcemia and metabolic alkalosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombocytopenia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypocalcemia and metabolic alkalosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypocalcemia and metabolic alkalosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypothermia: Hypothermia can be a complication of massive transfusion, but it&#x27;s primarily caused by the rapid infusion of cold blood products, not the citrate preservative.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypothermia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperkalemia: While hyperkalemia can occur during massive transfusion, it&#x27;s usually due to the breakdown of red blood cells releasing potassium, not the citrate itself.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperkalemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombocytopenia: Thrombocytopenia (low platelet count) can occur due to dilution from massive transfusion or consumption of platelets in trauma or sepsis. It&#x27;s not directly related to citrate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombocytopenia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Patients with liver disease are at increased risk for hypocalcemia and metabolic alkalosis following blood transfusion due to impaired citrate metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient receiving a massive transfusion develops bleeding and prolonged PT/aPTT/ increased INR. Which of the following is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Citrate toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothermia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dilution of clotting factors&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dilution of clotting factors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dilution of clotting factors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Citrate toxicity: While citrate, used as an anticoagulant in blood products, can bind calcium and potentially affect coagulation, it&#x27;s less likely to be the primary cause of bleeding and prolonged clotting times in massive transfusion. Citrate toxicity usually manifests with hypocalcemia (low calcium levels), tingling sensations, and muscle cramps.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Citrate toxicity:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypothermia: Hypothermia can exacerbate coagulopathy, but it&#x27;s more likely to slow down enzymatic reactions and platelet function rather than directly causing a deficiency in clotting factors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypothermia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperkalemia: Hyperkalemia (high potassium levels) can occur in massive transfusion due to the breakdown of red blood cells. However, it primarily affects cardiac function and does not directly cause coagulopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperkalemia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Dilution of clotting factors is a common complication of massive transfusion and requires close monitoring and appropriate intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient develops fever, chills, flank pain, and hypotension after starting a red blood cell transfusion. Urine output is significantly reduced, and the urine appears dark. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Febrile non-hemolytic transfusion reaction (FNHTR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transfusion-related acute lung injury (TRALI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allergic transfusion reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute hemolytic transfusion reaction (AHTR)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acute hemolytic transfusion reaction (AHTR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Acute hemolytic transfusion reaction (AHTR)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Febrile non-hemolytic transfusion reaction (FNHTR): While FNHTR is the most common transfusion reaction, it typically presents with fever and chills but not hypotension, flank pain, or dark urine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Febrile non-hemolytic transfusion reaction (FNHTR):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transfusion-related acute lung injury (TRALI): TRALI is characterized by acute respiratory distress (e.g., dyspnea, hypoxemia) and non-cardiogenic pulmonary edema, which are not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transfusion-related acute lung injury (TRALI):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allergic transfusion reaction: Allergic reactions usually manifest with urticaria (hives), itching, and sometimes bronchospasm. They typically do not cause flank pain, dark urine, or significant hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allergic transfusion reaction:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ AHTR is a life-threatening emergency requiring immediate recognition and intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common cause of acute hemolytic transfusion reactions (AHTR)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ABO incompatibility&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rh incompatibility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Kell antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-Jka antibodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ABO incompatibility&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ABO incompatibility&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rh incompatibility: While Rh incompatibility can cause hemolytic disease of the newborn (HDN) and delayed hemolytic transfusion reactions, it is less common as a cause of acute hemolytic reactions compared to ABO incompatibility.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rh incompatibility:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Kell antibodies: Anti-Kell antibodies can cause severe hemolytic transfusion reactions, both acute and delayed, but they are much rarer than ABO incompatibility.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Kell antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-Jka antibodies: Anti-Jka antibodies (part of the Kidd blood group system) can cause delayed hemolytic transfusion reactions, but they are less common than ABO incompatibility as a cause of acute reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-Jka antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Careful pre-transfusion testing for ABO compatibility is crucial for preventing AHTR.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the primary mechanism behind febrile non-hemolytic transfusion reactions (FNHTR)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Recipient antibodies reacting with donor white blood cells (WBCs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recipient antibodies reacting with donor red blood cells (RBCs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytokines released from donor WBCs during storage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and C&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Both A and C&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Both A and C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Recipient antibodies reacting with donor red blood cells (RBCs): This mechanism would lead to a hemolytic transfusion reaction, not FNHTR. Hemolytic reactions are more serious and involve the destruction of red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Recipient antibodies reacting with donor red blood cells (RBCs):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ FNHTR has both immunologic and non-immunologic causes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is receiving a blood transfusion. What is the approximate percentage of patients who experience a minor allergic reaction during or shortly after a transfusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.1-1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-3%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5-10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10-20%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1-3%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1-3%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of recurrent allergic reactions to blood transfusions presents for a scheduled surgery. Which of the following tests is most appropriate to assess their risk of anaphylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Direct antiglobulin test (DAT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum IgA levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HLA antibody screening&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet aggregation studies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum IgA levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum IgA levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Direct antiglobulin test (DAT): The DAT detects antibodies or complement proteins bound to red blood cells. While it is useful in diagnosing certain types of transfusion reactions (like hemolytic reactions), it doesn&#x27;t directly assess the risk of IgA-mediated anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Direct antiglobulin test (DAT):&lt;/li&gt;&lt;li&gt;â€¢ Option C. HLA antibody screening: HLA antibodies are directed against human leukocyte antigens (HLA) on white blood cells. While these antibodies can cause transfusion reactions, they are not the primary culprit in IgA deficiency-related anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HLA antibody screening:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelet aggregation studies: These tests assess platelet function and are primarily used to investigate bleeding disorders. They are not relevant to the diagnosis of IgA deficiency or the assessment of anaphylaxis risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelet aggregation studies:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Serum immunoglobulin levels are essential for diagnosing IgA deficiency in patients with a history of transfusion reactions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate initial treatment for a patient experiencing anaphylaxis during a blood transfusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antihistamines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epinephrine + Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous fluids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Epinephrine + Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Epinephrine + Corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antihistamines: Antihistamines like diphenhydramine can help with allergic symptoms like hives and itching, but they are not sufficient to treat anaphylaxis and should not be used alone.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antihistamines:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids alone: While corticosteroids are important, they do not provide the immediate, life-saving effects of epinephrine in anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids alone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous fluids: IV fluids are used to support blood pressure in anaphylaxis, but they are not the primary or initial treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous fluids:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Epinephrine is essential for managing anaphylactic transfusion reactions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient develops acute respiratory distress, fever, and hypotension within 2 hours of receiving a blood transfusion. On examination, there was no rise in JVP/pedal edema Chest X-ray reveals bilateral pulmonary infiltrates. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute hemolytic transfusion reaction (AHTR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transfusion-associated circulatory overload (TACO)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transfusion-related acute lung injury (TRALI)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaphylactic transfusion reaction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transfusion-related acute lung injury (TRALI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Transfusion-related acute lung injury (TRALI)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute hemolytic transfusion reaction (AHTR): While AHTR can also cause fever and hypotension, it typically presents with additional symptoms like flank pain, hemoglobinuria (dark urine), and signs of hemolysis (increased bilirubin, decreased haptoglobin).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute hemolytic transfusion reaction (AHTR):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transfusion-associated circulatory overload (TACO): TACO is characterized by signs of fluid overload, such as hypertension, elevated jugular venous pressure (JVP), and peripheral edema. Patients with TACO may also have respiratory distress due to pulmonary edema, but it is usually not associated with fever or hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transfusion-associated circulatory overload (TACO):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anaphylactic transfusion reaction: Anaphylactic reactions typically manifest with urticaria (hives), angioedema, and bronchospasm. While hypotension can occur, it is usually accompanied by other allergic symptoms not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anaphylactic transfusion reaction:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ TRALI is a serious complication of transfusion characterized by acute lung injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the first step in the management of a suspected TRALI reaction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start broad-spectrum antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate mechanical ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stop the transfusion&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Stop the transfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Stop the transfusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer diuretics: While pulmonary edema is a hallmark of TRALI, it is non-cardiogenic (not due to heart failure). Diuretics, which help remove excess fluid in cardiogenic edema, are not effective in TRALI and could worsen the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer diuretics:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start broad-spectrum antibiotics: TRALI is an immune-mediated reaction, not an infection. Antibiotics would not be helpful in this situation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start broad-spectrum antibiotics:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate mechanical ventilation: While mechanical ventilation may be necessary if the patient&#x27;s respiratory distress worsens, the first priority is to stop the transfusion, which is the source of the problem. Mechanical ventilation can be initiated later if needed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate mechanical ventilation:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Stopping the transfusion is the first and most crucial step in managing TRALI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old woman with a history of congestive heart failure receives 2 units of packed red blood cells (PRBCs) over 2 hours. Shortly after the transfusion, she develops dyspnea, orthopnea, and cough. Her blood pressure is 150/90 mmHg, and her jugular venous pressure (JVP) is elevated. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute hemolytic transfusion reaction (AHTR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transfusion-related acute lung injury (TRALI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transfusion-associated circulatory overload (TACO)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allergic transfusion reaction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transfusion-associated circulatory overload (TACO)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Transfusion-associated circulatory overload (TACO)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute hemolytic transfusion reaction (AHTR): While AHTR can cause dyspnea and hypotension, it typically presents with fever, chills, flank pain, and hemoglobinuria (dark urine), which are not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute hemolytic transfusion reaction (AHTR):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transfusion-related acute lung injury (TRALI): TRALI also causes respiratory distress, but it typically presents with fever and hypotension within 6 hours of transfusion and is not associated with elevated JVP or hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transfusion-related acute lung injury (TRALI):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allergic transfusion reaction: Allergic transfusion reactions usually manifest with mild symptoms like urticaria (hives), itching, and flushing. They do not typically cause the severe respiratory distress and cardiovascular symptoms seen in TACO.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allergic transfusion reaction:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ TACO is a complication of transfusion caused by fluid overload, and its symptoms can mimic congestive heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient develops jaundice, fever, and a gradual drop in hemoglobin levels one week after receiving a blood transfusion. The pre-transfusion antibody screen was negative. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute hemolytic transfusion reaction (AHTR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Febrile non-hemolytic transfusion reaction (FNHTR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transfusion-related acute lung injury (TRALI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Delayed hemolytic transfusion reaction (DHTR)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Delayed hemolytic transfusion reaction (DHTR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Delayed hemolytic transfusion reaction (DHTR)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute hemolytic transfusion reaction (AHTR): AHTR typically presents with rapid onset (within hours) of fever, chills, flank pain, and hemoglobinuria. It is usually caused by ABO incompatibility, which would have been detected in the pre-transfusion testing.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute hemolytic transfusion reaction (AHTR):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Febrile non-hemolytic transfusion reaction (FNHTR): FNHTR is the most common type of transfusion reaction and usually presents with fever and chills within a few hours of transfusion. It is not associated with jaundice or a drop in hemoglobin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Febrile non-hemolytic transfusion reaction (FNHTR):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transfusion-related acute lung injury (TRALI): TRALI presents with acute respiratory distress, hypotension, and pulmonary edema shortly after transfusion. It does not typically cause jaundice or a delayed drop in hemoglobin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transfusion-related acute lung injury (TRALI):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ DHTRs are typically delayed and caused by undetected antibodies against minor blood group antigens.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antibodies is most commonly implicated in the pathogenesis of Post-Transfusion Purpura (PTP)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-RhD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Kell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-HPA-1a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-Fya&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-HPA-1a&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-HPA-1a&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following heparin products is associated with the lowest risk of heparin-induced thrombocytopenia (HIT)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Unfractionated heparin (UFH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low molecular weight heparin (LMWH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fondaparinux&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bivalirudin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Fondaparinux&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Fondaparinux&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Unfractionated heparin (UFH): UFH has the highest risk of HIT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Unfractionated heparin (UFH):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low molecular weight heparin (LMWH) : LMWH has a lower risk than UFH but can still cause HIT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low molecular weight heparin (LMWH)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bivalirudin : Bivalirudin is a direct thrombin inhibitor and does not cause HIT, but it is not a heparin product.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bivalirudin&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Fondaparinux is the safest heparin product for patients with a history of or suspected HIT.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with fever, petechiae, confusion, and acute kidney injury. Her peripheral blood smear shows schistocytes and thrombocytopenia. Which of the following tests is MOST LIKELY to confirm the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coombs test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ADAMTS13 activity level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum haptoglobin level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. ADAMTS13 activity level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) ADAMTS13 activity level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coombs test is used to diagnose immune-mediated hemolytic anemias.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coombs test&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone marrow biopsy is not indicated in the initial workup of TTP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone marrow biopsy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum haptoglobin level is low in hemolysis, but it is not specific for TTP.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum haptoglobin level&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ADAMTS13 deficiency is the hallmark of TTP and its measurement is crucial for diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of systemic lupus erythematosus (SLE) presents with anemia, jaundice, and spherocytes on the peripheral smear. Which of the following is the most likely cause of the anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune hemolytic anemia (AIHA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Microangiopathic hemolytic anemia (MAHA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aplastic anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Autoimmune hemolytic anemia (AIHA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Autoimmune hemolytic anemia (AIHA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Microangiopathic hemolytic anemia (MAHA): MAHA is characterized by schistocytes, not spherocytes, on the peripheral smear.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Microangiopathic hemolytic anemia (MAHA):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vitamin B12 deficiency: Vitamin B12 deficiency causes megaloblastic anemia with hypersegmented neutrophils and macro-ovalocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Vitamin B12 deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aplastic anemia: Aplastic anemia is characterized by pancytopenia and hypocellular bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Aplastic anemia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ SLE is a common cause of secondary AIHA, and spherocytes are a hallmark of this condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a recent diagnosis of chronic lymphocytic leukemia (CLL) presents with fatigue, easy bruising, and petechiae. His platelet count is 20,000/ÂµL. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primary immune thrombocytopenia (ITP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug-induced thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin-induced thrombocytopenia (HIT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Secondary ITP associated with CLL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Secondary ITP associated with CLL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Secondary ITP associated with CLL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary immune thrombocytopenia (ITP): While ITP presents with isolated thrombocytopenia, the presence of CLL suggests a secondary cause in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Primary immune thrombocytopenia (ITP):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Drug-induced thrombocytopenia: There is no mention of recent medication use to suggest this diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Drug-induced thrombocytopenia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heparin-induced thrombocytopenia (HIT): HIT is an immune-mediated reaction to heparin, which is not mentioned in the patient&#x27;s history.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Heparin-induced thrombocytopenia (HIT):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Secondary ITP can be caused by various underlying conditions, including lymphoproliferative disorders like CLL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman on unfractionated heparin (UFH) for a deep vein thrombosis (DVT) develops a platelet count of 90,000/ÂµL on day 3 of therapy. Her baseline platelet count was 250,000/ÂµL. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I heparin-induced thrombocytopenia (HIT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type II HIT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudothrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug-induced thrombocytopenia (DITP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Type I heparin-induced thrombocytopenia (HIT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Type I heparin-induced thrombocytopenia (HIT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type II HIT : Type II HIT is an immune-mediated condition that usually occurs later (5-10 days) and is associated with a higher risk of thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type II HIT&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudothrombocytopenia : This is a lab artifact where platelets clump in the test tube, but the patient&#x27;s smear does not show clumping.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudothrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option D. DITP : This is less likely given the temporal association with heparin initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. DITP&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Early, mild thrombocytopenia in a patient on heparin is most likely Type I HIT, which is usually benign and does not require heparin discontinuation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of malignant hypertension presents with MAHA, thrombocytopenia, and acute kidney injury. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TTP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HUS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DIC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TMA&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TMA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) TMA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. TTP (Thrombotic Thrombocytopenic Purpura): While TTP can present with MAHA, thrombocytopenia, and acute kidney injury, it is typically associated with a deficiency of the ADAMTS13 enzyme. This patient&#x27;s history of malignant hypertension makes TMA a more likely diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. TTP (Thrombotic Thrombocytopenic Purpura):&lt;/li&gt;&lt;li&gt;â€¢ Option B. HUS (Hemolytic Uremic Syndrome): HUS is often associated with Shiga-toxin producing E. coli infection and commonly presents with bloody diarrhea. The patient&#x27;s history does not suggest this.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. HUS (Hemolytic Uremic Syndrome):&lt;/li&gt;&lt;li&gt;â€¢ Option C. DIC (Disseminated Intravascular Coagulation): DIC is a consumptive coagulopathy triggered by a systemic illness (e.g., sepsis, malignancy). While it can cause MAHA and thrombocytopenia, it would typically present with abnormal coagulation parameters (prolonged PT/PTT, low fibrinogen) which are not mentioned in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. DIC (Disseminated Intravascular Coagulation):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ It&#x27;s important to consider secondary causes of TMA, such as malignant hypertension, in patients with relevant risk factors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child presents with bloody diarrhea, pallor, and decreased urine output after eating undercooked meat at a family barbecue. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HUS D+&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HUS D-&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TTP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. HUS D+&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) HUS D+&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. HUS D : This form is not typically associated with bloody diarrhea and is usually caused by complement dysregulation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ HUS D&lt;/li&gt;&lt;li&gt;â€¢ Option C. TTP : TTP is characterized by severe ADAMTS13 deficiency and does not typically present with bloody diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TTP&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgA nephropathy : This condition typically presents with hematuria after an upper respiratory infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgA&lt;/li&gt;&lt;li&gt;â€¢ nephropathy&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ HUS D+ is a serious condition that can occur in children after consuming contaminated food&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic mutations is NOT typically associated with familial atypical HUS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CFI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD46&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;STXBP5&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. STXBP5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) STXBP5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CFH, Option B. CFI and Option C. CD46: These genes all encode complement regulatory proteins, and mutations in them can lead to familial aHUS.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. CFH, Option&lt;/li&gt;&lt;li&gt;â€¢ B. CFI&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. CD46:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Familial atypical HUS is a genetically heterogeneous disorder with mutations in several complement regulatory genes. Recognizing the role of these genes is essential for accurate diagnosis, genetic counseling, and potential targeted therapies. While STXBP5 mutations are more commonly associated with a neurological disorder and are not typically seen in familial cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with suspected TTP has a severely reduced ADAMTS13 activity level. Which of the following treatments is the cornerstone of management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet transfusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasma exchange&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Plasma exchange&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Plasma exchange&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Platelet transfusion: Platelet transfusions are contraindicated in TTP as they can worsen thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Platelet transfusion:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids: Corticosteroids can be used as adjunctive therapy but are not the primary treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Corticosteroids:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rituximab: Rituximab can be used in refractory or relapsing TTP but is not the first-line therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Rituximab:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Plasma exchange is the most effective treatment for TTP and should be initiated promptly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents to the clinic with a two-week history of easy bruising and pinprick red spots on her lower legs. She denies any recent injuries or medication use. On examination, she has multiple petechiae on her skin and mucous membranes. Blood investigations except low platelet count, imagings turned out to be normal. What&#x27;s the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aplastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immune thrombocytopenia (ITP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome (MDS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic microangiopathy (TMA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immune thrombocytopenia (ITP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Immune thrombocytopenia (ITP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aplastic anemia : While it can cause thrombocytopenia, it also affects other cell lines (red blood cells and white blood cells).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aplastic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myelodysplastic syndrome (MDS) : MDS can cause thrombocytopenia, but it is more common in older adults and often presents with other cytopenias.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myelodysplastic syndrome (MDS)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic microangiopathy (TMA) : TMA causes thrombocytopenia through a different mechanism (platelet consumption in microvascular thrombi).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic microangiopathy (TMA)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ITP is a diagnosis of exclusion, meaning other causes of thrombocytopenia need to be ruled out.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with fatigue, jaundice, and petechiae. Her blood work shows anemia, thrombocytopenia, and a positive direct Coombs test (DCT). Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Evans syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic thrombocytopenic purpura (TTP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Evans syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Evans syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune hepatitis : While it can cause jaundice, it doesn&#x27;t typically cause thrombocytopenia or a positive DCT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune hepatitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Systemic lupus erythematosus (SLE) : SLE can cause a variety of hematologic abnormalities, but the combination of findings is more specific for Evans syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Systemic lupus erythematosus (SLE)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic thrombocytopenic purpura (TTP) : TTP is a thrombotic microangiopathy that typically doesn&#x27;t cause a positive DCT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic thrombocytopenic purpura (TTP)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Evans syndrome is a rare but serious condition that requires prompt diagnosis and treatment. Recognizing the combination of ITP and AIHA is crucial.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old asymptomatic woman has a routine complete blood count (CBC) which shows a platelet count of 80,000/ÂµL. Peripheral blood smear shows large platelet clumps. Given the likely diagnosis, Which of the following is the most appropriate next step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Repeat the CBC in a sodium citrate tube&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start corticosteroids for ITP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Order a bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Begin heparin therapy for HIT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Repeat the CBC in a sodium citrate tube&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Repeat the CBC in a sodium citrate tube&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start corticosteroids for ITP : Corticosteroids are used to treat ITP, but this is not appropriate until pseudothrombocytopenia is ruled out.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start corticosteroids for ITP&lt;/li&gt;&lt;li&gt;â€¢ Option C. Order a bone marrow biopsy : A bone marrow biopsy is not necessary for the diagnosis of pseudothrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Order a bone marrow biopsy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Begin heparin therapy for HIT : Heparin therapy is contraindicated in HIT and should not be started until this diagnosis is ruled out.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Begin heparin therapy for HIT&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Repeating the CBC in a citrate tube is a simple and effective way to confirm pseudothrombocytopenia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with a 2-week history of fatigue, petechiae, and mucosal bleeding. Blood tests reveal isolated thrombocytopenia with a platelet count of 15,000/ÂµL. Which of the following is the MOST APPROPRIATE initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eltrombopag&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Splenectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rituximab : Second-line treatment for persistent/chronic ITP.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Rituximab&lt;/li&gt;&lt;li&gt;â€¢ Option C. Eltrombopag : Second-line treatment for persistent/chronic ITP.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Eltrombopag&lt;/li&gt;&lt;li&gt;â€¢ Option D. Splenectomy : Second-line treatment for persistent/chronic ITP.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Splenectomy&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Corticosteroids are the mainstay of initial therapy for acute ITP due to their rapid effect on platelet counts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with a 5-year history of chronic ITP has persistent thrombocytopenia (25,000/ÂµL) despite prior treatments with corticosteroids, IVIg, and TPO-RAs. She experiences frequent bleeding and seeks further management options. Which of the following is the next step in her management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Splenectomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Danazol therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fostamatinib therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Splenectomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Splenectomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rituximab infusion: While rituximab can be effective in some patients, its response rate is lower than splenectomy and the onset of action is delayed. It also carries potential for serious side effects like infections and infusion reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Rituximab infusion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Danazol therapy: Danazol is an older medication with limited evidence of efficacy in ITP and potential for masculinizing side effects in women, making it a less preferred option.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Danazol therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fostamatinib therapy: This is a newer option with promising results, but it has less long-term data than splenectomy and may have adverse effects like hypertension, diarrhea, and hepatotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Fostamatinib therapy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ In patients with chronic ITP refractory to initial therapies, splenectomy offers the highest chance of long-term remission, but it should be considered after weighing the risks and benefits of surgery. Other options like rituximab and fostamatinib may be considered in select cases, while danazol is less commonly used due to its limited efficacy and side effect profile.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with ITP has a platelet count of 35,000/ÂµL. She is asymptomatic and has no history of bleeding. Which of the following is the most appropriate management strategy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IVIG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Splenectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Observation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Observation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids : Corticosteroids are not indicated for asymptomatic patients with mild thrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option C. IVIG : IVIG is reserved for more severe cases or when there is active bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ IVIG&lt;/li&gt;&lt;li&gt;â€¢ Option D. Splenectomy : Splenectomy is a last resort for refractory ITP and is not indicated at this stage.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Splenectomy&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Observation is appropriate for asymptomatic patients with mild thrombocytopenia (platelet count &amp;gt;20-30K).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman develops new-onset thrombocytopenia and thrombosis 6 days after initiating unfractionated heparin (UFH) for DVT prophylaxis following knee replacement surgery. Her medical history is significant for hypertension and osteoarthritis. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune Thrombocytopenic Purpura (ITP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type I Heparin-Induced Thrombocytopenia (HIT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type II Heparin-Induced Thrombocytopenia (HIT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic Thrombocytopenic Purpura (TTP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type II Heparin-Induced Thrombocytopenia (HIT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type II Heparin-Induced Thrombocytopenia (HIT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune Thrombocytopenic Purpura (ITP) : ITP is an autoimmune disorder that can cause thrombocytopenia but is not typically associated with thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune Thrombocytopenic Purpura (ITP)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type I Heparin-Induced Thrombocytopenia (HIT): This is a non-immune mediated form of HIT that usually occurs within the first 2 days of heparin exposure and is not associated with thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type I Heparin-Induced Thrombocytopenia (HIT):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic Thrombocytopenic Purpura (TTP): TTP is a rare disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and neurologic symptoms. It is not typically associated with heparin use.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic Thrombocytopenic Purpura (TTP):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ New-onset thrombocytopenia and thrombosis in a patient recently started on heparin should raise suspicion for Type II HIT, which warrants immediate discontinuation of heparin and initiation of alternative anticoagulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female on prophylactic enoxaparin (LMWH) for 3 weeks after surgery develops a new DVT. Her platelet count has decreased by 40% from baseline. What is her 4Ts score for HIT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with HIT and no evidence of thrombosis requires anticoagulation. Which of the following is the recommended duration of anticoagulation therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1 month&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;6 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1 month&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1 month&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1 week: This is too short a duration. HIT antibodies can persist for weeks to months, and the risk of delayed thrombosis remains high during this period.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. 1 week:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 3 months: This duration is typically recommended for patients with HIT who have experienced thrombotic events. While there is some debate about extending anticoagulation beyond one month in patients without thrombosis, the current consensus leans towards 1 month as sufficient in most cases.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. 3 months:&lt;/li&gt;&lt;li&gt;â€¢ have&lt;/li&gt;&lt;li&gt;â€¢ Option D. 6 months: This duration is unnecessarily long for patients with HIT without thrombosis. Prolonged anticoagulation carries its own risks, such as bleeding&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. 6 months:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Even in the absence of thrombosis, HIT requires extended anticoagulation due to the persistent risk of thrombotic events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about re-exposure to heparin in patients with a history of HIT is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Re-exposure is safe after 6 months.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Re-exposure is safe if the platelet count is normal.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Re-exposure should be avoided due to the high risk of recurrence.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Re-exposure is safe if a different type of heparin is used (e.g., LMWH instead of UFH).&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Re-exposure should be avoided due to the high risk of recurrence.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Re-exposure should be avoided due to the high risk of recurrence.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical clinical feature of Thrombotic Microangiopathy (TMA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Microangiopathic hemolytic anemia (MAHA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolonged PT and PTT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal dysfunction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prolonged PT and PTT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prolonged PT and PTT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thrombocytopenia : A key feature of TMA due to platelet consumption in microthrombi.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Microangiopathic hemolytic anemia (MAHA) : Also a key feature of TMA due to mechanical damage to red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Microangiopathic hemolytic anemia (MAHA)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Renal dysfunction : Can occur due to microthrombi formation in the kidneys.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Renal&lt;/li&gt;&lt;li&gt;â€¢ dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Normal PT and PTT help differentiate TMA from other conditions like DIC, which typically present with abnormal coagulation tests.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents with fever, altered mental status, thrombocytopenia, and evidence of hemolysis seen. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune Thrombocytopenia (ITP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic Uremic Syndrome (HUS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombotic Thrombocytopenic Purpura (TTP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Disseminated Intravascular Coagulation (DIC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thrombotic Thrombocytopenic Purpura (TTP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Thrombotic Thrombocytopenic Purpura (TTP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune Thrombocytopenia ( ITP): ITP is characterized by isolated thrombocytopenia without MAHA or other systemic symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune Thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ ITP):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic Uremic Syndrome (HUS): HUS typically presents with renal failure and is more common in children following a gastrointestinal infection.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemolytic Uremic Syndrome (HUS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Disseminated Intravascular Coagulation (DIC): DIC is a consumptive coagulopathy with prolonged clotting times and often bleeding complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Disseminated Intravascular Coagulation&lt;/li&gt;&lt;li&gt;â€¢ (DIC):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The clinical pentad of TTP includes thrombocytopenia, MAHA, altered mental status, fever, and (less commonly) renal failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-month-old infant presents with lethargy, hypotonia, and developmental delay. Laboratory investigations reveal megaloblastic anemia, elevated homocysteine and methylmalonic acid (MMA) levels. Which of the following conditions is MOST LIKELY to predispose this infant to thrombotic microangiopathy (TMA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methylmalonic acidemia due to MMACHC mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dihydrofolate reductase (DHFR) deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Maple syrup urine disease (MSUD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tyrosinemia type I&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Methylmalonic acidemia due to MMACHC mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Methylmalonic acidemia due to MMACHC mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dihydrofolate reductase (DHFR) deficiency : DHFR deficiency primarily affects folate metabolism and does not directly predispose to TMA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dihydrofolate reductase (DHFR) deficiency&lt;/li&gt;&lt;li&gt;â€¢ Option C. Maple syrup urine disease (MSUD) : MSUD is an amino acid disorder and is not associated with increased risk of TMA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Maple syrup urine disease (MSUD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tyrosinemia type I : Tyrosinemia type I is a metabolic disorder affecting tyrosine metabolism and does not typically predispose to TMA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tyrosinemia type I&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ MMACHC mutations can lead to elevated homocysteine levels, which increases the risk of developing thrombotic microangiopathy (TMA) in affected individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the PRIMARY agonist responsible for platelet aggregation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thromboxane A2 (TxA2)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine Diphosphate (ADP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fibrinogen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Fibrinogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Fibrinogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thromboxane A2 (TxA2) : TxA2 is a potent platelet activator and vasoconstrictor, but it does not directly mediate platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thromboxane A2 (TxA2)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine Diphosphate (ADP) : ADP is a weak platelet activator that promotes platelet aggregation by binding to P2Y12 and P2Y1 receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine Diphosphate (ADP)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thrombin : Thrombin is a powerful platelet activator and promotes aggregation through protease-activated receptors (PARs).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thrombin&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Fibrinogen is the primary agonist responsible for platelet aggregation by cross-linking activated platelets through GP IIb/IIIa receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs inhibits platelet aggregation by irreversibly blocking the P2Y12 receptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abciximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eptifibatide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clopidogrel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Clopidogrel&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin : Aspirin irreversibly inhibits cyclooxygenase (COX)-1, preventing TxA2 production.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Abciximab : Abciximab is a monoclonal antibody that blocks GP IIb/IIIa receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Abciximab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eptifibatide : Eptifibatide is a cyclic heptapeptide that reversibly blocks GP IIb/IIIa receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eptifibatide&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Clopidogrel inhibits platelet aggregation by irreversibly blocking the P2Y12 receptor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy presents with a history of easy bruising, frequent nosebleeds, and prolonged bleeding after minor injuries. His parents report that he had significant bleeding during circumcision as a newborn. Platelet count and coagulation studies are normal. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Von Willebrand Disease (VWD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemophilia A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glanzmann thrombasthenia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune Thrombocytopenia Purpura (ITP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glanzmann thrombasthenia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Glanzmann thrombasthenia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand Disease (VWD): VWD is the most common inherited bleeding disorder caused by a deficiency or defect in von Willebrand factor (vWF). While it can present with mucocutaneous bleeding, it is usually associated with prolonged bleeding time and abnormal platelet function tests (e.g., ristocetin cofactor activity).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand Disease (VWD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemophilia A: Hemophilia A is an X-linked recessive disorder caused by a deficiency of factor VIII. It typically presents with deep tissue bleeding (e.g., hemarthrosis) rather than mucocutaneous bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemophilia A:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune Thrombocytopenia Purpura (ITP): ITP is an autoimmune disorder characterized by isolated thrombocytopenia due to increased platelet destruction. It is not typically associated with a history of significant bleeding in the neonatal period.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune Thrombocytopenia Purpura (ITP):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Glanzmann thrombasthenia is a rare but important differential diagnosis in patients presenting with a history of mucocutaneous bleeding and normal platelet count and coagulation studies. A platelet aggregation test can confirm the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with a history of heavy menstrual bleeding since menarche. She also reports easy bruising and prolonged bleeding after minor cuts. Physical examination reveals scattered petechiae. Which of the following tests is most likely to be diagnostic?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ristocetin cofactor activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelet aggregation studies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Factor VIII assay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Platelet aggregation studies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Platelet aggregation studies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ristocetin cofactor activity : This test measures the function of von Willebrand factor (vWF) and is used in the diagnosis of von Willebrand disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ristocetin cofactor activity&lt;/li&gt;&lt;li&gt;â€¢ Option C. Factor VIII assay : This test is used to diagnose hemophilia A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Factor VIII assay&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bone marrow biopsy : This test is not indicated in the initial workup of suspected Glanzmann thrombasthenia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bone marrow biopsy&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Platelet aggregation studies are the definitive test for diagnosing Glanzmann thrombasthenia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with a history of easy bruising, frequent epistaxis, and heavy menstrual bleeding (in females). Peripheral blood smear shows giant platelets. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Von Willebrand Disease (VWD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemophilia A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glanzmann thrombasthenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bernard-Soulier syndrome (BSS)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Bernard-Soulier syndrome (BSS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Bernard-Soulier syndrome (BSS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand Disease (VWD) : VWD presents with mucocutaneous bleeding and prolonged bleeding time, but not giant platelets.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand Disease (VWD)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemophilia A : Hemophilia A is characterized by a deficiency of factor VIII and typically presents with deep tissue bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemophilia A&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glanzmann thrombasthenia : Glanzmann thrombasthenia is a platelet aggregation disorder and does not cause giant platelets.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glanzmann thrombasthenia&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Giant platelets on peripheral blood smear are a hallmark of Bernard-Soulier syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following laboratory findings is NOT characteristic of Bernard-Soulier syndrome (BSS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Giant platelets on peripheral smear&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolonged bleeding time&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal ristocetin cofactor activity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Normal ristocetin cofactor activity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Normal ristocetin cofactor activity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child presents with a history of easy bruising, frequent nosebleeds, and prolonged bleeding after minor injuries. The platelet count is normal, but the peripheral blood smear reveals large platelets, Ultrasound imaging showed Mild spleenomegaly. Given the likely diagnosis, Which of the following is the most characteristic electron microscopy finding in Gray platelet syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant platelets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absence of dense granules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absence of alpha granules&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abnormal platelet aggregation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Absence of alpha granules&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Absence of alpha granules&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Giant platelets : While platelets may be large on peripheral smear, giant platelets are more characteristic of Bernard-Soulier syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Giant platelets&lt;/li&gt;&lt;li&gt;â€¢ Option B. Absence of dense granules : This is a feature of other platelet disorders, not Gray platelet syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Absence of dense granules&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abnormal platelet aggregation : Platelet aggregation is variable in Gray platelet syndrome but is not the most specific finding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abnormal platelet aggregation&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The absence of alpha granules on electron microscopy is the hallmark of Gray platelet syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child presents with oculocutaneous albinism, recurrent bacterial infections, and easy bruising. Peripheral smear shows normal platelet count but abnormal granulation. On further evaluation, Platelet EM studies show Î´ granule deficiency. The treating physician is suspecting a platelet disorder, Which of the following genetic mutations is NOT associated with the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HPS1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HPS3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HPS5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NBEAL2&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. NBEAL2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) NBEAL2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with recurrent pyogenic skin and respiratory infections, silver-grey hair, and nystagmus. Peripheral blood smear reveals giant granules in neutrophils. Given the likely diagnosis, Which of the following infections is MOST frequently associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Staphylococcus aureus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Streptococcus pneumoniae&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudomonas aeruginosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida albicans&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Staphylococcus aureus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Staphylococcus aureus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Streptococcus pneumoniae: While patients with Chediak-Higashi syndrome may be more susceptible to infections in general, there isn&#x27;t a specific predisposition towards Streptococcus pneumoniae compared to Staphylococcus aureus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Streptococcus pneumoniae:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudomonas aeruginosa: Pseudomonas is more commonly associated with patients with cystic fibrosis or other immunocompromised states. It&#x27;s not a hallmark infection for Chediak-Higashi.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudomonas aeruginosa:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida albicans: This is a fungal infection, and while Chediak-Higashi syndrome patients may be more susceptible to infections overall, bacterial infections (especially those caused by Staphylococcus aureus) are of greater concern.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida albicans:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Recurrent Staphylococcus aureus infections are a hallmark of Chediak-Higashi syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following gene mutations is responsible for Chediak-Higashi syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LYST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CHS1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NBEAL2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HPS1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CHS1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. LYST: While historically known as LYST, the official gene symbol is now CHS1. Both refer to the same gene, so this is not technically incorrect, but B) is the preferred answer due to the updated nomenclature.&lt;/li&gt;&lt;li&gt;â€¢ Option A. LYST:&lt;/li&gt;&lt;li&gt;â€¢ Option C. NBEAL2: Mutations in the NBEAL2 gene cause Gray Platelet Syndrome (GPS), a distinct disorder with large platelets and bleeding tendency.&lt;/li&gt;&lt;li&gt;â€¢ Option C. NBEAL2:&lt;/li&gt;&lt;li&gt;â€¢ Option D. HPS1: Mutations in the HPS1 gene cause a subtype of Hermansky-Pudlak Syndrome (HPS), another disorder with albinism, but with a different pattern of organ involvement than Chediak-Higashi syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. HPS1:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Mutations in the CHS1 gene lead to defective lysosomal trafficking, resulting in the characteristic giant granules and impaired immune function in Chediak-Higashi syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents with easy bruising, heavy menstrual bleeding, and prolonged bleeding after minor cuts. Her family history reveals similar bleeding tendencies in her mother and sister. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemophilia A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemophilia B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von Willebrand Disease (VWD) Type 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Von Willebrand Disease (VWD) Type 3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Von Willebrand Disease (VWD) Type 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Von Willebrand Disease (VWD) Type 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemophilia A and Option B. Hemophilia B: These are X-linked recessive disorders primarily affecting males and are characterized by factor VIII and IX deficiencies, respectively.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Hemophilia A&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemophilia B:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Von Willebrand Disease (VWD) Type 3 : This is a rare, severe form of VWD with almost complete absence of vWF, usually presenting with more severe bleeding symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Von Willebrand Disease (VWD) Type 3&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ VWD Type 1 is the most common inherited bleeding disorder and often presents with mucocutaneous bleeding and a positive family history.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man with a history of easy bruising and prolonged bleeding after minor procedures undergoes laboratory testing. The results reveal a normal von Willebrand factor (vWF) antigen level, but a decreased vWF ristocetin cofactor activity (RCoF). Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Von Willebrand disease (VWD) type 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Von Willebrand disease (VWD) type 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von Willebrand disease (VWD) type 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acquired von Willebrand syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Von Willebrand disease (VWD) type 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Von Willebrand disease (VWD) type 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand disease (VWD) type 1: In VWD type 1, both vWF antigen and RCoF levels are decreased proportionally, not just the RCoF.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand disease (VWD) type 1:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Von Willebrand disease (VWD) type 3: This is the most severe form of VWD with a near-complete absence of vWF, so both antigen and RCoF would be very low.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Von Willebrand disease (VWD) type 3:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acquired von Willebrand syndrome: While this can mimic VWD, it is usually associated with underlying conditions like lymphoproliferative disorders, autoimmune diseases, or certain medications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acquired von Willebrand syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ A normal vWF antigen level with a decreased RCoF strongly suggests a qualitative defect in vWF, which is characteristic of VWD type 2. Further testing can determine the specific subtype (2A, 2B, 2M, or 2N).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a lifelong history of heavy menstrual bleeding and easy bruising. She reports that her father also had similar bleeding issues. Her laboratory results show a normal platelet count, prolonged bleeding time, and reduced von Willebrand factor (vWF) antigen and ristocetin cofactor activity (R:Co). Which type of von Willebrand disease (VWD) is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 VWD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type 2A VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2B VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 3 VWD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Type 1 VWD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Type 1 VWD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type 2A VWD : Presents with normal vWF antigen but decreased R:Co activity due to a qualitative defect in vWF multimers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type 2A VWD&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type 2B VWD : Presents with thrombocytopenia due to increased vWF-platelet binding, unlike the normal platelet count in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type 2B VWD&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 3 VWD : Presents with severe deficiency of vWF, leading to more severe bleeding than described in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 3 VWD&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Type 1 VWD is the most common type and presents with a quantitative deficiency of vWF, causing mild to moderate bleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy presents with recurrent nosebleeds and prolonged bleeding after dental procedures. His laboratory results show a normal platelet count, prolonged bleeding time, and normal vWF antigen levels, but markedly reduced FVIII levels. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type 2A VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2M VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 2N VWD&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Type 2N VWD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Type 2N VWD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type 1 VWD: This type has a quantitative deficiency of vWF, so both vWF antigen and activity would be reduced.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type 1 VWD:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type 2A VWD: This type has a qualitative defect leading to decreased high molecular weight multimers of vWF, but FVIII levels are typically normal.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type 2A VWD:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type 2M VWD: This type also has a qualitative defect, but it mainly affects platelet adhesion, not FVIII binding. FVIII levels are usually normal.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type 2M VWD:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ When a patient presents with bleeding symptoms and a prolonged bleeding time, it is important to measure both vWF and FVIII levels to distinguish between VWD and hemophilia. A normal vWF antigen with decreased FVIII is highly suggestive of Type 2N VWD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with a history of heavy menstrual bleeding and easy bruising is diagnosed with von Willebrand disease (VWD) type 1. Which of the following is the most appropriate initial treatment for a minor bleeding episode?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor VIII concentrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recombinant von Willebrand factor (rVWF) concentrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Desmopressin (DDAVP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cryoprecipitate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Desmopressin (DDAVP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Desmopressin (DDAVP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor VIII concentrate : Primarily used for hemophilia A, not VWD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor VIII concentrate&lt;/li&gt;&lt;li&gt;â€¢ Option B. rVWF concentrate : Reserved for more severe bleeding or VWD types 2 and 3.&lt;/li&gt;&lt;li&gt;â€¢ Option B. rVWF concentrate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cryoprecipitate : An older treatment option, less preferred due to risk of viral transmission.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cryoprecipitate&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ DDAVP is a safe and effective initial treatment for mild bleeding in VWD type 1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old man with a history of frequent nosebleeds and prolonged bleeding after a tooth extraction presents with recurrent, painless bloody urine. Examination reveals multiple hematomas and decreased range of motion with crepitus in both ankles. Laboratory studies show a normal platelet count, prolonged partial thromboplastin time (PTT), and hematuria without RBC casts. An x-ray of the pelvis shows no abnormalities. Further evaluation of this patient is most likely to show which of the following findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Evasive behavior when asked about the hematomas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;History of spontaneous hematomas in paternal grandmother&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Petechiae in the oropharynx&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intraarticular iron deposition&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intraarticular iron deposition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Intraarticular iron deposition&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Evasive behavior when asked about the hematomas: While this might be present in some cases, it&#x27;s not specific to hemophilia and doesn&#x27;t help confirm the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Evasive behavior when asked about the hematomas:&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of spontaneous hematomas in paternal grandmother: While hemophilia is often inherited, a family history alone is not enough to diagnose the condition. Direct testing for factor deficiencies is needed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of spontaneous hematomas in paternal grandmother:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Petechiae in the oropharynx: Petechiae are typically associated with thrombocytopenia (low platelet count), not hemophilia. This patient&#x27;s platelet count is normal.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Petechiae in the oropharynx:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ In a patient with suspected hemophilia, further evaluation with imaging studies like MRI or ultrasound is essential to assess joint damage and confirm the diagnosis of hemophilic arthropathy. A positive family history can raise suspicion, but definitive diagnosis requires factor assays.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-year-old boy presents with a swollen and painful right knee after falling from a chair. He has a history of easy bruising and prolonged bleeding after minor injuries. Family history reveals a maternal uncle with a bleeding disorder. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Von Willebrand Disease (VWD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin K deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemophilia A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Disseminated Intravascular Coagulation (DIC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hemophilia A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hemophilia A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand Disease (VWD): While it can cause bleeding, hemarthrosis is less common and the family history points more towards hemophilia .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Von Willebrand Disease (VWD):&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin K deficiency: This would cause bleeding due to impaired clotting factor synthesis, but it&#x27;s less common in young children with no dietary restrictions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin K deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Disseminated Intravascular Coagulation (DIC): This is a life-threatening condition with widespread clotting and bleeding, not just isolated hemarthrosis .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Disseminated Intravascular Coagulation (DIC):&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Hemarthrosis in young boys with a family history of bleeding disorders should raise suspicion for hemophilia A.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy with severe hemophilia A has been receiving regular factor VIII replacement therapy. He presents with a hemarthrosis despite receiving his usual prophylactic dose. Which of the following is the most likely explanation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-compliance with therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Development of an inhibitor against factor VIII&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inadequate dose of factor VIII&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Factor VIII product contamination&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Development of an inhibitor against factor VIII&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Development of an inhibitor against factor VIII&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-compliance with therapy : Non-compliance is less likely in a patient receiving regular prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-compliance with therapy&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inadequate dose of factor VIII : Inadequate dose would not explain the failure of the usual dose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inadequate dose of factor VIII&lt;/li&gt;&lt;li&gt;â€¢ Option D. Factor VIII product contamination : Contamination is a rare occurrence.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Factor VIII product contamination&lt;/li&gt;&lt;li&gt;â€¢ Educational objectives :&lt;/li&gt;&lt;li&gt;â€¢ Educational objectives&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Suspect inhibitor development in hemophilia patients who fail to respond to their usual factor replacement dose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy with severe hemophilia A presents with sudden onset of abdominal pain and hematemesis. Which of the following is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate administration of factor VIII concentrate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emergency endoscopy to identify the bleeding source&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urgent CT scan of the abdomen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Admission to the ICU for monitoring&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Immediate administration of factor VIII concentrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Immediate administration of factor VIII concentrate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Emergency endoscopy to identify the bleeding source : Endoscopy can be helpful, but immediate factor replacement is a priority.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Emergency endoscopy to identify the bleeding source&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urgent CT scan of the abdomen : CT scan might be needed later, but not the most urgent step.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urgent CT scan of the abdomen&lt;/li&gt;&lt;li&gt;â€¢ Option D. Admission to the ICU for monitoring : ICU admission might be necessary depending on the severity, but factor replacement comes first.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Admission to the ICU for monitoring&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Prioritize immediate factor replacement in hemophilia patients with severe bleeding episodes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following coagulation factors are increased by the administration of DDAVP?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor VIII only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Factor IX only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both Factor VIII and von Willebrand Factor (vWF)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Factor VIII, vWF, and Factor IX&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both Factor VIII and von Willebrand Factor (vWF)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Both Factor VIII and von Willebrand Factor (vWF)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor VIII only : While DDAVP does increase Factor VIII, it also increases vWF.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor VIII only&lt;/li&gt;&lt;li&gt;â€¢ Option B. Factor IX only : DDAVP does not affect Factor IX levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Factor IX only&lt;/li&gt;&lt;li&gt;â€¢ Option D. Factor VIII, vWF, and Factor IX : This is incorrect because, as mentioned above, DDAVP does not affect Factor IX levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Factor VIII, vWF, and Factor IX&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ DDAVP is a useful therapeutic agent in certain bleeding disorders, particularly mild hemophilia A and some types of von Willebrand disease (VWD), due to its ability to increase the levels of both Factor VIII and vWF. Understanding its mechanism of action is crucial for selecting appropriate patients for treatment and anticipating its effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with a high fever, hypotension, and altered mental status. He has been experiencing abdominal pain and diarrhea for the past 24 hours. Laboratory investigations reveal prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombocytopenia. Which of the following is the most likely cause of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bacterial sepsis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malignant hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic thrombocytopenic purpura (TTP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bacterial sepsis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bacterial sepsis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s clinical presentation of fever, hypotension, altered mental status, and laboratory findings (prolonged PT/aPTT, thrombocytopenia) are consistent with disseminated intravascular coagulation (DIC). The most common cause of DIC is sepsis, and given the patient&#x27;s history of abdominal pain and diarrhea, bacterial sepsis is the most likely etiology.&lt;/li&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute pancreatitis : While pancreatitis can trigger DIC, it is less common than sepsis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignant hypertension : Malignant hypertension can cause thrombotic microangiopathy but not typically DIC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignant hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic thrombocytopenic purpura (TTP): TTP is a distinct disorder characterized by ADAMTS13 deficiency and does not typically present with prolonged PT/aPTT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic thrombocytopenic purpura (TTP):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Sepsis is the most common cause of disseminated intravascular coagulation (DIC), and the clinical presentation often includes signs of systemic infection and abnormal coagulation parameters.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male presents with a history of mild bleeding tendencies since childhood, primarily after trauma or surgery. He is found to have prolonged PT and aPTT, both of which correct with mixing studies. Which of the following genetic mutations is most likely associated with his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor VIII gene mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Factor V gene mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LMAN1 gene mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prothrombin gene mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. LMAN1 gene mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) LMAN1 gene mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor VIII gene mutation : Causes hemophilia A, with isolated prolongation of aPTT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor VIII gene mutation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Factor V gene mutation : Causes factor V deficiency, with isolated prolongation of PT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Factor V gene mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prothrombin gene mutation : Causes prothrombin deficiency, with isolated prolongation of PT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prothrombin gene mutation&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Combined factor V and factor VIII deficiency is associated with mutations in the LMAN1 gene, leading to mild bleeding tendencies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with fatigue and pallor. Her reticulocyte count is 5%, hemoglobin is 9 g/dL, and hematocrit is 28%. What is her corrected reticulocyte count?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2.5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3.0%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5.0%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10.0%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 3.0%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 3.0%.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of heavy alcohol use presents with macrocytic anemia on a routine blood test. His MCV is 105 fL and his RPI is 3.5. What is the next best step in her management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemoglobin electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum B12 and folate levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Direct antiglobulin test (DAT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum B12 and folate levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum B12 and folate levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemoglobin electrophoresis: This test is used to identify abnormal types of hemoglobin, as seen in conditions like sickle cell disease or thalassemia. It is not helpful in diagnosing vitamin B12 or folate deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemoglobin electrophoresis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Direct antiglobulin test (DAT): This test is used to diagnose autoimmune hemolytic anemias, where the body&#x27;s immune system attacks its own red blood cells. This is not the primary concern in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Direct antiglobulin test (DAT):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bone marrow biopsy : While a bone marrow biopsy can reveal megaloblastic changes (characteristic of B12/folate deficiency), it is an invasive procedure and usually reserved for cases where the diagnosis is unclear or there is suspicion of other marrow disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bone&lt;/li&gt;&lt;li&gt;â€¢ marrow biopsy&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ In a patient with macrocytic anemia and a history suggestive of vitamin B12 or folate deficiency, the most helpful initial test is measuring serum B12 and folate levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of chronic kidney disease presents with fatigue and shortness of breath. His laboratory findings show a MCV 88 fL with a low reticulocyte production index (RPI &amp;lt; 2). Which of the following is the MOST likely cause of his anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Folate deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anemia of chronic disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anemia of chronic disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Folate deficiency: Macrocytic anemia with high RPI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Folate deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia: Microcytic anemia with low RPI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemolytic anemia: Normocytic/macrocytic anemia with high RPI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemolytic anemia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Normocytic anemia with low RPI in the setting of chronic disease should prompt consideration of anemia of chronic disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of rheumatoid arthritis presents with fatigue and a normocytic anemia (MCV 90 fL). His iron studies show the following: Serum iron: 30 mcg/dL (normal: 60-170 mcg/dL) TIBC: 200 mcg/dL (normal: 240-450 mcg/dL) Ferritin: 350 ng/mL (normal: 20-500 ng/mL) Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia of chronic disease (ACD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency anemia (IDA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia trait&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sideroblastic anemia (SA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anemia of chronic disease (ACD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anemia of chronic disease (ACD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia (IDA): IDA would typically present with low serum iron, high TIBC, and low ferritin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency anemia (IDA):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia trait: This is a genetic condition causing microcytic anemia, not normocytic.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia trait:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sideroblastic anemia (SA): SA is less likely in this scenario as it often presents with elevated serum iron and ferritin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sideroblastic anemia (SA):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Recognizing the distinct pattern of iron studies in anemia of chronic disease (low serum iron, low TIBC, and normal to elevated ferritin) is crucial for differentiating it from iron deficiency anemia. In the setting of a chronic inflammatory condition like rheumatoid arthritis, anemia of chronic disease is a common consideration.&lt;/li&gt;&lt;li&gt;â€¢ Recognizing the distinct pattern of iron studies in anemia of chronic disease (low serum iron, low TIBC, and normal to elevated ferritin) is crucial for differentiating it from iron deficiency anemia.&lt;/li&gt;&lt;li&gt;â€¢ In the setting of a chronic inflammatory condition like rheumatoid arthritis, anemia of chronic disease is a common consideration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of chronic alcoholism presents with fatigue, pallor, and a microcytic anemia. His iron studies reveal elevated iron, TIBC, and ferritin. Blood smear shows basophilic stippling. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia (IDA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sideroblastic anemia (SA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia trait&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemia of chronic disease (ACD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sideroblastic anemia (SA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sideroblastic anemia (SA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia (IDA): IDA would typically present with microcytic anemia but with low serum iron, high TIBC, and low ferritin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia (IDA):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia trait: While thalassemia can also cause microcytic anemia, it would not typically cause elevated iron indices and basophilic stippling. Hemoglobin electrophoresis would be needed for definitive diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalassemia trait:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia of chronic disease (ACD): ACD usually presents as a normocytic anemia, though it can occasionally be microcytic. However, the iron indices in ACD would show low serum iron, low TIBC, and normal or elevated ferritin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia of chronic disease (ACD):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ the classic presentation and laboratory findings of sideroblastic anemia, particularly in the setting of chronic alcoholism:&lt;/li&gt;&lt;li&gt;â€¢ Microcytic anemia: Small red blood cells (MCV &amp;lt; 80 fL) Elevated iron indices: High serum iron, high total iron binding capacity (TIBC), and high ferritin Basophilic stippling: Characteristic finding on peripheral blood smear History of alcohol abuse: A risk factor for sideroblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Microcytic anemia: Small red blood cells (MCV &amp;lt; 80 fL)&lt;/li&gt;&lt;li&gt;â€¢ Elevated iron indices: High serum iron, high total iron binding capacity (TIBC), and high ferritin&lt;/li&gt;&lt;li&gt;â€¢ Basophilic stippling: Characteristic finding on peripheral blood smear&lt;/li&gt;&lt;li&gt;â€¢ History of alcohol abuse: A risk factor for sideroblastic anemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with microcytic anemia fails to respond to oral iron supplementation. Which of the following should be considered in the differential diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sideroblastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with heavy menstrual bleeding presents with fatigue and pallor. Her lab results show a microcytic anemia with an elevated red cell distribution width and a low reticulocyte count. Which of the following laboratory findings would MOST likely be seen in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal serum iron, normal TIBC, and normal ferritin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low serum iron, high TIBC, and low ferritin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low serum iron, low TIBC, and high ferritin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High serum iron, normal TIBC, and high ferritin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low serum iron, high TIBC, and low ferritin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Low serum iron, high TIBC, and low ferritin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman of Mediterranean descent is found to have mild microcytic anemia on routine blood work. Her iron studies are normal, and hemoglobin electrophoresis reveals an elevated HbA2 level. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anemia of chronic disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-thalassemia trait&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-thalassemia trait&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-thalassemia trait&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Beta-thalassemia trait&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia (IDA): While IDA is the most common cause of microcytic anemia, it would typically present with abnormal iron studies (low serum iron, low ferritin, and high total iron-binding capacity).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia (IDA):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anemia of chronic disease (ACD): ACD is typically normocytic, but can occasionally be microcytic. However, it would not typically cause elevated HbA2 levels on electrophoresis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anemia of chronic disease (ACD):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alpha-thalassemia trait: Alpha thalassemia is another inherited disorder that can cause microcytic anemia, but it would not typically cause elevated HbA2 levels. Instead, it may be associated with an elevated HbH level or a normal hemoglobin electrophoresis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alpha-thalassemia trait:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Beta-thalassemia is a common cause of microcytic anemia in individuals of Mediterranean descent. Hemoglobin electrophoresis is essential for diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female with a history of systemic lupus erythematosus (SLE) presents with fatigue, pallor, and jaundice. Her laboratory evaluation reveals a normocytic anemia with a positive direct antiglobulin test (DAT). Which of the following is the most likely mechanism of her anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Folate deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune-mediated hemolysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Impaired erythropoiesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Immune-mediated hemolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Immune-mediated hemolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency: While iron deficiency can cause anemia, it typically results in a microcytic anemia (smaller red blood cells), not normocytic. Additionally, it would not explain the positive DAT or jaundice.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Folate deficiency: Folate deficiency can lead to megaloblastic anemia, which is a type of macrocytic anemia (larger red blood cells), not normocytic. It would also not explain the positive DAT or jaundice.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Folate deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Impaired erythropoiesis: While SLE can sometimes affect the bone marrow and lead to impaired red blood cell production, it&#x27;s less common than immune-mediated hemolysis and wouldn&#x27;t explain the positive DAT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Impaired erythropoiesis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The combination of normocytic anemia, positive DAT, and jaundice in a patient with SLE strongly points toward immune-mediated hemolysis as the underlying cause.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a healthy adult male, the average daily iron absorption from dietary sources is approximately:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1.4 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2 mg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1 mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with heavy menstrual periods complains of fatigue and brittle nails. Her lab results show a serum ferritin of 18 ng/mL and her TIBC was 370. Peripheral smear turns out to be normal. What is the MOST likely stage of iron deficiency in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Negative iron balance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron-deficient erythropoiesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron overload&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Negative iron balance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Negative iron balance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron-deficient erythropoiesis: In this stage, hemoglobin and hematocrit would likely start to decline.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron-deficient erythropoiesis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron deficiency anemia: This stage is characterized by a clear drop in hemoglobin and hematocrit, along with microcytic and hypochromic red blood cells on peripheral smear.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Iron deficiency anemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron overload: This is the opposite of iron deficiency and is associated with elevated ferritin, normal to low TIBC, and other systemic complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron overload:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Early detection of iron deficiency through low serum ferritin is crucial for timely intervention and prevention of progression to iron deficiency anemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following substances can IMPAIR the absorption of iron supplements?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ascorbic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Orange juice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antacids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Antacids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Antacids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option (A, B, C): Vitamin C (in ascorbic acid and orange juice) and meat can all improve iron absorption.&lt;/li&gt;&lt;li&gt;â€¢ Option (A, B, C):&lt;/li&gt;&lt;li&gt;â€¢ ascorbic acid&lt;/li&gt;&lt;li&gt;â€¢ orange juice)&lt;/li&gt;&lt;li&gt;â€¢ meat&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Patients taking iron supplements should avoid taking antacids concurrently, as this can reduce absorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with iron deficiency anemia is prescribed ferrous sulfate. Which of the following statements about ferrous sulphate is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a common and effective oral iron supplement.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It should be taken on an empty stomach for optimal absorption.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is often combined with ascorbic acid to enhance absorption.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is the iron preparation with the highest elemental iron content.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is the iron preparation with the highest elemental iron content.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It is the iron preparation with the highest elemental iron content&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a common and effective oral iron supplement: This is correct. Ferrous sulfate is widely used and effective for treating iron deficiency anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a common and effective oral iron supplement:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It should be taken on an empty stomach for optimal absorption: This is also correct. Iron is best absorbed in an acidic environment, so taking it on an empty stomach or with vitamin C (which enhances acidity) improves absorption.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It should be taken on an empty stomach for optimal absorption:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is often combined with ascorbic acid to enhance absorption: This is true. Ascorbic acid (vitamin C) helps convert ferric iron to ferrous iron, the form more readily absorbed by the body.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is often combined with ascorbic acid to enhance absorption:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Different iron preparations vary in their elemental iron content, but most are well absorbed and effective in treating iron deficiency anemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has experienced anaphylaxis to iron dextran in the past. Which of the following statements is MOST accurate regarding their future management of iron deficiency anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They can safely receive any other parenteral iron formulation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral iron therapy is the only safe option for them.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They should be referred for blood transfusion as needed.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They may be able to receive alternative parenteral iron formulations under close supervision.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. They may be able to receive alternative parenteral iron formulations under close supervision.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) They may be able to receive alternative parenteral iron formulations under close supervision.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with severe iron deficiency anemia requires rapid replenishment of her iron stores. Which of the following parenteral iron preparations would provide the highest amount of iron in a single infusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ferric gluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron sucrose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ferric carboxymaltose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ferric derisomaltose&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ferric derisomaltose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ferric derisomaltose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ferric gluconate: Delivers a much lower dose of iron per infusion (125 mg).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ferric gluconate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron sucrose: Delivers a lower dose of iron per infusion (200 mg).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron sucrose:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ferric carboxymaltose: Delivers a lower dose of iron per infusion (750 mg).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ferric carboxymaltose:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Ferric derisomaltose is a valuable option for patients with severe iron deficiency anemia who require rapid correction of iron stores, as it allows for the administration of a large dose of iron in a single infusion. However, it&#x27;s important to consider potential side effects and contraindications before choosing this preparation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with iron deficiency anemia is started on oral iron supplementation. When would you expect to see the PEAK reticulocyte response, indicating that the bone marrow is actively producing new red blood cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Within 24-48 hours of starting therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3-4 days after starting therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;7-10 days after starting therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;14-21 days after starting therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 7-10 days after starting therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 7-10 days after starting therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Within 24-48 hours of starting therapy: This is too soon to expect a peak response. It takes several days for the bone marrow to ramp up red blood cell production.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Within 24-48 hours of starting therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 3-4 days after starting therapy: While the reticulocyte count may start to rise within 3-4 days, the peak response is typically later.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 3-4 days after starting therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 14-21 days after starting therapy: This is too late for the peak response. If there&#x27;s no significant increase by this time, it could suggest a lack of response to therapy or an alternative diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 14-21 days after starting therapy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The reticulocyte count is a valuable tool for monitoring the response to iron therapy in iron deficiency anemia. An increase in reticulocytes within 4-7 days and a peak response at 7-10 days are expected findings, indicating that the treatment is effective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with microcytic anemia is given an iron tolerance test. Two hours after ingesting two iron tablets on an empty stomach, her serum iron level increases by 80 mcg/dL. What is the most likely interpretation of this result?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal iron absorption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron malabsorption&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron overload&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Iron malabsorption&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Iron malabsorption&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In infants who survive Hb Bart&#x27;s hydrops fetalis, the approximate percentage that experiences neurodevelopmental delay is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;30%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;40%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 20%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 20%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10%: This underestimates the risk of neurodevelopmental delay in this population.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10%:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 30%: This overestimates the risk of neurodevelopmental delay in this population.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 30%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 40%: This is the percentage of survivors who experience growth retardation, not neurodevelopmental delay.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 40%:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Hb Bartâ€™s hydrops fetalis is best prevented by screening couples at risk and antenatal diagnosis. Intrauterine therapy and perinatal intensive care have permitted survival of some infants with Hb Bart hydrops fetalis. As growth retardation affects ~40% and neurodevelopmental delay is present in 20% of survivors, prevention is the best approach.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following alpha-globin gene arrangements is MOST likely to be associated with Hemoglobin H (HbH) disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î±Î±/Î±Î±&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;-Î±/Î±Î±&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;--/Î±Î±&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;--/-Î±&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. --/-Î±&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) --/-Î±&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Î±Î±/Î±Î±: Î±-thal. With Myelodysplasia - Mutations in ATRX ; striking male predominance. Hematologic findings of HbH disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Î±Î±/Î±Î±:&lt;/li&gt;&lt;li&gt;â€¢ Option B. -Î±/Î±Î±: Represents the silent carrier state of alpha-thalassemia, with only one alpha-globin gene deleted. It typically doesn&#x27;t cause significant clinical symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ -Î±/Î±Î±:&lt;/li&gt;&lt;li&gt;â€¢ Option C. --/Î±Î±: Represents alpha-thalassemia trait, where two alpha-globin genes are deleted. This condition can lead to mild anemia but is not associated with HbH disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ --/Î±Î±:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The specific arrangement and number of alpha-globin gene deletions determine the severity of alpha-thalassemia. HbH disease, a moderate form of the condition, is caused by the deletion or inactivation of three out of four alpha-globin genes, represented by the genotype --/-Î± (other gene arrangement: Î± T Î±/- -, Î± T Î±/Î± T Î±)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man with microcytic anemia is found to have a mutation in the 3&#x27; end-processing sequence of the beta-globin gene. Which of the following is the MOST likely consequence of this mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prevention of RNA polyadenylation and reduced beta-globin production&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Introduction of a stop codon and premature termination of translation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creation of an alternative splice site in an intron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Total absence of beta-globin production&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prevention of RNA polyadenylation and reduced beta-globin production&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prevention of RNA polyadenylation and reduced beta-globin production&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman of Mediterranean descent presents with mild anemia and microcytosis. Her iron studies are normal, and genetic testing reveals a change in the promoter region of the beta-globin gene. Which type of beta-thalassemia is she most likely to have?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta-zero ( Î² 0) thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta-plus ( Î² +) thalassemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Delta-beta ( Î´Î² ) thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemoglobin Lepore thalassemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Beta-plus ( Î² +) thalassemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Beta-plus (Î²+) thalassemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-zero (Î²0) thalassemia: Caused by severe mutations, not promoter changes, leading to complete absence of beta-globin production.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Beta-zero (Î²0) thalassemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Delta-beta (Î´Î²) thalassemia: Deletion of both delta and beta globin genes causes a different clinical picture.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Delta-beta (Î´Î²) thalassemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemoglobin Lepore thalassemia : Rare condition caused by delta-beta globin gene fusion, not promoter mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemoglobin Lepore thalassemia&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Promoter mutations are a common cause of milder beta-thalassemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with a history of mild anemia on routine blood work presents for a follow-up appointment. She reports good energy levels and denies any recent illnesses or blood loss. Her physical examination is unremarkable. A peripheral blood smear is shown in the image. Which of the following hematological conditions is MOST likely represented in this blood smear?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta-thalassemia intermedia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Beta-thalassemia intermedia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-31-124914.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Beta-thalassemia intermedia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia: While also microcytic and hypochromic, it usually does not exhibit target cells or the degree of poikilocytosis seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Iron deficiency anemia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin B12 deficiency: Causes macrocytic (large red blood cell) anemia, not microcytic.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin B12 deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sickle cell anemia: Characterized by sickle-shaped red blood cells, which are not present in this image.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sickle cell anemia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The presence of target cells, anisocytosis, poikilocytosis, hypochromia and microcytosis in a blood smear strongly suggests beta-thalassemia intermedia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-years-old male with a history of beta-thalassemia major has been receiving regular blood transfusions every 3 weeks to maintain a pre-transfusion hemoglobin level of 9.5 g/dL. Despite adherence to his transfusion schedule, he has recently developed fatigue, skin hyperpigmentation and hepatomegaly. Which of the following is the most likely cause of his new symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insufficient blood transfusions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron overload&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Folate deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Iron overload&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Iron overload&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Insufficient blood transfusions: The patient is adhering to the transfusion schedule, and his hemoglobin level is within the target range for thalassemia major. Thus, insufficient transfusions are unlikely to be the cause of his symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Insufficient blood transfusions:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Folate deficiency: Folate deficiency typically causes megaloblastic anemia with macrocytic red blood cells. This is not consistent with the patient&#x27;s history of thalassemia major or the presentation with microcytic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Folate deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency: Similar to folate deficiency, vitamin B12 deficiency causes megaloblastic anemia, which is inconsistent with the patient&#x27;s presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Iron chelation therapy is crucial in patients with thalassemia major receiving regular transfusions to prevent iron overload and its associated complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following chelating agents is administered orally for the treatment of iron overload in patients with thalassemia major?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deferoxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deferiprone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deferasirox&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both B and C&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Both B and C&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Both B and C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deferoxamine: Deferoxamine is an intravenous iron chelator and requires subcutaneous infusion over several hours, making it less convenient for long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deferoxamine:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Oral iron chelators like deferiprone and deferasirox have revolutionized the management of iron overload in thalassemia major by offering a more convenient and less invasive alternative to deferoxamine. Early and consistent chelation therapy is crucial for preventing iron-related complications and improving the quality of life for patients with thalassemia major.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with anemia and acrocyanosis that worsens in cold weather. Which of the following laboratory findings is most consistent with cold agglutinin syndrome (CAS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Positive direct antiglobulin test (DAT) with anti-IgG specificity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Positive DAT with anti-C3d specificity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Positive DAT with anti-IgM specificity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Negative DAT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Positive DAT with anti-IgM specificity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Positive DAT with anti-IgM specificity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Positive direct antiglobulin test (DAT) with anti-IgG specificity and Option B. Positive DAT with anti-C3d specificity are more commonly associated with WAIHA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Positive direct antiglobulin test (DAT) with anti-IgG specificity&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Positive DAT with anti-C3d specificity&lt;/li&gt;&lt;li&gt;â€¢ Option D. Negative DAT : A negative DAT would not be expected in a patient with autoimmune hemolytic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Negative DAT&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ A positive DAT with anti-IgM specificity is a key laboratory finding in the diagnosis of CAS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a history of lymphoma presents with fatigue, jaundice, and splenomegaly. Peripheral blood smear shows spherocytes. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cold agglutinin disease (CAD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paroxysmal cold hemoglobinuria (PCH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Warm autoimmune hemolytic anemia (WAIHA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Microangiopathic hemolytic anemia (MAHA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Warm autoimmune hemolytic anemia (WAIHA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Warm autoimmune hemolytic anemia (WAIHA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cold agglutinin disease (CAD): Primarily presents with acrocyanosis and anemia, and blood smear often reveals agglutination.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cold agglutinin disease (CAD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Paroxysmal cold hemoglobinuria (PCH): Paroxysmal cold hemoglobinuria (PCH) is rare and typically presents with biphasic hemolysis and hemoglobinuria after cold exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Paroxysmal cold hemoglobinuria (PCH):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Microangiopathic hemolytic anemia (MAHA): Presents with schistocytes on peripheral smear and is associated with underlying conditions like thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome (HUS).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Microangiopathic hemolytic anemia (MAHA):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ WAIHA is the most common type of autoimmune hemolytic anemia and can be associated with underlying lymphoproliferative disorders like lymphoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common cause of death in adult patients with sickle cell disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute chest syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute chest syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute chest syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke: While stroke is a significant cause of morbidity and mortality in children with sickle cell disease (SCD), it is less common in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sepsis: Sepsis is a major concern in SCD patients of all ages due to functional asplenia (decreased spleen function). However, acute chest syndrome remains the leading cause of death in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sepsis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary hypertension: Pulmonary hypertension is a serious complication of SCD, contributing to morbidity and mortality. However, it is not as frequent a cause of death as acute chest syndrome in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Early recognition and aggressive management of acute chest syndrome are crucial in preventing mortality in sickle cell disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The genetic mutation in sickle cell disease results in the substitution of which amino acid in the beta-globin chain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutamic acid to lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutamic acid to valine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valine to glutamic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine to glutamic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glutamic acid to valine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glutamic acid to valine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutamic acid to lysine: This substitution does occur in some hemoglobin variants (e.g., HbC), but not in sickle cell disease (HbS). HbC causes a milder form of anemia compared to HbS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutamic acid to lysine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Valine to glutamic acid: This would be the reverse of the actual mutation in sickle cell disease and would result in a different hemoglobin variant.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Valine to glutamic acid:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lysine to glutamic acid: This substitution is not associated with any known hemoglobinopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lysine to glutamic acid:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The specific amino acid substitution (glutamic acid to valine) in sickle cell disease is responsible for the structural and functional abnormalities of hemoglobin S (HbS) that lead to sickling and the associated clinical manifestations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old African American woman presents with mild anemia and complains of intermittent abdominal pain. On peripheral blood smear, target cells and rhomboid crystals are noted within red blood cells. Given the likely diagnosis, Which of the following amino acid changes is responsible for this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutamic acid to lysine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valine to glutamic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysine to glutamic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glutamic acid to valine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glutamic acid to lysine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glutamic acid to lysine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Valine to glutamic acid: This substitution is the characteristic change for sickle cell anemia (HbS).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Valine to glutamic acid:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine to glutamic acid: Swapping these two positively charged amino acids would likely have a minimal effect on hemoglobin function.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine to glutamic acid:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glutamic acid to valine: This substitution is also seen in HbS and leads to the polymerization of red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glutamic acid to valine:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ HbC disease is a milder form of hemoglobinopathy compared to sickle cell disease, but it is important to distinguish it based on the specific amino acid substitution.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old child presents with severe anemia, jaundice, and splenomegaly. Their hemoglobin level is 5 g/dL. The peripheral blood smear shows numerous target cells and sickled red blood cells. Which of the following hemoglobinopathies is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HbC disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HbSC disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HbD disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HbDC disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HbDC disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) HbDC disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. HbC disease: Usually mild anemia without severe complications.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HbC disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. HbSC disease: Typically less severe than HbSS, with a hemoglobin level usually &amp;gt;10 g/dL.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HbSC disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbD disease: Typically asymptomatic or mild anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbD disease:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ HbDC disease is a severe hemoglobinopathy that can present similarly to sickle cell disease (HbSS).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the MOST common inheritance pattern of G6PD deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autosomal dominant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Autosomal recessive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;X-linked dominant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;X-linked recessive&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. X-linked recessive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) X-linked recessive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with PNH treated with eculizumab develops recurrent abdominal pain and difficulty swallowing. Which of the following complications is MOST likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Budd-Chiari syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Portal vein thrombosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric ulcer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Portal vein thrombosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Portal vein thrombosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Budd-Chiari syndrome: This is a rare condition involving obstruction of hepatic veins, typically presenting with liver enlargement, abdominal pain, and ascites. While possible in PNH, it&#x27;s less likely than portal vein thrombosis given the dysphagia (difficulty swallowing).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Budd-Chiari syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture: Strictures usually cause progressive dysphagia and are not typically associated with acute abdominal pain. While PNH can cause esophageal dysmotility, strictures are less common.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastric ulcer: While abdominal pain is a possible symptom of gastric ulcers, they are not a common complication specifically associated with PNH.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gastric ulcer:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Paroxysmal nocturnal hemoglobinuria (PNH) predisposes individuals to a hypercoagulable state. This means they are at higher risk for blood clots forming in unusual locations. Portal vein thrombosis is one such complication, and its presentation can include abdominal pain and difficulty swallowing. It&#x27;s important for clinicians to maintain a high index of suspicion for thrombosis in PNH patients, even while on eculizumab therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old vegan presents with fatigue, pallor, and numbness and tingling in their hands and feet. Which of the following laboratory findings would be MOST consistent with the suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Microcytic anemia and normal methylmalonic acid (MMA) level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Macrocytic anemia and elevated MMA level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macrocytic anemia and normal MMA level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normocytic anemia and elevated homocysteine level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Macrocytic anemia and elevated MMA level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Macrocytic anemia and elevated MMA level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Microcytic anemia and normal methylmalonic acid (MMA) level: Microcytic anemia is associated with iron deficiency, not B12 deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Microcytic anemia and normal methylmalonic acid (MMA) level:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macrocytic anemia and normal MMA level: While macrocytic anemia is consistent with B12 deficiency, normal MMA levels would not be expected.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macrocytic anemia and normal MMA level:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normocytic anemia and elevated homocysteine level: Normocytic anemia is not typical of B12 deficiency, and while homocysteine can be elevated in both B12 and folate deficiencies, it&#x27;s not specific for B12.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normocytic anemia and elevated homocysteine level:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Vitamin B12 deficiency should be suspected in vegans presenting with neurological symptoms and macrocytic anemia. Elevated MMA levels are a specific marker for B12 deficiency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with vitamin B12 deficiency is found to have pancytopenia (low counts of all blood cell types). Which of the following is the most likely mechanism for this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune destruction of blood cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Impaired DNA synthesis in hematopoietic stem cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone marrow infiltration with malignant cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersplenism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Impaired DNA synthesis in hematopoietic stem cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Impaired DNA synthesis in hematopoietic stem cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune destruction of blood cells: While some autoimmune conditions can cause pancytopenia, it&#x27;s not the primary mechanism in vitamin B12 deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune destruction of blood cells:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone marrow infiltration with malignant cells: This would be more typical of leukemias or other malignancies, not vitamin B12 deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone marrow infiltration with malignant cells:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypersplenism: Hypersplenism can cause some degree of cytopenia, but it usually doesn&#x27;t affect all cell lines equally, and it&#x27;s not the primary cause in B12 deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypersplenism:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Vitamin B12 deficiency can cause pancytopenia due to impaired DNA synthesis in hematopoietic stem cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with pernicious anemia (PA) presents with severe anemia (hemoglobin 7 g/dL) and neurologic symptoms. Which of the following is the MOST appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral cyanocobalamin 1000 mcg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intramuscular (IM) hydroxocobalamin 1000 mcg every 3 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intramuscular (IM) hydroxocobalamin 1000 mcg every 3-7 days for 6 doses, then every 3 months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sublingual cyanocobalamin 1000 mcg daily&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intramuscular (IM) hydroxocobalamin 1000 mcg every 3-7 days for 6 doses, then every 3 months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intramuscular (IM) hydroxocobalamin 1000 mcg every 3-7 days for 6 doses, then every 3 months&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral cyanocobalamin 1000 mcg daily: While high-dose oral cyanocobalamin can be used in some cases, it is less efficient than IM injections, especially when rapid repletion is needed due to severe anemia or neurological symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral cyanocobalamin 1000 mcg daily:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intramuscular (IM) hydroxocobalamin 1000 mcg every 3 months: This is a typical maintenance dose, but the initial treatment for severe deficiency requires more frequent dosing to rapidly correct the deficit.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intramuscular (IM) hydroxocobalamin 1000 mcg every 3 months:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sublingual cyanocobalamin 1000 mcg daily: Sublingual absorption of B12 is less reliable and may not be sufficient for a patient with severe anemia and neurological symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sublingual cyanocobalamin 1000 mcg daily:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The preferred initial treatment for severe B12 deficiency with neurological symptoms is intramuscular hydroxocobalamin given every 3-7 days for 6 doses, followed by maintenance therapy every 3 months.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is MOST likely to interfere with folate metabolism and potentially lead to folate deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Methotrexate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Methotrexate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin: While aspirin can cause some minor interference with folate absorption at very high doses, it&#x27;s not a major contributor to folate deficiency at typical doses.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metformin: Metformin primarily affects glucose metabolism and doesn&#x27;t have a direct impact on folate metabolism. However, long-term metformin use has been associated with mild decreases in vitamin B12 levels, which can sometimes be confused with folate deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metformin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atorvastatin: Atorvastatin is a cholesterol-lowering medication (statin) and does not interfere with folate metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atorvastatin:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ While all medications should be reviewed when a patient presents with folate deficiency, methotrexate stands out as the most likely culprit due to its direct inhibitory effect on dihydrofolate reductase, a key enzyme in folate metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with fatigue, abdominal pain, and dark urine, especially in the morning. Laboratory tests reveal hemoglobinuria and decreased levels of CD55 and CD59 on red blood cells. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose-6-phosphate dehydrogenase (G6PD) deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal hemoglobinuria (PNH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sickle cell disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paroxysmal nocturnal hemoglobinuria (PNH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Paroxysmal nocturnal hemoglobinuria (PNH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune hemolytic anemia: While it can present with anemia and hemolysis, it typically does not cause hemoglobinuria or have decreased CD55/CD59 levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune hemolytic anemia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose-6-phosphate dehydrogenase (G6PD) deficiency: This usually presents with episodic hemolysis triggered by oxidative stress, not specifically at night.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose-6-phosphate dehydrogenase (G6PD) deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sickle cell disease: This is a genetic hemoglobinopathy with distinct clinical and laboratory findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sickle cell disease:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ PNH is a rare acquired hemolytic anemia characterized by intravascular hemolysis, often more pronounced at night, and decreased CD55 and CD59 levels on blood cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following hemoglobin electrophoresis patterns is consistent with sickle cell trait?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Predominant HbA peak with a small HbS peak&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Predominant HbS peak with a small HbA peak&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absence of HbA peak, predominant HbF peak&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Predominant HbA peak with elevated HbA2 peak&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Predominant HbA peak with a small HbS peak&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Predominant HbA peak with a small HbS peak&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Predominant HbS peak with a small HbA peak: This pattern is characteristic of sickle cell disease (SCD), not sickle cell trait. In SCD, both beta-globin genes are mutated, resulting in primarily HbS production.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Predominant HbS peak with a small HbA peak:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Absence of HbA peak, predominant HbF peak: This pattern can be seen in certain conditions like beta-thalassemia major or hereditary persistence of fetal hemoglobin (HPFH). It is not consistent with sickle cell trait.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Absence of HbA peak, predominant HbF peak:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Predominant HbA peak with elevated HbA2 peak: This pattern is suggestive of beta-thalassemia trait. While both beta-thalassemia trait and sickle cell trait can cause mild anemia, their Hb electrophoresis patterns differ.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Predominant HbA peak with elevated HbA2 peak:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The Hb electrophoresis pattern in sickle cell trait differs from that of sickle cell disease, which shows a predominant HbS peak.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a potential benefit of hydroxyurea therapy in sickle cell disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced frequency of vaso-occlusive crises&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased fetal hemoglobin (HbF) levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased risk of acute chest syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased risk of infection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased risk of infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Increased risk of infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient with sickle cell disease (SCD) and a history of frequent vaso-occlusive crises is being considered for treatment with crizanlizumab, a monoclonal antibody that targets P-selectin. What is the PRIMARY mechanism of action of crizanlizumab in preventing vaso-occlusive crises in SCD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increasing fetal hemoglobin (HbF) levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreasing red blood cell sickling&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibiting platelet aggregation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blocking adhesive interactions between sickle cells and endothelial cells&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Blocking adhesive interactions between sickle cells and endothelial cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Blocking adhesive interactions between sickle cells and endothelial cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increasing fetal hemoglobin (HbF) levels: Hydroxyurea, not crizanlizumab, is the primary medication used to increase HbF levels in sickle cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increasing fetal hemoglobin (HbF) levels:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreasing red blood cell sickling: While reducing adhesion can indirectly help prevent sickling, crizanlizumab&#x27;s primary mechanism is not directly targeting the sickling process itself.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreasing red blood cell sickling:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibiting platelet aggregation: While platelets play a role in vaso-occlusion, crizanlizumab&#x27;s primary target is P-selectin on endothelial cells, not platelets.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibiting platelet aggregation:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ P-selectin blockade is a novel therapeutic approach in SCD that targets the adhesive interactions involved in vaso-occlusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old boy is brought to the physician by his mother because of worsening fatigue. His mother reports that he seems to have trouble keeping up with his older brothers when playing outside. Physical examination shows conjunctival pallor. A hemoglobin electrophoresis is performed. This patient&#x27;s results are shown in comparison to those of a patient with known sickle cell anemia and a child with normal hemoglobin. Based on this electrophoresis, which of the following types of hemoglobin are dominant in this patient&#x27;s blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HbC only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HbA and HbC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HbA and HbS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HbS and HbC&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HbS and HbC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/whatsapp-image-2024-07-31-at-50300-pm.jpeg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) HbS and HbC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. HbC only: Individuals homozygous for HbC have hemoglobin C disease, which typically manifests with mild anemia. The electrophoresis pattern of a patient with HbC disease would show a single thicker band that migrates even less than HbS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HbC only:&lt;/li&gt;&lt;li&gt;â€¢ Option B. HbA and HbC: Individuals with the hemoglobin C trait would have both HbA and HbC in their blood. Hemoglobin electrophoresis of this patient shows HbC but not HbA. Moreover, hemoglobin C trait is usually an asymptomatic carrier state, unlike this patient with fatigue.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HbA and HbC:&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbA and HbS: Individuals heterozygous for the sickle cell trait would have both HbA and HbS in their blood. Hemoglobin electrophoresis of this patient shows HbS but not HbA. Moreover, individuals heterozygous for the sickle cell trait are usually asymptomatic, unlike this patient with fatigue.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbA and HbS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with G6PD deficiency presents with jaundice and fatigue. Her laboratory results show hemoglobin of 8 g/dL and elevated indirect bilirubin. Which of the following medications would be MOST likely to trigger this hemolytic episode?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetaminophen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Penicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nitrofurantoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nitrofurantoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Nitrofurantoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acetaminophen : Acetaminophen is not a common trigger of G6PD deficiency-related hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen&lt;/li&gt;&lt;li&gt;â€¢ Option B. Penicillin : Penicillin is generally safe in G6PD deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Penicillin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ciprofloxacin : Ciprofloxacin is not a common trigger of G6PD deficiency-related hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Ciprofloxacin&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ It is crucial to avoid medications that can trigger hemolysis in patients with G6PD deficiency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with a history of hereditary spherocytosis presents with fatigue and pallor. Her laboratory tests reveal anemia with an increased mean corpuscular hemoglobin concentration (MCHC) and an increased red cell distribution width (RDW). Which of the following tests would be MOST helpful in confirming the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemoglobin electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Osmotic fragility test (OFT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Direct antiglobulin test (DAT)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Osmotic fragility test (OFT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Osmotic fragility test (OFT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bone marrow biopsy is not typically needed for the diagnosis of HS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bone marrow biopsy&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Hemoglobin electrophoresis is used to diagnose hemoglobinopathies, not HS.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Hemoglobin electrophoresis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Direct antiglobulin test (DAT) is used to diagnose autoimmune hemolytic anemia, not HS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Direct antiglobulin test (DAT)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The osmotic fragility test is a useful tool for diagnosing hereditary spherocytosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most definitive treatment for hereditary spherocytosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Folate supplementation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood transfusions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splenectomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron chelation therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Splenectomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Splenectomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Folate supplementation and Option B. Blood transfusions are supportive measures but do not cure the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Folate supplementation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Blood transfusions&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron chelation therapy is used to treat iron overload, not hereditary spherocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron chelation therapy&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Splenectomy is the definitive treatment for hereditary spherocytosis but is typically reserved for patients with moderate to severe disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old girl with hereditary spherocytosis presents with right upper quadrant pain. Ultrasound reveals gallstones. Which of the following is the most likely mechanism of gallstone formation in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased cholesterol secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased bile acid synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased pigment excretion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased gallbladder motility&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased pigment excretion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased pigment excretion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased cholesterol secretion: While cholesterol is a major component of gallstones, increased secretion is not the primary culprit in HS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased cholesterol secretion:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased bile acid synthesis: Decreased bile acid synthesis can promote cholesterol gallstones, but it is not a major factor in pigment gallstone formation seen in HS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased bile acid synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased gallbladder motility: Decreased gallbladder motility can contribute to gallstone formation, but it is not the most specific or common finding in HS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased gallbladder motility:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Gallstones are a common complication of hereditary spherocytosis due to increased pigment excretion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following tests is considered the GOLD STANDARD for diagnosing paroxysmal nocturnal hemoglobinuria (PNH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peripheral blood smear&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ham&#x27;s test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sucrose hemolysis test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-sensitivity flow cytometry&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. High-sensitivity flow cytometry&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) High-sensitivity flow cytometry&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peripheral blood smear: While it may show signs of hemolysis (like fragmented red blood cells or spherocytes), it cannot definitively diagnose PNH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peripheral blood smear:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ham&#x27;s test: This is an older, less specific test for PNH that is rarely used today due to its lower sensitivity and potential for false positives.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ham&#x27;s test:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sucrose hemolysis test: This test is also less sensitive and specific than flow cytometry.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sucrose hemolysis test:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ High-sensitivity flow cytometry is the gold standard for diagnosing PNH due to its ability to directly detect the absence of GPI-anchored proteins on red and white blood cells. Older tests like the Ham&#x27;s test and sucrose hemolysis test are less reliable and have been largely replaced by flow cytometry.&lt;/li&gt;&lt;li&gt;â€¢ High-sensitivity flow cytometry is the gold standard for diagnosing PNH due to its ability to directly detect the absence of GPI-anchored proteins on red and white blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Older tests like the Ham&#x27;s test and sucrose hemolysis test are less reliable and have been largely replaced by flow cytometry.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the first-line treatment for paroxysmal nocturnal hemoglobinuria (PNH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ravulizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ravulizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ravulizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prednisone: While corticosteroids like prednisone may be used in some cases of autoimmune hemolytic anemia, they are not the first-line treatment for PNH. They are less effective than eculizumab or ravulizumab at controlling hemolysis and thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prednisone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rituximab: Rituximab is a monoclonal antibody that targets B cells. While it can be used in some autoimmune disorders, it is not indicated for PNH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rituximab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclosporine: Cyclosporine is an immunosuppressant used in various conditions, including organ transplantation and some autoimmune disorders. It has no direct effect on the complement system, which is the primary driver of PNH, and thus is not used in its treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclosporine:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Eculizumab and ravulizumab have revolutionized the treatment of PNH by significantly reducing hemolysis, thrombosis risk, and improving quality of life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old male presents with fatigue, recurrent infections, and easy bruising. Laboratory findings reveal pancytopenia, and a bone marrow biopsy shows hypocellular marrow replaced with fat. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute myeloid leukemia (AML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome (MDS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aplastic anemia (AA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aplastic anemia (AA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aplastic anemia (AA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute myeloid leukemia (AML): AML would typically present with blasts (immature white blood cells) in the peripheral blood and a hypercellular bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute myeloid leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myelodysplastic syndrome (MDS): MDS is characterized by dysplastic changes in the bone marrow and peripheral blood cells, which are not present in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myelodysplastic syndrome (MDS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency: While vitamin B12 deficiency can cause pancytopenia, it usually manifests with a macrocytic anemia (large red blood cells) and megaloblastic changes in the bone marrow.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Aplastic anemia is a diagnosis of exclusion, characterized by pancytopenia and hypocellular bone marrow.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Flow cytometry in a patient with suspected aplastic anemia is most likely to reveal:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased CD34+ cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased or absent CD34+ cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased blasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Monoclonal B-cell population&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased or absent CD34+ cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decreased or absent CD34+ cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased CD34+ cells: This would be seen in conditions with increased hematopoietic activity, such as recovery from chemotherapy or certain leukemias. It&#x27;s not expected in aplastic anemia where the bone marrow is failing.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased CD34+ cells:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased blasts: Increased blasts (immature blood cells) would suggest acute leukemia or myelodysplastic syndrome (MDS), not aplastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased blasts:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Monoclonal B-cell population: This finding would be more indicative of a lymphoproliferative disorder, such as chronic lymphocytic leukemia (CLL) or lymphoma, rather than aplastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Monoclonal B-cell population:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Flow cytometry can help confirm the diagnosis of aplastic anemia by demonstrating a lack of CD34+ cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old male presents with severe fatigue, recurrent infections, and easy bruising. Laboratory investigations reveal pancytopenia, and a bone marrow biopsy shows markedly hypocellular marrow. He has an HLA-matched sibling. Which of the following is the MOST appropriate first-line treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immunosuppressive therapy (IST)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allogeneic hematopoietic stem cell transplant (HSCT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supportive care with blood transfusions and antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Androgens&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Allogeneic hematopoietic stem cell transplant (HSCT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Allogeneic hematopoietic stem cell transplant (HSCT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immunosuppressive therapy (IST): While IST is an effective treatment for aplastic anemia, it&#x27;s typically the first-line choice for patients who don&#x27;t have a matched sibling donor or are older. It aims to suppress the immune system, which is often attacking the bone marrow in acquired aplastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immunosuppressive therapy (IST):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Supportive care with blood transfusions and antibiotics: This is crucial for managing the symptoms and complications of aplastic anemia (e.g., anemia, infection). However, it is not a curative treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Supportive care with blood transfusions and antibiotics:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Androgens: Androgens (male sex hormones) can sometimes stimulate the bone marrow, but their efficacy is limited and not usually the first-line choice in severe aplastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Androgens:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The best treatment approach for aplastic anemia depends on the patient&#x27;s age, severity of the disease, and availability of a matched sibling donor. For young patients with severe aplastic anemia and a matched sibling donor, allogeneic HSCT offers the best chance for a cure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman presents with pancytopenia and a bone marrow biopsy revealing trilineage dysplasia. Cytogenetic analysis shows a normal karyotype. Which of the following would be the most appropriate next step in the workup?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Repeat bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Molecular testing for gene mutations&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start treatment with erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transfuse packed red blood cells and platelets&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Molecular testing for gene mutations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Molecular testing for gene mutations&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Repeat bone marrow biopsy: Repeat bone marrow biopsy is not necessary if the initial biopsy is diagnostic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Repeat bone marrow biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start treatment with erythropoietin: Erythropoietin is used to treat anemia in MDS, but it is not a diagnostic test.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start treatment with erythropoietin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transfuse packed red blood cells and platelets: Transfusion support may be needed, but it is not the next step in the diagnostic workup.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transfuse packed red blood cells and platelets:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Molecular testing for gene mutations is essential for the accurate diagnosis and management of MDS, especially in cases with a normal karyotype.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about myelodysplastic syndromes (MDS) is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDS is a clonal hematopoietic stem cell disorder.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Most patients with MDS will eventually progress to acute myeloid leukemia (AML).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The risk of transformation to AML is higher in patients with complex karyotype abnormalities.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allogeneic stem cell transplantation is the only curative option for MDS.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Most patients with MDS will eventually progress to acute myeloid leukemia (AML).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Most patients with MDS will eventually progress to acute myeloid leukemia (AML).&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following morphological features on a peripheral blood smear is LEAST likely to be seen in myelodysplastic syndrome (MDS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pseudo-Pelger-Huet anomaly (hypolobulated neutrophils)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ring sideroblasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Howell-Jolly bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersegmented neutrophils&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypersegmented neutrophils&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypersegmented neutrophils&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pseudo-Pelger-Huet anomaly (hypolobulated neutrophils): This is a classic finding in MDS, reflecting the dysplasia (abnormal maturation) of the myeloid lineage. Neutrophils may have bilobed or unsegmented nuclei.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pseudo-Pelger-Huet anomaly (hypolobulated neutrophils):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ring sideroblasts: These are red blood cells with iron deposits arranged in a ring around the nucleus, often seen in MDS, especially in cases with sideroblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ring sideroblasts:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Howell-Jolly bodies: These are nuclear remnants in red blood cells, indicating impaired splenic function or dyserythropoiesis, both of which can be seen in MDS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Howell-Jolly bodies:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ MDS is characterized by dysplastic changes in various blood cell lines, but hypersegmented neutrophils are not typically seen.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with fatigue, weakness, and easy bruising. Peripheral blood smear shows macrocytic anemia and dysplastic neutrophils. Cytogenetic analysis reveals a deletion in the long arm of chromosome 5 (del(5q)). According to the IPSS-R, what is the patient&#x27;s prognostic risk category?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Very low&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intermediate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Low&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Very Low: While del(5q) MDS is a lower-risk subtype, it doesn&#x27;t fall into the \&quot;very low\&quot; category, which is usually reserved for patients with very few cytopenias and no cytogenetic abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Very Low:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intermediate: This category typically includes patients with more cytopenias or less favorable cytogenetic findings than those with isolated del(5q).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intermediate:&lt;/li&gt;&lt;li&gt;â€¢ Option D. High: These categories are reserved for MDS with a high risk of progression to acute myeloid leukemia (AML), which is not typical of isolated del(5q). These patients usually have excess blasts in the bone marrow, complex karyotypes, or specific genetic mutations associated with worse outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. High:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Del(5q) is a favorable cytogenetic abnormality in MDS associated with a better prognosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man is diagnosed with myelodysplastic syndrome (MDS) with an isolated deletion in chromosome 7 (del(7q)). Which of the following is the most appropriate treatment option for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lenalidomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azacitidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decitabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Supportive care&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Supportive care&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Supportive care&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lenalidomide: Lenalidomide is a targeted therapy specifically approved for MDS with isolated del(5q), not del(7q). It is not effective in patients with del(7q) MDS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lenalidomide:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azacitidine: Azacitidine is a hypomethylating agent used for higher-risk MDS, but it has not shown significant benefit in patients with isolated del(7q).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azacitidine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decitabine: Similar to azacitidine, decitabine is another hypomethylating agent used in higher-risk MDS and is not a specific treatment for del(7q).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decitabine:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Supportive care is the primary treatment for MDS with isolated del(7q).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman presents with complaints of headache, dizziness, and erythromelalgia (burning pain in the hands and feet). Her complete blood count (CBC) shows a platelet count of 950,000/ÂµL. Given likely diagnosis, which of the following genetic mutations is most commonly associated with essential thrombocythemia (ET)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;JAK2 V617F&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BCR-ABL1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CALR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MPL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. JAK2 V617F&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) JAK2 V617F&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Essential thrombocythemia (ET) is at increased risk for which of the following complications?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thrombosis (arterial or venous)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bleeding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transformation to acute myeloid leukemia (AML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic mutations is most commonly associated with primary myelofibrosis (PMF)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;JAK2 V617F&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BCR-ABL1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CALR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MPL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. JAK2 V617F&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) JAK2 V617F&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. BCR-ABL1 : This mutation is associated with chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;â€¢ Option B. BCR-ABL1&lt;/li&gt;&lt;li&gt;â€¢ Option C. CALR and Option D. MPL : These mutations are also found in PMF but are less common than JAK2 V617F.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CALR&lt;/li&gt;&lt;li&gt;â€¢ Option D. MPL&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ JAK2 V617F is the most common mutation in PMF and can have prognostic implications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man presents with fatigue, early satiety, and abdominal discomfort. Physical examination reveals massive splenomegaly. Peripheral blood smear shows teardrop cells, nucleated red blood cells, and giant platelets. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic myeloid leukemia (CML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polycythemia vera (PV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Essential thrombocythemia (ET)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary myelofibrosis (PMF)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Primary myelofibrosis (PMF)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Primary myelofibrosis (PMF)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic myeloid leukemia (CML) : CML presents with leukocytosis and a left shift but not typically with teardrop cells or marked splenomegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic myeloid leukemia (CML)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polycythemia vera (PV) : PV is characterized by elevated red blood cell mass, not fibrosis or teardrop cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polycythemia vera (PV)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Essential thrombocythemia (ET) : ET presents with isolated thrombocytosis, not the constellation of findings seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Essential thrombocythemia (ET)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Teardrop cells, nucleated red blood cells, giant platelets, and massive splenomegaly are key features of PMF.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following stains is used to differentiate between ALL and AML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Periodic acid-Schiff (PAS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myeloperoxidase (MPO)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sudan Black B (SBB)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonspecific esterase (NSE)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myeloperoxidase (MPO)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Myeloperoxidase (MPO)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Optio n A. Periodic acid-Schiff (PAS) : PAS stains glycogen and mucopolysaccharides and is used to identify lymphoid blasts in ALL.&lt;/li&gt;&lt;li&gt;â€¢ Optio&lt;/li&gt;&lt;li&gt;â€¢ n A. Periodic acid-Schiff (PAS)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sudan Black B (SBB) : SBB stains lipids and is positive in AML blasts.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sudan Black B (SBB)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonspecific esterase (NSE) : NSE stains esterases and is used to identify monocytic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonspecific esterase (NSE)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ MPO staining is a valuable tool for differentiating between AML and ALL based on the presence or absence of myeloperoxidase in blast cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child presents with fatigue, pallor, fever, and bone pain. Peripheral blood smear shows blasts. Which of the following laboratory findings is more suggestive of acute lymphoblastic leukemia (ALL) than acute myeloid leukemia (AML)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Auer rods on peripheral smear&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Terminal deoxynucleotidyl transferase (TdT) positivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myeloperoxidase (MPO) positivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated lactate dehydrogenase (LDH) levels&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Terminal deoxynucleotidyl transferase (TdT) positivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Terminal deoxynucleotidyl transferase (TdT) positivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient newly diagnosed with APL is started on all-trans retinoic acid (ATRA). Within two weeks, they develop fever, dyspnea, and pulmonary infiltrates. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Differentiation syndrome (APL differentiation syndrome)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor lysis syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Differentiation syndrome (APL differentiation syndrome)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Differentiation syndrome (APL differentiation syndrome)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tumor lysis syndrome: This is a metabolic complication that can occur in rapidly proliferating malignancies after chemotherapy. It is characterized by electrolyte abnormalities like hyperkalemia, hyperphosphatemia, and hypocalcemia, along with acute kidney injury. These features are not typically seen in differentiation syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tumor lysis syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism: While pulmonary infiltrates are seen in both differentiation syndrome and pulmonary embolism, the patient&#x27;s recent initiation of ATRA therapy makes differentiation syndrome more likely. Pulmonary embolism would typically present with sudden-onset pleuritic chest pain and hypoxia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumonia: Pneumonia is a possible differential diagnosis, but the temporal association with ATRA initiation and the absence of typical infectious symptoms (cough, sputum production) makes differentiation syndrome more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Differentiation syndrome is a serious but manageable complication of ATRA in APL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient presents with fatigue, bruising, and bleeding gums. Bone marrow biopsy reveals hypergranular promyelocytes with Auer rods. Which combination therapy is MOST appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ATRA + Hydroxyurea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATO + Cytarabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ATRA + ATO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ATRA + ATO + Chemotherapy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ATRA + ATO + Chemotherapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) ATRA + ATO + Chemotherapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ATRA + Hydroxyurea: Hydroxyurea is a cytoreductive agent used in other types of leukemia, but it is not effective for APL. The combination of ATRA and hydroxyurea is not the standard of care.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ATRA + Hydroxyurea:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ATO + Cytarabine: While both ATO and cytarabine are used in the treatment of APL, they are not typically used together without ATRA. ATRA is crucial for inducing differentiation of leukemic cells and preventing differentiation syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ATO + Cytarabine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. ATRA + ATO: This combination is highly effective in APL, but the addition of chemotherapy (usually an anthracycline like daunorubicin or idarubicin) further improves outcomes by targeting the leukemic cells directly.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ATRA + ATO:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Combination therapy with ATRA, ATO, and chemotherapy is the standard of care for APL due to its high cure rates and low relapse rates.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old patient is diagnosed with newly diagnosed AML but has significant comorbidities and is considered unfit for intensive induction chemotherapy (\&quot;7+3\&quot;). Which of the following is the most appropriate treatment option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Standard \&quot;7+3\&quot; induction chemotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Midostaurin + Gemtuzumab ozogamicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypomethylating agent (HMA) + Venetoclax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allogeneic stem cell transplant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypomethylating agent (HMA) + Venetoclax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypomethylating agent (HMA) + Venetoclax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Standard \&quot;7+3\&quot; induction chemotherapy : Standard \&quot;7+3\&quot; is too intensive for unfit patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Standard \&quot;7+3\&quot; induction chemotherapy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Midostaurin + Gemtuzumab ozogamicin : Midostaurin and Gemtuzumab are often added to standard induction, not used in isolation for unfit patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Midostaurin + Gemtuzumab ozogamicin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allogeneic stem cell transplant : Allogeneic stem cell transplant is a potential curative option but is generally not feasible for older patients with comorbidities.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allogeneic stem cell transplant&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ HMA + Venetoclax offers a less intensive, yet effective, treatment option for older or unfit AML patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with fatigue, weight loss, and abdominal fullness. Physical examination reveals splenomegaly. Peripheral blood smear shows a leukocytosis with left shift. Which of the following genetic abnormalities is most likely to be found in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;JAK2 V617F&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BCR-ABL1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FLT3-ITD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. BCR-ABL1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) BCR-ABL1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. JAK2 V617F : Associated with myeloproliferative neoplasms (MPNs) like polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).&lt;/li&gt;&lt;li&gt;â€¢ Option A. JAK2 V617F&lt;/li&gt;&lt;li&gt;â€¢ Option C. FLT3-ITD : More commonly associated with acute myeloid leukemia (AML).&lt;/li&gt;&lt;li&gt;â€¢ Option C. FLT3-ITD&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(15;17) : Associated with acute promyelocytic leukemia (APL), a subtype of AML.&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(15;17)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ BCR-ABL1 fusion gene is the diagnostic hallmark of CML.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a common feature of blast crisis in CML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increasing splenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constitutional symptoms (fever, night sweats, weight loss)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normalization of the white blood cell count&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Normalization of the white blood cell count&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Normalization of the white blood cell count&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increasing splenomegaly: Blast cells can infiltrate the spleen, causing it to enlarge further.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increasing splenomegaly:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bone pain: Blast cells can also infiltrate the bone marrow, leading to bone pain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bone pain:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Constitutional symptoms (fever, night sweats, weight loss): These are common symptoms of advanced CML and blast crisis due to the underlying malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Constitutional symptoms (fever, night sweats, weight loss):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Blast crisis is a serious complication of CML, and it is important to recognize its clinical features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with fatigue, weight loss, and abdominal fullness. Physical examination reveals splenomegaly. Which of the following tests is the MOST appropriate initial diagnostic step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flow cytometry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytogenetic analysis (karyotype)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Complete blood count (CBC) with differential&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Complete blood count (CBC) with differential&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Complete blood count (CBC) with differential&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bone marrow biopsy : While a bone marrow biopsy is eventually needed to confirm the diagnosis and assess response to therapy, it&#x27;s not the initial step.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bone marrow biopsy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Flow cytometry : Flow cytometry is helpful for further characterization of the leukemia cells, but not the initial diagnostic test.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Flow cytometry&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cytogenetic analysis (karyotype) : This is important to confirm the Philadelphia chromosome translocation, but CBC is done first.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cytogenetic analysis (karyotype)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CBC with differential is the first-line test in suspected CML due to its ability to detect characteristic hematologic abnormalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the diagnostic hallmark of chronic myeloid leukemia (CML)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;JAK2 V617F mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(15;17) translocation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(9;22) translocation (Philadelphia chromosome)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(8;21) translocation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(9;22) translocation (Philadelphia chromosome)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(9;22) translocation (Philadelphia chromosome)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. JAK2 V617F mutation : This mutation is associated with myeloproliferative neoplasms (MPNs), not CML.&lt;/li&gt;&lt;li&gt;â€¢ Option A. JAK2 V617F mutation&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(15;17) translocation : This translocation is the hallmark of acute promyelocytic leukemia (APL).&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(15;17) translocation&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(8;21) translocation : This translocation is associated with acute myeloid leukemia (AML).&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(8;21) translocation&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The Philadelphia chromosome is the defining genetic feature of CML.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old patient with CML in chronic phase has been on imatinib for 3 years and now has rising BCR-ABL1 transcripts. Genetic testing reveals a T315I mutation. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the dose of imatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Switch to dasatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Switch to nilotinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate ponatinib&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Initiate ponatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Initiate ponatinib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of imatinib: Increasing the dose of imatinib will not be effective because the T315I mutation confers resistance to this drug and other first and second-generation TKIs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of imatinib:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Switch to dasatinib: Dasatinib is a second-generation TKI, but it is not effective against the T315I mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Switch to dasatinib:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switch to nilotinib: Nilotinib is another second-generation TKI that is not effective against the T315I mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switch to nilotinib:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Ponatinib is a third-generation TKI specifically designed to overcome TKI resistance, especially due to the T315I mutation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a correct statement regarding nilotinib in CML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a first-line therapy for chronic phase CML.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is used in the treatment of accelerated phase CML.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is contraindicated in patients with blastic phase CML.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is used at a higher dose in patients who are resistant or intolerant to prior TKI therapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It is a first-line therapy for chronic phase CML.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) It is a first-line therapy for chronic phase CML.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is more commonly associated with acute lymphoblastic leukemia (ALL) than acute myeloid leukemia (AML)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatosplenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lymphadenopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gingival hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skin infiltration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lymphadenopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lymphadenopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hepatosplenomegaly: While hepatosplenomegaly (enlargement of the liver and spleen) can be seen in both ALL and AML, it is not a distinguishing feature between the two. Both conditions can cause infiltration of these organs by leukemic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hepatosplenomegaly:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gingival hyperplasia: This is a rare finding in both ALL and AML, but it is more commonly associated with acute monocytic leukemia (a subtype of AML).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gingival hyperplasia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin infiltration: Skin infiltration (leukemia cutis) can occur in both ALL and AML, but it is relatively uncommon in both.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin infiltration:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ While both ALL and AML can involve extramedullary sites, lymphadenopathy is more characteristic of ALL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents with fatigue, weight loss, and gingival bleeding. Peripheral blood smear shows myeloblasts with Auer rods. Which of the following cytogenetic abnormalities is most likely to be found in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(9;22)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;inv(16)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(8;21)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. t(15;17)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) t(15;17)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(9;22): This translocation is the hallmark of chronic myeloid leukemia (CML), not acute promyelocytic leukemia (APL).&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(9;22):&lt;/li&gt;&lt;li&gt;â€¢ Option C. inv(16): This inversion is associated with acute myeloid leukemia (AML) with eosinophilia, not APL.&lt;/li&gt;&lt;li&gt;â€¢ Option C. inv(16):&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(8;21): This translocation is associated with a favorable-risk subtype of AML, but not APL.&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(8;21):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Auer rods are highly specific for APL, and the presence of this cytogenetic abnormality (t(15;17)) is diagnostic for APL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following cytogenetic abnormalities is associated with a high risk of relapse in AML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;inv(16)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(8;21)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;-5/del(5q)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. -5/del(5q)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) -5/del(5q)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. inv(16): This inversion is associated with acute myeloid leukemia with abnormal eosinophils (AML M4Eo) and generally has a favorable prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. inv(16):&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(15;17): This translocation is the hallmark of acute promyelocytic leukemia (APL), a subtype of AML. APL has a good prognosis when treated promptly with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO).&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(15;17):&lt;/li&gt;&lt;li&gt;â€¢ Option C. t(8;21): This translocation is associated with acute myeloid leukemia with maturation (AML M2) and also has a relatively favorable prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. t(8;21):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Cytogenetic abnormalities can significantly impact prognosis and treatment choices in AML.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic mutations would make an IDH inhibitor a potential treatment option for an AML patient who is ineligible for HMA therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FLT3-ITD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NPM1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IDH1/IDH2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TP53&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IDH1/IDH2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IDH1/IDH2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child with Down syndrome presents with pallor, fatigue, and bruising. Bone marrow biopsy shows megakaryoblastic proliferation and fibrosis. Which of the following leukemia subtypes is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia (ALL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute myeloid leukemia (AML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute megakaryoblastic leukemia (AMKL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Juvenile myelomonocytic leukemia (JMML)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute megakaryoblastic leukemia (AMKL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute megakaryoblastic leukemia (AMKL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute lymphoblastic leukemia (ALL): While ALL is the most common leukemia in children with Down syndrome, it doesn&#x27;t usually present with the specific bone marrow findings described here (megakaryoblastic proliferation and fibrosis).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute lymphoblastic leukemia (ALL):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute myeloid leukemia (AML): This is too broad of a category. While AMKL is a subtype of AML, it has distinct features that differentiate it from other AML subtypes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute myeloid leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Juvenile myelomonocytic leukemia (JMML): JMML is another myeloid leukemia that can occur in young children, but it is not specifically associated with Down syndrome and usually presents with different bone marrow findings (monocytic proliferation).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Juvenile myelomonocytic leukemia (JMML):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ AMKL is a specific type of AML associated with Down syndrome and GATA1 mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient with newly diagnosed multiple myeloma and no significant comorbidities is being evaluated for treatment. Which of the following is the most appropriate initial therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daratumumab monotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids (CS) + IMiD (e.g., lenalidomide)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CS + proteasome inhibitor (e.g., bortezomib) + daratumumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autologous hematopoietic stem cell transplant (HSCT)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CS + proteasome inhibitor (e.g., bortezomib) + daratumumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Daratumumab monotherapy: While daratumumab is a potent anti-CD38 monoclonal antibody with significant efficacy in multiple myeloma, it is not typically used as a single agent in the initial treatment of newly diagnosed patients. It is usually combined with other drugs to achieve a more robust response.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Daratumumab monotherapy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corticosteroids (CS) + IMiD (e.g., lenalidomide): This combination can be effective, but it is not the standard of care for transplant-eligible patients. Adding a proteasome inhibitor (PI) to this regimen has been shown to improve response rates and survival.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Corticosteroids (CS) + IMiD (e.g., lenalidomide):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Autologous hematopoietic stem cell transplant (HSCT): HSCT is a consolidation therapy option for multiple myeloma patients after initial induction therapy. It is not the first-line treatment, but it is often considered for transplant-eligible patients who achieve a good response to induction therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Autologous hematopoietic stem cell transplant (HSCT):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The standard initial therapy for multiple myeloma involves a combination of drugs targeting different pathways to maximize efficacy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with stage IV CHL, an albumin of 3.5 g/dL, hemoglobin of 9 g/dL, and a WBC count of 16,000/ÂµL with 500 lymphocytes/ÂµL. According to the IPS, how many risk factors does he have?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old male presents with a rapidly enlarging jaw mass and systemic B symptoms. Biopsy reveals medium-sized lymphoid cells with a starry sky pattern. Which of the following cytogenetic abnormalities is most likely associated with this lymphoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(11;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(14;18)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(11;18)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(8;14)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(8;14)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(11;14): This translocation is characteristic of Mantle Cell Lymphoma. It involves the cyclin D1 gene and leads to increased cell cycle progression.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. t(11;14):&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(14;18): This translocation is associated with Follicular Lymphoma. It involves the BCL2 gene, which inhibits apoptosis and promotes cell survival.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. t(14;18):&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(11;18): This translocation is also associated with Mantle Cell Lymphoma, like option A.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. t(11;18):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Burkitt lymphoma is a highly aggressive B-cell lymphoma characterized by a specific translocation, t(8;14).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presents with abdominal pain and a palpable mass. Biopsy reveals Burkitt&#x27;s lymphoma. Which of the following infectious agents is most likely associated with this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Epstein-Barr virus (EBV)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Human Immunodeficiency Virus (HIV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatitis C virus (HCV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Helicobacter pylori (H. pylori)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Epstein-Barr virus (EBV)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Epstein-Barr virus (EBV)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Human Immunodeficiency Virus (HIV): While HIV infection increases the risk of various lymphomas, including Burkitt&#x27;s lymphoma, it is not the most common infectious agent directly associated with Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Human Immunodeficiency Virus (HIV):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hepatitis C virus (HCV): HCV is primarily associated with liver disease and certain types of lymphoma, but not Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Hepatitis C virus (HCV):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Helicobacter pylori (H. pylori): H. pylori is a bacterium that infects the stomach and is associated with gastric cancer and lymphoma of the stomach (MALT lymphoma), but not Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Helicobacter pylori (H. pylori):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ EBV plays a significant role in the pathogenesis of Burkitt&#x27;s lymphoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which genetic abnormality defines double-hit lymphoma (DHL)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(14;18) with MYC overexpression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MYC translocation with BCL2 or BCL6 rearrangement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BCL2 translocation with BCL6 rearrangement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trisomy 12 with BCL6 rearrangement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MYC translocation with BCL2 or BCL6 rearrangement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MYC translocation with BCL2 or BCL6 rearrangement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(14;18) with MYC overexpression: While t(14;18) is associated with BCL2 overexpression and is seen in follicular lymphoma, it alone does not define DHL. DHL requires the additional presence of a MYC translocation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. t(14;18) with MYC overexpression:&lt;/li&gt;&lt;li&gt;â€¢ Option C. BCL2 translocation with BCL6 rearrangement: This combination of rearrangements is not characteristic of DHL. DHL specifically requires a MYC translocation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. BCL2 translocation with BCL6 rearrangement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Trisomy 12 with BCL6 rearrangement: Trisomy 12 is associated with chronic lymphocytic leukemia (CLL), and while BCL6 rearrangement can occur in various lymphomas, this combination does not define DHL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Trisomy 12 with BCL6 rearrangement:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The combined dysregulation of MYC and BCL2/BCL6 is the defining feature of DHL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with painless, slowly enlarging lymph nodes in her neck and axillae. Lymph node biopsy reveals small, cleaved lymphocytes with a follicular pattern. Which of the following genetic abnormalities is most commonly associated with this type of lymphoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(11;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(14;18)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(14;18)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(14;18)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(8;14): This translocation is characteristic of Burkitt lymphoma. It leads to overexpression of the MYC oncogene, promoting cell growth and proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. t(8;14):&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(11;14): This translocation is associated with mantle cell lymphoma. It leads to overexpression of cyclin D1, which regulates the cell cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. t(11;14):&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(15;17): This translocation is associated with acute promyelocytic leukemia (APL). It leads to the fusion of the PML and RARA genes, disrupting normal cell differentiation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. t(15;17):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ t(14;18) is a diagnostic feature of FL and contributes to its indolent nature.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following chemotherapy regimens is NOT typically used as a first-line treatment for symptomatic follicular lymphoma (FL)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bendamustine-rituximab (BR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone): This is a widely used and effective first-line treatment for FL. It combines the monoclonal antibody rituximab with a standard chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone).&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone):&lt;/li&gt;&lt;li&gt;â€¢ Option B. R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone): This is another commonly used first-line regimen for FL, particularly in older or less fit patients. It is similar to R-CHOP but uses vincristine instead of doxorubicin, which is associated with less cardiotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. R-CVP (Rituximab, Cyclophosphamide, Vincristine, Prednisone):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bendamustine-rituximab (BR): This is a well-tolerated and effective regimen that has gained popularity as a first-line treatment for FL, especially in patients who may not tolerate the anthracycline component of R-CHOP.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Bendamustine-rituximab (BR):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ FL is typically treated with less intensive chemotherapy regimens compared to aggressive lymphomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with fatigue, splenomegaly, and pancytopenia. Peripheral blood smear shows \&quot;hairy cells\&quot; with cytoplasmic projections. Which of the following markers is most specific for the diagnosis of hairy cell leukemia (HCL)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD19&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD20&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD103&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD30&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CD103&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CD103&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CD19: This is a B-cell marker that is expressed in HCL, but it is not specific to HCL. It is also found on other B-cell malignancies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CD19:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CD20: Similar to CD19, this is a B-cell marker present in HCL but not specific to it.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CD20:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD30: This marker is primarily associated with classical Hodgkin lymphoma and anaplastic large cell lymphoma. It is not expressed in HCL.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD30:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ CD103 is a key diagnostic marker for hairy cell leukemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presents with fatigue and mild lymphadenopathy. Blood tests reveal lymphocytosis with smudge cells on peripheral smear. Flow cytometry shows CD5 and CD23 positivity. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute myeloid leukemia (AML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mantle cell lymphoma (MCL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hodgkin lymphoma (HL)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute myeloid leukemia (AML): AML is characterized by the proliferation of immature myeloid cells in the bone marrow and blood. It does not typically present with smudge cells or CD5/CD23 positivity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute myeloid leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mantle cell lymphoma (MCL): MCL is a type of B-cell lymphoma with a characteristic t(11;14) translocation. While it can present with lymphocytosis, it typically lacks smudge cells and does not express CD23.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Mantle cell lymphoma (MCL):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hodgkin lymphoma (HL): HL is characterized by the presence of Reed-Sternberg cells, which are large, atypical cells not seen in CLL/SLL. HL typically does not present with smudge cells or a predominantly lymphocytic infiltrate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hodgkin lymphoma (HL):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CLL/SLL is a B-cell neoplasm characterized by the accumulation of small, mature lymphocytes with specific immunophenotypic markers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a potential adverse effect of venetoclax, a BCL2 inhibitor used in CLL/SLL treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tumor lysis syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peripheral neuropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tumor lysis syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tumor lysis syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial fibrillation: While cardiac arrhythmias can be a side effect of some cancer therapies, atrial fibrillation is not a common side effect specifically associated with venetoclax.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Atrial fibrillation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diarrhea: Diarrhea is a common side effect of many chemotherapies but is not a characteristic side effect of venetoclax.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Diarrhea:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Peripheral neuropathy: Peripheral neuropathy (damage to peripheral nerves causing numbness, tingling, or pain) can be a side effect of certain chemotherapy agents, but it is not typically associated with venetoclax.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Peripheral neuropathy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Monitoring for and preventing TLS is crucial when initiating venetoclax therapy in CLL/SLL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic abnormalities is associated with a poor prognosis in CLL/SLL?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Del(13q)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Del(17p)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutated IgVH genes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trisomy 12&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Del(17p)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Del(17p)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Del(13q): This is the most common genetic abnormality in CLL/SLL and is associated with a favorable prognosis. It typically involves deletion of the microRNA genes miR-15a and miR-16-1, which regulate B-cell survival.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Del(13q):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mutated IgVH genes: CLL/SLL cases with mutated IgVH genes generally have a more indolent course and better prognosis compared to those with unmutated IgVH genes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Mutated IgVH genes:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Trisomy 12: This is an intermediate-risk genetic abnormality in CLL/SLL, with a prognosis between that of del(13q) and del(17p). It can be associated with atypical morphology and increased proliferative activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Trisomy 12:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ del(17p) is a high-risk genetic abnormality in CLL/SLL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a potential advantage of targeted therapies like BTK inhibitors or BCL2 inhibitors over traditional chemotherapy in CLL/SLL treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lower risk of infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Improved tolerability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Higher response rates in certain patient subgroups&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man from Japan presents with hypercalcemia, lytic bone lesions, and skin rash. Peripheral blood smear reveals atypical lymphocytes with \&quot;cloverleaf\&quot; nuclei. Which of the following viruses is most likely associated with this clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Epstein-Barr virus (EBV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Human T-lymphotropic virus type 1 (HTLV-1)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Human immunodeficiency virus (HIV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cytomegalovirus (CMV)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Human T-lymphotropic virus type 1 (HTLV-1)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Human T-lymphotropic virus type 1 (HTLV-1)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Epstein-Barr virus (EBV): EBV is associated with other lymphoid malignancies, such as Burkitt lymphoma and Hodgkin lymphoma, but not typically with ATLL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Epstein-Barr virus (EBV):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Human immunodeficiency virus (HIV): While HIV increases the risk of various malignancies, including lymphomas, it is not the primary cause of ATLL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Human immunodeficiency virus (HIV):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cytomegalovirus (CMV): CMV is a common virus that usually causes mild or asymptomatic infections. It is not linked to the development of ATLL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Cytomegalovirus (CMV):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ HTLV-1 infection is a crucial risk factor for ATLL, particularly in endemic regions like Japan and the Caribbean.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with a history of breast implants presents with a rapidly enlarging axillary lymph node. Excisional biopsy reveals large atypical cells with horseshoe-shaped nuclei and abundant cytoplasm. Immunohistochemical staining shows strong expression of CD30. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hodgkin lymphoma (HL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diffuse large B-cell lymphoma (DLBCL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anaplastic large cell lymphoma (ALCL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anaplastic large cell lymphoma (ALCL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anaplastic large cell lymphoma (ALCL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hodgkin lymphoma (HL): While HL can express CD30, it lacks the characteristic hallmark cells with horseshoe-shaped nuclei seen in ALCL. RS cells are usually larger and have a bilobed or multi-lobed nucleus.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Hodgkin lymphoma (HL):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diffuse large B-cell lymphoma (DLBCL): DLBCL is a B-cell lymphoma and would not express CD30. The cells in DLBCL are also not typically described as having horseshoe-shaped nuclei.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Diffuse large B-cell lymphoma (DLBCL):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS): PTCL-NOS is a heterogeneous group of T-cell lymphomas. While it can share some features with ALCL, it does not have the specific hallmark cells or the same association with breast implants.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ALCL is a T-cell lymphoma characterized by large atypical cells, CD30 expression, and potential association with breast implants.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of monoclonal gammopathy of undetermined significance (MGUS) presents with new-onset renal insufficiency. Which of the following is the most likely mechanism underlying his renal dysfunction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tubulointerstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Light chain cast nephropathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Obstructive uropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Light chain cast nephropathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Light chain cast nephropathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glomerulonephritis: Glomerulonephritis is an inflammation of the glomeruli, the tiny filters in the kidneys. While it can cause renal insufficiency, it&#x27;s not the most common mechanism in patients with MM or MGUS.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Glomerulonephritis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tubulointerstitial nephritis: This condition involves inflammation of the tubules and the surrounding tissue in the kidneys. It can be caused by medications or infections but is less likely in the context of MGUS progressing to MM.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Tubulointerstitial nephritis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Obstructive uropathy: This refers to a blockage of the urinary tract, which can lead to kidney damage. While it&#x27;s possible, it&#x27;s less likely to be the primary cause of renal insufficiency in a patient with MM or MGUS.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Obstructive uropathy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The progression of MGUS to multiple myeloma often leads to the production of excess light chains, which can cause kidney damage through light chain cast nephropathy. It&#x27;s a crucial consideration in the management of these patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a component of the SLIM criteria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;60% clonal bone marrow plasma cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Involved SFLC â‰¥100 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â‰¥2 focal lesions (&amp;gt;5mm) on whole-body MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum creatinine &amp;gt;2 mg/dL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum creatinine &gt;2 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum creatinine &amp;gt;2 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following bone marrow plasma cell (BMPC) percentages would NOT meet the criteria for myeloma-defining events (MDE)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;15%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;65%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;72%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 15%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 15%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents with a 3-month history of worsening fatigue, back pain, and unintentional weight loss. On examination, he is pale and has point tenderness over the lumbar spine. Laboratory findings reveal anemia, hypercalcemia, and elevated creatinine. A skeletal survey shows multiple lytic lesions in the spine and pelvis. Serum electrophoresis was done and the image is shown below. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monoclonal gammopathy of undetermined significance (MGUS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Smoldering multiple myeloma (SMM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple myeloma (MM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WaldenstrÃ¶m macroglobulinemia (WM)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Multiple myeloma (MM)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/02/screenshot-2024-08-02-104412.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Multiple myeloma (MM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Monoclonal gammopathy of undetermined significance (MGUS): MGUS is a benign condition where a small amount of monoclonal protein (M-protein) is present in the blood, but there are no symptoms or signs of end-organ damage (CRAB criteria). The patient in this scenario clearly has CRAB criteria, ruling out MGUS.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Monoclonal gammopathy of undetermined significance (MGUS):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Smoldering multiple myeloma (SMM): SMM is a precursor to multiple myeloma and is characterized by a higher level of M-protein or bone marrow plasma cells than MGUS, but still no CRAB criteria. This patient&#x27;s presentation with anemia, hypercalcemia, and renal insufficiency indicates organ damage, making SMM less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Smoldering multiple myeloma (SMM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. WaldenstrÃ¶m macroglobulinemia (WM): WM is a type of lymphoma where malignant B cells produce excessive IgM antibodies. While it can present with some similar features to multiple myeloma (like fatigue and anemia), it typically doesn&#x27;t cause bone pain, hypercalcemia, or lytic bone lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. WaldenstrÃ¶m macroglobulinemia (WM):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Multiple myeloma is a plasma cell malignancy that can present with various symptoms, including bone pain, anemia, renal insufficiency, and hypercalcemia. The presence of CRAB criteria, along with lytic bone lesions and monoclonal protein in the serum or urine, are key diagnostic features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents with painless cervical lymphadenopathy and pruritus. Excisional biopsy of a lymph node reveals Reed-Sternberg (RS) cells positive for CD15 and CD30. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Classical Hodgkin Lymphoma (CHL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse large B-cell lymphoma (DLBCL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Follicular lymphoma (FL)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Classical Hodgkin Lymphoma (CHL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Classical Hodgkin Lymphoma (CHL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) : This subtype is characterized by \&quot;popcorn\&quot; cells, which are negative for CD15 and CD30.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse large B-cell lymphoma (DLBCL) and Option D. Follicular lymphoma (FL) : These are non-Hodgkin lymphomas with different histopathological features.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse large B-cell lymphoma (DLBCL)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Follicular lymphoma (FL)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CHL is diagnosed based on the presence of classic RS cells positive for CD15 and CD30.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following markers is typically positive in NLPHL but negative in CHL?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD15&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD20&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD30&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD45&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CD20&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CD20&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CD15: This marker is often positive in CHL, particularly in the Reed-Sternberg cells. It may be positive in NLPHL but is not a defining characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ CD15:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CD30: This marker is typically positive in CHL, especially in the Reed-Sternberg cells. It is usually negative in NLPHL.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ CD30:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD45: This marker is a general leukocyte marker and is expressed in both CHL and NLPHL, but it is not helpful in differentiating between the two.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ CD45:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CD20 expression can help differentiate between CHL and NLPHL.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with a rapidly enlarging cervical lymph node and complains of fatigue, night sweats, and unintentional weight loss. A lymph node biopsy confirms the diagnosis of diffuse large B-cell lymphoma (DLBCL). Which of the following treatment regimens is the most appropriate initial therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;R-EPOCH (Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radiotherapy alone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. R-EPOCH (Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin): This is a more intensive regimen typically reserved for younger patients with high-risk disease or certain subtypes of DLBCL. It may not be suitable Option for older patients due to increased toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ R-EPOCH (Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin):&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ Option C. HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine): This is another intensive regimen often used in specific subtypes of aggressive lymphoma or for relapsed/refractory disease. It is not the standard first-line treatment for DLBCL.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiotherapy alone: While radiotherapy may be used in certain situations (e.g., localized disease), it is not sufficient as the sole treatment for most cases of DLBCL.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Radiotherapy alone:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ R-CHOP is the standard first-line treatment for most newly diagnosed patients with DLBCL, including the elderly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with abdominal discomfort, fatigue, and weight loss. Endoscopy reveals multiple gastric ulcers. Biopsy shows small to medium-sized lymphoid cells with CD5 expression but lacking CD23. Which of the following cytogenetic abnormalities is most characteristic of this lymphoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(14;18)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(11;14)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(11;14)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(11;14)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(14;18): This translocation is characteristic of follicular lymphoma, not mantle cell lymphoma. It involves the BCL2 gene, which inhibits apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(14;18):&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(8;14): This translocation is the hallmark of Burkitt lymphoma. It leads to overexpression of the MYC oncogene, which promotes cell growth and proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. t(8;14):&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(15;17): This translocation is associated with acute promyelocytic leukemia (APL), a type of acute myeloid leukemia. It involves the PML and RARA genes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. t(15;17):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ t(11;14) is a diagnostic feature of MCL and is associated with cyclin D1 overexpression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a standard treatment option for mantle cell lymphoma (MCL)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bendamustine-rituximab (BR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HyperCVAD (Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with Methotrexate and Cytarabine)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic abnormalities is most frequently associated with extranodal marginal zone lymphoma (ENMZL) of mucosa-associated lymphoid tissue (MALT)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(11;18)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(14;18)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(11;14)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. t(11;18)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) t(11;18)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(8;14): This translocation is the hallmark of Burkitt lymphoma, a highly aggressive B-cell lymphoma. It leads to the overexpression of the MYC oncogene.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. t(8;14):&lt;/li&gt;&lt;li&gt;â€¢ Option C. t(14;18): This translocation is characteristic of follicular lymphoma, another type of B-cell lymphoma. It involves the BCL2 gene, which inhibits apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. t(14;18):&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(11;14): This translocation is the hallmark of mantle cell lymphoma, a type of B-cell lymphoma. It leads to overexpression of cyclin D1, promoting cell cycle progression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(11;14):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The t(11;18) translocation is a characteristic feature of MALT lymphoma and can guide treatment decisions, as cases with this translocation may not respond to H. pylori eradication alone.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following infectious agents is most commonly associated with gastric MALT lymphoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Epstein-Barr Virus (EBV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Helicobacter pylori&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chlamydia psittaci&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Borrelia burgdorferi&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Helicobacter pylori&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Helicobacter pylori&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Epstein-Barr Virus (EBV): EBV is associated with several types of lymphomas, including Burkitt lymphoma and Hodgkin lymphoma, but not typically with gastric MALT lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Epstein-Barr Virus (EBV):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chlamydia psittaci: This bacterium is associated with psittacosis (parrot fever) and can sometimes cause conjunctivitis. It is not linked to the development of gastric MALT lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chlamydia psittaci:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Borrelia burgdorferi: This bacterium is the causative agent of Lyme disease and is sometimes associated with cutaneous (skin) MALT lymphoma, but not gastric MALT lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Borrelia burgdorferi:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ H. pylori infection is a significant risk factor for developing gastric MALT lymphoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following laboratory findings is characteristic of hairy cell leukemia (HCL)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Positive tartrate-resistant acid phosphatase (TRAP) stain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Positive myeloperoxidase (MPO) stain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased serum uric acid levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;BCR-ABL1 fusion gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Positive tartrate-resistant acid phosphatase (TRAP) stain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Positive tartrate-resistant acid phosphatase (TRAP) stain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Positive myeloperoxidase (MPO) stain: MPO is an enzyme found in myeloid cells (neutrophils, eosinophils, and monocytes) and is used to diagnose myeloid leukemias. It is not typically positive in HCL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Positive myeloperoxidase (MPO) stain:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased serum uric acid levels: While elevated uric acid levels can be seen in various hematologic malignancies due to increased cell turnover, it is not a specific finding for HCL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Increased serum uric acid levels:&lt;/li&gt;&lt;li&gt;â€¢ Option D. BCR-ABL1 fusion gene: This genetic abnormality is the hallmark of chronic myeloid leukemia (CML) and is not associated with HCL.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. BCR-ABL1 fusion gene:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ A positive TRAP stain is a useful diagnostic clue for hairy cell leukemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with a persistent itchy, scaly rash on his trunk that has progressed over several months. Skin biopsy reveals epidermotropic lymphoid infiltrates with haloed lymphocytes. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atopic dermatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mycosis fungoides (MF)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SÃ©zary syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mycosis fungoides (MF)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mycosis fungoides (MF)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Psoriasis: Psoriasis can present with scaly plaques, but it usually has a well-demarcated border and lacks the characteristic epidermotropic lymphoid infiltrate with haloed lymphocytes seen in MF.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atopic dermatitis: Atopic dermatitis is a chronic inflammatory skin condition characterized by itchy, red, and scaly rashes. However, it does not typically present with epidermotropic lymphoid infiltrates or haloed lymphocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Atopic dermatitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. SÃ©zary syndrome: SÃ©zary syndrome is an advanced form of cutaneous T-cell lymphoma (CTCL) characterized by erythroderma (widespread redness of the skin), circulating atypical T cells (SÃ©zary cells), and generalized lymphadenopathy. While it can present with similar skin findings to MF, the widespread involvement and presence of SÃ©zary cells in the blood distinguish it from early-stage MF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. SÃ©zary syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ MF is the most common type of cutaneous T-cell lymphoma (CTCL) and presents with a variety of skin manifestations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents with generalized erythroderma (redness of the skin), intense pruritus, and lymphadenopathy. Peripheral blood smear reveals atypical lymphocytes with cerebriform nuclei. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atopic dermatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mycosis fungoides (MF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SÃ©zary syndrome (SS)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. SÃ©zary syndrome (SS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) SÃ©zary syndrome (SS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atopic dermatitis: While atopic dermatitis can cause itchy skin, it usually presents with localized patches of dry, scaly skin and does not typically cause erythroderma or lymphadenopathy. It also doesn&#x27;t have the characteristic cerebriform nuclei seen in SS.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Atopic dermatitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis: Psoriasis can also cause itchy, scaly skin, but the plaques are usually well-demarcated and silvery. It does not typically progress to erythroderma or involve lymph nodes. Again, the cerebriform nuclei are not a feature of psoriasis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mycosis fungoides (MF): MF is another type of CTCL and can share some skin features with SS. However, it usually progresses more slowly and doesn&#x27;t always present with erythroderma. In the early stages of MF, the atypical lymphocytes are typically confined to the skin, not circulating in the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Mycosis fungoides (MF):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ SS is characterized by erythroderma, circulating SÃ©zary cells, and lymphadenopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old asymptomatic man undergoes routine blood tests, which reveal a serum M-protein level of 2.5 g/dL. Urine protein electrophoresis is negative. Bone marrow biopsy shows &amp;lt;10% clonal plasma cells. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple Myeloma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WaldenstrÃ¶m macroglobulinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monoclonal gammopathy of undetermined significance (MGUS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoldering multiple myeloma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Monoclonal gammopathy of undetermined significance (MGUS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Monoclonal gammopathy of undetermined significance (MGUS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple Myeloma: Multiple myeloma would present with a higher M-protein level, a greater percentage of plasma cells in the bone marrow, and evidence of end-organ damage.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Multiple Myeloma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. WaldenstrÃ¶m macroglobulinemia: This is characterized by the overproduction of IgM antibodies, resulting in a high serum M-protein level. It also often presents with symptoms like hyperviscosity syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. WaldenstrÃ¶m macroglobulinemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoldering multiple myeloma: This is a precursor to multiple myeloma with a higher M-protein level (&amp;gt;3 g/dL) and/or bone marrow plasma cells (10-60%) but no end-organ damage.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Smoldering multiple myeloma:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ MGUS is a common, premalignant condition that requires monitoring for progression to multiple myeloma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the approximate annual risk of progression of SMM to multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;25%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 10%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 10%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man presents with fatigue, bone pain, and elevated serum creatinine. Serum protein electrophoresis reveals an M-spike, and bone marrow biopsy shows 30% plasma cells. Skeletal survey reveals multiple lytic lesions. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monoclonal gammopathy of undetermined significance (MGUS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Smoldering multiple myeloma (SMM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple myeloma (MM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WaldenstrÃ¶m&#x27;s macroglobulinemia (WM)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Multiple myeloma (MM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Multiple myeloma (MM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Monoclonal gammopathy of undetermined significance (MGUS): MGUS is a benign condition characterized by a small M-spike and low levels of plasma cells in the bone marrow (&amp;lt;10%). Crucially, MGUS patients do not have end-organ damage (CRAB criteria).&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Monoclonal gammopathy of undetermined significance (MGUS):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Smoldering multiple myeloma (SMM): SMM is an intermediate stage between MGUS and multiple myeloma. While it has a higher risk of progression to myeloma, SMM patients typically lack the CRAB criteria that define multiple myeloma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Smoldering multiple myeloma (SMM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. WaldenstrÃ¶m&#x27;s macroglobulinemia (WM): WM is a type of lymphoma characterized by the overproduction of IgM antibodies. While it can share some features with multiple myeloma (like an M-spike), the clinical presentation and bone marrow findings are different. WM typically does not cause lytic bone lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. WaldenstrÃ¶m&#x27;s macroglobulinemia (WM):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Multiple myeloma is characterized by the presence of CRAB criteria, which distinguish it from MGUS and SMM.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a type of chimeric antigen receptor (CAR) T-cell therapy approved for multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cilta-cel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ide-cel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abecma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brexucabtagene autoleucel (Tecartus)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Brexucabtagene autoleucel (Tecartus)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Brexucabtagene autoleucel (Tecartus)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cilta-cel (Carvykti): This CAR T-cell therapy targets the B-cell maturation antigen (BCMA) on myeloma cells. It is FDA-approved for adult patients with relapsed or refractory multiple myeloma after at least four prior lines of therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Cilta-cel (Carvykti):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ide-cel (Abecma): This is another BCMA-directed CAR T-cell therapy approved for adult patients with relapsed or refractory multiple myeloma after at least four prior lines of therapy. It was the first CAR T-cell therapy approved for myeloma.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Ide-cel (Abecma):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Abecma: This is the same therapy as Ide-cel.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Abecma:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CAR T-cell therapy is a promising new treatment option for relapsed/refractory multiple myeloma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with newly diagnosed multiple myeloma has a serum Î²2-microglobulin (Î²2m) level of 2.8 mg/L and serum albumin of 3.8 g/dL. Based on the ISS, what is this patient&#x27;s stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stage I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stage I&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with newly diagnosed multiple myeloma has a bone marrow biopsy revealing a t(14;16) translocation. Which of the following statements is true regarding this patient&#x27;s prognosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The patient has standard-risk myeloma and a good prognosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The patient has high-risk myeloma and a poor prognosis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The t(14;16) translocation is not a significant prognostic factor in multiple myeloma.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The patient requires immediate allogeneic stem cell transplantation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The patient has high-risk myeloma and a poor prognosis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) The patient has high-risk myeloma and a poor prognosis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old male presents with fatigue, weight loss, and blurred vision. Laboratory findings show elevated IgM levels and anemia. Bone marrow biopsy reveals lymphoid cells with plasmacytic differentiation. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple Myeloma (MM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WaldenstrÃ¶m Macroglobulinemia (WM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monoclonal Gammopathy of Undetermined Significance (MGUS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoldering Multiple Myeloma (SMM)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. WaldenstrÃ¶m Macroglobulinemia (WM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) WaldenstrÃ¶m Macroglobulinemia (WM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple Myeloma (MM): While MM can cause fatigue, weight loss, and anemia, it is less likely in this case due to the absence of lytic bone lesions (holes in the bones) and hypercalcemia (high calcium levels). MM also typically presents with elevated IgG or IgA, not IgM.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Multiple Myeloma (MM):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Monoclonal Gammopathy of Undetermined Significance (MGUS): MGUS is a benign condition where a small amount of monoclonal protein is present in the blood. It usually doesn&#x27;t cause symptoms and wouldn&#x27;t explain the patient&#x27;s fatigue, weight loss, blurred vision, or anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Monoclonal Gammopathy of Undetermined Significance (MGUS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoldering Multiple Myeloma (SMM): SMM is a precursor to multiple myeloma. While it shares some similarities with MM, it typically doesn&#x27;t cause symptoms or organ damage. This patient&#x27;s presentation with fatigue, weight loss, and blurred vision suggests a more active disease process than SMM.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Smoldering Multiple Myeloma (SMM):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ WM often presents with hyperviscosity symptoms and bone marrow infiltration by lymphoplasmacytic cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient diagnosed with WM presents with tingling and numbness in their extremities. Which of the following autoantibodies is most likely associated with this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cold agglutinins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-MAG antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-cardiolipin antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-nuclear antibodies (ANA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anti-MAG antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Anti-MAG antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cold agglutinins: These antibodies are associated with cold agglutinin disease (CAD), a type of autoimmune hemolytic anemia. While CAD can occur in WM, it typically presents with symptoms of anemia like fatigue and shortness of breath, not peripheral neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Cold agglutinins:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-cardiolipin antibodies: These antibodies are associated with antiphospholipid syndrome, an autoimmune disorder that can cause blood clots. They are not typically associated with peripheral neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Anti-cardiolipin antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-nuclear antibodies (ANA): ANAs are a group of antibodies that target components of the cell nucleus. They are commonly seen in systemic lupus erythematosus (SLE) and other autoimmune diseases, but not typically in WM-associated neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Anti-nuclear antibodies (ANA):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Peripheral neuropathy in WM is often associated with anti-MAG antibodies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with acute myeloid leukemia (AML) in first remission is being evaluated for stem cell transplantation. Which of the following types of transplant is most likely to offer a graft-versus-tumor (GVT) effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autologous stem cell transplant (ASCT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allogeneic stem cell transplant (allo-SCT) from a matched related donor (MRD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allogeneic stem cell transplant (allo-SCT) from an unrelated donor (MUD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allogeneic stem cell transplant (allo-SCT) from umbilical cord blood (UCB)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Allogeneic stem cell transplant (allo-SCT) from a matched related donor (MRD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Allogeneic stem cell transplant (allo-SCT) from a matched related donor (MRD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autologous stem cell transplant (ASCT): In ASCT, the patient receives their own stem cells, which have been previously collected and stored. Since the immune system recognizes these cells as \&quot;self,\&quot; there is no GVT effect. ASCT is mainly used to allow for higher doses of chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Autologous stem cell transplant (ASCT):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allogeneic stem cell transplant (allo-SCT) from an unrelated donor (MUD): While MUD allo-SCT can also elicit a GVT effect, the risk of graft-versus-host disease (GVHD) is higher than with MRD transplants due to increased immunological disparity. GVHD is a serious complication where the donor&#x27;s immune cells attack the recipient&#x27;s tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Allogeneic stem cell transplant (allo-SCT) from an unrelated donor (MUD):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allogeneic stem cell transplant (allo-SCT) from umbilical cord blood (UCB): UCB transplants also have a GVT effect, but they are often associated with slower engraftment and a higher risk of infection compared to MRD or MUD transplants.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Allogeneic stem cell transplant (allo-SCT) from umbilical cord blood (UCB):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Allo-SCT offers the advantage of a GVT effect, but also carries a higher risk of graft-versus-host disease (GVHD).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoing allogeneic stem cell transplantation (allo-SCT) develops a maculopapular rash, diarrhea, and elevated liver enzymes. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute graft-versus-host disease (GVHD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic graft-versus-host disease (GVHD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytomegalovirus (CMV) reactivation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Engraftment syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute graft-versus-host disease (GVHD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute graft-versus-host disease (GVHD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic graft-versus-host disease (GVHD): While chronic GVHD can also affect the skin, gastrointestinal tract, and liver, it typically develops later after transplantation (months to years), and presents with different manifestations like skin thickening, dry eyes/mouth, and lung problems.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Chronic graft-versus-host disease (GVHD):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cytomegalovirus (CMV) reactivation: CMV reactivation is a common complication of allo-SCT, but it typically presents with fever, fatigue, and less specific gastrointestinal symptoms. It doesn&#x27;t usually cause the characteristic skin rash seen in GVHD.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Cytomegalovirus (CMV) reactivation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Engraftment syndrome: This is a non-infectious inflammatory syndrome that can occur shortly after transplant. It may present with fever, rash, and pulmonary edema, but it usually lacks the specific gastrointestinal symptoms of GVHD.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Engraftment syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Acute GVHD is a serious complication of allo-SCT and requires prompt diagnosis and treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 210 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test6" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medical Oncology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medical Oncology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                158 Questions | 632 Total Marks | 168 min Duration | ~63.8 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which cancer site had the highest incidence rate among males in 2021?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prostate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colorectal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prostate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Prostate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lung: While lung cancer is the leading cause of cancer deaths, it does not have the highest number of new cases (incidence) among males (12%).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lung:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colorectal: Colorectal cancer is the third most common (8%) cancer in men, but its incidence rate is lower than that of prostate cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colorectal:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreas: Pancreatic cancer is less common than prostate cancer, with a lower incidence rate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreas:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Prostate cancer screening and early detection are crucial for men&#x27;s health.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man, with a history of silicosis presents with progressive dyspnea and pleural plaques on imaging. Which of the following malignancies is he most likely at risk for developing in future?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Small cell lung cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mesothelioma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Squamous cell carcinoma of the lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenocarcinoma of the lung&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mesothelioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mesothelioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Small cell lung cancer: While smoking is the primary risk factor, it&#x27;s not directly associated with silicosis or pleural plaques.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Small cell lung cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Squamous cell carcinoma of the lung: Also primarily linked to smoking, not specifically to silicosis or asbestos.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Squamous cell carcinoma of the lung:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adenocarcinoma of the lung: The most common type of lung cancer but not directly associated with silicosis or asbestos.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adenocarcinoma of the lung:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The combination of silicosis and pleural plaques is a strong indicator of asbestos exposure and significantly increases the risk of developing mesothelioma. Early detection and monitoring are crucial for individuals with this history.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer from a developing country presents with jaundice, abdominal distention, and elevated alpha-fetoprotein (AFP) levels. Which of the following dietary contaminants is MOST likely associated with his suspected malignancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asbestos&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aflatoxin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arsenic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benzene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aflatoxin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aflatoxin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asbestos: While asbestos is a known carcinogen, it primarily affects the lungs and pleura, causing mesothelioma and lung cancer. It is not typically associated with hepatocellular carcinoma (HCC) or the symptoms presented by the farmer.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asbestos:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Arsenic: Arsenic exposure is linked to various cancers, including skin, bladder, and lung cancer. However, it is not the primary risk factor for HCC in the scenario described.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Arsenic:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Benzene: Benzene is an industrial solvent and a known carcinogen, primarily associated with leukemia and other blood cancers. It is not a major risk factor for HCC in the context of this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Benzene:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Aflatoxin contamination of food is a major global health concern and a significant risk factor for HCC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of smoking presents with cough, hemoptysis, and a lung mass on chest X-ray. Which of the following tumor markers is MOST likely to be elevated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CEA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AFP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSE&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CA 19-9&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. NSE&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. CEA (Carcinoembryonic Antigen): While CEA can be elevated in some lung cancers, it&#x27;s more commonly associated with colorectal, breast, and other gastrointestinal cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CEA (Carcinoembryonic Antigen):&lt;/li&gt;&lt;li&gt;â€¢ Option B. AFP (Alpha-fetoprotein): AFP is primarily used as a marker for liver cancer (hepatocellular carcinoma) and certain germ cell tumors. It&#x27;s not typically elevated in lung cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. AFP (Alpha-fetoprotein):&lt;/li&gt;&lt;li&gt;â€¢ Option D. CA 19-9 (Carbohydrate Antigen 19-9): CA 19-9 is most commonly used as a marker for pancreatic cancer and some other gastrointestinal malignancies. It&#x27;s not a primary marker for lung cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CA 19-9 (Carbohydrate Antigen 19-9):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ NSE is a useful marker for the diagnosis and monitoring of neuroendocrine tumors, particularly SCLC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with chronic pancreatitis presents with jaundice and weight loss. Which tumor marker would be the MOST helpful in evaluating for a possible malignancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CA 19-9&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CA-125&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PSA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD30&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CA 19-9&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CA 19-9&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CA-125: This marker is primarily used for ovarian cancer and is not typically elevated in pancreatic cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CA-125:&lt;/li&gt;&lt;li&gt;â€¢ Option C. PSA: This marker is specific for prostate cancer and would not be helpful in evaluating for a pancreatic malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. PSA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD30: This marker is used in lymphoma diagnosis and is not relevant for pancreatic cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD30:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ CA 19-9 can be a useful marker in evaluating for pancreatic cancer, especially in patients with risk factors like chronic pancreatitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the leading cause of cancer-related deaths in males worldwide?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lung cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prostate cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colorectal cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lung cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Prostate cancer is a common cancer in males, but it generally has a better prognosis than lung cancer, and thus it is not the leading cause of cancer-related deaths.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colorectal cancer is also a common cancer in males, but it is not the leading cause of cancer-related deaths.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D . Liver cancer is a significant cause of cancer-related deaths, but it is not the leading cause globally in males.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lung cancer is the leading cause of cancer-related deaths in males worldwide, due to its high incidence and poor prognosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about e-cigarettes (vaping) is MOST accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are a safe alternative to smoking.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They are proven to cause lung cancer.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Long-term cancer risks are unknown.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They only cause oral cancers.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Long-term cancer risks are unknown.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are a safe alternative to smoking. E-cigarettes are not harmless. While they may expose users to fewer toxins than traditional cigarettes, they still contain potentially harmful chemicals like nicotine and heavy metals.&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are a safe alternative to smoking.&lt;/li&gt;&lt;li&gt;â€¢ Option B. They are proven to cause lung cancer. While some studies have shown e-cigarettes contain carcinogenic substances, definitive long-term studies directly linking them to lung cancer are lacking. More research is needed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. They are proven to cause lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. They only cause oral cancers. While e-cigarettes expose the oral cavity to potentially harmful substances, their impact is not limited to this area. There are concerns about potential damage to the lungs and cardiovascular system as well.&lt;/li&gt;&lt;li&gt;â€¢ Option D. They only cause oral cancers.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ E-cigarettes are not harmless, and more research is needed to determine their long-term cancer risks.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Smoking is a major risk factor for various types of cancer. What percentage of cancer-related deaths are attributed to smoking?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;80%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man with HIV presents with multiple violet-colored skin lesions and lymphadenopathy. The lesion is shown below. Which of the following is the most common etiological agent for his skin condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Human herpesvirus 8 (HHV-8)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Epstein-Barr virus (EBV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Human papillomavirus (HPV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Human T-lymphotropic virus 1 (HTLV-1)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Human herpesvirus 8 (HHV-8)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-162222.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Epstein-Barr virus (EBV): While EBV is associated with several malignancies (lymphoma, nasopharyngeal carcinoma), it doesn&#x27;t typically cause the characteristic skin lesions seen in Kaposi sarcoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Epstein-Barr virus (EBV):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Human papillomavirus (HPV): HPV is primarily associated with cervical cancer and other anogenital cancers. It doesn&#x27;t cause the type of lesions seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Human papillomavirus (HPV):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Human T-lymphotropic virus 1 (HTLV-1): HTLV-1 is associated with adult T-cell leukemia/lymphoma, a type of blood cancer. It doesn&#x27;t usually cause the distinctive skin lesions of Kaposi sarcoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Human T-lymphotropic virus 1 (HTLV-1):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ HHV-8 is the causative agent of Kaposi sarcoma, a malignancy often seen in HIV-infected individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following types of UV radiation is MOST strongly linked to the development of skin cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;gamma rays&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;UVB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;x-rays&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;alpha - rays&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. UVB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) UVB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. gamma rays: Gamma rays are a type of ionizing radiation with very short wavelengths and high energy. While they are carcinogenic, they are not the primary type of radiation associated with skin cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A. gamma rays:&lt;/li&gt;&lt;li&gt;â€¢ Option C. x-rays: X-rays are also a type of ionizing radiation with shorter wavelengths than UV radiation. They are used in medical imaging and can also be carcinogenic, but their primary association is not with skin cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. x-rays:&lt;/li&gt;&lt;li&gt;â€¢ Option D. alpha-rays: Alpha rays are a type of particle radiation consisting of two protons and two neutrons. They have low penetrating power and are not associated with skin cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. alpha-rays:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ UVB radiation is the most significant contributor to skin cancer development.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a palpable breast mass and nipple discharge. Which tumor marker would be MOST appropriate to order in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CA 19-9&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CA 15-3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CA-125&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CEA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CA 15-3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CA 15-3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CA 19-9: This marker is primarily associated with pancreatic cancer and some gastrointestinal malignancies. It&#x27;s not routinely used in the initial evaluation of breast masses.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CA 19-9:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CA-125: This marker is primarily associated with ovarian cancer and is not routinely used in the evaluation of breast masses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CA-125:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CEA: This marker can be elevated in various cancers, including breast cancer. However, it is not specific for breast cancer and is typically used to monitor response to treatment or detect recurrence rather than in the initial diagnosis of a breast mass.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CEA:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ CA 15-3 is a useful marker for monitoring breast cancer progression and treatment response.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with a strong family history of breast and ovarian cancer undergoes genetic testing and is found to have a BRCA1 mutation. Which of the following statements is MOST accurate regarding her risk of developing breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;She has a 10-20% lifetime risk of developing breast cancer.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;She has a 30-40% lifetime risk of developing breast cancer.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;She has a 60-80% lifetime risk of developing breast cancer.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;She has a 90-100% lifetime risk of developing breast cancer.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. She has a 60-80% lifetime risk of developing breast cancer.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) She has a 60-80% lifetime risk of developing breast cancer.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman with a BRCA1 mutation wants to know the best breast cancer screening approach for her. Which of the following is MOST appropriate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Annual mammogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Annual MRI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Biennial mammogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clinical breast exam only&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Annual MRI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Annual MRI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Annual mammogram: While mammograms are an important part of breast cancer screening, they are less sensitive than MRI in detecting cancer in women with BRCA mutations, especially those with dense breast tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Annual mammogram:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Biennial mammogram: The frequency is not sufficient for women with BRCA mutations, who are at higher risk and require more frequent screening.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Biennial mammogram:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clinical breast exam only: Clinical breast exams are important, but they are not enough for screening high-risk women. Imaging modalities like MRI are more effective for early detection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clinical breast exam only:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Annual MRI (superior to MMG in high risk young female) is recommended for women with BRCA mutations due to their increased breast cancer risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with a strong family history of breast cancer wants to know the recommended age to start breast cancer screening. According to the American Cancer Society (ACS), what is the MOST appropriate recommendation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Begin annual mammograms at age 40&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Begin biennial mammograms at age 40&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Begin annual mammograms at age 45&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Begin biennial mammograms at age 50&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Begin annual mammograms at age 45&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Begin annual mammograms at age 45&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Begin annual mammograms at age 40: While some organizations recommend starting at age 40, the ACS specifically suggests starting annual screening at 45 for average-risk women.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Begin annual mammograms at age 40:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Begin biennial mammograms at age 40: This option is less frequent than the ACS recommendation for average-risk women, and biennial screening might miss some early-stage cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Begin biennial mammograms at age 40:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Begin biennial mammograms at age 50: This is the recommended starting age for biennial mammograms according to the U.S. Preventive Services Task Force (USPSTF), but the ACS recommends starting earlier for average-risk women and even earlier for women with increased risk due to family history.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Begin biennial mammograms at age 50:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The ACS recommends starting annual mammograms at age 45 for average-risk women.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with a known BRCA1 mutation desires the most effective risk reduction strategy for breast cancer. Which of the following options would you recommend?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral salpingo-oophorectomy (rrBSO)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Risk-reducing bilateral mastectomy (rrBLM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Annual mammogram starting at age 40&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tamoxifen chemoprevention&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Risk-reducing bilateral mastectomy (rrBLM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Risk-reducing bilateral mastectomy (rrBLM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilateral salpingo-oophorectomy (rrBSO): While rrBSO is a risk-reducing surgery, it primarily targets ovarian cancer risk. Although it can somewhat decrease breast cancer risk in premenopausal women, it is not as effective as rrBLM in directly addressing breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilateral salpingo-oophorectomy (rrBSO):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Annual mammogram starting at age 40: Mammography is a screening tool for early detection, not a preventive measure. In women with BRCA1 mutations, who often develop breast cancer at a younger age, mammography alone may not be sufficient for early detection.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Annual mammogram starting at age 40:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tamoxifen chemoprevention: While tamoxifen can reduce the risk of breast cancer in women with BRCA2 mutations, its effectiveness is not as high as rrBLM in BRCA1 carriers. Additionally, it comes with potential side effects and is not suitable for all women.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tamoxifen chemoprevention:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ rrBLM is the most effective risk reduction strategy for breast cancer in BRCA1/2 mutation carriers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following HPV types are covered by BOTH Gardasil and Cervarix vaccines?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;6 and 11&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;16 and 18&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;6, 11, and 16&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;11, 16, and 18&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 16 and 18&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 16 and 18&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman has a history of negative Pap smears for the past 10 years and underwent a total hysterectomy for benign reasons. Does she require further cervical cancer screening?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Yes, she should continue with annual Pap smears.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Yes, she should have a Pap smear every 3 years.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Yes, she should have co-testing (Pap smear and HPV DNA test) every 5 years.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No, she does not require further screening.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No, she does not require further screening.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) No, she does not require further screening.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Yes, she should continue with annual Pap smears: This is incorrect because the patient has a history of negative Pap smears for 10 years and had a total hysterectomy for benign reasons, which means her cervix was removed. There is no remaining cervical tissue to test.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Yes, she should continue with annual Pap smears:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Yes, she should have a Pap smear every 3 years: This is also incorrect for the same reasons as option A. There&#x27;s no need for Pap smears if there&#x27;s no cervix.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Yes, she should have a Pap smear every 3 years:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Yes, she should have co-testing (Pap smear and HPV DNA test) every 5 years: This is incorrect because co-testing is typically recommended for women aged 30-65. Since the patient is 67 and has a history of negative results, further testing is not necessary.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Yes, she should have co-testing (Pap smear and HPV DNA test) every 5 years:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Women with a history of adequate negative screening and no cervix do not require further cervical cancer screening.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman has a father who was diagnosed with colorectal cancer at age 55. When should she initiate screening for colorectal cancer, according to the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediately&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;At age 45&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;At age 50&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10 years before her father&#x27;s age of diagnosis (i.e., at age 45)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 10 years before her father&#x27;s age of diagnosis (i.e., at age 45)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 10 years before her father&#x27;s age of diagnosis (i.e., at age 45)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediately: While having a family history of colorectal cancer (CRC) does increase risk, immediate screening is not recommended unless there are other concerning symptoms or risk factors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediately:&lt;/li&gt;&lt;li&gt;â€¢ Option B. At age 45: This is the general recommended age to begin screening for those with average risk, but with a family history of CRC, earlier screening is appropriate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. At age 45:&lt;/li&gt;&lt;li&gt;â€¢ Option C. At age 50: This is too late for someone with a first-degree relative diagnosed with CRC at age 55. Earlier screening is necessary to detect potential problems early.&lt;/li&gt;&lt;li&gt;â€¢ Option C. At age 50:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Individuals with a family history of colorectal cancer should start screening 10 years younger than the age at which their first-degree relative was diagnosed. This allows for early detection and intervention of precancerous polyps or early-stage cancer, ultimately improving outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with metastatic lung cancer reports fatigue but is still able to perform most of their daily activities, including light housework and grocery shopping. Which ECOG performance status is MOST appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-172340.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents to the emergency department with severe pain in his lower back and legs. He reports that he has experienced similar pain episodes in the past, usually during times of stress or dehydration. He also mentions that he had a recent upper respiratory infection. On examination, he appears to be in distress due to pain, his temperature is 37.8Â°C (100Â°F), and his sclerae are icteric. Laboratory tests reveal a hemoglobin level of 8 g/dL, reticulocyte count of 12%, and elevated bilirubin. Peripheral blood smear shows sickle-shaped red blood cells. Which of the following is the most likely mutation responsible for the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-sense mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conservative missense mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-conservative missense mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frameshift mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Non-conservative missense mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-sense mutation : This type of mutation introduces a premature stop codon, leading to truncated proteins. It is not the cause of sickle cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-sense mutation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conservative missense mutation : This type of mutation changes an amino acid to another with similar properties, which usually does not significantly affect protein function. Sickle cell disease is caused by a non-conservative missense mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conservative missense mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Frameshift mutation : This type of mutation is caused by insertions or deletions that shift the reading frame of the genetic code, resulting in a completely different amino acid sequence downstream. It is not the cause of sickle cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Frameshift mutation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell disease is caused by a non-conservative missense mutation in the HBB gene, leading to the substitution of glutamic acid with valine at the sixth position of the beta-globin chain. This mutation alters the properties of hemoglobin, causing red blood cells to assume a sickle shape under low oxygen conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents with fatigue, weight loss, and splenomegaly. Blood tests reveal an elevated white blood cell count with a predominance of immature myeloid cells. Cytogenetic analysis of the patient&#x27;s bone marrow cells is most likely to reveal which of the following abnormalities?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HER2/ERBB2 amplification&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BCR-ABL1 fusion gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CBFB-MYH11 fusion gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polyploidy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. BCR-ABL1 fusion gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. HER2/ERBB2 amplification is associated with breast and other solid tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HER2/ERBB2 amplification&lt;/li&gt;&lt;li&gt;â€¢ Option C. CBFB-MYH11 and FIP1L1-PDGFRA are fusion genes associated with other hematological malignancies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CBFB-MYH11 and FIP1L1-PDGFRA&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polyploidy refers to an increased number of chromosome sets and is not typically seen in CML.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polyploidy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The BCR-ABL1 fusion gene is a specific genetic abnormality that is highly diagnostic for CML and serves as a target for tyrosine kinase inhibitor therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a family history of breast and ovarian cancer. Genetic testing reveals a germline mutation in a gene that normally functions to inhibit cell cycle progression and repair DNA damage. Which of the following best describes the role of the affected gene in this patient&#x27;s cancer predisposition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It promotes cell growth and division&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It controls proto-oncogene activity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It induces angiogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It evades apoptosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It controls proto-oncogene activity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Promote cell growth and division: This is the opposite of what tumor suppressor genes do. They actually inhibit cell growth and division, acting as a brake on the cell cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Promote cell growth and division:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Induce angiogenesis: Angiogenesis (the formation of new blood vessels) is often promoted by cancer cells, not suppressed. Tumor suppressor genes may indirectly inhibit angiogenesis by preventing uncontrolled cell growth.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Induce angiogenesis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Evade apoptosis: Apoptosis (programmed cell death) is a crucial process for eliminating damaged or abnormal cells. Tumor suppressor genes often promote apoptosis, not evade it.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Evade apoptosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The primary function of tumor suppressor genes is to control proto-oncogene activity, thereby preventing uncontrolled cell growth and maintaining genomic stability. Inherited mutations in tumor suppressor genes can significantly increase an individual&#x27;s risk of developing certain types of cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man presents to his primary care physician with a 3-month history of worsening fatigue and unintentional weight loss. His past medical history is significant for hypertension and type 2 diabetes, both well-controlled with medications. He has a 30-pack-year smoking history but quit 10 years ago. Physical examination reveals pallor and generalized lymphadenopathy. Laboratory studies show anemia and thrombocytopenia. A peripheral blood smear demonstrates blast cells. A bone marrow biopsy is performed, and the pathology report indicates acute myeloid leukemia (AML) with a specific chromosomal translocation. Further molecular studies reveal a mutation leading to increased activity of histone deacetylases (HDACs), which is known to be associated with a poor prognosis in this type of leukemia. The oncologist discusses treatment options with the patient, focusing on the potential use of HDAC inhibitors as part of his chemotherapy regimen. Which of the following is not a HDAC inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ivosidenib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Romidepsin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Panobinostat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Belinostat&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ivosidenib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B) Romidepsin, C)  panobinostat, and D) belinostat are all examples of HDAC inhibitors. These drugs work by inhibiting histone deacetylases, which are enzymes involved in the epigenetic regulation of gene expression. By inhibiting these enzymes, HDAC inhibitors can induce cell cycle arrest, differentiation, and apoptosis of cancer cells, making them useful in the treatment of certain hematologic malignancies and solid tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option B) Romidepsin, C)  panobinostat, and D) belinostat&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HDAC inhibitors, such as romidepsin, panobinostat, and belinostat, are used in cancer therapy to inhibit histone deacetylases, leading to epigenetic modulation of gene expression and inducing apoptosis in cancer cells. Ivosidenib, on the other hand, is an IDH1 inhibitor used in the treatment of cancers with IDH1 mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old patient presents with a darkly pigmented skin lesion that has been growing rapidly. A biopsy is performed and the pathology report reveals a malignant melanoma. Further molecular analysis identifies a BRAFV600E Mutation. This specific alteration is best classified as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Substitution&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deletion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insertion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Translocation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Substitution&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletions involve the removal of one or more nucleotides from the DNA sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Insertions involve the addition of one or more nucleotides to the DNA sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Translocations involve the rearrangement of genetic material between non-homologous chromosomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The BRAFV600E mutation is a common driver mutation in melanoma and is a target for targeted therapy with BRAF inhibitors. Recognizing this type of mutation has important implications for treatment decisions and prognosis in patients with melanoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of cancer development, which of the following statements best differentiates proto-oncogenes from tumor suppressor genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proto-oncogenes causes cancer by gain of function mutations, while tumor suppressor genes cause cancer due to loss of function mutations.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proto-oncogenes are typically inactivated in cancer, while tumor suppressor genes are overactivated.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proto-oncogenes are exclusively found in malignant tumors, while tumor suppressor genes are found in benign tumors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proto-oncogenes encode for growth factors, while tumor suppressor genes encode for growth factor receptors.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Proto-oncogenes causes cancer by gain of function mutations, while tumor suppressor genes cause cancer due to loss of function mutations.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B . Proto-oncogenes are not typically inactivated in cancer; they are activated or overexpressed. Tumor suppressor genes are often inactivated or under expressed in cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both proto-oncogenes and tumor suppressor genes can be involved in both malignant and benign tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proto-oncogenes and tumor suppressor genes can encode a variety of proteins, not limited to growth factors and growth factor receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Proto-oncogenes and tumor suppressor genes are two key classes of genes involved in cancer development. Proto-oncogenes promote cell growth and proliferation and can lead to cancer when mutated to gain function. Tumor suppressor genes normally inhibit cell growth, and their inactivation or loss of function can contribute to cancer development.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following mutations is MOST likely to be associated with a myeloproliferative neoplasm?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;JAK2 V617F&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;EGFR exon 20 insertion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BRAF V600E&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5q deletion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. JAK2 V617F&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. EGFR exon 20 insertion: This mutation is commonly found in non-small cell lung cancer (NSCLC) and is associated with resistance to certain targeted therapies.&lt;/li&gt;&lt;li&gt;â€¢ Option B. EGFR exon 20 insertion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. BRAF V600E: This mutation is commonly found in melanoma and some other solid tumors. It is not typically associated with myeloproliferative neoplasms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. BRAF V600E:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5q deletion: This is a chromosomal deletion frequently found in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), but not as commonly in myeloproliferative neoplasms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5q deletion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ JAK2 V617F is a key driver mutation in several myeloproliferative neoplasms and a target for therapies like ruxolitinib.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old African American boy presents with acute onset of severe bone pain in his lower extremities. His history includes similar episodes, often precipitated by dehydration or stress. Lab results reveal anemia, elevated reticulocyte count, and indirect hyperbilirubinemia. A peripheral blood smear demonstrates sickled erythrocytes. Which genetic alteration is MOST likely responsible for this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trinucleotide repeat expansion in the HTT gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deletion of phenylalanine at position 508 of the CFTR gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Point mutation resulting in a glutamate to valine substitution in the Î²-globin gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Translocation between chromosomes 9 and 22 (t(9;22))&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Point mutation resulting in a glutamate to valine substitution in the Î²-globin gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trinucleotide repeat expansion in the HTT gene: This mutation is associated with Huntington&#x27;s disease, a neurodegenerative disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trinucleotide repeat expansion in the HTT gene:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletion of phenylalanine at position 508 of the CFTR gene: This is the most common mutation in cystic fibrosis, causing defective chloride ion transport.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletion of phenylalanine at position 508 of the CFTR gene:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Translocation between chromosomes 9 and 22 (t(9;22)): This is the Philadelphia chromosome, a hallmark of chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Translocation between chromosomes 9 and 22 (t(9;22)):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell disease is a monogenic disorder caused by a specific point mutation in the Î²-globin gene. Understanding the molecular basis of SCD is crucial for diagnosis, management, and potential future gene therapies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an example of an epigenetic change that can contribute to cancer development?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Point mutation in the p53 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Deletion of the RB1 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypermethylation of the promoter region of a tumor suppressor gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Translocation between chromosomes 9 and 22&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypermethylation of the promoter region of a tumor suppressor gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Point mutation in the p53 gene: This is a genetic alteration where a single nucleotide in the DNA sequence of the p53 gene is changed. This can lead to the production of a dysfunctional p53 protein, which is a tumor suppressor.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Point mutation in the p53 gene:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletion of the RB1 gene: This is also a genetic alteration where a portion of the RB1 gene, another tumor suppressor, is removed. The absence of the RB1 protein can contribute to uncontrolled cell growth.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Deletion of the RB1 gene:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Translocation between chromosomes 9 and 22: This is a chromosomal rearrangement where a piece of chromosome 9 is transferred to chromosome 22, and vice versa. This translocation creates a new fusion gene, often the BCR-ABL gene, which drives the development of chronic myeloid leukemia (CML).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Translocation between chromosomes 9 and 22:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Epigenetic modifications, like DNA methylation, play a significant role in carcinogenesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following HPV genes is MOST directly implicated in the development of cervical cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;E2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;E4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;E6&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;E8&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. E6&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. E2: E2 is involved in viral replication and gene expression regulation. While important for the HPV lifecycle, it&#x27;s not directly implicated in cellular transformation and cancer development.&lt;/li&gt;&lt;li&gt;â€¢ Option A. E2:&lt;/li&gt;&lt;li&gt;â€¢ Option B. E4: E4 plays a role in viral release and assembly. It&#x27;s not considered a major oncogenic protein in the context of cervical cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. E4:&lt;/li&gt;&lt;li&gt;â€¢ Option D. E8: There is no E8 gene in the HPV genome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. E8:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The E6 and E7 proteins are the primary oncoproteins of HPV that drive the development of cervical cancer by interfering with critical cellular pathways that regulate cell growth and survival.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of refractory acute myeloid leukemia (AML) presents to the oncology clinic for a follow-up visit. He was recently started on enasidenib after genetic testing revealed a specific mutation in his leukemia cells. The patient has noticed a decrease in fatigue and an improvement in his overall well-being since starting the treatment. The oncologist explains the mechanism of action of the medication, which targets the leukemia cells. Which of the following best describes the mechanism of action of enasidenib?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of BCR-ABL tyrosine kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of mutant IDH2 enzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stimulation of the immune system to attack leukemia cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Induction of differentiation of leukemia cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of mutant IDH2 enzyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inhibition of mutant IDH2 enzyme&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of BCR-ABL tyrosine kinase : This is the mechanism of action of drugs like imatinib, which are used to treat chronic myeloid leukemia (CML), not AML.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of BCR-ABL tyrosine kinase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stimulation of the immune system to attack leukemia cells : This describes the mechanism of action of immunotherapies, such as CAR T-cell therapy, rather than enasidenib.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stimulation of the immune system to attack leukemia cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Induction of differentiation of leukemia cells : While enasidenib does lead to differentiation of leukemia cells, it is more specific to say that it inhibits the mutant IDH2 enzyme, which is the direct target of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Induction of differentiation of leukemia cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Enasidenib is a targeted therapy used to treat patients with acute myeloid leukemia (AML) who have a specific mutation in the IDH2 enzyme. It works by inhibiting the mutant enzyme, leading to a reduction in the oncometabolite 2-HG and promoting the differentiation of myeloid cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with mantle cell lymphoma (MCL). Which of the following genetic alterations is MOST likely associated with this malignancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CDKN2A (p16INK4A) mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CDKN1B (p27) mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CCND1 amplification&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TP53 mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CCND1 amplification&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CDKN2A (p16INK4A) mutation: While CDKN2A mutations can be seen in various cancers, they are more commonly associated with melanoma and other solid tumors. In mantle cell lymphoma, CDKN2A deletions are associated with poor prognosis but are not the primary driver of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CDKN2A (p16INK4A) mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN1B (p27) mutation: Mutations in CDKN1B are associated with MEN4 syndrome (multiple endocrine neoplasia type 4) and can be seen in other cancers, but not typically in mantle cell lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN1B (p27) mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TP53 mutation: TP53 is a tumor suppressor gene, and mutations are found in various cancers. While TP53 mutations can occur in MCL and are associated with a worse prognosis, they are not the primary genetic alteration driving the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TP53 mutation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ CCND1 amplification is a hallmark of mantle cell lymphoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman is diagnosed with breast cancer and is referred to an oncologist for treatment. The tumor is found to be estrogen receptor-positive and HER2-negative. The oncologist discusses the use of a targeted therapy that specifically interferes with the cell cycle of cancer cells, thereby inhibiting their proliferation. The medication targets a specific phase of the cell cycle, leading to cell cycle arrest and eventual apoptosis of the cancer cells. Which of the following best describes the mechanism of action of the medication likely prescribed to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of cyclin-dependent kinases (CDKs) in the G1/S phase transition&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activation of topoisomerase II in the S phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of microtubule formation in the M phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activation of DNA repair enzymes in the G2 phase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of cyclin-dependent kinases (CDKs) in the G1/S phase transition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Activation of topoisomerase II in the S phase : Topoisomerase II inhibitors, such as etoposide, work by interfering with the action of topoisomerase II, an enzyme involved in DNA replication and cell division during the S phase. This mechanism is not specific to CDK inhibitors used in breast cancer treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Activation of topoisomerase II in the S phase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of microtubule formation in the M phase : Microtubule inhibitors, such as taxanes (e.g., paclitaxel), target the M phase of the cell cycle by preventing the formation of microtubules, which are essential for chromosome separation during cell division. This mechanism is different from that of CDK inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of microtubule formation in the M phase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activation of DNA repair enzymes in the G2 phase : This option is not a common mechanism for targeted therapy in breast cancer. Drugs that target DNA repair pathways typically work by inhibiting, not activating, DNA repair enzymes to prevent cancer cells from repairing DNA damage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activation of DNA repair enzymes in the G2 phase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Cyclin-dependent kinase (CDK) inhibitors, such as palbociclib, ribociclib, and abemaciclib, are used in the treatment of estrogen receptor-positive, HER2-negative breast cancer. They work by inhibiting CDK4/6, leading to cell cycle arrest at the G1/S transition and preventing cancer cell proliferation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a negative regulator that prevents the progression of cells from the G1 phase to the S phase in the cell cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyclin A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclin-dependent kinase 2 (CDK2)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;p21&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclin E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. p21&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cyclin A: Is a positive regulator of the cell cycle that activates CDK2, promoting progression through the S phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cyclin A:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cyclin-dependent kinase 2 (CDK2): Is a positive regulator that, when activated by cyclins such as cyclin E and cyclin A, helps drive the cell cycle from the G1 phase to the S phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cyclin-dependent kinase 2 (CDK2):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclin E: Is a positive regulator of the cell cycle that activates CDK2, promoting the transition from the G1 phase to the S phase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclin E:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ p21 is a negative regulator of the cell cycle that inhibits the activity of cyclin-CDK complexes, preventing the progression of cells from the G1 phase to the S phase.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with a family history of early-onset colon cancer and multiple family members affected by various types of cancer. Which of the following genetic mutations is MOST likely responsible for her increased cancer risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BRCA1 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MUTYH mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MSH2 mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ATM mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MSH2 mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRCA1 mutation: BRCA1 mutations are primarily associated with increased risks of breast and ovarian cancers. While they can increase the risk of other cancers, the patient&#x27;s family history of colon cancer makes this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRCA1 mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. MUTYH mutation: MUTYH mutations are associated with MUTYH-associated polyposis (MAP), a hereditary condition that increases the risk of colorectal cancer. However, MAP usually presents with multiple polyps, and the patient&#x27;s family history doesn&#x27;t necessarily fit this pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option B. MUTYH mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ATM mutation: ATM mutations are associated with ataxia-telangiectasia, a rare neurodegenerative disorder characterized by ataxia, telangiectasias (small dilated blood vessels), and immune deficiencies. While individuals with ataxia-telangiectasia have an increased risk of certain cancers, the presentation in this question doesn&#x27;t match the typical features of this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ATM mutation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ MSH2 mutations are associated with Lynch syndrome, a hereditary cancer syndrome that significantly increases the risk of various cancers, including colorectal, endometrial, and ovarian cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman presents to your clinic with a newly discovered breast mass. Her family history is significant for multiple cases of breast and ovarian cancer, including her mother and sister. Genetic testing reveals a germline BRCA1 mutation. Which of the following DNA repair pathways is MOST likely deficient in this patient, contributing to her increased cancer risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-homologous end joining (NHEJ)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Base excision repair (BER)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Homologous recombination (HR)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Single-strand break repair&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Homologous recombination (HR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-homologous end joining (NHEJ): While important for DNA repair, NHEJ is not the primary pathway affected by BRCA1 mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-homologous end joining (NHEJ):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Base excision repair (BER): BER is primarily responsible for repairing single-base DNA damage and is not directly affected by BRCA1 mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Base excision repair (BER):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Single-strand break repair: This is a broader term encompassing several pathways, including BER and PARP. While PARP inhibitors are used in BRCA-mutant cancers, the primary defect lies in HR.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Single-strand break repair:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 mutations lead to a deficiency in homologous recombination (HR), a critical DNA repair mechanism. This defect contributes to genomic instability and significantly increases the risk of breast and ovarian cancers in affected individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child is brought to your clinic by their parents, who are concerned about their child&#x27;s extreme sensitivity to sunlight. The child easily sunburns and has developed multiple freckles and skin lesions after minimal sun exposure. On examination, you notice dry skin and patches of hypopigmentation. You suspect an underlying genetic disorder affecting DNA repair mechanisms. Which of the following DNA repair pathways is MOST likely deficient in this child?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Base excision repair (BER)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nucleotide excision repair (NER)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Homologous recombination (HR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-homologous end joining (NHEJ)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Nucleotide excision repair (NER)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Base excision repair (BER): BER primarily repairs damage to single bases in DNA, often caused by oxidation or alkylation. While important, it&#x27;s not the primary pathway for repairing the type of damage caused by UV radiation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Base excision repair (BER):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Homologous recombination (HR): HR is a complex process used to repair double-stranded DNA breaks. While critical for genome stability, it&#x27;s not the main mechanism for repairing UV-induced DNA damage.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Homologous recombination (HR):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-homologous end joining (NHEJ): Similar to HR, NHEJ repairs double-stranded breaks but does not play a major role in repairing UV-induced damage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-homologous end joining (NHEJ):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The inability to repair UV-induced DNA damage in XP leads to a significantly increased risk of skin cancer at a young age, as well as other complications like ocular problems and neurological abnormalities. Early diagnosis and strict sun protection measures are crucial for managing XP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is investigating a new drug that inhibits the formation of the inflammasome complex. Which of the following types of cell death would be MOST directly affected by this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Necrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pyroptosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Apoptosis: Apoptosis is a programmed cell death pathway, but it is not directly dependent on the inflammasome. It involves a different set of caspases (caspase-3, -6, -7) and is not typically associated with the same inflammatory response as pyroptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Apoptosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necroptosis: Necroptosis is another form of programmed cell death, but it is regulated by the RIPK1-RIPK3-MLKL pathway, not the inflammasome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necroptosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Necrosis: Necrosis is an unregulated form of cell death that is typically caused by injury or trauma. It is not a programmed process and is not mediated by the inflammasome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Necrosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The inflammasome is a multiprotein complex that plays a central role in pyroptosis. It senses danger signals and activates caspase-1, leading to the production of pro-inflammatory cytokines and ultimately cell death with membrane rupture. By inhibiting the inflammasome, the drug would directly block the pyroptotic pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A biopsy of a patient&#x27;s liver reveals hepatocytes with extensive swelling, loss of plasma membrane integrity, and leakage of cellular contents into the surrounding tissue. Which of the following types of cell death is MOST likely occurring in these cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apoptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyroptosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Necrosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Necrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Apoptosis: Apoptosis is a programmed cell death that involves cell shrinkage, nuclear condensation, and fragmentation into apoptotic bodies, without leakage of cellular contents.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Apoptosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necroptosis: Necroptosis is a regulated form of cell death that shares some features with necrosis, such as cell swelling and membrane rupture. However, it is initiated by specific signaling pathways and does not typically occur in the liver in response to injury.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necroptosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyroptosis: Pyroptosis is an inflammatory form of programmed cell death that involves the formation of pores in the cell membrane, but it is primarily associated with immune responses to infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyroptosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Necrosis is an unregulated cell death process characterized by cell swelling, membrane rupture, and leakage of cellular contents.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with follicular lymphoma (FL) is found to have a t(14;18) translocation. Which of the following is the MOST likely consequence of this translocation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Overexpression of BCL-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loss of p53 function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activation of RAS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amplification of MYC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Overexpression of BCL-2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loss of p53 function: While TP53 mutations (leading to loss of p53 function) are common in many cancers, they are not the primary driver of follicular lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Loss of p53 function:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activation of RAS: RAS mutations are associated with various cancers, but they are not the hallmark of follicular lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activation of RAS:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amplification of MYC: MYC amplification is more commonly associated with Burkitt lymphoma and other aggressive lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amplification of MYC:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The t(14;18) translocation is a hallmark of follicular lymphoma and contributes to its pathogenesis by inhibiting apoptosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient presents with painless hematuria and flank pain. Imaging reveals a renal mass with characteristic features of clear cell renal cell carcinoma (RCC). Which of the following genetic alterations is MOST likely involved in the pathogenesis of this tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mutation in BRCA1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amplification of HER2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loss of function mutation in VHL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activation of KRAS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Loss of function mutation in VHL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mutation in BRCA1: BRCA1 is a tumor suppressor gene primarily associated with breast and ovarian cancers. While it can be involved in other cancers, it&#x27;s not the primary driver of clear cell renal cell carcinoma (RCC).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mutation in BRCA1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amplification of HER2: HER2 amplification is a key feature of certain breast cancers and some other malignancies, but not clear cell RCC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amplification of HER2:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activation of KRAS: KRAS is an oncogene involved in various cancers, including some types of lung and colon cancer. It is not the hallmark of clear cell RCC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activation of KRAS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The VHL gene plays a crucial role in oxygen sensing and regulation of blood vessel growth. When VHL is inactivated, it leads to the stabilization and activation of hypoxia-inducible factor (HIF), which promotes angiogenesis (new blood vessel formation) and tumor growth. This is why VHL loss-of-function mutations are so strongly linked to clear cell RCC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs is a monoclonal antibody targeting VEGF and is used in the treatment of various cancers, including renal cell carcinoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bevacizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bevacizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cetuximab: This monoclonal antibody targets the epidermal growth factor receptor (EGFR), which is involved in cell growth and proliferation. It is not typically used to treat renal cell carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cetuximab:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Trastuzumab: This monoclonal antibody targets the human epidermal growth factor receptor 2 (HER2), which is overexpressed in some breast and stomach cancers. It is not indicated for renal cell carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Trastuzumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab: This monoclonal antibody targets CD20, a protein found on the surface of B cells. It is used to treat certain types of lymphomas and leukemias but not renal cell carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bevacizumab stands out as the correct answer because it specifically targets VEGF, a key player in angiogenesis, which is a crucial process for tumor growth and survival. The other options are monoclonal antibodies targeting different receptors or proteins involved in other cancer types.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man with metastatic melanoma has progressed on previous therapy. You are considering starting him on an immune checkpoint inhibitor along with nivolumab after which you are planning to keep him on nibolumab. Which of the following immune checkpoint molecules is the DIRECT target for the drug which you have planned to give for this patient along with nivolumab?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PD-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PD-L1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CTLA-4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD80/86&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CTLA-4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. PD-1: PD-1 is another inhibitory checkpoint on T cells, but it&#x27;s targeted by different drugs like nivolumab and pembrolizumab.&lt;/li&gt;&lt;li&gt;â€¢ Option A. PD-1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. PD-L1: PD-L1 is the ligand for PD-1, and it&#x27;s also targeted by different drugs like atezolizumab and durvalumab.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PD-L1:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD80/86: These are the ligands for CTLA-4, but ipilimumab doesn&#x27;t directly bind to them; it binds to CTLA-4 itself.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD80/86:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the specific targets of immune checkpoint inhibitors is crucial for selecting the right therapy for different types of cancer and managing potential immune-related side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with metastatic Merkel cell carcinoma has progressed on chemotherapy and is now being considered for immunotherapy. You plan to start him on an a monoclonal antibody designed to enhance the anti-tumor immune response. Which of the following immune checkpoint molecules is the DIRECT target of that drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CTLA-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PD-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PD-L1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;LAG-3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PD-L1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CTLA-4: CTLA-4 (Cytotoxic T-Lymphocyte-Associated protein 4) is another immune checkpoint molecule, but it is targeted by different drugs like ipilimumab. Avelumab does not directly bind to or inhibit CTLA-4.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CTLA-4:&lt;/li&gt;&lt;li&gt;â€¢ Option B. PD-1: PD-1 (Programmed Cell Death Protein 1) is the receptor on T cells that PD-L1 binds to. While avelumab indirectly affects PD-1 signaling by blocking its interaction with PD-L1, it doesn&#x27;t directly bind to PD-1. Other drugs like nivolumab and pembrolizumab are designed to directly target PD-1.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PD-1:&lt;/li&gt;&lt;li&gt;â€¢ Option D. LAG-3: LAG-3 (Lymphocyte Activation Gene-3) is another inhibitory receptor on T cells that is being investigated as a target for immunotherapy. However, avelumab does not target LAG-3.&lt;/li&gt;&lt;li&gt;â€¢ Option D. LAG-3:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Avelumab is a PD-L1 inhibitor used in the treatment of metastatic Merkel cell carcinoma and other cancers to unleash the body&#x27;s immune system against tumors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is studying the metabolic profile of cancer cells and notices that they primarily produce energy through glycolysis, even in the presence of oxygen. This phenomenon is BEST described as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxidative phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The Cori cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The Warburg effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gluconeogenesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The Warburg effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oxidative phosphorylation: This is the normal process of energy production in cells with sufficient oxygen. It occurs in the mitochondria and is much more efficient at generating ATP than glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oxidative phosphorylation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. The Cori cycle: This is a metabolic pathway that involves the interconversion of lactate and glucose between the liver and muscles. While lactate is a byproduct of glycolysis, the Cori cycle itself isn&#x27;t the primary energy production method in cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The Cori cycle:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gluconeogenesis: This is the process of synthesizing glucose from non-carbohydrate sources (like amino acids or lactate). While cancer cells may engage in gluconeogenesis, it&#x27;s not the main energy-producing pathway they rely on.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gluconeogenesis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The Warburg effect is a hallmark of cancer metabolism and has implications for both cancer diagnosis and potential therapeutic targets.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with metastatic renal cell carcinoma has recently shown disease progression despite initial chemotherapy. Her oncologist is considering a treatment strategy to target the tumor&#x27;s ability to create its own blood supply. Which of the following classes of drugs would be MOST appropriate for this purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyclin-dependent kinase inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BH3 mimetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;VEGF signaling inhibitors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PARP inhibitors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. VEGF signaling inhibitors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cyclin-dependent kinase inhibitors: These drugs target cell cycle progression and are not directly involved in angiogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cyclin-dependent kinase inhibitors:&lt;/li&gt;&lt;li&gt;â€¢ Option B. BH3 mimetics: These drugs target the apoptotic pathway to induce cell death and are not directly involved in angiogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. BH3 mimetics:&lt;/li&gt;&lt;li&gt;â€¢ Option D. PARP inhibitors: These drugs exploit DNA repair defects in cancer cells and are not directly involved in angiogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PARP inhibitors:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ VEGF signaling inhibitors are a class of drugs that target angiogenesis, a crucial process for tumor growth and survival. They are used in the treatment of various cancers, including renal cell carcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male presents with progressive headaches, gait instability, and visual disturbances. MRI was taken and shown below. Patient also has, multiple retinal angiomas. His family history is notable for his father died of uncontrolled hypertension during his 50s and his paternal side uncle was diagnosed with a brain tumor and uncontrolled hypertension along with frequent anger outbursts seeking psychiatric counselling. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neurofibromatosis type 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tuberous sclerosis complex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Von Hippel-Lindau disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Li-Fraumeni syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Von Hippel-Lindau disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-172814.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neurofibromatosis type 2: This condition is associated with bilateral vestibular schwannomas (tumors of the nerve responsible for hearing and balance) and other nerve tumors, not the specific findings in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neurofibromatosis type 2:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tuberous sclerosis complex: This syndrome is associated with benign tumors in various organs, including the brain, kidneys, heart, eyes, lungs, and skin. The characteristic brain tumors are cortical tubers and subependymal giant cell astrocytomas, not hemangioblastomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tuberous sclerosis complex:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Li-Fraumeni syndrome: This syndrome predisposes individuals to a wide range of cancers, including sarcomas, breast cancer, brain tumors, and leukemia. It is not typically associated with the specific combination of findings in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Li-Fraumeni syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of a cerebellar hemangioblastoma and retinal angiomas, especially in conjunction with a suggestive family history, should raise strong suspicion for Von Hippel-Lindau disease. Early diagnosis and surveillance are crucial for managing this condition and preventing complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with a family history of early-onset colon and endometrial cancer. Which of the following hereditary cancer syndromes is MOST likely in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Li-Fraumeni syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Von Hippel-Lindau disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hereditary diffuse gastric cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lynch syndrome (HNPCC)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lynch syndrome (HNPCC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Li-Fraumeni syndrome: Li-Fraumeni syndrome is associated with a broader range of cancers, including sarcomas, breast cancer, brain tumors, and leukemia. While colon cancer can occur in Li-Fraumeni syndrome, the prominence of endometrial cancer in the family history makes Lynch syndrome more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Li-Fraumeni syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Von Hippel-Lindau disease: This syndrome is primarily characterized by the development of hemangioblastomas, renal cell carcinomas, and pheochromocytomas. It&#x27;s not typically associated with a strong family history of colon or endometrial cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Von Hippel-Lindau disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hereditary diffuse gastric cancer: This syndrome is mainly linked to an increased risk of diffuse gastric cancer and lobular breast cancer. While other cancers can occur, the family history in this case points more towards Lynch syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hereditary diffuse gastric cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lynch syndrome is an inherited cancer syndrome characterized by an increased risk of colorectal, endometrial, and other cancers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with multiple pigmented skin lesions and cardiac myxomas. He also reports a family history of sudden cardiac death. Which gene is MOST likely to be mutated in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PRKAR1A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CDKN2A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SDH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MET&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PRKAR1A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN2A : This gene is associated with melanoma and pancreatic cancer in the context of familial atypical multiple mole melanoma (FAMMM) syndrome. While pigmented skin lesions can be present in FAMMM, cardiac myxomas and a family history of sudden cardiac death are not characteristic features.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN2A&lt;/li&gt;&lt;li&gt;â€¢ Option C. SDH : Mutations in SDH genes are linked to hereditary paraganglioma-pheochromocytoma syndrome, which primarily manifests with tumors of the adrenal glands and nervous system. Cardiac myxomas and pigmented skin lesions are not associated with this syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. SDH&lt;/li&gt;&lt;li&gt;â€¢ Option D. MET : MET mutations are involved in hereditary papillary renal cell carcinoma. This condition is not typically associated with cardiac myxomas or pigmented skin lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. MET&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The specific constellation of findings in this patient, including pigmented skin lesions, cardiac myxomas, and a family history of sudden cardiac death, is strongly suggestive of Carney complex, a rare autosomal dominant disorder caused by mutations in the PRKAR1A gene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with a history of recurrent kidney stones and hypercalcemia. Her family history is significant for her mother having a pituitary tumor and her brother having undergone surgery for a parathyroid adenoma. Given the patient&#x27;s clinical presentation and family history, which of the following tumors is LEAST likely to be associated with her suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prolactinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medullary thyroid carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Medullary thyroid carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastrinoma: Gastrinomas are tumors of the pancreas that secrete gastrin, leading to excessive stomach acid production and peptic ulcers. They are a common feature of MEN1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastrinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prolactinoma: Prolactinomas are pituitary tumors that secrete prolactin, causing symptoms like irregular periods, infertility, and milk production in women. Pituitary tumors are a key component of MEN1.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prolactinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulinoma: Insulinomas are pancreatic tumors that secrete insulin, leading to hypoglycemia. They are another common manifestation of MEN1.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulinoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The constellation of findings in this patient points strongly towards MEN1. While MEN1 can have a variety of manifestations, medullary thyroid carcinoma is a hallmark of MEN2 and is not typically associated with MEN1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old boy is brought to the pediatrician due to concerns about his small stature and sun sensitivity. He has also had recurrent respiratory infections. On physical examination, he is noted to have a photosensitive rash on his face, microcephaly, and low body weight for his age. Which of the following DNA repair pathways is MOST likely deficient in this child?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Homologous recombination (HR)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DNA crosslink repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-homologous end joining (NHEJ)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mismatch repair (MMR)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Homologous recombination (HR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Homologous recombination (HR)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. DNA crosslink repair: Defects in DNA crosslink repair are seen in Fanconi anemia, which presents with bone marrow failure, developmental abnormalities, and increased risk of leukemia, but not the other features seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. DNA crosslink repair:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Non-homologous end joining (NHEJ): NHEJ is another DNA repair pathway that repairs double-strand breaks. While important for maintaining genomic stability, it&#x27;s not the primary pathway affected in Bloom syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Non-homologous end joining (NHEJ):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mismatch repair (MMR): MMR corrects errors that occur during DNA replication. Defects in MMR are seen in Lynch syndrome, which is associated with an increased risk of colorectal and other cancers, but not the characteristic features of Bloom syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mismatch repair (MMR):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Bloom syndrome is a rare genetic disorder characterized by growth retardation, sun sensitivity, immunodeficiency, and predisposition to various cancers. It is caused by mutations in the BLM gene, which leads to defective homologous recombination and genomic instability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents with premature aging, bilateral cataracts, and diabetes mellitus. She also has a family history of early-onset cancer. On examination, you observe that she has a bird-like peculiar facial feature. Which of the following genetic disorders is MOST likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia-telangiectasia (AT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bloom syndrome (BLMS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fanconi anemia (FA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Werner syndrome (WRN)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Werner syndrome (WRN)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ataxia-telangiectasia (AT): This condition presents in childhood with ataxia (uncoordinated movements), telangiectasias (dilated blood vessels), and immune deficiency. While it also predisposes to cancer, the premature aging features and cataracts are not characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ataxia-telangiectasia (AT):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bloom syndrome (BLMS): Bloom syndrome is also associated with an increased cancer risk and sun sensitivity, but the hallmark feature is short stature, not premature aging or cataracts.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bloom syndrome (BLMS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fanconi anemia (FA): This condition is primarily characterized by bone marrow failure and an increased risk of leukemia and other cancers. Premature aging and cataracts are not typical features.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fanconi anemia (FA):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of premature aging, cataracts, diabetes, a family history of early-onset cancer, and a \&quot;bird-like\&quot; facial appearance strongly supports the diagnosis of Werner syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with metastatic pancreatic cancer is undergoing chemotherapy. Her oncologist is considering adding an antimetabolite that not only disrupts DNA synthesis but also has an inhibitory effect on RNA reductase to further hinder cancer cell growth. Which of the following medications would BEST fit this description?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fludarabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;6-Mercaptopurine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gemcitabine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-Fluorouracil (5-FU)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gemcitabine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gemcitabine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fludarabine : Fludarabine primarily acts by incorporating into DNA and inhibiting DNA polymerase and other enzymes involved in DNA synthesis and repair. It does not have a known mechanism of action involving RNA reductase inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fludarabine&lt;/li&gt;&lt;li&gt;â€¢ Option B. 6-Mercaptopurine : This purine analog inhibits purine synthesis, indirectly affecting both DNA and RNA synthesis. However, its primary target is not RNA reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 6-Mercaptopurine&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil (5-FU) : 5-FU acts by inhibiting thymidylate synthase, an enzyme crucial for DNA synthesis. It does not directly inhibit RNA reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil (5-FU)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gemcitabine&#x27;s dual mechanism of action, targeting both DNA and RNA synthesis, makes it a valuable chemotherapeutic option for various cancers, including pancreatic cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with breast cancer is being treated with a drug that stabilizes microtubules, preventing their depolymerization. Which of the following drugs is MOST likely being used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vincristine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paclitaxel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eribulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-Fluorouracil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Paclitaxel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vincristine: Vincristine is a vinca alkaloid that destabilizes microtubules by binding to tubulin and preventing its polymerization. This leads to disruption of the mitotic spindle and cell death.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vincristine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Eribulin: Eribulin is also a microtubule-destabilizing agent, though its mechanism of action is slightly different from vinca alkaloids. It binds to the plus end of microtubules, preventing their growth and leading to mitotic arrest.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Eribulin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil (5-FU): 5-FU is an antimetabolite that interferes with DNA synthesis. It has no direct effect on microtubules.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil (5-FU):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key difference lies in the mechanism of action. Paclitaxel stabilizes microtubules, preventing their normal breakdown, which is essential for cell division. In contrast, vinca alkaloids and eribulin destabilize microtubules, also disrupting cell division but through a different process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with Hodgkin&#x27;s lymphoma is undergoing combination chemotherapy. During a follow-up visit, he reports a new onset of dry cough and shortness of breath. Chest X-ray reveals diffuse interstitial infiltrates. Which of the following drugs included in his chemotherapy regimen is MOST likely responsible for these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitoxantrone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dactinomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitomycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bleomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bleomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitoxantrone: While mitoxantrone can cause some pulmonary toxicity, it is less common and less severe than that associated with bleomycin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitoxantrone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dactinomycin: Dactinomycin is not typically associated with significant pulmonary toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dactinomycin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mitomycin: Mitomycin is more commonly associated with hemorrhagic cystitis (inflammation of the bladder with bleeding) and myelosuppression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mitomycin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bleomycin is an important antitumor antibiotic with a significant risk of pulmonary toxicity, which can manifest as pneumonitis and fibrosis. Careful monitoring of lung function is essential during and after treatment with bleomycin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a 40 pack-year smoking history presents with a persistent cough and hemoptysis. Imaging reveals a central lung mass, and biopsy confirms small cell lung cancer (SCLC). He is started on a chemotherapy regimen including etoposide. Etoposide exerts its anti-cancer effects by targeting a specific phase of the cell cycle. During which phase is etoposide MOST effective?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G1 phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G2 phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M phase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. M phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. G1 phase: This is the phase where the cell grows and prepares for DNA replication. Etoposide&#x27;s mechanism doesn&#x27;t directly target processes in this phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. G1 phase:&lt;/li&gt;&lt;li&gt;â€¢ Option B. S phase: This is the phase of DNA replication. While DNA damage can occur here, etoposide&#x27;s primary action is on the M phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. S phase:&lt;/li&gt;&lt;li&gt;â€¢ Option C. G2 phase: This phase involves further cell growth and preparation for mitosis. Again, etoposide&#x27;s primary target is the M phase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. G2 phase:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Etoposide is a topoisomerase II inhibitor that is most effective during the M phase of the cell cycle, where it disrupts chromosome segregation and leads to cell death. Understanding the cell cycle specificity of chemotherapy drugs is crucial for optimizing treatment regimens.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with platinum-resistant ovarian cancer is started on topotecan. You counsel her that this medication works by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Directly blocking DNA synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Preventing cell division by disrupting microtubules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trapping an enzyme involved in DNA unwinding, leading to DNA breaks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inserting itself into DNA, causing structural damage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Trapping an enzyme involved in DNA unwinding, leading to DNA breaks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Directly blocking DNA synthesis: While topotecan ultimately disrupts DNA replication, it doesn&#x27;t directly block DNA synthesis in the same way that antimetabolites do. Antimetabolites, like 5-FU, are structurally similar to DNA building blocks and get incorporated into the DNA strand, thus halting its growth.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Directly blocking DNA synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Preventing cell division by disrupting microtubules: This is the mechanism of action of drugs like taxanes (paclitaxel, docetaxel) and vinca alkaloids (vincristine, vinblastine). They interfere with the formation of the mitotic spindle, which is essential for cell division.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Preventing cell division by disrupting microtubules:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inserting itself into DNA, causing structural damage: This describes the mechanism of action of anthracyclines (doxorubicin, daunorubicin). These drugs intercalate between DNA base pairs, leading to distortion of the DNA structure and interfering with replication and transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inserting itself into DNA, causing structural damage:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Topotecan targets topoisomerase I, disrupting DNA replication and causing lethal DNA damage in cancer cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic myeloid leukemia (CML) is started on a drug that alkylates DNA and forms cross-links. Which of the following drugs is MOST likely being used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Busulfan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Temozolomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Procarbazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Busulfan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Busulfan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cisplatin: Cisplatin is a platinum compound, not an alkylsulfonate. While it also forms DNA cross-links, it does so through a different mechanism involving platinum adducts. It&#x27;s not the primary choice for CML.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cisplatin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Temozolomide: Temozolomide is a triazene, a type of alkylating agent that primarily causes methylation of DNA. While effective in certain brain tumors and melanomas, it&#x27;s not the first-line treatment for CML.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Temozolomide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Procarbazine: Procarbazine is a miscellaneous alkylating agent with a complex mechanism of action involving free radical generation. It&#x27;s less commonly used in CML and doesn&#x27;t primarily cause DNA cross-linking.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Procarbazine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alkylsulfonates are bifunctional alkylating agents that cause DNA cross-linking, which is particularly effective against rapidly dividing cells like those in CML.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with non-Hodgkin lymphoma is undergoing chemotherapy. He presents to the emergency room with complaints of burning urination and blood in his urine. Which of the following classes of chemotherapeutic agents is MOST likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nitrogen mustards&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nitrosoureas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platinum compounds&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triazenes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nitrogen mustards&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nitrogen mustards&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nitrosoureas: While nitrosoureas can cause some bladder toxicity, they are more commonly associated with delayed myelosuppression and neurotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nitrosoureas:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platinum compounds: Platinum-based drugs like cisplatin and carboplatin can cause renal toxicity, but hemorrhagic cystitis is not a typical side effect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platinum compounds:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Triazenes: Triazenes are alkylating agents, but they are not specifically known to cause hemorrhagic cystitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Triazenes:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Hemorrhagic cystitis is a significant side effect of certain nitrogen mustards like cyclophosphamide. Preventive measures, including adequate hydration and the use of mesna (a drug that binds to acrolein), are crucial in managing this complication.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman with breast cancer has completed her primary treatment, which included several cycles of doxorubicin-containing chemotherapy. She is now in remission and attending a follow-up visit with her oncologist. Which of the following long-term complications is the oncologist MOST concerned about?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nausea and vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alopecia (hair loss)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiotoxicity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myelosuppression (bone marrow suppression)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiotoxicity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cardiotoxicity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nausea and vomiting: While common during active chemotherapy treatment, nausea and vomiting are usually acute side effects and not a significant long-term concern.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nausea and vomiting:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alopecia (hair loss): Hair loss is another common acute side effect of chemotherapy, but hair usually regrows after treatment is completed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alopecia (hair loss):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myelosuppression: Myelosuppression (suppression of bone marrow function, leading to decreased blood cell counts) is a significant side effect during active chemotherapy. However, it typically resolves once treatment is stopped and is not a major long-term concern in the same way as cardiotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myelosuppression:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anthracyclines, like doxorubicin, can cause delayed cardiotoxicity. Patients who have received these drugs need long-term cardiac follow-up, even years after completing treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with testicular cancer is scheduled to receive bleomycin- containing chemotherapy regimen. Bleomycin is MOST effective during which phase of the cell cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G1 phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G2 phase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M phase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. G2 phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) G2 phase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. G1 phase: This is the phase where the cell grows and prepares for DNA replication. Bleomycin&#x27;s DNA-damaging effects are not specifically targeted to this phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. G1 phase:&lt;/li&gt;&lt;li&gt;â€¢ Option B. S phase: This is the phase of DNA replication. While DNA damage can occur here, bleomycin&#x27;s peak activity is in the G2 phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. S phase:&lt;/li&gt;&lt;li&gt;â€¢ Option D. M phase: This is the phase of actual cell division (mitosis). While bleomycin-induced DNA damage can also affect mitosis, it&#x27;s most potent during the G2 phase when the cell is actively preparing for division.&lt;/li&gt;&lt;li&gt;â€¢ Option D. M phase:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bleomycin is a cell cycle-specific antitumor antibiotic that primarily targets the G2 phase of the cell cycle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with rapidly dividing tumor cells is being treated with a chemotherapy regimen that includes a drug that targets the M phase of the cell cycle. Which of the following drugs is MOST likely included in this regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doxorubicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paclitaxel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-Fluorouracil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paclitaxel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Paclitaxel&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate: Methotrexate is an antimetabolite that targets the S phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Doxorubicin: Doxorubicin is an antitumor antibiotic that is cell cycle non-specific.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Doxorubicin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil: 5-Fluorouracil is an antimetabolite that also targets the S phase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antimicrotubular agents like paclitaxel are effective in treating rapidly dividing tumors because they disrupt the M phase of the cell cycle, leading to cell death.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with acute myeloid leukemia (AML) is being treated with a drug that interferes with DNA synthesis. This drug is most likely:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytarabine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vincristine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cytarabine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bleomycin: Bleomycin is an antitumor antibiotic that acts on the G2 phase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bleomycin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vincristine: Vincristine is an antimicrotubular agent that acts on the M phase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vincristine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cisplatin: Cisplatin is an alkylating agent that is cell cycle non-specific.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cisplatin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antimetabolites disrupt DNA synthesis, making them effective against rapidly dividing cancer cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A postmenopausal woman with breast cancer is found to have a tumor that overexpresses aromatase. Which of the following medications is MOST likely to be effective in treating this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anastrozole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fulvestrant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Leuprolide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anastrozole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tamoxifen: Tamoxifen is a Selective Estrogen Receptor Modulator (SERM) that acts as an estrogen antagonist in breast tissue but an agonist in other tissues like the bone and uterus. While it can be effective in some cases of hormone-receptor-positive breast cancer, it doesn&#x27;t directly address the issue of increased estrogen production in tumors that overexpress aromatase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tamoxifen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fulvestrant: Fulvestrant is a Selective Estrogen Receptor Downregulator (SERD) that binds to and degrades estrogen receptors. While effective in hormone-receptor-positive breast cancer, it also doesn&#x27;t directly target the increased estrogen production in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fulvestrant:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leuprolide: Leuprolide is a Gonadotropin-Releasing Hormone (GnRH) agonist that suppresses ovarian function, leading to decreased estrogen production. However, it&#x27;s primarily used in premenopausal women. In postmenopausal women, the ovaries are already inactive, and most estrogen production occurs in peripheral tissues through aromatase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leuprolide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aromatase inhibitors are effective in treating hormone-receptor-positive breast cancer in postmenopausal women by reducing estrogen production.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with prostate cancer has been on androgen deprivation therapy (ADT) but recently shows signs of disease progression. His oncologist suspects that his tumor may be utilizing an alternative pathway to maintain androgen signalling. Which enzyme is MOST likely responsible for converting testosterone to a more potent androgen within the prostate, contributing to this resistance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5-alpha reductase (5-AR)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aromatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;17-alpha hydroxylase (17Î±1)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CYP17&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 5-alpha reductase (5-AR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 5-alpha reductase (5-AR)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aromatase: Aromatase converts androgens to estrogens and is relevant in breast cancer, not prostate cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aromatase:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 17-alpha hydroxylase (17Î±1): This enzyme is involved in the early steps of steroid hormone synthesis in the adrenal glands and gonads. It doesn&#x27;t directly convert testosterone to DHT.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 17-alpha hydroxylase (17Î±1):&lt;/li&gt;&lt;li&gt;â€¢ Option D. CYP17: CYP17 is another enzyme involved in steroid hormone synthesis, but it doesn&#x27;t directly convert testosterone to DHT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CYP17:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Understanding the role of 5-alpha reductase in androgen metabolism is important for comprehending mechanisms of resistance to hormone therapy in prostate cancer and for selecting appropriate treatment strategies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic myeloid leukemia (CML) initially responds well to imatinib therapy but later develops resistance. Which of the following mechanisms is MOST likely responsible for this acquired resistance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug Efflux&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug Inactivation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug Target Alteration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cell Death Inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug Target Alteration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug Efflux: While drug efflux pumps can contribute to resistance in some cancers, it&#x27;s not the most common mechanism in CML specifically. Imatinib resistance is primarily driven by mutations in the BCR-ABL target itself.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug Efflux:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Drug Inactivation: This mechanism involves the cancer cells metabolizing or breaking down the drug, rendering it ineffective. While this can occur, it&#x27;s less common in CML compared to target alteration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Drug Inactivation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cell Death Inhibition: While cancer cells can develop mechanisms to evade apoptosis (programmed cell death), this is usually a contributing factor to resistance rather than the primary cause in CML after imatinib therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cell Death Inhibition:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drug target alteration is a common mechanism of acquired resistance, particularly in targeted therapies like imatinib.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following mechanisms of drug resistance involves increased expression of proteins that pump drugs out of cancer cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug Influx&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug Efflux&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA Damage Repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;EMT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Drug Efflux&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug Influx: This is the opposite of the correct answer. Drug influx refers to the movement of drugs into the cell, which would increase their effectiveness, not contribute to resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug Influx:&lt;/li&gt;&lt;li&gt;â€¢ Option C. DNA Damage Repair: DNA damage repair mechanisms help cells fix damage caused by chemotherapy or radiation. While enhanced repair can contribute to resistance, it doesn&#x27;t directly involve pumping drugs out of the cell.&lt;/li&gt;&lt;li&gt;â€¢ Option C. DNA Damage Repair:&lt;/li&gt;&lt;li&gt;â€¢ Option D. EMT (Epithelial-Mesenchymal Transition): EMT is a process where cells lose their epithelial characteristics and gain mesenchymal properties, allowing them to migrate and invade. While EMT can contribute to resistance, it does so through various mechanisms, not specifically increased drug efflux.&lt;/li&gt;&lt;li&gt;â€¢ Option D. EMT (Epithelial-Mesenchymal Transition):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drug efflux pumps can contribute to multidrug resistance in cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is about to start a chemotherapy regimen containing high-dose cyclophosphamide (&amp;gt;1500mg/mÂ²). Which antiemetic regimen is MOST appropriate for preventing CINV in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dexamethasone alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5HT3 antagonist alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dexamethasone + 5HT3 antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dexamethasone + 5HT3 antagonist + NK1 receptor antagonist&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dexamethasone + 5HT3 antagonist + NK1 receptor antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dexamethasone + 5HT3 antagonist + NK1 receptor antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dexamethasone alone: While dexamethasone has antiemetic properties, it is not sufficient on its own to prevent CINV in high-risk regimens like those involving high-dose cyclophosphamide.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dexamethasone alone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5HT3 antagonist alone: 5HT3 antagonists are effective antiemetics, but they are not potent enough to control CINV in high-risk settings when used alone.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5HT3 antagonist alone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dexamethasone + 5HT3 antagonist: This combination provides better control than either drug alone, but it may still be inadequate for high-risk chemotherapy. The addition of an NK1 receptor antagonist further enhances antiemetic efficacy in these cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dexamethasone + 5HT3 antagonist:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ High-risk emetogenic chemotherapy requires a triple-drug antiemetic regimen to effectively prevent CINV.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman undergoing chemotherapy for ovarian cancer presents to your clinic with complaints of frequent, loose stools for the past 3 days. She reports having 5-6 bowel movements per day, with no blood or mucus. Her vital signs are stable, and she is otherwise feeling well. Which medication would be the MOST appropriate initial treatment for her chemotherapy-induced diarrhea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Palifermin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Loperamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Loperamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide: Octreotide is a somatostatin analog that can be used for refractory cases of chemotherapy-induced diarrhea, particularly if there is a secretory component. It is not the initial drug of choice.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ondansetron: Ondansetron is a 5-HT3 receptor antagonist primarily used for nausea and vomiting. It is not effective for diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ondansetron:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Racicodotril: Racicodotril is an antisecretory anti-diarrheal agent that works by inhibiting enkephalinase, an enzyme that breaks down enkephalins. Enkephalins are naturally occurring substances that decrease intestinal secretion. While it can be effective in some cases of diarrhoea, it is not the first-line treatment for chemotherapy-induced diarrhoea.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Racicodotril:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is the first-line treatment for chemotherapy-induced diarrhoea. It acts by slowing down gut motility and reducing the frequency of bowel movements.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 60-year-old woman with newly diagnosed breast cancer scheduled to start chemotherapy with a regimen known to have a high risk of causing neutropenia. In which of the following scenarios is the use of G-CSF therapy MOST strongly indicated for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Her current chemotherapy regimen has a 15% risk of causing febrile neutropenia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;She has a history of febrile neutropenia from prior chemotherapy.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;She develops a fever and her absolute neutrophil count (ANC) drops to 500/ÂµL during her current treatment.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;She is also scheduled to receive radiation therapy to her chest wall after completing chemotherapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. She has a history of febrile neutropenia from prior chemotherapy.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) She has a history of febrile neutropenia from prior chemotherapy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Her current chemotherapy regimen has a 15% risk of causing febrile neutropenia. While this is a moderate risk, it&#x27;s not high enough to warrant primary prophylaxis with G-CSF in the absence of other risk factors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Her current chemotherapy regimen has a 15% risk of causing febrile neutropenia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. She develops a fever and her absolute neutrophil count (ANC) drops to 500/ÂµL during her current treatment. This scenario indicates the patient has already developed febrile neutropenia. G-CSF would be used for secondary prophylaxis in this case, not primary prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. She develops a fever and her absolute neutrophil count (ANC) drops to 500/ÂµL during her current treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. She is also scheduled to receive radiation therapy to her chest wall after completing chemotherapy. Radiation therapy to the chest wall can sometimes cause a decrease in blood counts, but it&#x27;s not a primary indication for G-CSF prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. She is also scheduled to receive radiation therapy to her chest wall after completing chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ A history of febrile neutropenia is a strong indication for G-CSF prophylaxis, even if the current chemotherapy regimen is not considered high-risk. This is because patients who have experienced febrile neutropenia in the past are at a significantly higher risk of developing it again with subsequent chemotherapy. Use if FN risk â‰¥ 20%, H/o Febrile Neutropenia, Neutropenia prior to starting chemo or active infection while starting chemo.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the primary purpose of the instrument shown in the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To provide a site for repeated blood transfusions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To deliver high-dose chemotherapy directly to the tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To facilitate the continuous and safe administration of chemotherapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To monitor the progression of cancer through imaging&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. To facilitate the continuous and safe administration of chemotherapy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-093031.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) To facilitate the continuous and safe administration of chemotherapy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. To provide a site for repeated blood transfusions: While a port can be used for blood transfusions, its primary function is for chemotherapy administration.&lt;/li&gt;&lt;li&gt;â€¢ Option A. To provide a site for repeated blood transfusions:&lt;/li&gt;&lt;li&gt;â€¢ Option B. To deliver high-dose chemotherapy directly to the tumor: Ports deliver chemotherapy systemically, not directly to the tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option B. To deliver high-dose chemotherapy directly to the tumor:&lt;/li&gt;&lt;li&gt;â€¢ Option D. To monitor the progression of cancer through imaging: Ports are not used for imaging or monitoring cancer progression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. To monitor the progression of cancer through imaging:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Chemotherapy ports are implanted devices that provide convenient and safe access to the bloodstream for patients undergoing long-term chemotherapy or other intravenous treatments.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the MOST common adverse drug reaction (ADR) associated with immune checkpoint inhibitors, as indicated in the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rash&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;pneumonitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rash&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rash&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pneumonitis: While pneumonitis (inflammation of the lungs) is a serious potential side effect of immune checkpoint inhibitors, it&#x27;s not as frequent as rash .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pneumonitis:&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colitis: Colitis (inflammation of the colon) is another immune-related adverse event, but it&#x27;s also less common than rash.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatitis: Hepatitis (inflammation of the liver) can occur with immune checkpoint inhibitors, but it&#x27;s less frequent compared to rash.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatitis:&lt;/li&gt;&lt;li&gt;â€¢ Key point: Rash is the most common adverse event associated with immune checkpoint inhibitors, although other serious immune-related adverse events can occur and require vigilant monitoring .&lt;/li&gt;&lt;li&gt;â€¢ Key point:&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with breast cancer is scheduled to begin a chemotherapy regimen including doxorubicin. Which of the following pre-treatment evaluations is MOST essential for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary function tests&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver function tests&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Echocardiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Echocardiogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary function tests (PFTs): PFTs assess lung function and are not directly relevant to the primary concern of cardiotoxicity associated with doxorubicin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary function tests (PFTs):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal ultrasound: While some chemotherapy drugs can affect kidney function, it&#x27;s not the primary concern with doxorubicin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal ultrasound:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver function tests: Liver function tests are important for evaluating the liver&#x27;s ability to metabolize medications, but doxorubicin&#x27;s primary toxicity is cardiac, not hepatic.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver function tests:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Baseline cardiac evaluation with an echocardiogram is essential before starting anthracycline-based chemotherapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of heavy smoking is diagnosed with squamous cell lung cancer. He is started on chemotherapy with carboplatin and paclitaxel, along with bevacizumab, a targeted therapy. During his treatment, which of the following adverse events is his oncologist MOST concerned about monitoring for, given his specific cancer type and treatment regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemorrhagic cystitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary hemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Corneal opacity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pulmonary hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pulmonary hemorrhage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemorrhagic cystitis: This is a potential side effect of certain chemotherapy drugs, like cyclophosphamide, but not typically associated with bevacizumab.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hemorrhagic cystitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardiomyopathy: While some chemotherapy drugs can cause cardiotoxicity, it&#x27;s not a major concern with bevacizumab.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardiomyopathy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corneal opacity : Corneal opacity is not a recognized side effect of bevacizumab or the other drugs in this regimen.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corneal opacity&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Bevacizumab, while effective in treating various cancers, carries a risk of pulmonary hemorrhage, particularly in patients with squamous cell lung cancer. Close monitoring for any signs of respiratory distress or bleeding is essential in these patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with breast cancer is undergoing adjuvant chemotherapy with cyclophosphamide. During her second cycle, she complains of burning sensation while urinating and notices blood in her urine. You suspect a complication due to chemotherapy. Which of the following medications is MOST likely to prevent this complication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mesna&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mesna&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mesna&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dexamethasone: A corticosteroid used to manage nausea and vomiting associated with chemotherapy; it has no role in preventing hemorrhagic cystitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dexamethasone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ondansetron: A 5-HT3 receptor antagonist used to manage nausea and vomiting; it&#x27;s not effective for preventing hemorrhagic cystitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ondansetron:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allopurinol: A medication used to reduce uric acid levels, often in the context of tumor lysis syndrome; it has no role in preventing hemorrhagic cystitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allopurinol:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Mesna is the standard preventive agent for hemorrhagic cystitis associated with cyclophosphamide. It should be administered concurrently with cyclophosphamide to minimize bladder toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient receiving chemotherapy develops a \&quot;glove and stocking\&quot; pattern of numbness and tingling in their hands and feet. Which of the following drugs is MOST likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytarabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ifosfamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gemcitabine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cisplatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cisplatin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytarabine: Cytarabine is primarily associated with cerebellar toxicity and myelosuppression. While it can rarely cause peripheral neuropathy, it is not typically characterized by a glove and stocking distribution.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytarabine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ifosfamide: Ifosfamide can cause hemorrhagic cystitis and neurotoxicity, but the characteristic glove and stocking neuropathy is less common.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ifosfamide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gemcitabine: Gemcitabine is associated with myelosuppression, flu-like symptoms, and rash. Peripheral neuropathy is not a typical side effect of this drug.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gemcitabine:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Platinum-based chemotherapy agents carry the risk of peripheral neuropathy and ototoxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient receiving pembrolizumab develops new-onset cough and shortness of breath. Chest X-ray shows interstitial infiltrates. Which of the following adverse drug reactions (ADRs) is MOST likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pneumonitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pneumonitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary hemorrhage: While possible, pulmonary hemorrhage is less common than pneumonitis as an irAE of pembrolizumab. It would typically present with more dramatic symptoms like coughing up blood (hemoptysis).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary hemorrhage:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colitis: Colitis, or inflammation of the colon, can be an immune-related adverse event of checkpoint inhibitors. However, its primary symptoms would be diarrhea, abdominal pain, and possibly blood in the stool, not respiratory symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Colitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatitis: Hepatitis, or inflammation of the liver, can also be an immune-related adverse event. Its typical presentation would involve jaundice, elevated liver enzymes, and possibly right upper quadrant pain, rather than respiratory symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatitis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Immune checkpoint inhibitors can cause immune-related adverse events, including pneumonitis, which requires prompt recognition and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient receiving CAR T-cell therapy develops fever, hypotension, and tachycardia two days after infusion. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tumor lysis syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytokine release syndrome (CRS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Graft-versus-host disease (GVHD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cytokine release syndrome (CRS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cytokine release syndrome (CRS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tumor lysis syndrome: While it can cause fever and electrolyte abnormalities, it&#x27;s less likely to cause hypotension and tachycardia shortly after T-cell therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tumor lysis syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. GVHD: This occurs in allogeneic stem cell transplantation, not CAR T-cell therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. GVHD:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sepsis: Though sepsis can present similarly, the timing and context point more towards CRS in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sepsis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ CRS is a serious complication of CAR T-cell therapy characterized by a systemic inflammatory response due to cytokine release.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient receiving CAR T-cell therapy for refractory large B-cell lymphoma develops confusion, word-finding difficulty, and a severe headache three days after infusion. Which of the following neurological manifestations is LEAST likely to be associated with this patient&#x27;s suspected diagnosis of Immune effector cell-associated neurotoxicity syndrome (ICANS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Delirium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Optic neuritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Optic neuritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Optic neuritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Headache: Headache is a very common symptom of ICANS, often presenting early in the course of the syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Headache:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aphasia: Aphasia, or difficulty with language, is another frequent manifestation of ICANS, reflecting the impact of cerebral edema on language centers in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Delirium: Delirium, or acute confusional state, is a hallmark of ICANS and can range from mild confusion to severe agitation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Delirium:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ ICANS is a serious complication of CAR T-cell therapy that can present with a variety of neurological symptoms. Recognizing these symptoms early is crucial for prompt management and improved patient outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with breast cancer is undergoing adjuvant chemotherapy. Three days after her most recent cycle, she presents to the emergency department with a fever of 38.7Â°C (101.7Â°F) and generalized weakness. Her past medical history is significant for hypertension, well-controlled with medication. On examination, she appears fatigued but is otherwise stable. Laboratory tests reveal an absolute neutrophil count (ANC) of 500 cells/ÂµL, confirming neutropenia. Given her presentation with fever and neutropenia, the emergency department team considers her risk of complications using the Multinational Association for Supportive Care in Cancer (MASCC) risk index to guide her management. Based on the MASCC risk index for febrile neutropenia, which of the following factors would categorize this patient as low risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Presence of hypotension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;History of chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No dehydration requiring intravenous fluids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fever of unknown origin without localizing signs or symptoms&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. No dehydration requiring intravenous fluids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Presence of hypotension would categorize a patient as high risk, as it indicates hemodynamic instability, which is a serious complication of febrile neutropenia.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Option B. A history of chronic obstructive pulmonary disease (COPD) would also place a patient in a higher risk category, as underlying lung disease can complicate the management of febrile neutropenia.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fever of unknown origin without localizing signs or symptoms could apply to many cases of febrile neutropenia and, by itself, does not necessarily categorize a patient as low risk according to the MASCC risk index. Other factors, such as the patient&#x27;s overall clinical stability, presence of comorbidities, and intensity of the chemotherapy regimen, also need to be considered.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The MASCC risk index is used to identify febrile neutropenia patients who are at low risk for complications and might be suitable for outpatient management. Factors that indicate lower risk include stable vital signs, no significant comorbidities like COPD, and no dehydration requiring intravenous fluids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with metastatic lung cancer on chemotherapy develops fever, chills, and tenderness with purulent discharge at his PICC line site. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Febrile neutropenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor-related fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Central line-associated bloodstream infection (CLABSI)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Central line-associated bloodstream infection (CLABSI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CLABSI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Febrile neutropenia: While this patient likely has neutropenia due to chemotherapy, the local signs of infection at the PICC line point more specifically towards CLABSI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Febrile neutropenia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tumor-related fever: This is less likely in the presence of clear signs of infection at the catheter site.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tumor-related fever:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumonia: While possible, the absence of respiratory symptoms and the presence of local signs of infection at the catheter site make CLABSI more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective: CLABSI is a serious complication of central venous catheters. Prompt recognition and treatment are essential to prevent morbidity and mortality.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a known history of prostate cancer presents to your clinic complaining of severe back pain that has been progressively worsening over the past few weeks. The pain is particularly intense at night, making it difficult for him to sleep, and it does not improve with rest. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Muscle strain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metastatic spinal cord compression&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lumbar disc herniation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metastatic spinal cord compression&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Metastatic spinal cord compression (MSCC)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Muscle strain: Muscle strain typically presents with localized pain that worsens with movement and improves with rest. It&#x27;s less likely to be severe at night or associated with a history of cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Muscle strain:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osteoarthritis: Osteoarthritis is a degenerative joint disease that can cause back pain, but it&#x27;s usually associated with stiffness and pain that worsens with activity and improves with rest. The patient&#x27;s age and cancer history make MSCC more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osteoarthritis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lumbar disc herniation: While a herniated disc can cause severe back pain, it&#x27;s often associated with radicular pain (shooting pain down the leg) and neurological deficits. The patient&#x27;s presentation and cancer history are more consistent with MSCC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lumbar disc herniation:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Back pain in a patient with a history of cancer, especially if it&#x27;s worse at night or unrelieved by rest, warrants prompt evaluation for possible MSCC. Early diagnosis and treatment are critical to prevent neurological complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of lung cancer presents with severe back pain and weakness in his legs. Neurological examination reveals decreased lower extremity strength and hyperreflexia. What is the MOST appropriate initial management step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plain X-ray of the spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urgent intravenous dexamethasone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Whole spine MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgical decompression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Urgent intravenous dexamethasone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Urgent intravenous dexamethasone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plain X-ray of the spine: While plain X-rays can sometimes show bony destruction suggestive of metastases, they are not sensitive enough to visualize the spinal cord or nerve roots, which are crucial for assessing the extent of compression.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plain X-ray of the spine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Whole spine MRI: MRI is the gold standard for diagnosing MSCC, but it should not delay the administration of dexamethasone, which is crucial to prevent further neurological deterioration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Whole spine MRI:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical decompression: While surgery may be indicated in some cases of MSCC, it is not the initial management step. High-dose dexamethasone should be given first to reduce spinal cord edema and stabilize the patient before considering surgical intervention.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical decompression:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective: In patients with suspected MSCC and neurological deficits, urgent high-dose dexamethasone is the priority to reduce spinal cord edema and prevent further neurological damage.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with acute myeloid leukemia (AML) undergoing chemotherapy presents to the emergency department with a 2-day history of fever, right lower quadrant abdominal pain, and watery diarrhea. His absolute neutrophil count (ANC) is 300/ÂµL. Abdominal CT scan reveals cecal wall thickening. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Appendicitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diverticulitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neutropenic enterocolitis (typhlitis)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic colitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neutropenic enterocolitis (typhlitis)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neutropenic enterocolitis (typhlitis)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Appendicitis: While appendicitis can present with similar symptoms, it is less likely in this patient with neutropenia and cecal wall thickening.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Appendicitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diverticulitis: Diverticulitis typically affects the left colon and is less common in younger individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diverticulitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic colitis: Ischemic colitis is more common in older individuals with cardiovascular risk factors. It usually presents with bloody diarrhea and is less likely in the context of neutropenia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic colitis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Neutropenic enterocolitis is a life-threatening complication that can occur in patients with severe neutropenia. Early recognition and prompt treatment are essential.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with Burkitt&#x27;s lymphoma is undergoing chemotherapy. Three days after starting treatment, he presents with fatigue, muscle cramps, and nausea. Lab results show: Potassium: 6.2 mEq/L Uric acid: 9.0 mg/dL Phosphate: 5.5 mg/dL Calcium: 9.5 mg/dL Which of the following electrolyte abnormalities found in this patient is NOT a criterion for the diagnosis of Laboratory Tumor Lysis Syndrome (LTLS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperuricemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypercalcemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypercalcemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hyperkalemia: This is a defining feature of LTLS, as the breakdown of tumor cells releases intracellular potassium into the bloodstream.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hyperkalemia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperuricemia: Tumor cell lysis releases nucleic acids, which are metabolized to uric acid, leading to hyperuricemia in LTLS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperuricemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperphosphatemia: The breakdown of tumor cells also releases intracellular phosphate, contributing to hyperphosphatemia in LTLS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperphosphatemia:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ LTLS is a potentially life-threatening oncologic emergency characterized by specific electrolyte abnormalities: hyperkalemia, hyperuricemia, hyperphosphatemia, and sometimes hypocalcemia. CTLS (â‰¥ 1) (Clinical criteria for TLS) : AKI, arrhythmias, Sz, symptomatic hypocalcemia Prompt recognition and management of LTLS are critical to prevent complications like acute kidney injury, cardiac arrhythmias, and seizures.&lt;/li&gt;&lt;li&gt;â€¢ LTLS is a potentially life-threatening oncologic emergency characterized by specific electrolyte abnormalities: hyperkalemia, hyperuricemia, hyperphosphatemia, and sometimes hypocalcemia.&lt;/li&gt;&lt;li&gt;â€¢ CTLS (â‰¥ 1) (Clinical criteria for TLS) : AKI, arrhythmias, Sz, symptomatic hypocalcemia&lt;/li&gt;&lt;li&gt;â€¢ CTLS (â‰¥ 1)&lt;/li&gt;&lt;li&gt;â€¢ (Clinical criteria for TLS) :&lt;/li&gt;&lt;li&gt;â€¢ Prompt recognition and management of LTLS are critical to prevent complications like acute kidney injury, cardiac arrhythmias, and seizures.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents to your clinic with a rapidly growing neck mass that has caused him discomfort over the past few weeks. He also reports feeling fatigued and has lost some weight recently. On examination, you palpate a large, firm, non-tender lymph node in his left cervical region. A biopsy of the lymph node reveals Burkitt lymphoma. Further workup shows his lactate dehydrogenase (LDH) level is 3 times the upper limit of normal. Considering his diagnosis and laboratory findings, which Tumor Lysis Syndrome (TLS) risk category does this patient fall into?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Low risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intermediate risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High risk&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cannot be determined&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. High risk&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) High risk&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Low risk: Low-risk malignancies generally have a slower growth rate and lower tumor burden, making TLS less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Low risk:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intermediate risk: Intermediate-risk malignancies have a moderate risk of TLS, often based on specific tumor characteristics or laboratory findings. In this case, the patient&#x27;s elevated LDH level and rapid tumor growth place him in the high-risk category.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intermediate risk:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cannot be determined: The information provided is sufficient to determine the patient&#x27;s TLS risk category.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cannot be determined:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Burkitt lymphoma is a high-risk malignancy for TLS, especially when associated with elevated LDH levels. Patients with high-risk TLS require aggressive preventive measures, including intensive hydration and uric acid-lowering therapy, to minimize the risk of complications.&lt;/li&gt;&lt;li&gt;â€¢ Burkitt lymphoma is a high-risk malignancy for TLS, especially when associated with elevated LDH levels.&lt;/li&gt;&lt;li&gt;â€¢ Patients with high-risk TLS require aggressive preventive measures, including intensive hydration and uric acid-lowering therapy, to minimize the risk of complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old man presents to the emergency department with progressive swelling of his face and neck over the past two weeks. He also reports increasing breathlessness, especially when lying flat, and a feeling of fullness in his head. His medical history is significant for a 40-pack-year smoking history, although he quit smoking 10 years ago. On examination, his face appears plethoric, and there is evident distension of the veins in his neck and chest. Additionally, he exhibits mild cyanosis of the upper body and swelling of the arms. A chest X-ray reveals a mass in the right upper mediastinum. Based on the patient&#x27;s presentation and history, which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Superior vena cava (SVC) syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Superior vena cava (SVC) syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Superior vena cava (SVC) syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute heart failure can cause facial and upper extremity swelling due to fluid overload, but it is less likely to present with the pronounced venous distension and plethoric face that are characteristic of SVC syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary embolism typically presents with acute shortness of breath, chest pain, and possibly hemoptysis, but not with the venous distension and facial swelling seen in SVC syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Constrictive pericarditis can cause symptoms of venous congestion due to impaired cardiac filling, but it usually presents with generalized edema, ascites, and elevated jugular venous pressure, rather than the localized swelling of the face and neck and the specific venous distension seen in SVC syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Superior vena cava (SVC) syndrome is characterized by obstruction of the SVC, leading to impaired venous return from the head, neck, and upper extremities. Symptoms include facial and upper extremity swelling, plethoric facial appearance, distended neck and chest veins, and cyanosis of the upper body. A mediastinal mass, especially in patients with a significant smoking history, raises suspicion for an underlying malignancy such as lung cancer as a cause of SVC syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of smoking presents with facial swelling, distended neck veins, and shortness of breath. Chest X-ray shows a large right lung mass. Which of the following malignancies is the MOST likely cause of this patient&#x27;s diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Small cell lung cancer (SCLC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-small cell lung cancer (NSCLC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metastatic breast cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-small cell lung cancer (NSCLC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Small cell lung cancer (SCLC): While SCLC can also cause SVC syndrome, it is less common than NSCLC as a cause.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Small cell lung cancer (SCLC):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphoma: Lymphoma can sometimes cause SVC syndrome, but it is less frequent than lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lymphoma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metastatic breast cancer: While metastatic breast cancer can spread to the mediastinum and cause SVC syndrome, it&#x27;s less common than primary lung cancer as a cause in this clinical scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metastatic breast cancer:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ SVC syndrome is a medical emergency caused by obstruction of the superior vena cava, leading to impaired venous return from the head, neck, and upper extremities. Lung cancer, particularly NSCLC, is the most common cause of SVC syndrome.&lt;/li&gt;&lt;li&gt;â€¢ SVC syndrome is a medical emergency caused by obstruction of the superior vena cava, leading to impaired venous return from the head, neck, and upper extremities.&lt;/li&gt;&lt;li&gt;â€¢ Lung cancer, particularly NSCLC, is the most common cause of SVC syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with weight loss, fatigue, and a left supraclavicular lymph node. Biopsy reveals metastatic adenocarcinoma. Extensive imaging fails to identify a primary tumor site. Immunohistochemistry (IHC) is ordered to help determine the origin of the malignancy. Which IHC staining pattern would MOST STRONGLY suggest a gastrointestinal (GI) primary?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CK7 positive, CK20 negative, TTF-1 negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CK7 negative, CK20 positive, CDX2 positive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CK7 positive, TTF-1 positive, Napsin A positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ER positive, PR positive, HER2 negative&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CK7 negative, CK20 positive, CDX2 positive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CK7 negative, CK20 positive, CDX2 positive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CK7 positive, CK20 negative, TTF-1 negative: This pattern is more suggestive of lung or breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CK7 positive, CK20 negative, TTF-1 negative:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CK7 positive, TTF-1 positive, Napsin A positive: This pattern is strongly indicative of lung adenocarcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. CK7 positive, TTF-1 positive, Napsin A positive:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ER positive, PR positive, HER2 negative: This pattern is typically seen in breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ER positive, PR positive, HER2 negative:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective: IHC staining can aid in identifying the primary site in cancers of unknown primary (CUP), guiding further management and treatment decisions.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman Non-smoker presents to your clinic with a persistent cough and recent episodes of coughing up blood (hemoptysis). Chest X-ray reveals a suspicious lung mass. A biopsy is performed, and you suspect lung adenocarcinoma based on the initial histopathology. Which of the following immunohistochemical (IHC) markers would be MOST helpful in confirming this diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TTF-1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CDX2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;S-100&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ER&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. TTF-1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDX2: CDX2 is a marker of intestinal differentiation and is typically used to identify cancers of gastrointestinal origin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDX2:&lt;/li&gt;&lt;li&gt;â€¢ Option C. S-100: S-100 is a marker for melanomas and neural crest-derived tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C. S-100:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ER (Estrogen Receptor): ER is a hormone receptor that is primarily used in the context of breast cancer. While some lung adenocarcinomas can be ER-positive, it&#x27;s not a specific or sensitive marker for this diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ER (Estrogen Receptor):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ While smoking is a major risk factor for lung cancer, adenocarcinoma can occur in non-smokers as well. TTF-1 remains a valuable IHC marker for confirming the diagnosis of lung adenocarcinoma, regardless of smoking history. IHC staining can aid in differentiating between various types of lung cancer and metastases, which is critical for guiding treatment decisions.&lt;/li&gt;&lt;li&gt;â€¢ While smoking is a major risk factor for lung cancer, adenocarcinoma can occur in non-smokers as well.&lt;/li&gt;&lt;li&gt;â€¢ TTF-1 remains a valuable IHC marker for confirming the diagnosis of lung adenocarcinoma, regardless of smoking history.&lt;/li&gt;&lt;li&gt;â€¢ IHC staining can aid in differentiating between various types of lung cancer and metastases, which is critical for guiding treatment decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents with metastatic adenocarcinoma of unknown primary origin. Imaging and biopsy have failed to identify the primary site. What is the most appropriate initial approach to the treatment of her cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platinum and 5-FU&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pembrolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platinum and etoposide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Palliative care with a focus on symptom management&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Platinum and 5-FU&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Platinum and 5-FU&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pembrolizumab, a PD-1 inhibitor, has shown promise in certain types of cancers, particularly those with high levels of microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). While it represents an exciting advancement in cancer therapy, pembrolizumab would typically be considered in the context of CUP after specific testing for MSI-H or dMMR, or PD-L1 expression, rather than as an initial empiric treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Platinum and etoposide are often used together in the treatment of small cell lung cancer and other neuroendocrine tumors, but without evidence of a neuroendocrine component, this regimen would not be the first choice for an adenocarcinoma of unknown primary.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. While palliative care and symptom management are crucial aspects of cancer treatment, especially in advanced disease, they are not typically the initial approach for a patient who may still benefit from systemic therapy aimed at controlling the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with metastatic adenocarcinoma of unknown primary origin, an empiric chemotherapy regimen that includes a platinum agent (cisplatin or carboplatin) and 5-fluorouracil (5-FU) is often used as the initial treatment approach, aiming to control the disease and alleviate symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old woman presents to the oncology clinic with a 3-month history of unexplained weight loss, night sweats, and a palpable mass in her left axilla. A comprehensive workup, including mammography, abdominal CT, PET scan, and colonoscopy, fails to identify a primary tumor site. Biopsy of the axillary mass reveals adenocarcinoma. Which of the following features is considered unfavorable in the prognosis of cancer of unknown primary?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Single, small axillary node involvement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenocarcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated serum tumor markers with a single site of metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absence of liver metastasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adenocarcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Adenocarcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Single, small axillary node involvement, especially in women, can sometimes be managed similarly to breast cancer, with a relatively better prognosis than other forms of CUP. This is often considered a subset with a favorable prognosis if it resembles breast cancer histologically and clinically.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elevated serum tumor markers with a single site of metastasis could influence prognosis, depending on the specific context and markers involved. However, this alone does not universally signify an unfavorable prognosis without considering other clinical and histopathological features.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The absence of liver metastasis is generally a favorable prognostic sign in CUP. Liver involvement is often associated with a more aggressive disease course and a poorer prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of cancer of unknown primary (CUP), adenocarcinoma histology is generally considered to have an unfavorable prognosis compared to other subsets of CUP that may have more defined treatment approaches and better outcomes, such as squamous cell carcinoma confined to lymph nodes or women with axillary nodal metastases resembling breast cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with a history of squamous cell lung cancer presents with fatigue, constipation, and confusion. Her laboratory tests reveal a serum calcium level of 13 mg/dL. Which of the following is the MOST Common mechanism underlying her hypercalcemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Osteolytic bone metastases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC): This mechanism is more commonly seen in lymphomas and some other solid tumors, not as frequently in squamous cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteolytic bone metastases: While possible, it is less frequent than PTHrP production as the cause of hypercalcemia in squamous cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteolytic bone metastases:&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above: Although all three mechanisms can contribute to hypercalcemia in SCC, PTHrP-mediated bone resorption is the most prevalent.&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PTHrP-mediated bone resorption is the predominant mechanism of hypercalcemia in squamous cell lung cancer and certain other malignancies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with advanced lung cancer presents with confusion, polyuria, and dehydration. Laboratory tests reveal a serum calcium level of 13.5 mg/dL. The most likely diagnosis is humoral hypercalcemia of malignancy. Which of the following is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral calcium supplements&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous bisphosphonates&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcitonin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous bisphosphonates&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous bisphosphonates&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral calcium supplements : Would be contraindicated as the patient already has hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Oral calcium supplements&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thiazide diuretics : Would be inappropriate as they tend to increase serum calcium levels by promoting renal reabsorption of calcium.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Thiazide diuretics&lt;/li&gt;&lt;li&gt;â€¢ Option D. Calcitonin : Can be used as an additional therapy for hypercalcemia, but it has a much weaker effect compared to bisphosphonates and is often used in conjunction with bisphosphonates for a quicker response.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Calcitonin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The appropriate initial management of hypercalcemia of malignancy involves the use of intravenous bisphosphonates, after initial hydration with intravenous fluids. Bisphosphonates inhibit osteoclastic bone resorption and reduce serum calcium levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman complains of fatigue, constipation, increased thirst and urination, decreased appetite, and unintentional weight loss. Labs reveal hypercalcemia, normal creatinine, suppressed PTH, and elevated PTHrP. A chest X-ray identifies a right upper lung mass. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple myeloma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Humoral hypercalcemia of malignancy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Humoral hypercalcemia of malignancy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Humoral hypercalcemia of malignancy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary hyperparathyroidism: This would cause hypercalcemia but with elevated PTH levels, not suppressed.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary hyperparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis: Sarcoidosis can cause hypercalcemia due to increased vitamin D production, but PTHrP would not be elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple myeloma: While myeloma can cause hypercalcemia through bone destruction, PTHrP is usually not elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple myeloma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of hypercalcemia, suppressed PTH, and elevated PTHrP in the setting of a malignancy is indicative of humoral hypercalcemia of malignancy.&lt;/li&gt;&lt;li&gt;âž¤ Question Id-19836 Unique Key-Q3882817&lt;/li&gt;&lt;li&gt;âž¤ Question Id-19836 Unique Key-Q3882817&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of small cell lung cancer (SCLC) presents with confusion, lethargy, and muscle cramps. Laboratory findings reveal hyponatremia with a serum sodium level of 120 mEq/L, high urine sodium, and high urine osmolality. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Central diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephrogenic diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary hyperaldosteronism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Central diabetes insipidus: This condition is caused by deficient production of ADH, leading to excessive water loss and hypernatremia (high serum sodium), not hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Central diabetes insipidus:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nephrogenic diabetes insipidus: In this condition, the kidneys are unable to respond to ADH, also leading to excessive water loss and hypernatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nephrogenic diabetes insipidus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary hyperaldosteronism: This condition is characterized by excessive aldosterone production, leading to sodium retention, hypertension, and hypokalemia. It does not typically cause hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary hyperaldosteronism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SIADH is characterized by hyponatremia with inappropriately concentrated urine due to excessive ADH secretion. SCLC is a common cause of SIADH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman smoker with a recent diagnosis of small cell lung cancer (SCLC) presents with rapid weight gain, proximal muscle weakness, and easy bruising. She also reports experiencing mood swings and insomnia. On examination, she has central obesity, facial plethora, and purple striae on her abdomen. Her blood pressure is 150/90 mmHg. Further investigations reveal hypokalemia and hyperglycemia. Which of the following is the MOST likely underlying mechanism for her clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ectopic ACTH production&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary adrenal adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pituitary ACTH-secreting adenoma (Cushing&#x27;s disease)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exogenous glucocorticoid use&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ectopic ACTH production&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ectopic ACTH production&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary adrenal adenoma: While an adrenal adenoma could cause Cushing&#x27;s syndrome, it wouldn&#x27;t explain the recent onset of symptoms in the context of SCLC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary adrenal adenoma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pituitary ACTH-secreting adenoma (Cushing&#x27;s disease): Cushing&#x27;s disease is less likely in this scenario, especially with a known SCLC diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pituitary ACTH-secreting adenoma (Cushing&#x27;s disease):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exogenous glucocorticoid use: This is less likely given the absence of a history of glucocorticoid use and the presence of SCLC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exogenous glucocorticoid use:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ectopic Cushing&#x27;s syndrome is a paraneoplastic syndrome caused by the ectopic production of ACTH by non-pituitary tumors.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the clinical features of Cushing&#x27;s syndrome in patients with cancer is crucial for prompt diagnosis and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with recurrent episodes of flushing, accompanied by diarrhea and abdominal cramping. She has also noticed a rash on her face and neck that worsens during these episodes. On physical examination, you note telangiectasias on her cheeks and a palpable liver mass. Which of the following diagnostic tests is MOST likely to be elevated in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;24-hour urinary 5-HIAA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum calcitonin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum gastrin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 24-hour urinary 5-HIAA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 24-hour urinary 5-HIAA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum cortisol: Cortisol is elevated in Cushing&#x27;s syndrome, which presents with different clinical features (central obesity, muscle weakness, hypertension).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum cortisol:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum calcitonin: Calcitonin is a marker for medullary thyroid carcinoma (MTC), which can also cause flushing but usually presents with a neck mass or thyroid nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum calcitonin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum gastrin: Gastrin is elevated in gastrinomas (a type of neuroendocrine tumor), which primarily cause peptic ulcers and abdominal pain, not the classic carcinoid syndrome symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serum gastrin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carcinoid syndrome is caused by the release of vasoactive substances, mainly serotonin, from carcinoid tumors. 24-hour urinary 5-HIAA is the diagnostic test of choice for carcinoid syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Carcinoid syndrome is caused by the release of vasoactive substances, mainly serotonin, from carcinoid tumors.&lt;/li&gt;&lt;li&gt;âž¤ 24-hour urinary 5-HIAA is the diagnostic test of choice for carcinoid syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of weight loss and fatigue presents with recurrent episodes of confusion, sweating, and tremors. These episodes typically occur in the morning or after prolonged fasting. His blood glucose level during one of these episodes is 40 mg/dL. Abdominal imaging reveals a large retroperitoneal mass. Which of the following is the MOST likely cause of this patient&#x27;s hypoglycemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adrenal insufficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ectopic production of IGF-2 by the tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pituitary insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ectopic production of IGF-2 by the tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ectopic production of IGF-2 by the tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Insulinoma: Insulinomas are pancreatic neuroendocrine tumors that secrete insulin, leading to hypoglycemia. However, the presence of a retroperitoneal mass makes this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Insulinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adrenal insufficiency: Adrenal insufficiency can cause hypoglycemia, but it&#x27;s usually associated with other symptoms like hypotension, fatigue, and hyperpigmentation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adrenal insufficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pituitary insufficiency: Pituitary insufficiency can cause secondary adrenal insufficiency, which can lead to hypoglycemia. However, it&#x27;s less likely in this patient with a retroperitoneal mass.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pituitary insufficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Non-islet cell hypoglycemia is a rare but important paraneoplastic syndrome associated with certain tumors. Recognizing this syndrome is crucial for proper management and treatment of the underlying malignancy.&lt;/li&gt;&lt;li&gt;âž¤ Non-islet cell hypoglycemia is a rare but important paraneoplastic syndrome associated with certain tumors.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing this syndrome is crucial for proper management and treatment of the underlying malignancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents with persistent bone pain and muscle weakness for several months. He has a history of recurrent fractures. Laboratory findings show hypophosphatemia, normal serum calcium, and decreased 1,25-dihydroxyvitamin D levels. Imaging studies reveal multiple bone lesions. Which of the following is the MOST likely underlying cause of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin D deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mesenchymal tumor producing FGF23&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple myeloma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mesenchymal tumor producing FGF23&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary hyperparathyroidism: This would cause hypercalcemia, not hypophosphatemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary hyperparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin D deficiency: This would also cause hypophosphatemia, but 1,25-dihydroxyvitamin D levels would be low or inappropriately normal, not decreased.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vitamin D deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple myeloma: Myeloma can cause bone pain and fractures, but it typically presents with hypercalcemia and renal insufficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple myeloma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oncogenic osteomalacia is a rare paraneoplastic syndrome caused by tumors that secrete FGF23. Recognizing the characteristic clinical and laboratory findings is crucial for prompt diagnosis and treatment. Identifying and removing the underlying tumor can lead to resolution of the osteomalacia.&lt;/li&gt;&lt;li&gt;âž¤ Oncogenic osteomalacia is a rare paraneoplastic syndrome caused by tumors that secrete FGF23.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic clinical and laboratory findings is crucial for prompt diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ Identifying and removing the underlying tumor can lead to resolution of the osteomalacia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents to his primary care physician with complaints of breast tenderness and enlargement over the past 3 months. He has also noticed a significant decrease in his libido and erectile function during this time. On physical examination, you note bilateral gynecomastia without palpable masses and testicular atrophy. Laboratory findings reveal a normal testosterone level, elevated estradiol level, and a slightly elevated hCG level. A chest CT scan demonstrates a mass in the right lung&#x27;s lower lobe, with no evidence of metastasis. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Male breast cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gynecomastia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Male feminization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non cancerous breast lump&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Male feminization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Male feminization&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Male breast cancer: Usually presents as a unilateral, hard, and sometimes painful mass located beneath the nipple, without necessarily being associated with elevated estradiol levels or symptoms of feminization.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Male breast cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gynecomastia: Refers to the benign enlargement of breast tissue in males and can be a component of male feminization syndrome, but by itself, it does not explain the full clinical picture, including the lung mass and hormonal imbalances.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Gynecomastia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-cancerous breast lumps: Can cause breast enlargement, but they do not typically lead to hormonal changes like elevated estradiol or the systemic symptoms of feminization.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Non-cancerous breast lumps:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Male feminization syndrome, or paraneoplastic hyperestrogenism, can occur when tumors (commonly lung tumors) produce hormones or hormone-like substances leading to elevated estrogen levels, resulting in feminization effects such as gynecomastia, decreased libido, and erectile dysfunction. The diagnosis is supported by the presence of a lung mass, normal testosterone, elevated estradiol, and slightly elevated hCG levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with acute myeloid leukemia presents with stomatitis as shown in the image. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paraneoplastic pemphigus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyoderma gangrenosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sweet syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Paraneoplastic pemphigus&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-162506.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Paraneoplastic pemphigus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dermatomyositis: Generally presents with a heliotrope rash (purple discoloration around the eyes) and Gottron&#x27;s papules, not typically with the severe oral involvement shown.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Dermatomyositis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyoderma gangrenosum: Is a neutrophilic dermatosis that usually presents as rapidly progressing painful skin ulcers, primarily on the legs, not in the oral cavity.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Pyoderma gangrenosum:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sweet syndrome: or acute febrile neutrophilic dermatosis, presents with painful erythematous plaques on the skin, typically without the severe mucosal involvement depicted.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Sweet syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Paraneoplastic pemphigus is associated with underlying malignancies and presents with painful mucosal erosions and various skin lesions. It is important to recognize the oral manifestations which can be severe and impact a patient&#x27;s ability to eat and maintain oral hygiene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male patient presents with fever, arthralgia, and painful erythematous plaques on her upper extremities as shown in the image. Laboratory tests reveal leukocytosis with neutrophilia and anemia. A bone marrow biopsy is performed, suspecting an underlying hematological disorder. Which of the following conditions is most likely associated with this patient&#x27;s presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic lymphocytic leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hodgkin&#x27;s lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polycythemia vera&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myelodysplastic syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-163404.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Myelodysplastic syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic lymphocytic leukemia (CLL): May be associated with various skin manifestations, but Sweet&#x27;s syndrome is more classically associated with myeloid disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Chronic lymphocytic leukemia (CLL):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hodgkin&#x27;s lymphoma: Is not commonly associated with Sweet&#x27;s syndrome. Hodgkin&#x27;s lymphoma typically presents with lymphadenopathy and sometimes with B symptoms (fever, weight loss, night sweats), but not typically with the cutaneous manifestations seen in Sweet&#x27;s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Hodgkin&#x27;s lymphoma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polycythemia vera: Could present with a plethoric face and splenomegaly and is a myeloproliferative disorder, but it is not the hematologic disorder most typically associated with Sweet&#x27;s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Polycythemia vera:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sweet&#x27;s syndrome, characterized by painful erythematous plaques, fever, and arthralgias, is often associated with hematological disorders, particularly myelodysplastic syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old male, with a known case of GERD presents with a 6-month history of weight loss, decreased appetite along with darkening and thickening of the skin on his neck and axillae. The areas are asymptomatic but have been progressively worsening. He has no other significant past medical history. On examination, you note hyperpigmented, velvety plaques in the affected areas along with the small nodule near the umblicus. Given the patient&#x27;s presentation, which of the following is the MOST likely underlying condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addison&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastric adenocarcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gastric adenocarcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gastric adenocarcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Addison&#x27;s disease: While Addison&#x27;s disease can cause hyperpigmentation, it is typically more diffuse and doesn&#x27;t have the velvety texture characteristic of acanthosis nigricans. Additionally, Addison&#x27;s disease would present with other symptoms like hypotension, fatigue, and electrolyte imbalances.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Addison&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Insulin resistance: While insulin resistance can cause acanthosis nigricans, it&#x27;s usually seen in younger individuals with obesity and metabolic syndrome. The rapid progression, associated symptoms, and the presence of a Sister Mary Joseph nodule in this case point more towards malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Insulin resistance:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothyroidism: Hypothyroidism can cause skin changes like dryness and coarseness, but it doesn&#x27;t typically cause the velvety hyperpigmentation seen in acanthosis nigricans.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothyroidism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rapidly progressive acanthosis nigricans in an adult, especially with associated symptoms like weight loss, decreased appetite, and the presence of a Sister Mary Joseph nodule, should prompt immediate investigation for an underlying malignancy.&lt;/li&gt;&lt;li&gt;âž¤ Gastric adenocarcinoma is the most common malignancy associated with acanthosis nigricans in adults, and the presence of a Sister Mary Joseph nodule further supports this possibility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with progressive muscle weakness and peculiar rashes present on her knuckles and eyes as shown below. She also reports difficulty swallowing and has noticed a scaly rash over her shoulders and upper back. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Scleroderma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dermatomyositis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-163958.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dermatomyositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE): While SLE can cause a malar rash and muscle weakness, it doesn&#x27;t typically present with the specific skin findings seen in dermatomyositis (heliotrope rash, Gottron&#x27;s papules, shawl sign).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Scleroderma: Scleroderma primarily affects the skin and internal organs, causing thickening and tightening of the skin. It doesn&#x27;t typically present with the muscle weakness or characteristic rash seen in dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Scleroderma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polymyositis: Polymyositis presents with muscle weakness but lacks the characteristic skin manifestations of dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polymyositis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dermatomyositis is an inflammatory myopathy characterized by muscle weakness and distinctive skin manifestations. It is also associated with an increased risk of malignancy, particularly ovarian cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents to the clinic with a 2-month history of progressive memory loss, confusion, and episodes of hallucinations. Her family also reports a change in her behavior, describing her as increasingly irritable and sometimes displaying inappropriate emotional responses. She was recently diagnosed with lung cancer. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortical encephalitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Limbic encephalitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellar encephalitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brainstem encephalitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Limbic encephalitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Limbic encephalitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cortical encephalitis: Would involve more widespread cerebral cortex symptoms, including significant changes in cognition, motor, and sensory functions but might not specifically target memory and emotional regulation as in limbic encephalitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Cortical encephalitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellar encephalitis: Would primarily affect coordination, gait, and balance due to inflammation of the cerebellum, and would be less likely to cause the memory and behavioral symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Cerebellar encephalitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brainstem encephalitis: Would involve symptoms related to the functions of the brainstem, including vital functions, cranial nerve functions, and coordination, rather than primarily memory and behavior.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Brainstem encephalitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Limbic encephalitis presents with progressive memory loss, confusion, behavioral changes, and sometimes hallucinations due to the involvement of the limbic system. It can be associated with lung cancer as a paraneoplastic syndrome, where the immune system&#x27;s response to the cancer also affects the nervous system.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a recent diagnosis of ovarian cancer is brought to the emergency department due to altered mental status, memory loss, and involuntary movements. Her family reports that she has also been experiencing seizures. Further evaluation reveals anti-NMDA receptor antibodies in her serum. Which of the following is the most appropriate initial treatment for this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Corticosteroids and intravenous immunoglobulin (IVIG) or plasma exchange&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antiepileptic drugs only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemotherapy for ovarian cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radiation therapy to the brain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Corticosteroids and intravenous immunoglobulin (IVIG) or plasma exchange&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Corticosteroids and intravenous immunoglobulin (IVIG) or plasma exchange&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antiepileptic drugs only: While antiepileptic drugs are necessary to manage seizures, they do not address the underlying autoimmune process.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antiepileptic drugs only:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotherapy for ovarian cancer: While treating the underlying cancer is important, immediate immunotherapy is crucial to control the neurological symptoms and prevent further brain damage.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotherapy for ovarian cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiation therapy to the brain: Radiation therapy is not the primary treatment for anti-NMDA receptor encephalitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiation therapy to the brain:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-NMDA receptor encephalitis is a potentially reversible autoimmune disorder that requires prompt recognition and treatment with immunotherapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding antibodies in paraneoplastic neurological syndromes (PNS) is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibodies against intracellular antigens are almost always paraneoplastic.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibodies against cell surface antigens can be autoimmune and may not always be associated with cancer.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antibodies can be detected in both CSF and serum.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The presence of antibodies in CSF excludes an autoimmune cause.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The presence of antibodies in CSF excludes an autoimmune cause.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The presence of antibodies in CSF excludes an autoimmune cause.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibodies against intracellular antigens are almost always paraneoplastic: This is generally true. Antibodies targeting intracellular antigens, such as Hu, Yo, or Ri, are highly suggestive of a paraneoplastic neurological syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibodies against intracellular antigens are almost always paraneoplastic:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antibodies against cell surface antigens can be autoimmune and may not always be associated with cancer: This is also accurate. Some antibodies target cell surface antigens, and these can be associated with autoimmune conditions without an underlying malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antibodies against cell surface antigens can be autoimmune and may not always be associated with cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Antibodies can be detected in both CSF and serum: This is correct. In PNS, the antibodies can often be found in both the cerebrospinal fluid (CSF) and the serum.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Antibodies can be detected in both CSF and serum:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of antibodies in CSF does not differentiate between paraneoplastic and autoimmune causes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a BG of CA Breast on chemotherapy presents with progressive ataxia and opsoclonus (rapid, multidirectional eye movements). Which antibody is MOST likely to be found in her serum?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-Hu&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Yo&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ANNA-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-Ma2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ANNA-2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) ANNA - 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-Hu: Anti-Hu antibodies are associated with paraneoplastic encephalomyelitis and sensory neuronopathy, which typically present with sensory loss, limb weakness, and autonomic dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-Hu:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-Yo: Anti-Yo antibodies are linked to paraneoplastic cerebellar degeneration, causing ataxia, but not typically opsoclonus. They are more commonly associated with gynecological and breast cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-Yo:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-Ma2: Anti-Ma2 antibodies are associated with limbic encephalitis and brainstem encephalitis, which usually present with psychiatric symptoms, seizures, and sometimes brainstem dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-Ma2:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Certain antibodies are highly associated with specific paraneoplastic neurological syndromes. In this case, the presence of ataxia and opsoclonus, particularly in a patient with breast cancer, points strongly toward anti-Ri antibodies. Recognizing these paraneoplastic syndromes is crucial for early diagnosis and appropriate management.&lt;/li&gt;&lt;li&gt;âž¤ Certain antibodies are highly associated with specific paraneoplastic neurological syndromes.&lt;/li&gt;&lt;li&gt;âž¤ In this case, the presence of ataxia and opsoclonus, particularly in a patient with breast cancer, points strongly toward anti-Ri antibodies.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing these paraneoplastic syndromes is crucial for early diagnosis and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with a history of small cell lung cancer (SCLC) presents with unexplained vision loss and abnormal retinal pigmentation. Which of the following antibodies is MOST likely associated with her suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-Hu antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Yo antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-recoverin antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-amphiphysin antibodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-recoverin antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-recoverin antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-Hu antibodies: These antibodies are associated with paraneoplastic encephalomyelitis and sensory neuronopathy, which typically present with neurological symptoms like ataxia, sensory loss, and autonomic dysfunction, not primarily vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-Hu antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-Yo antibodies: Anti-Yo antibodies are linked to paraneoplastic cerebellar degeneration, causing ataxia but not typically vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-Yo antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-amphiphysin antibodies: These antibodies are associated with stiff person syndrome, a rare neurological disorder characterized by muscle rigidity and spasms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-amphiphysin antibodies:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cancer-associated retinopathy is a paraneoplastic syndrome that can cause vision loss in patients with underlying malignancies, particularly SCLC. Anti-recoverin antibodies are highly specific for CAR and their presence can help confirm the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ Cancer-associated retinopathy is a paraneoplastic syndrome that can cause vision loss in patients with underlying malignancies, particularly SCLC.&lt;/li&gt;&lt;li&gt;âž¤ Anti-recoverin antibodies are highly specific for CAR and their presence can help confirm the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with recent diagnosis of Hodgkin&#x27;s lymphoma presents to neurology clinic with a 3-month history of progressive unsteadiness and difficulty walking. He reports feeling clumsy and has noticed frequent stumbling, particularly when trying to navigate stairs. Additionally, he mentions episodes of slurred speech and difficulty swallowing. Given the presentation, which of the following antibodies is not involved in the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-mGluR1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-mGluR2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Tr&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti LGI1&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti LGI1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti LGI1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-mGluR1 : Antibodies are associated with paraneoplastic cerebellar degeneration, especially in cases related to Hodgkin&#x27;s lymphoma. These antibodies target the metabotropic glutamate receptor 1, which is involved in neuronal signaling in the cerebellum.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Anti-mGluR1&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-mGluR2 : Antibodies target the metabotropic glutamate receptor 2. While less commonly associated with PCD, they have been implicated in some paraneoplastic neurological syndromes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Anti-mGluR2&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Tr: Antibodies are strongly associated with paraneoplastic cerebellar degeneration, particularly in patients with Hodgkin&#x27;s lymphoma. They are one of the hallmark antibodies for this association.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Anti-Tr:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Paraneoplastic cerebellar degeneration (PCD) associated with Hodgkin&#x27;s lymphoma is commonly linked with Anti-mGluR1 and Anti-Tr antibodies, which target neuronal components in the cerebellum. In contrast, Anti-LGI1 antibodies are associated with limbic encephalitis and present with a different clinical picture, including seizures and cognitive changes, rather than the cerebellar dysfunction seen in PCD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male smoker with a 50-pack-year history presents with fatigue and a ruddy complexion. His hemoglobin is elevated at 18 g/dL and hematocrit is 55%. Which of the following malignancies is the MOST likely underlying cause of his erythrocytosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Renal cell carcinoma (RCC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatocellular carcinoma (HCC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellar hemangioblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Small cell lung cancer (SCLC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Renal cell carcinoma (RCC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatocellular carcinoma (HCC): While HCC can also be associated with erythrocytosis, it&#x27;s less common than RCC. Additionally, there&#x27;s no mention of risk factors for HCC in this patient&#x27;s history.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatocellular carcinoma (HCC):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellar hemangioblastoma: Although hemangioblastomas can produce erythropoietin and cause erythrocytosis, they are much rarer than RCC and usually present with neurological symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellar hemangioblastoma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Small cell lung cancer (SCLC): SCLC is a possible cause of paraneoplastic erythrocytosis, but it&#x27;s less common than RCC. The patient&#x27;s smoking history increases the risk of lung cancer, but the absence of other respiratory symptoms makes it less likely in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Small cell lung cancer (SCLC):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Erythrocytosis can be a paraneoplastic manifestation of RCC, and appropriate evaluation is warranted in patients with unexplained erythrocytosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old woman presents to the emergency department with acute onset of left-sided weakness and slurred speech that began 2 hours ago. She also mentions experiencing a burning sensation in her palms and soles for the past month, which she attributed to her new gardening hobby. On examination, she has noticeable splenomegaly. Laboratory tests reveal a platelet count of 950,000/Î¼L, hemoglobin of 12.2 g/dL, and a white blood cell count of 7,800/Î¼L. A chest X-ray reveals a mass in the right lung hilum. Which protein is most likely responsible for this patient&#x27;s thrombocytosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thrombopoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vascular endothelial growth factor (VEGF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interleukin-6 (IL-6)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Interleukin-6 (IL-6)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Interleukin-6 (IL-6)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Erythropoietin: Primarily regulates red blood cell production and is more associated with polycythemia than thrombocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Erythropoietin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thrombopoietin: Is the primary growth factor for platelet production. While it directly regulates platelet production, in the context of paraneoplastic thrombocytosis, it&#x27;s the production of cytokines like IL-6 by the tumor that indirectly leads to increased thrombopoietin levels and subsequent thrombocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Thrombopoietin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vascular endothelial growth factor (VEGF ): Is mainly involved in angiogenesis and not directly in the regulation of platelet production.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Vascular endothelial growth factor (VEGF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Interleukin-6 (IL-6) can be produced by tumor cells and lead to paraneoplastic thrombocytosis in patients with malignancies such as lung cancer. IL-6 acts indirectly by stimulating the liver to produce more thrombopoietin, which then promotes increased platelet production in the bone marrow. Recognizing the role of IL-6 in paraneoplastic syndromes is important for understanding the systemic effects of certain cancers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with a history of cervical cancer is being considered for targeted radionuclide therapy using an alpha-emitting radiopharmaceutical. The discussion focuses on the ionizing power of alpha particles in targeting residual microscopic disease. Which statement best describes the ionizing power of alpha particles in this therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Low ionizing power for deep tissue penetration and targeting distant metastases.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High ionizing power causing dense ionization with limited penetration, ideal for localized disease.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extremely high ionizing power causing widespread damage beyond targeted cells, high toxicity risk.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Similar ionizing power to beta particles but with longer range, suitable for larger tumors.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. High ionizing power causing dense ionization with limited penetration, ideal for localized disease.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) High ionizing power causing dense ionization with limited penetration, ideal for localized disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha particles actually have low penetration in tissue, not deep tissue penetration, which limits their use to more localized or superficial treatments rather than targeting distant metastases.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. While alpha particles have a high ionizing power, they do not cause widespread damage beyond targeted cells due to their limited penetration range. The risk of toxicity is more related to their potential to cause significant damage within a short range, which is why they need to be precisely targeted.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alpha particles have a much higher ionizing power compared to beta particles but a much shorter range in tissue. Beta particles can penetrate deeper into tissue, making them suitable for larger tumors, whereas alpha particles are more effective for localized treatment due to their short range.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alpha-emitting radiopharmaceuticals are utilized in targeted radionuclide therapy for their high ionizing power, which allows for dense ionization and significant DNA damage within cancer cells. Their limited penetration depth makes them ideal for treating localized microscopic disease while minimizing collateral damage to surrounding healthy tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with early-stage breast cancer has undergone lumpectomy and is now consulting with her radiation oncologist about adjuvant radiation therapy. The oncologist explains that the treatment will involve using a machine called a linear accelerator. Which of the following BEST describes how a linear accelerator generates X-rays for radiation therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It uses radioactive decay of elements like cobalt-60 to emit X-rays.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It accelerates electrons to high speeds, which then collide with a tungsten target to produce X-rays.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It accelerates protons in a circular path, and these protons generate X-rays when they hit a target.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It manipulates the path of high-speed electrons using magnetic fields to produce X-rays.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It accelerates electrons to high speeds, which then collide with a tungsten target to produce X-rays.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It accelerates electrons to high speeds, which then collide with a tungsten target to produce X-rays.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It uses radioactive decay of elements like cobalt-60 to emit X-rays: This describes the principle behind older cobalt-60 radiotherapy units, which are less commonly used today.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It uses radioactive decay of elements like cobalt-60 to emit X-rays:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It accelerates protons in a circular path, and these protons generate X-rays when they hit a target: This is the principle of proton therapy, a more specialized form of radiation therapy that uses protons instead of X-rays.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It accelerates protons in a circular path, and these protons generate X-rays when they hit a target:&lt;/li&gt;&lt;li&gt;â€¢ Option D. It manipulates the path of high-speed electrons using magnetic fields to produce X-rays: This describes the mechanism of a synchrotron, a type of particle accelerator used for research purposes and not typically for clinical radiation therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It manipulates the path of high-speed electrons using magnetic fields to produce X-rays:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Linear accelerators are the primary source of X-rays in modern radiation therapy for cancer treatment. They generate high-energy X-rays by accelerating electrons and colliding them with a tungsten target.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a deep-seated brain tumor is being considered for radiation therapy. The treatment plan involves using a type of radiation that has a distinct advantage in sparing surrounding healthy tissues while delivering a high dose to the tumor. Which type of radiation therapy is being considered for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Conventional photon therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gamma knife radiosurgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proton beam therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intensity-modulated radiation therapy (IMRT)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Proton beam therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Proton beam therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Conventional photon therapy: Uses X-rays to treat cancer. While effective, it may not offer the same level of precision in sparing surrounding tissues as proton therapy, especially for deep-seated tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Conventional photon therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gamma knife radiosurgery: Is a form of stereotactic radiosurgery that uses focused beams of gamma rays to treat small to medium-sized lesions, primarily in the brain. While it is highly precise, it may not be the best option for larger tumors or those located deep within the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Gamma knife radiosurgery:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intensity-modulated radiation therapy (IMRT): Is an advanced form of photon therapy that modulates the intensity of the radiation beams to conform to the shape of the tumor. It offers improved sparing of healthy tissues compared to conventional photon therapy but still uses X-rays, which have a different dose distribution compared to protons.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Intensity-modulated radiation therapy (IMRT):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proton beam therapy is particularly advantageous for treating deep-seated tumors, such as those in the brain, due to its ability to deliver a high dose of radiation to the tumor with minimal exposure to surrounding healthy tissues. This is achieved through the unique dose distribution of protons, characterized by the Bragg peak.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A radiologist is reviewing a chest X-ray of a 50-year-old patient. They note a clear distinction between the denser, brighter areas representing the ribs and the darker areas representing the lungs. This contrast allows them to visualize the lung parenchyma and identify any potential abnormalities. Which of the following radiation interactions is PRIMARILY responsible for creating the contrast observed on this chest X-ray?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Compton scattering&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Photoelectric effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pair production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bremsstrahlung radiation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Photoelectric effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Photoelectric effect&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Compton scattering: Contributes to image noise and reduces contrast.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Compton scattering:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pair production: Occurs at very high photon energies, not typically used in diagnostic imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pair production:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bremsstrahlung radiation: Is the process of X-ray production, not an interaction within the patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bremsstrahlung radiation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The photoelectric effect is crucial in generating image contrast in diagnostic radiology due to its dependence on the atomic number of the tissues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Law of Bergonie and Tribondeau describes the relative radiosensitivity of different cell types. Which of the following statements BEST encapsulates this law?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cells with a high mitotic rate and low differentiation are more radiosensitive.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cells with a low mitotic rate and high differentiation are more radiosensitive.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;All cell types are equally sensitive to radiation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radiosensitivity is independent of cell type and depends only on the radiation dose.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cells with a high mitotic rate and low differentiation are more radiosensitive.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cells with a high mitotic rate and low differentiation are more radiosensitive.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cells with a low mitotic rate and high differentiation are more radiosensitive: This is the opposite of the correct answer. Highly differentiated and slowly dividing cells are generally more resistant to radiation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Cells with a low mitotic rate and high differentiation are more radiosensitive:&lt;/li&gt;&lt;li&gt;â€¢ Option C. All cell types are equally sensitive to radiation: This is incorrect. Different cell types exhibit varying degrees of radiosensitivity based on their proliferative and differentiation status.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ All cell types are equally sensitive to radiation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiosensitivity is independent of cell type and depends only on the radiation dose: While radiation dose is a crucial factor, the inherent radiosensitivity of different cell types also plays a major role in determining the extent of radiation damage.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Radiosensitivity is independent of cell type and depends only on the radiation dose:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Law of Bergonie and Tribondeau is a fundamental principle in radiation biology that explains why some tissues are more susceptible to radiation damage than others. This has important implications for radiation therapy planning and minimizing side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical physicist is calculating the absorbed dose of radiation received by a patient during a radiotherapy session. Which of the following units is used to measure the absorbed dose of radiation in tissues?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sievert (Sv)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gray (Gy)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Becquerel (Bq)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Roentgen (R)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gray (Gy)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Gray (Gy)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sievert (Sv) : Is a unit that measures the biological effect of the absorbed radiation, not the absorbed dose itself. It takes into account the type of radiation and its biological effectiveness, and is often used in radiation protection to quantify the risk associated with the exposure to ionizing radiation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Sievert (Sv)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Becquerel (Bq) : Is a unit of radioactivity that measures the rate of decay or disintegration of radioactive material. It is defined as one disintegration per second and is not a measure of absorbed dose.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Becquerel (Bq)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Roentgen (R) : Is an older unit that was used to measure the exposure or the amount of ionization produced in air by X-rays or gamma rays. It does not directly measure the absorbed dose in tissue, which is why it has largely been replaced by the Gray in medical and scientific contexts.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Roentgen (R)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Gray (Gy) is the unit used to measure the absorbed dose of radiation in tissues, indicating the amount of radiation energy deposited per unit mass of tissue. It is a critical measurement in radiation therapy planning to ensure that the target area receives the prescribed dose while minimizing the dose to surrounding healthy tissues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following tissues has the LOWEST tissue weighting factor, indicating it is the LEAST sensitive to radiation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bone marrow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salivary glands&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thyroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gonads&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Salivary glands&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Salivary glands&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bone marrow: Bone marrow is highly radiosensitive due to its role in blood cell production. It has a tissue weighting factor of 0.12, indicating a relatively high risk of stochastic effects from radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bone marrow:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thyroid: The thyroid gland has an intermediate tissue weighting factor of 0.04, indicating moderate radiosensitivity. It&#x27;s more sensitive than salivary glands but less sensitive than bone marrow or gonads.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thyroid:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gonads: The gonads (ovaries and testes) are also relatively radiosensitive due to their role in reproduction. They have a tissue weighting factor of 0.08.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gonads:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tissues with low tissue weighting factors are less sensitive to radiation, meaning they can tolerate higher doses before experiencing significant damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a glioblastoma is undergoing radiation therapy to his brain. The radiation oncologist explains that while radiation therapy can be effective in treating the tumor, it&#x27;s important to be aware of potential side effects due to the varying sensitivity of different cell types to radiation. Considering the principles of radiosensitivity, which of the following cell types within the radiation field is MOST likely to be the LEAST affected by the radiation therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphocytes circulating in the blood&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spermatogonia in the testes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intestinal epithelial cells lining the gut&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurons in the brain&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Neurons in the brain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Neurons in the brain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lymphocytes circulating in the blood: Lymphocytes are a type of white blood cell involved in the immune response. They are actively dividing and relatively undifferentiated, making them quite sensitive to radiation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lymphocytes circulating in the blood:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spermatogonia in the testes: Spermatogonia are the stem cells in the testes that give rise to sperm. They are constantly dividing, making them highly radiosensitive.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spermatogonia in the testes:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intestinal epithelial cells lining the gut: These cells have a high turnover rate, constantly dividing to replenish the gut lining. This rapid cell division makes them more susceptible to radiation damage.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intestinal epithelial cells lining the gut:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The radiosensitivity of different cell types varies, and understanding these differences is important in predicting and managing the potential side effects of radiation therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Hodgkin lymphoma is receiving radiation therapy. Which of the following side effects is the physician MOST likely to monitor for due to the high radiosensitivity of the affected tissue?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cataracts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myelosuppression&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Infertility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cognitive decline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myelosuppression&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Myelosuppression&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cataracts: Cataracts are a long-term complication of radiation therapy, particularly when the lens of the eye is within the radiation field. While possible, they are less likely to be a primary concern during the active treatment phase compared to myelosuppression.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cataracts:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infertility: Infertility can occur if the gonads (testes or ovaries) are within the radiation field. In Hodgkin lymphoma treatment, the radiation field is often directed at lymph nodes in the chest, neck, or abdomen, making direct gonadal exposure less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infertility:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cognitive decline: Cognitive decline is a potential late complication of radiation therapy to the brain, but it&#x27;s not a primary concern in the treatment of Hodgkin lymphoma, where the radiation field usually doesn&#x27;t encompass the brain&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cognitive decline:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bone marrow is a highly radiosensitive tissue, and myelosuppression is a common side effect of radiation therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant radiation worker is concerned about the potential effects of radiation on her fetus. What is the recommended dose limit for the entire pregnancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5 mSv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1 mSv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5 mSv&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20 mSv&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 5 mSv&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 5 mSv&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 0.5 mSv: This is the recommended monthly dose limit for a pregnant radiation worker, not the limit for the entire pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 0.5 mSv:&lt;/li&gt;&lt;li&gt;â€¢ monthly&lt;/li&gt;&lt;li&gt;â€¢ Option B. 1 mSv: This is the annual dose limit for the general public, which is lower than the limit for occupational exposure during pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 1 mSv:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 20 mSv: This is the annual dose limit for radiation workers, which is significantly higher than the limit for pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 20 mSv:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pregnant radiation workers should take precautions to limit their radiation exposure to protect the developing fetus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which diagnostic modality typically involves the least radiation exposure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT head&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Extremity X-ray&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET-CT whole body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Extremity X-ray&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Extremity X-ray&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A CT (Computed Tomography) head scan involves a higher dose of radiation than an extremity X-ray because it uses multiple X-ray beams and a computer to create detailed cross-sectional images of the head, including the brain. CT scans provide more detailed information but at the cost of higher radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A chest X-ray is a common diagnostic test that uses a small amount of radiation to produce images of the chest, including the heart, lungs, airways, blood vessels, and bones of the spine and chest. While a chest X-ray involves more radiation than an extremity X-ray, it is still lower in dose compared to a CT scan.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A PET-CT (Positron Emission Tomography-Computed Tomography) whole-body scan combines a PET scan, which uses a radioactive tracer to show organ and tissue function, with a CT scan, which provides detailed anatomical information. This combination results in a higher radiation dose compared to the other options, making it the modality with the highest radiation exposure among those listed.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Among the diagnostic modalities listed, an extremity X-ray involves the least radiation exposure due to its focus on small areas and use of relatively low doses of radiation. It is important to consider the radiation dose and the diagnostic value of imaging tests when selecting the most appropriate modality for patient evaluation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The radiation exposure from a whole-body PET-CT scan is approximately equivalent to how many days/ months/ years of natural background radiation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;12 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;8 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1 year&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 8 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 8 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10 days: Of natural background radiation exposure is significantly less than the dose received from a whole-body PET-CT scan, which utilizes both the ionizing radiation from CT imaging and the radioactive tracer used in PET scanning.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ 10 days:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 12 years: Of natural background radiation exposure is higher than the typical exposure from a whole-body PET-CT scan, although estimates can vary based on specific protocols and equipment used.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ 12 years:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1 year: Of natural background radiation exposure is less than the typical dose received from a whole-body PET-CT scan. The comparison to several years of natural background radiation helps to contextualize the relative magnitude of exposure from such medical imaging procedures.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ 1 year:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The radiation exposure from a whole-body PET-CT scan is roughly equivalent to 8 years of natural background radiation, highlighting the significant amount of radiation involved in such diagnostic procedures. This comparison underscores the importance of judicious use of high-radiation diagnostic tests, ensuring that the potential benefits outweigh the risks associated with radiation exposure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A radiation oncologist is planning a course of radiotherapy for a patient with a large, solid tumor. The oncologist is concerned about the presence of hypoxic regions within the tumor, as these areas are known to be relatively resistant to radiation. To enhance the effectiveness of the treatment, the oncologist decides to fractionate the radiation dose, delivering it in multiple smaller doses over several weeks. Which of the following, oncologist primarily leveraging by using fractionated radiotherapy to target hypoxic tumor cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Re-assortment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Re-oxygenation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repopulation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Re-oxygenation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Re-assortment: This refers to the redistribution of tumor cells into more radiosensitive phases of the cell cycle after radiation. While this can contribute to overall tumor cell killing, it&#x27;s not the primary mechanism for overcoming hypoxia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Re-assortment:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repair: This process allows normal tissues to recover between radiation fractions, reducing toxicity. However, it&#x27;s not directly related to addressing hypoxia in tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repair:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repopulation: This refers to the accelerated growth of both normal and tumor cells between fractions. While it can benefit normal tissue repair, it can also lead to tumor regrowth and is not specifically aimed at hypoxic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repopulation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Re-oxygenation is a critical factor in the success of fractionated radiotherapy. By allowing time between doses for hypoxic tumor cells to become oxygenated, it increases their radiosensitivity and improves the overall effectiveness of the treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A radiation oncologist is considering the impact of oxygen on the effectiveness of radiation therapy for a tumor. The oxygen enhancement ratio (OER) is a measure of the increased effectiveness of ionizing radiation in the presence of oxygen. What is the typical value of the OER for X-rays?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. An OER of 1 would imply no difference in radiation sensitivity between oxygenated and anoxic conditions, which contradicts the known radiosensitizing effect of oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ 1&lt;/li&gt;&lt;li&gt;â€¢ Option B. An OER of 1.5 would indicate a moderate increase in radiation sensitivity due to oxygen, but this value is lower than what is typically observed for X-rays.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ 1.5&lt;/li&gt;&lt;li&gt;â€¢ Option C. An OER of 2.5 indicates a significant increase in radiation sensitivity with oxygen, but it&#x27;s still lower than the more commonly accepted value of 3 for X-rays.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ 2.5&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The oxygen enhancement ratio (OER) for X-rays is around 3, indicating that the presence of oxygen makes cells three times more susceptible to radiation damage compared to anoxic conditions. Understanding OER is crucial in radiation therapy, as it underscores the importance of tumor oxygenation in enhancing the therapeutic effect of radiation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with newly diagnosed head and neck squamous cell carcinoma (HNSCC) is about to start radiation therapy. His oncologist discusses the potential side effects of radiation, including mucositis (inflammation of the mucous membranes) and xerostomia (dry mouth). The oncologist also mentions the possibility of using a radioprotector to mitigate these side effects. However, they express concerns about one specific radioprotector due to its potential to worsen mucositis and xerostomia, despite being the most extensively studied in this context. Which of the following radioprotectors is the oncologist MOST likely referring to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zinc oxide (ZnO)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pentoxifylline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amifostine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Granulocyte-macrophage colony-stimulating factor (GM-CSF)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amifostine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Amifostine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Zinc oxide (ZnO): Zinc oxide is primarily used topically for its anti-inflammatory and wound-healing properties. It&#x27;s not a systemic radioprotector and doesn&#x27;t have the side effects mentioned.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Zinc oxide (ZnO):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pentoxifylline: Pentoxifylline improves blood flow and has some radioprotective effects, but it&#x27;s not associated with exacerbating mucositis or xerostomia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pentoxifylline:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Granulocyte-macrophage colony-stimulating factor (GM-CSF): GM-CSF stimulates white blood cell production and can help reduce the risk of infection during radiation therapy. It&#x27;s not known to cause mucositis or xerostomia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Granulocyte-macrophage colony-stimulating factor (GM-CSF):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While amifostine is a well-studied radioprotector, its potential to worsen mucositis and xerostomia in HNSCC patients limits its clinical use. This highlights the importance of carefully considering the potential benefits and risks of any intervention, even those that are well-researched, in the context of specific patient populations and treatment modalities.&lt;/li&gt;&lt;li&gt;âž¤ While amifostine is a well-studied radioprotector, its potential to worsen mucositis and xerostomia in HNSCC patients limits its clinical use.&lt;/li&gt;&lt;li&gt;âž¤ This highlights the importance of carefully considering the potential benefits and risks of any intervention, even those that are well-researched, in the context of specific patient populations and treatment modalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;50-year-old man with localized prostate cancer is undergoing external beam radiation therapy. The radiation oncologist uses a technique that involves delivering radiation from multiple angles, with varying doses to precisely target the tumor and spare surrounding normal tissues. This technique is called:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;3D conformal radiation therapy (3D CRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intensity-modulated radiation therapy (IMRT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Volumetric modulated arc therapy (VMAT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Image-guided radiation therapy (IGRT)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intensity-modulated radiation therapy (IMRT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intensity-modulated radiation therapy (IMRT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 3D conformal radiation therapy (3D CRT): While 3D CRT uses 3D imaging to shape radiation beams to the tumor, it does not modulate the intensity of the beam within each field. IMRT, on the other hand, can vary the intensity within each beam, allowing for even more precise dose delivery and sparing of surrounding normal tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 3D conformal radiation therapy (3D CRT):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Volumetric modulated arc therapy (VMAT): VMAT is an advanced form of IMRT where the radiation beam is continuously modulated as it rotates around the patient. While it offers even further precision and efficiency compared to traditional IMRT, the question stem emphasizes the use of multiple angles with varying doses, which is a core feature of IMRT.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Volumetric modulated arc therapy (VMAT):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Image-guided radiation therapy (IGRT): IGRT involves the use of imaging during treatment to ensure accurate targeting. While it enhances precision, it&#x27;s not a specific radiation delivery technique like IMRT or 3D CRT. IGRT can be used in conjunction with various delivery methods, including IMRT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Image-guided radiation therapy (IGRT):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IMRT is a sophisticated radiotherapy technique that allows for precise dose delivery and improved sparing of normal tissues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman undergoes a lumpectomy for a 2 cm, stage I, estrogen receptor-positive breast tumor. The patient is interested in adjuvant radiation therapy to reduce the risk of local recurrence. Which of the following radiation therapy regimens is most appropriate for this patient following breast-conserving surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;45 Gy in 25 fractions over 5 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;50 Gy in 25 fractions over 5 weeks, plus a boost of 10 Gy to the tumor bed&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;60 Gy in 30 fractions over 6 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;66 Gy in 33 fractions over 6.5 weeks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 50 Gy in 25 fractions over 5 weeks, plus a boost of 10 Gy to the tumor bed&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 45 Gy in 25 fractions over 5 weeks: Is a standard dose for whole breast irradiation, but it does not include a boost to the tumor bed, which is typically recommended for additional risk reduction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 45 Gy in 25 fractions over 5 weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 60 Gy in 30 fractions over 6 weeks: Is a higher total dose than typically used for adjuvant breast irradiation following breast-conserving surgery and may be more appropriate for certain other cancer types or treatment settings.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 60 Gy in 30 fractions over 6 weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 66 Gy in 33 fractions over 6.5 weeks: Is also a higher total dose than typically used for adjuvant breast irradiation and may increase the risk of side effects without providing additional benefit in the setting of early-stage breast cancer following lumpectomy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 66 Gy in 33 fractions over 6.5 weeks:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Following breast-conserving surgery for early-stage breast cancer, the standard adjuvant radiation therapy regimen involves whole breast irradiation with a total dose of approximately 45-50 Gy delivered over 5 weeks, often with an additional boost of 10 Gy to the lumpectomy bed to further reduce the risk of local recurrence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neurosurgeon is considering a non-invasive treatment option for a patient with a small, well-defined brain tumor. Which of the following radiation therapy techniques involves delivering a high dose of radiation to a precise target in the brain in a single session, minimizing exposure to surrounding healthy tissue?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intensity-Modulated Radiation Therapy (IMRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Volumetric Modulated Arc Therapy (VMAT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stereotactic Radiosurgery (SRS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stereotactic Body Radiation Therapy (SBRT)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stereotactic Radiosurgery (SRS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intensity-Modulated Radiation Therapy (IMRT): (IMRT) is an advanced form of radiation therapy that modulates the intensity of the radiation beams, allowing for the delivery of precise radiation doses to a tumor while minimizing the dose to surrounding normal tissue. IMRT is used for various cancers throughout the body, not limited to the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intensity-Modulated Radiation Therapy (IMRT):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Volumetric Modulated Arc Therapy (VMAT): (VMAT) is an advanced form of IMRT that delivers radiation by rotating the radiation machine around the patient, allowing for rapid and precise treatment of the tumor from multiple angles. Like IMRT, VMAT is used for various cancers, not just in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Volumetric Modulated Arc Therapy (VMAT):&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Stereotactic Body Radiation Therapy (SBRT): (SBRT) is similar to SRS in its precision and delivery of high-dose radiation, but it is used for tumors outside the brain, such as those in the lung, liver, spine, and prostate.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Stereotactic Body Radiation Therapy (SBRT):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Stereotactic radiosurgery (SRS) is a precise, non-invasive radiation therapy technique used to deliver a high dose of radiation to a small, well-defined target in the brain in a single session, minimizing exposure to surrounding healthy tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a history of lung cancer presents with new-onset seizures. Imaging reveals a single, 2 cm well-circumscribed lesion in the right frontal lobe, consistent with a brain metastasis. Which of the following treatment modalities is MOST appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Whole-brain radiation therapy (WBRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conventional external beam radiation therapy (EBRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stereotactic radiosurgery (SRS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brachytherapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stereotactic radiosurgery (SRS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Whole-brain radiation therapy (WBRT): WBRT treats the entire brain and is typically reserved for patients with multiple brain metastases or those who are at high risk of developing new metastases. It can cause cognitive decline and other side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Whole-brain radiation therapy (WBRT):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conventional external beam radiation therapy (EBRT): EBRT is less precise than SRS and typically requires multiple treatment sessions. It is also associated with a higher risk of side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conventional external beam radiation therapy (EBRT):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brachytherapy: Brachytherapy involves placing radioactive sources directly into or near the tumor. It is not typically used for brain metastases.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brachytherapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SRS is the preferred treatment for solitary brain metastases due to its precision, efficacy, and convenience.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with localized prostate cancer is being considered for a procedure, as shown in the image. Which of the following sources is not commonly used in the above procedure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Palladium-103&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iodine-125&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cesium-131&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cesium-137&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cesium-137&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-121235.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Palladium-103, Iodine-125, and Cesium-131: These are all commonly used radioactive isotopes in prostate brachytherapy. They emit low-energy radiation that is effective in treating the tumor while minimizing damage to surrounding tissues.&lt;/li&gt;&lt;li&gt;â€¢ Palladium-103, Iodine-125, and Cesium-131:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Prostate brachytherapy is a precise and effective treatment for localized prostate cancer. The choice of radioactive isotope depends on various factors, including tumor characteristics and desired dose rate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A radiation oncologist is planning to use the following instrument shown in the image for the treatment of cancer. Which of the following cancers is most likely to be treated with the instrument?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prostate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cervical&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Skin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cervical&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-121514.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prostate: Prostate cancer is also treated with brachytherapy, but the applicators used for prostate cancer typically involve seed implants rather than the ring applicators shown in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prostate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Skin: Skin cancer treatments typically do not use this type of brachytherapy applicator. Instead, external beam radiation or superficial brachytherapy might be used depending on the type and stage of the skin cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Skin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brain: Brain cancers are not commonly treated with brachytherapy. Treatment for brain tumors more often involves external beam radiation therapy, including stereotactic radiosurgery or Gamma Knife surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brain:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The instrument shown in the image is a brachytherapy applicator likely used for the treatment of cervical cancer, which allows for localized radiation treatment directly to the affected area with minimal impact on surrounding healthy tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a common indication for prophylactic whole-brain irradiation (WBI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Small cell lung cancer (SCLC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia (ALL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-small cell lung cancer (NSCLC)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Non-small cell lung cancer (NSCLC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A and option B. Small cell lung cancer (SCLC) and acute lymphoblastic leukemia (ALL): Are common indications for prophylactic WBI.&lt;/li&gt;&lt;li&gt;â€¢ Option A and option B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Medulloblastoma: Is treated with CSI, not prophylactic WBI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Medulloblastoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prophylactic WBI is used selectively in cancers with high risk of brain metastasis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with a medulloblastoma. Which of the following radiation therapy techniques is MOST appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TSEB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CSI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WBI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TBI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CSI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. TSEB: TSEB is used for cutaneous lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TSEB:&lt;/li&gt;&lt;li&gt;â€¢ Option C. WBI: Prophylactic WBI is used to prevent brain metastasis in certain cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option C. WBI:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TBI: TBI is used as conditioning before allogeneic stem cell transplantation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TBI:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CSI is crucial in treating medulloblastoma to address potential leptomeningeal spread.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a common indication for using total skin electron beam therapy (TSEBT) as part of the treatment regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Localized basal cell carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute sunburn&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mycosis fungoides&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mycosis fungoides&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Localized basal cell carcinoma: Localized basal cell carcinoma is typically treated with more focused forms of radiation therapy or other modalities such as surgical excision, cryotherapy, or topical treatments, rather than TSEBT which treats the entire skin surface.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Localized basal cell carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute sunburn: Acute sunburn is a condition caused by excessive exposure to ultraviolet (UV) radiation from the sun, leading to skin inflammation and damage. It does not require radiation therapy as a treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute sunburn:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Psoriasis: Psoriasis is a chronic autoimmune skin condition characterized by red, itchy, and scaly patches. Treatment options include topical treatments, phototherapy, systemic medications, and biologics, but not typically TSEBT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Psoriasis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Total skin electron beam therapy (TSEBT) is primarily indicated for the treatment of mycosis fungoides, a type of cutaneous T-cell lymphoma, as it allows for uniform radiation delivery across the entire skin surface, effectively targeting malignant cells without significant penetration into deeper tissues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents to the emergency department 6 hours after a radiation accident with nausea, vomiting, and headache. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute radiation syndrome (ARS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic radiation syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radiation-induced cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radiation-induced cataracts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute radiation syndrome (ARS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic radiation syndrome: This develops over months or years of low-dose radiation exposure, not within hours.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic radiation syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radiation-induced cancer: Cancer is a long-term effect of radiation exposure and wouldn&#x27;t present with symptoms this quickly.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radiation-induced cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiation-induced cataracts: Cataracts develop slowly over time due to radiation exposure and wouldn&#x27;t be an immediate concern in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiation-induced cataracts:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Early symptoms of ARS are non-specific and can easily be mistaken for other conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most important factor in determining the severity of acute radiation syndrome (ARS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age of the individual&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type of radiation exposure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dose of radiation received&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Time since exposure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dose of radiation received&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age of the individual: While age can influence an individual&#x27;s overall health and resilience, it is not the primary determinant of ARS severity. Younger individuals may recover faster, but the dose received is the key factor in determining the initial damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age of the individual:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type of radiation exposure: The type of radiation (alpha, beta, gamma, X-ray, neutron) does influence the biological effectiveness of the radiation, but the dose is still the primary determinant of overall severity. Different radiation types have different weighting factors in terms of damage, but the absorbed dose takes this into account.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type of radiation exposure:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Time since exposure: Time since exposure is important for determining the onset and progression of symptoms, but the dose ultimately determines the extent of the damage and potential for recovery. Early intervention can be crucial, but it cannot reverse the damage caused by a high dose of radiation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Time since exposure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Radiation dose is the primary determinant of ARS severity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the typical dosage range for radiotherapy in the treatment of cancer, and which of the following is a deterministic effect of local irradiation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;20-40 Gy; Acute skin erythema&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;50-70 Gy; Stochastic tumor induction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;10-30 Gy; Hormesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;60-80 Gy; Radiation pneumonitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 20-40 Gy; Acute skin erythema&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 50-70 Gy; Stochastic tumor induction: Stochastic tumor induction, or the development of a second cancer due to radiation exposure, is a stochastic effect, meaning it has a chance of occurring that increases with dose, but its severity does not depend on the dose. It typically occurs many years after radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 50-70 Gy; Stochastic tumor induction:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 10-30 Gy; Hormesis: Hormesis is a concept that low doses of radiation may have beneficial effects. It is not typically associated with the therapeutic dose ranges used in cancer treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 10-30 Gy; Hormesis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 60-80 Gy; Radiation pneumonitis: Radiation pneumonitis is a deterministic effect that can occur following irradiation of the chest, potentially within the 20-40 Gy range but more commonly associated with higher doses, particularly when large volumes of lung tissue are irradiated. It presents as inflammation of the lung tissue and usually occurs within weeks to a few months after therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 60-80 Gy; Radiation pneumonitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The typical dosage range for curative radiotherapy in cancer treatment varies but often falls within approximately 20-70 Gy, administered over several weeks. Acute skin erythema is a deterministic effect associated with radiotherapy and can occur within lower ranges of this dosage spectrum. Deterministic effects have a threshold and their severity increases with the dose above this threshold, unlike stochastic effects, which are probability-based and do not have a threshold.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman in her 6th week of pregnancy is involved in a motor vehicle accident. She is hemodynamically stable but requires a CT scan of the abdomen and pelvis to rule out internal injuries. The estimated fetal dose is 80 mGy. The fetus is at GREATEST risk for which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Miscarriage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fetal malformation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low IQ/Mental Retardation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No risk&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fetal malformation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Miscarriage: While high doses of radiation can increase the risk of miscarriage, especially in the very early stages of pregnancy, the risk is lower at 6 weeks compared to the risk of malformations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Miscarriage:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low IQ/Mental Retardation: This is a potential risk with radiation exposure between 9-15 weeks of gestation, but less likely at 6 weeks.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low IQ/Mental Retardation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No risk: There is no \&quot;no risk\&quot; level of radiation exposure during pregnancy. Although the risk from a single CT scan is low, it is not zero, and the potential for malformation is the greatest concern at this gestational age.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No risk:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The risk of specific radiation-induced effects on the developing fetus varies depending on the gestational age at the time of exposure. The 3rd-8th weeks are the most critical period for the development of fetal malformations&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with a history of Hodgkin&#x27;s lymphoma treated with mediastinal radiation 10 years ago presents with progressive dyspnea and orthopnea. He also reports fatigue and chest discomfort. On examination, you note elevated jugular venous pressure and muffled heart sounds. Which of the following is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radiation pneumonitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pericardial effusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Constrictive pericarditis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Constrictive pericarditis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Radiation pneumonitis: While possible, radiation pneumonitis typically occurs within the first few months after radiation therapy and is less likely to present years later.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Radiation pneumonitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pericardial effusion: Pericardial effusion can also be caused by radiation, but it usually presents with more acute symptoms and would not explain the muffled heart sounds.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pericardial effusion:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism: Pulmonary embolism is unlikely given the patient&#x27;s history of radiation therapy and the clinical findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Constrictive pericarditis is a late complication of radiation therapy to the chest that can present with dyspnea, orthopnea, and signs of right-sided heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man presents to the neurology clinic with complaints of progressive memory difficulties, difficulty concentrating, and episodes of confusion over the past six months. He has a history of medulloblastoma, for which he underwent surgical resection followed by cranial irradiation therapy 10 years ago. His neurological examination is notable for mild cognitive impairment without focal deficits. Which of the following is the most likely late effect of cranial irradiation that this patient is experiencing?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute radiation necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukoencephalopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radiotherapy myelopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Leukoencephalopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute radiation necrosis: Acute radiation necrosis is a potential acute or subacute complication of radiation therapy, usually occurring within the first few months to years after treatment. It involves the necrosis (death) of brain tissue due to radiation damage, but it is not consistent with the patient&#x27;s long-term post-irradiation timeframe.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute radiation necrosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meningioma: Meningioma is a type of benign brain tumor that can be a secondary effect of cranial irradiation, typically occurring many years after exposure. While it could cause cognitive symptoms depending on its location, the patient&#x27;s presentation of diffuse cognitive symptoms without focal deficits or mention of a new mass lesion makes leukoencephalopathy more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meningioma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiotherapy myelopathy: Radiotherapy myelopathy is a rare late complication affecting the spinal cord after radiation therapy. It typically presents with symptoms related to spinal cord dysfunction such as weakness, sensory loss, or bowel/bladder dysfunction, not primarily cognitive impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Radiotherapy myelopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Leukoencephalopathy is a late effect of cranial irradiation that can manifest as progressive cognitive impairments, including memory difficulties, concentration issues, and confusion. It results from radiation-induced damage to the white matter of the brain and typically develops several years after treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old female with a history of breast cancer treated with radiation therapy (RT) 6 months ago presents with a painful, erythematous rash on her chest within the radiation field. She recently started chemotherapy with doxorubicin and cyclophosphamide (AC). Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contact dermatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Radiation recall syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cellulitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allergic reaction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Radiation recall syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contact dermatitis: While contact dermatitis can cause a rash, it typically occurs in areas exposed to irritants or allergens, not necessarily within a previous radiation field. The patient&#x27;s history of recent chemotherapy makes radiation recall syndrome more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contact dermatitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cellulitis: Cellulitis is a bacterial skin infection characterized by warmth, redness, and swelling. However, it is less likely in this patient due to the rash occurring within the radiation field and the temporal association with chemotherapy initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cellulitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allergic reaction: Although an allergic reaction to chemotherapy is possible, it is less likely to be localized to the radiation field and typically presents with other systemic symptoms like fever or hives. Radiation recall syndrome is a more specific inflammatory reaction related to previous radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allergic reaction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Radiation recall syndrome is a rare but important consideration in patients receiving chemotherapy after radiation therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents for a routine follow-up appointment 5 years after completing radiation therapy for Hodgkin lymphoma. She is currently asymptomatic and disease-free. Which of the following statements BEST reflects her risk for developing a second solid cancer related to her previous radiation therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The risk is highest during the first year after radiation and declines rapidly thereafter.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The risk peaks around 5 years after radiation and then gradually declines.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The risk remains constant over time, independent of the time elapsed since radiation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The risk increases gradually over time, with the highest risk occurring &amp;gt;7 years after radiation.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The risk increases gradually over time, with the highest risk occurring &gt;7 years after radiation.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The risk increases gradually over time, with the highest risk occurring &amp;gt;7 years after radiation.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The risk is highest during the first year after radiation and declines rapidly thereafter: This is incorrect. The risk of developing a second solid cancer increases with time after radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The risk is highest during the first year after radiation and declines rapidly thereafter:&lt;/li&gt;&lt;li&gt;â€¢ Option B. The risk peaks around 5 years after radiation and then gradually declines: While some radiation-induced cancers may appear around 5 years, the risk for many solid tumors continues to rise beyond this point.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The risk peaks around 5 years after radiation and then gradually declines:&lt;/li&gt;&lt;li&gt;â€¢ Option C. The risk remains constant over time, independent of the time elapsed since radiation: This is incorrect. The risk of developing a second solid cancer is not constant and generally increases with time since radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The risk remains constant over time, independent of the time elapsed since radiation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The risk of developing a second solid cancer after radiation therapy is a long-term concern for patients. The risk increases over time, with the peak incidence often occurring 7-10 years or more after exposure. Continued surveillance and monitoring are essential for the early detection and management of potential secondary malignancies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding the latency period for a second hematological cancer after radiotherapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The latency period is typically less than 1 year.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The latency period is usually more than 2 years.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The latency period is always more than 20 years.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The latency period is variable and depends on the type of primary cancer.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The latency period is usually more than 2 years.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The latency period is typically less than 1 year: This is generally considered too short for the latency period associated with the development of second hematological cancers after radiotherapy. These cancers usually take a few years to develop due to the time required for radiation-induced DNA damage to manifest in the hematopoietic system.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The latency period is typically less than 1 year:&lt;/li&gt;&lt;li&gt;â€¢ Option C. The latency period is always more than 20 years: This is not accurate for hematological cancers, which tend to have a shorter latency period compared to solid tumors. Hematological malignancies like AML or MDS typically manifest within a decade after radiotherapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The latency period is always more than 20 years:&lt;/li&gt;&lt;li&gt;â€¢ Option D. The latency period is variable and depends on the type of primary cancer: While the latency period can indeed vary based on several factors, including the type of primary cancer, the statement is too broad. Specifically, for second hematological cancers following radiotherapy, the latency period is more consistently within the range of 2 to 10 years.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The latency period is variable and depends on the type of primary cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The latency period for second hematological cancers following radiotherapy, such as acute myeloid leukemia or myelodysplastic syndromes, typically ranges from 2 to 10 years. This shorter latency period compared to solid tumors reflects the time required for radiation-induced damage to affect hematopoietic stem cells and lead to hematological malignancy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old female with a history of Right breast cancer treated with radiation therapy (RT) 6 months ago presents with a painful rash on the right side as shown in the image. She recently started chemotherapy with doxorubicin and cyclophosphamide (AC). Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contact dermatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Radiation recall syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cellulitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allergic reaction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Radiation recall syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-124126.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contact dermatitis: While contact dermatitis can cause a rash, it typically occurs in areas exposed to irritants or allergens, not necessarily within a previous radiation field. The patient&#x27;s history of recent chemotherapy makes radiation recall syndrome more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contact dermatitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cellulitis: Cellulitis is a bacterial skin infection characterized by warmth, redness, and swelling. However, it is less likely in this patient due to the rash occurring within the radiation field and the temporal association with chemotherapy initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cellulitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allergic reaction: Although an allergic reaction to chemotherapy is possible, it is less likely to be localized to the radiation field and typically presents with other systemic symptoms like fever or hives. Radiation recall syndrome is a more specific inflammatory reaction related to previous radiation exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allergic reaction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Radiation recall syndrome is a rare but important consideration in patients receiving chemotherapy after radiation therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old postmenopausal woman with a family history of breast cancer is concerned about her risk of developing the disease. Her past medical history is significant for fibroadenoma and alcohol use. Which of the following factors most significantly increases her risk for breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Family history of breast cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Past history of fibroadenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Moderate alcohol consumption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Advanced age&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Advanced age&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Family history of breast cancer: Although a family history of breast cancer is an important risk factor, especially if the cancer occurred in a first-degree relative or involved high-risk genes like BRCA1 or BRCA2, the overall risk increases with age regardless of family history.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Family history of breast cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Past history of fibroadenoma : Fibroadenomas are benign breast tumors and are not considered a significant risk factor for developing breast cancer. They are common in younger women and do not significantly increase the risk of breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Past history of fibroadenoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Moderate alcohol consumption : While alcohol consumption is associated with an increased risk of breast cancer, the risk level is generally lower compared to the risk associated with advancing age. The risk increases with the amount of alcohol consumed, but age remains a more significant factor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Moderate alcohol consumption&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Advanced age is a significant risk factor for breast cancer, with most cases diagnosed in women aged 50 years and older. The risk increases with age due to factors such as cumulative exposure to estrogen and the increased likelihood of genetic mutations over time.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents with a 6-month history of a persistent, itchy rash on her right nipple. The area is also slightly red and crusted. On examination, you note a small amount of clear discharge from the nipple. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute mastitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ductal ectasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paget disease of the breast&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contact dermatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paget disease of the breast&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Paget disease of the breast&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute mastitis: Mastitis is a breast infection that typically presents with pain, swelling, redness, and fever. It is less likely to cause chronic eczema-like changes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute mastitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ductal ectasia: Ductal ectasia is a benign condition characterized by dilated ducts and thick, sticky nipple discharge, usually green or black in color. It is not typically associated with eczema.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ductal ectasia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Contact dermatitis: Contact dermatitis is an allergic skin reaction that can cause a rash. However, it is unlikely to be limited to the nipple and present with nipple discharge.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Contact dermatitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Paget disease of the breast is an important differential diagnosis for patients presenting with chronic nipple eczema and discharge. A biopsy is necessary to confirm the diagnosis and determine the extent of the underlying malignancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with skin changes over her left breast as shown in the image. This finding is most suggestive of the involvement of which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cooper&#x27;s ligament&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dermal lymphatics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chest wall&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dermal lymphatics&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-115533.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dermal lymphatics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cooper&#x27;s ligaments: These are fibrous bands that support breast tissue, and their involvement would lead to retraction and dimpling but not the widespread skin changes seen in peau d&#x27;orange.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cooper&#x27;s ligaments:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chest wall: Chest wall involvement would present with pain, fixation of the breast, and possibly ulceration, but not the specific peau d&#x27;orange pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chest wall:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin: While the skin is involved, the primary cause of peau d&#x27;orange is the blockage of lymphatic drainage within the dermis, not a primary skin condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Peau d&#x27;orange is a highly suggestive sign of inflammatory breast cancer due to tumor invasion of the dermal lymphatics. It requires prompt evaluation and diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman undergoes her annual screening mammogram. The radiologist identifies an abnormality which is shown below. There are no associated masses or architectural distortions. Which BI-RADS category is MOST appropriate for this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BI-RADS 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BI-RADS 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BI-RADS 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;BI-RADS 4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. BI-RADS 4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-115548.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) BI-RADS 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BI-RADS 1: Negative, normal mammogram&lt;/li&gt;&lt;li&gt;â€¢ Option A. BI-RADS 1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. BI-RADS 2: Benign finding, no further workup needed&lt;/li&gt;&lt;li&gt;â€¢ Option B. BI-RADS 2:&lt;/li&gt;&lt;li&gt;â€¢ Option C. BI-RADS 3: Probably benign, but short-term follow-up is recommended&lt;/li&gt;&lt;li&gt;â€¢ Option C. BI-RADS 3:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pleomorphic microcalcifications on a mammogram are a suspicious finding and should be investigated further with biopsy to rule out malignancy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old woman presents to her primary care physician with a palpable lump in her left breast that she discovered three weeks ago during a self-examination. She reports that the lump is painless and mobile. A mammography is performed, which is shown in the image. Given the clinical presentation and mammography findings, what is the appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enucleation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wide local excision with 1 cm margin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Local radiotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mastectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Enucleation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-115604.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Enucleation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wide local excision with 1 cm margin: Is typically reserved for malignant lesions where clear margins are necessary to ensure complete removal of cancerous cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wide local excision with 1 cm margin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Local radiotherapy : Is a treatment modality used in the management of breast cancer, not benign lesions like fibroadenomas.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Local radiotherapy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mastectomy: Or complete removal of the breast, is a more radical treatment generally reserved for invasive breast cancer or high-risk patients and is not indicated for benign lesions such as fibroadenomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mastectomy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fibroadenomas are benign breast tumors characterized by mammography findings of round densities with smooth borders and popcorn calcification. They can be managed conservatively with observation or enucleated if symptomatic or upon patient request.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-years-old woman presents with a rapidly enlarging mass in her right breast that has doubled in size over the past 2 months. The mass is now mildly tender to the touch. Ultrasound-guided core needle biopsy done and shown below. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Invasive ductal carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibrocystic changes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fibroadenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phyllodes tumor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phyllodes tumor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-115621.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Phyllodes tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Invasive ductal carcinoma: While invasive ductal carcinoma is the most common type of breast cancer, it typically does not grow as rapidly as described in this vignette.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Invasive ductal carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrocystic changes: Fibrocystic changes are benign and typically do not present with a rapidly enlarging mass.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrocystic changes:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fibroadenoma: Fibroadenomas are benign tumors that typically grow slowly and are well-circumscribed. They are not associated with the leaf-like pattern seen in the biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fibroadenoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phyllodes tumors are uncommon but should be considered in the differential diagnosis of rapidly growing breast masses, particularly when histopathology shows a leaf-like pattern and hypercellular stromal tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman presents with a newly diagnosed invasive ductal carcinoma of the breast. Immunohistochemistry (IHC) reveals that the tumor is strongly positive for both estrogen (ER) and progesterone (PR) receptors, negative for human epidermal growth factor receptor 2 (HER2), and has a low Ki-67 index (&amp;lt;14%). Which of the following treatment options is MOST appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chemotherapy alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endocrine therapy alone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-HER2 therapy alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Combined endocrine and chemotherapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Endocrine therapy alone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Endocrine therapy alone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chemotherapy alone: While chemotherapy can be beneficial in some breast cancers, Luminal A tumors are generally slow-growing and have a better prognosis. Endocrine therapy alone is usually sufficient to manage the disease and improve outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chemotherapy alone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-HER2 therapy alone: This patient&#x27;s tumor is HER2-negative, meaning it does not overexpress the HER2 protein. Therefore, anti-HER2 therapy would not be effective in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-HER2 therapy alone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Combined endocrine and chemotherapy: While some patients with Luminal A tumors may benefit from the addition of chemotherapy, it is typically reserved for those with higher risk features (e.g., larger tumor size, lymph node involvement). In this patient&#x27;s case, the low Ki-67 index suggests a low risk of proliferation, making endocrine therapy alone the most appropriate initial treatment choice.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Combined endocrine and chemotherapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Luminal A breast cancer is hormone receptor-positive and typically responds well to endocrine therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;58-year-old postmenopausal woman is diagnosed with locally advanced breast cancer (LABC) with involvement of the chest wall and skin. Biopsy reveals a hormone receptor (HR)-positive, HER2-negative tumor. Which of the following is the MOST appropriate neoadjuvant chemotherapy (NACT) regimen for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DCHP (Docetaxel, Carboplatin, Trastuzumab, Pertuzumab)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AC-T (Doxorubicin, Cyclophosphamide, Paclitaxel)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TC-AC (Docetaxel, Cyclophosphamide, Doxorubicin) + Anti-PD1 (Immune Checkpoint Inhibitor)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Letrozole (aromatase inhibitor)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AC-T (Doxorubicin, Cyclophosphamide, Paclitaxel)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) AC-T (Doxorubicin, Cyclophosphamide, Paclitaxel)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option  A. DCHP: This regimen includes Trastuzumab and Pertuzumab, which are anti-HER2 therapies not indicated for HER2-negative tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option  A. DCHP:&lt;/li&gt;&lt;li&gt;â€¢ Option C. TC-AC + Anti-PD1: This regimen includes an immune checkpoint inhibitor, which is typically reserved for triple-negative breast cancer (TNBC) and is not indicated in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TC-AC + Anti-PD1:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Letrozole : This is an endocrine therapy and is not suitable for NACT in LABC. It may be used as adjuvant therapy after surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Letrozole&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The choice of neoadjuvant chemotherapy in LABC depends on the tumor&#x27;s hormone receptor and HER2 status. For HR-positive, HER2-negative LABC in postmenopausal women, AC-T is the preferred regimen.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents to oncologist after being diagnosed with left breast invasive ductal carcinoma. On examination, two axillary nodes are palpable on the right side. Given the findings, what is the stage of the cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage IIIa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage IV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage IIIc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage II&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage IV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Stage IV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The stages are as follows:&lt;/li&gt;&lt;li&gt;â€¢ The stages are as follows:&lt;/li&gt;&lt;li&gt;â€¢ Stage II: The cancer is in the breast and may have spread to up to three axillary lymph nodes but not to distant sites. Stage IIIa: The cancer has extended into multiple axillary lymph nodes or the nodes are clumped together, but there is no spread to distant organs. Stage IIIc: The cancer is found in 10 or more axillary lymph nodes, nodes near the collarbone, or internal mammary nodes, but not to distant organs. Stage IV: The cancer has metastasized beyond the regional lymph nodes to distant organs, which could include contralateral lymph nodes or other body areas.&lt;/li&gt;&lt;li&gt;â€¢ Stage II: The cancer is in the breast and may have spread to up to three axillary lymph nodes but not to distant sites.&lt;/li&gt;&lt;li&gt;â€¢ Stage IIIa: The cancer has extended into multiple axillary lymph nodes or the nodes are clumped together, but there is no spread to distant organs.&lt;/li&gt;&lt;li&gt;â€¢ Stage IIIc: The cancer is found in 10 or more axillary lymph nodes, nodes near the collarbone, or internal mammary nodes, but not to distant organs.&lt;/li&gt;&lt;li&gt;â€¢ Stage IV: The cancer has metastasized beyond the regional lymph nodes to distant organs, which could include contralateral lymph nodes or other body areas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In breast cancer staging, stage IV indicates distant metastasis. This can include metastatic spread to lymph nodes not typically involved in local or regional breast cancer dissemination, such as contralateral cervical lymph nodes. This stage is consistent with the most advanced form of the disease, where the cancer has spread to other parts of the body beyond the breast and regional lymph nodes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman with a newly diagnosed T2N0 invasive ductal carcinoma of the right breast undergoes neoadjuvant chemotherapy (NACT). After NACT, she is restaged as ycT1cN1. Which of the following is the MOST appropriate surgical approach for managing the axilla in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sentinel lymph node biopsy (SLNB)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Axillary lymph node dissection (ALND)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No axillary surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation with serial ultrasounds&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sentinel lymph node biopsy (SLNB)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ALND: ALND is more extensive and associated with greater morbidity than SLNB. It would only be considered if the SLNB is positive.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ALND:&lt;/li&gt;&lt;li&gt;â€¢ Option C. No axillary surgery: Even though the patient is clinically node-negative after NACT, there is still a risk of residual disease in the axilla. SLNB is necessary to assess this risk.&lt;/li&gt;&lt;li&gt;â€¢ Option C. No axillary surgery:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation with serial ultrasounds: While ultrasound can be helpful in monitoring the axilla, it is not a substitute for definitive staging with SLNB.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation with serial ultrasounds:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The management of the axilla in breast cancer has evolved, and SLNB is now the preferred approach for staging the axilla in many cases. The decision between SLNB and ALND depends on clinical and pathological factors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman with HR-positive, HER2-negative breast cancer has a PIK3CA mutation detected on tumor genomic testing. Which of the following medications would be most appropriate to add to her treatment regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abemaciclib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpelisib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olaparib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pembrolizumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alpelisib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Alpelisib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abemaciclib: Abemaciclib is a CDK4/6 inhibitor, which is approved for HR-positive, HER2-negative breast cancer. However, it is not specifically targeted for PIK3CA mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Abemaciclib:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Olaparib: Olaparib is a PARP inhibitor primarily used in breast cancer patients with BRCA1/2 mutations. It is not indicated for PIK3CA mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Olaparib:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pembrolizumab: Pembrolizumab is an immune checkpoint inhibitor used in some types of triple-negative breast cancer (TNBC). It does not target PIK3CA mutations and is not indicated for HR-positive breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pembrolizumab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Targeted therapies like Alpelisib can be effective for specific breast cancer mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman with metastatic triple-negative breast cancer (TNBC) has a germline BRCA1 mutation. Which of the following treatments is MOST likely to be effective in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endocrine therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olaparib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pertuzumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Olaparib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Olaparib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Endocrine therapy: Triple-negative breast cancer (TNBC) lacks hormone receptors (estrogen and progesterone) and HER2 receptors, making it unresponsive to endocrine therapies that target these pathways.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Endocrine therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trastuzumab: This is an anti-HER2 therapy specifically designed for HER2-positive breast cancer. TNBC, by definition, is HER2-negative, making Trastuzumab ineffective.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trastuzumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pertuzumab: Similar to Trastuzumab, Pertuzumab is also an anti-HER2 therapy and is not indicated for TNBC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pertuzumab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PARP inhibitors are a targeted therapy for BRCA-mutated breast cancers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 168 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test7" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Nephrology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Nephrology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                103 Questions | 412 Total Marks | 113 min Duration | ~65.83 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A patient presents with the following laboratory values: Which of the following best describes the patientâ€™s acidâ€“base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20130956.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anion gap metabolic acidosis: Does not account for the extra bicarbonate drop.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anion gap metabolic acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anion gap metabolic acidosis plus metabolic alkalosis: Would typically yield a higher bicarbonate, often with Î”â€“Î” &amp;gt; 2.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anion gap metabolic acidosis plus metabolic alkalosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal anion gap metabolic acidosis: The elevated AG of 18 rules out a pure normal AG acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal anion gap metabolic acidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When you see a low bicarbonate and an elevated anion gap, use the Deltaâ€“Delta Ratio. A ratio &amp;lt;1 suggests coexisting anion gap and normal anion gap metabolic acidosis. Top of Form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acidâ€“base status&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute respiratory alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis with metabolic compensation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metabolic alkalosis with respiratory compensation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Metabolic alkalosis with respiratory compensation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131016.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Metabolic alkalosis with respiratory compensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory acidosis would present with a low pH (acidemia) and high PCOâ‚‚, not alkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory alkalosis would show a high pH but a low PCOâ‚‚.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic respiratory acidosis with metabolic compensation typically results in a less elevated pH; 7.55 is too alkalotic for that scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic respiratory acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A high bicarbonate and alkalemic pH accompanied by an elevated, appropriately compensated PCOâ‚‚ is characteristic of metabolic alkalosis with respiratory compensation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with chronic liver disease is admitted for worsening abdominal distension. His laboratory findings are as follows: Sodium (Naâº): 140 mEq/L Chloride (Clâ»): 115 mEq/L Bicarbonate (HCOâ‚ƒâ»): 26 mEq/L Albumin: 1.2 g/dL Which of the following best explains the anion gap?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Laboratory error in chloride measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoalbuminemia leading to a reduction in the anion gap&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unmeasured cation excess due to multiple myeloma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoalbuminemia leading to a reduction in the anion gap&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypoalbuminemia leading to a reduction in the anion gap&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Laboratory error in chloride measurement is unlikely because the sodium, chloride, and bicarbonate levels are consistent with normal measurement trends.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Laboratory error in chloride measurement&lt;/li&gt;&lt;li&gt;â€¢ Option C. Unmeasured cation excess due to multiple myeloma can reduce the anion gap through excess cationic monoclonal proteins, but this patient has no evidence of multiple myeloma, and hypoalbuminemia is a more likely explanation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Unmeasured cation excess due to multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metabolic alkalosis does not typically result in a low anion gap. It may raise bicarbonate, but that does not account for the reduction in the anion gap observed here.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metabolic alkalosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The anion gap is significantly influenced by albumin levels. Hypoalbuminemia decreases the anion gap by reducing unmeasured anions. In this case, the corrected anion gap appropriately accounts for the low albumin, ruling out other causes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old diabetic patient presents with fever and altered mental status. On examination, his blood pressure is 70/40 mm Hg and his pulse rate is 134/min. He has crackles over the left infrascapular region. Lab results are as follows: Naâº: 138 mEq/L, Clâ»: 98 mEq/L, HCOâ‚ƒâ»: 10 mEq/L, BUN: 58 mg/dL, Creatinine: 3.0 mg/dL, Blood glucose: 180 mg/dL. Which of the following best explains the anion gap?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Excessive administration of normal saline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ketone body production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperchloremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Accumulation of lactate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Accumulation of lactate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Accumulation of lactate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excessive administration of normal saline: Causes a normal anion gap (hyperchloremic) acidosis, not an elevated one.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excessive administration of normal saline:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ketone body production: Are less likely because the glucose of 180 mg/dL is not highly suggestive of diabetic ketoacidosis, and the clinical picture points more toward sepsis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ketone body production:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperchloremia: Results in Normal Anion Gap Metabolic Acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperchloremia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a hypotensive, septic patient, a high anion gap metabolic acidosis most often indicates lactic acidosis secondary to poor tissue perfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with hypokalemia and recurrent kidney stones presents with normal anion gap metabolic acidosis. His urinary anion gap is measured and found to be positive. Which of the following best explains this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Excess NHâ‚„âº excretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low NHâ‚„âº excretion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High Urinary Chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Excessive urinary acidification&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low NHâ‚„âº excretion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Low NHâ‚„âº excretion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excess NHâ‚„âº excretion : Would cause a negative urinary anion gap, more typical of GI bicarbonate loss rather than a renal defect.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excess NHâ‚„âº excretion&lt;/li&gt;&lt;li&gt;â€¢ negative&lt;/li&gt;&lt;li&gt;â€¢ Option C. High urinary chloride: Alone does not necessarily produce a positive urinary anion gap; in fact, increased urinary chloride often makes the gap more negative or closer to zero.&lt;/li&gt;&lt;li&gt;â€¢ Option C. High urinary chloride:&lt;/li&gt;&lt;li&gt;â€¢ positive&lt;/li&gt;&lt;li&gt;â€¢ Option D. Excessive urinary acidification : Is not consistent with a positive urinary anion gap; with adequate NHâ‚„âº excretion and acidification, the gap would be negative.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Excessive urinary acidification&lt;/li&gt;&lt;li&gt;â€¢ positive&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A positive urinary anion gap in a patient with normal anion gap metabolic acidosis typically indicates low NHâ‚„âº excretion and points to a renal rather than GI cause of the acidosis (e.g., distal RTA).&lt;/li&gt;&lt;li&gt;âž¤ positive&lt;/li&gt;&lt;li&gt;âž¤ low NHâ‚„âº excretion&lt;/li&gt;&lt;li&gt;âž¤ renal&lt;/li&gt;&lt;li&gt;âž¤ GI&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis plus acute metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chronic respiratory acidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131110.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chronic respiratory acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute metabolic acidosis : Incorrect because metabolic acidosis would present with a low bicarbonate and compensatory low PCOâ‚‚, not elevated PCOâ‚‚.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory acidosis : Incorrect because bicarbonate is elevated, indicating renal compensation, which occurs only in chronic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory acidosis plus acute metabolic acidosis : Incorrect because the elevated bicarbonate rules out a primary metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory acidosis plus acute metabolic acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic respiratory acidosis occurs with prolonged COâ‚‚ retention, leading to renal compensation by increasing bicarbonate. Differentiating acute from chronic respiratory acidosis requires assessing bicarbonate levels, which increase significantly only in chronic conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anion gap metabolic acidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131127.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anion gap metabolic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anion gap metabolic acidosis : Plus metabolic alkalosis is incorrect because there is no elevated bicarbonate or evidence of alkalosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anion gap metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis: Is incorrect as there is no hyperchloremia to suggest an additional non-anion gap acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal anion gap metabolic acidosis : Is incorrect as the elevated anion gap clearly indicates an anion gap metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal anion gap metabolic acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Delta-delta ratio analysis helps differentiate pure anion gap metabolic acidosis from mixed acid-base disorders. A ratio within the normal range (1â€“2) confirms a single anion gap metabolic acidosis without additional acid-base disturbances.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metabolic acidosis plus primary respiratory alkalosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metabolic acidosis with appropriate respiratory compensation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metabolic acidosis plus primary respiratory alkalosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131148.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Metabolic acidosis plus primary respiratory alkalosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory acidosis : Is incorrect because the PCOâ‚‚ is low, not elevated, ruling out respiratory acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic respiratory acidosis : Is incorrect because the bicarbonate would be elevated due to renal compensation, not reduced.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic respiratory acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metabolic acidosis with appropriate respiratory compensation : Is incorrect because the PCOâ‚‚ is lower than the expected range, indicating an additional primary respiratory alkalosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metabolic acidosis with appropriate respiratory compensation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The delta ratio and Winterâ€™s formula are essential tools for evaluating mixed acid-base disorders. A PCOâ‚‚ lower than expected in metabolic acidosis suggests an additional respiratory alkalosis. This highlights the importance of calculating expected compensation to detect hidden mixed disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis plus acute metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic metabolic acidosis with respiratory compensation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute respiratory acidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131209.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute respiratory acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute metabolic acidosis : Incorrect because metabolic acidosis would present with low bicarbonate and compensatory low PCOâ‚‚, which are not observed here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory acidosis plus acute metabolic acidosis : Incorrect because the bicarbonate is normal, ruling out metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory acidosis plus acute metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic metabolic acidosis with respiratory compensation : Incorrect because chronic metabolic acidosis would present with low bicarbonate and low PCOâ‚‚ as compensation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic metabolic acidosis with respiratory compensation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute respiratory acidosis is characterized by an acidemic pH, elevated PCOâ‚‚, and normal bicarbonate (before compensation occurs). Compensation for respiratory acidosis takes days, so normal bicarbonate suggests an acute process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute respiratory alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute respiratory alkalosis plus acute metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic respiratory alkalosis with metabolic compensation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chronic respiratory alkalosis with metabolic compensation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131229.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chronic respiratory alkalosis with metabolic compensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute metabolic acidosis : Incorrect, as acidosis would result in a low pH, not the alkalotic pH seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory alkalosis : Incorrect because bicarbonate levels are reduced, indicating renal compensation, which occurs only in chronic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory alkalosis plus acute metabolic alkalosis : Incorrect because the bicarbonate is low, ruling out metabolic alkalosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory alkalosis plus acute metabolic alkalosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic respiratory alkalosis occurs with prolonged hyperventilation, leading to renal compensation by reducing bicarbonate levels. The distinction between acute and chronic respiratory alkalosis is based on bicarbonate levels, which decrease significantly only in chronic conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus metabolic alkalosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anion gap metabolic acidosis plus metabolic alkalosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131245.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Anion gap metabolic acidosis plus metabolic alkalosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Anion gap metabolic acidosis: This is partially correct but incomplete as it doesn&#x27;t account for the mixed disorder indicated by the delta ratio &amp;gt; 2.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option C . Anion gap metabolic acidosis plus normal anion gap metabolic acidosis: Incorrect because the delta ratio &amp;gt; 2 indicates alkalosis, not a second acidosis. In mixed normal gap and high gap acidosis, the delta ratio would be &amp;lt; 1.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D . Normal anion gap metabolic acidosis: Clearly incorrect as the AG is significantly elevated at 40.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Use the delta ratio to identify mixed acid-base disorders. A delta ratio &amp;gt; 2 suggests concurrent metabolic alkalosis along with anion gap metabolic acidosis, which can occur in conditions like diabetic ketoacidosis with vomiting or lactic acidosis with diuretic use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Which of the following is the most likely acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metabolic acidosis with appropriate respiratory compensation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed metabolic acidosis and respiratory acidosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mixed metabolic acidosis and respiratory acidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131304.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mixed metabolic acidosis and respiratory acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory acidosis: The low bicarbonate and pH indicate metabolic involvement, which excludes isolated acute respiratory acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic respiratory acidosis: Chronic conditions show higher bicarbonate compensation, which is not present here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic respiratory acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metabolic acidosis with appropriate respiratory compensation: The observed PCOâ‚‚ is much higher than predicted by Winter&#x27;s formula, ruling out appropriate compensation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metabolic acidosis with appropriate respiratory compensation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Winter&#x27;s formula is a crucial tool to differentiate between simple and mixed acid-base disorders in metabolic acidosis. A discrepancy between observed and expected PCOâ‚‚ indicates an additional respiratory process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has the following laboratory findings: Bicarbonate (HCOâ‚ƒâ»): 32 mEq/L pH: 7.51 PCOâ‚‚: 35 mm Hg Which of the following best describes the patient&#x27;s acid-base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic respiratory alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute respiratory alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metabolic alkalosis plus respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metabolic alkalosis plus respiratory alkalosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Metabolic alkalosis plus respiratory alkalosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The pH of 7.51 indicates alkalemia (alkalotic state). The elevated bicarbonate (&amp;gt;24 mEq/L) signifies a primary metabolic alkalosis. In metabolic alkalosis, the respiratory system typically compensates by increasing&lt;/li&gt;&lt;li&gt;â€¢ The pH of 7.51 indicates alkalemia (alkalotic state).&lt;/li&gt;&lt;li&gt;â€¢ The elevated bicarbonate (&amp;gt;24 mEq/L) signifies a primary metabolic alkalosis.&lt;/li&gt;&lt;li&gt;â€¢ In metabolic alkalosis, the respiratory system typically compensates by increasing&lt;/li&gt;&lt;li&gt;â€¢ PCOâ‚‚ to help normalize pH. But here the PCOâ‚‚ is 35 mm Hg (&amp;lt;40), which is low indicating an independent respiratory alkalosis as well.&lt;/li&gt;&lt;li&gt;â€¢ Whenever HCOâ‚ƒâ» (high in this case) and PCO2 (low in this case), move in opposite directions  it is highly suggestive of a mixed disorder.&lt;/li&gt;&lt;li&gt;â€¢ Whenever HCOâ‚ƒâ» (high in this case) and PCO2 (low in this case), move in opposite directions  it is highly suggestive of a mixed disorder.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic respiratory alkalosis : Usually presents with decreased PCOâ‚‚ and a compensatory decrease in bicarbonate (not elevated). The elevated bicarbonate here rules this out. Option B. Acute respiratory alkalosis : Typically involves decreased PCOâ‚‚ with normal bicarbonate and an elevated pH. Since bicarbonate is grossly elevated here, this does not fit. Option C. Metabolic alkalosis plus respiratory acidosis : Respiratory acidosis involves elevated PCOâ‚‚, but here PCOâ‚‚ is low, so this is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic respiratory alkalosis : Usually presents with decreased PCOâ‚‚ and a compensatory decrease in bicarbonate (not elevated). The elevated bicarbonate here rules this out.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic respiratory alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory alkalosis : Typically involves decreased PCOâ‚‚ with normal bicarbonate and an elevated pH. Since bicarbonate is grossly elevated here, this does not fit.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metabolic alkalosis plus respiratory acidosis : Respiratory acidosis involves elevated PCOâ‚‚, but here PCOâ‚‚ is low, so this is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metabolic alkalosis plus respiratory acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When HCOâ‚ƒâ» and PCOâ‚‚ move in opposite directionsâ€”it indicates a mixed acid-base disorder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with severe metabolic acidosis and the following lab results: Sodium: 140 mEq/L Chloride: 100 mEq/L Bicarbonate: 8 mEq/L BUN: 56 mg/dL Plasma Glucose: 180 mg/dL Serum Osmolality: 332 mOsm/kg Which of the following is the most likely cause of the metabolic acidosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methanol poisoning&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diabetic ketoacidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Methanol poisoning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Methanol poisoning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diabetic ketoacidosis: Typically presents with hyperglycemia &amp;gt;250 mg/dL and does not cause an elevated osmolal gap.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diabetic ketoacidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lactic acidosis: Would present with elevated lactate levels, and would not present with elevated osmolal gap.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lactic acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Renal failure: Causes a high anion gap metabolic acidosis due to retention of uremic toxins but does not cause an elevated osmolal gap.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Renal failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of high anion gap metabolic acidosis with an elevated osmolal gap, toxic alcohol ingestion (e.g., methanol or ethylene glycol) should be strongly suspected. Calculate both gaps to narrow the differential diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with perioral tingling and paresthesias. His blood pressure is 100/60 mm Hg. His lab results are as follows: Sodium: 142 mEq/L Chloride: 110 mEq/L Bicarbonate: 32 mEq/L Urinary chloride: 10 mEq/L What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bartter syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gitelman syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary aldosteronism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vomiting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vomiting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bartter syndrome: Presents with metabolic alkalosis but is associated with high urinary chloride levels (&amp;gt; 20 mEq/L) due to renal chloride wasting. Blood pressure is usually normal or low.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bartter syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gitelman syndrome: Also causes metabolic alkalosis with high urinary chloride levels (&amp;gt; 20 mEq/L). It typically includes hypomagnesemia and hypocalciuria, which are not described here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gitelman syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary aldosteronism: Causes metabolic alkalosis with high urinary chloride levels (&amp;gt; 20 mEq/L) and is associated with hypertension due to mineralocorticoid excess, which is inconsistent with this patientâ€™s low blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary aldosteronism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metabolic alkalosis with low urinary chloride (&amp;lt; 20 mEq/L) is a hallmark of chloride-responsive alkalosis , commonly caused by vomiting or diuretic use. Alkalosis-induced hypocalcemia can lead to symptoms like paresthesias and perioral tingling.&lt;/li&gt;&lt;li&gt;âž¤ low urinary chloride (&amp;lt; 20 mEq/L)&lt;/li&gt;&lt;li&gt;âž¤ chloride-responsive alkalosis&lt;/li&gt;&lt;li&gt;âž¤ hypocalcemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with severe weakness and a long-standing history of dry mouth and dry eyes. His lab results are as follows: Serum Sodium (S. Na): 140 mEq/L Serum Potassium (S. K): 1.8 mEq/L Serum Chloride (S. Cl): 115 mEq/L Serum Bicarbonate (S. HCOâ‚ƒ): 12 mEq/L Urinary Sodium (Urinary Na): 25 mEq/L Urinary Potassium (Urinary K): 10 mEq/L Urinary Chloride (Urinary Cl): 20 mEq/L What is the most likely cause of the patientâ€™s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proximal RTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Distal RTA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Addison Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enterocutaneous Fistula&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Distal RTA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Distal RTA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Proximal RTA: Causes bicarbonate wasting and is associated with a negative UAG. Hypokalemia is usually milder.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Proximal RTA:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Addison Disease: Leads to hyperkalemia due to aldosterone deficiency, which is inconsistent with the severe hypokalemia in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Addison Disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enterocutaneous Fistula: Causes bicarbonate loss leading to metabolic acidosis but is associated with a negative UAG due to increased NHâ‚„âº excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enterocutaneous Fistula:&lt;/li&gt;&lt;li&gt;â€¢ negative UAG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A positive urinary anion gap in the context of normal anion gap metabolic acidosis indicates impaired renal ammonium excretion, a hallmark of distal RTA . This is a key differentiating feature from gastrointestinal bicarbonate losses, which present with a negative UAG. Recognizing these patterns helps narrow the differential diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ distal RTA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 61-year-old man presents with worsening fever, cough, and dyspnea for the past 2 days. He was started on empirical azithromycin 3 days ago, but his condition has worsened. ABG and lab results are as follows: What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute exacerbation of COPD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute exacerbation of COPD&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131403.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute exacerbation of COPD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic respiratory acidosis: Chronic respiratory acidosis is expected in stable COPD patients with compensated hypercapnia. However, the low pH in this patient indicates an acute decompensation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic respiratory acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory acidosis: Pure acute respiratory acidosis would not explain the elevated bicarbonate, which reflects chronic compensation in COPD.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute respiratory acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism: Pulmonary embolism typically causes respiratory alkalosis due to hyperventilation, with low pCOâ‚‚ levels, not the hypercapnia seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with known COPD, a low pH with elevated pCOâ‚‚ and bicarbonate indicates acute respiratory acidosis superimposed on chronic compensation, suggesting acute exacerbation of COPD (AECOPD) . Prompt recognition and treatment of the underlying cause, such as infection, are critical.&lt;/li&gt;&lt;li&gt;âž¤ acute exacerbation of COPD (AECOPD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old pregnant woman (30 weeks gestation) has been diagnosed with pneumonia. She is currently receiving high-flow oxygen with an FiOâ‚‚ of 0.5. Her ABG and lab results are as follows: pH: 7.42 pCOâ‚‚: 29 mmHg HCOâ‚ƒâ»: 20 mmol/L Base Excess: -5.1 mmol/L pOâ‚‚: 123 mmHg Oâ‚‚ Saturation: 99% Potassium: 3.0 mmol/L Sodium: 133 mmol/L Chloride: 109 mmol/L What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute respiratory distress syndrome (ARDS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type 1 respiratory failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alveolar hypoventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 4 respiratory failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type 1 respiratory failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Type 1 respiratory failure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute respiratory distress syndrome (ARDS): While ARDS can cause Type 1 respiratory failure, it typically presents with severe hypoxemia and bilateral infiltrates, and patients would not respond to 100% O2 due to significant shunting.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Acute respiratory distress syndrome (ARDS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alveolar hypoventilation: This condition leads to hypercapnia (elevated pCOâ‚‚), which is not present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Alveolar hypoventilation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 4 respiratory failure: Type 4 failure refers to hypoperfusion due to circulatory failure (e.g., septic shock), which is not indicated by the patient&#x27;s ABG or clinical scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Type 4 respiratory failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type 1 respiratory failure is characterized by hypoxemia with a normal or low pCOâ‚‚ and is caused by V/Q mismatch, diffusion limitation, or shunting. An elevated A-a gradient with a good response to supplemental oxygen suggests V/Q mismatch, commonly seen in pneumonia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with a history of alcohol use disorder presents with confusion and abdominal pain. His lab results are as follows: Sodium: 138 mEq/L Chloride: 102 mEq/L Bicarbonate: 12 mEq/L Blood glucose: 100 mg/dL Lactate: 3 mmol/L Serum osmolality: 350 mOsm/kg Ethanol level: Undetectable Urinary oxalate crystals: Present What is the most likely cause of his high anion gap metabolic acidosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methanol poisoning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diabetic ketoacidosis (DKA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethylene glycol poisoning&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ethylene glycol poisoning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ethylene glycol poisoning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methanol poisoning: Methanol poisoning causes high anion gap metabolic acidosis but typically presents with visual symptoms due to formate toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Methanol poisoning:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diabetic ketoacidosis (DKA): DKA causes high anion gap metabolic acidosis with elevated glucose, which is not present here.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Diabetic ketoacidosis (DKA):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lactic acidosis: Lactate is mildly elevated but not high enough to explain the metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Lactic acidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Suspect ethylene glycol poisoning in high anion gap metabolic acidosis with urinary oxalate crystals and an elevated osmolality gap.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with a history of chronic obstructive pulmonary disease (COPD). His ABG results show the following: pH: 7.37 pCOâ‚‚: 55 mmHg HCOâ‚ƒâ»: 32 mEq/L Using the marked image, identify the most likely area (A-G) on the ABG nomogram corresponding to his clinical picture.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;F&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;G&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. B&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131514.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131531.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. A corresponds to a normal ABG, which does not match the patient&#x27;s elevated pCOâ‚‚ and HCOâ‚ƒâ» values.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A&lt;/li&gt;&lt;li&gt;â€¢ Option C. F represents acute metabolic acidosis, where pH would be significantly lower without compensatory bicarbonate elevation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. F&lt;/li&gt;&lt;li&gt;â€¢ Option D. G represents metabolic acidosis with hyperchloremia or renal tubular acidosis, which does not fit this patient&#x27;s findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. G&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the interpretation of ABG values in relation to the ABG nomogram and their clinical significance in chronic respiratory acidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Using the marked ABG nomogram, identify the area D.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute respiratory alkalosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic respiratory alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal ABG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute respiratory alkalosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131553.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20131617.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute respiratory alkalosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metabolic alkalosis : Is associated with increased bicarbonate levels and compensatory respiratory changes, which do aligns with the region C on the given image.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metabolic alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic respiratory alkalosis : Would align with the region E on the given image.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic respiratory alkalosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal ABG: Values would fall within the central region (marked as A), not D.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal ABG:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Use the ABG nomogram to identify and interpret patterns of acid-base disturbances, specifically differentiating acute from chronic respiratory and metabolic conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient with long-standing type 2 diabetes presents with fatigue, pruritus, and elevated creatinine. Renal ultrasound shows bilaterally small kidneys measuring 7 cm in length. Which of the following laboratory findings would best support a diagnosis of CKD rather than acute kidney injury (AKI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated serum creatinine kinase (CK)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated parathyroid hormone (PTH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated parathyroid hormone (PTH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Elevated parathyroid hormone (PTH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated serum creatinine kinase (CK) : Elevated CK is primarily seen in muscle damage, not CKD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated serum creatinine kinase (CK)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercalcemia : CKD often leads to hypocalcemia (low calcium) due to impaired vitamin D metabolism, not hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypokalemia : Hypokalemia is not a primary feature of CKD, although it can occur in later stages due to medication use or other factors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypokalemia&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CKD is characterized by a gradual decline in kidney function over months or years, while AKI is a sudden onset of kidney dysfunction. Elevated parathyroid hormone (PTH) is a key laboratory marker for CKD due to secondary hyperparathyroidism caused by impaired vitamin D metabolism and phosphate retention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following clinical presentations would further support a diagnosis of chronic kidney disease (CKD) rather than acute kidney injury (AKI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sudden onset of flank pain and hematuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;History of recent contrast dye exposure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperkalemia and metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Progressive worsening of anemia over several months&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Progressive worsening of anemia over several months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Progressive worsening of anemia over several months&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sudden onset of flank pain and hematuria : This presentation is more suggestive of an acute process, such as kidney stones or a urinary tract infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sudden onset of flank pain and hematuria&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of recent contrast dye exposure : Contrast-induced nephropathy is an acute kidney injury that typically occurs within a few days of exposure to contrast dye.&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of recent contrast dye exposure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperkalemia and metabolic acidosis : While these electrolyte imbalances can occur in both AKI and CKD, they are more commonly associated with acute renal failure due to the rapid decline in kidney function.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperkalemia and metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CKD typically presents with a gradual onset of symptoms such as fatigue, edema, and foamy urine, along with progressive anemia due to reduced erythropoietin production. In contrast, AKI presents with a sudden onset of symptoms like flank pain, hematuria, or recent exposure to nephrotoxic agents.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of hypertension presents with acute onset oliguria and elevated creatinine. His blood pressure is 90/60 mmHg, and he reports recent episodes of diarrhea and vomiting. Which of the following is the most likely cause of his AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute tubular necrosis (ATN)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prerenal azotemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis (AIN)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postrenal obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prerenal azotemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Prerenal azotemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute tubular necrosis (ATN): While possible, it&#x27;s less likely in this scenario without a history of nephrotoxic drug exposure or prolonged hypotension&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Acute tubular necrosis (ATN):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute interstitial nephritis (AIN): This would typically present with fever, rash, or other signs of allergic reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Acute interstitial nephritis (AIN):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postrenal obstruction: Less likely given the absence of urinary symptoms suggestive of obstruction&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Postrenal obstruction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the different causes of acute kidney injury (AKI) and to be able to identify prerenal azotemia as the most likely cause in a patient with hypotension, dehydration, and oliguria. Prerenal azotemia is a functional AKI caused by decreased blood flow to the kidneys, often due to volume depletion or low blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of heart failure and diabetes mellitus is admitted to the hospital with worsening shortness of breath and leg edema. His serum creatinine has increased from 1.2 mg/dL to 2.5 mg/dL over the past 2 days. Which of the following medications is most likely to have precipitated this acute kidney injury?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lisinopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lisinopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin : Metformin is not directly nephrotoxic but can cause lactic acidosis, which can worsen AKI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Furosemide : Furosemide, a diuretic, might worsen AKI if dehydration is the underlying cause.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Furosemide&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspirin : Aspirin is not typically associated with AKI unless taken in very high doses.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspirin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize that angiotensin-converting enzyme (ACE) inhibitors, such as lisinopril, can precipitate acute kidney injury (AKI) in patients with pre-existing cardiac or renal dysfunction. ACE inhibitors can decrease glomerular filtration rate (GFR) by reducing efferent arteriolar resistance, particularly in patients with decreased renal perfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following scenarios would classify a patient as having Stage 3 AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A 40-year-old with baseline creatinine of 1.2 mg/dL, current creatinine of 2.6 mg/dL, and urine output of 0.4 mL/kg/hour for 18 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A 25-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.8 mg/dL, and anuria for 14 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A 50-year-old with a baseline creatinine of 0.9 mg/dL, current creatinine of 1.5 mg/dL, and anuria for 10 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 mÂ².&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 mÂ².&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-144229.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) A 15-year-old with a decrease in eGFR to 30 mL/min/1.73 mÂ².&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of diabetes mellitus presents with nausea, vomiting, and oliguria. Her serum creatinine is 2.5 mg/dL, and her urine microscopy shows muddy brown granular casts. Which of the following biomarkers would be most helpful in confirming the diagnosis of acute tubular necrosis (ATN)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plasma NGAL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urinary KIM-1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasma suPAR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary TIMP-2 and IGFBP7&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Urinary KIM-1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Urinary KIM-1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plasma NGAL : While NGAL is an early marker for AKI, it&#x27;s not specific for ATN and can be elevated in other causes of kidney injury.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plasma NGAL&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasma suPAR : suPAR is more useful in predicting the risk of developing AKI, not confirming ATN.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasma suPAR&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urinary TIMP-2 and IGFBP7 : These biomarkers are primarily used to predict the risk of severe AKI, not to diagnose the specific cause like ATN&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urinary TIMP-2 and IGFBP7&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the role of urinary biomarkers, specifically KIM-1, in confirming the diagnosis of acute tubular necrosis (ATN). ATN is a common cause of acute kidney injury (AKI), characterized by damage to the renal tubules. Urinary KIM-1 is a highly sensitive and specific biomarker for ATN, as it is released from injured proximal tubular cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a history of recurrent urinary tract infections presents with fever, chills, flank pain, and anuria. Ultrasound reveals bilateral hydronephrosis. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibiotics alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous fluids and observation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Percutaneous nephrostomy tube placement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ureteral stent placement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Percutaneous nephrostomy tube placement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Percutaneous nephrostomy tube placement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibiotics alone : Antibiotics alone will not address the underlying obstruction causing the anuria and potential kidney damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibiotics alone&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous fluids and observation : Intravenous fluids may worsen hydronephrosis and observation is not appropriate in the setting of anuria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous fluids and observation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ureteral stent placement : Ureteral stent placement, while a possible treatment, is not as immediate or effective as nephrostomy in relieving anuria&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ureteral stent placement&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Obstructive uropathy can quickly lead to irreversible kidney damage, and immediate intervention with a percutaneous nephrostomy tube is often necessary to preserve renal function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient with no prior kidney disease undergoes elective abdominal aortic aneurysm repair requiring cross-clamping of the aorta above the renal arteries. The procedure lasts 45 minutes, and the patient&#x27;s blood pressure is well-maintained throughout. Which of the following statements regarding the patient&#x27;s risk of acute kidney injury (AKI) is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The patient is at high risk of developing severe AKI requiring dialysis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The patient is at moderate risk of AKI, and close monitoring of renal function is necessary.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The patient&#x27;s risk of AKI cannot be determined without knowing their baseline creatinine level.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The patient is at low risk of severe AKI, as transient ischemia in a normal kidney is unlikely to cause significant damage.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. The patient is at high risk of developing severe AKI requiring dialysis : Severe AKI requiring dialysis is unlikely after a brief, well-managed ischemic event in a healthy individual.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The patient is at high risk of developing severe AKI requiring dialysis&lt;/li&gt;&lt;li&gt;â€¢ Option B. The patient is at moderate risk of AKI, and close monitoring of renal function is necessary : While some degree of AKI is possible, it is unlikely to be moderate in this specific scenario with a normal kidney and controlled blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The patient is at moderate risk of AKI, and close monitoring of renal function is necessary&lt;/li&gt;&lt;li&gt;â€¢ Option D. The patient&#x27;s risk of AKI cannot be determined without knowing their baseline creatinine level : While baseline creatinine is helpful, the focus here is the effect of transient ischemia on a normal kidney, not the pre-existing renal function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The patient&#x27;s risk of AKI cannot be determined without knowing their baseline creatinine level&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Factors like adequate blood supply, autoregulation mechanisms, and cellular repair processes contribute to the kidney&#x27;s resilience to transient ischemic events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a history of chronic heart failure (CHF) on furosemide presents with worsening dyspnea, oliguria, hypotension, and elevated serum creatinine and blood urea nitrogen (BUN) levels. Urinalysis demonstrates dilute urine. The treating physician is suspecting Pre-renal AKI rather than a ATN, which of the following findings supports his diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FeNa &amp;lt; 1%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FeNa 1-2%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FeNa 2-3%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FeNa &amp;gt; 3%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. FeNa &lt; 1%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) FeNa &amp;lt; 1%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. FeNa 1-2%: This is an indeterminate FeNa range, not definitively diagnostic of either prerenal AKI or ATN.&lt;/li&gt;&lt;li&gt;â€¢ Option B. FeNa 1-2%:&lt;/li&gt;&lt;li&gt;â€¢ Option C. FeNa 2-3%: This value suggests intrinsic renal injury, more characteristic of ATN where the tubules are unable to effectively reabsorb sodium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FeNa 2-3%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. FeNa &amp;gt; 3%: A FeNa greater than 3% strongly suggests intrinsic renal injury, likely ATN, where the tubules have lost their reabsorptive capacity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. FeNa &amp;gt; 3%:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ A low FeNa (&amp;lt;1%) is a hallmark of prerenal AKI, reflecting the kidney&#x27;s attempt to conserve sodium in response to decreased renal perfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications has been shown to potentially prevent AKI in patients with cirrhosis and spontaneous bacterial peritonitis treated with antibiotics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terlipressin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midodrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Albumin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Albumin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Albumin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Terlipressin : Terlipressin works by constricting blood vessels in the splanchnic circulation, which can improve blood flow to the kidneys.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Terlipressin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide : Octreotide reduces splanchnic blood flow and inhibits the release of hormones that worsen kidney function.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide&lt;/li&gt;&lt;li&gt;â€¢ Option D. Midodrine : Midodrine is a vasopressor that helps to increase blood pressure and improve renal perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Midodrine&lt;/li&gt;&lt;li&gt;â€¢ While these medications may indirectly improve kidney function in some patients, they are not the first-line therapy for preventing AKI in SBP. Albumin administration, on the other hand, has been shown to be more effective in this specific context.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that albumin administration is an effective intervention for preventing acute kidney injury (AKI) in patients with cirrhosis and spontaneous bacterial peritonitis (SBP) treated with antibiotics. Albumin helps improve renal perfusion and reduce inflammation, thereby mitigating the risk of AKI in this specific population.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old patient with decompensated cirrhosis and refractory ascites presents with oliguria, worsening creatinine, and a low urine sodium concentration (&amp;lt;10 mEq/L). Despite aggressive volume resuscitation with albumin, their renal function continues to decline. Which of the following represents the definitive treatment for their underlying condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terlipressin and albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide and midodrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Continuous renal replacement therapy (CRRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver transplantation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Liver transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Liver transplantation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Terlipressin and albumin: These are vasoconstrictor medications used as a bridge to transplant in HRS, providing temporary improvement in renal function.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Terlipressin and albumin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide and midodrine: This combination is another pharmacologic therapy used to manage HRS, but it doesn&#x27;t address the root cause.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide and midodrine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Continuous renal replacement therapy (CRRT): While CRRT can provide temporary support for kidney function, it does not treat the underlying cause of HRS and is not a definitive treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Continuous renal replacement therapy (CRRT):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize that liver transplantation is the definitive treatment for hepatorenal syndrome (HRS), a serious complication of advanced cirrhosis characterized by renal failure. While pharmacological interventions like terlipressin, albumin, octreotide, and midodrine can provide temporary support, they do not address the underlying liver dysfunction that drives HRS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a proposed mechanism for the cardiorenal syndrome in ADHF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced renal perfusion due to low cardiac output&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased venous congestion leading to renal venous hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurohormonal activation (RAAS, SNS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Direct nephrotoxicity of heart failure medications.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Reduced renal perfusion due to low cardiac output&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Reduced renal perfusion due to low cardiac output.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased venous congestion leading to renal venous hypertension: In ADHF, the heart&#x27;s reduced pumping capacity can lead to a backup of blood in the veins, including those draining the kidneys. This increased pressure can impede blood flow through the kidneys, leading to decreased glomerular filtration rate (GFR) and contributing to CRS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased venous congestion leading to renal venous hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neurohormonal activation (RAAS, SNS): In response to decreased cardiac output, the body activates neurohormonal systems like the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system (SNS). These systems can cause vasoconstriction in the kidneys, further reducing blood flow and contributing to renal dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neurohormonal activation (RAAS, SNS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Direct nephrotoxicity of heart failure medications: Some medications used to treat heart failure, such as certain diuretics and NSAIDs, can be directly toxic to the kidneys, especially in patients with pre-existing renal dysfunction. This can worsen or precipitate AKI in the context of CRS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Direct nephrotoxicity of heart failure medications:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the pathophysiology of cardiorenal syndrome (CRS) in acute decompensated heart failure (ADHF), recognizing that reduced renal perfusion due to low cardiac output is NOT a primary mechanism in most cases. Instead, venous congestion, neurohormonal activation, and direct nephrotoxicity of medications are the main contributors to this complex syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with stage 4 CKD on dialysis develops nephrogenic systemic fibrosis (NSF) after an MRI. Which contrast agent was most likely used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gadolinium-based contrast agent (GBCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iodine-based contrast agent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Barium sulfate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Air contrast&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gadolinium-based contrast agent (GBCA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gadolinium-based contrast agent (GBCA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iodine- based contrast agents: These are primarily used in X-ray and CT imaging. While they can cause contrast-induced nephropathy (CIN), they are not associated with nephrogenic systemic fibrosis (NSF).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iodine-&lt;/li&gt;&lt;li&gt;â€¢ based contrast agents:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barium sulfate: This contrast agent is used for gastrointestinal imaging and is not typically administered intravenously. Thus, it would not be expected to cause NSF, which is related to systemic exposure to contrast agents.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Barium&lt;/li&gt;&lt;li&gt;â€¢ sulfate:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Air contrast : This is not a chemical contrast agent, but rather air or carbon dioxide used to enhance the visibility of certain structures in imaging studies. It does not pose a risk of NSF&lt;/li&gt;&lt;li&gt;â€¢ Option D. Air contrast&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the association between gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) in patients with advanced kidney disease. Recognizing that GBCA exposure is the primary risk factor for NSF is crucial for preventing this debilitating condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old diabetic patient with chronic kidney disease (eGFR 35 mL/min) is scheduled for a coronary angiogram. Which of the following measures is most likely to prevent contrast-induced nephropathy (CIN)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer high-dose furosemide before and after the procedure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Use low-osmolar or iso-osmolar contrast media.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pretreat with oral N-acetylcysteine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hold metformin for 48 hours before and after the procedure.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Use low-osmolar or iso-osmolar contrast media.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Use low-osmolar or iso-osmolar contrast media.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer high-dose furosemide before and after the procedure : Furosemide may actually worsen renal function in this setting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer high-dose furosemide before and after the procedure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pretreat with oral N-acetylcysteine : N-acetylcysteine has limited evidence for CIN prevention.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pretreat with oral N-acetylcysteine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hold metformin for 48 hours before and after the procedure : Metformin is held due to lactic acidosis risk, not CIN.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hold metformin for 48 hours before and after the procedure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the importance of using low-osmolar or iso-osmolar contrast media in patients with chronic kidney disease (CKD) to prevent contrast-induced nephropathy (CIN). While other measures like hydration and withholding certain medications are also important, the choice of contrast agent plays a significant role in mitigating the risk of CIN in these patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man presents with livedo reticularis, blue toes, and acute kidney injury (AKI) after undergoing a coronary angiogram. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contrast-induced nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atheroembolic renal disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cholesterol emboli syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atheroembolic renal disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Atheroembolic renal disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute interstitial nephritis : AIN is not associated with livedo reticularis or blue toes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute interstitial nephritis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Contrast-induced nephropathy : CIN typically presents within 24-48 hours of contrast exposure, not days later.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Contrast-induced nephropathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cholesterol emboli syndrome : While similar, cholesterol emboli syndrome typically lacks renal involvement&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cholesterol emboli syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the classic presentation of atheroembolic renal disease (AERD), which includes livedo reticularis, blue toes (cyanosis), and acute kidney injury (AKI) following a vascular procedure. This triad of symptoms is highly suggestive of AERD and should prompt further investigation and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with rhabdomyolysis develops acute kidney injury (AKI). Which of the following is the most likely mechanism of AKI in this setting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune-mediated glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal artery stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal tubular obstruction by myoglobin casts&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Crystal nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Renal tubular obstruction by myoglobin casts&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Renal tubular obstruction by myoglobin casts&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune-mediated glomerulonephritis: This is an inflammatory process affecting the glomeruli (filtering units of the kidney) and is not the primary mechanism in rhabdomyolysis-induced AKI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immune-mediated glomerulonephritis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Renal artery stenosis: This is a narrowing of the artery supplying the kidney, which can reduce blood flow and cause kidney damage, but it is not directly related to rhabdomyolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Renal artery stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Crystal nephropathy: This is caused by the deposition of crystals in the kidneys, most commonly from medications like acyclovir or sulfa drugs, and is not the primary mechanism in rhabdomyolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Crystal nephropathy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The pathophysiology of acute kidney injury (AKI) in rhabdomyolysis, specifically recognizing that renal tubular obstruction by myoglobin casts is the primary mechanism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is known to increase the risk of rhabdomyolysis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Statins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amphetamines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old patient presents with acute kidney injury (AKI), fever, maculopapular rash, and arthralgias after recently starting a new medication. A renal biopsy is performed. Which of the following HPE findings will be seen in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glomerular crescent formation and fibrinoid necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tubular atrophy and interstitial fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial edema and inflammatory infiltrate with predominantly eosinophils&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thickening of the glomerular basement membrane with immune complex deposits&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Interstitial edema and inflammatory infiltrate with predominantly eosinophils&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Interstitial edema and inflammatory infiltrate with predominantly eosinophils&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glomerular crescent formation and fibrinoid necrosis: These are characteristic of rapidly progressive glomerulonephritis (RPGN), a different type of kidney disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glomerular crescent formation and fibrinoid necrosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tubular atrophy and interstitial fibrosis: These findings are more indicative of chronic kidney disease (CKD) rather than the acute inflammatory process of AIN.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tubular atrophy and interstitial fibrosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thickening of the glomerular basement membrane with immune complex deposits: This is a common feature of immune-complex mediated glomerulonephritis, not AIN.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thickening of the glomerular basement membrane with immune complex deposits:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The characteristic histopathological features of acute interstitial nephritis (AIN) on a renal biopsy, which include interstitial edema, inflammatory infiltrate with predominantly eosinophils, and tubulitis. Recognizing these findings is crucial for the accurate diagnosis and management of AIN, a common cause of acute kidney injury (AKI).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presents to the emergency department with fever, flank pain, and dysuria. Urinalysis is performed as part of her evaluation, which is shown in the image. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pyelonephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute Interstitial Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute tubular necrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pyelonephritis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150231.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pyelonephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute glomerulonephritis : Acute glomerulonephritis is usually characterized by hypertension, hematuria with red blood cell casts, proteinuria, and varying degrees of renal insufficiency, which is not consistent with the presented findings.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Acute glomerulonephritis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute interstitial nephritis : Acute interstitial nephritis typically presents with a rash, fever, and eosinophilia and is often a hypersensitivity reaction to medications. WBC casts may be present, but the clinical symptoms and the absence of medication history make this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Acute interstitial nephritis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute tubular necrosis (ATN) : Acute tubular necrosis (ATN) often presents with a history of ischemia or nephrotoxic injury, and the urinalysis would typically show muddy brown casts, not the white blood cell casts indicative of infection.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Acute tubular necrosis (ATN)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Pyelonephritis is diagnosed based on the combination of clinical symptoms such as fever, flank pain, and dysuria, along with laboratory findings of white blood cell casts in the urine, indicating an infection that has reached the renal pelvis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old male with hypertension and type 2 diabetes presents with oliguria, weakness, nausea, and recent initiation of a new anti-hypertensive medication. He has elevated creatinine, BUN, and hyperkalemia. Urinalysis slide is shown below. Whatâ€™s the most likely cause of his kidney injury?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prerenal azotemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute tubular necrosis (ATN)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postrenal obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute tubular necrosis (ATN)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-150358.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute tubular necrosis (ATN)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prerenal azotemia: While possible given the patient&#x27;s history, prerenal AKI usually presents with bland urine sediment and a BUN/creatinine ratio &amp;gt;20:1. The presence of granular casts makes this diagnosis less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prerenal azotemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute glomerulonephritis: This typically presents with hematuria, proteinuria, and RBC casts. The absence of these findings and the presence of granular casts make this diagnosis less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute glomerulonephritis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postrenal obstruction: This would likely present with anuria and pain. Ultrasound would be needed to confirm this diagnosis. The presence of granular casts points toward intrinsic renal injury rather than obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postrenal obstruction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The characteristic findings of acute tubular necrosis (ATN) on urinalysis, which include muddy brown granular casts. These casts, in combination with the patient&#x27;s clinical presentation and history (recent medication change, elevated creatinine, BUN, and hyperkalemia), can help distinguish ATN from other causes of acute kidney injury (AKI).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which dialysis modality is most appropriate for a hemodynamically unstable patient with AKI and severe fluid overload?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intermittent hemodialysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continuous renal replacement therapy (CRRT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peritoneal dialysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sustained low-efficiency dialysis (SLED)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Continuous renal replacement therapy (CRRT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Continuous renal replacement therapy (CRRT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intermittent hemodialysis : Intermittent hemodialysis can cause hemodynamic instability in these patients.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Intermittent hemodialysis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Peritoneal dialysis : Peritoneal dialysis is less efficient and may not be suitable for severe fluid overload.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Peritoneal dialysis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sustained low-efficiency dialysis (SLED) : SLED is a hybrid modality but may not be tolerated in unstable patients&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Sustained low-efficiency dialysis (SLED)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the role of continuous renal replacement therapy (CRRT) as the preferred dialysis modality for hemodynamically unstable patients with acute kidney injury (AKI) and severe fluid overload. CRRT allows for gentle and continuous removal of fluids and solutes, minimizing the risk of hypotension compared to intermittent hemodialysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT an absolute indication for dialysis in AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Severe hyperkalemia unresponsive to medical therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uremic pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Severe fluid overload unresponsive to diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;BUN level of 120 mg/dL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. BUN level of 120 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) BUN level of 120 mg/Dl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Severe hyperkalemia unresponsive to medical therapy , Option B. Uremic pericarditis and Option C. Severe fluid overload unresponsive to diuretics : These are all absolute indications for dialysis in AKI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Severe hyperkalemia unresponsive to medical therapy&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Uremic pericarditis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Severe fluid overload unresponsive to diuretics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The absolute indications for dialysis in AKI, which include severe hyperkalemia unresponsive to medical therapy, uremic pericarditis, and severe fluid overload unresponsive to diuretics. Elevated BUN alone is not an absolute indication, and the decision to initiate dialysis should be based on the overall clinical context and the presence of life-threatening complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about ambulatory blood pressure monitoring (ABPM) is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It measures BP every 15-30 minutes during the day and every 15-60 minutes at night.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It provides a more comprehensive assessment of BP than isolated clinic readings.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is less reliable than home BP monitoring for predicting target organ damage.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An attenuated nocturnal BP dip is associated with increased cardiovascular risk.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is less reliable than home BP monitoring for predicting target organ damage.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is less reliable than home BP monitoring for predicting target organ damage.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night : ABPM takes frequent BP readings throughout the day and night, providing a more complete picture than clinic readings.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night&lt;/li&gt;&lt;li&gt;â€¢ Option B. It provides a more comprehensive assessment of BP than isolated clinic readings : ABPM captures BP variations throughout the day, unlike isolated clinic readings.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It provides a more comprehensive assessment of BP than isolated clinic readings&lt;/li&gt;&lt;li&gt;â€¢ Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk : Less pronounced or absent nocturnal BP dips are linked to higher cardiovascular risk. ABPM helps identify these patterns.&lt;/li&gt;&lt;li&gt;â€¢ Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ABPM is a valuable tool for diagnosing and managing hypertension because it provides a more complete and accurate assessment of blood pressure patterns than other methods.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman visits her primary care physician for an annual health examination. Her blood pressure is measured as 135/85 mmHg, with no prior history of hypertension. The physician schedules two additional blood pressure measurements over the next month. Which of the following methods is the physician using to diagnose hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ABPM (Ambulatory Blood Pressure Monitoring)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HBPM (Home Blood Pressure Monitoring)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;OBPM (Office Blood Pressure Monitoring)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. OBPM (Office Blood Pressure Monitoring)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) OBPM (Office Blood Pressure Monitoring)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ABPM (Ambulatory Blood Pressure Monitoring): This involves continuous blood pressure monitoring over 24 hours using a wearable device. It is more precise than OBPM but not the method described in the vignette.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ABPM (Ambulatory Blood Pressure Monitoring):&lt;/li&gt;&lt;li&gt;â€¢ Option B. HBPM (Home Blood Pressure Monitoring): This involves the patient measuring their blood pressure at home using their own device. While valuable, the vignette does not mention the patient taking measurements at home.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HBPM (Home Blood Pressure Monitoring):&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above: This is incorrect as the vignette only describes the use of OBPM in a clinical setting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The initial diagnosis of hypertension typically relies on Office Blood Pressure Monitoring (OBPM) , where multiple readings are taken in a clinical setting over a period of time to confirm the diagnosis and rule out white coat hypertension. While ABPM and HBPM are valuable tools for monitoring blood pressure and assessing its patterns, they are not typically the first step in diagnosing hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Office Blood Pressure Monitoring (OBPM)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man with a family history of hypertension has normal clinic blood pressure readings (128/82 mmHg) but 24-hour ambulatory monitoring reveals consistently elevated readings (135-145/85-90 mmHg). What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;White coat hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Masked hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Secondary hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Masked hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Masked hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. White coat hypertension : This is the opposite of masked hypertension, where blood pressure is elevated in the clinic but normal outside.&lt;/li&gt;&lt;li&gt;â€¢ Option A. White coat hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary hypertension : While this patient likely has hypertension, the term \&quot;primary\&quot; doesn&#x27;t account for the specific pattern seen here with normal clinic readings.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option D. Secondary hypertension : This refers to hypertension caused by an underlying medical condition, which is not indicated in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Secondary hypertension&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The diagnosis in this case is masked hypertension , characterized by normal blood pressure readings in a clinical setting but elevated readings during ambulatory monitoring. This highlights the importance of using ambulatory monitoring to accurately assess blood pressure and diagnose hypertension, especially in individuals with a family history of hypertension or other risk factors.&lt;/li&gt;&lt;li&gt;â€¢ masked hypertension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman with well-controlled type 2 diabetes presents for a routine health examination. Her in-office blood pressure is 142/88 mmHg, but her average blood pressure at home over two weeks is 122/78 mmHg. She reports feeling nervous during medical appointments. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Masked hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;White coat hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Secondary hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. White coat hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) White coat hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Masked hypertension: This is the opposite of white coat hypertension, with normal clinic readings but elevated blood pressure outside the clinic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Masked hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary hypertension: While this patient may eventually develop sustained hypertension, the current findings are not consistent with this diagnosis. Primary hypertension would typically present with consistently elevated readings in both clinic and home settings.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Secondary hypertension: This refers to hypertension caused by an underlying medical condition, such as renal artery stenosis or pheochromocytoma. There is no indication of secondary hypertension in this patient&#x27;s history or presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Secondary hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The diagnosis in this case is white coat hypertension , where blood pressure readings are elevated in a clinical setting but normal at home. This is often caused by anxiety or stress related to the medical environment, which the patient reports experiencing.&lt;/li&gt;&lt;li&gt;â€¢ white coat hypertension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a pheochromocytoma scheduled for surgical resection presents with a blood pressure of 180/100 mmHg and episodic headaches and sweating. Which of the following medications should be initiated pre-operatively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta-blocker (e.g., propranolol)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpha-blocker (e.g., phenoxybenzamine)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calcium channel blocker (e.g., amlodipine)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Angiotensin-converting enzyme inhibitor (e.g., lisinopril)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alpha-blocker (e.g., phenoxybenzamine)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alpha-blocker (e.g., phenoxybenzamine)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-blocker: Beta-blockers should be avoided initially as they can worsen hypertension by causing unopposed alpha-adrenergic stimulation. They may be added later for tachycardia control after adequate alpha-blockade is established.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-blocker:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Calcium channel blocker: While calcium channel blockers have antihypertensive effects, they are not the first-line agents for pheochromocytoma and are less effective in controlling the episodic hypertension caused by catecholamine surges.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Calcium channel blocker:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Angiotensin-converting enzyme inhibitor (ACE inhibitor): ACE inhibitors are not recommended for initial blood pressure control in pheochromocytoma, as they do not directly address the underlying catecholamine excess and may not effectively control blood pressure fluctuations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Angiotensin-converting enzyme inhibitor (ACE inhibitor):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Alpha-blockers are the first-line medication for pre-operative blood pressure control in patients with pheochromocytoma. They counteract the effects of catecholamines released by the tumor, preventing hypertensive crises during surgery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following congenital cardiovascular conditions is most commonly associated with hypertension in children and young adults?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial septal defect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coarctation of the aorta&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Coarctation of the aorta&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Coarctation of the aorta&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patent ductus arteriosus (PDA): While PDA can cause heart murmurs and other symptoms, it doesn&#x27;t typically cause hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patent ductus arteriosus (PDA):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial septal defect (ASD): ASD is a hole in the wall separating the atria, and it usually doesn&#x27;t cause significant hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atrial septal defect (ASD):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal defect (VSD): VSD is a hole in the wall separating the ventricles. It can cause heart failure if large, but doesn&#x27;t typically cause isolated hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventricular septal defect (VSD):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Coarctation of the aorta is the most common congenital heart defect associated with hypertension in children and young adults. This narrowing of the aorta increases blood pressure before the constriction and can lead to various symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about alcohol consumption and blood pressure is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Moderate alcohol consumption has no effect on blood pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drinking three or more alcoholic drinks per day is associated with lower blood pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reducing alcohol consumption can lead to a decrease in blood pressure.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alcohol consumption has no impact on the risk of stroke.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reducing alcohol consumption can lead to a decrease in blood pressure.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reducing alcohol consumption can lead to a decrease in blood pressure.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Moderate alcohol consumption has no effect on blood pressure : Moderate alcohol consumption may have a slight effect on blood pressure, but it is not considered neutral.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Moderate alcohol consumption has no effect on blood pressure&lt;/li&gt;&lt;li&gt;â€¢ Option B. Drinking three or more alcoholic drinks per day is associated with lower blood pressure : Excessive alcohol intake is associated with higher , not lower, blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Drinking three or more alcoholic drinks per day is associated with lower blood pressure&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alcohol consumption has no impact on the risk of stroke : Excessive alcohol intake is a risk factor for stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alcohol consumption has no impact on the risk of stroke&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Excessive alcohol consumption is a modifiable risk factor for hypertension. Reducing alcohol intake can lead to a decrease in blood pressure, improving overall cardiovascular health and reducing the risk of stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with a history of diabetes and hypertension presents for a routine check-up. Her blood pressure is 150/95 mmHg. Which of the following laboratory tests is NOT routinely recommended as part of the initial evaluation of hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum creatinine and estimated glomerular filtration rate (eGFR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum electrolytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fasting blood glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renin-aldosterone ratio&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Renin-aldosterone ratio&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Renin-aldosterone ratio&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum creatinine and estimated glomerular filtration rate (eGFR), Option B. Serum electrolytes, and Option C. Fasting blood glucose : Serum creatinine, eGFR, electrolytes, and fasting blood glucose are all part of the basic laboratory tests recommended for the initial evaluation of hypertension. They help assess renal function, electrolyte balance, and underlying conditions like diabetes that can contribute to hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum creatinine and estimated glomerular filtration rate (eGFR), Option B. Serum electrolytes,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fasting blood glucose&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The initial evaluation of hypertension focuses on assessing end-organ damage (kidneys), identifying contributing factors (electrolytes, diabetes), and establishing a baseline for monitoring the patient&#x27;s condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical symptom of hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatigue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Palpitations&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Epistaxis (nosebleed)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Palpitations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Palpitations&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Headache, Option B. Fatigue and Option D. Epistaxis (nosebleed) : These symptoms can sometimes be associated with hypertension, although they are not specific&lt;/li&gt;&lt;li&gt;â€¢ Option A. Headache, Option B. Fatigue&lt;/li&gt;&lt;li&gt;â€¢ Option D. Epistaxis (nosebleed)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Recognize that hypertension is often asymptomatic and emphasize the importance of regular blood pressure checks for early detection and management. Differentiate between potential, but not typical, symptoms of hypertension (headache, fatigue, epistaxis) and symptoms not typically associated with hypertension (palpitations). Highlight the importance of considering other potential causes for these nonspecific symptoms when evaluating a patient.&lt;/li&gt;&lt;li&gt;â€¢ Recognize that hypertension is often asymptomatic and emphasize the importance of regular blood pressure checks for early detection and management.&lt;/li&gt;&lt;li&gt;â€¢ Recognize&lt;/li&gt;&lt;li&gt;â€¢ Differentiate between potential, but not typical, symptoms of hypertension (headache, fatigue, epistaxis) and symptoms not typically associated with hypertension (palpitations).&lt;/li&gt;&lt;li&gt;â€¢ Differentiate&lt;/li&gt;&lt;li&gt;â€¢ Highlight the importance of considering other potential causes for these nonspecific symptoms when evaluating a patient.&lt;/li&gt;&lt;li&gt;â€¢ Highlight&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following physical examination findings is most suggestive of secondary hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abdominal bruit&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Retinal arteriolar narrowing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;S4 gallop&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Abdominal bruit&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Abdominal bruit&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obesity : Obesity is a risk factor for primary hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Obesity&lt;/li&gt;&lt;li&gt;â€¢ Option C. Retinal arteriolar narrowing : Retinal arteriolar narrowing is a sign of hypertensive retinopathy, a consequence of hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Retinal arteriolar narrowing&lt;/li&gt;&lt;li&gt;â€¢ Option D. S4 gallop : S4 gallop can be heard in hypertensive heart disease but is not specific for secondary hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. S4 gallop&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Abdominal bruit is a significant finding on physical examination that should raise suspicion for secondary hypertension, specifically renal artery stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with hypertension presents with a blood pressure of 210/120 mmHg, headache, and mild dyspnea. He has no evidence of acute organ damage. What is the best management strategy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate BP reduction to normal with IV drugs.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gradual BP reduction to 25% of initial value over 24 hours.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ICU admission for aggressive BP control.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Discharge with outpatient follow-up.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gradual BP reduction to 25% of initial value over 24 hours.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Gradual BP reduction to 25% of initial value over 24 hours.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Immediate BP reduction to normal with IV drugs : Immediate reduction to normal BP is too aggressive for a hypertensive urgency and could cause ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Immediate BP reduction to normal with IV drugs&lt;/li&gt;&lt;li&gt;â€¢ Option C. ICU admission for aggressive BP control : ICU admission is unnecessary as there is no evidence of organ damage.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ICU admission for aggressive BP control&lt;/li&gt;&lt;li&gt;â€¢ Option D. Discharge with outpatient follow-up : Discharge without treatment is inappropriate due to the severity of the hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Discharge with outpatient follow-up&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The distinction between hypertensive urgency and emergency is crucial for appropriate management. Hypertensive urgency requires gradual blood pressure reduction, while hypertensive emergency necessitates rapid intervention to prevent end-organ damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with a history of hypertension and chronic kidney disease presents with a blood pressure of 200/120 mmHg and acute visual disturbances. Which of the following is the most appropriate medication for initial blood pressure control in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous sodium nitroprusside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous labetalol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sublingual nifedipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous labetalol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intravenous labetalol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous sodium nitroprusside : Sodium nitroprusside is a potent vasodilator, but it can cause cyanide toxicity, especially in patients with renal insufficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous sodium nitroprusside&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral clonidine : Oral clonidine is not used in hypertensive emergencies due to its slow onset of action.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral clonidine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sublingual nifedipine : Sublingual nifedipine is associated with unpredictable blood pressure drops and is not recommended.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sublingual nifedipine&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Intravenous labetalol is a preferred medication for initial blood pressure control in hypertensive emergencies, especially in patients with underlying renal disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old pregnant woman in her third trimester presents with a blood pressure of 170/110 mmHg and proteinuria. Which of the following medications is most appropriate for controlling her blood pressure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nitroprusside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enalaprilat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phentolamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hydralazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nitroprusside : Should be avoided in pregnancy due to the risk of cyanide toxicity to the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nitroprusside&lt;/li&gt;&lt;li&gt;â€¢ Option C. Enalaprilat (an ACE inhibitor) : Contraindicated in pregnancy due to the risk of fetal harm.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Enalaprilat (an ACE inhibitor)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phentolamine : Not typically used for hypertension in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Phentolamine&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine is a safe and effective vasodilator for controlling blood pressure in pregnant women with preeclampsia/eclampsia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with hypertension and a recent myocardial infarction (MI) is being discharged from the hospital. Which medication combination is most appropriate for his secondary prevention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACEi + ARB + CCB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BB + ACEi + Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BB + CCB + Thiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ARB + Thiazide + Spironolactone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. BB + ACEi + Spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) BB + ACEi + Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other options either lack evidence for post-MI benefit or include combinations that could be harmful (e.g., ACEi + ARB).&lt;/li&gt;&lt;li&gt;â€¢ other options&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ This combination is recommended for secondary prevention in patients with hypertension and a recent MI due to strong evidence for mortality reduction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a history of hypertension and migraines presents for follow-up. Which antihypertensive medication would be most suitable given her comorbidities?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Metoprolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Metoprolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Other options do not have the dual indication.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers are the only class of antihypertensives indicated for both hypertension and migraine prophylaxis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old pregnant woman is diagnosed with gestational hypertension. Which of the following antihypertensive medications is considered safe for use during pregnancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Labetalol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Labetalol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACE inhibitors (Lisinopril) and Option B. ARBs (Losartan) are contraindicated in pregnancy due to fetal risks.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACE inhibitors (Lisinopril)&lt;/li&gt;&lt;li&gt;â€¢ Option B. ARBs (Losartan)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amlodipine: The safety of amlodipine and hydrochlorothiazide during pregnancy is not well established.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amlodipine:&lt;/li&gt;&lt;li&gt;â€¢ amlodipine&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Labetalol is the first-line medication for gestational hypertension due to its established safety profile in pregnancy. ACE inhibitors and ARBs are contraindicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the first line treatment of hypertensive emergency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV labetalol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV labetalol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IV labetalol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral amlodipine : Oral medications are not indicated in emergency situations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral amlodipine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral furosemide and Option D. IV furosemide: IV furosemide is a diuretic and may be used as an adjunct, but not as the primary treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral furosemide&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV furosemide:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ IV labetalol is a common first-line treatment for hypertensive emergencies due to its rapid onset and combined alpha- and beta-blocking effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of hypertension and chronic obstructive pulmonary disease (COPD) requires an additional antihypertensive medication. Which of the following would be the most appropriate choice given his comorbidities?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atenolol (beta-blocker)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lisinopril (ACE inhibitor)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine (calcium channel blocker)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide (thiazide diuretic) e) Losartan (ARB)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amlodipine (calcium channel blocker)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Amlodipine (calcium channel blocker)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other options may be less suitable due to potential adverse effects on lung function or lack of evidence for specific benefits in COPD.&lt;/li&gt;&lt;li&gt;â€¢ other options&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Calcium channel blockers are often preferred in patients with hypertension and COPD due to their neutral effect on lung function, while beta-blockers should be used with caution.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a cause of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diuretic excess&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mineralocorticoid deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebral salt wasting syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diuretic excess, Option B. Mineralocorticoid deficiency, and Option C. Cerebral salt wasting syndrome are all causes of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diuretic excess, Option B. Mineralocorticoid deficiency, and Option C. Cerebral salt wasting syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the different types of hyponatremia and their associated urine sodium levels. Hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L is caused by renal sodium loss (e.g., diuretics, mineralocorticoid deficiency) or extrarenal sodium loss (e.g., cerebral salt wasting). SIADH is euvolemic hyponatremia with high urine sodium due to excessive water retention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with a history of congestive heart failure presents with confusion, nausea, and a serum sodium level of 128 mEq/L. Her physical exam reveals jugular venous distention and bilateral crackles on lung auscultation. Which of the following is the most likely cause of her hyponatremia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary adrenal insufficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypervolemic hyponatremia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypervolemic hyponatremia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypervolemic hyponatremia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH): While SIADH can cause hyponatremia, it is typically euvolemic (normal fluid volume status) and does not present with signs of fluid overload like JVD and crackles.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypothyroidism: Hypothyroidism can cause mild hyponatremia, but it is usually not associated with the degree of hyponatremia and fluid overload seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypothyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary adrenal insufficiency: Primary adrenal insufficiency can cause hyponatremia due to aldosterone deficiency. However, it typically presents with additional symptoms such as fatigue, weight loss, and hypotension, which are not present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary adrenal insufficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the clinical presentation of hypervolemic hyponatremia, which is characterized by low serum sodium, fluid overload (JVD, edema, crackles), and often associated with underlying conditions like heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a common cause of euvolemic hyponatremia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SIADH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary polydipsia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cirrhosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion): In SIADH, excess antidiuretic hormone (ADH) leads to water retention, diluting sodium levels. However, the body&#x27;s total sodium content remains normal, resulting in euvolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary polydipsia: Excessive water intake in individuals with normal kidney function can overwhelm the kidneys&#x27; ability to excrete water, leading to dilutional hyponatremia without changes in total body sodium (euvolemic).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary polydipsia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypothyroidism: In hypothyroidism, decreased thyroid hormone levels can impair water excretion by the kidneys, leading to water retention and dilutional hyponatremia without changes in total body sodium (euvolemic).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypothyroidism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that cirrhosis is typically associated with hypervolemic hyponatremia, not euvolemic hyponatremia. Euvolemic hyponatremia is usually caused by SIADH, primary polydipsia, or hypothyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with severe hyponatremia (serum sodium 115 mEq/L) develops seizures and altered mental status. Which of the following is the most appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Normal saline infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertonic saline infusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Demeclocycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypertonic saline infusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypertonic saline infusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluid restriction : Fluid restriction is appropriate for mild hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluid restriction&lt;/li&gt;&lt;li&gt;â€¢ Option B. Normal saline infusion : Normal saline is not effective in severe hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Normal saline infusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Demeclocycline : Demeclocycline is used for chronic SIADH, not acute, severe hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Demeclocycline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize severe symptomatic hyponatremia as a medical emergency requiring prompt treatment with hypertonic saline (3%) to rapidly raise serum sodium levels and prevent neurological complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is NOT associated with the development of SIAD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorpropamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Selective serotonin reuptake inhibitors (SSRIs)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hydrochlorothiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hydrochlorothiazide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chlorpropamide , Option B. Carbamazepine , and Option D. Selective serotonin reuptake inhibitors (SSRIs ) are listed in the table as drugs that can stimulate ADH release or enhance its action, leading to SIAD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chlorpropamide&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Selective serotonin reuptake inhibitors (SSRIs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize that hydrochlorothiazide is not associated with the development of SIADH, while other medications like chlorpropamide, carbamazepine, and SSRIs can stimulate ADH release or enhance its action, leading to SIADH. Understanding the potential side effects of medications is crucial for accurate diagnosis and management of hyponatremia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with small cell lung cancer presents with chronic hyponatremia (125 mEq/L) due to SIADH. Which of the following is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertonic saline (3%) infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid restriction to 500-800 ml/day&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Demeclocycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tolvaptan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fluid restriction to 500-800 ml/day&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fluid restriction to 500-800 ml/day&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertonic saline (3%) infusion : Hypertonic saline is reserved for severe symptomatic hyponatremia or rapid correction in specific situations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertonic saline (3%) infusion&lt;/li&gt;&lt;li&gt;â€¢ Option C. Demeclocycline : Demeclocycline is a second-line agent used if fluid restriction fails.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Demeclocycline&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tolvaptan : Tolvaptan is a vasopressin receptor antagonist, also considered second-line after fluid restriction.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Tolvaptan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that fluid restriction is the most appropriate initial treatment for chronic SIADH, as it allows for gradual correction of hyponatremia without the risks associated with more aggressive therapies like hypertonic saline or medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man with a recent subarachnoid hemorrhage develops hyponatremia, hypotension, and polyuria. His urine sodium is 50 mEq/L. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cerebral salt wasting (CSW)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary polydipsia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute tubular necrosis (ATN)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cerebral salt wasting (CSW)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cerebral salt wasting (CSW)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) : Typically euvolemic (normal fluid status) with low urine sodium (&amp;lt;20 mEq/L).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary polydipsia : Euvolemic with low urine sodium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Primary polydipsia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute tubular necrosis (ATN) : Would cause oliguria, not polyuria.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute tubular necrosis (ATN)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the characteristic features of cerebral salt wasting (CSW), a syndrome that can occur after brain injury and presents with hyponatremia, hypovolemia, and elevated urine sodium. Distinguishing CSW from other causes of hyponatremia, such as SIADH, is crucial for appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with hypovolemic hyponatremia and a urine sodium of 10 mEq/L should be treated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertonic saline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Demeclocycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Normal saline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Normal saline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluid restriction : Fluid restriction would worsen hypovolemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluid restriction&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertonic saline : Hypertonic saline is not the initial choice for hypovolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertonic saline&lt;/li&gt;&lt;li&gt;â€¢ Option D. Demeclocycline : Demeclocycline is not indicated for hypovolemic hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Demeclocycline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that hypovolemic hyponatremia with low urine sodium (&amp;lt;20 mEq/L) indicates extrarenal salt loss and should be treated with normal saline to restore both volume and sodium balance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of alcohol abuse presents with progressive weakness and spasticity in his legs two days after rapid correction of severe hyponatremia. Given the likely diagnosis, Which of the following neuroimaging findings would be present in the MRI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;T2 hyperintensity in the basal ganglia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gadolinium enhancement in the thalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T2 hyperintensity in the central pons with sparing of the periphery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diffusion restriction in the cerebral cortex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. T2 hyperintensity in the central pons with sparing of the periphery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) T2 hyperintensity in the central pons with sparing of the periphery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. T2 hyperintensity in the basal ganglia and Option B. Gadolinium enhancement in the thalamus : These findings are not specific to CPM.&lt;/li&gt;&lt;li&gt;â€¢ Option A. T2 hyperintensity in the basal ganglia&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Gadolinium enhancement in&lt;/li&gt;&lt;li&gt;â€¢ the&lt;/li&gt;&lt;li&gt;â€¢ thalamus&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diffusion restriction in the cerebral cortex : Diffusion restriction can be seen in various acute brain lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diffusion restriction in the cerebral cortex&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the classic MRI findings of central pontine myelinolysis (CPM), which include T2 hyperintensity in the central pons with sparing of the periphery. This is a crucial diagnostic feature that can help differentiate CPM from other neurological conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most effective intervention to prevent or attenuate osmotic demyelination syndrome (ODS) after overly rapid correction of hyponatremia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous mannitol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral urea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous mannitol : Mannitol may worsen osmotic stress.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous mannitol&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral urea : Oral urea is not indicated in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Oral urea&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corticosteroids : Corticosteroids have no proven benefit in preventing ODS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corticosteroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize that re-lowering of plasma sodium concentration with desmopressin (DDAVP) and/or free water is the most effective intervention for preventing or attenuating osmotic demyelination syndrome (ODS) after overly rapid correction of hyponatremia. This is based on the principle of reversing the osmotic gradient that causes myelinolysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with dementia presents with lethargy, decreased oral intake for two days, and a serum sodium of 160 mEq/L. His weight is 70kg. Assuming total body water (TBW) is 60% of his body weight, what is his estimated free water deficit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2 liters&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4 liters&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;6 liters&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;8 liters&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 6 liters&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 6 liters&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 2 liters, Option B. 4 liters and Option D. 8 liters: These options represent incorrect calculations of the free water deficit using the formula above.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 2 liters, Option B. 4 liters&lt;/li&gt;&lt;li&gt;â€¢ Option D. 8 liters:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand how to calculate free water deficit in a patient with hypernatremia. This is a crucial step in determining the appropriate amount of fluid replacement needed to correct the hypernatremia safely.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical ECG finding in hyperkalemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peaked T waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prolonged PR interval&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;U waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Widened QRS complex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. U waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) U waves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peaked T waves, Option B. Prolonged PR interval and Option D. Widened QRS complex : These are all characteristic ECG changes seen in hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Peaked T waves, Option B. Prolonged PR interval&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Widened QRS&lt;/li&gt;&lt;li&gt;â€¢ complex&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the characteristic ECG findings in hyperkalemia, which include peaked T waves, prolonged PR interval, and widened QRS complex. U waves, on the other hand, are typically associated with hypokalemia. Understanding these ECG changes is crucial for the prompt diagnosis and management of hyperkalemia, a potentially life-threatening electrolyte imbalance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with chronic kidney disease presents to the emergency department with muscle weakness, peaked T waves on ECG, and a serum potassium level of 7.0 mEq/L. Which of the following is the most appropriate immediate intervention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer oral sodium polystyrene sulfonate (Kayexalate)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer intravenous calcium gluconate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate hemodialysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Administer intravenous insulin and glucose&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Administer intravenous calcium gluconate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Administer intravenous calcium gluconate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer oral sodium polystyrene sulfonate ( Kayexalate) : Kayexalate is a potassium binder but works too slowly for acute hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Administer oral sodium polystyrene sulfonate (&lt;/li&gt;&lt;li&gt;â€¢ Kayexalate)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate hemodialysis : Hemodialysis is effective but may not be immediately available.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate hemodialysis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer intravenous insulin and glucose : Insulin and glucose shift potassium intracellularly, but calcium should be given first to protect the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer intravenous insulin and glucose&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the importance of administering intravenous calcium gluconate as the immediate intervention for patients presenting with hyperkalemia and ECG changes. This medication acts quickly to stabilize the cardiac membrane and protect against potentially fatal arrhythmias. While other options like Kayexalate, hemodialysis, and insulin/glucose can help lower potassium levels, they may not act rapidly enough to prevent immediate cardiac complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a history of chronic diarrhea presents with muscle weakness, fatigue, and palpitations. Her serum potassium is 2.8 mEq/L. Which of the following ECG findings would be most consistent with her presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peaked T waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Shortened QT interval&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent U waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ST segment elevation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prominent U waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prominent U waves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peaked T waves : Peaked T waves are associated with hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peaked T waves&lt;/li&gt;&lt;li&gt;â€¢ Option B. Shortened QT interval : Hypokalemia typically prolongs the QT interval, not shortens it.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Shortened QT interval&lt;/li&gt;&lt;li&gt;â€¢ Option D. ST segment elevation : ST segment elevation is typically seen in myocardial infarction or pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ST segment elevation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the characteristic ECG finding of hypokalemia, which is the presence of prominent U waves. This finding, along with the patient&#x27;s symptoms (muscle weakness, fatigue, palpitations) and history of chronic diarrhea (a potential cause of potassium loss), helps confirm the diagnosis of hypokalemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with poorly controlled type 2 diabetes presents with altered mental status, Kussmaul respirations, and fruity breath. Labs show glucose of 650 mg/dL, pH of 7.20, and potassium of 2.9 mEq/L. Which mechanism best explains his hypokalemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased urinary potassium excretion due to glycosuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vomiting-induced potassium loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insulin deficiency-induced intracellular shift of potassium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Shift of potassium into cells in exchange for hydrogen ions&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Shift of potassium into cells in exchange for hydrogen ions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Shift of potassium into cells in exchange for hydrogen ions.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ DKA causes urinary potassium loss and a shift of potassium into cells to buffer acidosis. This initial exchange can lead to a temporary rise in potassium, but overall potassium stores are depleted.&lt;/li&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased urinary potassium excretion due to glycosuria: While glycosuria (glucose in the urine) can contribute to potassium loss, it is not the primary mechanism in DKA. The exchange mechanism with hydrogen ions plays a more significant role.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased urinary potassium excretion due to glycosuria:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vomiting-induced potassium loss: Vomiting can cause hypokalemia, but it is not the dominant factor in DKA, where the underlying metabolic derangements are more critical.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vomiting-induced potassium loss:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Insulin deficiency-induced intracellular shift of potassium: Insulin deficiency does initially cause potassium to shift out of cells, leading to a temporary increase in serum potassium. However, this is followed by the exchange with hydrogen ions, resulting in overall potassium depletion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Insulin deficiency-induced intracellular shift of potassium:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the complex mechanisms of hypokalemia in diabetic ketoacidosis (DKA). It is important to recognize that the initial hyperkalemia is transient, and the overall effect is total body potassium depletion due to the shift of potassium into cells to buffer acidosis and urinary potassium loss through glycosuria. This understanding is crucial for appropriate management of DKA, which includes potassium replacement along with insulin and fluid therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with muscle cramps and weakness. Her serum potassium is 2.5 mEq/L. She has been taking furosemide for hypertension and reports frequent watery diarrhea. Her blood pressure is 110/70 mmHg. What is the most likely cause of her hypokalemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gitelman syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperaldosteronism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal tubular acidosis (RTA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diuretic use&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diuretic use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diuretic use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gitelman syndrome: This is a genetic disorder causing hypokalemia, but it typically presents with milder hypokalemia and often involves low urine calcium excretion, which is not mentioned in the case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gitelman syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary hyperaldosteronism: This condition can cause hypokalemia due to increased potassium excretion, but it usually leads to high blood pressure, which is not present in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary hyperaldosteronism:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal tubular acidosis (RTA): RTA can also cause hypokalemia, but it often presents with metabolic acidosis, which is not mentioned in the case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal tubular acidosis (RTA):&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ To identify diuretic use as the most common cause of hypokalemia in patients presenting with muscle cramps and weakness, especially in those with a history of diuretic therapy and additional sources of potassium loss like diarrhea.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with a history of Crohn&#x27;s disease and chronic diarrhea presents with fatigue and muscle cramps. Laboratory tests reveal a serum potassium of 3.0 mEq/L and metabolic alkalosis. Which of the following is the most likely mechanism of her hypokalemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Renal tubular acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperaldosteronism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastrointestinal losses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diuretic use&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gastrointestinal losses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gastrointestinal losses&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Renal tubular acidosis : Renal tubular acidosis typically presents with metabolic acidosis and hyperkalemia, not alkalosis and hypokalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Renal tubular acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Primary hyperaldosteronism : Primary hyperaldosteronism causes hypokalemia but not metabolic alkalosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Primary hyperaldosteronism&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diuretic use : Diuretic use is not mentioned in the patient&#x27;s history&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diuretic use&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the association between chronic diarrhea in Crohn&#x27;s disease and hypokalemia with metabolic alkalosis. Gastrointestinal losses of potassium and bicarbonate can lead to this electrolyte imbalance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old athlete presents with sudden-onset muscle paralysis after completing a marathon. He has been consuming large amounts of water during the race. His blood pressure is normal, and he is afebrile. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypokalemic periodic paralysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exertional rhabdomyolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heat stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyponatremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypokalemic periodic paralysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypokalemic periodic paralysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exertional rhabdomyolysis: While marathon running can cause rhabdomyolysis, this would usually present with muscle pain, weakness, and dark urine, rather than sudden paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exertional rhabdomyolysis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heat stroke: Heat stroke would likely cause hyperthermia and altered mental status, neither of which is mentioned in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heat stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyponatremia: Excessive water intake during a marathon can cause hyponatremia, which can also lead to neurological symptoms, but sudden paralysis is more characteristic of hypokalemic periodic paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyponatremia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that hypokalemic periodic paralysis can present with sudden-onset muscle paralysis, often triggered by strenuous exercise and excessive water intake. This condition should be considered in athletes experiencing such symptoms after intense physical activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are preparing to administer potassium chloride (KCl) to a patient with hypokalemia. The physician has ordered 40 mEq of KCl, and the available solution concentration is 2 mEq/mL. How many milliliters of KCl should you draw up in the syringe?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20 mL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;40 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;80 mL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 20 mL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 20 mL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the calculation of medication dosage and volume based on the desired dose and concentration of the solution. In this case, the formula Volume (mL) = Dose (mEq) / Concentration (mEq/mL) was used to determine the correct volume of potassium chloride (KCl) to administer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of chronic alcoholism and diuretic use is admitted to the hospital for community-acquired pneumonia. Laboratory results reveal a serum potassium level of 2.8 mEq/L and an ECG demonstrating flattened T waves and prominent U waves. What other electrolyte abnormality are you suspecting in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypocalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypermagnesemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypomagnesemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypomagnesemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypomagnesemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypernatremia: Hypernatremia (high sodium) is not typically associated with hypokalemia in this clinical scenario. Alcoholism is more often associated with hyponatremia (low sodium).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypernatremia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypocalcemia: While hypocalcemia can occur in alcoholics, it is not directly related to hypokalemia and its correction is not necessary for effective potassium repletion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypocalcemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypermagnesemia: Hypermagnesemia (high magnesium) is rare and usually occurs in the setting of renal failure or excessive magnesium intake. It is not a common finding in alcoholism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypermagnesemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the association between chronic alcoholism and hypomagnesemia, which often coexists with hypokalemia. Understanding this relationship is crucial for effective treatment, as magnesium repletion is often necessary for successful potassium replacement in these patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In CKD, the remaining nephrons undergo hyperfiltration and hypertrophy to compensate for lost renal mass. Which of the following is a long-term consequence of these adaptations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Improved renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glomerulosclerosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased renal blood flow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased intrarenal pressure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glomerulosclerosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glomerulosclerosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Improved renal function: Hyperfiltration and hypertrophy only temporarily maintain GFR and eventually lead to decline.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Improved renal function:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased renal blood flow: While blood flow initially increases, it eventually decreases as nephrons are lost.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased renal blood flow:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased intrarenal pressure: Intrarenal pressure actually increases due to hyperfiltration, contributing to damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased intrarenal pressure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that while hyperfiltration and hypertrophy are initially compensatory mechanisms in chronic kidney disease (CKD), they ultimately lead to glomerulosclerosis and progressive decline in renal function. Recognizing this pathophysiological process highlights the importance of early intervention and management to slow down the progression of CKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a 10-year history of systemic lupus erythematosus (SLE) presents with fatigue, edema, and hypertension. Laboratory tests reveal proteinuria and an estimated glomerular filtration rate (eGFR) of 40 mL/min/1.73m2. Which of the following is the most likely cause of her chronic kidney disease (CKD)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetic nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertensive nephrosclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diabetic nephropathy : Diabetic nephropathy is not associated with SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diabetic nephropathy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertensive nephrosclerosis : While hypertension can contribute to CKD, it&#x27;s less likely to be the primary cause in a young patient with SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypertensive nephrosclerosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgA nephropathy : IgA nephropathy typically presents with recurrent hematuria, not the constellation of symptoms seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgA nephropathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize lupus nephritis as a common and potentially serious complication of systemic lupus erythematosus (SLE). Early detection and management are crucial to preventing the progression of lupus nephritis to chronic kidney disease (CKD) and end-stage renal disease (ESRD).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about cardiovascular disease (CVD) in chronic kidney disease (CKD) is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CVD is the leading cause of death in patients with CKD.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The risk of CVD decreases as CKD progresses.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Traditional CVD risk factors are not important in CKD patients.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Early-stage CKD patients do not require CVD screening.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CVD is the leading cause of death in patients with CKD.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CVD is the leading cause of death in patients with CKD.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. The risk of CVD decreases as CKD progresses : The risk of CVD increases as CKD progresses.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The risk of CVD decreases as CKD progresses&lt;/li&gt;&lt;li&gt;â€¢ Option C. Traditional CVD risk factors are not important in CKD patients : Traditional CVD risk factors are important, but CKD-specific risk factors must also be considered.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Traditional CVD risk factors are not important in CKD patients&lt;/li&gt;&lt;li&gt;â€¢ Option D. Early-stage CKD patients do not require CVD screening : Early CVD screening and prevention are crucial in CKD patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Early-stage CKD patients do not require CVD screening&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the significant impact of cardiovascular disease (CVD) on patients with chronic kidney disease (CKD). It is crucial to recognize that CVD is the leading cause of death in this population and that the risk increases as CKD progresses. This knowledge highlights the importance of early CVD screening and aggressive management of both traditional and CKD-specific risk factors to improve outcomes for patients with CKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient presents with a GFR of 50 mL/min/1.73mÂ² and an albuminuria level of 150 mg/g. According to the KDIGO 2012 classification, what is the patient&#x27;s CKD stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G2A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;G3aA2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G3bA2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;G4A2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. G3aA2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ According to the KDIGO 2012 classification, CKD staging is determined by both GFR levels and albuminuria categories. With a GFR of 50 mL/min/1.73mÂ², this patient falls into the G3a category (45-59 mL/min/1.73mÂ²), which represents \&quot;mildly to moderately decreased\&quot; kidney function. The albuminuria level of 150 mg/g places the patient in the A2 category (30-300 mg/g), representing \&quot;moderately increased\&quot; albuminuria. Together, these values classify the patient as G3aA2.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A) G2A2 - This is incorrect because while the albuminuria category (A2) is appropriate, the GFR of 50 mL/min/1.73mÂ² does not fall into G2 range, which is 60-89 mL/min/1.73mÂ².&lt;/li&gt;&lt;li&gt;â€¢ Option A) G2A2&lt;/li&gt;&lt;li&gt;â€¢ Option C) G3bA2 - This is incorrect because G3b represents a GFR range of 30-44 mL/min/1.73mÂ². The patient&#x27;s GFR of 50 mL/min/1.73mÂ² is higher than this range and falls into G3a instead.&lt;/li&gt;&lt;li&gt;â€¢ Option C) G3bA2&lt;/li&gt;&lt;li&gt;â€¢ Option D) G4A2 - This is incorrect because G4 represents a GFR range of 15-29 mL/min/1.73mÂ², indicating severely decreased kidney function. The patient&#x27;s GFR of 50 mL/min/1.73mÂ² is substantially higher and does not indicate this level of severity.&lt;/li&gt;&lt;li&gt;â€¢ Option D) G4A2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The KDIGO 2012 classification system evaluates CKD by incorporating both GFR and albuminuria levels, providing a more comprehensive assessment of kidney disease severity and progression risk than GFR alone.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a typical finding in uremic pericarditis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pericardial friction rub&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PR depression on ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated troponin levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diffuse ST-segment elevation on ECG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated troponin levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Elevated troponin levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pericardial friction rub , Option B. PR depression on ECG and Option D. Diffuse ST-segment elevation on ECG : These are classic findings in uremic pericarditis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pericardial friction rub&lt;/li&gt;&lt;li&gt;â€¢ Option B. PR depression on ECG&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Diffuse ST-segment elevation on ECG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the typical findings in uremic pericarditis, including pericardial friction rub, PR depression on ECG, and diffuse ST-segment elevation on ECG. It is important to recognize that elevated troponin levels are not a typical finding in uremic pericarditis, as it is not associated with myocardial damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with CKD stage 5 presents with asterixis, pericarditis, and platelet dysfunction. Which of the following is the most likely explanation for these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated BUN and creatinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uremic toxin accumulation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Uremic toxin accumulation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Uremic toxin accumulation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated BUN and creatinine : BUN and creatinine are markers of kidney function but don&#x27;t directly cause these specific symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated BUN and creatinine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperphosphatemia : Hyperphosphatemia is a complication of CKD but is not the primary cause of these symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperphosphatemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metabolic acidosis : Metabolic acidosis can contribute to uremic symptoms but is not the sole cause of these specific findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metabolic acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the classic manifestations of uremia, such as asterixis, pericarditis, and platelet dysfunction. These symptoms are caused by the accumulation of uremic toxins in the body due to severely impaired kidney function. Understanding this pathophysiology is crucial for early diagnosis and management of uremia in patients with chronic kidney disease (CKD).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with stage 4 CKD presents with fatigue and dyspnea on exertion. His hemoglobin level is 9.5 g/dL. Which of the following is the most likely cause of his anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased erythropoietin production&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Folate deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decreased erythropoietin production&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Decreased erythropoietin production&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin B12 deficiency and Option D. folate deficiency : Can also cause anemia, but they are less common causes of anemia in CKD. These deficiencies can be ruled out with blood tests.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;â€¢ Option D. folate deficiency&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency: Iron deficiency can contribute to anemia in some patients with CKD, but it is not the primary cause. Iron stores are usually assessed before starting treatment for anemia in CKD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iron deficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that the primary cause of anemia in chronic kidney disease (CKD) is decreased erythropoietin (EPO) production due to kidney damage. This knowledge is essential for the accurate diagnosis and management of anemia in CKD patients, as it guides the choice of treatment, which often involves administering erythropoiesis-stimulating agents (ESAs) to compensate for the lack of endogenous EPO.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications directly suppresses PTH secretion in CKD patients with secondary hyperparathyroidism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium carbonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sevelamer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cinacalcet&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcitriol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Calcitriol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Calcitriol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium carbonate : Calcium carbonate is a phosphate binder, not a PTH suppressant.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium carbonate&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sevelamer : Sevelamer is a phosphate binder, not a PTH suppressant.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sevelamer&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cinacalcet : Cinacalcet is a calcimimetic that increases the sensitivity of the parathyroid gland to calcium, indirectly lowering PTH&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cinacalcet&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the different classes of medications used to manage secondary hyperparathyroidism in chronic kidney disease (CKD), and to recognize that calcitriol is the only medication listed that directly suppresses parathyroid hormone (PTH) secretion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with CKD stage 3 has a PTH level of 150 pg/mL and a normal serum calcium level. Which of the following is the most appropriate management strategy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No treatment is necessary at this time&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate calcium carbonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate calcitriol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate cinacalcet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. No treatment is necessary at this time&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) No treatment is necessary at this time&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate calcium carbonate , Option C. Initiate calcitriol and Option D. Initiate cinacalcet : These medications are not indicated unless PTH levels exceed the target range or there are other complications of CKD-MBD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate calcium carbonate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate calcitriol&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Initiate&lt;/li&gt;&lt;li&gt;â€¢ cinacalcet&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that not all elevated PTH levels in CKD require immediate intervention. Treatment decisions should be based on the severity of PTH elevation, calcium levels, and the presence of other complications of CKD-mineral bone disease (CKD-MBD).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old woman with kidney failure on dialysis develops a rapidly progressing, painful nodule on her abdomen that breaks down and forms an open sore (see image). She takes medications for high blood pressure (losartan) and blood clots (warfarin). Which of the following is LEAST likely about her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium supplements may worsen it.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood vessel blockage is involved.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudomonas infection is common.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Warfarin use is a risk factor.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pseudomonas infection is common.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/13/screenshot-2024-08-13-174056.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pseudomonas infection is common.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium supplements may worsen it: True. Calcium-based phosphate binders and vitamin D analogs can contribute to the development of calciphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium supplements may worsen it:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcium supplements may worsen it: True. Calciphylaxis is characterized by calcification of small blood vessels leading to ischemia and necrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcium supplements may worsen it:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Warfarin use is a risk factor: True. Warfarin is associated with an increased risk of calciphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Warfarin use is a risk factor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the key features and risk factors associated with calciphylaxis, a rare but severe complication of chronic kidney disease (CKD). It is important to recognize that while Pseudomonas infection can occur in any open wound, it is not the most common pathogen associated with calciphylaxis. Staphylococcus aureus is more frequently implicated in these infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common presenting symptom in patients with ADPKD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flank or back pain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gross hematuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary tract infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flank or back pain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Flank or back pain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertension : Hypertension is common but may not be the initial presenting symptom.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gross hematuria : Gross hematuria occurs in a significant proportion of patients but is less common than pain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gross hematuria&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urinary tract infection : Urinary tract infections are a complication but not the most common initial presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urinary tract infection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize that flank or back pain is the most common presenting symptom in autosomal dominant polycystic kidney disease (ADPKD). This pain is often due to cyst enlargement, hemorrhage, or infection and may be the first sign of the disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is FDA-approved for slowing kidney disease progression in ADPKD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tolvaptan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Everolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cinacalcet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tolvaptan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tolvaptan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Everolimus : Everolimus is an mTOR inhibitor under investigation but not FDA-approved for ADPKD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Everolimus&lt;/li&gt;&lt;li&gt;â€¢ Option C. Octreotide : Octreotide is a somatostatin analogue with potential benefits but not FDA-approved.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Octreotide&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cinacalcet : Cinacalcet is used to treat secondary hyperparathyroidism in CKD&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Cinacalcet&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that tolvaptan is the only FDA-approved medication for slowing the progression of kidney disease in ADPKD. It works by inhibiting vasopressin, which plays a role in cyst growth.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old end-stage renal disease (ESRD) patient requires hemodialysis access. Given the need for long-term vascular access, which arteriovenous fistula (AVF) would be the most suitable choice for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brachiocephalic AVF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Radiocephalic AVF&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brachiobasilic AVF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Femoral AVF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Radiocephalic AVF&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Radiocephalic AVF&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brachiocephalic AVF and Option C. Brachiobasilic AVF : Larger vessels, higher flow, risk of steal syndrome/heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brachiocephalic AVF&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brachiobasilic AVF&lt;/li&gt;&lt;li&gt;â€¢ Option D. Femoral AVF : Higher infection risk, deeper cannulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Femoral AVF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the importance of choosing the most suitable arteriovenous fistula (AVF) for long-term hemodialysis access. The radiocephalic AVF at the wrist is generally preferred due to its lower complication rates, easier cannulation, and preservation of future access sites.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a determinant of hemodialysis efficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood flow rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dialysate flow rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dialyzer characteristics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Patient&#x27;s age&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Patient&#x27;s age&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Patient&#x27;s age&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood flow rate: Higher blood flow rates allow for greater clearance of solutes from the bloodstream across the dialyzer membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood flow rate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dialysate flow rate: Faster dialysate flow rates create a steeper concentration gradient between the blood and dialysate, enhancing the diffusion of solutes from the blood into the dialysate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dialysate flow rate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dialyzer characteristics: The dialyzer membrane&#x27;s surface area, porosity, and permeability all influence how effectively solutes are removed from the blood. For instance, a larger surface area allows for more clearance of solutes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dialyzer characteristics:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the key factors that determine hemodialysis efficiency, including blood flow rate, dialysate flow rate, and dialyzer characteristics. While a patient&#x27;s age can influence their overall dialysis needs, it doesn&#x27;t directly affect the efficiency of the hemodialysis process itself.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following findings is NOT typically associated with peritonitis in peritoneal dialysis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cloudy dialysate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abdominal pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypotension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypotension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cloudy dialysate, Option B. Abdominal pain and Option C. Fever : Cloudy dialysate, abdominal pain, and fever are classic signs of peritonitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Cloudy dialysate, Option B. Abdominal pain&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fever&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the typical clinical presentation of peritonitis in peritoneal dialysis, including cloudy dialysate, abdominal pain, and fever. Recognizing these signs and symptoms is crucial for early diagnosis and treatment to prevent complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with end-stage renal disease and uremia starts hemodialysis. During the session, he becomes restless, confused, and develops a headache. Which of the following is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute intradialytic hypotension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemodialysis-associated thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dialysis disequilibrium syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Air embolism during hemodialysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dialysis disequilibrium syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dialysis disequilibrium syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute intradialytic hypotension: This would typically cause dizziness, lightheadedness, or fainting, but not the neurologic symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute intradialytic hypotension:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemodialysis-associated thrombosis: This would cause issues with the dialysis access site (e.g., pain, swelling, decreased blood flow) rather than neurologic symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hemodialysis-associated thrombosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Air embolism during hemodialysis: This is a rare but serious complication that would present with sudden respiratory distress, chest pain, and potentially cardiac arrest.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Air embolism during hemodialysis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the signs and symptoms of dialysis disequilibrium syndrome (DDS), a complication that can occur during the initial stages of hemodialysis in patients with uremia. DDS is caused by the rapid removal of urea, creating an osmotic gradient that leads to cerebral edema and neurological symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with secondary hyperparathyroidism due to end-stage renal disease undergoes a successful parathyroidectomy. During their first hemodialysis session post-surgery, which of the following dialysate modifications would be most appropriate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased potassium concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased potassium concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased calcium concentration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased calcium concentration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased calcium concentration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased calcium concentration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased potassium concentration : Not relevant to HBS management. Potassium levels may need to be adjusted based on the patient&#x27;s serum potassium.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased potassium&lt;/li&gt;&lt;li&gt;â€¢ concentration&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased potassium concentration : This could worsen hypokalemia, which is not a primary concern in HBS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased potassium&lt;/li&gt;&lt;li&gt;â€¢ concentration&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased calcium concentration : This would exacerbate the existing hypocalcemia in HBS and should be avoided&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased calcium concentration&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the importance of modifying dialysate calcium concentration after parathyroidectomy in patients with secondary hyperparathyroidism due to end-stage renal disease. Increasing the calcium concentration helps prevent severe hypocalcemia and its associated complications, known as \&quot;hungry bone syndrome\&quot; (HBS).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following immunosuppressive medications binds to CD80 and CD86 on antigen-presenting cells, inhibiting T-cell activation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sirolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Everolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Belatacept&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Basiliximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Belatacept&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Belatacept&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sirolimus: Sirolimus (rapamycin) is an mTOR inhibitor. It works by forming a complex with FKBP-12, which then binds to and inhibits the mTOR protein, thus blocking T-cell proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sirolimus:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Everolimus: Everolimus is also an mTOR inhibitor and has a similar mechanism of action to sirolimus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Everolimus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Basiliximab: Basiliximab is a monoclonal antibody that binds to the IL-2 receptor on activated T cells, preventing their proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Basiliximab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the different mechanisms of action of immunosuppressive medications used in transplantation. Belatacept is unique in its ability to specifically inhibit T-cell activation by blocking the interaction between CD80/CD86 on antigen-presenting cells and CD28 on T cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old kidney transplant recipient, 3 weeks post-transplant, presents with a sudden rise in serum creatinine, decreased urine output, and tenderness over the allograft. Doppler ultrasound shows increased renal artery resistance. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute tubular necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calcineurin inhibitor toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute T-cell mediated rejection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antibody-mediated rejection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute T-cell mediated rejection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute T-cell mediated rejection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute tubular necrosis (ATN): ATN usually occurs immediately post-transplant and is less likely weeks later. It would not typically cause allograft tenderness or increased arterial resistance on Doppler.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute tubular necrosis (ATN):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcineurin inhibitor toxicity: While this can cause elevated creatinine, it usually presents with more gradual onset and less specific symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcineurin inhibitor toxicity:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antibody-mediated rejection: This is less likely to occur early post-transplant and typically presents with more severe features like glomerulitis and vascular injury on biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antibody-mediated rejection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the clinical presentation and diagnostic findings of acute T-cell mediated rejection in kidney transplant recipients. This type of rejection typically occurs early post-transplant and presents with a sudden rise in creatinine, decreased urine output, allograft tenderness, and increased renal artery resistance on Doppler ultrasound. Differentiating this from other causes of graft dysfunction is crucial for prompt and appropriate intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A kidney transplant recipient with a positive CMV IgG serostatus develops fever, leukopenia, and elevated liver enzymes 4 months post-transplant. Which of the following is the most appropriate diagnostic test to confirm CMV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood culture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CMV PCR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CMV PCR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CMV PCR&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood culture : Blood culture is not useful for diagnosing viral infections like CMV.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Blood culture&lt;/li&gt;&lt;li&gt;â€¢ Option C. Liver biopsy : Liver biopsy is invasive and not typically needed for diagnosing CMV infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Liver biopsy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung biopsy : Lung biopsy is not indicated in this scenario as the primary organ involvement is not the lungs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung biopsy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that CMV PCR is the most sensitive and specific test for diagnosing CMV infection in transplant recipients, allowing for early detection and treatment to prevent complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A kidney transplant recipient presents 3 months post-transplant with fever, dry cough, and shortness of breath. Chest X-ray reveals bilateral interstitial infiltrates. Which of the following is the most likely diagnosis and the drug of choice for its prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytomegalovirus (CMV) â€“ Valganciclovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pneumocystis jirovecii pneumonia (PJP) â€“ Trimethoprim-sulfamethoxazole (TMP-SMX)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aspergillus fumigatus â€“ Fluconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nocardia asteroides â€“ Ganciclovir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pneumocystis jirovecii pneumonia (PJP) â€“ Trimethoprim-sulfamethoxazole (TMP-SMX)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pneumocystis jirovecii pneumonia (PJP) â€“ Trimethoprim-sulfamethoxazole (TMP-SMX)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytomegalovirus (CMV) â€“ Valganciclovir : Cytomegalovirus (CMV) is a common infection after transplantation, but it usually presents with nonspecific symptoms like fever and fatigue, and it does not typically cause the classic chest X-ray findings of PJP. Valganciclovir is used for CMV prophylaxis and treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytomegalovirus (CMV) â€“ Valganciclovir&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aspergillus fumigatus â€“ Fluconazole : Aspergillus fumigatus is a mold infection that can cause pulmonary symptoms, but it is less common in the early post-transplant period. Fluconazole is an antifungal medication, not used for PJP prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aspergillus fumigatus â€“ Fluconazole&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nocardia asteroides â€“ Ganciclovir : Nocardia asteroides is a bacterial infection that can cause pulmonary or disseminated disease, but it is less common than PJP in this setting. Ganciclovir is used for CMV prophylaxis and treatment&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nocardia asteroides â€“ Ganciclovir&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To recognize the clinical presentation and chest X-ray findings of Pneumocystis jirovecii pneumonia (PJP) in kidney transplant recipients and to understand that trimethoprim-sulfamethoxazole (TMP-SMX) is the preferred prophylactic agent for PJP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the leading cause of death in kidney transplant recipients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiovascular events&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Graft failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiovascular events&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cardiovascular events&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Infection: While infection is a significant cause of mortality in transplant recipients (18%), it is not as common as cardiovascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Infection:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignancy : Malignancy, including PTLD, is also a concern for transplant recipients (17%), but it is still less common than cardiovascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Malignancy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Graft failure: While graft failure can lead to death, it is not as frequent a cause as cardiovascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Graft failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that cardiovascular events are the leading cause of death in kidney transplant recipients, highlighting the importance of cardiovascular risk assessment and management in this population.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 113 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test8" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Neurology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Neurology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                133 Questions | 532 Total Marks | 143 min Duration | ~64.51 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which type of aphasia is characterized by fluent speech, but impaired comprehension and repetition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Broca&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s aphasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Global aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Conduction aphasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Wernicke&#x27;s aphasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia: Broca&#x27;s aphasia is non-fluent with effortful speech, but relatively preserved comprehension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Global aphasia: Global aphasia is a severe impairment of both production and comprehension of language.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Global aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conduction aphasia: Conduction aphasia is characterized by fluent speech, relatively good comprehension, but impaired repetition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conduction aphasia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate Wernicke&#x27;s aphasia from other types by its characteristic fluent but nonsensical speech and impaired comprehension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman has progressively worsening difficulty finding words during conversations. Her speech is fluent, she can follow commands and repeat phrases, but struggles to name common objects. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Broca&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anomic aphasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Global aphasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anomic aphasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia: Broca&#x27;s aphasia is characterized by non-fluent, effortful speech.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wernicke&#x27;s aphasia: Presents with fluent but nonsensical speech and poor comprehension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wernicke&#x27;s aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Global aphasia: Global aphasia is a severe impairment in all aspects of language.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Global aphasia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize anomic aphasia as a specific type of aphasia primarily affecting word-finding ability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of hypertension and TIAs is found unresponsive. On exam, he&#x27;s awake but unable to follow commands or produce meaningful speech, only uttering repetitive sounds. He has right-sided hemiparesis and facial droop. CT shows a large left MCA infarct. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Broca&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anomic aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Global aphasia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Global aphasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia : Broca&#x27;s aphasia is non-fluent but comprehension is relatively preserved.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wernicke&#x27;s aphasia : Wernicke&#x27;s aphasia is fluent but nonsensical, with poor comprehension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Wernicke&#x27;s aphasia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anomic aphasia : Anomic aphasia is primarily a word-finding difficulty with otherwise preserved language.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anomic aphasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Understand that global aphasia is the most severe form of aphasia, typically resulting from large lesions in the dominant hemisphere.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man with hypertension has sudden difficulty reading. Words appear jumbled. He can write and understand spoken language but cannot read what he just wrote. He has right homonymous hemianopia. What is the most likely vascular territory affected?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left ACA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left MCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right PCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left temporal lobe&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Left temporal lobe&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left ACA: ACA strokes affect the medial aspects of the frontal and parietal lobes, causing contralateral leg weakness and sensory loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left ACA:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left MCA: MCA strokes affect the lateral aspects of the brain, causing contralateral face and arm weakness, sensory loss, and aphasia if in the dominant hemisphere.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left MCA:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right PCA: PCA strokes affect the occipital lobe, causing visual field deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right PCA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the classic presentation of alexia without agraphia, a syndrome caused by damage to specific regions of the left temporal lobe, often due to stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man experiences a loss of vision in the upper right quadrant of both eyes. Where is the lesion most likely located?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right parietal lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left parietal lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right occipital lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left temporal lobe&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Left temporal lobe&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right parietal lobe: Right parietal lobe lesions cause left inferior quadrantanopia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right parietal lobe:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left parietal lobe: Left parietal lobe lesions cause right inferior quadrantanopia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left parietal lobe:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right occipital lobe: Right occipital lobe lesions cause left homonymous hemianopia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right occipital lobe:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the anatomy of the visual pathway and how lesions in different locations can cause specific visual field defects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man has difficulty writing, calculating, distinguishing left from right, and recognizing objects by touch. He has intact speech and follows commands. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gerstmann syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemispatial neglect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ideomotor apraxia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gerstmann syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wernicke&#x27;s aphasia: Affects language comprehension and expression, not these specific skills.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wernicke&#x27;s aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemispatial neglect: Involves ignoring one side of space, not the deficits seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemispatial neglect:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ideomotor apraxia: Ideomotor apraxia is the inability to perform learned motor tasks despite intact motor function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ideomotor apraxia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize Gerstmann syndrome, a rare but classic neurological syndrome with specific deficits related to parietal lobe function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of smoking and hypertension presents with sudden right-sided weakness, difficulty walking, confusion, and difficulty following instructions. On exam, he has right lower extremity weakness, urinary incontinence, apraxia, and intact speech. Which artery is most likely involved?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right MCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left ACA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right PCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left basilar artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Left ACA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right MCA: Right MCA stroke would cause left-sided weakness, sensory loss, and possible aphasia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right MCA:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right PCA: Right PCA stroke would mainly cause visual field deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right PCA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left basilar artery: Left basilar artery stroke would result in more widespread brainstem symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left basilar artery:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the distinct clinical features of ACA stroke, particularly the lower extremity weakness, frontal lobe dysfunction, and urinary incontinence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with atrial fibrillation suddenly becomes impulsive, disinhibited, and has difficulty concentrating. What is the most likely affected brain area?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prefrontal cortex&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parietal lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Temporal lobe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Orbitofrontal cortex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prefrontal cortex&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Parietal lobe: Sensory processing and spatial awareness&lt;/li&gt;&lt;li&gt;â€¢ Option B. Parietal lobe:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Temporal lobe: Memory and language&lt;/li&gt;&lt;li&gt;â€¢ Option C. Temporal lobe:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Orbitofrontal cortex: Involved in emotional regulation, but not the primary site for these symptoms&lt;/li&gt;&lt;li&gt;â€¢ Option D. Orbitofrontal cortex:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of the prefrontal cortex in executive function, judgment, and social behavior, and recognize the clinical presentation of its dysfunction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man with hypertension has sudden difficulty reading, with words appearing jumbled. He can write and understand spoken language but cannot read what he just wrote. He also has right homonymous hemianopia. Which artery is most likely involved?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PCA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ICA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PCA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACA: Supplies the medial frontal and parietal lobes, causing contralateral leg weakness and sensory loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACA:&lt;/li&gt;&lt;li&gt;â€¢ Option B. MCA: Supplies the lateral frontal, temporal, and parietal lobes, causing contralateral face and arm weakness, sensory loss, and aphasia if in the dominant hemisphere.&lt;/li&gt;&lt;li&gt;â€¢ Option B. MCA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ICA: Main artery supplying the anterior circulation of the brain, occlusion would cause more extensive deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ICA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the specific visual and reading deficits associated with PCA strokes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman with atrial fibrillation has a sudden onset of difficulty seeing the right half of her visual field in both eyes and an inability to recognize familiar faces. A CT angiogram shows occlusion of the left PCA. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left MCA stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left ACA stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left PCA stroke&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right occipital lobe tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Left PCA stroke&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left MCA stroke: Would present with right-sided weakness, sensory loss, and possible aphasia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left MCA stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left ACA stroke: Typically affects the leg more than the visual field or face recognition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left ACA stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option D. A right occipital lobe tumor: Could cause a left homonymous hemianopia, but it&#x27;s less likely to be sudden and wouldn&#x27;t explain the prosopagnosia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A right occipital lobe tumor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand that the PCA supplies the occipital lobe (vision) and the inferior temporal lobe (facial recognition), so strokes in this territory can present with these specific deficits.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man with a history of smoking and hypercholesterolemia presents with sudden-onset left-sided weakness, numbness, and difficulty speaking and understanding. He has left facial droop, hemiparesis, hemisensory loss, and global aphasia. A CT angiogram shows occlusion of the right ICA. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right MCA stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right ACA stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right ICA stroke&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right PCA stroke&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right ICA stroke&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right MCA stroke: Would not explain the full extent of deficits seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right MCA stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right ACA stroke: Typically affects the leg more than the face and arm.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right ACA stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right PCA stroke: Would primarily cause visual field deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right PCA stroke:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize that ICA strokes can cause extensive deficits due to involvement of both the MCA and ACA territories.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with a history of smoking and hypercholesterolemia has sudden-onset dizziness, nausea, vomiting, right-sided facial numbness, left-sided body numbness, ataxia, hoarse voice, and diminished gag reflex on the right. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medial medullary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lateral medullary syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Basilar artery stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pontine stroke&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lateral medullary syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Medial medullary syndrome: Involves contralateral hemiparesis, contralateral proprioceptive loss, and ipsilateral tongue deviation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Medial medullary syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Basilar artery stroke: Can cause a variety of symptoms, but the specific constellation here is more consistent with lateral medullary syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Basilar artery stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pontine stroke: Typically presents with bilateral motor deficits, facial weakness, and other cranial nerve palsies.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pontine stroke:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the hallmark features of lateral medullary syndrome, a brainstem stroke with specific crossed sensory and cranial nerve findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old man with hypertension and diabetes has sudden onset of left-sided weakness, drooping left eyelid, double vision when looking to the right, left-sided ptosis, upward and outward deviation of the left eye, and right-sided hemiparesis. What brain structure is most likely involved?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Midbrain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medial medulla&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lateral medulla&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Midbrain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pons: Lesions here can cause various cranial nerve palsies and hemiparesis, but the specific combination points to the midbrain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pons:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Medial medulla: Medial medullary syndrome involves contralateral hemiparesis, contralateral proprioceptive loss, and ipsilateral tongue deviation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Medial medulla:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lateral medulla: Lateral medullary syndrome (Wallenberg) involves ipsilateral facial numbness, contralateral body numbness, ataxia, and other cranial nerve deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lateral medulla:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the signs of Weber&#x27;s syndrome, a midbrain stroke characterized by ipsilateral oculomotor palsy and contralateral hemiparesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with hypertension and atrial fibrillation is found unresponsive. On exam, she&#x27;s awake but unable to speak or move any limbs, though she can blink and move her eyes vertically. She has quadriplegia and anarthria but is conscious. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Locked-in syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amyotrophic lateral sclerosis (ALS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Locked-in syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome: Guillain-BarrÃ© syndrome is a progressive ascending paralysis, not sudden quadriplegia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myasthenia gravis: Causes fluctuating muscle weakness, not sudden and complete paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myasthenia gravis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amyotrophic lateral sclerosis (ALS): ALS is a progressive neurodegenerative disease with a slower onset.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amyotrophic lateral sclerosis (ALS):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of locked-in syndrome, a devastating condition where patients are fully conscious but unable to move or communicate verbally, except for vertical eye movements and blinking.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with a history of smoking and hypercholesterolemia has sudden double vision, drooping right eyelid, enlarged pupil, and limited eye movement on the right. He also has tremors and ataxia in his left arm and leg. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Weber&#x27;s syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Benedikt&#x27;s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Claude&#x27;s syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Millard-Gubler syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Benedikt&#x27;s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Weber&#x27;s syndrome: Involves ipsilateral oculomotor palsy and contralateral hemiparesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Weber&#x27;s syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Claude&#x27;s syndrome: Involves ipsilateral oculomotor palsy and contralateral ataxia, but not the prominent tremor seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Claude&#x27;s syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Millard-Gubler syndrome: Involves ipsilateral facial palsy and contralateral hemiparesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Millard-Gubler syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the unique features of Benedikt&#x27;s syndrome, a midbrain lesion with a combination of oculomotor nerve palsy and contralateral movement disorder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with uncontrolled hypertension presents unconscious with sudden severe headache, vomiting, pinpoint pupils, and a GCS of 6. CT shows a hemorrhage. What is the most likely site of the bleed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Putamen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pons&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thalamus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pons&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Putamen: Putaminal hemorrhages usually present with contralateral hemiparesis, hemisensory loss, and homonymous hemianopia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Putamen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellum: Cerebellar hemorrhages often present with ataxia and may not cause pinpoint pupils or rapid coma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellum:&lt;/li&gt;&lt;li&gt;â€¢ Option D.Thalamus: Thalamic hemorrhages usually present with sensory loss, hemiparesis, and upgaze palsy.&lt;/li&gt;&lt;li&gt;â€¢ Option D.Thalamus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of pontine hemorrhage, a life-threatening condition often associated with hypertension, requiring immediate medical attention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with uncontrolled hypertension presents unconscious with severe headache, nausea, and left-sided hemiplegia. His right pupil is larger than the left and unreactive to light. CT scan shows a large right-sided intracerebral hemorrhage with midline shift. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subarachnoid hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertensive intracerebral hemorrhage (ICH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brain tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypertensive intracerebral hemorrhage (ICH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ischemic strokes: Ischemic strokes don&#x27;t usually cause large hemorrhages with midline shift.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ischemic strokes:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Subaracnoid haemorrhage: Subarachnoid hemorrhage would show blood in the subarachnoid space on CT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Subaracnoid haemorrhage:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brain tumor: While brain tumors can cause mass effect, the acute presentation and history of hypertension favor ICH.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brain tumor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the typical presentation and imaging findings of hypertensive ICH, a common type of stroke associated with high blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with poorly controlled hypertension presents with sudden severe headache, nausea, vomiting, difficulty walking, dysmetria, nystagmus, and a wide-based gait. CT shows a hyperdense lesion in the cerebellum with edema. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebellar hypertensive intracerebral hemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute ischemic stroke in the PICA territory&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ruptured cerebellar arteriovenous malformation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebellar abscess&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebellar hypertensive intracerebral hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ischemic stroke in the PICA territory: Would not show a hyperdense lesion on CT in the acute phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ischemic stroke in the PICA territory:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ruptured cerebellar arteriovenous malformation: AVM rupture is less likely given the history of hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ruptured cerebellar arteriovenous malformation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebellar abscess: Is less likely due to the acute presentation and absence of infectious signs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebellar abscess:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that cerebellar hemorrhages can present with distinct cerebellar signs and are often associated with hypertension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with hypertension and hyperlipidemia presents with sudden left-sided weakness, slurred speech, and multiple microbleeds on MRI. What is the gold standard investigation to confirm the suspected diagnosis of cerebral amyloid angiopathy (CAA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebral angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brain biopsy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET scan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Brain biopsy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cerebral angiography: Angiography may not show the small vessel changes associated with CAA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cerebral angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lumbar puncture: Lumbar puncture may show amyloid-beta, but it&#x27;s not specific for CAA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lumbar puncture:&lt;/li&gt;&lt;li&gt;â€¢ Option D. PET scan: PET scan can detect amyloid but may not differentiate CAA from other types of amyloid deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PET scan:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that while MRI findings and clinical presentation can suggest CAA, brain biopsy remains the gold standard for definitive diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of warfarin use for atrial fibrillation presents with sudden left-sided weakness, slurred speech, and an INR of 4.5. A CT scan reveals a large hyperdense lesion in the right parietal lobe with surrounding edema. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coagulopathy-related intracerebral hemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brain tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subdural hematoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Coagulopathy-related intracerebral hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute ischemic stroke: Ischemic strokes typically do not show hyperdensity on CT in the acute phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute ischemic stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brain tumor: Brain tumors usually have a more gradual onset and may not cause such acute deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brain tumor:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Subdural hematoma: Subdural hematomas often present as crescent-shaped hyperdensities on CT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Subdural hematoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the importance of considering coagulopathy as a cause of intracerebral hemorrhage in patients on anticoagulation therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with chronic headaches presents with a sudden, severe headache, nausea, vomiting, and photophobia. He has neck stiffness and a positive Brudzinski&#x27;s sign. CT shows a hyperdense lesion in the right temporal lobe with surrounding edema and blood in the subarachnoid space. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertensive intracerebral hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ruptured cerebral aneurysm with secondary intracerebral hemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brain tumor with hemorrhagic transformation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic stroke with hemorrhagic conversion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ruptured cerebral aneurysm with secondary intracerebral hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertensive intracerebral haemorrhage: Hypertensive ICH wouldn&#x27;t typically have subarachnoid blood.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertensive intracerebral haemorrhage:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brain tumor with hemorrhagic transformation: Brain tumors can bleed, but the acute onset and meningeal signs point to an aneurysm.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brain tumor with hemorrhagic transformation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic stroke with hemorrhagic conversion: Ischemic stroke with hemorrhage is less likely to cause such sudden, severe headache and meningeal irritation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic stroke with hemorrhagic conversion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the typical presentation and CT findings of ruptured cerebral aneurysm, a life-threatening condition requiring urgent intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a component of the ICH score used to predict mortality in patients with intracerebral hemorrhage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glasgow Coma Scale score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of intraventricular hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of subarachnoid hemorrhage&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Presence of subarachnoid hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A, B and C: Are all components of the ICH score.&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A, B&lt;/li&gt;&lt;li&gt;â€¢ C:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the components of the ICH score and its role in predicting outcomes in patients with intracerebral hemorrhage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man has a large right basal ganglia hemorrhage with significant mass effect. Which factor most strongly indicates the need for surgical intervention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age over 70 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Presence of intraventricular hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hematoma volume &amp;gt; 30 cm3 with clinical deterioration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blood pressure of 180/100 mmHg on admission&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hematoma volume &gt; 30 cm3 with clinical deterioration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age over 70 years: Age is a factor, but not the sole determinant for surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age over 70 years:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Presence of intraventricular haemorrhage: IVH can be managed with external ventricular drainage if needed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Presence of intraventricular haemorrhage:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blood pressure of 180/100 mmHg on admission: High blood pressure needs to be controlled medically, but it&#x27;s not an absolute surgical indication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blood pressure of 180/100 mmHg on admission:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the key factors guiding surgical decision-making in intracerebral hemorrhage, with large hematoma and clinical deterioration being the strongest indicators.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In managing intracerebral hemorrhage (ICH) during surgery, what is the target systolic blood pressure (SBP)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 120 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 140 mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 160 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt; 180 mmHg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. &lt; 140 mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;lt; 120 mmHg: Is too low and may compromise cerebral perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;lt; 120 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;lt; 160 mmHg: Was a previous recommendation but is now considered less optimal.&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;lt; 160 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;lt; 180 mmHg: Is too high and may not adequately control bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;lt; 180 mmHg:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the target SBP during ICH surgery, a crucial aspect of perioperative management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman with hypertension and smoking presents with sudden severe \&quot;thunderclap\&quot; headache, nausea, and photophobia. CT reveals subarachnoid hemorrhage, and angiography shows a 7 mm berry aneurysm in the anterior communicating artery. Which factor most significantly increases the risk of rupture?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Location in the anterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Size of 7 mm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;History of hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;History of smoking&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Size of 7 mm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Location in the anterior communicating artery: Location can influence risk, but size is more significant.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Location in the anterior communicating artery:&lt;/li&gt;&lt;li&gt;â€¢ Option C. History of hypertension: Hypertension is a risk factor for aneurysm formation and growth, but not the strongest predictor of rupture.&lt;/li&gt;&lt;li&gt;â€¢ Option C. History of hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option D. History of smoking: Smoking is a risk factor, but again, not as directly predictive as size.&lt;/li&gt;&lt;li&gt;â€¢ Option D. History of smoking:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that aneurysm size is the most critical factor in determining rupture risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man experiences a sudden, severe \&quot;thunderclap\&quot; headache while playing basketball. He has a stiff neck, photophobia, and CT reveals subarachnoid hemorrhage. Angiography shows a 4 mm aneurysm in the middle cerebral artery. Which grading scale is most appropriate to assess his SAH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glasgow Coma Scale (GCS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hunt and Hess scale&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Modified Rankin Scale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;World Federation of Neurological Surgeons (WFNS) grading system&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hunt and Hess scale&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glasgow Coma Scale (GCS): GCS assesses level of consciousness but not the specific severity of SAH.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Glasgow Coma Scale (GCS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Modified Rankin Scale: Modified Rankin Scale measures disability after stroke, not acute SAH severity.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Modified Rankin Scale:&lt;/li&gt;&lt;li&gt;â€¢ Option D. World Federation of Neurological Surgeons (WFNS) grading system: WFNS grading system is another SAH scale, but Hunt and Hess is more commonly used for initial assessment.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ World Federation of Neurological Surgeons (WFNS) grading system:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of the Hunt and Hess scale in assessing the severity and prognosis of subarachnoid hemorrhage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;On day 5 post-SAH, a patient becomes confused and lethargic with a serum sodium of 125 mEq/L (down from 138 mEq/L). Fluid intake has been restricted, and there are no signs of edema or dehydration. What is the most likely cause of hyponatremia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Excessive hypotonic fluids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SIADH secondary to SAH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebral salt wasting (CSW) due to SAH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cerebral salt wasting (CSW) due to SAH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excessive hypotonic fluids: Excessive fluids would cause fluid overload, not seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excessive hypotonic fluids:&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIADH secondary to SAH: SIADH would present with euvolemia or fluid overload.&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIADH secondary to SAH:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal insufficiency: Adrenal insufficiency is less common and usually involves hypotension and hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal insufficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize CSW as a potential cause of hyponatremia in SAH, differentiated from SIADH by volume status.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with poorly controlled hypertension presents with a sudden, severe \&quot;thunderclap\&quot; headache, nausea, and vomiting. She is drowsy with a stiff neck and positive Kernig&#x27;s sign. CT reveals SAH and angiography shows a 5 mm aneurysm in the posterior communicating artery. What is the most appropriate immediate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Surgical clipping of the aneurysm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endovascular coiling of the aneurysm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nimodipine to prevent vasospasm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nimodipine to prevent vasospasm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A &amp;amp; B. Clipping or coiling are definitive treatments but not the immediate priority.&lt;/li&gt;&lt;li&gt;â€¢ Options A &amp;amp; B.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corticosteroids are not indicated for SAH.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the importance of nimodipine for preventing vasospasm in the acute management of SAH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with SAH becomes increasingly confused and lethargic on day 5 of hospitalization. Her serum sodium is 125 mEq/L (decreased from baseline). Her fluid intake has been restricted. What is the most likely cause of hyponatremia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Excessive hypotonic fluids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SIADH secondary to SAH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebral salt wasting (CSW) due to SAH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cerebral salt wasting (CSW) due to SAH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excessive hypotonic fluids: Excessive fluid administration is unlikely given fluid restriction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Excessive hypotonic fluids:&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIADH secondary to SAH: SIADH would present with euvolemia or hypervolemia, not hypovolemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIADH secondary to SAH:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal insufficiency: Adrenal insufficiency is less common and presents with hypotension and hyperkalemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal insufficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize CSW as a potential cause of hyponatremia in SAH, differentiating it from SIADH by the presence of hypovolemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with hypertension and smoking presents with sudden severe headache, confusion, and visual disturbances. He has bilateral papilledema and flame-shaped hemorrhages on fundoscopy. Brain MRI shows diffuse cerebral edema but no infarction. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertensive encephalopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intracerebral hemorrhage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypertensive encephalopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute ischemic stroke: Ischemic stroke would show focal deficits and infarction on MRI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute ischemic stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meningitis: Meningitis would typically present with fever and neck stiffness.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meningitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intracerebral haemorrhage: Intracerebral hemorrhage would show a focal bleed on MRI.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intracerebral haemorrhage:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical and imaging features of hypertensive encephalopathy, a medical emergency requiring prompt blood pressure control.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male with uncontrolled hypertension presents with sudden left-sided weakness and difficulty speaking. He has right-sided hemiparesis and aphasia. An urgent non-contrast head CT scan is shown. What is this finding indicative of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperdense middle cerebral artery (MCA) sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stripe sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radial band sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eye-of-the-tiger sign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hyperdense middle cerebral artery (MCA) sign&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111854.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stripe sign: Thin line of contrast enhancement within a hyperdense vessel, indicating partial occlusion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stripe sign:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radial band sign: Linear bands of differing density in white matter, seen in multiple sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radial band sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eye-of-the-tiger sign: Hypointense globus pallidus with central hyperintensity on MRI, seen in PKAN.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eye-of-the-tiger sign:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the hyperdense MCA sign on NCCT as an early indicator of acute ischemic stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with atrial fibrillation presents with right-sided weakness and slurred speech. NCCT head is normal, DWI is done. What does this hyperintense area represent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Salvageable ischemic area&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Core infarct area&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Older infarct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic penumbra&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Core infarct area&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111907.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Salvageable ischemic area: Salvageable ischemic area (penumbra) is not hyperintense on DWI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Salvageable ischemic area:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Older infarcts area: Older infarcts may appear hypointense on DWI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Older infarcts area:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic penumbra: Ischemic penumbra is the area surrounding the core, potentially salvageable with timely intervention, but not hyperintense on DWI.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic penumbra:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that hyperintensity on DWI indicates the core of an acute ischemic stroke, where tissue damage is irreversible.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents with sudden left-sided weakness and slurred speech. He has left facial droop, left arm and leg weakness, and slurred speech. He is alert and oriented, follows commands, and has no visual field deficits. Which of the following findings would contribute to his NIHSS score?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left facial droop&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Slurred speech&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left arm weakness&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The NIHSS is a comprehensive stroke scale. All the mentioned findings â€“ facial droop, slurred speech, and arm weakness â€“ are assessed under different items of the NIHSS and would contribute to the overall score.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the NIHSS encompasses various neurological deficits, including motor function, language, and cranial nerve function, to provide a comprehensive assessment of stroke severity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old female with atrial fibrillation presents with sudden right-sided weakness and aphasia. Her NIHSS score is 14, and non-contrast head CT shows no hemorrhage. What is the most appropriate management based on current guidelines?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous tissue plasminogen activator (tPA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immediate anticoagulation with warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral aspirin therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endovascular thrombectomy without intravenous tPA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Intravenous tissue plasminogen activator (tPA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate anticoagulation with warfarin: Warfarin is for long-term prevention, not acute treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Immediate anticoagulation with warfarin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral aspirin therapy: Aspirin is used after the acute phase for secondary prevention.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral aspirin therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endovascular thrombectomy without intravenous tPA: Thrombectomy may be considered later if tPA fails or is contraindicated.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endovascular thrombectomy without intravenous tPA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that IV tPA is the first-line treatment for eligible patients with acute ischemic stroke within the appropriate time window.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with hypertension has sudden left-sided weakness and aphasia, last seen well 6 hours ago. His NIHSS score is 12, and NCCT head shows no hemorrhage. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Angiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous tPA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endovascular thrombectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Angiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. MRI brain: MRI is more detailed but takes longer in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. MRI brain:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intravenous tPA: tPA is contraindicated beyond 4.5 hours from symptom onset.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Intravenous tPA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endovascular thrombectomy: Thrombectomy cannot be performed without confirming LVO.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endovascular thrombectomy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that CT angiogram is the next step in stroke management after the tPA window to evaluate for LVO and determine eligibility for thrombectomy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old female with diabetes presents with sudden right-sided weakness and difficulty speaking 8 hours ago. NIHSS is 15, NCCT shows no hemorrhage, and CTA reveals an LVO in the left MCA. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT perfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Repeat NCCT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MR angiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT perfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Repeat NCCT: Is unnecessary as there&#x27;s no suspicion of new hemorrhage.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Repeat NCCT:&lt;/li&gt;&lt;li&gt;â€¢ Option C. MR Angiogram: Confirms LVO but doesn&#x27;t provide tissue viability information.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MR Angiogram:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lumbar puncture: Is not indicated in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lumbar puncture:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of CT perfusion in assessing tissue viability and guiding endovascular therapy decisions in stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old male with atrial fibrillation and recent GI bleeding presents with sudden left-sided weakness and slurred speech 90 minutes ago. His NIHSS score is 10, and NCCT shows no hemorrhage. Which of the following is a contraindication to IV tPA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stroke onset 90 minutes ago&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;History of atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Recent gastrointestinal bleeding&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blood glucose level of 140 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Recent gastrointestinal bleeding&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stroke onset 90 minutes ago : Onset of 90 minutes is within the tPA window.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stroke onset 90 minutes ago&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of atrial fibrillation: Atrial fibrillation is a risk factor for stroke, not a contraindication to tPA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. History of atrial fibrillation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blood glucose level of 140 mg/dL: Blood glucose of 140 mg/dL is within the acceptable range for tPA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blood glucose level of 140 mg/dL:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Be aware of the contraindications to tPA, including recent bleeding, to avoid serious complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the appropriate dosing of tenecteplase for a 70kg patient with acute ischemic stroke?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.25 mg/kg as a single bolus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.25 mg/kg as 10% bolus followed by 90% infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;0.9 mg/kg as a single bolus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;0.9 mg/kg infused over 60 minutes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 0.25 mg/kg as a single bolus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 0.25 mg/kg as 10% bolus followed by 90% infusion: This is the dosing for alteplase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 0.25 mg/kg as 10% bolus followed by 90% infusion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 0.9 mg/kg as a single bolus: This is the maximum dose for alteplase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 0.9 mg/kg as a single bolus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 0.9 mg/kg infused over 60 minutes: Tenecteplase is not infused over time.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 0.9 mg/kg infused over 60 minutes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Know the correct dosing and administration of tenecteplase, a thrombolytic agent used in acute stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents with acute left hemiparesis and facial droop 3 hours ago. Her NIHSS score is 18, and NCCT shows early ischemic changes (ASPECTS score of 5). CTA reveals a right ICA occlusion. Which factor would make her ineligible for endovascular therapy (thrombectomy)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age of 52 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NIHSS score of 18&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of extensive early ischemic changes (ASPECTS 5)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CTA showing right ICA occlusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of extensive early ischemic changes (ASPECTS 5)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age of 52 years : Age is not an absolute contraindication.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age of 52 years&lt;/li&gt;&lt;li&gt;â€¢ Option B. NIHSS score of 18: High NIHSS score indicates severity but doesn&#x27;t exclude thrombectomy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. NIHSS score of 18:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CTA showing right ICA occlusion: ICA occlusion is an indication for thrombectomy if other criteria are met.&lt;/li&gt;&lt;li&gt;â€¢ Option D. CTA showing right ICA occlusion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the presence of extensive early ischemic changes, reflected by a low ASPECTS score, is a contraindication for endovascular therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with hypertension presents with sudden left-sided weakness and difficulty speaking. His blood pressure is 200/124 mmHg. His NIHSS score is 14, and NCCT shows no hemorrhage. What is the most appropriate management of his blood pressure before administering tPA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start IV labetalol to reduce SBP &amp;lt;185 mmHg and DBP &amp;lt;110 mmHg.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer oral antihypertensives to gradually reduce BP over 24 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Withhold antihypertensive treatment unless SBP exceeds 220 mmHg.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immediately start IV tPA.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Start IV labetalol to reduce SBP &lt;185 mmHg and DBP &lt;110 mmHg.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer oral antihypertensives to gradually reduce BP over 24 hours: Oral antihypertensives are too slow for this acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer oral antihypertensives to gradually reduce BP over 24 hours:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Withhold antihypertensive treatment unless SBP exceeds 220 mmHg: Withholding treatment with such high BP is inappropriate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Withhold antihypertensive treatment unless SBP exceeds 220 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immediately start IV tPA: tPA should not be given before achieving target BP.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immediately start IV tPA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the importance of blood pressure control before administering tPA in acute ischemic stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the recommended target range for blood glucose in acute ischemic stroke management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;70-110 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;110-150 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;140-180 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;180-220 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 140-180 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 70-110 mg/dL: This range is too narrow and risks hypoglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 70-110 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 110-150 mg/dL: This range is on the lower end and may also risk hypoglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 110-150 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 180-220 mg/dL: This range is too high and may exacerbate ischemic injury.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 180-220 mg/dL:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Know the target blood glucose range for acute ischemic stroke management to optimize outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with hypertension, diabetes, and hyperlipidemia presents with sudden expressive aphasia, right facial droop, and right hemiparesis. He receives IV tPA, but 24 hours later his condition worsens, and repeat CT shows significant cerebral edema with midline shift. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevate the head of the bed to 30 degrees&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate decompressive craniectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Intravenous mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevate the head of the bed to 30 degrees: Head elevation can help, but it&#x27;s unlikely to be enough in this severe case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevate the head of the bed to 30 degrees:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate decompressive craniectomy: Decompressive craniectomy is a last resort if medical management fails.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate decompressive craniectomy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose corticosteroids: Corticosteroids are not recommended for cerebral edema in ischemic stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose corticosteroids:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of mannitol in managing increased intracranial pressure due to cerebral edema in stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man with a history of hypertension, hyperlipidemia, and smoking presents with sudden confusion and right-sided weakness. He also has difficulty chewing. Which factor most likely increases his risk of dysphagia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BP of 170/100 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Age of 63 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Difficulty in chewing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;History of hyperlipidemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Difficulty in chewing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BP of 170/100 mmHg: High blood pressure is a risk factor for stroke, but not directly for dysphagia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. BP of 170/100 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age of 63 years: While dysphagia is more common in older individuals, difficulty chewing is a more specific indicator in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age of 63 years:&lt;/li&gt;&lt;li&gt;â€¢ Option D. History of hyperlipidemia: Hyperlipidemia is a risk factor for stroke but doesn&#x27;t directly affect swallowing.&lt;/li&gt;&lt;li&gt;â€¢ Option D. History of hyperlipidemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that difficulty chewing in an acute stroke patient indicates a higher risk of dysphagia, requiring further assessment and intervention to prevent complications like aspiration pneumonia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with atrial fibrillation and hypertension on warfarin presents with right-sided weakness, slurred speech, and left MCA stroke. Her INR is 2.6. She is immobile due to hemiplegia. What is the most appropriate VTE prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue warfarin with INR 2-3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer low-molecular-weight heparin (LMWH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start unfractionated heparin (UFH) infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional prophylaxis is needed&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Administer low-molecular-weight heparin (LMWH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue warfarin with INR 2-3: Continuing warfarin may not provide adequate VTE prophylaxis in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue warfarin with INR 2-3:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start unfractionated heparin (UFH) infusion: UFH requires more frequent monitoring and adjustments.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start unfractionated heparin (UFH) infusion:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No additional prophylaxis is needed: Immobile stroke patients are at high risk for VTE and require prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No additional prophylaxis is needed:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the importance of VTE prophylaxis in immobile stroke patients, and that LMWH is generally preferred over UFH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with hypertension, hyperlipidemia, and a 30-pack-year smoking history presents with right-sided weakness and aphasia. CT shows a left MCA stroke. Carotid duplex shows 80% stenosis of the left ICA. He is started on aspirin and a high-intensity statin. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue medical management with aspirin and statin therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Schedule a carotid endarterectomy (CEA).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate anticoagulation with warfarin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Perform carotid artery stenting (CAS).&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Schedule a carotid endarterectomy (CEA).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue medical management with aspirin and statin therapy: Medical management alone is not sufficient for high-grade stenosis with recent symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue medical management with aspirin and statin therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate anticoagulation with warfarin: Anticoagulation is primarily for cardioembolic strokes, not carotid stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate anticoagulation with warfarin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Perform carotid artery stenting (CAS): CAS is an alternative for high-risk surgical patients, but CEA is generally preferred.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Perform carotid artery stenting (CAS):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In symptomatic patients with high-grade carotid stenosis, CEA is recommended to prevent future strokes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old woman with atrial fibrillation and hypertension on warfarin presents with left-sided weakness, slurred speech, and a right MCA stroke. Her INR is subtherapeutic (1.5). What is the most appropriate anticoagulation strategy going forward?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue warfarin with more frequent INR monitoring.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Switch to a direct oral anticoagulant (DOAC).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate aspirin therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start dual antiplatelet therapy with aspirin and clopidogrel.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Switch to a direct oral anticoagulant (DOAC).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue warfarin with more frequent INR monitoring: Frequent INR monitoring may not guarantee optimal warfarin control.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue warfarin with more frequent INR monitoring:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate aspirin therapy: Aspirin is not sufficient for stroke prevention in atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiate aspirin therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start dual antiplatelet therapy with aspirin and clopidogrel: Dual antiplatelet therapy is not routinely recommended for atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start dual antiplatelet therapy with aspirin and clopidogrel:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the advantages of DOACs over warfarin in stroke prevention for atrial fibrillation, especially in cases of subtherapeutic INR.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man experiences sudden right-sided weakness and difficulty speaking that completely resolved within 30 minutes. He has a history of hypertension, hyperlipidemia and smoking. Neurological exam and head CT are normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dissociative disorder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transient ischemic attack (TIA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transient ischemic attack (TIA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute ischemic stroke: Ischemic stroke would have persistent neurological deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute ischemic stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dissociative disorder: Dissociative disorders are psychological in nature and don&#x27;t typically mimic stroke symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dissociative disorder:&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above: This presentation fits the definition of TIA.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ None of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that TIAs are warning signs of potential stroke and require prompt evaluation and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with hypertension and diabetes has a TIA with speech difficulty and right-sided weakness lasting 20 minutes. What is her ABCD2 score?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;6&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Age (0 points for &amp;lt;60 years old) Blood pressure (1 point for â‰¥140/90 mmHg) Clinical features (2 points for unilateral weakness) Duration (1 point for 10-59 minutes) Diabetes (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Age (0 points for &amp;lt;60 years old)&lt;/li&gt;&lt;li&gt;â€¢ Blood pressure (1 point for â‰¥140/90 mmHg)&lt;/li&gt;&lt;li&gt;â€¢ Clinical features (2 points for unilateral weakness)&lt;/li&gt;&lt;li&gt;â€¢ Duration (1 point for 10-59 minutes)&lt;/li&gt;&lt;li&gt;â€¢ Diabetes (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Total = 5&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Know how to calculate the ABCD2 score, a clinical tool to assess stroke risk after a TIA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with hypertension has acute dysarthria. MRI reveals a lacunar stroke. Which part of the brain is most likely affected?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Posterior limb of internal capsule&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ventral thalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Genu of internal capsule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventral pons&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Genu of internal capsule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Posterior limb: Affects contralateral limbs, causing hemiparesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Posterior limb:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ventral thalamus: Affects sensory and motor relay, causing sensory disturbances or movement disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ventral thalamus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventral pons: Could cause dysarthria but typically also involves hemiparesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventral pons:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the anatomy of lacunar strokes and how different locations can lead to specific neurological deficits.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with hypertension presents with sudden severe headache, right-sided partial vision loss, and difficulty speaking. He has right homonymous hemianopia and slurred speech. CT head is normal. What is the MRA most likely to show?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aneurysmal dilation of the anterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Occlusion of the left middle cerebral artery (MCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dissection of the right internal carotid artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arteriovenous malformation in the occipital lobe&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Occlusion of the left middle cerebral artery (MCA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aneurysmal dilation of the anterior communicating artery: Aneurysm would more likely present with subarachnoid hemorrhage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aneurysmal dilation of the anterior communicating artery:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dissection of the right internal carotid artery: Carotid dissection could cause stroke, but the symptoms are more suggestive of MCA territory.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dissection of the right internal carotid artery:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Arteriovenous malformation in the occipital lobe: AVM would be visible on CT, and occipital AVM would likely cause only visual symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Arteriovenous malformation in the occipital lobe:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the presentation of MCA stroke and the role of MRA in confirming the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with SLE and chronic kidney disease presents with sudden severe headache, blurred vision, confusion, and hypertension. Fundoscopy shows bilateral papilledema. MRI is most likely to show which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple hyperintense lesions in white matter on T2-weighted images&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute infarction in the MCA territory&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningeal enhancement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal brain parenchyma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Multiple hyperintense lesions in white matter on T2-weighted images&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute infarction in the MCA territory: MCA infarction would present with focal neurological deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute infarction in the MCA territory:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meningeal enhancement: Meningeal enhancement suggests meningitis or meningeal carcinomatosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meningeal enhancement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal brain parenchyma: MRI in PRES is usually not normal.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal brain parenchyma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical and imaging features of PRES, a condition often associated with hypertension and renal dysfunction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman presents with a sudden, severe \&quot;thunderclap\&quot; headache, different from her usual migraines. She recently started a new weight loss medication. CT head is normal, and LP shows no SAH. What is the MRA most likely to show?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beading of cerebral arteries&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aneurysmal dilation of the anterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occlusion of the left MCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal cerebral vasculature&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Beading of cerebral arteries&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aneurysmal dilation of the anterior communicating artery: Aneurysm would more likely present with SAH.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aneurysmal dilation of the anterior communicating artery:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Occlusion of the left MCA: MCA occlusion would present with focal neurological deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Occlusion of the left MCA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal cerebral vasculature: Normal vasculature is unlikely in the presence of a vascular headache.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal cerebral vasculature:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the presentation of RCVS and the characteristic \&quot;beading\&quot; pattern on MRA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman on oral contraceptives presents with worsening headache, nausea, vomiting, and papilledema. MRV reveals thrombosis in the superior sagittal sinus. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anticoagulation with heparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antiplatelet therapy with aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate surgical intervention&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation with serial imaging&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anticoagulation with heparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antiplatelet therapy with aspirin: Aspirin is insufficient for CVST.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antiplatelet therapy with aspirin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate surgical intervention: Surgery is not the initial treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate surgical intervention:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation with serial imaging: Observation without treatment is inappropriate for CVST.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Observation with serial imaging:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the presentation of CVST and the importance of immediate anticoagulation for its management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old boy presents with sudden severe headache, vomiting, and confusion. He has a history of recurrent muscle weakness and pain after exercise, progressive hearing loss, and migraines. Exam shows lethargy, bilateral ptosis, and weakness. Fundoscopy reveals pigmentary retinopathy. Lactate is elevated in blood and CSF. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leigh syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MERRF syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MELAS syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kearns-Sayre syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MELAS syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leigh syndrome :  Presents in infancy with developmental regression and respiratory abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leigh syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. MERRF syndrome: Presents with myoclonus and ragged-red fibers on muscle biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. MERRF syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Kearns-Sayre syndrome: Presents with ophthalmoplegia, pigmentary retinopathy, and heart block.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Kearns-Sayre syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the classic presentation of MELAS syndrome, a mitochondrial disorder with a multisystemic presentation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman presents with increasing forgetfulness, misplacing items, forgetting appointments, depressed mood, and a lack of interest in activities. What is NOT suggestive of cortical dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Forgetfulness&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Depressed mood&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fluent speech&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Difficulty naming objects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Depressed mood&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ While forgetfulness , fluent speech with anomia (difficulty naming objects), and executive dysfunction are common in cortical dementia, depressed mood is more characteristic of subcortical dementias or primary mood disorders.&lt;/li&gt;&lt;li&gt;â€¢ forgetfulness&lt;/li&gt;&lt;li&gt;â€¢ fluent speech&lt;/li&gt;&lt;li&gt;â€¢ anomia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between cortical and subcortical dementia presentations, noting that depressed mood is not a hallmark of cortical dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman presents with progressive memory loss, difficulty recalling recent events and naming objects, fluent but with word-finding difficulty, and trouble with complex tasks. MRI shows generalized cortical atrophy. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s dementia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Frontotemporal dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewy body dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alzheimer&#x27;s dementia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Frontotemporal dementia: Frontotemporal dementia presents with early personality and behavioral changes or primary progressive aphasia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Frontotemporal dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vascular dementia: Vascular dementia has a stepwise decline with focal neurological signs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vascular dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia: Lewy body dementia presents with fluctuating cognition, hallucinations, and Parkinsonism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the typical presentation and imaging findings of Alzheimer&#x27;s dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A brain autopsy of a patient with Alzheimer&#x27;s dementia is most likely to reveal which finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lewy bodies in the substantia nigra&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neurofibrillary tangles&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spongiform changes in the cerebral cortex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Demyelination of white matter tracts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neurofibrillary tangles&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lewy bodies in the substantia nigra: Lewy bodies are characteristic of Parkinson&#x27;s disease and Lewy body dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lewy bodies in the substantia nigra:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spongiform changes in the cerebral cortex: Spongiform changes are seen in prion diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spongiform changes in the cerebral cortex:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Demyelination of white matter tracts: Demyelination is seen in multiple sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Demyelination of white matter tracts:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the key pathological finding of neurofibrillary tangles in Alzheimer&#x27;s disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What CSF finding is most consistent with Alzheimer&#x27;s dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated protein, normal glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased beta-amyloid 42, elevated tau protein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated WBCs, decreased glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased beta-amyloid 42, elevated tau protein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased beta-amyloid 42, elevated tau protein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated protein, normal glucose: This pattern is more suggestive of infection or inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated protein, normal glucose:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elevated WBCs, decreased glucose: This indicates meningitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elevated WBCs, decreased glucose:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased beta-amyloid 42, elevated tau protein: This is the opposite of the expected finding in Alzheimer&#x27;s.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased beta-amyloid 42, elevated tau protein:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic CSF biomarker changes in Alzheimer&#x27;s dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman has increasing forgetfulness, difficulty managing finances, and getting lost while driving. She is disoriented to time and has an MMSE score of 22/30. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start donepezil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start sertraline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Start donepezil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start Memantine: Memantine is for moderate to severe Alzheimer&#x27;s.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start Memantine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start Haloperidol: Haloperidol is an antipsychotic and not a primary treatment for dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start Haloperidol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start Sertraline: Sertraline is an antidepressant and may be used adjunctively if depression is present.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start Sertraline:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Know the initial management of mild Alzheimer&#x27;s dementia with cholinesterase inhibitors like donepezil.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man has significant personality changes, impulsivity, apathy, decreased hygiene, voracious appetite for sweets, and language deterioration over the past year. Memory and spatial orientation are intact. MRI shows frontal and anterior temporal lobe atrophy. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Frontotemporal dementia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewy body dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Frontotemporal dementia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s dementia: Alzheimer&#x27;s primarily affects memory early on.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vascular dementia: Vascular dementia has a stepwise decline with focal neurological signs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vascular dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia : Lewy body dementia presents with fluctuating cognition, hallucinations, and parkinsonism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the distinctive early features of frontotemporal dementia, with prominent behavioral and language changes rather than memory loss.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman presents with progressive personality changes, inappropriate behavior, lack of empathy, difficulty naming objects, and impaired executive function. Memory is relatively preserved. MRI shows marked atrophy in the frontal and temporal lobes, more pronounced on the right side. What pathology is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta-amyloid plaques and neurofibrillary tangles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lewy bodies and alpha-synuclein pathology&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tau-positive inclusions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple lacunar infarcts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tau-positive inclusions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-amyloid plaques and neurofibrillary tangles: Amyloid plaques and neurofibrillary tangles are hallmarks of Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-amyloid plaques and neurofibrillary tangles:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lewy bodies and alpha-synuclein pathology: Lewy bodies are associated with Lewy body dementia and Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lewy bodies and alpha-synuclein pathology:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple lacunar infarcts: Lacunar infarcts are associated with vascular dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple lacunar infarcts:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the neuropathology of frontotemporal dementia, primarily involving tau-positive inclusions leading to degeneration of the frontal and temporal lobes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man has progressive cognitive decline, fluctuating alertness, visual hallucinations, Parkinsonism, and REM sleep behavior disorder. MRI shows generalized atrophy. What is the most likely pathology responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta-amyloid plaques and neurofibrillary tangles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lewy bodies and alpha-synuclein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tau protein aggregates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple lacunar infarcts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lewy bodies and alpha-synuclein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-amyloid plaques and neurofibrillary tangles: These are associated with Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Beta-amyloid plaques and neurofibrillary tangles:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tau protein aggregates: Tau protein aggregates are seen in various neurodegenerative diseases but less specific to LBD.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tau protein aggregates:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple lacunar infarcts: Lacunar infarcts are associated with vascular dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple lacunar infarcts:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Recognize Lewy body dementia as a distinct entity with its hallmark features and underlying pathology.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presents with progressive cognitive decline, fluctuating attention, visual hallucinations, slow shuffling gait, stiffness, falls, and acting out dreams. Examination reveals mild rigidity and bradykinesia. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lewy body dementia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal pressure hydrocephalus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lewy body dementia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease: Alzheimer&#x27;s disease has progressive memory loss as the main feature.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vascular dementia: Vascular dementia has a stepwise decline related to vascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vascular dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal pressure hydrocephalus (NPH): Presents with gait disturbance, incontinence, and cognitive decline, without the hallucinations or sleep disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal pressure hydrocephalus (NPH):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the key features of Lewy body dementia that differentiate it from other forms of dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man has progressive difficulty walking, cognitive decline, and urinary incontinence. His gait is slow and shuffling. MRI shows enlarged ventricles with normal cerebral sulci. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal pressure hydrocephalus (NPH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parkinson&#x27;s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Normal pressure hydrocephalus (NPH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease: Alzheimer&#x27;s mainly affects memory.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vascular dementia: Vascular dementia is associated with vascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vascular dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Parkinson&#x27;s disease: Parkinson&#x27;s primarily affects motor function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Parkinson&#x27;s disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the classic presentation of NPH, a potentially reversible cause of dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with progressive difficulty walking, cognitive decline, and urinary incontinence has ventriculomegaly on MRI. A lumbar puncture with large-volume CSF removal temporarily improves her gait. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start a cholinesterase inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ventriculoperitoneal (VP) shunt surgery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase physical therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start dopamine agonist therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ventriculoperitoneal (VP) shunt surgery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a cholinesterase inhibitor: Cholinesterase inhibitors are used in Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start a cholinesterase inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase physical therapy: Physical therapy can be helpful, but the underlying problem is excess CSF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase physical therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start dopamine agonist therapy: Dopamine agonists are used in Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start dopamine agonist therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize that VP shunt surgery is the definitive treatment for NPH after a positive response to CSF removal.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old man with uncontrolled hypertension, type 2 diabetes, and a previous stroke presents with stepwise decline in memory, attention, and problem-solving over the past year. He also has a history of TIAs. Exam shows mild right-sided weakness and brisk reflexes. Brain imaging shows multiple infarcts and chronic small vessel disease. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lewy body dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Frontotemporal dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vascular dementia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease: Alzheimer&#x27;s has a gradual, progressive decline without the stepwise pattern or focal signs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lewy body dementia: Lewy body dementia presents with fluctuating cognition, hallucinations, and Parkinsonism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lewy body dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Frontotemporal dementia: Frontotemporal dementia primarily affects personality and behavior or language.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Frontotemporal dementia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical features and imaging findings suggestive of vascular dementia, which is often related to cerebrovascular disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man has rapidly progressive memory loss, behavioral changes, and difficulty with coordination. He has myoclonic jerks, ataxia, startle response, periodic sharp wave complexes on EEG, and high signal abnormalities in the caudate and putamen on MRI DWI. CSF shows 14-3-3 protein. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Creutzfeldt-Jakob disease (CJD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewy body dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Creutzfeldt-Jakob disease (CJD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease: Alzheimer&#x27;s has a slower progression and different clinical/imaging features.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alzheimer&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple sclerosis: Multiple sclerosis typically has relapsing-remitting course and different MRI findings.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple sclerosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia: Lewy body dementia presents with fluctuating cognition, hallucinations, and Parkinsonism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the unique features of CJD, a rapidly progressive and fatal neurodegenerative disease with characteristic diagnostic findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with rapidly progressive memory loss, behavioral changes, and myoclonic jerks. What is the MRI finding shown?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortical ribboning&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dural tail sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reversal sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tram-track sign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cortical ribboning&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-125012.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dural tail sign: Dural tail sign is associated with meningiomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dural tail sign:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reversal sign: Reversal sign is seen in hypoxic-ischemic encephalopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reversal sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tram-track sign: Tram-track sign is seen in some tumors and cortical venous thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tram-track sign:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Identify cortical ribboning as a key MRI finding in Creutzfeldt-Jakob disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a 2-year history of progressive difficulty walking and a resting tremor in his right hand that improves with movement also reports stiffness and difficulty buttoning his shirt. On exam, he has rigidity in the upper extremities and a shuffling gait with reduced arm swing. MRI brain is normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Essential tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parkinson&#x27;s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Huntington&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple system atrophy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Parkinson&#x27;s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Essential tremor: Essential tremor is an action tremor that worsens with movement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Essential tremor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Huntington&#x27;s disease: Involves chorea and cognitive decline.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Huntington&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple system atrophy: Presents with Parkinsonism plus autonomic dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple system atrophy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the classic clinical features of Parkinson&#x27;s disease, a neurodegenerative disorder primarily affecting movement.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with a 6-month history of left-hand resting tremors, stiffness in the left arm and leg, and bradykinesia. His father was diagnosed with Parkinson&#x27;s disease at age 50. Genetic testing reveals a mutation associated with familial Parkinson&#x27;s disease. Which gene is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DJ-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HTT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SNCA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FUS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. SNCA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. DJ-1: It is also associated with early-onset PD, but SNCA is more common.&lt;/li&gt;&lt;li&gt;â€¢ Option A. DJ-1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. HTT: It is the gene associated with Huntington&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HTT:&lt;/li&gt;&lt;li&gt;â€¢ Option D. FUS: It is associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. FUS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the association of SNCA gene mutations with familial Parkinson&#x27;s disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman with a 3-year history of Parkinson&#x27;s disease on levodopa/carbidopa therapy develops sudden involuntary movements, nausea, and light headedness. On examination, she has choreiform movements, facial grimacing, and orthostatic hypotension. What is the most likely explanation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parkinson&#x27;s disease dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Levodopa-induced dyskinesia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Progression of Parkinson&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Onset of a secondary movement disorder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Levodopa-induced dyskinesia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Parkinson&#x27;s disease dementia: Is a cognitive decline, not a movement disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Parkinson&#x27;s disease dementia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Progression of Parkinson&#x27;s disease: Disease progression usually causes worsening of the original motor symptoms, not new types of dyskinesia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Progression of Parkinson&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Onset of a secondary movement disorder: A secondary movement disorder is less likely given the clear temporal relationship with levodopa use.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Onset of a secondary movement disorder:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize levodopa-induced dyskinesia as a common complication of long-term levodopa therapy in Parkinson&#x27;s disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with a 10-year history of Parkinson&#x27;s disease has motor symptoms no longer controlled by medications, significant motor fluctuations and dyskinesias. He is a suitable candidate for deep brain stimulation (DBS). Which brain structure is the most likely target for DBS in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Globus pallidus interna (GPi)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Caudate nucleus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Globus pallidus interna (GPi)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cerebellum : The cerebellum is not a target for DBS in Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cerebellum&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalamus: The thalamus is sometimes targeted for essential tremor, but not typically for Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thalamus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Caudate nucleus: The caudate nucleus is not a target for DBS in Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Caudate nucleus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of the globus pallidus interna (GPi) as a target for deep brain stimulation in Parkinson&#x27;s disease, especially in patients with dyskinesias.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a 4-year history of Parkinson&#x27;s disease experiences \&quot;wearing-off\&quot; episodes and early morning tremors despite taking levodopa/carbidopa three times a day. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the frequency of levodopa/carbidopa dosing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add a dopamine agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add an MAO-B inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch to a controlled-release formulation of levodopa/carbidopa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increase the frequency of levodopa/carbidopa dosing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adding a dopamine agonist: Can be considered, but it may worsen dyskinesia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adding a dopamine agonist:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Add an MAO-B inhibitors: Add an MAO-B inhibitors are typically used in early Parkinson&#x27;s disease or as an adjunct to levodopa.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Add an MAO-B inhibitors:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Switch to a controlled-release formulation of levodopa/carbidopa: Controlled-release formulations may have unpredictable absorption and may not be effective in managing early morning off periods.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Switch to a controlled-release formulation of levodopa/carbidopa:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize that adjusting the frequency of levodopa/carbidopa dosing is the preferred initial step in managing \&quot;wearing-off\&quot; phenomena in Parkinson&#x27;s disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with a 2-year history of progressive difficulty walking, frequent falls, dizziness upon standing, constipation and erectile dysfunction. Exam reveals stooped posture, shuffling gait, decreased facial expression, low-volume monotone voice, orthostatic hypotension, rigidity, and bradykinesia but no resting tremor. MRI is shown. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hot cross bun sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mickey Mouse sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Race car sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Empty delta sign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hot cross bun sign&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-131020.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mickey Mouse sign: enlarged basal cisterns, seen in hydrocephalus or frontal lobe compression.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mickey Mouse sign:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Race car sign: bilateral hyperintensities in putamen and caudate, seen in Wilson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Race car sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Empty delta sign: filling defect in superior sagittal sinus on CT, seen in cerebral venous thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Empty delta sign:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical features and characteristic \&quot;hot cross bun\&quot; sign on MRI associated with Multiple System Atrophy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman presents with progressive difficulty walking, frequent falls, cognitive decline and difficulty looking downward. She has a stiff posture and tends to fall backward. What MRI finding is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebellar and brainstem atrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral hyper intensities in basal ganglia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;\&quot;Hummingbird\&quot; sign with midbrain atrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple white matter lesions&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. \&quot;Hummingbird\&quot; sign with midbrain atrophy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cerebellar and brainstem atrophy : Is more characteristic of multiple system atrophy (MSA).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cerebellar and brainstem atrophy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral hyperintensities in basal ganglia: Are seen in other conditions like Wilson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral hyperintensities in basal ganglia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple white matter lesions: Are seen in multiple sclerosis and other demyelinating disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple white matter lesions:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the \&quot;hummingbird\&quot; sign on MRI as a key finding in PSP, which presents with gait difficulty, falls, cognitive decline, and vertical gaze palsy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman presents with a 1-year history of balance difficulty, falls, right hand stiffness and clumsiness, forgetfulness, confusion, and visual hallucinations. Exam reveals increased tone, cogwheel rigidity, wide-based shuffling gait, impaired fine motor skills, and mild cognitive impairment. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple system atrophy (MSA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Progressive supranuclear palsy (PSP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticobasal syndrome (CBS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lewy body dementia (LBD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Corticobasal syndrome (CBS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple system atrophy (MSA): MSA typically presents with autonomic dysfunction and Parkinsonism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple system atrophy (MSA):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Progressive supranuclear palsy (PSP): PSP is characterized by early gait instability, falls, and vertical gaze palsy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Progressive supranuclear palsy (PSP):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia (LBD): LBD has more prominent fluctuations in cognition and visual hallucinations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lewy body dementia (LBD):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the unique combination of motor, cognitive, and behavioral symptoms in CBS, distinguishing it from other parkinsonian syndromes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man presents with a 6-month history of involuntary jerking movements, mood swings, irritability, and cognitive decline. His father had similar symptoms in his 40s. Exam shows impaired rapid alternating movements and a positive Romberg sign. What genetic abnormality is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trinucleotide repeat expansion in the HTT gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Point mutation in the HTT gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hexanucleotide repeat expansion in the C9orf72 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deletion in the HTT gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Trinucleotide repeat expansion in the HTT gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Point mutations in the HTT gene: Are not typically associated with Huntington&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Point mutations in the HTT gene:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hexanucleotide repeat expansion in the C9orf72 gene: Is associated with ALS and frontotemporal dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hexanucleotide repeat expansion in the C9orf72 gene:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deletions in the HTT gene: Are not the cause of Huntington&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deletions in the HTT gene:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the genetic basis of Huntington&#x27;s disease and its characteristic clinical presentation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman has a 3-month history of sudden, brief, involuntary jerking movements of her arms and legs, worsened by stress and fatigue. Exam reveals sporadic, brief, shock-like jerks involving both upper and lower extremities. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Essential tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myoclonus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Parkinson&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Epilepsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myoclonus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Essential tremor: Essential tremor is a rhythmic tremor, not shock-like jerks.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Essential tremor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Parkinson&#x27;s disease: Parkinson&#x27;s disease involves resting tremor, rigidity, and bradykinesia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Parkinson&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Epilepsy: While myoclonus can be a symptom of epilepsy, there are no other features to suggest seizures in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Epilepsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of myoclonus, which can be a symptom of various neurological disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with poorly controlled type 2 diabetes presents with sudden, involuntary, violent flinging movements of her left arm and leg. Blood glucose is 350 mg/dL, and there are no other focal deficits. CT shows a hyperdensity in the right subthalamic nucleus. What is the most appropriate management for her hemiballism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start haloperidol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start levetiracetam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immediate surgical intervention&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Start haloperidol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start levodopa: Levodopa can worsen hemiballism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Start levodopa:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start levetiracetam: Levetiracetam is an antiepileptic drug.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start levetiracetam:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immediate surgical intervention: Surgery is not the initial treatment for hemiballism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immediate surgical intervention:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the management of hemiballism, primarily with dopamine receptor antagonists like haloperidol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy presents with repetitive, involuntary blinking, head jerking, and grunting noises for the past year. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Attention-deficit/hyperactivity disorder (ADHD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obsessive-compulsive disorder (OCD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tourette&#x27;s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Epilepsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tourette&#x27;s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Attention-deficit/hyperactivity disorder (ADHD): ADHD is characterized by inattention, hyperactivity, and impulsivity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Attention-deficit/hyperactivity disorder (ADHD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Obsessive-compulsive disorder (OCD): OCD involves obsessions and compulsions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Obsessive-compulsive disorder (OCD):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Epilepsy: Epilepsy involves recurrent seizures, which are distinct from tics.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Epilepsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the diagnostic criteria for Tourette&#x27;s syndrome, a disorder characterized by motor and vocal tics.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common blood vessel involved in trigeminal neuralgia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basilar artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Superior cerebellar artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inferior cerebellar artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Superior cerebellar artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Superior cerebellar artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45yr old patient suffering from chronic tension-type headache. Which of the following is treatment of choice in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amitriptyline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sertraline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amitriptyline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Amitriptyline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Familial hemiplegic migraine type 1 is caused due to mutation in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CACNA1A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATP1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SCN1A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SCN2A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CACNA1A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Alcohol is trigger in which of the following type of headache?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cluster headache&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paroxysmal hemicrania&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SUNCT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SUNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cluster headache&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/untitled-797.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Cluster headache&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Complete response to indomethacin is seen in which of the following type of headache?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cluster headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paroxysmal hemicrania&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SUNCT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SUNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Paroxysmal hemicrania&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/untitled-797_RAumwfO.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Paroxysmal hemicrania&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Treatment of choice for Acute attack of Cluster headache is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral sumatriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen inhalation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oxygen inhalation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Oxygen inhalation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Noninvasive vagus nerve stimulation (nVNS) is FDA approved for which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute treatment of Tension headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic treatment of Tension headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute treatment of cluster headache&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic treatment of cluster headache&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute treatment of cluster headache&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Acute treatment of cluster headache&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Treatment of Choice for hypnic headache?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amitriptyline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lithium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Treatment of choice for Primary cough headache?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amitriptyline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Indomethacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Indomethacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;MIDAS Questionnaire is used in evaluation of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Motor neuron disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Migrane headache&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Migrane headache&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/untitled-796.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Migrane headache&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;5-HT1F receptor agonist used in the management of migrane are called?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eletriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rimegepant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lasmiditan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ubrogepant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lasmiditan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lasmiditan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with progressive weakness in his right arm and leg, difficulty climbing stairs, and smaller, less legible handwriting. Exam reveals increased tone and brisk reflexes in the right extremities, along with a positive Babinski sign. Which of the following is the most likely impairment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Upper motor neuron (UMN) lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lower motor neuron (LMN) lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neuromuscular junction (NMJ) lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Upper motor neuron (UMN) lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower motor neuron (LMN) lesions: LMN lesions present with weakness, decreased reflexes, atrophy, and fasciculations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower motor neuron (LMN) lesions:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neuromuscular junction (NMJ) lesions: NMJ lesions (e.g., myasthenia gravis) cause fatigable weakness and typically have normal reflexes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neuromuscular junction (NMJ) lesions:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myopathy: Myopathies cause weakness with normal reflexes and tone, affecting proximal muscles.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical features that distinguish UMN lesions from other neuromuscular disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with hypertension presents with progressive weakness and atrophy of the intrinsic muscles of his left hand, diminished reflexes, and no Babinski sign. What is the most appropriate next step in evaluation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Electromyography (EMG) and nerve conduction studies (NCS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Magnetic resonance imaging (MRI) of the brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Muscle biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Electromyography (EMG) and nerve conduction studies (NCS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lumbar puncture: Lumbar puncture is not indicated for suspected peripheral nerve lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lumbar puncture:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Magnetic resonance imaging (MRI) of the brain: Brain MRI would be useful for central nervous system (CNS) lesions, but not for peripheral issues.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Magnetic resonance imaging (MRI) of the brain:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Muscle biopsy: Muscle biopsy may be needed later, but EMG/NCS is the initial step to localize the lesion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Muscle biopsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the utility of EMG/NCS in evaluating suspected LMN or peripheral nerve disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with fluctuating weakness and fatigue, worsening with activity, ptosis, diplopia, and proximal muscle weakness. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;UMN lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LMN lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NMJ lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. NMJ lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. UMN lesions: Would not present with fluctuating weakness and fatigability.&lt;/li&gt;&lt;li&gt;â€¢ Option A. UMN lesions:&lt;/li&gt;&lt;li&gt;â€¢ Option B. LMN lesions: Do not typically involve ocular muscles and have more consistent weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option B. LMN lesions:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myopathy: Myopathies present with symmetrical proximal weakness without the fluctuating nature.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of NMJ disorders, such as myasthenia gravis, including fluctuating weakness and ocular involvement.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a 4-month history of progressive proximal muscle weakness, with difficulty climbing stairs, rising from a chair, and lifting objects overhead. Exam reveals symmetrical proximal muscle weakness with preserved distal strength. Muscle tone and reflexes are normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;UMN lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LMN lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NMJ lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myopathy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Myopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. UMN lesions : UMN lesions would cause spasticity and hyperreflexia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. UMN lesions&lt;/li&gt;&lt;li&gt;â€¢ Option B. LMN lesions : LMN lesions would cause weakness, atrophy, and fasciculations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. LMN lesions&lt;/li&gt;&lt;li&gt;â€¢ Option C. NMJ lesions : NMJ lesions Would cause fluctuating weakness and fatigability.&lt;/li&gt;&lt;li&gt;â€¢ Option C. NMJ lesions&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic presentation of myopathy, a disorder primarily affecting muscle tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man presents with complete loss of sensation and movement in both legs below the umbilicus after a motorcycle accident. He also reports loss of bladder and bowel control. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cauda equina syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Central cord syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anterior cord syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Complete spinal cord transection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Complete spinal cord transection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cauda equina syndrome: Causes lower back pain, radicular pain, saddle anesthesia, and bowel/bladder dysfunction, but usually not complete paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cauda equina syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Central cord syndrome: Typically presents with greater weakness in the upper extremities.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Central cord syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anterior cord syndrome: Causes loss of motor function and pain/temperature sensation below the lesion, but proprioception is preserved.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anterior cord syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the signs of complete spinal cord transection, a devastating injury with complete loss of sensory and motor function below the level of injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman was stabbed in the back and now has decreased sensation on the right side of her body and weakness in her left leg. She has decreased pain and temperature sensation on the right below the mid-thorax, and decreased strength and vibratory/proprioceptive sensation on the left below the mid-thorax. What is the most likely spinal level of the injury?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C5-C6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;T5-T6&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;L1-L2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;S1-S2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. T5-T6&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. C5-C6 : C5-C6 would involve the arms and upper chest.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ C5-C6&lt;/li&gt;&lt;li&gt;â€¢ Option C. L1-L2 : L1-L2 would affect the legs and lower abdomen.&lt;/li&gt;&lt;li&gt;â€¢ Option C. L1-L2&lt;/li&gt;&lt;li&gt;â€¢ Option D. S1-S2 : S1-S2 would affect the perineal area and bowel/bladder function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. S1-S2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the patterns of sensory and motor loss in Brown-SÃ©quard syndrome and how to localize the spinal level of injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with cervical spondylosis presents with weakness in both arms after a fall, more severe than in his legs. He also has difficulty with fine motor tasks. Exam shows greater upper extremity weakness with preserved sensation. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brown-SÃ©quard syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Central cord syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anterior cord syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Conus medullaris syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Central cord syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brown-SÃ©quard syndrome: Brown-SÃ©quard syndrome involves ipsilateral motor weakness and contralateral pain/temperature loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brown-SÃ©quard syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anterior cord syndrome: Anterior cord syndrome causes loss of motor function and pain/temperature sensation below the lesion, with preserved proprioception.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anterior cord syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conus medullaris syndrome: Conus medullaris syndrome affects the sacral cord and causes bowel/bladder dysfunction and saddle anesthesia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conus medullaris syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the typical presentation of central cord syndrome, which is greater weakness in the upper extremities compared to the lower extremities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with severe atherosclerosis has sudden paralysis and loss of pain and temperature sensation in both legs, along with urinary retention. Vibration and proprioception are intact. What is the LEAST likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disc protrusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anterior spinal artery thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperflexion injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syringomyelia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syringomyelia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Disc protrusion, Option B. Anterior spinal artery thrombosis and Option C. Hyperflexion injury can all cause acute anterior cord syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Disc protrusion, Option B. Anterior spinal artery thrombosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperflexion injury&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the clinical presentation and potential causes of anterior cord syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man has progressive lower back pain radiating to both legs, difficulty initiating urination, fecal incontinence, decreased perineal sensation, and weakness in ankle muscles. MRI shows a mass lesion at L1. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cauda equina syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conus medullaris syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lumbar disc herniation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spinal stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Conus medullaris syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cauda equina syndrome: Involves radicular pain and neurological deficits in the legs but usually doesn&#x27;t cause bowel/bladder dysfunction as early.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cauda equina syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lumbar disc herniation: Typically affects one leg more than the other.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lumbar disc herniation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spinal stenosis: Causes gradual pain and weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spinal stenosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the signs and symptoms of conus medullaris syndrome, a neurological emergency caused by damage to the conus medullaris.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents with severe lower back pain radiating to both legs, saddle anesthesia, urinary retention, fecal incontinence, decreased saddle sensation, and weakness in the lower extremities. Straight leg raise test is positive bilaterally. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cauda equina syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conus medullaris syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lumbar disc herniation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spinal stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cauda equina syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conus medullaris syndrome : Conus medullaris syndrome has a higher sensory level and upper motor neuron signs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conus medullaris syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Disc herniation: Usually affects one leg and doesn&#x27;t cause bilateral symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Disc herniation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spinal stenosis : Causes gradual pain and weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spinal stenosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the red flag symptoms of cauda equina syndrome, requiring urgent surgical intervention to prevent permanent neurological damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-month-old infant presents with generalized muscle weakness, particularly in the proximal muscles, reduced muscle tone, absent reflexes, and a \&quot;frog-leg\&quot; posture. There is no family history of neuromuscular disorders. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duchenne muscular dystrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myotonic dystrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spinal muscular atrophy (SMA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Congenital myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spinal muscular atrophy (SMA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Duchenne muscular dystrophy : Duchenne muscular dystrophy typically presents later in childhood with progressive weakness starting in the legs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Duchenne muscular dystrophy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myotonic dystrophy : Myotonic dystrophy is characterized by myotonia (delayed muscle relaxation) and typically has a later onset.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myotonic dystrophy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Congenital myopathy : Congenital myopathies are a diverse group of muscle disorders present at birth with varying presentations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Congenital myopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the early signs of SMA, a common cause of infant hypotonia and weakness.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with progressive right-hand weakness, muscle cramps, twitching, difficulty swallowing, slurred speech, and emotional lability. Exam reveals intrinsic hand muscle atrophy, fasciculations, increased tone, hyperreflexia, and bulbar muscle weakness. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyotrophic lateral sclerosis (ALS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis (MS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myasthenia gravis (MG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome (GBS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amyotrophic lateral sclerosis (ALS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple sclerosis (MS): MS typically has a relapsing-remitting course with multifocal neurological deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple sclerosis (MS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myasthenia gravis (MG): MG causes fluctuating weakness that worsens with use and improves with rest.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myasthenia gravis (MG):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Guillain-BarrÃ© syndrome (GBS): GBS is an acute inflammatory demyelinating polyneuropathy with ascending weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Guillain-BarrÃ© syndrome (GBS):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the classic presentation of ALS, a neurodegenerative disease affecting both upper and lower motor neurons.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a 1-year history of progressive weakness in the left hand and arm, difficulty with speech and swallowing, muscle atrophy and fasciculations in the left arm, spasticity in the legs, hyperreflexia, slurred speech, and tongue weakness has a mild restrictive pattern on pulmonary function tests. Which medication can slow the progression of this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Riluzole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pyridostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous immunoglobulin (IVIG)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Riluzole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pyridostigmine : Pyridostigmine is used for myasthenia gravis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pyridostigmine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prednisone : Prednisone is a corticosteroid used for inflammatory conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prednisone&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous immunoglobulin (IVIG) : IVIG is used for immune-mediated conditions like Guillain-BarrÃ© syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous immunoglobulin (IVIG)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that riluzole is the only medication shown to have a modest effect on slowing the progression of ALS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents with a 1-month history of intermittent numbness and tingling in her right arm and leg, blurred vision in her left eye that resolved spontaneously, fatigue, and difficulty with balance. Exam reveals decreased sensation in the right arm and leg, intention tremor, and a positive Romberg sign. MRI shows multiple demyelinating lesions in the brain and spinal cord, some enhancing with gadolinium. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome (GBS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis (MS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Multiple sclerosis (MS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome (GBS): GBS typically presents with ascending weakness and areflexia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome (GBS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stroke: Stroke typically causes sudden onset of focal deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency: Vitamin B12 deficiency can cause neurological symptoms but not the typical MRI findings of MS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 deficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the typical presentation and MRI findings of multiple sclerosis, a chronic inflammatory demyelinating disease of the CNS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with a history of two previous MS relapses presents with sudden severe left leg weakness and numbness. Exam reveals marked weakness and decreased sensation in the left leg. What is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High-dose intravenous corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Plasmapheresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interferon beta-1a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. High-dose intravenous corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Plasmapheresis: Plasmapheresis is considered for severe relapses not responding to corticosteroids.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Plasmapheresis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Interferon beta-1a: Interferon beta-1a is a disease-modifying therapy for long-term management, not acute relapses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Interferon beta-1a:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral corticosteroids: Oral corticosteroids may be used for less severe relapses or as a taper after IV steroids.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral corticosteroids:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the use of high-dose intravenous corticosteroids as the initial treatment for acute relapses in multiple sclerosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man is diagnosed with relapsing-remitting multiple sclerosis (RRMS) after an episode of optic neuritis and MRI findings of demyelinating lesions. He&#x27;s had two relapses requiring corticosteroids. He now has mild left-sided weakness and decreased sensation in his right leg. What is the most appropriate first-line treatment for his MS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High-dose intravenous corticosteroids as maintenance therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interferon beta-1a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasmapheresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Natalizumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Interferon beta-1a&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-dose intravenous corticosteroids as maintenance therapy: High-dose IV corticosteroids are for acute relapses, not maintenance.&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-dose intravenous corticosteroids as maintenance therapy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasmapheresis : Plasmapheresis is for severe, refractory relapses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasmapheresis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Natalizumab: Natalizumab is a second-line option due to the risk of progressive multifocal leukoencephalopathy (PML).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Natalizumab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the role of interferon beta-1a as a first-line disease-modifying therapy for RRMS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with sudden right-sided weakness and difficulty with coordination, as well as a prior episode of transient left-sided facial numbness. Which finding best supports a diagnosis of MS according to the McDonald criteria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Presence of both brain and spinal cord lesions on MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Demonstration of dissemination in space (DIS) and time (DIT) on MRI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Detection of oligoclonal bands in cerebrospinal fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;History of multiple neurological symptoms&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Demonstration of dissemination in space (DIS) and time (DIT) on MRI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Presence of both brain and spinal cord lesions on MRI: While this shows DIS, it doesn&#x27;t confirm DIT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Presence of both brain and spinal cord lesions on MRI:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Detection of oligoclonal bands in cerebrospinal fluid: Oligoclonal bands are supportive, but not the primary criterion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Detection of oligoclonal bands in cerebrospinal fluid:&lt;/li&gt;&lt;li&gt;â€¢ Option D. History of multiple neurological symptoms: Multiple episodes are suggestive, but MRI findings are more definitive.&lt;/li&gt;&lt;li&gt;â€¢ Option D. History of multiple neurological symptoms:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the importance of demonstrating dissemination in space and time on MRI for diagnosing MS according to the McDonald criteria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with RRMS on natalizumab for 2 years presents with progressive weakness, confusion, personality changes, and new non-enhancing white matter lesions on MRI. Which serious side effect of natalizumab is suggested?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Progressive multifocal leukoencephalopathy (PML)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute disseminated encephalomyelitis (ADEM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Central pontine myelinolysis (CPM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MS rebound syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Progressive multifocal leukoencephalopathy (PML)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute disseminated encephalomyelitis (ADEM): ADEM is an acute inflammatory demyelinating disorder not specifically linked to natalizumab.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute disseminated encephalomyelitis (ADEM):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Central pontine myelinolysis (CPM): CPM is associated with rapid correction of hyponatremia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Central pontine myelinolysis (CPM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. MS rebound syndrome: MS rebound is a potential risk after stopping natalizumab, not while on it.&lt;/li&gt;&lt;li&gt;â€¢ Option D. MS rebound syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Be aware of the risk of PML with natalizumab and its presentation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman presents with worsening vision in her right eye, eye pain with movement, recent severe back pain, and leg weakness/numbness. Exam reveals vision loss in the right eye with RAPD and longitudinally extensive transverse myelitis (LETM) on spinal MRI. Serum AQP4 antibodies are positive. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple sclerosis (MS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuromyelitis optica spectrum disorder (NMOSD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute disseminated encephalomyelitis (ADEM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Optic neuritis of unknown etiology&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neuromyelitis optica spectrum disorder (NMOSD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The combination of optic neuritis, LETM on MRI, and positive AQP4 antibodies is highly specific for NMOSD.&lt;/li&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple sclerosis (MS): MS can have similar symptoms, but the LETM and AQP4 antibodies are more characteristic of NMOSD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple sclerosis (MS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute disseminated encephalomyelitis (ADEM): ADEM is an acute demyelinating disorder, not usually associated with AQP4 antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute disseminated encephalomyelitis (ADEM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Optic neuritis of unknown etiology: Isolated optic neuritis is less likely given the spinal cord involvement and positive AQP4 antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Optic neuritis of unknown etiology:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the distinct clinical and laboratory features of NMOSD, differentiating it from MS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT part of the 2015 International Consensus Diagnostic Criteria for NMOSD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Positive aquaporin-4 antibody (AQP4-IgG) serostatus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An episode of optic neuritis, myelitis, or area postrema syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of oligoclonal bands in CSF&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;At least one core clinical characteristic in the absence of AQP4-IgG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of oligoclonal bands in CSF&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Positive aquaporin-4 antibody (AQP4-IgG) serostatus, Option B. An episode of optic neuritis, myelitis, or area postrema syndrome and Option D. At least one core clinical characteristic in the absence of AQP4-IgG are all part of the diagnostic criteria for NMOSD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Positive aquaporin-4 antibody (AQP4-IgG) serostatus, Option B. An episode of optic neuritis, myelitis, or area postrema syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. At least one core clinical characteristic in the absence of AQP4-IgG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the specific diagnostic criteria for NMOSD, including the importance of AQP4 antibodies and core clinical characteristics.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old boy presents with sudden-onset fever, headache, confusion, hyperreflexia, and bilateral Babinski signs following a recent upper respiratory tract infection. MRI shows multiple, bilateral, asymmetric lesions involving both white and gray matter with no enhancement after contrast administration. Lumbar puncture reveals mild lymphocytic pleocytosis with normal glucose and elevated protein levels. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple sclerosis (MS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute disseminated encephalomyelitis (ADEM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bacterial meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebral abscess&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute disseminated encephalomyelitis (ADEM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple sclerosis (MS): MS typically has a relapsing-remitting course and more discrete lesions on MRI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Multiple sclerosis (MS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bacterial meningitis: Bacterial meningitis usually presents with higher fever, nuchal rigidity, and CSF findings of elevated neutrophils and low glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bacterial meningitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebral abscesses: Cerebral abscesses typically cause focal neurological deficits and appear as ring-enhancing lesions on MRI.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebral abscesses:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical and imaging features of ADEM, an acute inflammatory demyelinating disorder often following infection or vaccination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common cause of mononeuropathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune diseases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Compression or trauma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metabolic disorders&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infectious diseases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Compression or trauma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune diseases: Autoimmune diseases more commonly cause multiple nerve involvement (polyneuropathy).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Autoimmune diseases:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metabolic disorders: Metabolic disorders (e.g., diabetes) can cause neuropathy, but it&#x27;s usually a polyneuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Metabolic disorders:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious diseases: Infectious diseases can cause neuropathy, but it&#x27;s less common than compression/trauma as a cause of mononeuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious diseases:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the most common cause of mononeuropathy is compression or trauma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with chronic lower back pain and burning/electric shock-like pain radiating down her left leg has sensory loss in the L5 dermatome. She is cautious about using NSAIDs due to peptic ulcer disease. Which is NOT a first-line treatment for her pain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SSRIs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TCAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SNRIs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcium channel blockers (gabapentinoids)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SSRIs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. TCAs, Option C. SNRIs and Option D. Calcium channel blockers (gabapentinoids) are all considered first-line treatments for neuropathic pain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TCAs, Option C. SNRIs&lt;/li&gt;&lt;li&gt;â€¢ Option D. Calcium channel blockers (gabapentinoids)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that SSRIs are not typically first-line for neuropathic pain, while TCAs, SNRIs, and gabapentinoids are.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old man has progressive ascending weakness in both legs and arms over 2 days, preceded by a diarrheal illness 10 days prior. Exam reveals symmetrical weakness, areflexia, and mild sensory loss. CSF shows elevated protein with normal white cell count. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome (GBS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis (MS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amyotrophic lateral sclerosis (ALS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myasthenia gravis (MG)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Guillain-BarrÃ© syndrome (GBS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple sclerosis (MS): MS usually has a relapsing-remitting course and different MRI findings.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple sclerosis (MS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amyotrophic lateral sclerosis (ALS): ALS is a progressive neurodegenerative disease with upper and lower motor neuron signs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amyotrophic lateral sclerosis (ALS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myasthenia gravis (MG): MG causes fluctuating weakness that worsens with use.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myasthenia gravis (MG):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the typical presentation and CSF findings of Guillain-BarrÃ© syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 37-year-old man has progressive difficulty walking, double vision, and incomplete eyelid closure over the past week, preceded by an upper respiratory tract infection 3 weeks prior. He has bilateral limb weakness, areflexia, and normal sensation. Lumbar puncture shows elevated protein with normal white cell count. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome (GBS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Miller Fisher syndrome (MFS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myasthenia gravis (MG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brainstem stroke&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Miller Fisher syndrome (MFS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome (GBS): GBS can have similar features but usually lacks the prominent ophthalmoplegia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome (GBS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myasthenia gravis (MG): MG typically presents with fluctuating weakness and fatigability, not ataxia or areflexia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myasthenia gravis (MG):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brainstem stroke: Brainstem stroke would likely have other focal neurological deficits and abnormal imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brainstem stroke:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic triad of MFS and its association with recent infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with GBS is admitted to the ICU due to rapidly progressive weakness and respiratory distress. Which of the following is the MOST appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous immunoglobulin (IVIG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasmapheresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intubation and mechanical ventilation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intubation and mechanical ventilation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous immunoglobulin (IVIG) and Option C. Plasmapheresis: While IVIG and plasmapheresis are effective treatments for GBS, they are immunomodulatory therapies that take time to work. They are not the immediate priority in a patient with respiratory distress.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intravenous immunoglobulin (IVIG)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasmapheresis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral corticosteroids: Corticosteroids are not beneficial in GBS and may even worsen the outcome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral corticosteroids:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the immediate priority in managing a patient with GBS and respiratory distress is to secure the airway and initiate mechanical ventilation before considering immunomodulatory therapies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with rapidly ascending muscle weakness, areflexia, and mild sensory loss following gastroenteritis has a lumbar puncture. What CSF finding is most indicative of their condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Significantly elevated WBCs with lymphocytic predominance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Albumino-cytological dissociation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oligoclonal bands&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Albumino-cytological dissociation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Significantly elevated WBCs with lymphocytic predominance: Elevated WBCs suggest infection, not GBS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Significantly elevated WBCs with lymphocytic predominance:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased glucose: Decreased glucose suggests bacterial/fungal infection.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased glucose:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oligoclonal bands: Oligoclonal bands are associated with multiple sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oligoclonal bands:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize albuminocytologic dissociation as a key CSF finding in Guillain-BarrÃ© syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with rapidly progressing ascending weakness and tingling is diagnosed with Guillain-BarrÃ© syndrome (GBS). What is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High-dose oral corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous immunoglobulin (IVIG) therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasmapheresis (plasma exchange)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Broad-spectrum antibiotics&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous immunoglobulin (IVIG) therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-dose oral corticosteroids : Corticosteroids are not beneficial in GBS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-dose oral corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasmapheresis : Plasmapheresis is an alternative to IVIG.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasmapheresis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Broad-spectrum antibiotics : Antibiotics are not indicated for GBS, which is immune-mediated.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Broad-spectrum antibiotics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that IVIG and plasmapheresis are the first-line treatments for GBS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents with fluctuating muscle weakness worsening in the evening, difficulty keeping her eyelids open, double vision, and difficulty chewing. Symptoms improve with rest. Exam shows bilateral ptosis and diplopia on sustained upward gaze. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lambert-Eaton myasthenic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Myasthenia gravis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome (GBS) : GBS is an acute ascending paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Guillain-BarrÃ© syndrome (GBS)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple sclerosis (MS) : MS is a chronic demyelinating disease with diverse symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple sclerosis (MS)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lambert-Eaton myasthenic syndrome (LEMS) : LEMS is similar to MG but improves with repetitive exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lambert-Eaton myasthenic syndrome (LEMS)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of myasthenia gravis, including fluctuating weakness, ocular symptoms, and fatigability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a smoking history has progressive proximal muscle weakness, dry mouth, erectile dysfunction, and a cough. The weakness improves with continued use. Exam shows proximal muscle weakness, diminished reflexes at rest with incremental response upon repetitive stimulation. A chest CT reveals a lung mass. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myasthenia gravis (MG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome (GBS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lambert-Eaton myasthenic syndrome (LEMS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lambert-Eaton myasthenic syndrome (LEMS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myasthenia gravis (MG) : MG worsens with use, not improves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myasthenia gravis (MG)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Guillain-BarrÃ© syndrome (GBS) : GBS is acute and ascending.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Guillain-BarrÃ© syndrome (GBS)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polymyositis : Polymyositis does not improve with use or have autonomic symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polymyositis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of LEMS, a paraneoplastic syndrome often associated with small cell lung cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with complaints of double vision and drooping eyelids, especially at the end of the day or after prolonged reading. She also reports difficulty swallowing and arm weakness after repetitive tasks. Her symptoms improve after resting. On examination, she has bilateral ptosis and diplopia with sustained upward gaze. Acetylcholine receptor antibodies are positive. What is the most appropriate initial treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High-dose corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pyridostigmine therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate thymectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous immunoglobulin (IVIG) therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pyridostigmine therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-dose corticosteroids : Corticosteroids are used for severe or refractory MG.&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-dose corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate thymectomy : Thymectomy may be considered later for certain patients with MG.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immediate thymectomy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous immunoglobulin (IVIG) therapy : IVIG is reserved for acute exacerbations or refractory MG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous immunoglobulin (IVIG) therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the presentation of myasthenia gravis and the role of pyridostigmine as the initial treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 41-year-old woman presents with muscle weakness in her neck and bulbar muscles, difficulty holding her head upright, and problems with speech and swallowing. She also reports double vision. Symptoms have worsened over 6 months. Acetylcholine receptor antibodies are negative, but muscle-specific kinase (MuSK) antibodies are positive. Pyridostigmine provides minimal improvement. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the dose of pyridostigmine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate corticosteroids and consider adding rituximab.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schedule immediate thymectomy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prescribe cholinesterase inhibitors as the sole treatment.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Initiate corticosteroids and consider adding rituximab.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of pyridostigmine : Increasing pyridostigmine is unlikely to be effective.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of pyridostigmine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Schedule immediate thymectomy : Thymectomy is less beneficial in MuSK MG.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Schedule immediate thymectomy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prescribe cholinesterase inhibitors as the sole treatment : Cholinesterase inhibitors alone are insufficient for MuSK MG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prescribe cholinesterase inhibitors as the sole treatment&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the management of MuSK antibody-positive MG, which often requires immunosuppressive therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In patients with myasthenia gravis, thymectomy is most commonly indicated in which scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Patients over 60 with mild symptoms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients with purely ocular symptoms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patients with thymoma, regardless of symptom severity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Patients in medication-induced remission&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Patients with thymoma, regardless of symptom severity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patients over 60 with mild symptoms : Thymectomy is generally not recommended in older patients with mild MG.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patients over 60 with mild symptoms&lt;/li&gt;&lt;li&gt;â€¢ Option B. Patients with purely ocular symptoms : Thymectomy is considered less often in ocular MG.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Patients with purely ocular symptoms&lt;/li&gt;&lt;li&gt;â€¢ Option D. Patients in medication-induced remission : Medication-induced remission does not negate the need for thymectomy if a thymoma is present.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Patients in medication-induced remission&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the importance of thymectomy in MG patients with thymoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy presents with difficulty running, frequent falls, Gowers&#x27; sign, and calf pseudohypertrophy. He was late to start walking and has always been clumsy. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spinal Muscular Atrophy (SMA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Duchenne Muscular Dystrophy (DMD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Becker Muscular Dystrophy (BMD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Charcot-Marie-Tooth Disease (CMT)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Duchenne Muscular Dystrophy (DMD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spinal Muscular Atrophy (SMA) : SMA presents with progressive weakness and atrophy, but typically not with Gowers&#x27; sign or pseudohypertrophy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spinal Muscular Atrophy (SMA)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Becker Muscular Dystrophy (BMD) : BMD is a milder form of muscular dystrophy with a later onset.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Becker Muscular Dystrophy (BMD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Charcot-Marie-Tooth Disease (CMT) : CMT primarily affects the peripheral nerves, leading to distal weakness and sensory loss.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Charcot-Marie-Tooth Disease (CMT)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical features of DMD, a severe X-linked recessive muscular dystrophy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following repetitive nerve stimulation (RNS) findings is most commonly associated with myasthenia gravis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Incremental response&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decremental response at low-frequency stimulation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal response to both low and high-frequency stimulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prolonged direct muscle stimulation response&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decremental response at low-frequency stimulation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incremental response : Incremental response is seen in Lambert-Eaton myasthenic syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incremental response&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal response to both low and high-frequency stimulation : A normal response would not be expected in MG.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal response to both low and high-frequency stimulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prolonged direct muscle stimulation response : Prolonged direct muscle stimulation response is not characteristic of MG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prolonged direct muscle stimulation response&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the diagnostic utility of repetitive nerve stimulation in MG, specifically the decremental response at low frequencies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents with difficulty running, frequent falls, and using Gowers&#x27; sign to stand up. He has calf muscle hypertrophy and elevated serum creatine kinase (CK) levels. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duchenne Muscular Dystrophy (DMD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Becker Muscular Dystrophy (BMD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myotonic Dystrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Limb-Girdle Muscular Dystrophy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Becker Muscular Dystrophy (BMD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Duchenne Muscular Dystrophy (DMD) : DMD presents earlier in childhood (3-5 years) with more rapid progression.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Duchenne Muscular Dystrophy (DMD)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myotonic Dystrophy : Myotonic dystrophy is associated with myotonia, facial weakness, and multisystem involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myotonic Dystrophy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Limb-Girdle Muscular Dystrophy : Limb-Girdle MD affects shoulders and hips, not calves.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Limb-Girdle Muscular Dystrophy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate Becker MD from Duchenne MD based on age of onset and clinical presentation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents with difficulty releasing his grip (myotonia), muscle stiffness, facial weakness, temporalis and masseter muscle atrophy, cataracts, daytime sleepiness, and constipation. EMG shows myotonic discharges. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myasthenia Gravis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myotonic Dystrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple Sclerosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Myotonic Dystrophy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polymyositis : Polymyositis is an inflammatory myopathy with proximal muscle weakness and elevated muscle enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polymyositis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myasthenia gravis : Myasthenia gravis presents with fluctuating weakness, often with ocular involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myasthenia gravis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple sclerosis : Multiple sclerosis is a demyelinating disease with a wide range of symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple sclerosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the multisystemic manifestations of myotonic dystrophy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents with muscle weakness, elbow contractures, weak upper arm and calf muscles, mild scoliosis, and ECG conduction abnormalities:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Facioscapulohumeral Muscular Dystrophy (FSHD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emery-Dreifuss Muscular Dystrophy (EDMD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Becker Muscular Dystrophy (BMD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Duchenne Muscular Dystrophy (DMD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Emery-Dreifuss Muscular Dystrophy (EDMD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Facioscapulohumeral Muscular Dystrophy (FSHD) : FSHD typically affects facial, shoulder, and upper arm muscles without early contractures or significant cardiac involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Facioscapulohumeral Muscular Dystrophy (FSHD)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Becker Muscular Dystrophy (BMD) : BMD presents with later onset and predominantly affects proximal muscles.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Becker Muscular Dystrophy (BMD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Duchenne Muscular Dystrophy (DMD) : DMD has an earlier onset and more severe progression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Duchenne Muscular Dystrophy (DMD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the early contractures and cardiac involvement as key features of Emery-Dreifuss Muscular Dystrophy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old woman has progressive numbness, tingling, and burning pain in her hands and feet, worse at night. Examination shows loss of pinprick and temperature sensation in a stocking-glove distribution. Nerve conduction studies are normal, but a skin biopsy shows reduced intraepidermal nerve fiber density. What is least likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcohol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Amyloidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diabetes mellitus : Diabetes is a common cause of small fiber neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcohol : Alcohol is a common cause of small fiber neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcohol&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotherapy : Chemotherapy can cause small fiber neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chemotherapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize small fiber neuropathy as a distinct entity and be aware of its common causes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female complains of numbness and tingling in her thumb, index finger, and middle finger. Symptoms are worse at night and improve with shaking her hand. Which nerve is most likely affected?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ulnar nerve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Radial nerve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Median nerve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Musculocutaneous nerve&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Median nerve&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ulnar nerve : The ulnar nerve supplies the little finger and the ulnar half of the ring finger. Compression of this nerve would result in symptoms in these fingers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ulnar nerve&lt;/li&gt;&lt;li&gt;â€¢ Option B. Radial nerve : The radial nerve supplies the back of the hand and the thumb side of the forearm. Compression of this nerve would cause weakness and sensory loss in these areas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Radial nerve&lt;/li&gt;&lt;li&gt;â€¢ Option D. Musculocutaneous nerve : The musculocutaneous nerve supplies the muscles of the front of the upper arm and the skin on the radial side of the forearm. Compression of this nerve would cause weakness in elbow flexion and sensory loss in the forearm.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Musculocutaneous nerve&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the classic presentation of carpal tunnel syndrome, including the distribution of symptoms and the characteristic features of worsening at night and improvement with shaking the hand. This knowledge is essential for early diagnosis and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is known to cause peripheral neuropathy as a side effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Amiodarone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin : Metformin is an oral antidiabetic medication. It is not typically associated with peripheral neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atorvastatin : Atorvastatin is a statin medication used to lower cholesterol levels. While rare cases of muscle pain (myopathy) have been reported, peripheral neuropathy is not a common side effect.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atorvastatin&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lisinopril : Lisinopril is an ACE inhibitor used to treat high blood pressure and heart failure. It is not known to cause peripheral neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lisinopril&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Be aware that amiodarone can cause peripheral neuropathy as a side effect and monitor patients on this medication for neurological symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of monoclonal gammopathy presents with progressive weakness and sensory loss in his legs. Nerve conduction studies reveal demyelinating neuropathy. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic inflammatory demyelinating polyneuropathy (CIDP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diabetic peripheral neuropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amyloid neuropathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paraneoplastic neuropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amyloid neuropathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic inflammatory demyelinating polyneuropathy (CIDP) : While CIDP is a demyelinating neuropathy, it is not typically associated with monoclonal gammopathies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic inflammatory demyelinating polyneuropathy (CIDP)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diabetic peripheral neuropathy : Diabetic neuropathy is usually axonal, not demyelinating, and it presents with a more symmetrical, length-dependent pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diabetic peripheral neuropathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Paraneoplastic neuropathy : Paraneoplastic neuropathies are associated with underlying cancers and can present with various patterns, but the presence of monoclonal gammopathy points more towards amyloid neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Paraneoplastic neuropathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that monoclonal gammopathy in a patient with progressive demyelinating neuropathy should raise a strong suspicion for amyloid neuropathy. Early diagnosis and treatment are essential for managing this condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 143 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test9" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pulmonary Medicine &amp;amp; Critical Care&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pulmonary Medicine &amp;amp; Critical Care&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                184 Questions | 736 Total Marks | 194 min Duration | ~63.26 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A patient with a history of fever for the past 4 days and new onset of breathlessness was admitted to ICU as he was deteriorating. He was unresponsive to the incremental flow rate of oxygen and his oxygen saturation was progressively decreasing. He was intubated and a Chest X-ray was ordered, and the findings are shown in the image below. His PaO2/FiO2 was 204 mmHg. What is the most likely diagnosis? (FMGE JUNE 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ARDS&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atelectasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heart Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary Fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ARDS&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/28/screenshot-2024-09-28-175412.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ARDS&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ARDS is diagnosed based on acute onset, bilateral infiltrates on chest imaging, non-cardiogenic pulmonary edema, and a PaO2/FiO2 ratio indicative of the severity of hypoxemia. Recognizing these criteria is crucial for timely and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to the berlin definition, moderate ARDS is characterized by all, except: (NEET PG 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PaO2/FiO2 ratio 200-300 mm/Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral interstitial infiltrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Symptom onset within a week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No cardiac failure on echocardiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PaO2/FiO2 ratio 200-300 mm/Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. PaO2/FiO2 ratio 200-300 mm/Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral interstitial infiltrates: This is correct and consistent with all classifications of ARDS, which require bilateral opacities on imaging, either from chest radiographs or CT, indicative of pulmonary edema not fully explained by cardiac failure or fluid overload.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral interstitial infiltrates:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Symptom onset within a week: True for the Berlin definition, which stipulates that ARDS must occur within 7 days of a known clinical insult or new or worsening respiratory symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Symptom onset within a week:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No cardiac failure on echocardiography: Also true according to the Berlin definition, as the pulmonary edema should not be fully explained by cardiac failure or fluid overload, thus necessitating the exclusion of cardiac failure through echocardiography.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No cardiac failure on echocardiography:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 2012 Berlin Definition:&lt;/li&gt;&lt;li&gt;âž¤ 2012 Berlin Definition:&lt;/li&gt;&lt;li&gt;âž¤ Onset within 7 days after a known clinical insult or new or worsening respiratory symptoms B/L opacities (Alveolar/Interstitial that are \&quot;consistent with pulmonary edema\&quot; on chest radiographs or chest CT) Minimum PEEP setting or CPAP, 5 cm of water.&lt;/li&gt;&lt;li&gt;âž¤ Onset within 7 days after a known clinical insult or new or worsening respiratory symptoms&lt;/li&gt;&lt;li&gt;âž¤ Onset within 7 days&lt;/li&gt;&lt;li&gt;âž¤ B/L opacities (Alveolar/Interstitial that are \&quot;consistent with pulmonary edema\&quot; on chest radiographs or chest CT)&lt;/li&gt;&lt;li&gt;âž¤ \&quot;consistent with pulmonary edema\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Minimum PEEP setting or CPAP, 5 cm of water.&lt;/li&gt;&lt;li&gt;âž¤ PaO 2 : FiO 2 assessed on invasive mechanical ventilation (CPAP criterion used for the diagnosis of mild ARDS).&lt;/li&gt;&lt;li&gt;âž¤ Categorization of ARDS severity (on the basis of FiO 2 ):&lt;/li&gt;&lt;li&gt;âž¤ Categorization of ARDS severity (on the basis of FiO 2 ):&lt;/li&gt;&lt;li&gt;âž¤ Mild: 200-300 Moderate: 100-200 Severe: &amp;lt;100&lt;/li&gt;&lt;li&gt;âž¤ Mild: 200-300&lt;/li&gt;&lt;li&gt;âž¤ Moderate: 100-200&lt;/li&gt;&lt;li&gt;âž¤ Severe: &amp;lt;100&lt;/li&gt;&lt;li&gt;âž¤ In resource limited settings Kigali Modifications was proposed (2016):&lt;/li&gt;&lt;li&gt;âž¤ Kigali Modifications&lt;/li&gt;&lt;li&gt;âž¤ Bilateral opacities could be documented by either ultrasonography or chest radiograph . Oxygenation criteria: pulse oximetry oxygen saturation (SpO 2 )/FiO 2 ratio â‰¤ 315 without the requirement for PEEP.&lt;/li&gt;&lt;li&gt;âž¤ Bilateral opacities could be documented by either ultrasonography or chest radiograph .&lt;/li&gt;&lt;li&gt;âž¤ Oxygenation criteria: pulse oximetry oxygen saturation (SpO 2 )/FiO 2 ratio â‰¤ 315 without the requirement for PEEP.&lt;/li&gt;&lt;li&gt;âž¤ (SpO 2 )/FiO 2 ratio â‰¤ 315 without the requirement for PEEP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference - Harrison/Respiratory Failure/Chap 301&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents to the emergency department with severe shortness of breath and confusion. On examination, he is febrile, has a turbid urine and tachypneic with diffuse crackles heard on lung auscultation. His arterial blood gas (ABG) shows pH 7.50, PaCO2 30 mmHg, and PaO2 45 mmHg despite being on 100% oxygen. What is the most likely cause of his hypoxemia ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute Respiratory Distress Syndrome (ARDS)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acute Respiratory Distress Syndrome (ARDS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Acute Respiratory Distress Syndrome (ARDS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary embolism: Typically causes an increased V/Q ratio and can result in hypoxemia, but it often responds to 100% oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary embolism:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pneumonia : Causes hypoxemia due to V/Q mismatch or shunting, but some improvement is usually seen with 100% oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pneumonia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoventilation : Leads to hypercapnia and hypoxemia but usually presents with a normal A-a gradient and improves with supplemental oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoventilation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ ARDS causes severe V/Q mismatch and shunting due to widespread inflammation and damage to the alveolar-capillary membrane, leading to refractory hypoxemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents to the emergency department with sudden onset of shortness of breath and pleuritic chest pain. Her arterial blood gas (ABG) shows pH 7.45, PaCO2 35 mmHg, and PaO2 60 mmHg on room air. Which condition is associated with an increased V/Q ratio and results in increased dead space ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Severe pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atelectasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary arteriovenous malformation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary embolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Severe pneumonia : Typically causes a decreased V/Q ratio due to alveolar filling with inflammatory exudate, leading to a shunt-like effect.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Severe pneumonia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Atelectasis : Causes a decreased V/Q ratio due to collapse of alveoli, leading to areas of the lung being under-ventilated.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Atelectasis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary arteriovenous malformation : Typically causes a right-to-left shunt, leading to a decreased V/Q ratio and hypoxemiaTop of Form&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary arteriovenous malformation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Pulmonary embolism increases the V/Q ratio and dead space by obstructing blood flow, causing areas of the lung to be ventilated but not perfused, leading to hypoxemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of COPD exacerbation is brought to the emergency department with worsening shortness of breath and wheezing. Her arterial blood gas (ABG) shows a PaO2 of 55 mmHg on room air. The intervening physician decides to deliver oxygen precisely at 24-28% FiO2. Which oxygen delivery system would be most appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Simple nasal cannula (SNC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-rebreather mask (NRBM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Venturi mask&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Partial rebreather mask (PRBM)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Venturi mask&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Venturi mask&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Simple nasal cannula (SNC): Provides variable FiO2 (24-44%) depending on the flow rate and the patient&#x27;s breathing pattern, which does not ensure consistent oxygen delivery.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Simple nasal cannula (SNC):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-rebreather mask (NRBM): Delivers a high FiO2 (60-90%) but does so variably and is generally used for short-term situations due to the risk of oxygen toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-rebreather mask (NRBM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Partial rebreather mask (PRBM): Provides a variable FiO2 (40-70%) and is less precise in delivering a controlled and consistent oxygen concentration, which is not ideal for patients with COPD who need stable oxygen levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Partial rebreather mask (PRBM):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The Venturi mask provides a controlled FiO2, ideal for patients needing consistent oxygen levels, such as those with COPD exacerbation, ensuring precise delivery of the desired oxygen concentration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient in the ICU has just been extubated after mechanical ventilation. The medical team wants to prevent reintubation by providing adequate respiratory support. Which oxygen delivery system should be considered?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Simple nasal cannula (SNC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High flow nasal oxygen (HFNO)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Simple face mask (SFM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-rebreather mask (NRBM)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. High flow nasal oxygen (HFNO)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â High flow nasal oxygen (HFNO)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Simple nasal cannula (SNC): Provides variable and lower flow rates (1-6 L/min) with FiO2 ranging from 24-44%, which may not be sufficient for post-extubation support.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Simple nasal cannula (SNC):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Simple face mask (SFM): Delivers variable FiO2 (35-60%) with flow rates of 5-10 L/min, but does not provide the high flow and CPAP-like effects needed for post-extubation support.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Simple face mask (SFM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-rebreather mask (NRBM): Provides high FiO2 (60-90%) and is suitable for short-term use in severe hypoxemia, but does not offer the same level of support and comfort as HFNO for preventing reintubation in post-extubation patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-rebreather mask (NRBM):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ High flow nasal oxygen (HFNO) provides effective respiratory support and reduces the risk of reintubation in post-extubation patients by delivering high oxygen flow rates, CPAP-like effects, and reducing inspiratory effort.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the Oxygen delivery systems:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A â€“ iv, B-i, C-iv, D-iii&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-iii, B-iv, C-i, D-ii&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-iv, D-ii&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-i, B-ii, C-iii, D-iv&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A-iii, B-i, C-iv, D-ii&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-120216.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) A-iii, B-i, C-iv, D-ii&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Understand and correctly identify the various oxygen delivery systems and their corresponding features to ensure appropriate usage in clinical settings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with a history of congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) presents to the emergency department with severe shortness of breath, a respiratory rate of 28 breaths per minute, and signs of increased work of breathing. The medical team considers initiating non-invasive ventilation (NIV). All of the following are contraindications except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Claustrophobia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Severe upper gastrointestinal bleeding (UGIB)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Poor mask fit&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe dyspnea with increased work of breathing&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Severe dyspnea with increased work of breathing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Severe dyspnea with increased work of breathing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Claustrophobia: Patients with claustrophobia may not tolerate the mask required for NIV, making it a contraindication.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Claustrophobia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Severe upper gastrointestinal bleeding (UGIB): UGIB poses a risk for aspiration, which can be exacerbated by positive pressure ventilation, making NIV unsafe.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Severe upper gastrointestinal bleeding (UGIB):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Poor mask fit: An effective seal is crucial for NIV to work properly. Poor mask fit can lead to air leaks, reducing the efficacy of the treatment and increasing the risk of failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Poor mask fit:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of congestive heart failure (CHF) is in the ICU after being successfully extubated following mechanical ventilation. During a spontaneous breathing trial (SBT), his PaCO2 is measured at 48 mmHg. What is the most appropriate management to reduce this risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiate NIPPV for 24 hours post-extubation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Place the patient on a simple nasal cannula&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Observe without additional support&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reintubate immediately&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Initiate NIPPV for 24 hours post-extubation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Initiate NIPPV for 24 hours post-extubation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Place the patient on a simple nasal cannula: This provides supplemental oxygen but does not offer the same level of respiratory support as NIPPV, which is crucial for preventing reintubation in high-risk patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Place the patient on a simple nasal cannula:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Observe without additional support: Observation alone does not address the underlying risk of respiratory failure and reintubation in a high-risk patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Observe without additional support:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reintubate immediately: Immediate reintubation is not necessary if the patient is currently stable and NIPPV can provide sufficient support to prevent respiratory failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Reintubate immediately:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ NIPPV should be initiated for 24 hours post-extubation in high-risk patients to reduce the risk of reintubation and associated mortality.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify A and B:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-EPAP, B-IPAP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-IPAP, B-EPAP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-CPAP, B-IPAP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-IPAP, B-CPAP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A-EPAP, B-IPAP&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-104756.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A-EPAP, B-IPAP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. A-IPAP, B-EPAP: This is incorrect because A represents the lower pressure during exhalation (EPAP), and B represents the higher pressure during inhalation (IPAP), not the other way around.&lt;/li&gt;&lt;li&gt;â€¢ Option B. A-IPAP, B-EPAP:&lt;/li&gt;&lt;li&gt;â€¢ Option C. A-CPAP, B-IPAP: This is incorrect because CPAP provides a constant level of pressure throughout the breathing cycle, not the variable pressures shown in the image. The image illustrates the variable pressures of BPAP, not CPAP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A-CPAP, B-IPAP:&lt;/li&gt;&lt;li&gt;â€¢ Option D. A-IPAP, B-CPAP: This is incorrect because CPAP provides a single, continuous pressure and does not have variable pressures like those shown for IPAP and EPAP in the image. The image illustrates BPAP, with A as EPAP and B as IPAP.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A-IPAP, B-CPAP:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ In bilevel positive airway pressure (BPAP) therapy, EPAP (Expiratory Positive Airway Pressure) keeps airways open during exhalation, while IPAP (Inspiratory Positive Airway Pressure) provides support during inhalation to improve ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are features of the MOANS criteria except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mask seal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neck mobility&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Neck mobility&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Neck mobility&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mask seal: Difficulty in achieving a proper mask seal due to facial hair, facial injuries, etc., is a feature of MOANS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mask seal:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Obesity: Obesity is a factor in the MOANS criteria that can complicate bag-mask ventilation due to increased airway obstruction and difficulty in ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Obesity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Age: Age over 55 can affect airway anatomy and lung compliance, making ventilation more challenging.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Age:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neck mobility is part of the LEMON criteria for assessing difficult intubation, not the MOANS criteria for predicting difficult bag-mask ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are features of the LEMON criteria except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Look externally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Evaluate 3-3-2 rule&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mallampati score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No teeth&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. No teeth&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) No teeth&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Look externally: This involves a visual assessment of external features that might predict difficulty with intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Look externally:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Evaluate 3-3-2 rule: This assesses mouth opening, mandible space, and neck distance to predict intubation difficulty.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Evaluate 3-3-2 rule:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mallampati score: This evaluates the visibility of oropharyngeal structures to predict intubation difficulty.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mallampati score:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;No teeth\&quot; is part of the MOANS criteria for assessing difficult bag-mask ventilation, not the LEMON criteria for predicting difficult intubation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man is being assessed for intubation. The clinician uses the Mallampati score to evaluate the visibility of the oropharyngeal structures. Which of the following best describes a Mallampati Grade III?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Entire soft palate, uvula, and tonsillar pillars are visible&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Soft palate, base of uvula, and part of the tonsillar pillars are visible&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Soft palate and base of uvula are visible, but the tonsillar pillars are not visible&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only the hard palate is visible&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Soft palate and base of uvula are visible, but the tonsillar pillars are not visible&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-093638.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Soft palate and base of uvula are visible, but the tonsillar pillars are not visible&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Entire soft palate, uvula, and tonsillar pillars are visible: This describes a Mallampati Grade I, indicating an easy intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Entire soft palate, uvula, and tonsillar pillars are visible:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Soft palate, base of uvula, and part of the tonsillar pillars are visible: This describes a Mallampati Grade II, suggesting a slightly more difficult intubation than Grade I.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Soft palate, base of uvula, and part of the tonsillar pillars are visible:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only the hard palate is visible: This describes a Mallampati Grade IV, indicating a very difficult intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only the hard palate is visible:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A Mallampati Grade III indicates that the soft palate and base of the uvula are visible, but the tonsillar pillars are not visible, predicting a moderately difficult intubation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman is undergoing intubation, and the clinician uses the Cormack-Lehane classification to describe the view of the glottis during laryngoscopy. Which of the following best describes a Cormack-Lehane Grade III view?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Full view of the glottis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Partial view of the glottis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Only the epiglottis is visible, no part of the glottis can be seen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neither the glottis nor the epiglottis is visible&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Only the epiglottis is visible, no part of the glottis can be seen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Only the epiglottis is visible, no part of the glottis can be seen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Full view of the glottis: This describes a Cormack-Lehane Grade I, indicating an easy intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Full view of the glottis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Partial view of the glottis: This describes a Cormack-Lehane Grade II, suggesting a moderately difficult intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Partial view of the glottis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neither the glottis nor the epiglottis is visible: This describes a Cormack-Lehane Grade IV, indicating a very difficult intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Neither the glottis nor the epiglottis is visible:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A Cormack-Lehane Grade III view indicates that only the epiglottis is visible, with no view of the glottis, predicting a difficult intubation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old obese patient with a history of obstructive sleep apnea presents with breathlessness. Rapid Sequence Intubation is initiated, and the emergency physician decides to use a modified position for intubation. What is the ideal position ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Simple head extension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Simple head flexion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HEAD/RAMP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recovery position&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HEAD/RAMP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-094119_Lcv5tQt.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HEAD/RAMP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Simple head extension: This position may not provide the optimal alignment needed for intubation in obese patients or those with obstructive sleep apnea.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Simple head extension:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Simple head flexion: This position is not suitable for intubation as it can obstruct the airway and worsen the glottic view.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Simple head flexion:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recovery position: This position is used for unconscious but breathing patients to maintain an open airway, not for intubation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recovery position:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The HEAD/RAMP (Head-Elevated Laryngoscopy Position/Rapid Airway Management Position) is ideal for intubating obese patients or those with obstructive sleep apnea, aligning the external auditory meatus with the sternal notch to improve glottic view during laryngoscopy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man is found unconscious but breathing with a stable pulse at a park. To ensure his airway remains open and to prevent aspiration, the first responder decides to place him in the recovery position. What is the correct description of the recovery position ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lying flat on his back with head extension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lying flat on his back with head flexion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lying on his side with his lower arm extended and upper leg bent&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sitting up with head tilted forward&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lying on his side with his lower arm extended and upper leg bent&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/25/screenshot-2024-06-25-171344.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lying on his side with his lower arm extended and upper leg bent&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lying flat on his back with head extension: This position does not protect the airway from aspiration and may not keep it open in an unconscious patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lying flat on his back with head extension:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lying flat on his back with head flexion: This position can obstruct the airway and increase the risk of aspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lying flat on his back with head flexion:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sitting up with head tilted forward: While this can help maintain an airway, it is not a stable position for an unconscious person and does not prevent aspiration as effectively as the recovery position.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sitting up with head tilted forward:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The recovery position involves placing an unconscious but breathing patient on their side with the lower arm extended and the upper leg bent to maintain an open airway and prevent aspiration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient in septic shock requires intubation and sedation. The intensivist gives a bolus of hydrocortisone after intubation. What sedative is given ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Etomidate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midazolam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propofol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Etomidate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Etomidate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ketamine: Ketamine does not suppress adrenal function and is known for its bronchodilatory properties and catecholamine release.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ketamine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Midazolam: Midazolam is an amnestic and antiepileptic but does not have significant effects on adrenal function.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Midazolam:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Propofol: Propofol does not suppress adrenal function but can cause hypotension, which is undesirable in septic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Propofol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Etomidate is often used for sedation in septic shock due to its excellent sedation profile and minimal hypotensive effects, but it requires administration of hydrocortisone to counteract its adrenal suppression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with refractory status epilepticus and propofol infusion was started. Which of the following is false regarding propofol infusion syndrome (PRIS) ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PRIS is associated with use of high doses of propofol (&amp;gt; 5 mg/kg/h)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PRIS can present with metabolic acidosis and rhabdomyolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PRIS is characterized by hyperglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PRIS can lead to cardiac and renal failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PRIS is characterized by hyperglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) PRIS is characterized by hyperglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRIS is associated with high doses of propofol (&amp;gt; 5 mg/kg/h): This is true. High doses and prolonged infusions of propofol are risk factors for developing PRIS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRIS is associated with high doses of propofol (&amp;gt; 5 mg/kg/h):&lt;/li&gt;&lt;li&gt;â€¢ Option B. PRIS can present with metabolic acidosis and rhabdomyolysis: This is true. Metabolic acidosis and rhabdomyolysis are key features of PRIS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PRIS can present with metabolic acidosis and rhabdomyolysis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. PRIS can lead to cardiac and renal failure: This is true. PRIS can result in severe complications, including cardiac and renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PRIS can lead to cardiac and renal failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propofol infusion syndrome (PRIS) is associated with metabolic acidosis, rhabdomyolysis, hyperkalemia, and can lead to cardiac and renal failure, but it is not typically characterized by hyperglycemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of asthma presents with status asthmaticus and requires sedation for intubation. Which sedative from the table is the most appropriate choice due to its bronchodilatory properties ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Etomidate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midazolam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiopental sodium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ketamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ketamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Etomidate: While Etomidate provides excellent sedation without causing hypotension, it does not have bronchodilatory properties.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Etomidate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Midazolam: Midazolam is an amnestic and antiepileptic but does not have bronchodilatory effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Midazolam:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thiopental sodium: Thiopental sodium is a potent sedative and myocardial depressant but is relatively contraindicated in patients with reactive airway disease (RAD) and does not have bronchodilatory properties.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thiopental sodium:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ketamine is the preferred sedative for intubation in patients with status asthmaticus due to its bronchodilatory properties, which help manage severe asthma exacerbations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man with a history of muscular dystrophy presents to the emergency department with severe respiratory distress. The team decides to perform rapid sequence intubation (RSI). Which of the following conditions is NOT a contraindication for the use of succinylcholine in this patient ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignant hyperthermia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Muscular dystrophy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignant hyperthermia: Succinylcholine can trigger malignant hyperthermia, a potentially life-threatening condition, making it a contraindication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignant hyperthermia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertension: Hypertension itself is not a contraindication for succinylcholine, but it is important to monitor blood pressure as succinylcholine can have cardiovascular effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Muscular dystrophy: Succinylcholine is contraindicated in patients with muscular dystrophy because it can cause severe hyperkalemia and rhabdomyolysis, leading to potentially fatal complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Muscular dystrophy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypokalemia is not a contraindication for the use of succinylcholine; however, conditions like malignant hyperthermia and muscular dystrophy are contraindications due to the risk of severe hyperkalemia and other complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child requires rapid sequence intubation (RSI) due to severe trauma after falling from a height. What is a potential side effect of succinylcholine in this patient ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothermia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bradycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertension: While succinylcholine can cause transient increases in blood pressure, it is not as significant a concern as bradycardia, especially in pediatric patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperglycemia: Hyperglycemia is not a known side effect of succinylcholine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperglycemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothermia: Succinylcholine is associated with malignant hyperthermia, which is a hypermetabolic state, not hypothermia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothermia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Succinylcholine can cause bradycardia, particularly in pediatric patients, often requiring treatment with atropine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old chronic alcoholic with cirrhosis and portal hypertension requires intubation and continuous neuromuscular blockade in the ICU. Which agent is the most appropriate ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Succinylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rocuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vecuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cisatracurium&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cisatracurium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cisatracurium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Succinylcholine: Succinylcholine is used for rapid sequence intubation due to its fast onset and short duration, but it is not suitable for continuous neuromuscular blockade due to its short duration and potential side effects such as hyperkalemia and malignant hyperthermia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Succinylcholine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rocuronium: Rocuronium is primarily metabolized by the liver, making it less suitable for continuous use in patients with significant liver impairment like cirrhosis, due to the risk of prolonged effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rocuronium:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vecuronium: Vecuronium also relies significantly on hepatic metabolism and renal elimination, which can lead to prolonged neuromuscular blockade in patients with liver failure, making it less ideal for continuous use in such patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vecuronium:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cisatracurium is the preferred agent for continuous neuromuscular blockade in patients with liver dysfunction, such as cirrhosis and portal hypertension, due to its metabolism via Hofmann elimination and ester hydrolysis, which are independent of liver function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with sick sinus syndrome requires intubation. Which neuromuscular blocker could be beneficial in him?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Succinylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rocuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vecuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancuronium&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pancuronium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pancuronium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Succinylcholine: Succinylcholine is not ideal for patients with sick sinus syndrome as it can cause bradycardia and is primarily used for rapid sequence intubation rather than continuous blockade.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Succinylcholine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rocuronium: Rocuronium does not have vagal blocking properties and would not provide the same benefit in preventing bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rocuronium:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vecuronium: Vecuronium also lacks vagal blocking properties and would not be as beneficial in managing bradycardia associated with sick sinus syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vecuronium:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pancuronium is beneficial for patients with sick sinus syndrome requiring intubation due to its vagal blocking properties, which help mitigate bradycardia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22 year old lady patient presents with an anaphylactic shock after consuming a peanut. Which of the following drugs should be avoided?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mivacurium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Etomidate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinylcholine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mivacurium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mivacurium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Etomidate: Etomidate is not known to cause histamine release and is generally considered safe in anaphylactic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Etomidate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ketamine: Ketamine is also safe in anaphylactic reactions and can be beneficial due to its bronchodilatory properties.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ketamine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Succinylcholine: While succinylcholine has other side effects, it does not typically cause significant histamine release that would exacerbate anaphylactic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Succinylcholine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mivacurium should be avoided in patients experiencing anaphylactic shock as it can cause histamine release, potentially worsening the anaphylactic reaction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During rapid sequence intubation (RSI), the Sellick maneuver is performed to prevent aspiration. What is a potential complication associated with improper application of this maneuver?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased gastric reflux&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal rupture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased ventilation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchospasm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decreased ventilation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100044.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Decreased ventilation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased gastric reflux: The maneuver is intended to prevent this by occluding the esophagus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased gastric reflux:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal rupture: While theoretically possible, this is extremely rare and not a common complication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal rupture:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bronchospasm: This is not typically associated with the Sellick maneuver; it is more related to airway irritants or asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bronchospasm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Improper application of the Sellick maneuver (cricoid pressure) during rapid sequence intubation can lead to decreased ventilation by compressing the trachea or obstructing the airway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is undergoing rapid sequence intubation (RSI), and the initial attempt to visualize the vocal cords is unsuccessful. The clinician applies the BURP maneuver. What is the primary purpose of this maneuver ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To increase the diameter of the trachea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To improve visualization of the vocal cords&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To prevent aspiration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To stabilize the patient&#x27;s neck&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. To improve visualization of the vocal cords&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) To improve visualization of the vocal cords&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. To increase the diameter of the trachea: The maneuver does not affect the tracheal diameter.&lt;/li&gt;&lt;li&gt;â€¢ Option A. To increase the diameter of the trachea:&lt;/li&gt;&lt;li&gt;â€¢ Option C. To prevent aspiration: This is not the primary goal of the BURP maneuver; cricoid pressure is used for preventing aspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. To prevent aspiration:&lt;/li&gt;&lt;li&gt;â€¢ Option D. To stabilize the patient&#x27;s neck: While it may help to some extent, stabilization is not the primary goal of the BURP maneuver.&lt;/li&gt;&lt;li&gt;â€¢ Option D. To stabilize the patient&#x27;s neck:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The primary purpose of the BURP maneuver (Backward Upward Rightward Pressure) is to improve visualization of the vocal cords during intubation by optimizing the position of the larynx.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the technique â€“&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C-E technique&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;V-E technique&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BURP technique&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sellick technique&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. C-E technique&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100504.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100609_q8LfTRt.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100826.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-100857.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) C-E technique&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. V-E technique: With this technique, the thumbs and thenar eminence are placed over each side of the mask while the second through fifth digits pull the jaw upward&lt;/li&gt;&lt;li&gt;â€¢ Option B. V-E technique:&lt;/li&gt;&lt;li&gt;â€¢ Option C. BURP technique: The BURP technique involves applying backward, upward, and rightward pressure on the thyroid cartilage to improve glottic visualization, not related to mask sealing.&lt;/li&gt;&lt;li&gt;â€¢ Option C. BURP technique:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sellick technique: The Sellick technique involves applying pressure to the cricoid cartilage to prevent aspiration, not related to the mask sealing technique shown.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sellick technique:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The C-E technique for bag-valve-mask ventilation involves using the thumb and index finger to form a \&quot;C\&quot; shape around the mask to create a seal, while the other three fingers form an \&quot;E\&quot; shape to lift the mandible and open the airway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which reversal agent is used for quick reversal of rocuronium ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sugammadex&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Edrophonium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sugammadex&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sugammadex&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neostigmine: Neostigmine is a cholinesterase inhibitor used to reverse non-depolarizing neuromuscular blockers, but it is not as rapid or specific as sugammadex for rocuronium.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neostigmine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Atropine: Atropine is an anticholinergic agent used to treat bradycardia and to reduce secretions, not for reversing neuromuscular blockade.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Atropine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Edrophonium: Edrophonium is a cholinesterase inhibitor used for diagnosing myasthenia gravis and reversing neuromuscular blockade, but it is not as effective or specific as sugammadex for rocuronium.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Edrophonium:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sugammadex is the specific and rapid reversal agent for rocuronium, encapsulating the neuromuscular blocking agent to quickly reverse its effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old patient presented with severe pneumonia and was intubated. His condition improved and he was planned to extubate. On TOF stimulation, he has a TOF ratio of 0.9. What does this suggest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Safe to extubate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Unsafe to extubate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;He is at risk of reintubation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Incomplete recovery from neuromuscular blockade&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Safe to extubate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Safe to extubate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Unsafe to extubate: A TOFR of 0.9 indicates adequate recovery, so it is not unsafe to extubate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Unsafe to extubate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. He is at risk of reintubation: While all extubated patients should be monitored, a TOFR of 0.9 suggests that the patient has sufficiently recovered from neuromuscular blockade, making the risk of reintubation due to neuromuscular weakness low.&lt;/li&gt;&lt;li&gt;â€¢ Option C. He is at risk of reintubation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incomplete recovery from neuromuscular blockade: Incomplete recovery is suggested by a TOFR below 0.9; a TOFR of 0.9 indicates complete recovery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incomplete recovery from neuromuscular blockade:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A TOF ratio (TOFR) of 0.9 or higher indicates adequate recovery from neuromuscular blockade, suggesting that it is safe to proceed with extubation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The image shows an end-tidal CO2 (ETCO2) waveform. What does the pattern in the ETCO2 waveform suggest ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchospasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rebreathing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal intubation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Esophageal intubation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-101651.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Esophageal intubation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoventilation: Hypoventilation would show a gradual rise in the ETCO2 levels, not a flat line.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoventilation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchospasm: Bronchospasm typically produces a shark-fin appearance in the ETCO2 waveform due to prolonged expiration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchospasm:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rebreathing: Rebreathing results in a gradually rising baseline of the ETCO2 waveform, not a flat line.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rebreathing:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A flat ETCO2 waveform suggests esophageal intubation, indicating that the endotracheal tube is incorrectly placed in the esophagus rather than the trachea, preventing proper ventilation and resulting in minimal or absent CO2 detection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male patient is undergoing surgery and is intubated with mechanical ventilation. The ETCO2 waveform shown in the image is observed. What does this indicate ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spontaneous diaphragmatic movements&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rebreathing of exhaled gases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal intubation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Spontaneous diaphragmatic movements&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-101933.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Spontaneous diaphragmatic movements&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoventilation: Hypoventilation would show elevated ETCO2 levels with longer intervals between the peaks but would not have the characteristic cleft.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoventilation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rebreathing of exhaled gases: Rebreathing results in a gradually rising baseline of the ETCO2 waveform due to the accumulation of CO2.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rebreathing of exhaled gases:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal intubation: Esophageal intubation would result in a flat or very low ETCO2 waveform, indicating minimal CO2 detection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal intubation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;curare cleft\&quot; in the ETCO2 waveform indicates spontaneous diaphragmatic movements or breaths in a patient who is partially recovering from neuromuscular blockade. This occurs when the effects of muscle relaxants are wearing off, and the patient begins to take spontaneous breaths.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with sudden onset of chest pain and shortness of breath shortly after the insertion of a subclavian catheter. The chest X-ray shown in the image was taken following the procedure. What is the most likely diagnosis based on the X-ray findings ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right Hemothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right upper lobe collapse&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right Pneumothorax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspiration Pneumonia (R) lower lobe&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right Pneumothorax&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-102105.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right Pneumothorax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right Hemothorax: Hemothorax would present with fluid accumulation in the pleural space, appearing as a homogenous opacity on the affected side, not the absence of lung markings seen in pneumothorax.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right Hemothorax:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right upper lobe collapse: Upper lobe collapse would show signs of volume loss such as elevation of the horizontal fissure, not the absence of lung markings characteristic of pneumothorax.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right upper lobe collapse:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspiration Pneumonia (R) lower lobe: Aspiration pneumonia would present with infiltrates or consolidation in the lower lobe, not the absence of lung markings seen in pneumothorax.Top of Form&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspiration Pneumonia (R) lower lobe:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The chest X-ray shows a right pneumothorax, indicated by the presence of a visible pleural line with the absence of lung markings beyond this line on the right side, a common complication following subclavian catheter insertion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old female patient requires the insertion of a nasogastric (NG) tube for feeding. What describes the best method to ensure adequate length of the tube ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Measuring from the nose to the xiphoid process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Measuring from the nose to the earlobe to the xiphoid process&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Measuring from the nose to the earlobe to the umbilicus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Measuring from the nose to the sternum to the umbilicus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Measuring from the nose to the earlobe to the xiphoid process&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Measuring from the nose to the earlobe to the xiphoid process&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Measuring from the nose to the xiphoid process: This method does not account for the curvature of the nasopharynx and esophagus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Measuring from the nose to the xiphoid process:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Measuring from the nose to the earlobe to the umbilicus: This method would result in an excessively long tube length.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Measuring from the nose to the earlobe to the umbilicus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Measuring from the nose to the sternum to the umbilicus: This method is not a recognized technique for NG tube placement and would result in an incorrect tube length.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Measuring from the nose to the sternum to the umbilicus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The NEX method for measuring the adequate length of a nasogastric (NG) tube involves measuring from the nose (N) to the earlobe (E) to the xiphoid process (X) to ensure the tube reaches the stomach without coiling in the esophagus or stopping short.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male patient presents to the emergency department after a motor vehicle accident. He is experiencing severe shortness of breath and chest pain on the left side. The chest X-ray shown in the image was taken upon arrival. What is the most likely diagnosis based on the X-ray findings ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right Hemothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right Pneumothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right endobronchial intubation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left Tension Pneumothorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right endobronchial intubation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-102454.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right endobronchial intubation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right Hemothorax: A hemothorax would present with fluid accumulation, appearing as a homogenous opacity on the affected side rather than hyperinflation of one lung and collapse of the other.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Right Hemothorax:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right Pneumothorax: A pneumothorax would show absence of lung markings on the affected side and potentially tracheal deviation, not hyperinflation and collapse.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right Pneumothorax:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left Tension Pneumothorax: A tension pneumothorax would show absence of lung markings on the affected side and tracheal deviation away from the affected side, which is not seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left Tension Pneumothorax:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The chest X-ray shows hyperinflation of the right lung and collapse of the left lung, indicating right endobronchial intubation, where the endotracheal tube is inserted too far and enters the right mainstem bronchus, leading to overventilation of the right lung and collapse of the left lung.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female patient is on mechanical ventilation and is being weaned off. Which mode of ventilation is best in this situation ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IMV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SIMV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PSV&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. PSV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) PSV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. IMV: Intermittent Mandatory Ventilation provides a set number of mandatory breaths per minute with no support to patient-initiated breaths, which is not ideal for weaning.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IMV:&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIMV: Synchronized Intermittent Mandatory Ventilation provides a set number of mandatory breaths per minute with synchronized support to patient-initiated breaths, but it may still provide more support than necessary for a weaning patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIMV:&lt;/li&gt;&lt;li&gt;â€¢ Option C. AC: Assist Control Ventilation provides a set number of mandatory breaths per minute with full support to any additional breaths initiated by the patient, which is ideal to support respiratory failure but not during weaning.&lt;/li&gt;&lt;li&gt;â€¢ Option C. AC:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pressure Support Ventilation (PSV) is the most suitable mode for weaning a patient off mechanical ventilation as it provides partial support to patient-initiated breaths, facilitating gradual assumption of breathing effort by the patient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with acute respiratory distress syndrome (ARDS) is admitted to the ICU and placed on mechanical ventilation. The physician needs to set the ventilator to ensure the patient receives a fixed number of mandatory breaths per minute with full support to patient-initiated breaths. Which mode of ventilation should be used ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Assist Control (AC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intermittent Mandatory Ventilation (IMV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Synchronized Intermittent Mandatory Ventilation (SIMV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pressure Support Ventilation (PSV)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Assist Control (AC)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Assist Control (AC)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intermittent Mandatory Ventilation (IMV): IMV delivers a set number of mandatory breaths per minute but does not provide support for patient-initiated breaths, making it less suitable for a patient requiring full support.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intermittent Mandatory Ventilation (IMV):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Synchronized Intermittent Mandatory Ventilation (SIMV): SIMV delivers a set number of mandatory breaths per minute and synchronizes support with patient-initiated breaths but does not provide full support to each breath, which may not be sufficient for severe ARDS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Synchronized Intermittent Mandatory Ventilation (SIMV):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pressure Support Ventilation (PSV): PSV does not deliver mandatory breaths and only provides support to spontaneous breaths, which is not adequate for a patient with severe ARDS who requires consistent mandatory ventilation support.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pressure Support Ventilation (PSV):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Assist Control (AC) ventilation is suitable for patients with ARDS as it provides a set number of mandatory breaths per minute with full support to any patient-initiated breaths, ensuring consistent ventilatory support.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male patient with ARDS is on mechanical ventilation. What is the target peak Plateau pressure (P-PLATEAU) to ensure lung protection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â‰¤ 20 cm H2O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â‰¤ 25 cm H2O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â‰¤ 30 cm H2O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;â‰¤ 40 cm H2O&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. â‰¤ 30 cm H2O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) â‰¤ 30 cm H2O&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. â‰¤ 20 cm H2O: While a plateau pressure this low would certainly minimize the risk of VILI, it is often not practical or achievable in patients with ARDS who require higher pressures to maintain adequate oxygenation and ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. â‰¤ 20 cm H2O:&lt;/li&gt;&lt;li&gt;â€¢ Option B. â‰¤ 25 cm H2O: Incorrect since the target plateau pressure is â‰¤ 30 cm H2O&lt;/li&gt;&lt;li&gt;â€¢ Option B. â‰¤ 25 cm H2O:&lt;/li&gt;&lt;li&gt;â€¢ Option D. â‰¤ 40 cm H2O: This is the target PIP (Peak Inspiratory Pressure) and not plateau pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. â‰¤ 40 cm H2O:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients with ARDS on mechanical ventilation, the target plateau pressure (P-PLATEAU) should be â‰¤ 30 cm H2O to minimize the risk of ventilator-induced lung injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For a ventilated patient, the tidal volume (VT) is 350 mL, PEEP is 5 cm H2O and Plateau pressure is 40 cm H2O. What is the inference?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C = 10, Poor compliance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C = 60, good compliance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C = 10, good compliance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C = 60, poor compliance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. C = 10, Poor compliance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) C = 10, Poor compliance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. C = 60, good compliance: Incorrect calculation and interpretation. Compliance is not 60 and poor compliance is inferred.&lt;/li&gt;&lt;li&gt;â€¢ Option B. C = 60, good compliance:&lt;/li&gt;&lt;li&gt;â€¢ Option C. C = 10, good compliance: The calculation is correct, but compliance of 10 is poor, not good.&lt;/li&gt;&lt;li&gt;â€¢ Option C. C = 10, good compliance:&lt;/li&gt;&lt;li&gt;â€¢ Option D. C = 60, poor compliance: Incorrect calculation. Compliance of 60 mL/cm H2O would indicate good compliance, not poor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. C = 60, poor compliance:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For ventilated patients, a compliance value significantly lower than 60 mL/cm H2O indicates poor lung compliance, reflecting increased lung stiffness or decreased distensibility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old woman with history of SLE presents to the emergency department with sudden onset of severe shortness of breath. She is rapidly intubated due to respiratory failure. During mechanical ventilation, both the peak inspiratory pressure (PIP) and plateau pressure (P-PLATEAU) are observed to be within normal limits. What is the most likely cause of her symptoms ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchospasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute Respiratory Distress Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pulmonary embolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchospasm: This condition usually increases airway resistance, leading to elevated PIP with a normal P-PLATEAU.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchospasm:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute Respiratory Distress Syndrome: ARDS typically results in decreased lung compliance, causing increased PIP and P-PLATEAU.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acute Respiratory Distress Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumonia: Pneumonia can cause increased airway pressures due to reduced compliance or increased secretions, typically resulting in elevated PIP and sometimes P-PLATEAU depending on the severity and extent of the infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumonia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Normal PIP and P-PLATEAU in mechanically ventilated patients with severe respiratory symptoms suggest an extra-thoracic cause such as pulmonary embolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of chronic obstructive pulmonary disease (COPD) is admitted to the ICU with severe respiratory distress. He is placed on mechanical ventilation. During his course, you observe an increase in plateau pressure (P-PLATEAU). Which condition is most likely causing the increase P-PLATEAU?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchospasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumothorax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspiration of mucus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pneumothorax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pneumothorax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary embolism: Presents with normal pressures&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary embolism:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchospasm: Bronchospasm increases airway resistance, which would elevate PIP but not P-PLATEAU because the issue lies within the airways rather than lung compliance.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchospasm:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspiration of mucus: Aspiration of mucus primarily increases airway resistance, leading to an elevated PIP but P-PLATEAU will be normal as lung compliance is relatively normal&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspiration of mucus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An increase in plateau pressure (P-PLATEAU) in a mechanically ventilated patient suggests a decrease in lung compliance, which is commonly seen in conditions such as pneumothorax.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male patient has been on mechanical ventilation for several days. Currently he is being weaned. Which of the following conditions excludes performing a spontaneous breathing trial (SBT)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TOFR 0.9 &amp;amp; off paralysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hb of 10g/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;pH of 7.26&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RR of 32/min&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. RR of 32/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) RR of 32/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. TOFR 0.9 &amp;amp; off paralysis: This is a required condition for performing an SBT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TOFR 0.9 &amp;amp; off paralysis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hb of 10g/dL: This is an additional criterion but does not exclude performing an SBT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hb of 10g/dL:&lt;/li&gt;&lt;li&gt;â€¢ Option C. pH of 7.26: This meets the required condition of pH &amp;gt; 7.25 and does not exclude performing an SBT.&lt;/li&gt;&lt;li&gt;â€¢ Option C. pH of 7.26:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A respiratory rate (RR) of 32/min is higher than the required threshold for a spontaneous breathing trial (SBT), indicating the patient is not ready for an SBT.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male patient has been on mechanical ventilation for several days. The medical team is assessing his readiness for a spontaneous breathing trial (SBT). Which of the following is appropriate for conducting a spontaneous breathing trial (SBT)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;T piece ventilation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NIPPV (Non-Invasive Positive Pressure Ventilation)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NRBM (Non-Rebreather Mask) at 10-15L per minute&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Simple Face Mask at 8L per minute&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. T piece ventilation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) T piece ventilation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. NIPPV (Non-Invasive Positive Pressure Ventilation): Used post intubation to reduce the rates of re-intubation in a high risk patient. Since SBTs are performed prior to extubation NIPPV makes no sense.&lt;/li&gt;&lt;li&gt;â€¢ Option B. NIPPV (Non-Invasive Positive Pressure Ventilation):&lt;/li&gt;&lt;li&gt;â€¢ Option C. NRBM (Non-Rebreather Mask) at 10-15L per minute: This is used to deliver high concentrations of oxygen but does not support SBTs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. NRBM (Non-Rebreather Mask) at 10-15L per minute:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Simple Face Mask at 8L per minute: Unsuitable for SBTs. Can be used post-extubation if patients are NOT at high risk, to provide O2 support.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Simple Face Mask at 8L per minute:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ T piece ventilation is commonly used for spontaneous breathing trials (SBT) as it allows the patient to breathe spontaneously without any assistance, closely simulating the conditions post-extubation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old female patient with a history of COPD is admitted to the ICU and requires mechanical ventilation due to a severe exacerbation. On the 10th day of mechanical ventilation, she develops a fever and worsening oxygenation. CXR revealed new infiltrates. The patient has a recent history of hospitalization for a UTI. Which of the following antibiotic regimens is most appropriate ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Piperacillin + tazobactam + Amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefepime + Doxycycline + Linezolid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Levofloxacin + Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Meropenem + levofloxacin + Linezolid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Meropenem + levofloxacin + Linezolid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Meropenem + Levofloxacin + Linezolid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Piperacillin + tazobactam + Amikacin: This combination MRSA coverage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Piperacillin + tazobactam + Amikacin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cefepime + Doxycycline + Linezolid: Second drug must be an aminoglycoside or a respiratory quinolone or a polypeptide drug (colistin/polymyxin B). Doxycycline is not recommended in VAP.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cefepime + Doxycycline + Linezolid:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Levofloxacin + Vancomycin: Beta lactams are a must in VAP, hence this regime is inadequate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Levofloxacin + Vancomycin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Broad-spectrum antibiotic regimens, such as Meropenem + Levofloxacin + Linezolid, are necessary to cover multidrug-resistant gram-negative bacteria and MRSA in ventilator-associated pneumonia (VAP).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male patient has been diagnosed with ventilator-associated pneumonia (VAP) and is receiving appropriate antibiotic therapy. What is the recommended duration of antibiotic treatment for VAP to ensure optimal clinical outcomes ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;3-5 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;7 days&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;10-14 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;21 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 7 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 7 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 3-5 days: This duration is generally considered too short for treating VAP and may not be sufficient to ensure complete eradication of the infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 3-5 days:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 10-14 days: Although previously recommended, this longer duration is not typically necessary for most cases of VAP and can increase the risk of antibiotic resistance and adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 10-14 days:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 21 days: Such an extended duration is rarely necessary and would likely contribute to the development of antibiotic resistance and other negative consequences.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 21 days:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The recommended duration of antibiotic treatment for ventilator-associated pneumonia (VAP) is 7 days to ensure optimal clinical outcomes and minimize the risk of antibiotic resistance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male patient is intubated and on mechanical ventilation in the ICU. Which of the following strategies is least likely to reduce the risk of VAP ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hand hygiene practices&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevation of the head of the bed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Routine suctioning of subglottic secretions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Avoiding unnecessary antibiotic use&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Avoiding unnecessary antibiotic use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Avoiding unnecessary antibiotic use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hand hygiene practices: Effective hand hygiene practices are fundamental in preventing hospital-acquired infections, including VAP, by reducing the transmission of pathogens.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hand hygiene practices:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevation of the head of the bed: Elevating the head of the bed to 30-45 degrees helps prevent aspiration, a significant risk factor for VAP.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevation of the head of the bed:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Routine suctioning of subglottic secretions: This practice helps remove secretions that accumulate above the cuff of the endotracheal tube, which can reduce the risk of aspiration and subsequent pneumonia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Routine suctioning of subglottic secretions:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Avoiding unnecessary antibiotic use is essential for preventing antibiotic resistance but does not directly reduce the risk of ventilator-associated pneumonia (VAP).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with COPD is admitted due to worsening fever, fatigue, and shortness of breath. Chest X-ray shows left lower lobe consolidation. Despite treatment and resolution of pneumonia, the patient develops dyspnea and elevated pCO2 during attempts to wean from mechanical ventilation. Which test is used to identify the cause of weaning failure ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Muscle biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electroneuromyography (ENMG)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoxic response test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;End-tidal CO2 (EtCO2) measurements&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Electroneuromyography (ENMG)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Electroneuromyography (ENMG)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Muscle biopsy: While a muscle biopsy can provide detailed information about muscle pathology, it is invasive and not typically the first-line diagnostic test for weaning failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Muscle biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoxic response test: This test is not relevant for diagnosing the cause of weaning failure and is more commonly used to assess chemoreceptor function.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoxic response test:&lt;/li&gt;&lt;li&gt;â€¢ Option D. End-tidal CO2 (EtCO2) measurements: While EtCO2 can monitor ventilation and detect issues like hypoventilation, it does not diagnose neuromuscular causes of weaning failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. End-tidal CO2 (EtCO2) measurements:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Electroneuromyography (ENMG) is used to assess neuromuscular function and can help identify causes of weaning failure related to critical illness polyneuropathy or myopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female patient who has been on mechanical ventilation for 10 days is found to have stridor upon an attempted extubation. What is the most appropriate management in this patient ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer Methylprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Perform an immediate tracheostomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase the inspiratory pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Administer Salbutamol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administer Methylprednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Administer Methylprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Perform an immediate tracheostomy: This is not the first-line treatment for stridor due to laryngeal edema. It is considered if less invasive measures fail and if the airway obstruction is severe.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Perform an immediate tracheostomy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase the inspiratory pressure: This approach does not address the underlying issue of laryngeal edema and can lead to further complications by increasing airway pressures unnecessarily.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase the inspiratory pressure:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer Salbutamol: While useful for bronchospasm and lower airway obstruction, Salbutamol does not reduce inflammation or edema in the upper airway, such as the larynx.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer Salbutamol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Administering methylprednisolone is the standard management for stridor caused by laryngeal edema in ventilated patients, as it helps reduce inflammation and edema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40 year old man developed severe respiratory distress after a viral pneumonia. Which of the following is incorrect regarding ARDS ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ARDS is a diagnosis of exclusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral infiltrates on lung USG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PaO2/FiO2 ratio of 250 on HFNO 20L per minute&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SpO2 of 95% and SpO2/FiO2 ratio of 295&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PaO2/FiO2 ratio of 250 on HFNO 20L per minute&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture1_ORDcJzP.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) PaO2/FiO2 ratio of 250 on HFNO 20L per minute&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. To diagnose ARDS , other causes has to be ruled out, hence it is a true statement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. To diagnose ARDS&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral infiltrates on lung USG (or Chest X ray or CT scan) is a requirement for ARDS diagnosis, hence it is a true statement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral infiltrates on lung USG&lt;/li&gt;&lt;li&gt;â€¢ Option D. SpO2/FiO2 â‰¤ 315 with SpO2 â‰¤ 97% is a new addition and can be used as an alternative to the traditional PaO2/FiO2 ratio in resource poor settings. Hence it is a true statement&lt;/li&gt;&lt;li&gt;â€¢ Option D. SpO2/FiO2 â‰¤ 315 with SpO2 â‰¤ 97%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PaO2/FiO2 ratio for ARDS diagnosis can now be measured with NIV/CPAP or HFNC with O2 flow &amp;gt; 30 L/min. SpO2/FiO2 ratio should be â‰¤ 315 with SpO2 â‰¤ 97%.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33 year old man developed sepsis and ARDS following a penetrating injury to the abdomen. Which of the following is the earliest pathology in ARDS ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endothelial injury&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exudative damage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse Alveolar Damage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 2 Pneumocyte hyperplasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Endothelial injury&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Endothelial injury&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exudative damage : This phase follows endothelial injury and is characterized by the accumulation of protein-rich fluid in the alveoli, formation of hyaline membranes, and the presence of inflammatory cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exudative damage&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse Alveolar Damage : This is a histopathological term often used to describe the changes seen in the exudative and proliferative phases of ARDS, but it is not the earliest event.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse Alveolar Damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 2 Pneumocyte hyperplasia : This occurs later in the course of ARDS as part of the reparative process during the proliferative or fibrotic phases.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 2 Pneumocyte hyperplasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The earliest pathology in ARDS involves injury to the pulmonary endothelium, which leads to increased permeability and edema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common cause of ARDS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspiration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trauma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sepsis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Sepsis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspiration: While aspiration can cause ARDS, it is less common than sepsis. The patient&#x27;s clinical context and history of sepsis make this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspiration:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trauma: Trauma is another cause of ARDS but is not relevant in this patientâ€™s history, which centers on sepsis from a urinary tract infection.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trauma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia: Pneumonia can lead to ARDS, but in this case, the primary underlying cause is sepsis secondary to a urinary tract infection, as indicated by the patientâ€™s clinical presentation and progression.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sepsis is the most common cause of ARDS due to the systemic inflammatory response leading to widespread endothelial injury and increased vascular permeability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60kg female with a history of diabetes and hypertension is admitted to the ICU with acute respiratory distress syndrome (ARDS) secondary to severe pneumonia. She is intubated and placed on mechanical ventilation. What is the most appropriate tidal volume setting for this patient to minimize ventilator-induced lung injury ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;360 mL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;480 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;600 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;720 mL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 360 mL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 360 mL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. 480 mL: This tidal volume (8 mL/kg) exceeds the recommended range and could increase the risk of lung injury.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 480 mL:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 600 mL: This tidal volume (10 mL/kg) is too high and significantly increases the risk of barotrauma and volutrauma in ARDS patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 600 mL:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 720 mL: This tidal volume (12 mL/kg) is excessively high and would likely cause severe ventilator-induced lung injury.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 720 mL:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The recommended tidal volume for ARDS management is 4-6 mL/kg of predicted body weight to minimize the risk of ventilator-induced lung injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male) is admitted to the ICU with severe ARDS secondary to COVID-19 pneumonia. Despite optimal ventilator settings, the patient remains severely hypoxemic with a PaO2/FiO2 ratio of 80.Which of the following interventions is most appropriate to improve oxygenation in this patient ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase tidal volume to 8 mL/kg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prone positioning&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase FiO2 to 100%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prone positioning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prone positioning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase tidal volume to 8 mL/kg: Increasing the tidal volume to 8 mL/kg is not recommended in ARDS as it can lead to ventilator-induced lung injury due to overdistention of the alveoli. The recommended tidal volume for ARDS is 4-6 mL/kg of predicted body weight.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase tidal volume to 8 mL/kg:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer diuretics: While diuretics can be useful in managing fluid overload, they are not a primary intervention for improving oxygenation in severe ARDS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer diuretics:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase FiO2 to 100%: Increasing FiO2 to 100% may temporarily improve oxygenation but can lead to oxygen toxicity if used for prolonged periods. It does not address the underlying issue of poor oxygenation due to lung mechanics and is not a sustainable long-term solution.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase FiO2 to 100%:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prone positioning is an evidence-based intervention that can significantly improve oxygenation in patients with severe ARDS by redistributing lung perfusion, improving ventilation-perfusion matching, and enhancing alveolar recruitment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50 kg female is admitted to the ICU with severe ARDS. he is intubated and on mechanical ventilation. Her ventilator settings are as follows: Tidal volume 300 mL, FiO2 80% and PEEP 8 cm H2O. Her ABG reports show a PaO2/FiO2 ratio of 100 and her SpO2 is 94%. Which of the following interventions should be the next step ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase tidal volume to 400 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase FiO2 to 100%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase PEEP to 12 cm H2O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase respiratory rate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increase PEEP to 12 cm H2O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increase PEEP to 12 cm H2O&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase tidal volume to 400 mL: Increasing the tidal volume is not recommended in ARDS as it can lead to ventilator-induced lung injury. The current tidal volume of 300 mL (6 mL/kg) is appropriate for this 50 kg patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase tidal volume to 400 mL:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase FiO2 to 100%: Increasing FiO2 to 100% can temporarily improve oxygenation, but prolonged use can lead to oxygen toxicity. The goal is to reduce FiO2 while maintaining adequate oxygenation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase FiO2 to 100%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase respiratory rate: Increasing the respiratory rate helps with carbon dioxide removal but does not directly improve oxygenation. The primary intervention should focus on enhancing oxygenation through alveolar recruitment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase respiratory rate:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increasing Positive End-Expiratory Pressure (PEEP) helps improve oxygenation in severe ARDS by increasing alveolar recruitment, preventing alveolar collapse, and improving ventilation-perfusion matching, thereby reducing the need for high FiO2 and minimizing the risk of oxygen toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70 kg male is admitted to the ICU with ARDS after cholangitis. His ventilator settings in the prone position are as follows: Tidal volume 300 mL, PEEP 15 cm H2O, FiO2 100%. His ABG reveals a PaO2/FiO2 ratio of 50, PaCO2 of 50 mmHg, and an arterial pH of 7.13. His SpO2 is 85%, and his plateau pressure is 35 cm H2O. What is the most appropriate next step ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduce tidal volume to 200 mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase PEEP to 18 cm H2O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase the duration of prone position&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Consider ECMO&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Consider ECMO&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Consider ECMO&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduce tidal volume to 200 mL: Reducing tidal volume below the recommended 4-6 mL/kg would likely lead to inadequate ventilation and worsening hypercapnia without significantly improving oxygenation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduce tidal volume to 200 mL:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase PEEP to 18 cm H2O: Increasing PEEP might marginally improve oxygenation, but with a high plateau pressure of 35 cm H2O, further increasing PEEP carries a significant risk of barotrauma and overdistention of the lungs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increase PEEP to 18 cm H2O:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase the duration of prone position: While prolonged prone positioning can sometimes enhance oxygenation, the patient&#x27;s severe hypoxemia and hypercapnia suggest that a more advanced intervention, such as ECMO, is necessary.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase the duration of prone position:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ECMO (Extracorporeal Membrane Oxygenation) is indicated for patients with severe ARDS who have refractory hypoxemia and hypercapnia despite optimal ventilatory management, providing adequate oxygenation and CO2 removal, allowing the lungs to rest and recover.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with a 30-pack-year smoking history presents with chronic cough and shortness of breath. Spirometry shows an FEV1/FVC ratio of 0.60. What does this finding suggest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Restrictive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obstructive lung disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal lung function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interstitial lung disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Obstructive lung disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A reduced FEV1/FVC ratio (typically &amp;lt; 0.70) is a hallmark of obstructive lung diseases, where airflow is limited, such as COPD and asthma.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Restrictive lung disease: Characterized by reduced lung volumes with a normal or increased FEV1/FVC ratio.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Restrictive lung disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal lung function: Normal PFTs would show a normal FEV1/FVC ratio.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal lung function:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interstitial lung disease: A type of restrictive lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interstitial lung disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A reduced FEV1/FVC ratio (&amp;lt; 0.70) on spirometry is indicative of obstructive lung disease, commonly seen in conditions like COPD and asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of smoking and progressive dyspnea presents with a barrel chest and expiratory wheezing. Which PFT finding is LEAST likely in this patient with suspected emphysema?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal residual volume (RV)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased forced vital capacity (FVC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal vital capacity (VC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased FEV1/FVC ratio&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Normal residual volume (RV)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Emphysema, a type of COPD, is characterized by air trapping and hyperinflation, leading to increased residual volume.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased forced vital capacity (FVC) : Common in emphysema due to air trapping.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Decreased forced vital capacity (FVC)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal vital capacity (VC): While possible in early disease, VC often decreases as emphysema progresses.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal vital capacity (VC):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased FEV1/FVC ratio: Hallmark of obstructive lung disease like emphysema.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Decreased FEV1/FVC ratio:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In emphysema, expect increased residual volume (RV) due to air trapping, along with decreased FEV1/FVC ratio and forced vital capacity (FVC).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical student is using the following device to assess lung function in a patient with suspected asthma. Which of the following lung volumes cannot be directly measured using this device?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tidal volume (TV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vital capacity (VC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Functional residual capacity (FRC)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Forced expiratory volume in 1 second (FEV1)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Functional residual capacity (FRC)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Functional residual capacity (FRC)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The given instrument is a hand held spirometer. Spirometry can measure airflow during forced maneuvers and can estimate FVC, FEV1, and peak expiratory flow rate (PEFR). Spirometry cannot measure residual volume and the associated capacities (like TLC/FRC).&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tidal volume (TV): The volume of air inhaled or exhaled during normal breathing. Can be measured in Spirometry&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tidal volume (TV):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vital capacity (VC): The maximum volume of air that can be exhaled after a maximal inhalation. Can be measured in Spirometry&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vital capacity (VC):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Forced expiratory volume in 1 second (FEV1): The volume of air exhaled in the first second of a forced exhalation. Can be measured in Spirometry&lt;/li&gt;&lt;li&gt;â€¢ Option D. Forced expiratory volume in 1 second (FEV1):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spirometry can measure FVC, FEV1, and TV, but it cannot measure RV or FRC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient&#x27;s flow-volume (FV) loop demonstrates the following (red line in the image is the patients actual FV loop, background blue line is the predicted normal). What does this finding indicate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal lung function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Restrictive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Upper airway obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Obstructive lung disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Obstructive lung disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Obstructive lung disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The concave shape with scooped appearance of expiratory limb and reduced PEFR on the expiratory limb are classic for obstructive lung diseases like COPD and asthma, indicating airflow limitation during exhalation. The patient also has a near normal FVC, further strengthening the diagnosis of obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Normal lung function: Normal flow-volume loops are relatively linear.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Normal lung function:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Restrictive lung disease: Usually shows a smaller loop with normal shape.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Restrictive lung disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Upper airway obstruction: Typically shows flattening on the inspiratory limb of the flow-volume loop.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Upper airway obstruction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A concave, scooped expiratory flow-volume loop with reduced PEFR is indicative of obstructive lung disease such as COPD or asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with wheezing and shortness of breath undergoes spirometry. A decreased maximum mid-expiratory flow rate (MMEF or FEF25-75%) is observed. Which airways are most likely affected?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trachea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mainstem bronchi&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medium-sized bronchi&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Small airways (bronchioles)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Small airways (bronchioles)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Small airways (bronchioles)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ MMEF, also known as FEF25-75%, reflects airflow in the small airways (bronchioles). A decrease in MMEF suggests obstruction in these airways, which is a common finding in conditions like asthma and COPD.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trachea: Obstruction here would cause stridor, a high-pitched sound on inspiration.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Trachea:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mainstem bronchi: Obstruction here would cause more severe symptoms and a different flow-volume loop pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Mainstem bronchi:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Medium-sized bronchi: While potentially affected, these airways are not the primary site of obstruction reflected by a decreased MMEF&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Medium-sized bronchi:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A decreased MMEF (FEF25-75%) indicates obstruction in the small airways (bronchioles), which is common in asthma and COPD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of heavy smoking presents with a new onset of stridor and progressive dyspnea. His flow-volume loop is shown. What is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Main bronchus obstruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Large airway tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COPD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Main bronchus obstruction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Main bronchus obstruction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient has a unilateral mainstem bronchus obstruction. The flow-volume loop shows both an end-inspiratory and end-expiratory tail and is most commonly known as a biphasic flow-volume curve. This finding has also been described as â€œtwo compartments.â€&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma: Typically shows a concave expiratory limb without biphasic flattening.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Large airway tumor: While it can cause fixed obstruction with flattening of both limbs, a biphasic pattern is more indicative of a main bronchus obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Large airway tumor:&lt;/li&gt;&lt;li&gt;â€¢ Option D. COPD: Shows a concave expiratory limb and does not typically cause a biphasic pattern in the flow-volume loop.&lt;/li&gt;&lt;li&gt;â€¢ Option D. COPD:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A biphasic flow-volume loop indicates a main bronchus obstruction, often presenting with both end-inspiratory and end-expiratory tailing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is in ICU and you are noticing the flow-volume loop as shown. What is the most likely explanation for this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spontaneous breathing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Positive pressure ventilation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Airway obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung collapse&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Positive pressure ventilation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Positive pressure ventilation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In this FV loop expiration precedes inspiration and this is opposite to normal spontaneous respiration. This is due to positive pressure ventilation, where air is forced into the lungs.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spontaneous breathing : Would show a normal pattern with inspiration preceding expiration.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spontaneous breathing&lt;/li&gt;&lt;li&gt;â€¢ Option C. Airway obstruction : Would cause a concave shape on the expiratory limb.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Airway obstruction&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung collapse : Would result in a smaller loop with decreased flows.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung collapse&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A flow-volume loop where expiration precedes inspiration indicates positive pressure ventilation, commonly seen in patients receiving mechanical ventilation in the ICU.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a history of rheumatoid arthritis presents with progressive shortness of breath. Pulmonary function tests reveal a decreased diffusing capacity of the lung for carbon monoxide (DLCO). Which of the following conditions is the most likely cause of her decreased DLCO?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congestive heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interstitial lung disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Interstitial lung disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Interstitial lung disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Interstitial lung disease, a known complication of rheumatoid arthritis, leads to thickening and fibrosis of the alveolar-capillary membrane, reducing gas diffusion and causing a decrease in DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma: While asthma can cause a reduced DLCO due to air trapping, it is not the most likely cause in this clinical scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure : Can cause a reduced DLCO due to pulmonary edema, but the patient&#x27;s history of rheumatoid arthritis makes ILD more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary hemorrhage : Can cause a transient increase in DLCO due to the presence of blood in the alveoli.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary hemorrhage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with rheumatoid arthritis and progressive shortness of breath, a decreased DLCO is most likely due to interstitial lung disease, a common pulmonary complication associated with rheumatoid arthritis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with systemic lupus erythematosus (SLE) presents with sudden onset of hemoptysis and shortness of breath. Her DLCO is 163%. What underlying pathology is most likely responsible for this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interstitial lung disease (ILD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alveolar hemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alveolar hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alveolar hemorrhage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In patients with systemic lupus erythematosus (SLE) presenting with hemoptysis and an increased DLCO, alveolar hemorrhage is the most likely cause. The presence of blood in the alveoli increases the binding capacity for carbon monoxide, thereby increasing DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pneumonia : Typically associated with normal or decreased DLCO due to inflammation and consolidation, not an increase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pneumonia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Interstitial lung disease (ILD) : Usually associated with a decreased DLCO due to fibrosis and thickening of the alveolar-capillary membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Interstitial lung disease (ILD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pleural effusion : Does not typically affect DLCO in the same manner; it might decrease lung volumes but not directly increase DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pleural effusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increased DLCO in a patient with SLE and sudden hemoptysis suggested alveolar hemorrhage, where the presence of blood in the alveoli elevates carbon monoxide binding capacity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of systemic sclerosis presents with progressive dyspnea. Which of the following pulmonary function test results would be most consistent with her underlying condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased DLCO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Normal DLCO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased DLCO&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased FEV1/FVC ratio&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decreased DLCO&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Systemic sclerosis can cause interstitial lung disease (ILD), a condition that decreases the diffusing capacity of the lung for carbon monoxide (DLCO) due to fibrosis and thickening of the alveolar-capillary membrane.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased DLCO: Seen in conditions like asthma, pulmonary hemorrhage, or polycythemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased DLCO:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Normal DLCO: Unlikely in ILD, which typically causes a reduced DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Normal DLCO:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased FEV1/FVC ratio: Not characteristic of ILD, which is a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased FEV1/FVC ratio:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Systemic sclerosis can lead to interstitial lung disease (ILD), characterized by a decreased DLCO due to fibrosis and thickening of the alveolar-capillary membrane.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old former naval ship worker with a 40-pack-year smoking history presents with progressive dyspnea, dry cough, bilateral end-inspiratory crackles, and no clubbing. PFT is given below. Total lung capacity 67% of predicted Residual volume 72% of predicted FVC 65% of predicted FEVI 75% of predicted FEV I/FVC ratio 89% (Normal) DLCO 52% of predicted Chest X-ray reveals bilateral lower zone predominant lesions. Which diagnosis is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asbestosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Asbestosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Asbestosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The history of asbestos exposure (naval ship worker), progressive dyspnea, dry cough, restrictive PFT pattern, and bilateral lower zone opacities are consistent with asbestosis.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Emphysema: Typically causes obstructive pattern on PFTs, upper lobe predominant changes, and may present with wheezing.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Emphysema:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia: Usually acute onset with fever and consolidation on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bronchogenic carcinoma: Often associated with a history of smoking but usually presents as a mass or nodule on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bronchogenic carcinoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Asbestosis is characterized by a history of asbestos exposure, restrictive PFT pattern, progressive dyspnea, and bilateral lower zone opacities on imaging.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;65-year-old man undergoes pulmonary function testing (PFT) as part of a routine medical health check (MHC). He has no pulmonary issues and is a lifelong non-smoker. The PFT results are shown below. Which of the following findings is most likely consistent with the observed data?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obstructive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Restrictive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal lung function&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Combined obstructive and restrictive lung disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Normal lung function&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-194313.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Normal lung function&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The PFT results show normal FVC (102% predicted), FEV1 (95% predicted), FEV1/FVC ratio (73%) and DLCO (84% of predicted) No significant change post-bronchodilator indicates no reversible obstruction.&lt;/li&gt;&lt;li&gt;â€¢ The PFT results show normal FVC (102% predicted), FEV1 (95% predicted), FEV1/FVC ratio (73%) and DLCO (84% of predicted)&lt;/li&gt;&lt;li&gt;â€¢ No significant change post-bronchodilator indicates no reversible obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obstructive lung disease : Typically has an FEV1/FVC ratio &amp;lt; 70%.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obstructive lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Restrictive lung disease : Typically shows a reduced TLC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Restrictive lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Combined obstructive and restrictive lung disease : Would show both a reduced FEV1/FVC ratio and reduced TLC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Combined obstructive and restrictive lung disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Normal PFT results include an FEV1/FVC ratio around 75-80%, no significant change post-bronchodilator, and normal predicted values for FVC, FEV1, and DLCO.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 41-year-old smoker presents with shortness of breath (SOB). His pulmonary function test (PFT) results are shown below. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Restrictive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chronic obstructive pulmonary disease (COPD)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-113621.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chronic obstructive pulmonary disease (COPD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The PFT results indicate severe obstruction: FEV1 is markedly reduced (19% predicted). FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease. RV is increased (257% predicted), indicating air trapping. TLC is within normal limits (108% predicted), ruling out restrictive lung disease. DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.&lt;/li&gt;&lt;li&gt;â€¢ The PFT results indicate severe obstruction: FEV1 is markedly reduced (19% predicted). FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease. RV is increased (257% predicted), indicating air trapping. TLC is within normal limits (108% predicted), ruling out restrictive lung disease. DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.&lt;/li&gt;&lt;li&gt;â€¢ FEV1 is markedly reduced (19% predicted). FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease. RV is increased (257% predicted), indicating air trapping. TLC is within normal limits (108% predicted), ruling out restrictive lung disease. DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.&lt;/li&gt;&lt;li&gt;â€¢ FEV1 is markedly reduced (19% predicted).&lt;/li&gt;&lt;li&gt;â€¢ FEV1/FVC ratio is significantly decreased (54%), consistent with obstructive lung disease.&lt;/li&gt;&lt;li&gt;â€¢ RV is increased (257% predicted), indicating air trapping.&lt;/li&gt;&lt;li&gt;â€¢ TLC is within normal limits (108% predicted), ruling out restrictive lung disease.&lt;/li&gt;&lt;li&gt;â€¢ DLCO is severely reduced (3% predicted), consistent with emphysema, a common cause of COPD.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma : Typically shows reversible airflow obstruction with significant improvement post-bronchodilator, which is not seen here (FEV1 change of -10%).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma&lt;/li&gt;&lt;li&gt;â€¢ Option C. Restrictive lung disease : Typically shows a reduced TLC, which is not present in these results.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Restrictive lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism : Generally does not present with such a pronounced obstructive pattern and reduced DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ COPD is characterized by reduced FEV1 and FEV1/FVC ratio, increased RV indicating air trapping, and a reduced DLCO, particularly in cases of emphysema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents for evaluation of shortness of breath on exertion for 2 months. She is a non-smoker and has no prior history of asthma or other pulmonary problems. She works as a receptionist in a hotel and has two cats and three parakeets at home. Her pulmonary function test (PFT) results are shown below. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypersensitivity pneumonitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypersensitivity pneumonitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-113701.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypersensitivity pneumonitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (43% predicted). FVC is significantly reduced (40% predicted) suggesting a restrictive pattern. FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern. Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern. DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD) The patient&#x27;s exposure to birds (parakeets) is a common cause of hypersensitivity pneumonitis, leading to lung inflammation and fibrosis (ILD)&lt;/li&gt;&lt;li&gt;â€¢ The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (43% predicted). FVC is significantly reduced (40% predicted) suggesting a restrictive pattern. FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern. Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern. DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD)&lt;/li&gt;&lt;li&gt;â€¢ FEV1 is significantly reduced (43% predicted). FVC is significantly reduced (40% predicted) suggesting a restrictive pattern. FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern. Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern. DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD)&lt;/li&gt;&lt;li&gt;â€¢ FEV1 is significantly reduced (43% predicted).&lt;/li&gt;&lt;li&gt;â€¢ FVC is significantly reduced (40% predicted) suggesting a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ FEV1/FVC ratio is increased (91%), consistent with a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Total Lung Capacity (TLC) is reduced (44% predicted), confirming a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ DLCO is severely reduced (16% predicted), which is suggestive of intrinsic restriction (ILD)&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s exposure to birds (parakeets) is a common cause of hypersensitivity pneumonitis, leading to lung inflammation and fibrosis (ILD)&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD) : Typically shows a reduced FEV1/FVC ratio and increased TLC due to air trapping, not a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myasthenia gravis : Can cause a restrictive pattern but typically presents with muscle weakness rather than severe reductions in lung volumes and DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myasthenia gravis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism : Generally does not present with a restrictive pattern on PFT and primarily affects DLCO if significant, but not the overall lung volumes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypersensitivity pneumonitis is characterized by a restrictive pattern on PFTs, decreased TLC, and significantly reduced DLCO. Bird exposure, particularly to parakeets, is a common cause.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman presents with worsening shortness of breath on exertion and exercise limitation. She is a lifelong non-smoker and has no significant past medical history. Her pulmonary function test (PFT) results are shown below. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial lung disease (ILD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Myasthenia gravis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/26/screenshot-2024-06-26-102120.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Myasthenia gravis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (30% predicted). FEV1/FVC ratio is normal (99%) FVC is significantly reduced (26% predicted) suggesting a restrictive pattern. Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern. RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength. DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.&lt;/li&gt;&lt;li&gt;â€¢ The PFT results indicate a restrictive pattern: FEV1 is significantly reduced (30% predicted). FEV1/FVC ratio is normal (99%) FVC is significantly reduced (26% predicted) suggesting a restrictive pattern. Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern. RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength. DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.&lt;/li&gt;&lt;li&gt;â€¢ FEV1 is significantly reduced (30% predicted). FEV1/FVC ratio is normal (99%) FVC is significantly reduced (26% predicted) suggesting a restrictive pattern. Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern. RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength. DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.&lt;/li&gt;&lt;li&gt;â€¢ FEV1 is significantly reduced (30% predicted).&lt;/li&gt;&lt;li&gt;â€¢ FEV1/FVC ratio is normal (99%)&lt;/li&gt;&lt;li&gt;â€¢ FVC is significantly reduced (26% predicted) suggesting a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Total Lung Capacity (TLC) is reduced (53% predicted), confirming a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ RV/TLC ratio is increased (65%), which can be seen in conditions that affect muscle strength.&lt;/li&gt;&lt;li&gt;â€¢ DLCO is relatively normal (84% predicted), which typically occurs in extrinsic restriction.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD) : Typically shows a reduced FEV1/FVC ratio and increased TLC due to air trapping, not a restrictive pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Interstitial lung disease (ILD) : Causes intrinsic restriction hence presents with significant diffusion impairment, often with very low DLCO values.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Interstitial lung disease (ILD)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism : Generally does not present with a restrictive pattern on PFT and primarily affects DLCO if significant enough, not the overall lung volumes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myasthenia gravis can present with a restrictive pattern on PFTs characterized by reduced FEV1 and FVC with a normal FEV1/FVC ratio, reduced TLC, and an increased RV/TLC ratio.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a history of deep vein thrombosis (DVT) six months ago. She is concerned about her risk of recurrence. Which of the following factors is the strongest predictor of recurrent venous thromboembolism (VTE)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor V Leiden mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral contraceptive use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Active malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prior history of DVT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prior history of DVT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prior history of DVT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor V Leiden mutation: While a significant risk factor for VTE, it is not the strongest predictor of recurrence compared to a prior VTE event.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor V Leiden mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral contraceptive use: This is a transient risk factor that decreases after discontinuation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral contraceptive use:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Active malignancy: Increases VTE risk but is less predictive of recurrence than a prior VTE.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Active malignancy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A prior history of venous thromboembolism (VTE) is the strongest predictor of recurrent events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man with a recent left leg fracture presents with sudden severe pain, swelling, and bluish discoloration as shown in the picture. Doppler ultrasound confirms non compressible femoral, popliteal, and saphenous veins. Which of the following statements is TRUE regarding this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a benign condition with low risk of complications&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a surgical emergency requiring immediate intervention&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is typically managed with anticoagulation alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is associated with a low risk of pulmonary embolism.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is a surgical emergency requiring immediate intervention&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is a surgical emergency requiring immediate intervention.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a benign condition with low risk of complications: It is a serious condition with high risk of limb loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ It is a benign condition with low risk of complications:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is typically managed with anticoagulation alone: Anticoagulation alone is insufficient; surgical intervention is necessary.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ It is typically managed with anticoagulation alone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is associated with a low risk of pulmonary embolism: It carries a high risk of pulmonary embolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ It is associated with a low risk of pulmonary embolism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phlegmasia cerulea dolens is a surgical emergency requiring immediate intervention to prevent limb ischemia and gangrene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with suspected acute pulmonary embolism (PE) undergoes transthoracic echocardiography (TTE). 2D Echo shows akinesia of the right ventricle (RV) mid-free wall with preserved contraction of the RV apex. What is this characteristic finding called?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;McConnell&#x27;s sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;60/60 sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RV strain pattern&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. McConnell&#x27;s sign&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. D sign: Indicates RV dilation in PE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. D sign:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 60/60 sign: Refers to specific Doppler findings in pulmonary hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 60/60 sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. RV strain pattern: A more general term for RV dysfunction, not specific to PE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. RV strain pattern:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ McConnell&#x27;s sign is a specific echocardiographic finding in acute pulmonary embolism, indicating regional right ventricular dysfunction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman on chronic steroid therapy presents with sudden-onset shortness of breath and syncope. CT pulmonary angiography (CTPA) confirms a large saddle Pulmonary Embolism (PE). She is normotensive, but echocardiogram shows moderate right ventricular (RV) dysfunction and elevated brain natriuretic peptide (BNP). Which of the following classifies her Pulmonary Embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Massive PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sub-massive PE&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low risk PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unclassified&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sub-massive PE&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sub-massive PE&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Massive PE: Characterized by sustained hypotension (systolic BP &amp;lt; 90 mmHg for at least 15 minutes), shock, or requiring inotropic support. This is not applicable here as the patient is normotensive.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Massive PE:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low Risk PE: Patients are normotensive and do not have evidence of RV dysfunction or myocardial injury. This is incorrect because the patient has RV dysfunction and elevated BNP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low Risk PE:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Unclassified: Not a standard clinical classification for PE. PE cases are typically classified as massive, submassive, or low risk based on hemodynamic stability and RV function.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Unclassified:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Submassive PE is characterized by normotension with evidence of right ventricular dysfunction or myocardial injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of recent surgery presents with swelling and pain in his right calf. Which of the following conditions would NOT be associated with an elevated D-dimer level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deep vein thrombosis (DVT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary embolism (PE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron-deficiency anemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Iron-deficiency anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Iron-deficiency anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. DVT: DVT leads to clot formation and breakdown, resulting in elevated D-dimer levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. DVT:&lt;/li&gt;&lt;li&gt;â€¢ Option B. PE: PE is often preceded by DVT, leading to elevated D-dimer levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PE:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sepsis: Sepsis can cause systemic inflammation and activation of coagulation, leading to elevated D-dimer levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sepsis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iron-deficiency anemia does not typically lead to elevated D-dimer levels, unlike conditions that activate the coagulation system or fibrinolysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old patient with allergic bronchopulmonary aspergillosis (ABPA) on chronic steroids presents to the ER with swelling and pain in the left lower limb and sudden onset breathlessness. On arrival, the patient is hemodynamically stable but the shock index is &amp;gt;1. Compression ultrasound showed a left lower limb DVT. Which of the following tests would be the most definitive to confirm the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Pulmonary angiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MRI of infont of thorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Pulmonary angiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CT Pulmonary angiogram (CTPA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ECG: Might show nonspecific signs like sinus tachycardia or right heart strain but cannot definitively diagnose PE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ECG:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Echocardiogram: Can detect right ventricular dysfunction, a common finding in PE, but not always diagnostic, especially in patients with pre-existing cardiac conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Echocardiogram:&lt;/li&gt;&lt;li&gt;â€¢ Option D. MRI of infont of thorax : Less readily available and not as sensitive or specific as CTPA for diagnosing PE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. MRI&lt;/li&gt;&lt;li&gt;â€¢ of infont of thorax&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CT Pulmonary Angiogram (CTPA) is the gold standard for diagnosing pulmonary embolism, providing detailed visualization of the pulmonary vasculature to detect emboli.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with prostate cancer presents with worsening breathlessness, chest pain, and syncope. He is tachycardic and CTPA confirms pulmonary embolism (PE). Cardiac troponins and BNP levels are normal, but echocardiogram shows reduced RV function. Which of the following is the most appropriate in-hospital treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LMWH (Low Molecular Weight Heparin)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bivalirudin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. LMWH (Low Molecular Weight Heparin)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) LMWH (Low Molecular Weight Heparin)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warfarin: Requires close INR monitoring, has a delayed onset of action and has numerous drug interactions. Hence, not appropriate for in-hospital management.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warfarin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bivalirudin: A direct thrombin inhibitor typically used primarily in patients with heparin-induced thrombocytopenia (HIT).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bivalirudin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alteplase: A thrombolytic agent reserved for high-risk PE with hemodynamic instability.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alteplase:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cancer patients with intermediate-low risk pulmonary embolism (PE), Low Molecular Weight Heparin (LMWH) is preferred due to its efficacy and lower bleeding risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old gentleman with a family history of colorectal cancer presents with pleuritic chest pain, breathlessness and syncope. On examination he has a swollen right leg. His ECG is shown. Which of the following statements regarding the condition is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sinus tachycardia is the most common finding in PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S1Q3T3 is pathognomonic of Pulmonary Embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T-wave inversion in the anterior leads can be a sign of right heart strain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The ECG findings in this patient are suggestive of Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S1Q3T3 is pathognomonic of Pulmonary Embolism&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-101539.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S1Q3T3 is pathognomonic of Pulmonary Embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sinus tachycardia is the most common ECG finding in PE: True.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sinus tachycardia is the most common ECG finding in PE:&lt;/li&gt;&lt;li&gt;â€¢ Option C. T-wave inversions in the anterior leads can be a sign of right heart strain: True.&lt;/li&gt;&lt;li&gt;â€¢ Option C. T-wave inversions in the anterior leads can be a sign of right heart strain:&lt;/li&gt;&lt;li&gt;â€¢ Option D. The ECG findings in this patient are suggestive of PE: Patient has the classic S1Q3T3 pattern along with T inversions in anterior leads and RBBB. ECG also shows a borderline right axis deviation&lt;/li&gt;&lt;li&gt;â€¢ Option D. The ECG findings in this patient are suggestive of PE:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The S1Q3T3 pattern is highly suggestive of pulmonary embolism (PE) but is not pathognomonic, as it can occur in other conditions causing acute right heart strain.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with massive pulmonary embolism and shock undergoes thrombolysis with alteplase, but their blood pressure remains low despite aggressive fluid resuscitation, and oxygen saturation does not improve. What is the next most appropriate step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Repeat thrombolysis with a higher dose of alteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer anticoagulation with heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proceed with surgical embolectomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Continue supportive care and monitor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Proceed with surgical embolectomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Proceed with surgical embolectomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Repeat thrombolysis with a higher dose of alteplase : Not recommended due to increased bleeding risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Repeat thrombolysis with a higher dose of alteplase&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Administer anticoagulation with heparin : Indicated after successful thrombolysis or embolectomy.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Administer anticoagulation with heparin&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option D. Continue supportive care and monitor: Not sufficient in a patient with persistent shock and hypoxemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Continue supportive care and monitor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of massive PE with hemodynamic instability where thrombolysis fails, surgical or catheter-directed embolectomy is the next step to remove the clot and restore blood flow.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman with no significant past medical history presents with pleuritic chest pain and shortness of breath after a long flight. Her heart rate is 110 beats per minute. Which of the following would NOT increase her Wells probability score for pulmonary embolism (PE)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SBP â‰¤ 90 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recent immobilization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;History of DVT or PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heart rate &amp;gt; 100 beats/minute&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SBP â‰¤ 90 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) SBP â‰¤ 90 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Recent immobilization: Increased risk of DVT and PE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Recent immobilization:&lt;/li&gt;&lt;li&gt;â€¢ Option C. History of DVT or PE: Increases the likelihood of recurrent events.&lt;/li&gt;&lt;li&gt;â€¢ Option C. History of DVT or PE:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Heart rate &amp;gt; 100 beats/minute: A sign of tachycardia, which can be seen in PE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Heart rate &amp;gt; 100 beats/minute:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Hemoptysis, while a possible symptom of PE, is not a criterion in the modified Wells score for PE.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with sudden onset chest pain and syncope. ECG showed sinus tachycardia. CTPA confirmed Pulmonary embolism. Chest radiograph given below. Identify the sign found on CXR?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hamptoms Hump&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Palla sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Westermark sig&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Split pleura sign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Palla sign&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/whatsapp-image-2024-06-20-at-103358-am.jpeg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/24/whatsapp-image-2024-06-24-at-55611-pm.jpeg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Palla sign&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hamptons hump: refers to wedge shaped opacity due to pulmonary infarct.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hamptons hump:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Westermark sign: Refers to focal oligemia due to cutoff of blood supply&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Westermark sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Split pleura sign : refers to thickening and separation of pleura with enhancement occurring in empyema.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Split pleura sign&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Enlargement of right descending pulmonary artery is termed Palla sign.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with acute pulmonary embolism (PE). He is currently on anticoagulation therapy but has developed a major gastrointestinal bleed. Which of the following is the best next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the dose of anticoagulants&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Place an inferior vena cava (IVC) filter&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Switch to a different anticoagulant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Perform an embolectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Place an inferior vena cava (IVC) filter&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Place an inferior vena cava (IVC) filter&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of anticoagulants : This would exacerbate the bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase the dose of anticoagulants&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switch to a different anticoagulant : This is not advisable in the context of active major bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Switch to a different anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ Option D. Perform an embolectomy : This is an invasive procedure not typically indicated as a primary step when an IVC filter can effectively prevent further emboli.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Perform an embolectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ An IVC filter is recommended for patients with PE who cannot continue anticoagulation therapy due to major bleeding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with redness, swelling, and tenderness along a superficial vein in her upper arm following an IV catheter placement. There is no fever or signs of systemic infection. What is the initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warm compresses and NSAIDs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgical removal of the affected vein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Warm compresses and NSAIDs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Warm compresses and NSAIDs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral antibiotics : Not necessary unless there are signs of infection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral antibiotics&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heparin therapy : Anticoagulation is not needed unless there is extension into deep veins.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heparin therapy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical removal of the affected vein : Surgery is not indicated for initial treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical removal of the affected vein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment for catheter-associated superficial thrombophlebitis includes conservative measures like warm compresses and NSAIDs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Thrombosis in which of the following is least likely to cause pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Superficial femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Great saphenous vein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Common femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Popliteal vein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Great saphenous vein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Great saphenous vein&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Superficial femoral vein: Although termed superficial, SFV is part of deep venous system&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Superficial femoral vein:&lt;/li&gt;&lt;li&gt;â€¢ Option C . Common femoral vein and D. Popliteal vein: are veins of the deep venous system and thrombus propagation can cause pulmonary embolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ . Common femoral vein&lt;/li&gt;&lt;li&gt;â€¢ and&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Popliteal vein:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombosis in great saphenous vein is least likely to cause pulmonary embolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with chronic kidney disease (CKD) stage 4 presents to the emergency department with acute onset shortness of breath and pleuritic chest pain. His D-dimer test is elevated, and clinical examination raises suspicion for pulmonary embolism (PE). What is the preferred diagnostic test in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT pulmonary angiography (CTPA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;V/Q scan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D-dimer assay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. V/Q scan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) V/Q scan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT pulmonary angiography (CTPA) : Although CTPA is the gold standard for PE diagnosis, it requires iodinated contrast, which can cause contrast-induced nephropathy in patients with CKD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CT pulmonary angiography (CTPA)&lt;/li&gt;&lt;li&gt;â€¢ Option C. D-dimer assay : While useful as an initial screening test, a positive D-dimer is not definitive for diagnosing PE and must be followed by imaging studies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. D-dimer assay&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiography : This can identify right heart strain, a secondary effect of PE, but is not sufficient for primary diagnosis of PE and does not provide direct visualization of pulmonary emboli.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with advanced chronic kidney disease, a V/Q scan is preferred for diagnosing PE.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with a history of deep vein thrombosis (DVT) treated one year ago presents with complaints of persistent leg swelling, pain, and hyperpigmentation around her ankles. What is the recommended initial management for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Long-term anticoagulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Compression therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical vein stripping&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systemic corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Compression therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Compression therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Long-term anticoagulation : Prevents new clots but does not treat the chronic symptoms of PTS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Long-term anticoagulation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical vein stripping : Not typically indicated for PTS; it&#x27;s more for varicose veins without significant post-thrombotic changes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical vein stripping&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic corticosteroids : Not a treatment for PTS and do not address the underlying venous insufficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic corticosteroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Compression therapy is the mainstay of treatment for post-thrombotic syndrome (PTS).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old banker with a history of DVT presents with progressive dyspnea, chest tightness, and syncope. PFTs are normal, but DLCO is reduced. ECHO shows elevated Right Ventricular Systolic Pressure (RVSP). What is the next BEST step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI angiogram of the thorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT pulmonary angiogram (CTPA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start prostacyclin therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CT pulmonary angiogram (CTPA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI angiogram of the thorax: While useful for some vascular imaging, not as sensitive or readily available as CTPA for CTEPH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI angiogram of the thorax:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography: This assesses coronary arteries, not pulmonary circulation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start prostacyclin therapy: This is a treatment option for PAH, but not the initial step in diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start prostacyclin therapy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ CTPA is the primary imaging modality for diagnosing chronic thromboembolic pulmonary hypertension (CTEPH).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with a history of pulmonary embolism (PE) has undergone pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension (CTEPH) but continues to experience exertional dyspnea and fatigue. Which of the following is an approved medication for treatment of CTEPH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Riociguat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sildenafil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macitentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Epoprostenol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Riociguat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Riociguat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sildenafil: Primarily used in pulmonary arterial hypertension (PAH), not CTEPH.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sildenafil:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macitentan: An endothelin receptor antagonist, not specifically indicated for CTEPH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macitentan:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Espoprostenol: Espoprostenol is a PGI2 analog used in PAAH but not approved for CTEPH.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Espoprostenol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Riociguat is an approved medication for the treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary endarterectomy.&lt;/li&gt;&lt;li&gt;âž¤ Riociguat is an approved medication for the treatment of persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary endarterectomy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with idiopathic pulmonary arterial hypertension (PAH) is being evaluated for disease progression. Which hemodynamic parameter is the LEAST reliable predictor of survival in PAH patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain Natriuretic Peptide (BNP) levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WHO functional class&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mean pulmonary artery pressure (mPAP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac index (CI)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mean pulmonary artery pressure (mPAP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mean pulmonary artery pressure (mPAP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brain Natriuretic Peptide (BNP) levels : Elevated BNP levels correlate with right ventricular dysfunction and are a strong predictor of morbidity and mortality in PAH patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Brain Natriuretic Peptide (BNP) levels&lt;/li&gt;&lt;li&gt;â€¢ Option B. WHO functional class : The functional classification of patients based on symptoms and exercise capacity is a well-established predictor of survival in PAH.&lt;/li&gt;&lt;li&gt;â€¢ Option B. WHO functional class&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cardiac index (CI) : A measure of cardiac output relative to body size, CI is a critical parameter in assessing the severity and prognosis of PAH. A lower CI is associated with worse outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cardiac index (CI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Mean pulmonary artery pressure (mPAP) is not the most reliable predictor of survival in PAH compared to parameters such as cardiac index (CI), WHO functional class, and BNP levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with systemic sclerosis undergoes right heart catheterization. What is the threshold value of mean pulmonary arterial pressure (mPAP) that confirms the diagnosis of pulmonary hypertension (PH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;15 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt;20 mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;25 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt;30 mmHg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. &gt;20 mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) &amp;gt;20 mmHg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;15 mmHg: Current cut off is &amp;gt; 20 mm Hg for diagnosing PH&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;15 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;gt;25 mmHg: Old recommendation, not followed now.&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;gt;25 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;30 mmHg: False&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;30 mmHg:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary hypertension is defined as mPAP &amp;gt; 20 mmHg at rest&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with a family history of early-onset pulmonary hypertension presents with exertional dyspnea. Genetic testing is being considered. Which gene is most commonly associated with hereditary pulmonary arterial hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BRCA1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CFTR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BMPR2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;KCNH2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. BMPR2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) BMPR2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRCA1: Associated with breast and ovarian cancer susceptibility.&lt;/li&gt;&lt;li&gt;â€¢ Option A. BRCA1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CFTR: Associated with cystic fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CFTR:&lt;/li&gt;&lt;li&gt;â€¢ Option D. KCNH2: Associated with long QT syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. KCNH2:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Mutations in the BMPR2 gene are the most frequent cause of hereditary pulmonary arterial hypertension (PAH), leading to dysregulation of pulmonary vascular growth and remodeling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents with progressive dyspnea. Initial CXR, CT, and PFT are normal. However, echocardiography reveals an elevated RVSP of 55 mmHg. Right heart catheterization reveals normal PCWP and mPAP of 35 mmHg. What is the most likely cause of her dyspnea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial Pulmonary artery hypertension (FPAH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic thromboembolic pulmonary hypertension (CTEPH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary arterial hypertension (IPAH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Associated Pulmonary artery hypertension (APAH)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Idiopathic pulmonary arterial hypertension (IPAH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â Idiopathic pulmonary arterial hypertension (IPAH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial Pulmonary artery hypertension (FPAH): While this is a possible cause, there is no indication of a family history provided in the case, making it less likely compared to IPAH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial Pulmonary artery hypertension (FPAH):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic thromboembolic pulmonary hypertension (CTEPH): Typically, patients have a history of thromboembolic events, and CT may show chronic thromboembolic disease. The normal CT in this case makes CTEPH less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic thromboembolic pulmonary hypertension (CTEPH):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Associated Pulmonary artery hypertension (APAH): This refers to PAH associated with other conditions (e.g., connective tissue disease, HIV, portal hypertension). There is no mention of such associated conditions in the patient&#x27;s history, making IPAH more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Associated Pulmonary artery hypertension (APAH):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic pulmonary arterial hypertension (IPAH) is diagnosed in the absence of known familial, associated, or secondary causes of PAH, and is characterized by elevated RVSP, normal PCWP, and elevated mPAP (â‰¥ 25 mmHg).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old smoker with progressive breathlessness for one year presents with hyperinflated lungs on chest X-ray and moderate airflow obstruction on PFTs. Echocardiogram reveals an RVSP of 60 mmHg. According to the WHO classification, which group of pulmonary hypertension (PH) does this patient most likely belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Group 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Group 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Group 3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Group 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Group 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Group 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Group 1: PAH - Typically occurs in younger individuals without significant lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Group 1: PAH -&lt;/li&gt;&lt;li&gt;â€¢ Option B. Group 2: Would be caused by left heart disease, not supported by the clinical picture.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Group 2:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Group 4: CTEPH - While possible in smokers, the absence of a prior PE history makes this less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Group 4: CTEPH -&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The patient&#x27;s history of smoking, hyperinflated lungs on X-ray, and obstructive PFTs point towards an underlying lung disease (COPD), which is a common cause of Group 3 PH (PH due to Lung Diseases and/or Hypoxemia).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoes right heart catheterization (RHC) for evaluation of pulmonary hypertension. The results show: mPAP: 50 mmHg PCWP: 40 mmHg PVR: 2 Wood units What is the likely type of pulmonary hypertension this patient is suffering from?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pre-capillary pulmonary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Post-capillary pulmonary hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Combined post- and pre-capillary pulmonary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary arterial hypertension (IPAH)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Post-capillary pulmonary hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Post-capillary pulmonary hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A . Pre-capillary pulmonary hypertension : Would show elevated PVR.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ . Pre-capillary pulmonary hypertension&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option C. Combined post- and pre-capillary pulmonary hypertension: Would show elevated mPAP, PCWP, and PVR.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Combined post- and pre-capillary pulmonary hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Idiopathic pulmonary arterial hypertension (IPAH): A type of pre-capillary PH, would have elevated PVR.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Idiopathic pulmonary arterial hypertension (IPAH):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The elevated mPAP and PCWP (which reflects left atrial pressure) with normal PVR are characteristic of post-capillary pulmonary hypertension, often caused by left heart disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman with Pulmonary arterial hypertension (PAH) undergoes a vasoreactivity test during right heart catheterization. The test is positive, showing a significant decrease in mPAP with vasodilators. Which medication would be the most appropriate initial treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ambrisentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epoprostenol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tadalafil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nifedipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ambrisentan: Endothelin receptor antagonist, used in non-vasoreactive PAH.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ambrisentan:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Epoprostenol: Prostacyclin analog, used in severe PAH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Epoprostenol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tadalafil: PDE5 inhibitor, used in non-vasoreactive PAH.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tadalafil:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Positive vasoreactivity testing suggests that the patient&#x27;s pulmonary vasculature is responsive to vasodilators. High-dose calcium channel blockers (CCBs) like nifedipine are the first-line therapy for vasoreactive PAH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with pulmonary arterial hypertension (PAH) is being considered for a novel therapy that targets the activin signaling pathway to reduce pulmonary vascular remodeling. Which medication is an activin receptor fusion protein that has been shown to improve cardiopulmonary function in PAH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sotatercept&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Luspatercept&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Selexipag&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Macitentan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sotatercept&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sotatercept&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Luspatercept: Activin receptor type IIB fusion protein that binds and inhibits members of the TGF-Î² superfamily. This reduces SMAD signalling and increases erythroid maturation. Used to treat anemia in MDS and thalassemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Luspatercept:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Selexipag: Prostacyclin receptor agonist used in PAH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Selexipag:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Macitentan: Endothelin receptor antagonist used in PAH.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Macitentan:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Sotatercept is an activin receptor type IIA fusion protein that binds and inhibits members of the TGF-Î² superfamily, including activins, leading to improved hemodynamics and exercise capacity in PAH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female presents with progressive dyspnea and exercise intolerance. She has a history of recurrent pulmonary embolisms. Right heart catheterization confirms pulmonary hypertension, and imaging studies show organized thrombi within the pulmonary arteries. Which of the following is considered the best treatment option for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Long-term anticoagulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary endarterectomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Balloon pulmonary angioplasty&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pulmonary endarterectomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pulmonary endarterectomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Long-term anticoagulation : Essential for preventing new clots but does not address the existing organized thrombi causing CTEPH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Long-term anticoagulation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Balloon pulmonary angioplasty : An option for patients who are not candidates for surgery or have residual disease post-endarterectomy, but not considered the first-line treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Balloon pulmonary angioplasty&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung transplantation : Considered for patients with advanced disease who are not candidates for other treatments, but pulmonary endarterectomy is preferred if feasible.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung transplantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary endarterectomy is the best treatment for chronic thromboembolic pulmonary hypertension (CTEPH) as it removes organized thrombi from the pulmonary arteries, improving hemodynamics and symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents to the OPD with exertional dyspnea, fatigue, syncope, and peripheral edema. On examination, JVP is raised and a loud P2 is noted. ECHO shows right atrial and right ventricular enlargement with a mean pulmonary artery pressure of 30 mmHg. Which of the following statements is false regarding the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diuretics are given to reduce peripheral edema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen supplementation is given if PO2 is reduced&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;For patients with persistent right heart failure, lung transplantation may be considered&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary arterial hypertension is more common in males&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary arterial hypertension is more common in males&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pulmonary arterial hypertension is more common in males&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diuretics are given to reduce peripheral edema : True. Diuretics are commonly used to manage symptoms of right heart failure, including peripheral edema.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diuretics are given to reduce peripheral edema&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxygen supplementation is given if PO2 is reduced : True. Oxygen therapy is used to maintain adequate oxygenation and prevent hypoxemia in PAH patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxygen supplementation is given if PO2 is reduced&lt;/li&gt;&lt;li&gt;â€¢ Option C. For patients with persistent right heart failure, lung transplantation may be considered : True. Lung transplantation is a treatment option for patients with advanced PAH and right heart failure that is refractory to medical therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. For patients with persistent right heart failure, lung transplantation may be considered&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic Pulmonary arterial hypertension (IPAH) is more common in females than in males, with a female-to-male ratio of approximately 3:1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with chronic progressive breathlessness. On examination, his JVP is elevated, there is a loud 2nd heart sound, and bilateral pedal edema. Right heart catheterization reveals pulmonary hypertension. Pre-capillary pulmonary hypertension is defined as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;mPAP &amp;gt;20 mm Hg, PCWP &amp;gt; 15 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;mPAP &amp;gt;25 mm Hg, PCWP &amp;gt; 15 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;mPAP &amp;gt;20 mm Hg, PCWP &amp;lt; 15 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;mPAP &amp;gt;25 mm Hg, PCWP &amp;lt; 15 mm Hg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. mPAP &gt;20 mm Hg, PCWP &lt; 15 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) mPAP &amp;gt;20 mm Hg, PCWP &amp;lt; 15 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. mPAP &amp;gt;20 mm Hg, PCWP &amp;gt; 15 mm Hg : This describes post-capillary pulmonary hypertension, indicating elevated pressures due to left heart disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. mPAP &amp;gt;20 mm Hg, PCWP &amp;gt; 15 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ Option B. mPAP &amp;gt;25 mm Hg, PCWP &amp;gt; 15 mm Hg : This was the previous threshold for post-capillary pulmonary hypertension but has been updated to mPAP &amp;gt;20 mm Hg.&lt;/li&gt;&lt;li&gt;â€¢ Option B. mPAP &amp;gt;25 mm Hg, PCWP &amp;gt; 15 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ Option D. mPAP &amp;gt;25 mm Hg, PCWP &amp;lt; 15 mm Hg : This was the previous threshold for pre-capillary pulmonary hypertension but has been updated to mPAP &amp;gt;20 mm Hg.&lt;/li&gt;&lt;li&gt;â€¢ Option D. mPAP &amp;gt;25 mm Hg, PCWP &amp;lt; 15 mm Hg&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Pre-capillary pulmonary hypertension is defined by a mean pulmonary artery pressure (mPAP) greater than 20 mm Hg and a pulmonary capillary wedge pressure (PCWP) less than 15 mm Hg.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male from an endemic region presents with signs of pulmonary hypertension (PH). He has a history of hepatosplenic disease and portal hypertension. Which of the following is the most likely cause of his pulmonary hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary arterial hypertension (IPAH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schistosomiasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left heart disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Schistosomiasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Schistosomiasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD) : Typically associated with a history of smoking and different clinical features.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Idiopathic pulmonary arterial hypertension (IPAH) : A diagnosis of exclusion when other causes of PH are ruled out.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Idiopathic pulmonary arterial hypertension (IPAH)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left heart disease : Causes post-capillary pulmonary hypertension, typically with elevated PCWP, which is not the scenario here.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left heart disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Pre-capillary pulmonary hypertension is defined by a mean pulmonary artery pressure (mPAP) greater than 20 mm Hg and a pulmonary capillary wedge pressure (PCWP) less than 15 mm Hg.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Gold&#x27;s criteria for very severe COPD is: (NEET PG 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt; 30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt;70%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC&amp;lt;0.7 and FEV1&amp;lt; 50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. FEV1/FVC &lt;0.7 and FEV1 &lt; 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164040.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt; 30%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Note:&lt;/li&gt;&lt;li&gt;âž¤ Note:&lt;/li&gt;&lt;li&gt;âž¤ Currently Class C+D have been combined and called Class E Classification of types have been updated.&lt;/li&gt;&lt;li&gt;âž¤ Currently Class C+D have been combined and called Class E&lt;/li&gt;&lt;li&gt;âž¤ Classification of types have been updated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference: GOLD 2023 guidelines&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with a history of asthma presents to the clinic with worsening wheezing, cough, and shortness of breath. Which of the following is the LEAST likely trigger for his current exacerbation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exposure to cat dander&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recent URI with rhinovirus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Using beta-blocker for hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Consuming large amounts of alcohol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Consuming large amounts of alcohol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Options A. Exposure to cat dander: Animal dander is a common allergen and a well-known trigger for asthma exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Options A. Exposure to cat dander:&lt;/li&gt;&lt;li&gt;â€¢ Options B. Recent URI with rhinovirus: Viral respiratory infections are among the most common triggers of asthma exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Options B. Recent URI with rhinovirus:&lt;/li&gt;&lt;li&gt;â€¢ Options C. Using a beta-blocker for hypertension: Beta-blockers can worsen asthma symptoms due to their bronchoconstrictive effects by blocking beta-2 receptors in the airways.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Using a beta-blocker for hypertension:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Alcohol consumption is not a direct trigger for bronchoconstriction and airway inflammation in asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy with a family history of asthma and allergies presents with recurrent wheezing, coughing, and shortness of breath. Genetic testing is being considered to assess his risk of developing persistent asthma. Which of the following genes is MOST consistently associated with asthma susceptibility?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFTR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BRCA1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ORMDL3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;KCNH2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ORMDL3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) ORMDL3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Options A. CFTR: Associated with cystic fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Options A. CFTR:&lt;/li&gt;&lt;li&gt;â€¢ Options B. BRCA1: Associated with breast and ovarian cancer.&lt;/li&gt;&lt;li&gt;â€¢ Options B. BRCA1:&lt;/li&gt;&lt;li&gt;â€¢ Options D. KCNH2: Associated with long QT syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Options D. KCNH2:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ ORMDL3 is the most consistently associated gene with asthma susceptibility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman experiences recurrent episodes of wheezing and nasal congestion after taking aspirin for a headache. Which of the following is most likely associated with her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Raised serum IgE levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Positive skin test for inhaled allergens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nasal polyps&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A type of extrinsic asthma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nasal polyps&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nasal polyps&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Raised serum IgE levels: Associated with allergic asthma, not AERD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Raised serum IgE levels:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Positive skin test for inhaled allergens: Also associated with allergic asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Positive skin test for inhaled allergens:&lt;/li&gt;&lt;li&gt;â€¢ Option D. A type of extrinsic asthma: AERD is a type of intrinsic (non-allergic) asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A type of extrinsic asthma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Nasal polyps are characteristic of aspirin-exacerbated respiratory disease (AERD) in patients with asthma and aspirin sensitivity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient experiences recurrent episodes of wheezing, cough, and shortness of breath. Which test is most reliable in confirming the diagnosis of bronchial asthma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skin prick test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1 measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Demonstration of reversible obstruction on PFT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Demonstration of reversible obstruction on PFT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Demonstration of reversible obstruction on PFT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray: Typically normal in asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Skin prick test: Identifies allergic triggers, but not diagnostic of asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Skin prick test:&lt;/li&gt;&lt;li&gt;â€¢ Option C. FEV1 measurement: May show obstruction, but reversibility is key for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FEV1 measurement:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Demonstration of reversible obstruction on PFTs is the most reliable test for confirming the diagnosis of bronchial asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After administering a short-acting beta-agonist (SABA) inhaler like salbutamol for suspected asthma, how long should you wait before repeating spirometry to assess for reversibility?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5 minutes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;15 minutes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;30 minutes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;60 minutes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 15 minutes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 15 minutes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5 minutes: Too soon; the full effect of the bronchodilator may not yet be evident.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ 5 minutes:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 30 minutes and, D. 60 minutes : Waiting longer may lead to the bronchodilator effect wearing off, giving a false negative result.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ 30 minutes and,&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ 60 minutes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Wait 15 minutes after administering a SABA inhaler like salbutamol before repeating spirometry to assess for reversibility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with stable COPD and resting oxygen saturation of 88% on room air is started on long-term oxygen therapy (LTOT). Which of the following is NOT a known benefit of LTOT in COPD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Improved survival&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduced pulmonary vascular resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased hematocrit&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Improved V/Q mismatch&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased hematocrit&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased hematocrit&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Long-term oxygen therapy (LTOT) in COPD patients with chronic hypoxemia (resting SpO2 â‰¤ 88%) has several established benefits:&lt;/li&gt;&lt;li&gt;â€¢ Improved survival: LTOT has been shown to increase survival in patients with severe resting hypoxemia (PaO2 â‰¤ 55 mmHg). Reduced pulmonary vascular resistance: LTOT helps reduce pulmonary hypertension by improving oxygenation and decreasing hypoxic vasoconstriction. Improved V/Q mismatch: By increasing alveolar oxygen tension, LTOT can help correct the ventilation-perfusion mismatch often seen in COPD. Decreased hematocrit (polycythemia): Chronic hypoxemia can trigger an increase in red blood cell production (polycythemia). LTOT can reverse this effect&lt;/li&gt;&lt;li&gt;â€¢ Improved survival: LTOT has been shown to increase survival in patients with severe resting hypoxemia (PaO2 â‰¤ 55 mmHg).&lt;/li&gt;&lt;li&gt;â€¢ Improved survival:&lt;/li&gt;&lt;li&gt;â€¢ Reduced pulmonary vascular resistance: LTOT helps reduce pulmonary hypertension by improving oxygenation and decreasing hypoxic vasoconstriction.&lt;/li&gt;&lt;li&gt;â€¢ Reduced pulmonary vascular resistance:&lt;/li&gt;&lt;li&gt;â€¢ Improved V/Q mismatch: By increasing alveolar oxygen tension, LTOT can help correct the ventilation-perfusion mismatch often seen in COPD.&lt;/li&gt;&lt;li&gt;â€¢ Improved V/Q mismatch:&lt;/li&gt;&lt;li&gt;â€¢ Decreased hematocrit (polycythemia): Chronic hypoxemia can trigger an increase in red blood cell production (polycythemia). LTOT can reverse this effect&lt;/li&gt;&lt;li&gt;â€¢ Decreased hematocrit (polycythemia):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Long-term oxygen therapy (LTOT) in COPD improves survival, reduces pulmonary vascular resistance, and improves V/Q mismatch, but it does not increase hematocrit.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with severe emphysema secondary to alpha-1 antitrypsin deficiency is being evaluated for long-term oxygen therapy (LTOT). Which of the following scenarios would NOT meet the criteria for LTOT in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Resting PaO2 of 54 mmHg and evidence of cor pulmonale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Resting SpO2 of 88% on room air and a history of two COPD exacerbations in the past year&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Resting PaO2 of 58 mmHg and a hematocrit of 55%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resting SpO2 of 89% and a normal 6-minute walk distance&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Resting SpO2 of 89% and a normal 6-minute walk distance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Resting PaO2 of 54 mmHg and evidence of cor pulmonale: Meets the criteria for LTOT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Resting PaO2 of 54 mmHg and evidence of cor pulmonale:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Resting SpO2 of 88% and a history of two COPD exacerbations: Meets the criteria due to low SpO2.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Resting SpO2 of 88% and a history of two COPD exacerbations:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Resting PaO2 of 58 mmHg and a hematocrit of 55%: Meets the criteria due to low PaO2 and high hematocrit&lt;/li&gt;&lt;li&gt;â€¢ Option C. Resting PaO2 of 58 mmHg and a hematocrit of 55%:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Resting SpO2 of 89% and a normal 6-minute walk distance do not meet the criteria for long-term oxygen therapy (LTOT) in COPD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with severe COPD and chronic bronchitis presents with a history of frequent exacerbations despite optimal bronchodilator therapy. He has a 50-pack-year smoking history and continues to smoke 1 pack per day. Which of the following medications is most likely to reduce the frequency of his exacerbations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tiotropium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salmeterol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Roflumilast&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Roflumilast&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tiotropium: While a LAMA improves lung function and symptoms, it doesn&#x27;t have the same impact on exacerbation frequency as roflumilast.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tiotropium:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Salmeterol: LABAs improve lung function but don&#x27;t specifically target exacerbations like roflumilast.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Salmeterol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisolone: Oral steroids are used for acute exacerbations, not long-term prevention.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisolone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Roflumilast (PDE4 inhibitor) is indicated for severe COPD with chronic bronchitis and frequent exacerbations, reducing inflammation and mucus production.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old smoker with a history of COPD presents to the clinic with a COPD Assessment Test (CAT) score of 15 and two hospitalizations for COPD exacerbations in the past year. Which GOLD category does he belong to based on the 2023 GOLD guidelines?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GOLD A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GOLD B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GOLD C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GOLD E&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. GOLD E&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture41.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) GOLD E&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. GOLD A: Low risk, low symptoms&lt;/li&gt;&lt;li&gt;â€¢ Option A. GOLD A:&lt;/li&gt;&lt;li&gt;â€¢ Option B. GOLD B: Low risk, high symptoms&lt;/li&gt;&lt;li&gt;â€¢ Option B. GOLD B:&lt;/li&gt;&lt;li&gt;â€¢ Option C. GOLD C: No longer used in the 2023 guidelines&lt;/li&gt;&lt;li&gt;â€¢ Option C. GOLD C:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Patients with a high symptom burden (CAT score â‰¥10) or a history of exacerbations belong to GOLD category E according to the 2023 GOLD guidelines.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a long history of smoking and progressive dyspnea presents with a barrel chest and expiratory wheezing. Which of the following pulmonary function test (PFT) findings is NOT typically seen in emphysema?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased total lung capacity (TLC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased FEV1/FVC ratio&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased diffusing capacity of the lung for carbon monoxide (DLCO)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased vital capacity (VC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased diffusing capacity of the lung for carbon monoxide (DLCO)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased diffusing capacity of the lung for carbon monoxide (DLCO)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased total lung capacity (TLC) : Common in emphysema due to air trapping and hyperinflation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Increased total lung capacity (TLC)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased FEV1/FVC ratio: Hallmark of obstructive lung disease like emphysema.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased FEV1/FVC ratio:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased vital capacity (VC): Often seen in emphysema due to severe air trapping - also called as â€˜pseudo-restrictionâ€™&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased vital capacity (VC):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Increased DLCO is not typically seen in emphysema, as this condition reduces gas exchange surface area, leading to decreased DLCO.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with severe COPD undergoes spirometry after bronchodilator administration. His FEV1 is 28% of the predicted value. Which GOLD stage does he belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GOLD 1 (Mild)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GOLD 2 (Moderate)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GOLD 3 (Severe)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GOLD 4 (Very Severe)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. GOLD 4 (Very Severe)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) GOLD 4 (Very Severe)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. GOLD 1 (Mild) : FEV1 â‰¥ 80% predicted&lt;/li&gt;&lt;li&gt;â€¢ Option A. GOLD 1&lt;/li&gt;&lt;li&gt;â€¢ (Mild)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. GOLD 2 ( Moderate) : 50% â‰¤ FEV1 &amp;lt; 80% predicted&lt;/li&gt;&lt;li&gt;â€¢ Option B. GOLD 2 (&lt;/li&gt;&lt;li&gt;â€¢ Moderate)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option C. GOLD 3 (Severe) : 30% â‰¤ FEV1 &amp;lt; 50% predicted&lt;/li&gt;&lt;li&gt;â€¢ Option C. GOLD 3&lt;/li&gt;&lt;li&gt;â€¢ (Severe)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Very severe COPD (GOLD 4) is defined by a post-bronchodilator FEV1 less than 30% of the predicted value.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with COPD reports that she becomes short of breath when walking at her own pace on level ground, and sometimes has to stop for breath. Based on the modified Medical Research Council (mMRC) dyspnea scale, what is her dyspnea grade?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;mMRC 0&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;mMRC 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;mMRC 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;mMRC 3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. mMRC 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) mMRC 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. mMRC 0: No breathlessness except with strenuous exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option A. mMRC 0:&lt;/li&gt;&lt;li&gt;â€¢ Option B. mMRC 1: Breathlessness when hurrying or walking up a slight hill.&lt;/li&gt;&lt;li&gt;â€¢ Option B. mMRC 1:&lt;/li&gt;&lt;li&gt;â€¢ Option D. mMRC 3: Walks slower than others of same age due to breathlessness or stops for breath at own pace.&lt;/li&gt;&lt;li&gt;â€¢ Option D. mMRC 3:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The patient&#x27;s description matches the mMRC grade 2 criterion: \&quot;Short of breath when hurrying on the level or walking up a slight hill.\&quot;&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a component of the BODE index, a prognostic tool in COPD that incorporates the mMRC dyspnea scale?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Body mass index (BMI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Airflow obstruction (FEV1)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dyspnea (mMRC grade)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exacerbation frequency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Exacerbation frequency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Exacerbation frequency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. BMI: Lower BMI is associated with worse prognosis in COPD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. BMI:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Airflow obstruction (FEV1): Lower FEV1 indicates worse lung function and prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Airflow obstruction (FEV1):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dyspnea (mMRC grade): Higer mMRC grade indicates more severe dyspnea and worse prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dyspnea (mMRC grade):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Exacerbation frequency, while important, is not included in the BODE index, which incorporates BMI, FEV1, mMRC dyspnea grade, and 6-minute walk distance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a 20-pack-year smoking history presents with progressive shortness of breath and chronic cough. Spirometry reveals an FEV1 of 62% predicted and an FEV1/FVC ratio of 39%. After administration of a bronchodilator (BD), the FEV1 improves to 75% predicted, and the FEV1/FVC ratio improves to 73%. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;COPD (Chronic Obstructive Pulmonary Disease)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allergic Bronchopulmonary Aspergillosis (ABPA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary Langerhans Cell Histiocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Asthma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Asthma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. COPD (Chronic Obstructive Pulmonary Disease) : Although COPD can also cause airflow obstruction, it is typically less reversible with bronchodilators.&lt;/li&gt;&lt;li&gt;â€¢ Option B. COPD&lt;/li&gt;&lt;li&gt;â€¢ (Chronic Obstructive Pulmonary Disease)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allergic Bronchopulmonary Aspergillosis (ABPA) : While ABPA can cause asthma-like symptoms, it is usually associated with elevated IgE levels and positive Aspergillus serology.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Allergic Bronchopulmonary Aspergillosis (ABPA)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary Langerhans Cell Histiocytosis: Primarily seen in smokers and associated with cystic lung lesions on imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary Langerhans Cell Histiocytosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Post-bronchodilator FEV1/FVC &amp;gt; 70% rules out COPD and establishes the diagnosis of asthma, with significant improvement in FEV1 indicating reversibility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old smoker with a long-standing history of dyspnea and a scanty cough experiences relief with bronchodilator therapy. Pulmonary function tests reveal an FEV1/FVC 54% and FEV1 50% predicted. Post Bronchodilator neb his FEV1/FVC improved to 65% and FEV1 improved to 57%. Which of the following is NOT a typical feature of this patient&#x27;s likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Irreversible airflow limitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased residual volume (RV)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Affects small airways&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Can occur due to protease-antiprotease imbalance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased residual volume (RV)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decreased residual volume (RV)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Irreversible airflow limitation: This is the hallmark of COPD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Irreversible airflow limitation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Affects small airways: Small airway inflammation and narrowing contribute to COPD.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Affects small airways:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Can occurs due to protease-antiprotease imbalance: This imbalance contributes to the destruction of lung tissue in emphysema, which is a major cause of COPD&lt;/li&gt;&lt;li&gt;â€¢ Option D. Can occurs due to protease-antiprotease imbalance:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ COPD is characterized by air trapping, leading to an increased residual volume (RV), not decreased.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with alpha-1 antitrypsin deficiency is found to have emphysema predominantly affecting the lower lobes of the lungs. Which type of emphysema is this most consistent with?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Centrilobular emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paraseptal emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Panacinar emphysema&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bullous emphysema&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Panacinar emphysema&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Panacinar emphysema&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Centrilobular emphysema: Predominantly affects the respiratory bronchioles and is more common in smokers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Centrilobular emphysema:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Paraseptal emphysema: Occurs adjacent to pleural surfaces and interlobular septa.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Paraseptal emphysema:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bullous emphysema: Refers to large bullae formation, not a distinct type.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bullous emphysema:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Panacinar emphysema involves uniform destruction of the acinus and is typically seen in the lower lobes of patients with alpha-1 antitrypsin deficiency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with moderate to severe COPD is being considered for treatment with inhaled corticosteroids (ICS). Which of the following statements is TRUE regarding the use of ICS in COPD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ICS reduce mortality in COPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ICS reduce the frequency of COPD exacerbations.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ICS reduce the rate of decline of FEV1 in COPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ICS reduce the incidence of pneumonia in COPD.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. ICS reduce the frequency of COPD exacerbations.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) ICS reduce the frequency of COPD exacerbations.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ICS reduce mortality in COPD : Not true. But recently, triple combinations (LABA + LAMA + ICS) in selected patients (Group E) has shown to reduce mortality.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ ICS reduce mortality in COPD&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option C. ICS reduce the rate of decline of FEV1 in COPD : Not true.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ ICS reduce the rate of decline of FEV1 in COPD&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option D. ICS reduce the incidence of pneumonia in COPD : Actually, ICS may slightly increase the risk of pneumonia.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ ICS reduce the incidence of pneumonia in COPD&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Inhaled corticosteroids (ICS) reduce the frequency of COPD exacerbations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old smoker with COPD has had three hospitalizations for exacerbations in the past year. He is already on LABA(long acting beta 2 agonist), LAMA long acting muscarinic antagonist) and ICS (inhaled corticosteroids). Which of the following treatments is most likely to decrease the frequency of his exacerbations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daily azithromycin 500mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continuous oxygen at 2 L/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nocturnal BiPAP (bilevel positive airway pressure)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhaled corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Daily azithromycin 500mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Daily azithromycin 500mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Continuous oxygen at 2 L/min: While oxygen therapy is crucial for patients with chronic hypoxemia, it doesn&#x27;t directly reduce the frequency of exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Continuous oxygen at 2 L/min:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nocturnal BiPAP (bilevel positive airway pressure) : This is indicated for COPD patients with hypercapnic respiratory failure or nocturnal desaturation, not as a primary prevention for exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Nocturnal BiPAP (bilevel positive airway pressure)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhaled corticosteroids: The patient is already on ICS, and further increasing the dose is unlikely to provide additional benefit in preventing exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhaled corticosteroids:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Daily azithromycin 500mg can significantly reduce the frequency of exacerbations in severe COPD patients already on LABA, LAMA, and ICS therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with an acute exacerbation of COPD presents with respiratory distress, tachypnea, and altered mental status. Which of the following would be an absolute contraindication to initiating non-invasive ventilation (NIV)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoxemia (PaO2 &amp;lt; 60 mmHg on room air)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercapnia (PaCO2 &amp;gt; 50 mmHg)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory acidosis (pH &amp;lt; 7.35)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inability to protect airway&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inability to protect airway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Inability to protect airway&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoxemia (PaO2 &amp;lt; 60 mmHg on room air): NIV can be used to improve oxygenation in COPD exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoxemia (PaO2 &amp;lt; 60 mmHg on room air):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercapnia (PaCO2 &amp;gt; 50 mmHg): NIV can improve ventilation and reduce CO2 levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Hypercapnia (PaCO2 &amp;gt; 50 mmHg):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Respiratory acidosis (pH &amp;lt; 7.35): NIV can help correct acidosis caused by hypercapnia.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Respiratory acidosis (pH &amp;lt; 7.35):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Inability to protect the airway is an absolute contraindication to initiating non-invasive ventilation (NIV) in patients with acute exacerbation of COPD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old occasional smoker presents with a chronic cough and dyspnea on exertion. Physical examination is unremarkable, and chest X-ray is normal. Spirometry reveals an FEV1 of 60% predicted and an FEV1/FVC ratio of 80%. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;COPD (Chronic Obstructive Pulmonary Disease)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Preserved Ratio Impaired Spirometry (PRISm)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal lung function&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Preserved Ratio Impaired Spirometry (PRISm)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Preserved Ratio Impaired Spirometry (PRISm)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma: Usually shows a reduced FEV1/FVC ratio with reversibility.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asthma:&lt;/li&gt;&lt;li&gt;â€¢ Option B. COPD (Chronic Obstructive Pulmonary Disease) : Requires an FEV1/FVC &amp;lt; 0.70.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ COPD (Chronic Obstructive Pulmonary Disease)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal lung function: Not possible with reduced FEV1.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal lung function:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PRISm (Preserved Ratio Impaired Spirometry) is characterized by a reduced FEV1 with a normal FEV1/FVC ratio, often seen as a potential precursor to COPD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with a history of asthma presents with worsening wheezing, cough, and shortness of breath. There is no associated angioedema or urticaria. Her vital signs are stable, and her oxygen saturation is 94% on room air. Would intramuscular epinephrine be indicated in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Yes, epinephrine is indicated for all asthma exacerbations.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Yes, but only if she fails to respond to inhaled bronchodilators.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No, epinephrine is only indicated for asthma associated with anaphylaxis or angioedema.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No, epinephrine should only be used in patients with severe asthma exacerbations requiring hospitalization.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. No, epinephrine is only indicated for asthma associated with anaphylaxis or angioedema.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Yes, epinephrine is indicated for all asthma exacerbations: Incorrect. Epinephrine is a potent drug reserved for life-threatening situations like anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Yes, epinephrine is indicated for all asthma exacerbations:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Yes, but only if she fails to respond to inhaled bronchodilators: Incorrect. While epinephrine may be used in refractory cases, it&#x27;s not the initial therapy for most asthma exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Yes, but only if she fails to respond to inhaled bronchodilators:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No, epinephrine should only be used in patients with severe asthma exacerbations requiring hospitalization: Incorrect. While epinephrine is often used in severe cases, it&#x27;s indicated for any asthma exacerbation with anaphylaxis or angioedema, regardless of severity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No, epinephrine should only be used in patients with severe asthma exacerbations requiring hospitalization:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Intramuscular epinephrine is only indicated for asthma exacerbations associated with anaphylaxis or angioedema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with mild persistent asthma is well-controlled on a low-dose inhaled corticosteroid (ICS) as maintenance therapy. She experiences occasional wheezing and shortness of breath, especially after exercise. According to current asthma guidelines, which of the following is the preferred reliever medication for her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Short-acting beta-agonist (SABA) alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Short-acting muscarinic antagonist (SAMA) alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low-dose ICS + SABA combination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Low-dose ICS + LABA (long-acting beta-agonist) combination&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Low-dose ICS + LABA (long-acting beta-agonist) combination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Low-dose ICS + LABA (long-acting beta-agonist) combination&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Short-acting beta-agonist (SABA) alone: Although SABAs provide quick relief, they don&#x27;t address underlying inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Short-acting beta-agonist (SABA) alone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Short-acting muscarinic antagonist (SAMA) alone: Less effective than SABAs in most cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Short-acting muscarinic antagonist (SAMA) alone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Low-dose ICS + SABA combination : Not preferred as the LABA component is short-acting and doesn&#x27;t provide sustained bronchodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Low-dose ICS + SABA combination&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The preferred reliever medication for mild persistent asthma is a combination inhaler containing both low-dose ICS and a LABA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old man with severe asthma remains symptomatic despite high-dose inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA), and long-acting beta-agonists (LABA). He is also on oral steroids and montelukast. Further evaluation reveals elevated IgE levels and FeNO (fractional exhaled nitric oxide) of 55 ppb. Which therapy is most likely to be effective for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhaled short-acting beta-agonists (SABA) as needed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchial thermoplasty&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-IgE therapy (e.g., omalizumab)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral corticosteroids at higher doses&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-IgE therapy (e.g., omalizumab)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-IgE therapy (e.g., omalizumab)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhaled short-acting beta-agonists (SABA) as needed: Used for quick relief, not long-term control.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Inhaled short-acting beta-agonists (SABA) as needed:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchial thermoplasty: Considered for severe refractory asthma but not the first-line option in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchial thermoplasty:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral corticosteroids at higher doses: Already on high doses, increasing further may lead to adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Oral corticosteroids at higher doses:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Anti-IgE therapy (e.g., omalizumab) is indicated for severe allergic asthma not controlled with standard therapy, especially in the presence of elevated IgE and FeNO levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy with a history of mild persistent asthma is brought to the ER with an acute exacerbation. His symptoms include wheezing, shortness of breath, and cough. He is using accessory muscles to breathe, and his peak flow is 50% of his personal best. Which of the following is NOT recommended as part of his initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen therapy to maintain SpO2 â‰¥ 94%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Repeated doses of nebulized salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral prednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhaled Formeterol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inhaled Formeterol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Inhaled Formeterol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oxygen therapy to maintain SpO2 â‰¥ 94%: Essential to correct hypoxemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oxygen therapy to maintain SpO2 â‰¥ 94%:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Repeated doses of nebulized salbutamol: Mainstay of acute bronchodilator therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Repeated doses of nebulized salbutamol:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral prednisolone: Oral corticosteroids reduce airway inflammation and are important in exacerbation management.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oral prednisolone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ LABAs like formoterol are not used in the acute management of asthma exacerbations due to their delayed onset of action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are complications of CPAP therapy in OSA except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nasal congestion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Difficulty inhaling&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Claustrophobia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aerophagia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Difficulty inhaling&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nasal congestion: Common due to the air pressure and can be mitigated with humidification or steroid/saline nasal sprays.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nasal congestion:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Claustrophobia: A common issue due to the mask, which can make some patients feel confined. Can mitigate by changing mask interface (e.g., nasal prongs)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Claustrophobia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aerophagia: Swallowing air, which can lead to bloating and discomfort, is a known side effect of CPAP therapy. Can mitigate to some extent by administering antacids&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aerophagia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Difficulty inhaling is not a typical complication of CPAP therapy; common issues include nasal congestion, claustrophobia, and aerophagia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of severe COPD presents to the emergency department with an acute exacerbation. He is tachypneic, using accessory muscles of respiration, and his oxygen saturation is 88% on room air. Arterial blood gas analysis shows a pH of 7.28 and PaCO2 of 65 mmHg. Which of the following is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiate noninvasive positive pressure ventilation (NIPPV)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start intravenous (IV) methylprednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administer a nebulized bronchodilator&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proceed with endotracheal intubation (ETT) and mechanical ventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Initiate noninvasive positive pressure ventilation (NIPPV)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Initiate noninvasive positive pressure ventilation (NIPPV)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start IV methylprednisolone: Corticosteroids are indicated in COPD exacerbations, but NIPPV should be prioritized in patients with respiratory failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Start IV methylprednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administer a nebulized bronchodilator: Bronchodilators are important for symptom relief, but they won&#x27;t address the primary issue of hypercapnia and acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administer a nebulized bronchodilator:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proceed with endotracheal intubation (ETT) and mechanical ventilation: While intubation may be necessary if NIPPV fails or the patient deteriorates, it is not the first-line treatment due to its associated risks and complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proceed with endotracheal intubation (ETT) and mechanical ventilation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Initiate noninvasive positive pressure ventilation (NIPPV) for patients with acute COPD exacerbation and respiratory failure to improve ventilation and avoid invasive mechanical ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young patient with asthma is given a device to monitor his asthma. What is the device?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peak flow meter&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spirometer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Body plethysmograph&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Incentive spirometer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Peak flow meter&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture5.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture6.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture7.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Peak flow meter&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spirometer: Measures lung volumes and flow rates during forced exhalation and inhalation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spirometer:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Body plethysmograph: Measures total lung capacity and airway resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Body plethysmograph:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incentive spirometer: Helps improve lung function by encouraging deep breaths.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Incentive spirometer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The dveice shown in the image is a peak flow meter used by asthmatics to measure how fast they can forcefully exhale, providing a quick assessment of airway obstruction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old patient with known bronchiectasis is hospitalized with acute worsening of cough, sputum production, and fever. Which antibiotic regimen is most appropriate for this exacerbation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Piperacillin-tazobactam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Piperacillin-tazobactam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Piperacillin-tazobactam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amoxicillin: Not effective against Pseudomonas .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amoxicillin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azithromycin: May be used in chronic management but not first-line for acute exacerbations with Pseudomonas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azithromycin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Doxycycline: Not effective against Pseudomonas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Doxycycline:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Piperacillin-tazobactam is the preferred antibiotic for acute exacerbations of bronchiectasis due to its broad-spectrum activity against Pseudomonas aeruginosa and other gram-negative organisms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with chronic cough and sputum production undergoes bronchoscopy, which reveals dilated airways and nodular lesions. Bronchial washings culture positive for Mycobacterium avium complex (MAC). Which type of bronchiectasis is most likely associated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cylindrical bronchiectasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Varicose bronchiectasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cystic bronchiectasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Traction bronchiectasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Varicose bronchiectasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Varicose bronchiectasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cylindrical bronchiectasis: This type of bronchiectasis is characterized by uniformly dilated airways, typically seen in post-infectious bronchiectasis or bronchiectasis associated with bronchial obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cylindrical bronchiectasis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cystic bronchiectasis: This is the most severe form of bronchiectasis, with large, balloon-like dilations of the airways. While it can be seen in NTM infections, it&#x27;s less common than varicose bronchiectasis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cystic bronchiectasis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Traction bronchiectasis: This type is caused by fibrosis pulling on the airways, often seen in conditions like tuberculosis or sarcoidosis. It presents with irregular dilations and distortions of the airways but is less common in NTM infections.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Traction bronchiectasis:&lt;/li&gt;&lt;li&gt;â€¢ Key Point: Varicose bronchiectasis is the most common type seen in NTM infections, particularly Mycobacterium avium complex (MAC). The irregular dilations and constrictions of the airways resemble varicose veins.&lt;/li&gt;&lt;li&gt;â€¢ Key Point:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Varicose bronchiectasis, with irregular airway dilation and constriction, is commonly seen in NTM infections like Mycobacterium avium complex (MAC).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old man presented after coughing up copious amounts of blood-tinged sputum at his nursing home Physical examination shows digital clubbing and cyanosis of the lips. Coarse crackles are heard throughout the lung fields and his SpO2 is 95%. A chest X-ray reveals increased translucency and tram-track opacities in the right lower lung field. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchiectasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic bronchitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aspiration pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bronchiectasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Bronchiectasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic bronchitis: Typically seen in patients with a history of smoking and characterized by a chronic, productive cough. However, copious amounts of blood-tinged sputum and signs of chronic hypoxia (e.g., digital clubbing, lip cyanosis) are less typical.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Chronic bronchitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aspiration pneumonia: Common in patients with a history of stroke, which may result in dysphagia. Patients with aspiration pneumonia may present with dyspnea, cough, and hypoxemia, but would not typically show the tram-track opacities seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Aspiration pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emphysema: Usually presents with a history of a chronic cough that is characteristically worse in the mornings, production of small amounts of sputum, and dyspnea. Chest X-rays typically show hyperinflation rather than tram-track opacities.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Emphysema:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Bronchiectasis presents with chronic cough, copious sputum, hemoptysis, coarse crackles, and tram-track opacities on X-ray, along with digital clubbing and cyanosis due to chronic hypoxia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old girl presents with productive cough, high fever, poor weight gain, and frequent respiratory infections. Exam reveals crackles in the left lower lung. Chest X-ray shows dilated bronchi and infiltrates. Sputum culture: pink rods on Gram stain, non-lactose fermenting, oxidase positive. She is at increased risk for which condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Panacinar emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreatitis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pancreatitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pancreatitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cirrhosis: Although CF can lead to liver disease, pancreatitis is a more immediate and common complication.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cirrhosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypothyroidism: Not typically associated with CF.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypothyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Panacinar emphysema: More commonly related to alpha-1 antitrypsin deficiency, not CF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Panacinar emphysema:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Cystic fibrosis, characterized by chronic respiratory infections and bronchiectasis, increases the risk of pancreatitis due to thick mucus secretions affecting the pancreas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man complains of cough, shortness of breath, and daily copious sputum production. He has a history of frequent lung infections. His SpO2 is 95%. Diffuse crackles and wheezing are heard on auscultation throughout the lung fields. A CT scan is shown. The patient is at greatest risk for which of the following complications?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemoptysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rhizopus infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hemoptysis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hemoptysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rhizopus infections: Causes Mucormycosis. Uncommon in bronchiectasis. More common in patients with DKA or COVID19&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rhizopus infections:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumothorax: While possible, it is less common in bronchiectasis. More common in Emphysema&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumothorax:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung cancer: Bronchiectasis is not a risk factor for lung cancer&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Bronchiectasis, characterized by chronic productive cough and recurrent lung infections, significantly increases the risk of hemoptysis due to damage and dilation of the bronchial arteries.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man with a history of upper respiratory tract infections presents with four other respiratory infections this year and frequent bouts of otitis media. He was diagnosed with bronchiectasis as a child. Which structure is most likely defective in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cells with multilobular nuclei and enzyme-filled granules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Collagen Î±-chains in triplets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heavy and light protein chains linked by disulfide bonds&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tubular arrangements of linked heavy chains that slide against one another&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tubular arrangements of linked heavy chains that slide against one another&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tubular arrangements of linked heavy chains that slide against one another&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cells with multilobular nuclei and enzyme-filled granules: Refers to neutrophils, not related to this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cells with multilobular nuclei and enzyme-filled granules:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Collagen Î±-chains in triplets: Related to collagen structure, not relevant here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Collagen Î±-chains in triplets:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heavy and light protein chains linked by disulfide bonds: Refers to immunoglobulins, not relevant here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Heavy and light protein chains linked by disulfide bonds:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The patient&#x27;s symptoms suggest primary ciliary dyskinesia (Kartagener syndrome), where the defect is in the cilia&#x27;s dynein arms, which are tubular arrangements of linked heavy chains that slide against one another to facilitate movement.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child with cystic fibrosis presents with a persistent cough and frequent respiratory infections over the past year. Sputum cultures have consistently grown a specific pathogen. Given the patient&#x27;s age and clinical history, which pathogen is most likely responsible for these early respiratory infections?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pseudomonas aeruginosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Staphylococcus aureus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Haemophilus influenzae&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptococcus pneumoniae&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Staphylococcus aureus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Staphylococcus aureus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pseudomonas aeruginosa: This pathogen typically becomes more prevalent in the respiratory tracts of cystic fibrosis patients as they get older and is associated with chronic lung infections and a more rapid decline in lung function.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pseudomonas aeruginosa:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Haemophilus influenzae: This bacterium can cause respiratory infections but is less common and less significant than Staphylococcus aureus in the early stages of cystic fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Haemophilus influenzae:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Streptococcus pneumoniae: Although it can cause respiratory infections, it is not the primary pathogen in early cystic fibrosis respiratory infections.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Streptococcus pneumoniae:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Staphylococcus aureus is the primary pathogen responsible for early respiratory infections in young children with cystic fibrosis, frequently causing persistent and recurrent infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old patient with cystic fibrosis, who has been colonized with Burkholderia cepacia complex (BCC), is scheduled for a lung transplant evaluation. What is a major concern related to BCC colonization in this context?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased risk of liver dysfunction post-transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduced success rates of lung transplantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Higher likelihood of developing diabetes post-transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased risk of gastrointestinal complications&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Reduced success rates of lung transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Reduced success rates of lung transplantation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased risk of liver dysfunction post-transplant: This is not specifically related to BCC colonization.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased risk of liver dysfunction post-transplant:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Higher likelihood of developing diabetes post-transplant: Diabetes can occur post-transplant but is not specifically linked to BCC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Higher likelihood of developing diabetes post-transplant:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased risk of gastrointestinal complications: Gastrointestinal issues are common in cystic fibrosis but not specifically related to BCC colonization.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased risk of gastrointestinal complications:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Burkholderia cepacia complex (BCC) colonization in cystic fibrosis patients is a significant concern due to the reduced success rates and increased risk of severe infections post-lung transplantation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient with a history of non-CF bronchiectasis presents for a routine follow-up. The patient has experienced a noticeable decline in lung function over the past few years. What is the typical annual decline in FEV1 for patients with non-CF bronchiectasis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10-15 mL per year&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20-30 mL per year&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50-55 mL per year&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;70-80 mL per year&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 50-55 mL per year&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 50-55 mL per year&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A . 10-15 mL per year: This rate is too low and more typical of normal aging in healthy individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ 10-15 mL per year:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 20-30 mL per year: This is the decline seen in healthy controls, not in bronchiectasis patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 20-30 mL per year:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 70-80 mL per year: This rate is higher than what is typically observed in non-CF bronchiectasis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 70-80 mL per year:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Patients with non-CF bronchiectasis typically experience an annual decline in FEV1 of about 50-55 mL, highlighting the progressive nature of the disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male patient with cystic fibrosis is found to be infertile despite having normal spermatogenesis. What is the most likely cause of this infertility?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obstruction of the epididymis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complete involution of the vas deferens&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defective spermatogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hormonal imbalances&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complete involution of the vas deferens&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Complete involution of the vas deferens&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obstruction of the epididymis: Not the primary cause.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obstruction of the epididymis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Defective spermatogenesis: Spermatogenesis is typically normal in CF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Defective spermatogenesis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hormonal imbalances: Infertility in CF is primarily due to anatomical defects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hormonal imbalances:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ In cystic fibrosis, nearly 99% of males are infertile due to the complete involution of the vas deferens, despite having normal spermatogenesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old with cystic fibrosis presents with right lower quadrant abdominal pain, nausea, vomiting, and obstipation. Abdominal X-ray reveals a mass in the ileocecal region with dilated bowel loops. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Appendicitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Crohn&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Distal intestinal obstruction syndrome (DIOS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intussusception&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Distal intestinal obstruction syndrome (DIOS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Distal Intestinal Obstruction Syndrome (DIOS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Appendicitis: While appendicitis can present with similar symptoms, the presence of a mass in the ileocecal region and the patient&#x27;s history of cystic fibrosis make DIOS a more likely diagnosis&lt;/li&gt;&lt;li&gt;â€¢ Option A. Appendicitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Crohn&#x27;s disease: Crohn&#x27;s disease is an inflammatory bowel disease that can cause abdominal pain and bowel obstruction. However, it is less common in cystic fibrosis patients and typically presents with a different clinical picture and radiological findings&lt;/li&gt;&lt;li&gt;â€¢ Option B. Crohn&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intussusception: Intussusception is the telescoping of one segment of the intestine into another. While it can cause bowel obstruction, it is more common in children and usually presents with a sausage-shaped mass on palpation, which is not seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intussusception:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Distal Intestinal Obstruction Syndrome (DIOS) is a common complication in cystic fibrosis, characterized by the buildup of thick, sticky stools in the distal ileum and cecum, leading to abdominal pain, nausea, vomiting, and obstipation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female patient with cystic fibrosis is found to have the most common mutation seen in these patients. What is the primary defect caused by this mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Impaired synthesis of the CFTR protein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Defective chloride channel function at the cell surface&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased degradation of the CFTR protein in the endoplasmic reticulum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abnormal post-translational modification of the CFTR protein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased degradation of the CFTR protein in the endoplasmic reticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased degradation of the CFTR protein in the endoplasmic reticulum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Impaired synthesis of the CFTR protein: The delta F508 mutation affects protein folding, not synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Impaired synthesis of the CFTR protein:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Defective chloride channel function at the cell surface : This is a consequence, but the primary issue is the degradation before reaching the cell surface.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Defective chloride channel function at the cell surface&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abnormal post-translational modification of the CFTR protein : This is not the main issue with the delta F508 mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abnormal post-translational modification of the CFTR protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The most common mutation in cystic fibrosis, delta F508, leads to increased degradation of the CFTR protein in the endoplasmic reticulum, preventing it from reaching the cell surface and causing impaired chloride and water transport.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old patient with cystic fibrosis has a homozygous F508del mutation in the CFTR gene. What is the most appropriate treatment regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ivacaftor monotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumacaftor/Ivacaftor combination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tezacaftor/Ivacaftor combination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elexacaftor/Tezacaftor/Ivacaftor combination&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Elexacaftor/Tezacaftor/Ivacaftor combination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Elexacaftor/Tezacaftor/Ivacaftor combination&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ivacaftor monotherapy: Effective for certain gating mutations but not sufficient for the F508del mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ivacaftor monotherapy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lumacaftor/Ivacaftor combination: Provides benefit for F508del mutation but is less effective than the triple therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lumacaftor/Ivacaftor combination:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tezacaftor/Ivacaftor combination: An improvement over Lumacaftor/Ivacaftor but still not as effective as the triple therapy for the F508del mutation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tezacaftor/Ivacaftor combination:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The Elexacaftor/Tezacaftor/Ivacaftor combination (Trikafta) is the most advanced and effective treatment for patients with the F508del mutation in the CFTR gene.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old cystic fibrosis patient is found to have a CFTR mutation that results in defective protein processing and impaired channel function. Which type of CFTR defect is most effectively treated with a combination of potentiators and correctors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I mutation leading to no CFTR protein production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II mutation causing defective protein processing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III mutation resulting in defective channel regulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV mutation causing decreased conductance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II mutation causing defective protein processing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class II mutation causing defective protein processing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I mutation leading to no CFTR protein production: These mutations produce little to no CFTR protein, making correctors and potentiators ineffective.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I mutation leading to no CFTR protein production:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class III mutation resulting in defective channel regulation : Typically treated effectively with potentiators alone, as the CFTR protein is present but dysfunctional.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class III mutation resulting in defective channel regulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV mutation causing decreased conductance: Potentiators may help, but the primary defect involves reduced channel function rather than misprocessing.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV mutation causing decreased conductance:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Class II CFTR mutations causing defective protein processing are most effectively treated with a combination of correctors and potentiators.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with massive hemoptysis and is desaturating. Which of the following is incorrect according to AAFP guidelines?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avoid Endotracheal intubation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Selective intubation of the bleeding lung to remove blood clots&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insert a single-lumen endotracheal tube&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Position the patient with the bleeding side down&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Selective intubation of the bleeding lung to remove blood clots&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Selective intubation of the bleeding lung to remove blood clots&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Avoid Endotracheal intubation: Recommended unless absolutely necessary, to use the cough reflex for blood removal.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Avoid Endotracheal intubation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Insert a single-lumen endotracheal tube: Incorrect as it does not allow for selective ventilation and protection of the nonbleeding lung.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Insert a single-lumen endotracheal tube:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Position the patient with the bleeding side down : Correct as it uses gravitational advantage to prevent blood from entering the nonbleeding lung.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Position the patient with the bleeding side down&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ According to AAFP guidelines, selective intubation should be performed on the nonbleeding lung, not the bleeding lung, to protect the nonbleeding lung from contamination and ensure effective ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old lady presents with non-massive hemoptysis. What is the most common cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Viral bronchitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lung cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Viral bronchitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Viral bronchitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculosis: It is one of the most common causes in developing countries like India.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tuberculosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lung cancer: A significant cause but not the most common.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lung cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism: Can cause hemoptysis, but it is not the most common cause of non-massive hemoptysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Viral bronchitis is the most common cause of non-massive hemoptysis, typically resulting from inflammation and irritation of the airways.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with massive hemoptysis. What is the procedure of choice for controlling the bleeding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchial artery embolization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical resection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous antibiotic therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bronchial artery embolization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bronchial artery embolization&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchoscopy: Useful for diagnosis and initial management but not primarily for controlling severe bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchoscopy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical resection: Considered when embolization fails or is not feasible, but it is more invasive.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Surgical resection:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous antibiotic therapy: Used to treat underlying infections but not effective for immediate control of severe bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intravenous antibiotic therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bronchial artery embolization is the procedure of choice for controlling bleeding in life-threatening cases of massive hemoptysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are complications of obstructive sleep apnea (OSA) except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiovascular disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pulmonary fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pulmonary fibrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Options A. Hypertension: Common in OSA due to repeated hypoxic episodes and increased sympathetic activity.&lt;/li&gt;&lt;li&gt;â€¢ Options A. Hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke: Increased risk due to the association of OSA with hypertension and other cardiovascular risk factors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cardiovascular disease: Strongly linked with OSA, including conditions such as heart failure and arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cardiovascular disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary fibrosis is not a typical complication of obstructive sleep apnea (OSA); common complications include hypertension, stroke, and cardiovascular disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presents with dyspnea and pleuritic chest pain. A chest X-ray reveals a pleural effusion. Diagnostic thoracentesis is performed, and pleural fluid analysis shows the following: pleural fluid protein/serum protein ratio of 0.7. How would this pleural effusion be classified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transudative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exudative&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemorrhagic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Exudative&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Exudative&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Transudative : Transudative effusions do not meet Light&#x27;s criteria for exudative effusions and are typically due to systemic factors such as heart failure or cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Transudative&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignant : While malignancy can cause exudative effusions, this classification is based on Light&#x27;s criteria, not etiology.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignant&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemorrhagic : Refers to the presence of blood in the pleural fluid, which is a descriptive term rather than a classification based on Light&#x27;s criteria.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemorrhagic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A pleural effusion is classified as exudative if one or more of Light&#x27;s criteria are met, such as a pleural fluid protein/serum protein ratio &amp;gt; 0.5. In this case, the pleural fluid protein/serum protein ratio is 0.7, classifying it as exudative.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presents with dyspnea and pleuritic chest pain. Thoracentesis reveals loculated pleural fluid, pH of 7.15, glucose of 2.8 mmol/L (50 mg/dL), and gross pus in the pleural space. Which of the following is not an indication for chest drain placement?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loculated pleural fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleural fluid pH &amp;lt; 7.2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid glucose &amp;lt; 60 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of gross pus in the pleural space&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pleural fluid glucose &lt; 60 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pleural fluid glucose &amp;lt;60 mg/dL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Loculated pleural fluid : Indicates complicated effusion that often requires drainage&lt;/li&gt;&lt;li&gt;â€¢ Option A. Loculated pleural fluid&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pleural fluid pH &amp;lt;7.2 : Suggests a more severe infection or inflammation needing drainage&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pleural fluid pH &amp;lt;7.2&lt;/li&gt;&lt;li&gt;â€¢ Option D. Presence of gross pus in the pleural space: Clearly indicates empyema, which requires drainage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Presence of gross pus in the pleural space:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While low pleural fluid glucose (&amp;lt;3.3 mmol/L or &amp;lt;60 mg/dL) suggests a complicated effusion, it is not an absolute indication for chest drain placement. However, loculated pleural fluid, pleural fluid pH &amp;lt;7.2, and the presence of gross pus in the pleural space are definite indications for chest drain placement to prevent or treat empyema or complicated parapneumonic effusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with loculated pleural effusion has been treated with antibiotics and tube thoracostomy. Despite treatment, the patient continues to have fever, leukocytosis, and anorexia. Which of the following treatments should be considered next to improve clinical outcomes ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intrapleural fibrinolytic agents alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repeat thoracostomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High-dose corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intrapleural fibrinolytic agents alone : Controlled trials have not shown improvement in drainage with fibrinolytic agents alone.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Intrapleural fibrinolytic agents alone&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repeat thoracostomy : Not typically the next step when combination therapy of tPA and DNase can be more effective.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repeat thoracostomy&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose corticosteroids : Not indicated for improving drainage or treating persistent symptoms in pleural effusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-dose corticosteroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) should be considered when fever, leukocytosis, or anorexia persist despite antibiotics and tube thoracostomy, as this combination has been shown to improve clinical outcomes, including increased drainage, decreased length of stay, and decreased surgical referral.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of alcoholism presents with acute onset of left-sided chest pain and shortness of breath. Chest X-ray reveals a left-sided pleural effusion and pneumothorax. Thoracentesis yields turbid, red-brown fluid with a pH of 5.5. Which of the following is the most likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Uncomplicated parapneumonic effusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esophageal rupture&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Esophageal rupture&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Esophageal rupture&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Uncomplicated parapneumonic effusions typically have clear to turbid fluid with a near normal pH&lt;/li&gt;&lt;li&gt;â€¢ Option A. Uncomplicated parapneumonic effusions&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignant effusions are rarely associated with pneumothorax or a low pH&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignant&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tuberculosis effusions are usually serous to serosanguineous  and have a near normal pH&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tuberculosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of pleural effusion, pneumothorax, red-brown fluid, and low pH strongly suggests esophageal rupture.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male presents with sudden onset of pleuritic chest pain and dyspnea. On examination he had an irregularly irregular pulse. X ray showed a wedge shaped opacity with effusion in the left lung. Which of the following is the most likely cause of the effusion ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal rupture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parapneumonic effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary infarction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary infarction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal rupture: This would present with severe chest pain, often radiating to the back, and may be associated with subcutaneous emphysema or mediastinal air.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal rupture:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignancy: While malignancy can cause pleural effusions, they are typically more indolent in onset and not associated with the acute presentation or wedge-shaped opacity seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignancy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Parapneumonic effusion: This is an effusion associated with pneumonia and would likely present with fever, cough, and a more diffuse consolidation on chest X-ray.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Parapneumonic effusion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of sudden-onset pleuritic chest pain, dyspnea, irregularly irregular pulse (suggesting atrial fibrillation), and a wedge-shaped opacity on chest X-ray is highly suggestive of pulmonary embolism with subsequent pulmonary infarction, which can cause pleural effusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with a history of lymphoma presents with dyspnea and a large pleural effusion. Pleural fluid analysis reveals a milky white appearance and an elevated triglyceride level. Which of the following is the most likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Empyema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chylothorax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pseudochylous effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chylothorax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chylothorax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Empyema presents with purulent fluid and a low glucose level.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Empyema&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemothorax presents with bloody fluid.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hemothorax&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pseudochylothorax has a milky white appearance but normal triglyceride levels&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pseudochylothorax&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A milky white appearance and elevated triglyceride level in pleural fluid are characteristic of chylothorax, which results from the disruption of the thoracic duct.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with a gradual onset of dyspnea and a non-productive cough. Ultrasound confirms the presence of pleural effusion. Which of the following minimum fluid pocket depths on ultrasound would be considered adequate for a safe diagnostic thoracentesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5 mm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10 mm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;15 mm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20 mm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 10 mm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 10 mm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5 mm: This is too shallow and increases the risk of puncturing the lung.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5 mm:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 15 mm and D. 20 mm: While these depths are safe, they are not the minimum required. A 10 mm pocket is sufficient for a diagnostic thoracentesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 15 mm and D. 20 mm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A minimum pleural fluid pocket depth of 10 mm on ultrasound is considered adequate for a safe diagnostic thoracentesis, providing sufficient space to insert the needle and aspirate fluid without risking lung injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old tall, thin male presents with acute-onset left-sided chest pain and shortness of breath. He reports a 10-pack-year smoking history. Chest X-ray reveals a small apical pneumothorax. Which of the following statements is most accurate regarding his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;This is most likely a secondary spontaneous pneumothorax due to underlying lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The presence of apical blebs is highly suggestive of Marfan syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Smoking is an important risk factor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recurrence of pneumothorax is unlikely in this patient population.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Smoking is an important risk factor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) smoking is an important risk factor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. This is most likely a secondary spontaneous pneumothorax due to underlying lung disease : This is likely a primary, not secondary, spontaneous pneumothorax given the absence of underlying lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ This is most likely a secondary spontaneous pneumothorax due to underlying lung disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. The presence of apical blebs is highly suggestive of Marfan syndrome : Apical blebs are not specific to Marfan syndrome; they are common in Primary spontaneous pneumothorax&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ The presence of apical blebs is highly suggestive of Marfan syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Recurrence of pneumothorax is unlikely in this patient population : Recurrence of PSP is common, especially in smokers.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Recurrence of pneumothorax is unlikely in this patient population&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Smoking is an important risk factor for primary spontaneous pneumothorax, which is often associated with the rupture of subpleural apical blebs in young, tall, thin individuals. Recurrence is common, especially in smokers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with no significant past medical history presents to the emergency department with sudden onset of sharp, right-sided chest pain and shortness of breath. His JVP is normal and BP is 110/70 mm Hg. He denies any recent trauma or illness. X-ray is shown. What is the likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary spontaneous pneumothorax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tension pneumothorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Primary spontaneous pneumothorax&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-160110.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Primary spontaneous pneumothorax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pneumonia: would typically present with consolidation or infiltrates on chest x-ray.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pulmonary embolism: could present with chest pain and shortness of breath, but x-ray findings are usually normal or show subtle abnormalities.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pulmonary embolism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tension pneumothorax: this is a life-threatening emergency where the patients would be having high JVP and hypotension and X rays usually show mediastinal shift and tracheal deviation, which are not seen in this image.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tension pneumothorax:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The chest X-ray shows a visible visceral pleural line with no lung markings peripheral to it, indicating a pneumothorax. Given the patient&#x27;s young age, lack of underlying lung disease, and absence of trauma, the most likely diagnosis is a primary spontaneous pneumothorax, typically caused by the rupture of apical blebs in the lungs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male presents to the emergency department with sudden onset of shortness of breath, chest pain, and tachycardia. Upon examination, he has decreased breath sounds on the left side, jugular venous distention, and tracheal deviation to the right. The most appropriate immediate management of this patient is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest X-ray to confirm the diagnosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Needle decompression in the second intercostal space, midclavicular line&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Placement of a chest tube in the fourth intercostal space, anterior axillary line&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intubation and mechanical ventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Needle decompression in the second intercostal space, midclavicular line&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Needle decompression in the second intercostal space, midclavicular line&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray to confirm the diagnosis: While a chest X-ray can confirm the diagnosis, it should not delay the immediate treatment of needle decompression in a suspected tension pneumothorax.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray to confirm the diagnosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Placement of a chest tube in the fourth intercostal space, anterior axillary line: This is the definitive treatment for pneumothorax, but needle decompression is the immediate life-saving intervention in a tension pneumothorax.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Placement of a chest tube in the fourth intercostal space, anterior axillary line:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intubation and mechanical ventilation: While intubation and mechanical ventilation may be necessary later in the management, needle decompression is the priority in stabilizing the patient&#x27;s condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intubation and mechanical ventilation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The immediate management of a tension pneumothorax is needle decompression in the second intercostal space, midclavicular line, to relieve the pressure in the pleural space and stabilize the patient&#x27;s condition. This is a life-saving intervention that should be performed promptly based on clinical suspicion without waiting for imaging confirmation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man is diagnosed with idiopathic pulmonary fibrosis (IPF) after presenting with progressive dyspnea and a dry cough and he has a strong family history. Which gene mutation is most commonly associated with idiopathic pulmonary fibrosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFTR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MUC5B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BRCA1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;KRAS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MUC5B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CFTR: Associated with cystic fibrosis, not IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. CFTR:&lt;/li&gt;&lt;li&gt;â€¢ Option C. BRCA1: Associated with breast and ovarian cancer, not IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. BRCA1:&lt;/li&gt;&lt;li&gt;â€¢ Option D. KRAS: Commonly associated with various cancers, including lung cancer, but not specifically IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. KRAS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The MUC5B gene mutation is the most commonly associated genetic variant with idiopathic pulmonary fibrosis (IPF).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman presents with progressive shortness of breath and a dry cough. High-resolution CT of the chest reveals honeycombing and reticular opacities. Based on epidemiological data, which of the following is the most common interstitial lung disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-specific interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desquamative interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory bronchiolitis associated interstitial lung disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Idiopathic pulmonary fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-specific interstitial pneumonia: Less common than IPF and has different radiographic and clinical features.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Non-specific interstitial pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Desquamative interstitial pneumonia: Also less common and typically associated with smoking.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Desquamative interstitial pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Respiratory bronchiolitis associated interstitial lung disease: Primarily seen in smokers but less common than IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Respiratory bronchiolitis associated interstitial lung disease:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The most common interstitial lung disease is idiopathic pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ The most common interstitial lung disease is idiopathic pulmonary fibrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old retired coal miner presents with progressive shortness of breath and chronic cough. He has a long history of working in coal mines. Which of the following conditions is least likely to be associated with his occupational history?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interstitial lung disease (ILD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic bronchitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung cancer&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lung cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lung cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD): CWP can lead to the development of COPD due to long-term exposure to coal dust.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic obstructive pulmonary disease (COPD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Interstitial lung disease (ILD): CWP is a form of ILD caused by coal dust inhalation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Interstitial lung disease (ILD):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic bronchitis: Chronic bronchitis is common in coal workers due to continuous exposure to coal dust.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic bronchitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Coal workers&#x27; pneumoconiosis (CWP), or black lung disease, is associated with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and chronic bronchitis due to long-term inhalation of coal dust. However, CWP is not directly associated with an increased risk of lung cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of working in the mining industry presents with chronic cough and joint pain. Chest X-ray shows multiple, rounded nodules in the lungs. He also has a known diagnosis of rheumatoid arthritis. Which of the following diagnoses best explains his clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Caplan syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interstitial lung disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Caplan syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Caplan syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sarcoidosis: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not typically associated with rheumatoid arthritis and mining exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tuberculosis: Typically presents with cavitary lesions or consolidations, not rounded nodules, and is not associated with rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tuberculosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interstitial lung disease (ILD): Refers to a group of disorders causing fibrosis and scarring of the lung tissue, which can include conditions like idiopathic pulmonary fibrosis, but does not typically present with the specific combination of rheumatoid arthritis and mining exposure seen in Caplan syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interstitial lung disease (ILD):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Caplan syndrome, or rheumatoid pneumoconiosis, occurs in patients with rheumatoid arthritis who are exposed to dust such as silica or coal dust. It is characterized by multiple, rounded nodules on chest X-ray in the setting of pneumoconiosis and rheumatoid arthritis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man who works in an aerospace manufacturing plant presents with progressive dyspnea, cough, and fatigue. Chest X-ray showed bilateral hilar lymphadenopathy, and a transbronchial lung biopsy revealed non-caseating granulomas. Which diagnostic test is most appropriate for confirming the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoalveolar lavage (BAL) with CD4/CD8 ratio&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beryllium lymphocyte proliferation test (BeLPT)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum angiotensin-converting enzyme (ACE) level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HRCT of the chest&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Beryllium lymphocyte proliferation test (BeLPT)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Beryllium lymphocyte proliferation test (BeLPT)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchoalveolar lavage (BAL) with CD4/CD8 ratio : Useful in sarcoidosis but not specific for berylliosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchoalveolar lavage (BAL) with CD4/CD8 ratio&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum angiotensin-converting enzyme (ACE) level: Elevated in sarcoidosis but not specific for berylliosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum angiotensin-converting enzyme (ACE) level:&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-resolution CT scan of the chest: Helps in identifying interstitial lung disease but does not confirm beryllium exposure or CBD.&lt;/li&gt;&lt;li&gt;â€¢ Option D. High-resolution CT scan of the chest:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Beryllium lymphocyte proliferation test (BeLPT) is the most appropriate diagnostic test for confirming chronic beryllium disease (CBD) in a patient with a history of beryllium exposure and findings of non-caseating granulomas on biopsy. The BeLPT measures the proliferation of lymphocytes in response to beryllium exposure and is specific for diagnosing beryllium sensitization and chronic beryllium disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with chronic cough, dyspnea, and fatigue. She keeps birds as pets, and high-resolution CT of the chest is done and shown. All are useful for diagnosis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoalveolar lavage (BAL) with lymphocyte count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum angiotensin-converting enzyme (ACE) level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum antigen-specific IgG testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-caseating granulomas in lung biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum angiotensin-converting enzyme (ACE) level&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-124749.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum angiotensin-converting enzyme (ACE) level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchoalveolar lavage (BAL) with lymphocyte count : An increased lymphocyte count and CD4/CD8 ration of &amp;lt; 1 in BAL fluid is indicative of HP and helps in the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchoalveolar lavage (BAL) with lymphocyte count&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum antigen-specific IgG testing : Identifies antibodies against specific antigens (such as bird proteins) that can cause HP, making it useful for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum antigen-specific IgG testing&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-caseating granulomas in lung biopsy : The presence of non-caseating granulomas is a key histopathological feature of HP, supporting the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Non-caseating granulomas in lung biopsy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum angiotensin-converting enzyme (ACE) level is typically elevated in sarcoidosis but is not specific for hypersensitivity pneumonitis (HP). Therefore, it is not useful for diagnosing HP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old agricultural worker presents with symptoms of chronic cough, dyspnea, and fatigue. He reports working with moldy hay and grain regularly. Based on the table, which pathogen is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Penicillium casei&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coffee bean dust&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Saccharopolyspora rectivirgula&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Botrytis cinerea&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Saccharopolyspora rectivirgula&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Saccharopolyspora rectivirgula&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Penicillium casei: Associated with Cheese washerâ€™s lung, not typically found in moldy hay or grain.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Penicillium casei:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coffee bean dust : Associated with Coffee workerâ€™s lung, not relevant to this patient&#x27;s agricultural exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Coffee bean dust&lt;/li&gt;&lt;li&gt;â€¢ Option D. Botrytis cinerea: Associated with Wine makerâ€™s lung, linked to grape exposure, not moldy hay or grain.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Botrytis cinerea:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patient&#x27;s occupational exposure to moldy hay and grain is consistent with Farmer&#x27;s lung, caused by inhaling thermophilic actinomycetes such as Saccharopolyspora rectivirgula.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with a known diagnosis of sarcoidosis presents with new-onset facial weakness and decreased tear production. She also reports episodes of dry mouth and swelling near her jawline. Which specific manifestation of sarcoidosis is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mikulicz syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heerfordt syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LÃ¶fgren syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blau syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Heerfordt syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Heerfordt syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mikulicz syndrome : Characterized by chronic, painless enlargement of the parotid and lacrimal glands, often associated with SjÃ¶gren&#x27;s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mikulicz syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. LÃ¶fgren syndrome : Characterized by bilateral hilar lymphadenopathy, erythema nodosum, and arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. LÃ¶fgren syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blau syndrome : A genetic disorder presenting with granulomatous arthritis, uveitis, and dermatitis, seen in children, not related to Heerfordt syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blau syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Heerfordt syndrome, also known as uveoparotid fever, is a rare manifestation of sarcoidosis characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old African American woman presents with bilateral hilar lymphadenopathy, erythema nodosum, and arthritis. She also reports occasional fever and malaise. What is the most likely clinical syndrome associated with her presentation in the context of sarcoidosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LÃ¶fgren syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heerfordt syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mikulicz syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blau syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. LÃ¶fgren syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Heerfordt syndrome : Associated with uveoparotid fever, characterized by parotid gland enlargement, uveitis, fever, and facial nerve palsy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Heerfordt syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mikulicz syndrome: Characterized by chronic, painless enlargement of the parotid and lacrimal glands, not specific to sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mikulicz syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blau syndrome: A genetic disorder presenting with granulomatous arthritis, uveitis, and dermatitis, seen in children, not related to LÃ¶fgren syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Blau syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LÃ¶fgren syndrome is a clinical syndrome associated with sarcoidosis characterized by the triad of bilateral hilar lymphadenopathy, erythema nodosum, and arthritis, often accompanied by fever and malaise.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with multiple facial lesions as shown in the image. She also reports chronic fatigue and dyspnea. Biopsy of the skin lesions shows non-caseating granulomas. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lupus vulgaris&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leprosy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus pernio&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Discoid lupus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus pernio&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-131733.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus pernio&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lupus vulgaris: A form of cutaneous tuberculosis that presents with reddish-brown plaques, not typically associated with non-caseating granulomas.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lupus vulgaris:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leprosy: Presents with hypopigmented or reddish skin lesions with sensory loss and is diagnosed by the presence of Mycobacterium leprae in skin biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leprosy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Discoid lupus : Presents with chronic discoid lesions, erythematous plaques with scaling, and can be associated with systemic lupus erythematosus, but does not typically show non-caseating granulomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Discoid lupus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lupus pernio is a specific form of cutaneous sarcoidosis characterized by chronic, violaceous, indurated lesions on the face, especially around the nose, cheeks, and ears, and is associated with systemic sarcoidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with a known diagnosis of sarcoidosis presents with new-onset vision problems and facial droop on one side. Which of the following neurological manifestations is least likely to be associated with her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Optic neuritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CN VII nerve palsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Posterior hypothalamic involvement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Basilar meningitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Posterior hypothalamic involvement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Posterior hypothalamic involvement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Optic neuritis : Sarcoidosis can cause inflammation of the optic nerve, leading to vision problems.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Optic neuritis&lt;/li&gt;&lt;li&gt;â€¢ Option B. 7th nerve palsy : Facial nerve palsy is a well-known manifestation of neurosarcoidosis, presenting as facial droop.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 7th nerve palsy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Basilar meningitis : Sarcoidosis can lead to chronic basilar meningitis, presenting with symptoms such as headache and cranial nerve deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Basilar meningitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sarcoidosis can involve the nervous system, leading to various neurological manifestations such as CN VII palsy, optic neuritis, and basilar meningitis. Posterior hypothalamic involvement is least likely in this context.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with biopsy-proven pulmonary sarcoidosis presents with worsening dyspnea and cough. Imaging shows progressive pulmonary involvement which is progressing despite initial management by his clinician. Which of the following is the treatment for refractory disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Infliximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Infliximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate : Used as a second-line treatment or steroid-sparing agent, but not typically first-line for refractory disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prednisone : The first-line treatment for sarcoidosis, but the patient has refractory disease, indicating that prednisone alone is not sufficient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prednisone&lt;/li&gt;&lt;li&gt;â€¢ Option D. Azathioprine: An immunosuppressive agent used as a second-line treatment or steroid-sparing agent, but not the first choice for refractory disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Azathioprine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Infliximab, a TNF-alpha inhibitor, is used for treating severe or refractory sarcoidosis when initial treatments such as corticosteroids (e.g., prednisone) and second-line agents (e.g., methotrexate, azathioprine) are not effective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with progressive dyspnea, recurrent pneumothoraces, and chylous pleural effusions. High-resolution CT of the chest shows diffuse thin-walled cysts. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphangioleiomyomatosis (LAM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis (IPF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lymphangioleiomyomatosis (LAM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis: Typically presents with bilateral hilar lymphadenopathy and non-caseating granulomas, not diffuse thin-walled cysts.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Idiopathic pulmonary fibrosis (IPF): Characterized by progressive fibrosis and honeycombing on CT, not thin-walled cysts.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Idiopathic pulmonary fibrosis (IPF):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic obstructive pulmonary disease (COPD): Characterized by airflow obstruction and emphysematous changes, not diffuse thin-walled cysts.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic obstructive pulmonary disease (COPD):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lymphangioleiomyomatosis (LAM) is a rare lung disease affecting women of childbearing age, characterized by diffuse thin-walled cysts on high-resolution CT, recurrent pneumothoraces, and chylous pleural effusions. It involves the proliferation of abnormal smooth muscle-like cells, distinguishing it from other conditions like sarcoidosis, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man presents with progressive dyspnea and a chronic cough productive of white, frothy sputum. Chest X-ray shows bilateral alveolar infiltrates, and high-resolution CT of the chest reveals a \&quot;crazy paving\&quot; pattern. Bronchoalveolar lavage (BAL) yields milky fluid with periodic acid-Schiff (PAS)-positive material. Which of the following is the most likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis (IPF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary alveolar proteinosis (PAP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumocystis jirovecii pneumonia (PJP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pulmonary alveolar proteinosis (PAP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pulmonary alveolar proteinosis (PAP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Idiopathic pulmonary fibrosis (IPF): Typically presents with progressive fibrosis and honeycombing on CT, not a \&quot;crazy paving\&quot; pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Idiopathic pulmonary fibrosis (IPF):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not PAS-positive material in BAL.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumocystis jirovecii pneumonia (PJP): Can present with diffuse bilateral infiltrates, but the BAL fluid would typically show Pneumocystis organisms on special staining, not PAS-positive material.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pneumocystis jirovecii pneumonia (PJP):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary alveolar proteinosis (PAP) is diagnosed by the accumulation of surfactant-like material in the alveoli, presenting with progressive dyspnea, a chronic cough with white frothy sputum, bilateral alveolar infiltrates on chest X-ray, and a \&quot;crazy paving\&quot; pattern on high-resolution CT. The presence of PAS-positive material in bronchoalveolar lavage fluid confirms the diagnosis. This condition is distinct from idiopathic pulmonary fibrosis, sarcoidosis, and Pneumocystis jirovecii pneumonia, each having unique diagnostic features and findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents with a three-month history of non-productive cough, low-grade fever, and progressive dyspnea. Chest X-ray reveals bilateral patchy infiltrates, and high-resolution CT shows peripheral consolidation and ground-glass opacities. Lung biopsy reveals organizing pneumonia with granulation tissue within the alveolar ducts and bronchioles. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cryptogenic organizing pneumonia (COP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis (IPF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic eosinophilic pneumonia (CEP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cryptogenic organizing pneumonia (COP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Idiopathic pulmonary fibrosis (IPF): Typically presents with progressive fibrosis and honeycombing on CT, not peripheral consolidation and ground-glass opacities.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Idiopathic pulmonary fibrosis (IPF):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis : Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not organizing pneumonia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sarcoidosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic eosinophilic pneumonia (CEP): Characterized by peripheral infiltrates on imaging and an increased number of eosinophils in the lung and blood, not organizing pneumonia with granulation tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic eosinophilic pneumonia (CEP):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cryptogenic organizing pneumonia (COP) is identified by granulation tissue within the alveolar ducts and bronchioles, presenting with a non-productive cough, low-grade fever, and progressive dyspnea. Imaging shows bilateral patchy infiltrates and peripheral consolidation with ground-glass opacities. It is differentiated from idiopathic pulmonary fibrosis, sarcoidosis, and chronic eosinophilic pneumonia, each having unique histopathological and radiological features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a history of asthma, progressive dyspnea, and weight loss over the past few months. She also reports night sweats and cough. Chest X-ray shows peripheral infiltrates, and blood tests reveal marked eosinophilia. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic eosinophilic pneumonia (CEP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute eosinophilic pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypereosinophilic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Loeffler&#x27;s syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronic eosinophilic pneumonia (CEP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute eosinophilic pneumonia: Typically presents with acute onset of respiratory failure, diffuse pulmonary infiltrates, and eosinophilia in bronchoalveolar lavage fluid but not always in blood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute eosinophilic pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypereosinophilic syndrome : Characterized by persistent eosinophilia and multi-organ involvement, not specifically peripheral infiltrates on chest X-ray.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypereosinophilic syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Loeffler&#x27;s syndrome : Characterized by transient pulmonary infiltrates and blood eosinophilia, often due to parasitic infections, and usually resolves within a few weeks without leading to chronic symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Loeffler&#x27;s syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic eosinophilic pneumonia (CEP) is identified by peripheral infiltrates on chest imaging and marked eosinophilia in the blood. It presents with a history of asthma, progressive dyspnea, weight loss, night sweats, and cough. This condition is distinguished from acute eosinophilic pneumonia, hypereosinophilic syndrome, and Loeffler&#x27;s syndrome based on the specific clinical features, imaging findings, and chronicity of symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents with cough, dyspnea, fatigue, weight loss, and splenomegaly. Blood tests reveal marked eosinophilia and elevated white blood cell count. Chest X-ray shows diffuse infiltrates. Bone marrow biopsy shows increased cellularity with eosinophil precursors and myeloid hyperplasia. What is the next step ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High-resolution computed tomography (HRCT) chest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluorescence in situ hybridization (FISH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bronchoalveolar lavage (BAL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fluorescence in situ hybridization (FISH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fluorescence in situ hybridization (FISH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-resolution computed tomography (HRCT) chest: While it provides detailed imaging of lung pathology, it does not identify specific genetic mutations needed for diagnosing MPN-HES.&lt;/li&gt;&lt;li&gt;â€¢ Option A. High-resolution computed tomography (HRCT) chest:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bronchoalveolar lavage (BAL): Useful for diagnosing infections and certain interstitial lung diseases but not for identifying genetic mutations associated with MPN-HES.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bronchoalveolar lavage (BAL):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung biopsy: While it can provide histopathological information, it is invasive and does not identify specific genetic mutations crucial for diagnosing MPN-HES.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung biopsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients with marked eosinophilia and bone marrow findings suggestive of hypereosinophilic syndrome (HES), FISH testing for specific genetic mutations is essential to confirm the diagnosis and guide treatment&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with a chronic cough, wheezing, and night sweats. Blood tests reveal marked eosinophilia. Chest X-ray shows diffuse miliary nodules. Which of the following is the most likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic eosinophilic pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tropical pulmonary eosinophilia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Loeffler&#x27;s syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tropical pulmonary eosinophilia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tropical pulmonary eosinophilia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic eosinophilic pneumonia: Typically presents with peripheral infiltrates on chest imaging, not miliary nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic eosinophilic pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tuberculosis : Miliary tuberculosis can present with diffuse miliary nodules, but it is not typically associated with marked eosinophilia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Loeffler&#x27;s syndrome: Characterized by transient pulmonary infiltrates and blood eosinophilia, often due to parasitic infections, but typically resolves within a few weeks and does not present with chronic symptoms or miliary nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Loeffler&#x27;s syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tropical pulmonary eosinophilia (TPE) is characterized by chronic cough, wheezing, night sweats, and marked eosinophilia. It is caused by an immunological reaction to filarial parasites and commonly presents with persistent infiltrates and diffuse miliary nodules on chest X-ray. This condition is distinguished from chronic eosinophilic pneumonia, tuberculosis, and Loeffler&#x27;s syndrome based on the combination of eosinophilia, respiratory symptoms, and characteristic radiographic findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male smoker presents with chronic cough and dyspnea. He reports unintentional weight loss and episodes of spontaneous pneumothorax. High-resolution CT of the chest shows numerous thin-walled cysts and nodules predominantly in the upper lobes. Lung biopsy reveals characteristic tennis racquet like granules on electron microscopy. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lymphangioleiomyomatosis (LAM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary Langerhans cell histiocytosis (PLCH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis (IPF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pulmonary Langerhans cell histiocytosis (PLCH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pulmonary Langerhans cell histiocytosis (PLCH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lymphangioleiomyomatosis (LAM): Typically affects women of childbearing age and is characterized by diffuse thin-walled cysts but not associated with Birbeck granules.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lymphangioleiomyomatosis (LAM):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Idiopathic pulmonary fibrosis (IPF ): Presents with progressive fibrosis and honeycombing on imaging, not thin-walled cysts and nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Idiopathic pulmonary fibrosis (IPF&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sarcoidosis: Characterized by bilateral hilar lymphadenopathy and non-caseating granulomas, not thin-walled cysts and Birbeck granules.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sarcoidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease characterized by numerous thin-walled cysts and nodules predominantly in the upper lobes and presence of Birbeck granules on electron microscopy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old non-smoker male with progressive dry cough, SOB, and NYHA Class III presents with fine bibasilar crackles and no clubbing. HRCT is shown. Which investigation is required for further evaluation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Measurement of serum precipitating antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Laboratory testing for connective tissue disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transbronchial biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgical lung biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Laboratory testing for connective tissue disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-133026.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Laboratory testing for connective tissue disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Measurement of serum precipitating antibodies: Typically used to diagnose hypersensitivity pneumonitis, which is less likely given the lack of exposure history.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Measurement of serum precipitating antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transbronchial biopsy: Can be helpful in certain interstitial lung diseases but may not provide sufficient tissue for a definitive diagnosis of NSIP or an underlying CTD.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transbronchial biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical lung biopsy : Provides more tissue for diagnosis but is more invasive. It may be considered if initial non-invasive tests do not yield a diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Surgical lung biopsy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Laboratory testing for connective tissue diseases is essential when HRCT shows features suggestive of Non Specific Interstitial Pneumonia (NSIP) to identify any underlying autoimmune conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female is referred for chronic cough and dyspnea with exertion. Over the past year, her symptoms have steadily worsened. Pulmonary function testing shows FVC: 72%, FEV1: 80%, DLCO: 38%. HRCT of the chest is shown. Lung biopsy shows foci of scarring dispersed and surrounded by healthy lung parenchyma and fibroblasts. Which of the following is the appropriate therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pirfenidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bosentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetylcysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone/azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pirfenidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bosentan: Primarily used to treat pulmonary arterial hypertension, not idiopathic pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bosentan:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acetylcysteine : An antioxidant used in the management of various conditions, but not first-line for IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acetylcysteine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisolone/azathioprine: Immunosuppressive therapy that has not shown benefit and may even be harmful in patients with IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisolone/azathioprine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pirfenidone is the appropriate therapy for idiopathic pulmonary fibrosis (IPF), as it helps to slow disease progression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with suspected sarcoidosis presents with bilateral hilar lymphadenopathy, erythema nodosum, and distal renal tubular acidosis (dRTA). Which of the following statements about the disease is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACE is elevated in 60% of cases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercalcemia occurs in about 10% of patients&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BAL CD4/CD8 ratio &amp;gt; 3.5 is a characteristic finding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung biopsy is the gold standard for diagnosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lung biopsy is the gold standard for diagnosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACE is elevated in 60% of cases : Elevated angiotensin-converting enzyme (ACE) levels are seen in about 60% of patients with sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACE is elevated in 60% of cases&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercalcemia occurs in about 10% of patients : Hypercalcemia occurs in approximately 10% of patients with sarcoidosis due to increased production of vitamin D by granulomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercalcemia occurs in about 10% of patients&lt;/li&gt;&lt;li&gt;â€¢ Option C. BAL CD4/CD8 ratio &amp;gt; 3.5 is a characteristic finding : A high CD4/CD8 ratio in bronchoalveolar lavage (BAL) fluid is a characteristic finding in sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. BAL CD4/CD8 ratio &amp;gt; 3.5 is a characteristic finding&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While lung biopsy showing non-caseating granulomas is highly suggestive of sarcoidosis and can be critical in diagnosis, it is not considered the gold standard as the diagnosis often relies on a combination of clinical, radiographic, and histopathological findings. Other conditions can also present with non-caseating granulomas, necessitating clinical correlation and exclusion of other diseases for accurate diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a history of atrial fibrillation presents with progressive dyspnea and a dry cough over the past three months. He has been on amiodarone therapy for the past year. High-resolution CT of the chest reveals findings consistent with interstitial lung disease (ILD). All of the following medications are known to cause ILD except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cisplatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone: Known to cause ILD, particularly with long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate: Associated with ILD in patients, particularly those with rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bleomycin: A chemotherapeutic agent well known for its potential to cause ILD&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Bleomycin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone, methotrexate, and bleomycin are known to cause drug-induced interstitial lung disease (ILD), while cisplatin is not typically associated with ILD; its primary toxicities are nephrotoxicity and ototoxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a 30-pack-year smoking history presents with progressive dyspnea and chronic cough. High-resolution CT of the chest shows diffuse interstitial changes. Which of the following interstitial lung diseases is least likely to be associated with smoking?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Respiratory bronchiolitis associated ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desquamative Interstitial Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Langerhans Cell Histiocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Usual Interstitial Pneumonia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Usual Interstitial Pneumonia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Respiratory bronchiolitis associated ILD: Commonly seen in smokers.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Respiratory bronchiolitis associated ILD:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Desquamative Interstitial Pneumonia: Strongly associated with smoking.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Desquamative Interstitial Pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Langerhans Cell Histiocytosis: Typically seen in smokers and characterized by cystic lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Langerhans Cell Histiocytosis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Usual Interstitial Pneumonia is least likely to be associated with smoking.&lt;/li&gt;&lt;li&gt;â€¢ is least likely to be associated with smoking.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of working in a construction agency involved in rock tunnelling presents with acute onset of dyspnea, cough, and fatigue for the last 3 weeks. High-resolution CT shows diffuse ground-glass opacities and a crazy paving pattern. Bronchoalveolar lavage reveals large amounts of periodic acid-Schiff-positive material. Which of the following conditions is most likely ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute silicosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary alveolar proteinosis (PAP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis (IPF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersensitivity pneumonitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute silicosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute silicosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pulmonary alveolar proteinosis (PAP): Although PAP can present with similar imaging findings, the patient&#x27;s occupational history and acute onset suggest acute silicosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Pulmonary alveolar proteinosis (PAP):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Idiopathic pulmonary fibrosis (IPF): Typically presents with chronic progressive dyspnea and honeycombing on imaging, not acute symptoms and crazy paving pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Idiopathic pulmonary fibrosis (IPF):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypersensitivity pneumonitis: Related to environmental exposures, presenting with cough, dyspnea, and fatigue, but typically involves centrilobular nodules rather than crazy paving pattern&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Hypersensitivity pneumonitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Acute silicosis can present with diffuse ground-glass opacities and a crazy paving pattern on high-resolution CT, and bronchoalveolar lavage may reveal large amounts of periodic acid-Schiff-positive material, reflecting occupational exposure to silica dust.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a long history of working in construction presents with chronic cough and shortness of breath. He reports joint pain and stiffness, and a recent chest X-ray shows interstitial lung disease (ILD). Which of the following conditions is least likely to be associated with his diagnosis of silicosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Interstitial lung disease (ILD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Interstitial lung disease (ILD): Silicosis is a form of ILD caused by inhalation of silica dust.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Interstitial lung disease (ILD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic obstructive pulmonary disease (COPD): Long-term exposure to silica can lead to COPD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic obstructive pulmonary disease (COPD):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rheumatoid arthritis: Silicosis can be associated with rheumatoid arthritis in the form of Caplan&#x27;s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rheumatoid arthritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Silicosis is primarily associated with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) due to inhalation of silica dust and can also be associated with autoimmune conditions like rheumatoid arthritis, but not with lymphoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of working in shipyards presents with chest pain and shortness of breath. Imaging reveals a pleural mass, and biopsy confirms malignant mesothelioma. Which of the following is true regarding the association of mesotheliomas with asbestos exposure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mesotheliomas are strongly associated with smoking&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Short-term asbestos exposures of â‰¤1â€“2 years can lead to mesotheliomas&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mesotheliomas are not associated with asbestos exposure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mesotheliomas develop within a few years of exposure to asbestos&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Short-term asbestos exposures of â‰¤1â€“2 years can lead to mesotheliomas&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Short-term asbestos exposures of â‰¤1â€“2 years can lead to mesotheliomas&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mesotheliomas are strongly associated with smoking: Mesotheliomas are not associated with smoking.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mesotheliomas are strongly associated with smoking:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mesotheliomas are not associated with asbestos exposure: Mesotheliomas are indeed associated with asbestos exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mesotheliomas are not associated with asbestos exposure:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mesotheliomas develop within a few years of exposure to asbestos: Mesotheliomas can develop decades after exposure to asbestos.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Mesotheliomas develop within a few years of exposure to asbestos:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mesotheliomas are strongly associated with asbestos exposure and can develop even after short-term exposures of â‰¤1â€“2 years, occurring up to 40 years in the past. They are not associated with smoking.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old retired construction worker presents for a routine check-up. His chest radiograph is shown. What does it indicate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Significant pulmonary impairment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Past exposure to asbestos&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural effusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Active tuberculosis infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Past exposure to asbestos&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-124125.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Past exposure to asbestos&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Significant pulmonary impairment: Pleural plaques indicate exposure but do not imply pulmonary impairment without additional manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Significant pulmonary impairment:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pleural effusion : Benign pleural effusions can occur with asbestos exposure but are not seen in this CXR&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pleural effusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Active tuberculosis infection: Pleural plaques are not associated with tuberculosis (but silicosis has association)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Active tuberculosis infection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chest X-ray showing bilateral calcified pleural plaques indicates past exposure to asbestos. Pleural plaques are a hallmark of asbestos exposure but do not imply significant pulmonary impairment without additional findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents with acute onset of severe dyspnea and fever. She was previously healthy but has rapidly deteriorated over the past week. Chest X-ray shows diffuse bilateral alveolar infiltrates, and HRCT of the chest reveals widespread ground-glass opacities and consolidation. Routine work up did not reveal any identifiable cause. Lung biopsy demonstrates diffuse alveolar damage with hyaline membrane formation. What is the likely diagnosis ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial pneumonia (AIP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute respiratory distress syndrome (ARDS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cryptogenic organizing pneumonia (COP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis (IPF)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute interstitial pneumonia (AIP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute interstitial pneumonia (AIP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory distress syndrome (ARDS): While ARDS also presents with diffuse alveolar damage and similar imaging findings, it is typically secondary to an identifiable cause such as sepsis, trauma, or pneumonia, whereas AIP occurs without a known trigger.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute respiratory distress syndrome (ARDS):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cryptogenic organizing pneumonia (COP) : Usually presents with subacute symptoms and patchy lung infiltrates, not rapid onset and diffuse alveolar damage.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cryptogenic organizing pneumonia (COP)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Idiopathic pulmonary fibrosis (IPF): Characterized by chronic progressive dyspnea and fibrosis with honeycombing, not acute onset or diffuse alveolar damage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Idiopathic pulmonary fibrosis (IPF):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute interstitial pneumonia (AIP) is characterized by rapid onset of severe respiratory symptoms, diffuse bilateral alveolar infiltrates, and lung biopsy showing diffuse alveolar damage with hyaline membrane formation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 194 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test10" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Rheumatology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Rheumatology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                120 Questions | 480 Total Marks | 130 min Duration | ~65.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;During a temporal artery biopsy for suspected giant cell arteritis, which of the following factors is MOST important for improving diagnostic yield?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obtaining a biopsy sample from the most tender area of the artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Using a large bore needle for biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obtaining a biopsy segment of at least 3-5 cm in length&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Performing the biopsy under general anesthesia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Obtaining a biopsy segment of at least 3-5 cm in length&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Obtaining a biopsy segment of at least 3-5 cm in length&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obtaining a biopsy sample from the most tender area of the artery: While tenderness might indicate inflammation, a longer segment is more important for sampling.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obtaining a biopsy sample from the most tender area of the artery:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Using a large bore needle for biopsy: The needle size is less relevant than the length of the biopsy specimen.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Using a large bore needle for biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Performing the biopsy under general anesthesia: General anesthesia is not typically required.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Performing the biopsy under general anesthesia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Adequate biopsy length is essential for accurate diagnosis of GCA. While other factors like tenderness or imaging findings can guide the biopsy site, the length of the specimen is the most critical determinant of diagnostic yield.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman presents with a 2-week history of headaches, jaw claudication, and scalp tenderness. She has been taking low-dose prednisone for polymyalgia rheumatica (PMR) for the past 5 days. Which of the following is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Discontinue prednisone and observe for symptom resolution&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Order a temporal artery ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform a temporal artery biopsy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase the dose of prednisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Perform a temporal artery biopsy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Perform a temporal artery biopsy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinue prednisone and observe for symptom resolution: While low-dose prednisone may be used to manage polymyalgia rheumatica (PMR), it&#x27;s not sufficient to treat giant cell arteritis (GCA). Discontinuing it without a definitive diagnosis could lead to worsening symptoms and potentially irreversible vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Discontinue prednisone and observe for symptom resolution:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Order a temporal artery ultrasound: While ultrasound can be a helpful tool in the assessment of GCA, it is not as definitive as a biopsy. A negative ultrasound doesn&#x27;t rule out GCA, and a positive result still requires biopsy confirmation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Order a temporal artery ultrasound:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase the dose of prednisone: Increasing the dose of prednisone without a biopsy-confirmed diagnosis of GCA is not recommended. Higher doses of prednisone carry a significant risk of side effects, and it&#x27;s important to establish the diagnosis first to determine the appropriate treatment course.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increase the dose of prednisone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Early diagnosis and treatment of GCA are crucial to prevent complications like vision loss. Even if a patient is already on glucocorticoids, a biopsy should not be delayed, as it is the gold standard for confirming the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with newly diagnosed temporal arteritis complains of blurred vision in one eye. Which of the following is the most appropriate immediate intervention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue with oral prednisone 40 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the dose of oral prednisone to 60 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administer intravenous methylprednisolone 1000 mg daily for 3 days&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Refer urgently to ophthalmology for assessment&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Administer intravenous methylprednisolone 1000 mg daily for 3 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Administer intravenous methylprednisolone 1000 mg daily for 3 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue with oral prednisone 40 mg daily: Oral prednisone is the standard treatment for temporal arteritis, but higher doses or IV steroids are needed for ocular involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Continue with oral prednisone 40 mg daily:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Refer urgently to ophthalmology for assessment: Ophthalmology referral is essential, but not the immediate first step&lt;/li&gt;&lt;li&gt;â€¢ Option D. Refer urgently to ophthalmology for assessment:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Prompt recognition and treatment of visual symptoms in temporal arteritis are critical to preserve vision. High-dose intravenous glucocorticoids are the mainstay of initial therapy for ocular involvement.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman presents with new-onset headache, jaw claudication, and scalp tenderness. Her erythrocyte sedimentation rate (ESR) is elevated. Which of the following medications is FDA approved for the treatment of giant cell arteritis (GCA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tocilizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tocilizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tocilizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate and Option B. Rituximab are not FDA-approved for GCA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rituximab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infliximab is a TNF inhibitor and is not used in GCA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infliximab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ While glucocorticoids remain the first-line treatment for GCA, tocilizumab is an important alternative for patients who cannot tolerate glucocorticoids or who experience relapses despite glucocorticoid therapy. It is essential to be aware of the available treatment options for GCA to provide optimal care for patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with fatigue, weight loss, and claudication in her arms and legs. Physical exam reveals diminished pulses in the upper extremities and a carotid bruit. Which of the following imaging modalities is the GOLD STANDARD for confirming the diagnosis of Takayasu arteritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doppler ultrasound of the carotid arteries&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Contrast-enhanced CT angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Magnetic resonance angiography (MRA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Contrast-enhanced CT angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Contrast-enhanced CT angiography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray: Chest X-ray is not sensitive enough to detect early vascular changes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Doppler ultrasound of the carotid arteries: Doppler ultrasound can assess blood flow but is limited in visualizing the arterial wall in detail.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Doppler ultrasound of the carotid arteries:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Magnetic resonance angiography (MRA): MRA is a good alternative to CT angiography, but CT is often more readily available.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Magnetic resonance angiography (MRA):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the gold standard imaging modality for TAK is essential for timely diagnosis and appropriate management. While other imaging modalities can provide supportive evidence, CT angiography remains the most definitive diagnostic tool.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old Asian woman presents with fatigue, weight loss, and arm claudication. Physical exam reveals a blood pressure discrepancy between arms and diminished brachial pulses. Which of the following diagnoses is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant cell arteritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polyarteritis nodosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kawasaki disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Takayasu arteritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Takayasu arteritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Takayasu arteritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Giant cell arteritis: Typically affects older individuals and involves cranial arteries.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Giant cell arteritis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyarteritis nodosa: Affects medium-sized arteries and presents with multisystem involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyarteritis nodosa:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Kawasaki disease: Kawasaki disease is a childhood vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Kawasaki disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Takayasu arteritis is a large vessel vasculitis that predominantly affects young women, particularly those of Asian descent. It is important to consider this diagnosis in patients presenting with characteristic clinical features and to initiate prompt evaluation and treatment to prevent complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of hepatitis B presents with fever, weight loss, and abdominal pain. He also complains of new-onset muscle weakness and skin nodules. Which of the following diagnostic tests would have the HIGHEST diagnostic yield for polyarteritis nodosa (PAN)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antineutrophil cytoplasmic antibody (ANCA) testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biopsy of a skin nodule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abdominal ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Electromyography (EMG)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Biopsy of a skin nodule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Biopsy of a skin nodule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antineutrophil cytoplasmic antibody (ANCA) testing: ANCA is usually negative in PAN.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Antineutrophil cytoplasmic antibody (ANCA) testing:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Abdominal ultrasound: Ultrasound might show organ ischemia, but not the underlying vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Abdominal ultrasound:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Electromyography (EMG): EMG can assess muscle involvement but is not diagnostic&lt;/li&gt;&lt;li&gt;â€¢ Option D. Electromyography (EMG):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ When suspecting PAN, a tissue biopsy of an affected organ (such as skin, nerve, or muscle) is the most reliable diagnostic test. While other tests can provide supportive evidence, biopsy provides definitive proof of vasculitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with a recent diagnosis of polyarteritis nodosa (PAN) is most likely to present with which of the following renal manifestations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nephrotic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rapidly progressive glomerulonephritis (RPGN)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal failure and hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nephrolithiasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Renal failure and hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Renal failure and hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nephrotic syndrome : This is characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia. It&#x27;s not the typical presentation of renal involvement in PAN.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nephrotic syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rapidly progressive glomerulonephritis (RPGN): While RPGN can cause renal failure, it&#x27;s less common in PAN and usually associated with other vasculitides like microscopic polyangiitis or granulomatosis with polyangiitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rapidly progressive glomerulonephritis (RPGN):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nephrolithiasis (Kidney Stones): Kidney stones are not directly related to the vasculitic process of PAN&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nephrolithiasis (Kidney Stones):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ PAN commonly affects the kidneys, leading to hypertension and renal failure. Recognizing this association is crucial for early diagnosis and appropriate management to prevent irreversible kidney damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child presents with a 5-day history of high fever, bilateral conjunctivitis, erythema of the oral mucosa and lips, and cervical lymphadenopathy. The childâ€™s tongue is shown below. Which of the following diagnoses is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Scarlet fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Measles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kawasaki disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infectious mononucleosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Kawasaki disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-174133.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Kawasaki disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Scarlet fever typically presents with a sandpaper-like rash and sore throat.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Scarlet fever&lt;/li&gt;&lt;li&gt;â€¢ Option B. Measles has a characteristic maculopapular rash and Koplik spots in the mouth.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Measles&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious mononucleosis is associated with fatigue, lymphadenopathy, and atypical lymphocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious mononucleosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic clinical features of Kawasaki disease is crucial for timely diagnosis and treatment to prevent complications, such as coronary artery aneurysms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child with Kawasaki disease is found to have coronary artery aneurysms on echocardiogram. Which of the following histopathological findings would most likely be present in the affected coronary arteries?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granulomatous inflammation with giant cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transmural inflammation with fibrinoid necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intimal proliferation and infiltration of mononuclear cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medial calcification and fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intimal proliferation and infiltration of mononuclear cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intimal proliferation and infiltration of mononuclear cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Granulomatous inflammation with giant cells: Granulomatous inflammation is seen in conditions like giant cell arteritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Granulomatous inflammation with giant cells:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transmural inflammation with fibrinoid necrosis: Transmural inflammation with fibrinoid necrosis is seen in polyarteritis nodosa.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transmural inflammation with fibrinoid necrosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Medial calcification and fibrosis: Medial calcification and fibrosis are more typical of atherosclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Medial calcification and fibrosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the pathological changes in coronary arteries caused by Kawasaki disease is important for recognizing the potential for long-term cardiovascular complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old boy with a history of Kawasaki disease presents with chest pain and signs of myocardial ischemia. Echocardiogram reveals giant coronary artery aneurysms with evidence of thrombosis. Which of the following surgical interventions is MOST likely to be considered for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary artery stenting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pericardiectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thromboendarterectomy and aneurysmal reconstruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thromboendarterectomy and aneurysmal reconstruction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Thromboendarterectomy and aneurysmal reconstruction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary artery stenting: Stenting is less suitable for giant aneurysms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary artery stenting:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pericardiectomy: Pericardiectomy is the removal of the pericardium and is not relevant to coronary artery disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pericardiectomy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cardiac transplantation: Cardiac transplantation is a last resort for severe, refractory cases.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cardiac transplantation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Timely surgical intervention is crucial for managing giant coronary artery aneurysms in Kawasaki disease to prevent life-threatening complications like myocardial infarction and sudden cardiac death.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old boy presents with fever, rash, conjunctival injection, and swollen glands, raising suspicion for Kawasaki disease. What is the most likely initial dose of aspirin that would be prescribed by the doctor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10 mg/kg/day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20 mg/kg/day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50 mg/kg/day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;80-100 mg/kg/day&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 80-100 mg/kg/day&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 80-100 mg/kg/day&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10 mg/kg/day: This is a low dose of aspirin and would not be sufficient for the anti-inflammatory effect needed in acute Kawasaki disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 10 mg/kg/day:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 20 mg/kg/day: This dose is also too low for the initial treatment of Kawasaki disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 20 mg/kg/day:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 50 mg/kg/day: This dose may be appropriate for some children, but the standard initial dose is generally higher.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 50 mg/kg/day:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ High-dose aspirin (80-100 mg/kg/day) is the standard initial treatment for Kawasaki disease due to its anti-inflammatory and antipyretic (fever-reducing) effects. This higher dose is crucial during the acute phase of the illness to control inflammation and potentially reduce the risk of coronary artery complications. Once the fever subsides, the aspirin dose is typically tapered down to a lower dose (3-5 mg/kg/day) for its antiplatelet effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of recurrent sinusitis and chronic cough now presents with bloody nasal discharge and a new saddle nose deformity. Which additional finding would MOST strongly support a diagnosis of granulomatosis with polyangiitis (GPA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Positive rheumatoid factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated antinuclear antibody (ANA) titer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eosinophilia on complete blood count (CBC)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Positive cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Positive rheumatoid factor and Option B. Elevated antinuclear antibody (ANA) titer are not specific for GPA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Positive rheumatoid factor&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated antinuclear antibody (ANA) titer are&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eosinophilia on complete blood count (CBC): Eosinophilia is more characteristic of eosinophilic granulomatosis with polyangiitis (EGPA).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eosinophilia on complete blood count (CBC):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the significance of c-ANCA positivity in the context of suspected GPA is crucial for early diagnosis and prompt initiation of treatment to prevent irreversible organ damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about renal involvement in GPA is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is the most common cause of mortality in untreated GPA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It typically presents with rapidly progressive renal failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is often associated with pulmonary hemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can be effectively treated with immunosuppressive therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is often associated with pulmonary hemorrhage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is often associated with pulmonary hemorrhage.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other statements are true regarding renal involvement in GPA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the patterns of organ involvement in GPA is important for accurate diagnosis and management. While renal involvement is a serious complication, it is not typically associated with pulmonary hemorrhage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with GPA presents with rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage. Which of the following is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral prednisone 1 mg/kg/day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate 25 mg/week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rituximab 375 mg/m2 weekly for 4 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous methylprednisolone 1000 mg daily for 3 days&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intravenous methylprednisolone 1000 mg daily for 3 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Intravenous methylprednisolone 1000 mg daily for 3 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral prednisone 1 mg/kg/day: Oral prednisone is too slow and less potent for this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral prednisone 1 mg/kg/day:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate 25 mg/week: Methotrexate is a DMARD and not appropriate for acute life-threatening disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate 25 mg/week:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rituximab 375 mg/m2 weekly for 4 weeks: Rituximab is an option, but high-dose glucocorticoids are typically used first.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rituximab 375 mg/m2 weekly for 4 weeks:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the need for rapid intervention with high-dose glucocorticoids in patients with life-threatening manifestations of GPA is essential for optimal management and improved outcomes. Early diagnosis and aggressive treatment can significantly reduce morbidity and mortality associated with this disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with asthma, eosinophilia, and a skin biopsy revealing a necrotizing vasculitis with extravascular granulomas. Which of the following histopathological findings is most characteristic of EGPA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leukocytoclastic vasculitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fibrinoid necrosis without granulomas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Granulomas with eosinophilic infiltration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphocytic vasculitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Granulomas with eosinophilic infiltration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Granulomas with eosinophilic infiltration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leukocytoclastic vasculitis: This type of vasculitis is characterized by the fragmentation of neutrophils (leukocytoclasis) in small blood vessel walls. While it can be seen in EGPA, it is not specific and can occur in other vasculitides as well.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leukocytoclastic vasculitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrinoid necrosis without granulomas: Fibrinoid necrosis, a type of tissue damage, is often present in various vasculitides, including EGPA. However, the absence of granulomas makes this finding less specific for EGPA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fibrinoid necrosis without granulomas:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lymphocytic vasculitis: This refers to vasculitis with predominantly lymphocytic infiltration. While lymphocytes may be present in EGPA lesions, the predominance of eosinophils and the presence of granulomas are more characteristic features.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lymphocytic vasculitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the unique histological pattern of granulomas with eosinophils is crucial for diagnosing EGPA. This finding, combined with clinical and serological evidence, can confirm the diagnosis and guide treatment decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Eosinophilic granulomatosis with polyangiitis (EGPA) can affect multiple organ systems. What is the approximate percentage of EGPA patients who experience mononeuritis multiplex (MM), the second most common manifestation of this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;25%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;55%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;63%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;72%&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 72%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 72%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the prevalence of MM in EGPA is essential for recognizing potential neurological complications and initiating appropriate management. Early diagnosis and treatment can prevent irreversible nerve damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of asthma and eosinophilia presents with new-onset shortness of breath, chest pain, and fatigue. He has recently been diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). An echocardiogram reveals significant LV dysfunction and evidence of myocarditis. Which of the following treatment regimens is most appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral prednisone alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate and prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclophosphamide and prednisone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab and prednisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cyclophosphamide and prednisone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cyclophosphamide and prednisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral prednisone alone: Oral prednisone alone is insufficient for severe disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral prednisone alone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate and prednisone: Methotrexate is less potent than cyclophosphamide.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate and prednisone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab and prednisone: Rituximab is an option for refractory disease or in those who cannot tolerate cyclophosphamide.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab and prednisone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Severe EGPA, especially with cardiac involvement, requires aggressive treatment to achieve remission and prevent complications. Cyclophosphamide and prednisone are the mainstay of initial therapy, but other immunosuppressive agents like rituximab may be considered in refractory cases or when cyclophosphamide is contraindicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman presents with a purpuric rash, hematuria, and hemoptysis. Renal biopsy reveals a pauci-immune necrotizing crescentic glomerulonephritis. Which of the following serological markers is MOST likely to be positive in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-glomerular basement membrane (GBM) antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antinuclear antibodies (ANA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-proteinase 3 (PR3) antibodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti- Glomerular Basement Membrane (GBM) antibodies: These are characteristic of Goodpasture syndrome, which usually presents with pulmonary hemorrhage and rapidly progressive glomerulonephritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti- Glomerular Basement Membrane (GBM) antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antinuclear antibodies (ANA): While ANA can be positive in some vasculitides, it is not specific for MPA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antinuclear antibodies (ANA):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti- Proteinase 3(PR3) antibodies: These are cytoplasmic ANCA (c-ANCA) and are more specific for granulomatosis with polyangiitis (GPA).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-&lt;/li&gt;&lt;li&gt;â€¢ Proteinase 3(PR3) antibodies:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Microscopic polyangiitis (MPA) is a small vessel vasculitis characterized by kidney inflammation, lung involvement, skin involvement, and possible involvement of other organs.Testing p-ANCA, especially against myeloperoxidase (MPO), is a key diagnostic marker for MPA, found in about 70% of patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with a purpuric rash on the lower extremities and buttocks, abdominal pain, and joint swelling. Which of the following diagnostic approaches would be MOST helpful in confirming a diagnosis of IgA vasculitis (Henoch-SchÃ¶nlein purpura)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antinuclear antibody (ANA) testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum IgA levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Skin biopsy with immunofluorescence&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abdominal ultrasound&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Skin biopsy with immunofluorescence&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Skin biopsy with immunofluorescence&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antinuclear antibody (ANA) testing: ANA is typically negative in IgA vasculitis, and a positive result would suggest a different autoimmune condition.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Antinuclear antibody (ANA) testing:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serum IgA levels: While IgA levels may be elevated in IgA vasculitis, they are not specific for the disease and can be elevated in other conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serum IgA levels:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abdominal ultrasound: Abdominal ultrasound can help assess for gastrointestinal complications (e.g., intussusception) in IgA vasculitis, but it does not confirm the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Abdominal ultrasound:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ While other tests may provide supportive evidence, a skin biopsy with immunofluorescence remains the gold standard for definitive diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of Hepatitis C presents with fatigue, arthralgia, palpable purpura on the lower extremities, and peripheral neuropathy. Laboratory tests reveal elevated rheumatoid factor and low complement levels. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I cryoglobulinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type II cryoglobulinemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type III cryoglobulinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type IV cryoglobulinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type II cryoglobulinemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Type II cryoglobulinemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type I cryoglobulinemia : Type I is associated with lymphoproliferative disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type I cryoglobulinemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type III cryoglobulinemia: Type III is associated with autoimmune diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type III cryoglobulinemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type IV cryoglobulinemia : There is no type IV cryoglobulinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type IV cryoglobulinemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the association between Hepatitis C and type II cryoglobulinemia is crucial for accurate diagnosis and management of cryoglobulinemic vasculitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with hepatitis C-associated cryoglobulinemic vasculitis has achieved sustained virologic response (SVR) after antiviral therapy. Which of the following is the most likely outcome regarding their vasculitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No improvement in vasculitis activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Worsening of vasculitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Complete resolution of vasculitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Partial improvement with decreased cryoglobulin levels&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Partial improvement with decreased cryoglobulin levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Partial improvement with decreased cryoglobulin levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. No improvement in vasculitis activity: Achieving SVR often leads to significant improvement in symptoms and reduction of cryoglobulin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. No improvement in vasculitis activity:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Worsening of vasculitis: While rare, there have been some cases where antiviral therapy can lead to a temporary worsening of vasculitis followed by improvement, and overall, antiviral therapy is expected to be beneficial.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Worsening of vasculitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Complete resolution of vasculitis: While SVR often leads to significant improvement in vasculitis, complete resolution may not always occur.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Complete resolution of vasculitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Antiviral therapy is essential for managing hepatitis C-associated cryoglobulinemic vasculitis. While SVR is associated with improved outcomes, patients may still require additional immunosuppressive therapy or other interventions to achieve complete remission of vasculitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents with recurrent, long-lasting wheals on her trunk and limbs, accompanied by joint pain and abdominal discomfort. The lesions often leave a bruise-like mark. Laboratory tests reveal normal C3 and C4 complement levels. Which of the following autoantibodies is most likely to be elevated in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-nuclear antibody (ANA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-double stranded DNA (anti-dsDNA) antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-C1q antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antineutrophil cytoplasmic antibody (ANCA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-C1q antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-C1q antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-nuclear antibody (ANA): While ANA can be positive in some cases of HUV, it is not specific and can be found in other autoimmune diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-nuclear antibody (ANA):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti- double stranded DNA (dsDNA) antibody: This antibody is more specific for systemic lupus erythematosus (SLE).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-&lt;/li&gt;&lt;li&gt;â€¢ double stranded DNA (dsDNA) antibody:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antineutrophil cytoplasmic antibody (ANCA): ANCA is associated with other vasculitides, like granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), not urticarial vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Antineutrophil cytoplasmic antibody (ANCA):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Hypocomplementemic Urticarial Vasculitis (HUV):&lt;/li&gt;&lt;li&gt;âž¤ Characterized by urticarial lesions lasting &amp;gt;24 hours, leaving bruise-like marks, and systemic symptoms like joint pain and abdominal discomfort. Laboratory findings may show low complement levels, but normal C3 and C4 levels can occur. Anti-C1q antibodies are highly associated with HUV and considered a diagnostic marker.&lt;/li&gt;&lt;li&gt;âž¤ Characterized by urticarial lesions lasting &amp;gt;24 hours, leaving bruise-like marks, and systemic symptoms like joint pain and abdominal discomfort.&lt;/li&gt;&lt;li&gt;âž¤ Laboratory findings may show low complement levels, but normal C3 and C4 levels can occur.&lt;/li&gt;&lt;li&gt;âž¤ Anti-C1q antibodies are highly associated with HUV and considered a diagnostic marker.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with recurrent painful oral and genital ulcers. He also has a history of erythema nodosum. Which of the following tests is most likely to be positive and aid in the diagnosis of BehÃ§et syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pathergy test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-nuclear antibody (ANA) test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid factor (RF) test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-neutrophil cytoplasmic antibody (ANCA) test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pathergy test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pathergy test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-nuclear antibody (ANA) , Option C. Rheumatoid factor (RF) , and Option D. Anti-neutrophil cytoplasmic antibody (ANCA) tests are not specific for BehÃ§et&#x27;s and are more commonly associated with other autoimmune diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-nuclear antibody (ANA)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rheumatoid factor (RF)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-neutrophil cytoplasmic antibody (ANCA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the utility of the pathergy test is essential in the diagnosis of BehÃ§et disease. While it is not pathognomonic, a positive pathergy test, along with the characteristic clinical manifestations, can strongly support the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man of Turkish descent presents with recurrent oral ulcers, genital ulcers, and uveitis. You suspect BehÃ§et disease. Which of the following statements regarding HLA-B*51 testing in this patient is MOST accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HLA-B51 testing is the gold standard for diagnosing BehÃ§et disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A positive HLA-B51 test confirms the diagnosis of BehÃ§et disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A negative HLA-B51 test rules out the diagnosis of BehÃ§et disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HLA-B51 testing can be helpful, but it&#x27;s not definitive for diagnosis due to its prevalence in the general population.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HLA-B51 testing can be helpful, but it&#x27;s not definitive for diagnosis due to its prevalence in the general population.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) HLA-B*51 testing can be helpful, but it&#x27;s not definitive for diagnosis due to its prevalence in the general population.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Options A. HLA-B51 testing is the gold standard for diagnosing BehÃ§et disease and B. A positive HLA-B51 test confirms the diagnosis of BehÃ§et disease: HLA-B*51 testing is not the gold standard for diagnosis and does not confirm the diagnosis on its own.&lt;/li&gt;&lt;li&gt;â€¢ Options A.&lt;/li&gt;&lt;li&gt;â€¢ HLA-B51 testing is the gold standard for diagnosing BehÃ§et disease&lt;/li&gt;&lt;li&gt;â€¢ B. A positive HLA-B51 test confirms the diagnosis of BehÃ§et disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. A negative HLA-B51 test rules out the diagnosis of BehÃ§et disease: A negative HLA-B51 test does not exclude the diagnosis of BehÃ§et disease, as some patients with the disease are HLA-B51 negative.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A negative HLA-B51 test rules out the diagnosis of BehÃ§et disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ HLA-B*51 testing should be interpreted with caution and in the context of the overall clinical picture. A positive test can increase suspicion for BehÃ§et disease, but it does not confirm or rule out the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman with BehÃ§et syndrome presents with recurrent, painful oral ulcers that have not responded to topical corticosteroids. She has no significant comorbidities. Which of the following medications is FDA-approved for the treatment of oral ulcers in BehÃ§et syndrome and would be the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Apremilast&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Apremilast&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Apremilast&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Colchicine: Primarily used for acute gout flares and sometimes for erythema nodosum in BehÃ§et&#x27;s, but not specifically approved for oral ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Colchicine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azathioprine: An immunosuppressant used for various autoimmune diseases, but not the first-line treatment for oral ulcers in BehÃ§et&#x27;s.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azathioprine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclophosphamide: A potent immunosuppressant used for severe manifestations of BehÃ§et&#x27;s (e.g., ocular or neurological involvement), not typically the first choice for isolated oral ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclophosphamide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Apremilast is a relatively new treatment option for managing oral ulcers in BehÃ§et syndrome. It offers a targeted approach with a favorable safety profile compared to more traditional immunosuppressive therapies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with a 6-month history of photosensitivity, malar rash, and recurrent episodes of mucositis. He also reports headaches, seizures, and difficulty concentrating. Anti-nuclear antibody (ANA) testing is positive, and anti-dsDNA antibodies are present. A kidney biopsy reveals signs of lupus nephritis. A mutation analysis of which of the following genes is most likely to be informative, regarding the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TLR7&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IRF5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TREX1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TNFSF4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TREX1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) TREX1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. TLR7: Gain-of-function mutations in TLR7 are associated with SLE, but they typically lead to adult-onset disease with a milder phenotype, not the early-onset and severe neuropsychiatric manifestations seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TLR7:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IRF5: Variants in IRF5 increase susceptibility to SLE, but they are not typically associated with monogenic forms or severe neuropsychiatric presentations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IRF5:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TNFSF4: Mutations in TNFSF4 are linked to an increased risk of SLE, but they do not usually cause the specific combination of early-onset, neuropsychiatric symptoms, and lupus nephritis seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TNFSF4:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Monogenic lupus: A small percentage of SLE cases are caused by single gene mutations, with TREX1 being one of the most well-characterized. Patients with monogenic lupus often present with early-onset disease and may have more severe manifestations, including neuropsychiatric involvement. Identifying a TREX1 mutation can confirm the diagnosis of monogenic lupus and has implications for prognosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ Monogenic lupus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with pain, swelling, and tenderness in multiple joints, particularly her wrists and knees. She reports morning stiffness lasting about 30 minutes. Physical exam reveals warmth and tenderness in the affected joints, but no obvious deformities. On further question, patient used to experience photosensitive rash usually occurring over the cheeks. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Psoriatic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SLE-associated polyarthritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. SLE-associated polyarthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) SLE-associated polyarthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis typically presents with more persistent morning stiffness and may cause joint erosions over time.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osteoarthritis primarily affects weight-bearing joints and is characterized by bony enlargement and crepitus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osteoarthritis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Psoriatic arthritis is often associated with skin psoriasis and typically involves the distal interphalangeal joints.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Psoriatic arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ SLE-associated polyarthritis is a common manifestation of systemic lupus erythematosus (SLE), an autoimmune disease. It is important to recognize the clinical presentation of SLE-associated polyarthritis, which can include pain, swelling, and tenderness in multiple joints, along with other systemic symptoms like fatigue, fever, and rash.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with a circular, erythematous lesion on her cheek with a raised, scaly border and a depigmented, atrophic center. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tinea corporis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discoid lupus erythematosus (DLE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Seborrheic dermatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Discoid lupus erythematosus (DLE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Discoid lupus erythematosus (DLE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tinea corporis (Ringworm): While ringworm can present as a circular lesion, it typically has a more active, inflamed border and central clearing, often with itching. The description of depigmentation and atrophy doesn&#x27;t fit this diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tinea corporis (Ringworm):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis: Psoriasis lesions are typically well-demarcated plaques with silvery scales, and they don&#x27;t usually present with the same degree of central atrophy as seen in DLE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Seborrheic dermatitis: This condition presents as greasy, yellowish scales and erythema, usually affecting areas rich in sebaceous glands like the scalp, eyebrows, and nasolabial folds. The depigmentation and atrophy seen in this patient are not characteristic of seborrheic dermatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Seborrheic dermatitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic features of DLE lesions is important for differentiating it from other skin conditions and initiating appropriate treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the approximate percentage of patients with DPGN who either die or develop ESRD within 10 years of diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;20%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 20%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 20%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ DPGN is a severe form of lupus nephritis with a poor prognosis. Early recognition and aggressive treatment are essential to improve outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A renal biopsy from a patient with systemic lupus erythematosus (SLE) shows diffuse mesangial hypercellularity with mesangial immune deposits on immunofluorescence. There is no evidence of glomerular crescents or endocapillary proliferation. This finding is consistent with which class of lupus nephritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV-S(A)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I LN has normal glomeruli on light microscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class III LN involves focal segmental or global lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class III&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV-S(A) involves diffuse segmental proliferative lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV-S(A)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Classifying lupus nephritis is crucial for determining prognosis and guiding treatment decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman with SLE presents with fatigue, dyspnea on exertion, and orthopnea. Physical examination reveals an S3 gallop, jugular venous distension, and bilateral lower extremity edema. Which of the following is the most likely cause of her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pericardial effusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral valve regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dilated cardiomyopathy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dilated cardiomyopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dilated cardiomyopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pericardial effusion can cause similar symptoms, but the S3 gallop and bilateral edema are more suggestive of left ventricular dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pericardial effusion&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral valve regurgitation can also cause heart failure, but it&#x27;s less common in SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mitral valve&lt;/li&gt;&lt;li&gt;â€¢ regurgitation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary hypertension can cause right heart failure, but the patient&#x27;s symptoms and signs are more suggestive of left heart failure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary hypertension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ SLE can affect the heart in various ways, including pericarditis, myocarditis, and valvular disease. Recognizing these cardiac manifestations is essential for early intervention and preventing complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with SLE presents with fatigue, pallor, and jaundice. Laboratory tests reveal anemia, elevated reticulocyte count, and a positive direct Coombs test. Which of the following is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydroxychloroquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High-dose glucocorticoids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet transfusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. High-dose glucocorticoids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) High-dose glucocorticoids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hydroxychloroquine is used for SLE management but not as the primary treatment for AIHA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hydroxychloroquine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rituximab is a second-line agent for refractory AIHA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rituximab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelet transfusion is not indicated for AIHA unless there is severe thrombocytopenia with bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Platelet transfusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ AIHA is a common hematologic manifestation of SLE and requires prompt treatment to prevent complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with systemic lupus erythematosus (SLE) presents with edema, fatigue, and foamy urine. Laboratory tests reveal proteinuria of 4.5 g/24 hours, hypoalbuminemia, and hyperlipidemia. What percentage of SLE patients with renal involvement typically develop nephrotic syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5-10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;25%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;30-60%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;80-90%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 25%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 25%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5-10%: This is the percentage of SLE patients who develop end-stage renal disease, not nephrotic syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5-10%:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 30-60%: This is the percentage of SLE patients who develop renal involvement (proteinuria and cellular casts), not specifically nephrotic syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 30-60%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 80-90%: This is an overestimation of the prevalence of nephrotic syndrome in SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 80-90%:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Renal involvement is common in SLE, and a subset of these patients will develop nephrotic syndrome. Early detection and management are crucial for preventing kidney damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with a history of SLE for 10 years presents to the emergency department complaining of sudden, painless vision loss in his left eye. He denies any recent trauma, eye pain, redness, or light sensitivity. On examination, his vision is 20/200 in the left eye and normal in the right eye. Funduscopic examination of the left eye reveals cotton wool spots, retinal hemorrhages, and a pale optic disc. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sicca syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conjunctivitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Episcleritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retinal vasculitis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Retinal vasculitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Retinal vasculitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sicca syndrome: While common in SLE, it mainly causes dryness, irritation, and blurred vision, not sudden, painless vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sicca syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conjunctivitis: This is inflammation of the conjunctiva (the membrane lining the eyelids and covering the white part of the eye). It usually presents with redness, itching, tearing, and discharge, not sudden vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conjunctivitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Episcleritis: This is inflammation of the episclera (the thin layer of tissue between the conjunctiva and the sclera, the white outer coating of the eye). It typically causes mild redness and discomfort, not sudden vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Episcleritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Retinal vasculitis is a serious complication of SLE and requires urgent evaluation and treatment to preserve vision.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of systemic lupus erythematosus (SLE) presents to the hospital with acute confusion, disorientation, and new-onset seizures. Brain MRI reveals multiple white matter hyperintensities. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primary central nervous system (CNS) lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuropsychiatric SLE (NPSLE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebral vasculitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neuropsychiatric SLE (NPSLE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Neuropsychiatric SLE (NPSLE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary central nervous system ( CNS) lymphoma: While CNS lymphoma can occur in SLE patients, it is less common than NPSLE and typically presents with focal lesions rather than diffuse white matter hyperintensities.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Primary&lt;/li&gt;&lt;li&gt;â€¢ central nervous system (&lt;/li&gt;&lt;li&gt;â€¢ CNS) lymphoma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple sclerosis: Multiple sclerosis can also present with white matter lesions on MRI, but the clinical history of SLE and other systemic symptoms makes it less likely in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple sclerosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebral vasculitis: Cerebral vasculitis is a possible complication of SLE, but it usually presents with focal neurological deficits and less commonly with diffuse cognitive impairment. Additionally, MRI findings in cerebral vasculitis often show ischemic lesions rather than predominantly white matter hyperintensities.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cerebral vasculitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ NPSLE is a common and potentially debilitating manifestation of SLE. Early recognition and treatment are essential to prevent long-term neurological damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 37-year-old female presents with a 6-month history of joint pain, photosensitive rash, and intermittent oral ulcers. Laboratory investigations were ordered to assess for autoimmune disorders. An Antinuclear Antibody (ANA) test was performed using indirect immunofluorescence on HEp-2 cells. The result is shown in the image below. Based on the pattern observed, which of the following conditions is most likely associated with this patient&#x27;s presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic Lupus Erythematosus (SLE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatoid Arthritis (RA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Scleroderma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SjÃ¶gren&#x27;s Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Systemic Lupus Erythematosus (SLE)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/27/screenshot-2024-07-27-162500.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Systemic Lupus Erythematosus (SLE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rheumatoid Arthritis (RA): RA may show a positive ANA with different patterns, but the homogeneous pattern is not as strongly associated with RA as it is with SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rheumatoid Arthritis (RA):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Scleroderma: Scleroderma ANA patterns often include nucleolar, centromere, or speckled patterns, not typically homogenous.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Scleroderma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. SjÃ¶gren&#x27;s Syndrome : SjÃ¶gren&#x27;s Syndrome is more commonly associated with a speckled ANA pattern and anti-SSA/Ro and anti-SSB/La antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option D. SjÃ¶gren&#x27;s Syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the homogeneous pattern in ANA testing is important, as it strongly suggests the possibility of SLE. However, further testing, including specific antibody tests and clinical evaluation, is necessary for a definitive diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old man is evaluated for symptoms of arthritis, fatigue, and an intermittent rash. Considering his clinical presentation, an Antinuclear Antibody (ANA) test is performed, and the results show a distinct immunofluorescence pattern, shown below. Which autoimmune disease is most closely associated with this ANA pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rheumatoid Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Systemic Lupus Erythematosus (SLE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SjÃ¶gren&#x27;s Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systemic Sclerosis (Scleroderma)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Systemic Lupus Erythematosus (SLE)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/27/screenshot-2024-07-27-162710.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Systemic Lupus Erythematosus (SLE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid Arthritis is typically associated with rheumatoid factor and anti-CCP antibodies, not the &#x27;rim&#x27; ANA pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid Arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option C. SjÃ¶gren&#x27;s Syndrome is more commonly associated with anti-Ro/SSA and anti-La/SSB antibodies, which can produce a different ANA pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option C. SjÃ¶gren&#x27;s Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic Sclerosis (Scleroderma) often shows ANA patterns such as the nucleolar pattern, not the &#x27;rim&#x27; pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Systemic Sclerosis (Scleroderma)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Identifying the rim pattern in ANA testing is a valuable clue for diagnosing SLE. It signifies the presence of specific autoantibodies targeting dsDNA, a hallmark of the disease. However, it&#x27;s important to remember that not all SLE patients will exhibit this pattern, and further diagnostic workup is necessary.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a criterion for defining Lupus Low Disease Activity State (LLDAS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SLEDAI-2K score â‰¤ 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;No new lupus disease activity compared to the previous visit&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physician&#x27;s global assessment â‰¤ 1 (scale 0-3)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-double-stranded DNA antibody titer &amp;lt; 1:80&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti-double-stranded DNA antibody titer &lt; 1:80&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti-double-stranded DNA antibody titer &amp;lt; 1:80&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ The other options (A, B, and C) are all essential criteria for LLDAS.&lt;/li&gt;&lt;li&gt;â€¢ options&lt;/li&gt;&lt;li&gt;â€¢ (A, B, and C)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ LLDAS is a state of low disease activity in SLE, defined by specific criteria including a SLEDAI-2K score â‰¤ 4, no new disease activity compared to the previous visit, and a physician&#x27;s global assessment â‰¤ 1 (scale 0-3). Understanding these criteria is essential for monitoring disease activity and adjusting treatment plans in SLE patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with severe lupus nephritis is scheduled to begin treatment with high-dose cyclophosphamide. She is concerned about the potential side effects of this medication, particularly the risk of ovarian failure. Which of the following medications can be used to reduce this risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leuprolide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Belimumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Leuprolide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Leuprolide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other option s do not protect against cyclophosphamide-induced ovarian failure.&lt;/li&gt;&lt;li&gt;â€¢ other option&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Cyclophosphamide is a potent immunosuppressive agent used in severe lupus nephritis, but it can cause premature ovarian failure. Co-administration of leuprolide can mitigate this risk and preserve fertility in young women.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young woman with SLE presents with new confusion, seizures, and shortness of breath. Exam shows fever, rash, and fluid overload. Labs reveal worsening kidney function and blood counts. Urine analysis suggests nephrotic range proteinuria. Biopsy confirms class IV lupus nephritis. What is the typical initial dose of glucocorticoids?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.1-0.2 mg/kg per day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.5-1 mg/kg per day&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2-3 mg/kg per day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-10 mg/kg per day&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 0.5-1 mg/kg per day&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 0.5-1 mg/kg per day&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ High-dose glucocorticoids are the cornerstone of initial therapy for severe SLE manifestations due to their rapid anti-inflammatory and immunosuppressive effects. However, their use should be balanced with the risk of side effects and tapered as soon as possible.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with SLE has a renal biopsy showing diffuse proliferative glomerulonephritis (DPGN) classified as ISN/RPS Class IV. Which of the following is the most appropriate induction therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydroxychloroquine alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low-dose prednisone alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mycophenolate mofetil (MMF) alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucocorticoids + cyclophosphamide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glucocorticoids + cyclophosphamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Glucocorticoids + cyclophosphamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hydroxychloroquine alone: Hydroxychloroquine is used for milder SLE manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Hydroxychloroquine alone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low-dose prednisone alone: Low-dose prednisone is insufficient for severe nephritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Low-dose prednisone alone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mycophenolate mofetil (MMF) alone: MMF can be used but is not the standard of care for induction in Class IV LN.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mycophenolate mofetil (MMF) alone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Class IV lupus nephritis is the most severe form of lupus nephritis and requires aggressive induction therapy. The combination of glucocorticoids and cyclophosphamide is the standard of care for induction, followed by maintenance therapy with mycophenolate mofetil or azathioprine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old Caucasian man presents with fatigue, arthralgia, myalgia, and a low-grade fever. He has been taking hydralazine for hypertension for the past six months. Blood investigations showed Positive ANA. Given the likely diagnosis, which of the following antibodies will be present in this patient, in high titres?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-dsDNA antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Smith antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Ro/SSA antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-histone antibodies&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti-histone antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti-histone antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-dsDNA antibodies: These are more specific for systemic lupus erythematosus (SLE) and are less likely to be elevated in DILE.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-dsDNA antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-Smith antibodies: While present in SLE, anti-Smith antibodies are not usually elevated in DILE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-Smith antibodies:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Ro/SSA antibodies: These antibodies are associated with both SLE and SjÃ¶gren&#x27;s syndrome but are not a hallmark of DILE.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Ro/SSA antibodies:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the association between anti-histone antibodies and DILE is crucial for accurate diagnosis. This is especially important when a patient presents with lupus-like symptoms while taking a medication known to trigger DILE.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with DILE induced by hydralazine has been successfully treated. Which of the following statements regarding prognosis is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The patient has a high risk of developing systemic lupus erythematosus (SLE).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The patient is likely to have permanent organ damage.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The patient is expected to have complete resolution of symptoms upon drug withdrawal.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The patient will require lifelong immunosuppressive therapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The patient is expected to have complete resolution of symptoms upon drug withdrawal.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The patient is expected to have complete resolution of symptoms upon drug withdrawal.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The risk of developing SLE is not increased after DILE. Permanent organ damage and lifelong immunosuppression are not usually necessary for DILE.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The prognosis of DILE is generally good, especially with prompt recognition and discontinuation of the offending drug. Patients should be reassured that their symptoms are likely to resolve and long-term complications are rare. However, monitoring for recurrence of symptoms is important if the drug is reintroduced.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a 5-year history of Raynaud&#x27;s phenomenon presents with progressive skin thickening that is limited to his fingers, hands, and face. He also reports occasional episodes of facial and hand swelling. He offers no other complaints. Physical examination reveals sclerodactyly, telangiectasias on the face, and puffy fingers. Pulmonary function tests and echocardiogram are normal. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Limited cutaneous systemic sclerosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diffuse cutaneous systemic sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Scleroderma sine scleroderma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Overlap syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Limited cutaneous systemic sclerosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Limited cutaneous systemic sclerosis (lcSSc)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diffuse cutaneous systemic sclerosis (dcSSc) : This subtype involves skin thickening that extends proximal to the wrists and affects the trunk. Internal organ involvement is more common and occurs earlier in dcSSc compared to lcSSc.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diffuse cutaneous systemic sclerosis (dcSSc)&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Scleroderma sine scleroderma: This rare variant of SSc is characterized by Raynaud&#x27;s phenomenon and internal organ involvement without significant skin thickening.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Scleroderma sine scleroderma:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Overlap syndrome: This refers to a combination of SSc with features of other connective tissue diseases like polymyositis, dermatomyositis, or systemic lupus erythematosus. There is no evidence of overlap in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Overlap syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the distinct clinical features of lcSSc is essential for accurate diagnosis and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antibodies is considered an SSc-specific autoantibody?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-nuclear antibody (ANA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-double stranded DNA (anti-dsDNA) antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-topoisomerase I (Scl-70) antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-cyclic citrullinated peptide (anti-CCP) antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-topoisomerase I (Scl-70) antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-topoisomerase I (Scl-70) antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-nuclear antibody ( ANA) : ANA is not specific to SSc and can be found in other autoimmune diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-nuclear antibody (&lt;/li&gt;&lt;li&gt;â€¢ ANA)&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-double stranded DNA (anti-dsDNA) antibody : Anti-dsDNA is specific for SLE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-double stranded DNA (anti-dsDNA) antibody&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-cyclic citrullinated peptide (anti-CCP) antibody: Anti-CCP is specific for rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-cyclic citrullinated peptide (anti-CCP) antibody:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Identifying SSc-specific autoantibodies like anti-Scl-70 can aid in diagnosis, subtype classification, and prognostication in patients with suspected SSc.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman presents with Raynaud&#x27;s phenomenon and progressive skin thickening of her hands. Which of the following haplotypes is most strongly associated with an increased risk of systemic sclerosis (SSc)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HLA-DRB104:01&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HLA-DRB107:01&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HLA-DRB111:04&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HLA-DRB115:01&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HLA-DRB111:04&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HLA-DRB111:04&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. HLA-DRB104:01 is associated with rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HLA-DRB104:01&lt;/li&gt;&lt;li&gt;â€¢ Option B. HLA-DRB107:01 and Option D. HLA-DRB115:01 have not been consistently linked to SSc.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HLA-DRB107:01&lt;/li&gt;&lt;li&gt;â€¢ Option D. HLA-DRB115:01&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the genetic predisposition to SSc can help identify individuals at higher risk and potentially contribute to the development of targeted preventive strategies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with suspected systemic sclerosis presents with a speckled pattern on antinuclear antibody (ANA) testing. Which autoantibody is most likely associated with this pattern and carries an increased risk of scleroderma renal crisis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-centromere antibody (ACA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-topoisomerase I (Scl-70) antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-RNA polymerase III antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-U3-RNP (fibrillarin) antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-RNA polymerase III antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-RNA polymerase III antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option ACA: Centromere pattern, limited SSc, lower renal crisis risk.&lt;/li&gt;&lt;li&gt;â€¢ Option ACA:&lt;/li&gt;&lt;li&gt;â€¢ Option Scl-70: Nucleolar/speckled nucleolar pattern, diffuse SSc, lower renal crisis risk.&lt;/li&gt;&lt;li&gt;â€¢ Option Scl-70:&lt;/li&gt;&lt;li&gt;â€¢ Option Anti-U3-RNP: Nucleolar pattern, overlap syndromes, less common in SSc, lower renal crisis risk&lt;/li&gt;&lt;li&gt;â€¢ Option Anti-U3-RNP:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the association between the speckled ANA pattern, anti-RNA polymerase III antibodies, and scleroderma renal crisis is crucial for early detection and prompt intervention to prevent renal failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with a 3-year history of Raynaud&#x27;s phenomenon and new onset skin tightening of the fingers. Which of the following investigations is MOST helpful in differentiating between primary Raynaud&#x27;s disease and limited cutaneous systemic sclerosis (lcSSc)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antinuclear antibody (ANA) test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary function tests (PFTs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nailfold capillaroscopy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nailfold capillaroscopy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nailfold capillaroscopy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antinuclear antibody (ANA) test: ANA testing can be positive in both conditions but is not specific for differentiation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antinuclear antibody (ANA) test:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pulmonary function tests ( PFTs) and Option D. Echocardiogram assess for internal organ involvement, which is more common in later stages of SSc and not helpful in early differentiation.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary function tests (&lt;/li&gt;&lt;li&gt;â€¢ PFTs)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiogram&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Nailfold capillaroscopy is a valuable tool in the early diagnosis of SSc, particularly in patients presenting with Raynaud&#x27;s phenomenon. It can detect microvascular abnormalities before the onset of significant skin changes or internal organ involvement.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications has shown promising results in recent clinical trials for slowing the progression of SSc-associated interstitial lung disease (SSc-ILD)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;D-penicillamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mycophenolate mofetil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nintedanib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nintedanib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. D-penicillamine has not shown consistent benefits in recent controlled trials for SSc-ILD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. D-penicillamine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mycophenolate mofetil is often used in SSc, but its primary role is in treating skin and other organ involvement, not specifically ILD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mycophenolate mofetil&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclophosphamide is a potent immunosuppressant used for severe SSc manifestations, but it&#x27;s not the first-line treatment for ILD.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclophosphamide&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Nintedanib is an emerging treatment option for SSc-ILD, offering potential hope for patients with this debilitating complication of SSc.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PAH is a rare complication of SSc.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PAH is typically symptomatic early in its course.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PAH accounts ~30% of deaths in SSc.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The prognosis of PAH in SSc is generally favorable.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PAH accounts ~30% of deaths in SSc.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) PAH accounts ~30% of deaths in SSc.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. PAH is a rare complication of SSc: PAH is not rare in SSc; it occurs in a significant minority of patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ PAH is a rare complication of SSc:&lt;/li&gt;&lt;li&gt;â€¢ Option B. PAH is typically symptomatic early in its course: PAH is often asymptomatic until advanced stages, making early detection crucial.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ PAH is typically symptomatic early in its course:&lt;/li&gt;&lt;li&gt;â€¢ Option D. The prognosis of PAH in SSc is generally favorable: The prognosis of PAH in SSc is poor without treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The prognosis of PAH in SSc is generally favorable:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ PAH is a common and serious complication of SSc. Recognizing the symptoms and initiating appropriate treatment can improve outcomes and prolong survival.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with scleroderma renal crisis (SRC) is found to have activation of the complement pathway on renal biopsy. Which of the following medications might be considered as an adjunct to ACE inhibitor therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mycophenolate mofetil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eculizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bosentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Eculizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Eculizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The other medications are not specifically targeted towards complement inhibition.&lt;/li&gt;&lt;li&gt;â€¢ The other medications are not specifically targeted towards complement inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Eculizumab is a novel therapeutic option for SRC that targets the underlying pathophysiology of the disease. Further research is needed to determine its long-term efficacy and safety in this setting.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with complaints of dry mouth, dry eyes, and fatigue. On examination, you note enlarged parotid glands and dental caries. Given the likely diagnosis, which of the following is the characteristic histopathological findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granulomatous inflammation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neutrophilic infiltration of exocrine glands&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphocytic infiltration of exocrine glands&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deposition of immune complexes in blood vessels&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lymphocytic infiltration of exocrine glands&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lymphocytic infiltration of exocrine glands&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Granulomatous inflammation: Granulomatous inflammation is seen in sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Granulomatous inflammation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neutrophilic infiltration of exocrine glands: Neutrophilic infiltration is characteristic of acute infections.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neutrophilic infiltration of exocrine glands:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deposition of immune complexes in blood vessels: Immune complex deposition is seen in vasculitis .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Deposition of immune complexes in blood vessels:&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic histopathological findings in SjÃ¶gren&#x27;s syndrome is crucial for confirming the diagnosis. A lip biopsy is commonly performed to assess the minor salivary glands for lymphocytic infiltration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female is diagnosed with primary SjÃ¶gren Syndrome after presenting with dry mouth, difficulty swallowing, and bilateral parotid gland enlargement. Which of the following tests is most specific for diagnosing primary SjÃ¶gren Syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rheumatoid factor (RF)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-nuclear antibody (ANA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Ro/SSA and Anti-La/SSB antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-smooth muscle antibody (ASMA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-Ro/SSA and Anti-La/SSB antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-Ro/SSA and Anti-La/SSB antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid factor (RF) can be positive in SjÃ¶gren Syndrome but is not specific as it can be positive in other autoimmune diseases, including rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid factor (RF)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-nuclear antibody (ANA) can be positive in a wide range of autoimmune diseases and is not specific to SjÃ¶gren Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-nuclear antibody (ANA)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-smooth muscle antibody (ASMA) is associated with autoimmune hepatitis and not specific for SjÃ¶gren Syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-smooth muscle antibody (ASMA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ While other tests like RF and ANA can be positive in SjÃ¶gren&#x27;s syndrome, they are not as specific as anti-Ro/SSA and anti-La/SSB antibodies. These antibodies, in combination with clinical features, are crucial for establishing the diagnosis of primary SjÃ¶gren&#x27;s syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the MOST common extraglandular manifestation in primary SjÃ¶gren&#x27;s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fatigue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arthralgias/Arthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Raynaud&#x27;s phenomenon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung involvement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Arthralgias/Arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Arthralgias/Arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fatigue (25%),&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Fatigue&lt;/li&gt;&lt;li&gt;â€¢ Option C. Raynaud&#x27;s phenomenon (37%),&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Raynaud&#x27;s phenomenon&lt;/li&gt;&lt;li&gt;â€¢ Option D. lung involvemen t (14%) are less common.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ lung involvemen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the wide range of extraglandular manifestations in SjÃ¶gren&#x27;s syndrome is important for comprehensive patient care. While the primary symptoms involve dryness of the eyes and mouth, other organs can be affected, with arthralgias/arthritis being the most prevalent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with SjÃ¶gren&#x27;s syndrome presents with palpable purpura on the lower extremities, arthralgia, and peripheral neuropathy. Which of the following is the most likely underlying pathophysiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cryoglobulinemia-associated vasculitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;T-cell mediated cytotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Ro/SSA antibody-mediated damage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Granulomatous inflammation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cryoglobulinemia-associated vasculitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cryoglobulinemia-associated vasculitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. T-cell mediated cytotoxicity: T-cell mediated cytotoxicity is involved in other autoimmune diseases but not the primary mechanism in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B. T-cell mediated cytotoxicity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Ro/SSA antibody-mediated damage : Anti-Ro/SSA antibodies are associated with SjÃ¶gren&#x27;s but don&#x27;t directly cause vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Ro/SSA antibody-mediated damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Granulomatous inflammation: Granulomatous inflammation is more characteristic of conditions like sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Granulomatous inflammation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Cryoglobulinemia-associated vasculitis is a serious complication of SjÃ¶gren&#x27;s syndrome. Recognizing the associated symptoms and understanding the underlying pathophysiology is crucial for timely diagnosis and appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following autoantibodies is associated with an increased risk of multiple myeloma in SjÃ¶gren&#x27;s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-dsDNA antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Sm antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-centromere antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-Ro52 antibodies&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti-Ro52 antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti-Ro52 antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While the exact mechanism linking anti-Ro52 antibodies to multiple myeloma is not fully understood, this association highlights the importance of monitoring SjÃ¶gren&#x27;s patients with these antibodies for potential hematological malignancies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of well-controlled hypertension on medication presents with worsening Raynaud&#x27;s phenomenon over the past few months. He recently started taking a new medication for migraine prophylaxis. Which medication is most likely to be contributing to his worsening Raynaud&#x27;s?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium channel blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Angiotensin-converting enzyme (ACE) inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Statin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta blocker&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Beta blocker&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium channel blockers: These are often used to treat Raynaud&#x27;s phenomenon because they promote vasodilation and improve blood flow to the extremities.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Calcium channel blockers:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Angiotensin-converting enzyme (ACE) inhibitors: These medications can also help improve blood flow, but they are not as commonly used for Raynaud&#x27;s as calcium channel blockers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Angiotensin-converting enzyme (ACE) inhibitors:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Statins: Statins are used to lower cholesterol and are not known to worsen Raynaud&#x27;s phenomenon.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Statins:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ It is crucial to consider the potential impact of medications on Raynaud&#x27;s phenomenon when managing patients with this condition. Beta blockers should be used with caution or avoided in individuals with Raynaud&#x27;s, and alternative medications may need to be considered.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with a 2-year history of episodic color changes in her fingers when exposed to cold temperatures. The episodes start with blanching, followed by cyanosis, and then redness as her fingers rewarm. Physical examination reveals the changes shown in the picture. Which of the following is the most appropriate next step in differentiating primary from secondary raynaudâ€™s?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reassurance and observation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate treatment with nifedipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform nailfold capillaroscopy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Order an antinuclear antibody (ANA) test and rheumatoid factor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Perform nailfold capillaroscopy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/01/screenshot-2024-08-01-170358.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Perform nailfold capillaroscopy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reassurance and observation: While primary Raynaud&#x27;s phenomenon is generally benign, it&#x27;s crucial to rule out secondary causes, especially in patients with new-onset symptoms or those with additional features suggestive of a connective tissue disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reassurance and observation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate treatment with nifedipine: Nifedipine, a calcium channel blocker, can be helpful in managing Raynaud&#x27;s phenomenon, but it&#x27;s important to establish the diagnosis first.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Initiate treatment with nifedipine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Order an antinuclear antibody (ANA) test and rheumatoid factor: These tests can help identify underlying autoimmune diseases, but nailfold capillaroscopy is a more specific and sensitive test for differentiating primary and secondary Raynaud&#x27;s phenomenon.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Order an antinuclear antibody (ANA) test and rheumatoid factor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Nailfold capillaroscopy is a valuable diagnostic tool for distinguishing primary and secondary Raynaud&#x27;s phenomenon. Early differentiation is essential for identifying and managing any underlying connective tissue disease that may be causing the secondary Raynaud&#x27;s.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Raynaud&#x27;s phenomenon presents with severe digital ischemia and necrosis of the fingertips. Which of the following medications is most likely to be considered for treatment in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iloprost&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sildenafil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Iloprost&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Iloprost&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Nifedipine, losartan, and sildenafil are used in milder cases or as preventive measures.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize that severe Raynaud&#x27;s phenomenon requires aggressive treatment with potent vasodilators like iloprost to prevent tissue loss and improve outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man with secondary Raynaud&#x27;s phenomenon due to systemic sclerosis experiences severe episodes of digital ischemia, leading to fingertip ulcers. His condition has not improved with calcium channel blockers. Which of the following therapeutic options is most appropriate for managing his severe condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thermal biofeedback&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endothelin receptor antagonists&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topical nitroglycerin ointment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Endothelin receptor antagonists&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Endothelin receptor antagonists&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thermal biofeedback: This non-pharmacological therapy can be helpful in mild to moderate Raynaud&#x27;s, but it is unlikely to be sufficient for severe cases with digital ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thermal biofeedback:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Topical nitroglycerin ointment: This medication is primarily used to improve local blood flow and may be beneficial in milder cases of Raynaud&#x27;s, but its efficacy in severe cases with ulcers is limited.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Topical nitroglycerin ointment:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclophosphamide: Cyclophosphamide is an immunosuppressant used for severe manifestations of systemic sclerosis, but it is not the first-line treatment for Raynaud&#x27;s phenomenon.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cyclophosphamide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand that ERAs are effective in treating severe Raynaud&#x27;s phenomenon, especially in the context of systemic sclerosis. They target the endothelin pathway, which plays a key role in vasoconstriction and vascular remodelling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male with a history of alcohol abuse presents with sudden onset of severe pain, redness, and swelling in his left big toe. What is the MOST LIKELY diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gouty arthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudogout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gouty arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Gouty arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis : This is an autoimmune condition that typically affects multiple joints symmetrically (both sides of the body). It tends to develop gradually and doesn&#x27;t usually cause sudden, severe pain in a single joint like gout does.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudogout: While similar to gout in terms of causing acute joint pain, pseudogout more commonly affects the knee rather than the big toe. Also, it&#x27;s not as strongly associated with alcohol use as gout.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Pseudogout:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Osteoarthritis: This is a degenerative joint disease that usually develops slowly over time. It can affect the big toe, but the onset is typically more gradual and less severe than the sudden pain seen in gout.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Osteoarthritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gouty arthritis is a common inflammatory arthritis associated with alcohol use. It typically presents with sudden, severe pain, redness, and swelling in the big toe (podagra). Recognizing the classic presentation and risk factors can help guide appropriate diagnosis and treatment&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old office worker complains of pain and stiffness in the neck and shoulders. She reports feeling exhausted and having trouble sleeping. Physical examination is unremarkable. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fibromyalgia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymyalgia rheumatica&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fibromyalgia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fibromyalgia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymyalgia rheumatica (PMR): PMR typically affects older adults (over 50) and causes pain and stiffness in the shoulders and hips. It&#x27;s also associated with elevated inflammatory markers, which this patient lacks.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymyalgia rheumatica (PMR):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rheumatoid arthritis (RA): RA is an autoimmune disease that causes joint inflammation. While it can cause pain and fatigue, it usually affects multiple joints and would likely show up on a physical exam.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rheumatoid arthritis (RA):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Osteoarthritis (OA): OA is a degenerative joint disease that usually affects weight-bearing joints like the knees and hips. While it can affect the neck, it&#x27;s less common and usually occurs in older individuals with a history of joint wear and tear.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Osteoarthritis (OA):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fibromyalgia is a common chronic pain disorder affecting young to middle-aged women. It&#x27;s characterized by widespread pain, fatigue, sleep disturbances, and cognitive difficulties. The diagnosis is often made based on clinical presentation and the absence of other explanatory conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with joint pain undergoes arthrocentesis. The synovial fluid appears clear and forms a long string when expressed from the syringe. Which of the following is the most likely interpretation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal synovial fluid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Septic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Normal synovial fluid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Normal synovial fluid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Septic arthritis: This is an infection within a joint. The synovial fluid would typically be cloudy or purulent (pus-like) due to the presence of bacteria and white blood cells. It would not form a long string due to decreased viscosity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Septic arthritis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gout: Gout is caused by uric acid crystal deposition in the joints. While the synovial fluid can be inflammatory, it is not typically cloudy in the early stages. Urate crystals might be seen under a microscope, but the fluid would not necessarily lose its viscosity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gout:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rheumatoid arthritis: This is an autoimmune disease causing chronic joint inflammation. Synovial fluid in rheumatoid arthritis can be cloudy and less viscous, but not always.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rheumatoid arthritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Normal synovial fluid is clear or pale yellow, with normal viscosity, and forms a string when expressed. Abnormal findings can indicate infection, inflammation, or other joint pathology.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with a swollen, painful knee. Synovial fluid analysis reveals a cloudy, yellow fluid with a WBC count of 60,000/Î¼L and a predominance of neutrophils. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal synovial fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Septic arthritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Septic arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Septic arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Normal synovial fluid: Normal synovial fluid is clear or pale yellow, with a low white blood cell (WBC) count (&amp;lt;200/ÂµL) and few neutrophils.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Normal synovial fluid:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gout: While gout can cause inflammation in the joint, the synovial fluid typically contains urate crystals and a lower WBC count (usually under 50,000/ÂµL) compared to septic arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gout:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteoarthritis: Osteoarthritis is a degenerative joint disease, and the synovial fluid is usually clear or slightly yellow with a low WBC count and few inflammatory cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteoarthritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Septic arthritis is a joint infection characterized by cloudy, yellow synovial fluid with a high WBC count and predominantly neutrophils. Prompt diagnosis and treatment are crucial to prevent joint damage and complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman presents with pain and swelling in multiple joints, including the wrists, hands (predominantly PIP/MTP joints, sparing DIP), and knees. She reports morning stiffness lasting over an hour. Which of the following statements is MOST accurate regarding her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Her risk of rheumatoid arthritis (RA) is increased if she has a history of smoking.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Her risk of RA is decreased if she has a family history of autoimmune disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RA affects men and women equally.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RA is primarily a disease of the elderly.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Her risk of rheumatoid arthritis (RA) is increased if she has a history of smoking.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Her risk of rheumatoid arthritis (RA) is increased if she has a history of smoking.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Her risk of RA is decreased if she has a family history of autoimmune disease: A family history of autoimmune disease actually increases the risk of developing RA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Her risk of RA is decreased if she has a family history of autoimmune disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. RA affects men and women equally : RA is more common in women than men, with a ratio of approximately 3:1.&lt;/li&gt;&lt;li&gt;â€¢ Option C. RA affects men and women equally&lt;/li&gt;&lt;li&gt;â€¢ Option D. RA is primarily a disease of the elderly : While RA can occur at any age, it most commonly begins between the ages of 30 and 60.&lt;/li&gt;&lt;li&gt;â€¢ Option D. RA is primarily a disease of the elderly&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the risk factors for rheumatoid arthritis (RA) is crucial for identifying individuals at higher risk and potentially implementing preventive measures or early interventions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which HLA-DRB1 allele is associated with the HIGHEST risk of developing rheumatoid arthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;*0101&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;*0404&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;*0401&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;*1001&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. *0401&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) *0401&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. *0101 : This is a moderate risk allele, not the highest.&lt;/li&gt;&lt;li&gt;â€¢ Option A. *0101&lt;/li&gt;&lt;li&gt;â€¢ Option B. *0404 : This is also a moderate risk allele.&lt;/li&gt;&lt;li&gt;â€¢ Option B. *0404&lt;/li&gt;&lt;li&gt;â€¢ Option D. *1001 : Another moderate risk allele&lt;/li&gt;&lt;li&gt;â€¢ Option D. *1001&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HLA-DRB1 alleles, particularly *0401, are important genetic risk factors for rheumatoid arthritis. Understanding the role of these alleles in RA development can help with risk assessment and potentially inform personalized treatment approaches in the future.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with rheumatoid arthritis (RA) presents with pain and swelling in the distal interphalangeal (DIP) joints of their fingers. Which of the following statements is MOST likely true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DIP joint involvement is a common initial manifestation of RA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DIP joint involvement is rare in RA and should prompt consideration of other diagnoses.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DIP joint involvement in RA usually indicates coexisting osteoarthritis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DIP joint involvement in RA typically responds poorly to standard RA treatment.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. DIP joint involvement in RA usually indicates coexisting osteoarthritis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) DIP joint involvement in RA usually indicates coexisting osteoarthritis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. DIP joint involvement is a common initial manifestation of RA: DIP involvement is less common than PIP/MCP in early RA.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ DIP joint involvement is a common initial manifestation of RA:&lt;/li&gt;&lt;li&gt;â€¢ Option B. DIP joint involvement is rare in RA and should prompt consideration of other diagnoses: DIP involvement in RA can occur, but suggests possible co-existing osteoarthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. DIP joint involvement is rare in RA and should prompt consideration of other diagnoses:&lt;/li&gt;&lt;li&gt;â€¢ Option D. DIP joint involvement in RA typically responds poorly to standard RA treatment: RA treatment should help DIP involvement if due to RA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. DIP joint involvement in RA typically responds poorly to standard RA treatment:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ DIP joint involvement in RA is less common than PIP and MCP joint involvement. It often suggests coexisting osteoarthritis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common flexor tendon to be affected by rheumatoid arthritis (RA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flexor digitorum superficialis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flexor digitorum profundus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flexor carpi radialis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Flexor pollicis longus&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Flexor pollicis longus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Flexor pollicis longus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Options (A, B, C): While other flexor tendons (flexor digitorum superficialis, flexor digitorum profundus, flexor carpi radialis) can be involved in RA, the FPL is the most frequently affected .&lt;/li&gt;&lt;li&gt;â€¢ Options (A, B, C):&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The flexor pollicis longus tendon is the most commonly affected flexor tendon in RA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about wrist involvement in RA is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It often occurs early in the disease course.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It typically involves the radiocarpal and intercarpal joints.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is always symmetrical.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can lead to carpal tunnel syndrome.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is always symmetrical.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is always symmetrical.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It often occurs early in the disease course : It often occurs early: True.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It often occurs early in the disease course&lt;/li&gt;&lt;li&gt;â€¢ Option B. It typically involves the radiocarpal and intercarpal joints : It typically involves the radiocarpal and intercarpal joints: True.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ It typically involves the radiocarpal and intercarpal joints&lt;/li&gt;&lt;li&gt;â€¢ Option D. It can lead to carpal tunnel syndrome: It can lead to carpal tunnel syndrome: True due to synovial inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It can lead to carpal tunnel syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ While wrist involvement is common in RA, it is not always symmetrical, particularly in the early stages of the disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is false regarding extra-articular manifestation of RA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Extra-articular manifestations may develop in 40% of patients.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Extra-articular manifestations will always occur after the onset of arthritis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patients most likely to develop extraarticular disease have a history of cigarette smoking.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;~10% of patients with RA have secondary SjÃ¶grenâ€™s syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Extra-articular manifestations will always occur after the onset of arthritis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Extra-articular manifestations will always occur after the onset of arthritis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Extra-articular manifestations may develop in 40% of patients: This is true.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Extra-articular manifestations may develop in 40% of patients:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patients most likely to develop extraarticular disease have a history of cigarette smoking: This is generally true, as smoking is a known risk factor for both RA and its extra-articular manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patients most likely to develop extraarticular disease have a history of cigarette smoking:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ~10% of patients with RA have secondary SjÃ¶grenâ€™s syndrome: This is also true. Secondary SjÃ¶gren&#x27;s syndrome is a common extra-articular manifestation of RA, affecting approximately 10% of patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ~10% of patients with RA have secondary SjÃ¶grenâ€™s syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ EAMs are common in RA and can affect various organs. Recognizing them is crucial for early diagnosis and appropriate management to prevent complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is FALSE regarding Felty&#x27;s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a triad of neutropenia, splenomegaly, and nodular RA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It typically occurs in the late stages of severe RA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Its incidence is increasing with more aggressive RA treatment.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is more common in whites than other racial groups.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Its incidence is increasing with more aggressive RA treatment.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Its incidence is increasing with more aggressive RA treatment.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a triad of neutropenia, splenomegaly, and nodular RA: This is the classic definition of Felty&#x27;s syndrome. Neutropenia is a low count of neutrophils (a type of white blood cell), splenomegaly is an enlarged spleen, and nodular RA refers to the presence of rheumatoid nodules.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a triad of neutropenia, splenomegaly, and nodular RA:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It typically occurs in the late stages of severe RA: Felty&#x27;s syndrome is usually seen in patients who have had RA for a long time and whose disease is not well controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It typically occurs in the late stages of severe RA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is more common in whites than other racial groups: While the exact reason is unknown, studies have shown that Felty&#x27;s syndrome is more prevalent in white populations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is more common in whites than other racial groups:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Felty&#x27;s syndrome is a rare but severe complication of RA. Recognizing its classic triad (neutropenia, splenomegaly, nodular RA) is crucial for timely intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is TRUE regarding the treatment of Caplan&#x27;s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It primarily involves treating the underlying pneumoconiosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It requires aggressive immunosuppression to control the lung nodules.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It focuses on managing the rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;There is no specific treatment for Caplan&#x27;s syndrome.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It focuses on managing the rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It focuses on managing the rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs).&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It primarily involves treating the underlying pneumoconiosis: Treating pneumoconiosis alone won&#x27;t address the RA component.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It primarily involves treating the underlying pneumoconiosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It requires aggressive immunosuppression to control the lung nodules : Aggressive immunosuppression is not typically required.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It requires aggressive immunosuppression to control the lung nodules&lt;/li&gt;&lt;li&gt;â€¢ Option D. There is no specific treatment for Caplan&#x27;s syndrome : There is a specific treatment approach, focused on managing RA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. There is no specific treatment for Caplan&#x27;s syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Caplan&#x27;s syndrome is a rare lung disease occurring in individuals with RA and exposure to dust. Treatment focuses on managing RA to improve both joint and lung outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common cause of death in patients with rheumatoid arthritis (RA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infectious diseases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory diseases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiovascular disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiovascular disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cardiovascular disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Infectious diseases: While RA patients may be at a slightly increased risk of infections due to immunosuppressive treatments, it is not the most common cause of death.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Infectious diseases:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Respiratory diseases: Respiratory complications can occur in RA, such as interstitial lung disease, but CVD is still a more significant risk factor.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Respiratory diseases:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cancer: Some studies suggest a slightly elevated cancer risk in RA, but it is not the primary cause of death.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the increased risk of CVD in RA is essential for implementing preventive strategies like lifestyle modifications and appropriate medication to reduce cardiovascular mortality.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient&#x27;s hand is shown in the picture below. Which of the following is the MOST LIKELY associated underlying condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Psoriatic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gout&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Rheumatoid arthritis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/picture4_3vVtYeA.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Rheumatoid arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Osteoarthritis: Can cause joint deformities, but they typically present as bony enlargements (Heberden&#x27;s and Bouchard&#x27;s nodes) rather than the specific swan neck configuration.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Osteoarthritis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Psoriatic arthritis: Can involve various joints, it doesn&#x27;t typically cause the swan neck deformity.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Psoriatic arthritis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gout: Usually affects the big toe and other joints, causing acute inflammatory attacks, but not the swan neck deformity.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Gout:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the swan neck deformity is essential for identifying potential RA in patients presenting with hand deformities. It highlights the importance of a thorough assessment, including history, physical examination, and potentially laboratory and imaging studies, to confirm the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinical photograph shows a patient&#x27;s hand with a visible deformity of the ring finger. There is no sign of trauma, and the patient has a known history of chronic synovitis. Which of the following conditions does this finger deformity represent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Swan neck deformity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Boutonniere deformity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trigger finger&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Jersey finger&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Boutonniere deformity&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/picture5_xQGW74n.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/20/picture6_akQEJNQ.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/02/screenshot-2024-08-02-115356.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Boutonniere deformity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A . Swan neck deformity: Swan neck deformity is characterized by hyperextension of the PIP joint and flexion of the DIP joint, which is the opposite of the observed deformity.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Swan neck deformity:&lt;/li&gt;&lt;li&gt;â€¢ Option C . Trigger finger: Trigger finger involves the locking of a finger in a bent position, typically at the metacarpophalangeal joint, not the PIP joint.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Trigger finger:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Jersey finger: Jersey finger is an injury to the flexor tendon of the finger, which usually presents with an inability to flex the DIP joint, contrasting with the hyperextension seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Jersey finger:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Boutonniere deformity is a common complication of chronic synovitis, often seen in conditions like rheumatoid arthritis. Recognizing this deformity can aid in diagnosing the underlying condition and guide appropriate treatment to prevent further joint damage and functional impairment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is TRUE regarding rheumatoid factor (RF) in rheumatoid arthritis (RA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;All RA patients have a positive RF test.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A positive RF test is diagnostic for RA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A negative RF test rules out RA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RF can be present in both healthy individuals and those with RA.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. RF can be present in both healthy individuals and those with RA.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) RF can be present in both healthy individuals and those with RA.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. All RA patients have a positive RF test: Not all RA patients have a positive RF test. Some patients have seronegative RA, meaning they test negative for both RF and anti-CCP antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. All RA patients have a positive RF test:&lt;/li&gt;&lt;li&gt;â€¢ Option B. A positive RF test is diagnostic for RA: While a positive RF increases the risk of RA, it&#x27;s not diagnostic on its own. Other conditions can cause elevated RF, and some RA patients are seronegative.&lt;/li&gt;&lt;li&gt;â€¢ Option B. A positive RF test is diagnostic for RA:&lt;/li&gt;&lt;li&gt;â€¢ Option C. A negative RF test rules out RA: A negative RF test doesn&#x27;t necessarily rule out RA. Some patients have seronegative RA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A negative RF test rules out RA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the limitations of RF testing is crucial for accurate RA diagnosis. A positive RF test should be interpreted in conjunction with clinical presentation, other lab tests (like anti-CCP antibodies), and imaging findings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with early morning stiffness and swelling in multiple small joints of the hands. Which of the following imaging modalities is MOST sensitive for detecting early synovitis in suspected rheumatoid arthritis (RA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plain radiography (X-ray)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Computed tomography (CT) scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Magnetic resonance imaging (MRI)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Magnetic resonance imaging (MRI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Magnetic resonance imaging (MRI)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Plain radiography (X-ray): X-rays are insensitive for detecting synovitis, as they primarily image bone and can miss soft tissue inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Plain radiography (X-ray):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ultrasound : While ultrasound is a good option for visualizing synovitis, it may not be as sensitive as MRI for detecting very early inflammatory changes, especially in deeper joints.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ultrasound&lt;/li&gt;&lt;li&gt;â€¢ Option C. Computed tomography (CT) scan: CT scans are not routinely used for diagnosing RA due to higher radiation exposure compared to X-ray and MRI. They also may not be as sensitive for detecting synovitis as MRI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Computed tomography (CT) scan:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ MRI is the preferred imaging modality for early detection of synovitis in RA. Early diagnosis and intervention are crucial for preventing joint damage and improving long-term outcomes in RA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient newly diagnosed with rheumatoid arthritis (RA) is prescribed methotrexate. The patient asks when they can expect to see improvement in their symptoms. Which of the following is the most appropriate response?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Within a few days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Within 1-2 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Within 6-12 weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Within 6-12 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Within 6-12 weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Within 6-12 weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Within a few days and Option B. Within 1-2 weeks: These time frames are too short for the onset of DMARDs&#x27; action.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Within a few days&lt;/li&gt;&lt;li&gt;â€¢ Option B. Within 1-2 weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Within 6-12 months: This time frames is too long; improvement should be evident sooner&lt;/li&gt;&lt;li&gt;â€¢ Option D. Within 6-12 months:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Managing patient expectations regarding the onset of action of DMARDs is important for adherence and successful treatment. Patients should be counselled about the delayed onset of action and encouraged to continue therapy even if they don&#x27;t experience immediate relief.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding chronic low-dose prednisone therapy in rheumatoid arthritis (RA) is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It should be the first-line treatment for all RA patients.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is not associated with any long-term complications.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It should be avoided whenever possible due to the risk of osteoporosis and other side effects.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is safe to abruptly discontinue prednisone without tapering.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It should be avoided whenever possible due to the risk of osteoporosis and other side effects.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It should be avoided whenever possible due to the risk of osteoporosis and other side effects.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It should be the first-line treatment for all RA patients : Prednisone is not a first-line treatment, as other DMARDs are preferred initially.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It should be the first-line treatment for all RA patients&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is not associated with any long-term complications : It is associated with numerous long-term complications.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is not associated with any long-term complications&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is safe to abruptly discontinue prednisone without tapering : Abrupt discontinuation can lead to adrenal insufficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is safe to abruptly discontinue prednisone without tapering&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ While low-dose prednisone can provide rapid symptomatic relief in RA, its long-term use should be minimized due to potential complications. It is often used as a bridge therapy while waiting for DMARDs to take effect or as an adjunctive treatment for flares.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male with early ankylosing spondylitis (AS) and evidence of sacroiliitis on MRI is considering treatment options. Which of the following statements is MOST accurate regarding the potential benefits of early anti-TNF therapy in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-TNF therapy is contraindicated in early AS due to the risk of exacerbating spinal fusion.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early initiation of anti-TNF therapy may decrease the risk of spinal fusion in the long term.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-TNF therapy should only be considered after spinal fusion has occurred.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-TNF therapy has no impact on the progression of spinal fusion in AS.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Early initiation of anti-TNF therapy may decrease the risk of spinal fusion in the long term.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Early initiation of anti-TNF therapy may decrease the risk of spinal fusion in the long term.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-TNF therapy is contraindicated in early AS due to the risk of exacerbating spinal fusion : Anti-TNF therapy is not contraindicated; it might actually be beneficial in preventing fusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-TNF therapy is contraindicated in early AS due to the risk of exacerbating spinal fusion&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-TNF therapy should only be considered after spinal fusion has occurred: Early intervention is preferred to prevent irreversible damage.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-TNF therapy should only be considered after spinal fusion has occurred:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-TNF therapy has no impact on the progression of spinal fusion in AS: Anti-TNF therapy does have an impact on slowing down structural damage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-TNF therapy has no impact on the progression of spinal fusion in AS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Early intervention with anti-TNF therapy is crucial in AS to prevent irreversible structural damage and maintain spinal flexibility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with stiffness and mild pain in his thoracic spine. Radiographs reveal flowing ossification along the anterior vertebral bodies, with preserved intervertebral disc spaces. Sacroiliac and facet joints appear normal. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse idiopathic skeletal hyperostosis (DISH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse idiopathic skeletal hyperostosis (DISH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse idiopathic skeletal hyperostosis (DISH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ankylosing spondylitis : Typically involves sacroiliac joints and can lead to fusion of the spine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ankylosing spondylitis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osteoarthritis : Affects the joints primarily, not the ligaments.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Osteoarthritis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rheumatoid arthritis : An inflammatory arthritis that can affect the spine but not in this characteristic pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rheumatoid arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ DISH is a common condition in older adults characterized by bony outgrowths in the spine. Recognizing its typical radiographic features is essential for accurate diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with AS planned for etanercept therapy, should be screened for which of the following conditions BEFORE initiating treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Latent tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatitis B and C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Human Immunodeficiency Virus (HIV)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Anti-TNF therapy can reactivate latent infections like TB and worsen hepatitis or HIV, so screening is crucial.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Screening for infections before initiating anti-TNF therapy is crucial for patient safety and preventing complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is TRUE regarding the relationship between psoriasis and psoriatic arthritis (PsA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;All patients with psoriasis will eventually develop PsA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PsA always develops before the onset of psoriasis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Up to 30% of patients with psoriasis may develop PsA.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Psoriasis and PsA are caused by different underlying mechanisms.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Up to 30% of patients with psoriasis may develop PsA.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Up to 30% of patients with psoriasis may develop PsA.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. All patients with psoriasis will eventually develop PsA: Not all psoriasis patients develop PsA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. All patients with psoriasis will eventually develop PsA:&lt;/li&gt;&lt;li&gt;â€¢ Option B. PsA always develops before the onset of psoriasis: PsA can develop before, after, or concurrently with psoriasis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PsA always develops before the onset of psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Psoriasis and PsA are caused by different underlying mechanisms : Both conditions share similar underlying inflammatory pathways.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Psoriasis and PsA are caused by different underlying mechanisms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Psoriasis and PsA are linked, but not everyone with psoriasis will develop PsA. Recognizing the potential for PsA is crucial for early diagnosis and intervention to prevent joint damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with psoriatic arthritis (PsA) is found to have elevated serum levels of RANKL. Which of the following is the most likely consequence of this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased bone resorption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased bone formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased osteoclastogenesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased inflammation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased osteoclastogenesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased osteoclastogenesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased bone resorption : RANKL promotes, not decreases, bone resorption.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased bone resorption&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased bone formation : RANKL primarily affects osteoclasts, not osteoblasts.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased bone formation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased inflammation : RANKL is pro-inflammatory and can exacerbate the inflammatory process.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ RANKL plays a crucial role in bone remodeling and is implicated in the pathogenesis of PsA. Understanding its role can lead to the development of targeted therapies aimed at inhibiting RANKL to prevent joint damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is TRUE regarding arthritis mutilans in psoriatic arthritis (PsA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a common finding in most PsA patients.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It typically occurs early in the disease course.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is associated with a good prognosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can lead to significant functional impairment.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It can lead to significant functional impairment.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It can lead to significant functional impairment.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a common finding in most PsA patients: It is a rare and severe form of PsA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is a common finding in most PsA patients:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It typically occurs early in the disease course: It usually occurs in long-standing, poorly controlled PsA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It typically occurs early in the disease course:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is associated with a good prognosis: It has a poor prognosis due to its destructive nature.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is associated with a good prognosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Arthritis mutilans is a rare but devastating complication of PsA. Early recognition and aggressive treatment are essential to preserve joint function and quality of life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the structure of infliximab?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fully human monoclonal antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fully mouse monoclonal antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chimeric monoclonal antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Humanized monoclonal antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chimeric monoclonal antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Chimeric monoclonal antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fully human monoclonal antibody : These are entirely derived from human sources.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fully human monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fully mouse monoclonal antibody : These are entirely derived from mouse sources and can trigger immune reactions in humans.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Fully mouse monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option D. Humanized monoclonal antibody : These have a higher proportion of human components than chimeric antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Humanized monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the structure of monoclonal antibodies is crucial for comprehending their mechanism of action and potential for adverse effects. Chimeric antibodies offer a balance between efficacy and reduced immunogenicity compared to fully mouse antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a direct comparison study for the treatment of PsA, the efficacy of tofacitinib was found to be:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Superior to adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inferior to adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Comparable to adalimumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not comparable to adalimumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Comparable to adalimumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Comparable to adalimumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Options A. Superior to adalimumab &amp;amp; B. Inferior to adalimumab suggest a difference in efficacy, which is not supported by evidence.&lt;/li&gt;&lt;li&gt;â€¢ Options A. Superior to adalimumab &amp;amp; B. Inferior to adalimumab&lt;/li&gt;&lt;li&gt;â€¢ Option D . Not comparable to adalimumab suggests no comparison was made, which is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Not comparable to adalimumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Both tofacitinib (a Janus kinase inhibitor) and adalimumab (a TNF inhibitor) are effective treatment options for PsA. The choice between them may depend on individual patient factors, comorbidities, and preferences.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents with acute onset asymmetric oligoarthritis following a gastrointestinal infection. He is HLA-B27 positive. Synovial fluid analysis is most likely to reveal:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monosodium urate crystals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calcium pyrophosphate crystals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aseptic inflammatory pattern&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Septic arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aseptic inflammatory pattern&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aseptic inflammatory pattern&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Monosodium urate crystals are characteristic of gout,&lt;/li&gt;&lt;li&gt;â€¢ Option A. Monosodium urate crystals&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcium pyrophosphate crystals of pseudogout, and&lt;/li&gt;&lt;li&gt;â€¢ Option B. Calcium pyrophosphate crystals&lt;/li&gt;&lt;li&gt;â€¢ Option D. Septic arthritis involves infection of the joint.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Septic arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the typical synovial fluid findings in reactive arthritis helps differentiate it from septic arthritis (where bacteria are present in the joint) and crystal-induced arthritis (where crystals are found in the fluid).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following skin manifestations is most specific for reactive arthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Keratoderma blennorrhagica&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythema nodosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Erythema multiforme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Keratoderma blennorrhagica&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Keratoderma blennorrhagica&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Psoriasis: While psoriasis can occur in patients with ReA, it is not specific to this condition and has a distinct pathophysiology unrelated to ReA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Erythema nodosum: Erythema nodosum is a panniculitis (inflammation of subcutaneous fat) that can be triggered by various infections and inflammatory conditions, including ReA. However, it is not specific to ReA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Erythema nodosum:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Erythema multiforme: Erythema multiforme is a hypersensitivity reaction often triggered by infections (e.g., herpes simplex virus) or medications. While it can occasionally occur in the context of ReA, it is not a specific manifestation of this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Erythema multiforme:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Keratoderma blennorrhagica is a hallmark feature of reactive arthritis and can aid in diagnosis, especially when accompanied by other characteristic symptoms like arthritis, urethritis, and conjunctivitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most appropriate initial treatment for acute reactive arthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sulfasalazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High-dose NSAIDs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intra-articular corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. High-dose NSAIDs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) High-dose NSAIDs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate: Methotrexate is a disease-modifying antirheumatic drug (DMARD) used for chronic inflammatory arthritis like rheumatoid arthritis. It is not typically used as the initial treatment for acute reactive arthritis due to its delayed onset of action and potential side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sulfasalazine: Sulfasalazine is another DMARD with anti-inflammatory properties. While it may be considered in cases of persistent ReA that do not respond to NSAIDs, it is not the first-line treatment due to its slower onset of action and potential gastrointestinal side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sulfasalazine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intra-articular corticosteroids: These are steroid injections directly into the affected joint. While they can be effective in reducing inflammation and pain in a specific joint, they are not the initial treatment of choice for ReA, as the condition often affects multiple joints and may resolve spontaneously or with NSAIDs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intra-articular corticosteroids:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Prompt initiation of high-dose NSAIDs is crucial for managing acute reactive arthritis and minimizing joint damage. If NSAIDs are ineffective or contraindicated, other options like intra-articular corticosteroids or DMARDs may be considered.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Crohn&#x27;s disease presents with acute hip pain and limited range of motion. Radiographs show severe joint space narrowing and osteolysis of the femoral head. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Avascular necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Septic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isolated destructive hip arthritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Isolated destructive hip arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Isolated destructive hip arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Osteoarthritis (OA): While OA is a common cause of hip pain and joint space narrowing, it typically presents with gradual onset, and radiographs show osteophyte formation (bone spurs) rather than osteolysis (bone destruction). The acute presentation and destructive pattern seen in this patient make OA less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Osteoarthritis (OA):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Avascular necrosis (AVN): AVN of the femoral head can also cause hip pain and radiographic changes, but it often presents with a subacute or chronic course. Furthermore, the radiographic findings in AVN usually include sclerosis (increased bone density) and subchondral collapse, which are not as prominent in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Avascular necrosis (AVN):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Septic arthritis: Septic arthritis is an infection of the joint that can cause acute pain and joint destruction. However, it is usually accompanied by systemic symptoms like fever and elevated inflammatory markers. Additionally, joint aspiration would reveal purulent fluid with positive cultures, which is not the case here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Septic arthritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ It&#x27;s important to be aware of isolated destructive hip arthritis as a potential complication in Crohn&#x27;s disease patients, as it requires prompt recognition and specific management strategies to prevent further joint damage and disability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following skin manifestations is MOST characteristic of SAPHO syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythema nodosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Palmoplantar pustulosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyoderma gangrenosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Psoriasis vulgaris&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Palmoplantar pustulosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Palmoplantar pustulosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other options are not typically associated with SAPHO syndrome (syndrome of synovitis, acne, pustulosis, hyperostosis, and osteitis), although they can be seen in other inflammatory conditions.&lt;/li&gt;&lt;li&gt;â€¢ other options&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing palmoplantar pustulosis as a key feature of SAPHO syndrome can aid in the diagnosis and guide appropriate management of this complex inflammatory disorder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents with sudden onset of severe pain and swelling in his right great toe at 3 AM. He has a history of hypertension and hyperlipidemia. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Septic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudogout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute gouty arthritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acute gouty arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Acute gouty arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis typically presents with symmetric polyarthritis and morning stiffness.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Septic arthritis would usually be accompanied by fever and systemic signs of infection.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Septic arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudogout can mimic gout but is less likely to involve the great toe.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudogout&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Acute gouty arthritis is a common inflammatory arthritis characterized by sudden onset severe pain in a single joint, often the great toe. Recognizing the classic presentation and risk factors can help guide appropriate diagnosis and treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with acute pain and swelling in the knee, and synovial fluid analysis reveals rhomboid-shaped crystals with positive birefringence under polarized light microscopy. Which of the following genetic mutations is most likely associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PRPP synthetase mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HPRT mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ANKH mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COL2A1 mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ANKH mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) ANKH mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRPP synthetase mutation: This mutation is associated with increased uric acid production and is a known cause of gout, not pseudogout. Gout typically presents with needle-shaped crystals with negative birefringence under polarized light microscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRPP synthetase mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. HPRT mutation: This mutation leads to Lesch-Nyhan syndrome, a rare genetic disorder characterized by hyperuricemia and neurological symptoms. While Lesch-Nyhan syndrome can cause gout, it&#x27;s not directly linked to pseudogout or CPPD crystal formation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HPRT mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. COL2A1 mutation: This mutation is associated with various skeletal dysplasias, including some types of osteoarthritis. While it can affect joint health, it doesn&#x27;t directly cause pseudogout or CPPD crystal deposition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. COL2A1 mutation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the genetic basis of pseudogout is crucial for accurate diagnosis and the development of targeted therapies. Identifying the ANKH mutation in patients with pseudogout can also help assess the risk of familial transmission and guide genetic counseling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of gout presents with an acute flare. He is currently taking clarithromycin for a respiratory infection. Which of the following medications should be used with caution in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Celecoxib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Colchicine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Colchicine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other medications are not significantly affected by CYP3A4 interactions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Be aware of potential drug interactions when prescribing colchicine, especially with medications that affect CYP3A4 metabolism. Dose adjustments or alternative medications may be necessary to avoid adverse effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with recurrent gout flares has failed to achieve target serum urate levels with allopurinol alone. Which of the following is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase the dose of allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Switch to febuxostat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add probenecid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Consider pegloticase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Add probenecid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Add probenecid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Increasing allopurinol dose might be an option, but the patient may have already reached the maximum tolerated dose. Switching to febuxostat or considering pegloticase are options for patients who do not tolerate or respond to allopurinol/probenecid combination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understand the various treatment options for gout and the rationale for combining different medications to achieve target serum urate levels. While increasing the allopurinol dose may be considered, it&#x27;s important to balance efficacy with potential side effects and consider the maximum tolerated dose. Switching to febuxostat or pegloticase might be considered in patients who don&#x27;t tolerate or respond to allopurinol/probenecid combination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with gout and stage 3 chronic kidney disease tests positive for the HLA-B*5801 allele. Which of the following is the most appropriate urate-lowering therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol at a reduced dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Probenecid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Febuxostat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Febuxostat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Febuxostat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allopurinol at a reduced dose: Allopurinol should be avoided in patients with HLA-B*5801 positivity due to the risk of SCARs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allopurinol at a reduced dose:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Probenecid: Probenecid is not recommended in patients with CKD due to the risk of kidney stones.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Probenecid:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colchicine: Colchicine is not a urate-lowering therapy but is used for acute gout flare management.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Colchicine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Patients with gout and HLA-B*5801 positivity should be screened before starting allopurinol due to the risk of SCARs. Febuxostat is a safe and effective alternative in these patients, even in the presence of CKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the pathophysiology behind paradoxical gout flares?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased production of uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased renal excretion of uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inflammatory reaction to MSU crystals shed from dissolving tophi&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune complex formation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inflammatory reaction to MSU crystals shed from dissolving tophi&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Inflammatory reaction to MSU crystals shed from dissolving tophi&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other options are not the primary mechanisms behind paradoxical flares.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Paradoxical gout flares are a common complication of ULT initiation. They are usually self-limited and can be managed with prophylactic anti-inflammatory medications. Recognizing this phenomenon can help healthcare providers explain it to patients and ensure proper management during ULT initiation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic polymorphisms is most strongly associated with an increased risk of osteoarthritis (OA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HLA-B27&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GDF5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NOD2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PTPN22&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. GDF5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) GDF5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. HLA-B27: This gene is primarily associated with ankylosing spondylitis and other inflammatory conditions, not osteoarthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HLA-B27:&lt;/li&gt;&lt;li&gt;â€¢ Option C. NOD2: This gene is associated with Crohn&#x27;s disease, an inflammatory bowel disease, and not directly linked to osteoarthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. NOD2:&lt;/li&gt;&lt;li&gt;â€¢ Option D. PTPN22: This gene is associated with autoimmune diseases such as rheumatoid arthritis and type 1 diabetes, but not with osteoarthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. PTPN22:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the genetic factors that contribute to OA susceptibility can help identify individuals at higher risk and potentially lead to the development of personalized prevention and treatment strategies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The presence of osteophytes in a joint is most indicative of which stage of osteoarthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early OA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Moderate OA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Late OA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteophytes are not specific to any stage of OA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Late OA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Late OA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ While osteophytes may be present in earlier stages, they are more prominent and widespread in late-stage OA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the radiographic features of OA, such as osteophytes, can help clinicians determine the stage and severity of the disease, which can guide treatment decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following interventions is most likely to result in sustained weight loss and improvement in knee OA symptoms in the long term?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A very low-calorie diet for rapid weight loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A combination of diet, exercise, and behavioral therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Over-the-counter weight loss supplements&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liposuction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A combination of diet, exercise, and behavioral therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A combination of diet, exercise, and behavioral therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. A very low-calorie diet for rapid weight loss: Very low-calorie diets are often difficult to sustain and may not be safe for everyone.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A very low-calorie diet for rapid weight loss:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Over-the-counter weight loss supplements: Weight loss supplements have limited efficacy and potential side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Over-the-counter weight loss supplements:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liposuction: Liposuction is not a sustainable weight loss solution and does not address the underlying lifestyle factors contributing to OA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liposuction:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Sustainable weight loss and lifestyle modifications are crucial for managing knee OA. A comprehensive approach involving diet, exercise, and behavioral changes is most likely to result in long-term improvement in symptoms and joint health.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common form of bursitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Olecranon bursitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prepatellar bursitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischial bursitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subacromial bursitis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Subacromial bursitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Subacromial bursitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ The other options represent different types of bursitis that occur in other locations in the body (elbow, knee, and hip, respectively).&lt;/li&gt;&lt;li&gt;â€¢ other options&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Bursitis is the inflammation of a bursa, a fluid-filled sac that cushions and reduces friction between bones, tendons, and muscles near joints. Subacromial bursitis is the most common type, typically affecting the shoulder due to overuse or injury.&lt;/li&gt;&lt;li&gt;âž¤ Bursitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with progressive muscle weakness, difficulty swallowing, and a persistent skin rash. She reports feeling tired and experiencing muscle aches. Physical examination reveals erythematous papules and plaques over the knuckles and elbows. Additionally, she has a purplish rash on her eyelids and periorbital edema. On examination patient&#x27;s hands showing erythematous papules and plaques over the knuckles (as shown in the image below): Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scleroderma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dermatomyositis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-120241.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dermatomyositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE): While SLE can present with muscle weakness and skin rash, the pattern of skin involvement and presence of Gottron sign are more characteristic of dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis: Psoriasis typically presents with well-demarcated, silvery plaques on extensor surfaces, not the violaceous rash seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Scleroderma: Scleroderma is characterized by skin thickening and fibrosis, not the muscle weakness and specific rash seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Scleroderma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the key clinical features of dermatomyositis, including Gottron&#x27;s papules and heliotrope rash, as these are important for early diagnosis and prompt initiation of treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In adult-onset dermatomyositis, the approximate risk of developing a malignancy within the first 2-3 years is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;15%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;30%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 15%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 15%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1% : This underestimates the risk of malignancy in adult-onset dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1%&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5% : While a significant risk, this is lower than the actual estimated risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5%&lt;/li&gt;&lt;li&gt;â€¢ Option D. 30% : This overestimates the risk of malignancy in adult-onset dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 30%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Be aware of the increased risk of malignancy in adult-onset dermatomyositis and consider appropriate screening and surveillance for these patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The predominant inflammatory cell infiltrate in the muscle tissue of dermatomyositis patients is composed of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neutrophils&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eosinophils&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macrophages, B cells, and plasmacytoid dendritic cells (PDCs)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphocytes and plasma cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Macrophages, B cells, and plasmacytoid dendritic cells (PDCs)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Macrophages, B cells, and plasmacytoid dendritic cells (PDCs)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neutrophils : Not the predominant cell type&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neutrophils&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eosinophils : Not the predominant cell type&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eosinophils&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lymphocytes and plasma cells : While present, not the most prominent cell types&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lymphocytes and plasma cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the immune cell composition in dermatomyositis can help elucidate the underlying pathophysiology of the disease and guide the development of targeted therapies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT associated with a favorable prognosis in dermatomyositis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early diagnosis and treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Young age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of interstitial lung disease (ILD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of anti-Mi-2 antibodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of interstitial lung disease (ILD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Presence of interstitial lung disease (ILD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Early diagnosis and treatment: Early diagnosis and aggressive treatment can significantly improve outcomes in dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Early diagnosis and treatment:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Young age: Younger patients generally have a better prognosis than older patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Young age:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Presence of anti-Mi-2 antibodies: The presence of anti-Mi-2 antibodies is often associated with a milder disease course and better response to treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Presence of anti-Mi-2 antibodies:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the negative impact of ILD on the prognosis of dermatomyositis highlights the importance of early detection and aggressive management of this complication.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Polymyositis (PM) is best characterized by which of the following clinical presentations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asymmetric distal muscle weakness with rapid progression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Symmetric proximal muscle weakness with gradual progression over weeks to months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Painless muscle atrophy with sensory loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Focal muscle involvement with cranial nerve palsies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Symmetric proximal muscle weakness with gradual progression over weeks to months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Symmetric proximal muscle weakness with gradual progression over weeks to months&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asymmetric distal muscle weakness with rapid progression : This is more suggestive of other neuromuscular disorders like Guillain-BarrÃ© syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Asymmetric distal muscle weakness with rapid progression&lt;/li&gt;&lt;li&gt;â€¢ Option C. Painless muscle atrophy with sensory loss : This pattern is more indicative of neuropathic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Painless muscle atrophy with sensory loss&lt;/li&gt;&lt;li&gt;â€¢ Option D. Focal muscle involvement with cranial nerve palsies : This might be seen in certain myopathies, but not the typical presentation of polymyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Focal muscle involvement with cranial nerve palsies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the classic presentation of PM is crucial for timely diagnosis and appropriate management. Distinguishing PM from other neuromuscular disorders with similar symptoms can guide further diagnostic testing and treatment decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman presents with progressive muscle weakness, particularly in her thighs and shoulders. She has difficulty climbing stairs and lifting objects. She also reports a persistent cough and shortness of breath on exertion. Additionally, she experiences joint pain and swelling in her hands and knees. Given the likely diagnosis, Which is the most common aminoacyl-tRNA synthetase (ARS) antibody found in this patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-PL-7&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-PL-12&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-OJ&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-Jo-1&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti-Jo-1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti-Jo-1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-PL-7, B. Anti-PL-12 and C. Anti-OJ are other ARS antibodies but are less common than anti-Jo-1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-PL-7, B. Anti-PL-12&lt;/li&gt;&lt;li&gt;â€¢ C. Anti-OJ&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the association between anti-Jo-1 antibodies and the clinical triad of myositis, ILD, and arthritis is crucial for accurate diagnosis and management of anti-synthetase syndrome, a subtype of inflammatory myopathy. This syndrome often requires aggressive immunosuppressive therapy to control both the muscle and lung disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In patients with Inclusion Body Myositis (IBM), the average time from symptom onset to requiring a wheelchair or scooter is approximately:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;15 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 15 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 15 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the natural history and progression of IBM is important for patient counselling and planning for future care needs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man presents with gradual onset of difficulty gripping objects and rising from a chair. He also reports occasional choking when swallowing. Which of the following diagnoses is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyotrophic Lateral Sclerosis (ALS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymyositis (PM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inclusion Body Myositis (IBM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myasthenia Gravis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inclusion Body Myositis (IBM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Inclusion Body Myositis (IBM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amyotrophic Lateral Sclerosis (ALS): While ALS can cause muscle weakness, it typically presents with a combination of upper and lower motor neuron signs (e.g., spasticity, hyperreflexia) and does not usually involve dysphagia early in the disease course.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amyotrophic Lateral Sclerosis (ALS):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymyositis (PM): PM usually presents with symmetric proximal muscle weakness, rather than the asymmetric pattern of weakness often seen in IBM.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymyositis (PM):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myasthenia Gravis: Myasthenia Gravis typically causes fluctuating muscle weakness that worsens with activity and improves with rest. It does not typically cause the pattern of muscle weakness seen in IBM.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myasthenia Gravis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the typical clinical presentation of IBM is essential for early diagnosis and appropriate management. IBM can be easily misdiagnosed as other neuromuscular disorders, so a high index of suspicion is necessary.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following staining techniques is most sensitive for detecting inclusions in Inclusion Body Myositis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congo red stain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hematoxylin and eosin stain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Periodic acid-Schiff (PAS) stain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immunostaining for p62&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Immunostaining for p62&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Immunostaining for p62&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congo red stain: While Congo red is used to detect amyloid deposits, it is not the most sensitive method for visualizing inclusions in IBM, especially in paraffin-embedded sections. The inclusions in IBM often do not stain well with Congo red due to their specific protein composition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congo red stain:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hematoxylin and eosin (H&amp;amp;E) stain: H&amp;amp;E is a standard stain for routine histological examination. It can visualize the general architecture of the muscle tissue and some inclusions, but it lacks the specificity and sensitivity of immunostaining for p62.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hematoxylin and eosin (H&amp;amp;E) stain:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Periodic acid-Schiff (PAS) stain: PAS stain is used to detect glycogen and other carbohydrates. While it can highlight some inclusions in IBM, it is not as specific or sensitive as p62 immunostaining for detecting the beta-sheet misfolded proteins that are characteristic of these inclusions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Periodic acid-Schiff (PAS) stain:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Immunostaining for p62 is a valuable diagnostic tool for confirming the presence of characteristic inclusions in IBM muscle biopsies. It is more sensitive and specific than other staining techniques like Congo red, H&amp;amp;E, or PAS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the recommended approach for patients with known TPMT deficiency who require azathioprine therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer the standard dose of azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Avoid azathioprine completely and use an alternative immunosuppressant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start azathioprine at a significantly reduced dose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Begin with a standard dose and monitor closely for adverse effects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Start azathioprine at a significantly reduced dose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Start azathioprine at a significantly reduced dose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ It is crucial to test for TPMT deficiency before initiating azathioprine therapy. If deficiency is detected, the dose must be significantly reduced to avoid serious complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman presents with 6 months of progressive proximal muscle weakness, worsened after statin use. Examination reveals no rash. Labs show elevated creatine kinase (CK). Muscle biopsy demonstrates necrotic muscle fibers without significant inflammation. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Necrotizing Autoimmune Myopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myasthenia Gravis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Necrotizing Autoimmune Myopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Necrotizing Autoimmune Myopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polymyositis: Typically presents with symmetrical proximal weakness but would show inflammatory infiltrates on muscle biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Polymyositis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dermatomyositis: Similar to polymyositis but with characteristic skin findings (absent in this case).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dermatomyositis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myasthenia Gravis: Presents with fluctuating muscle weakness that worsens with activity and improves with rest. Muscle biopsy would not show necrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myasthenia Gravis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Necrotizing autoimmune myopathy (NAM) is a rare subtype of autoimmune myopathies characterized by progressive muscle weakness, elevated creatine kinase, and muscle biopsy showing muscle fiber necrosis with minimal inflammation. Statin use can be a trigger. Treatment involves immunosuppressive medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with rheumatoid arthritis on corticosteroids for 6 months presents with new-onset proximal muscle weakness and fatigue. Physical examination confirms the muscle weakness. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymyalgia rheumatica&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Steroid myopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothyroid myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Steroid myopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Steroid myopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE): While SLE can cause muscle weakness, it is usually accompanied by other systemic symptoms like rash, joint pain, and fever.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymyalgia rheumatica: Typically affects older individuals and causes pain and stiffness in the shoulders and hips, not weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymyalgia rheumatica:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothyroid myopathy: Can cause muscle weakness, but it is usually associated with other signs of hypothyroidism, such as fatigue, cold intolerance, and constipation. This patient&#x27;s symptoms developed after starting corticosteroids, making steroid myopathy more likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothyroid myopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Be aware of the potential for steroid myopathy in patients taking corticosteroids. It is important to monitor for muscle weakness and consider dose reduction or alternative therapies if this side effect develops.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with a 6-month history of widespread pain, fatigue, and difficulty sleeping. She also reports experiencing headaches, irritable bowel syndrome (IBS) symptoms, and anxiety. Physical examination is unremarkable except for multiple tender points. Given her symptoms and physical examination findings, which group of conditions is most likely to include her diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic Fatigue Syndromes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Overlapping Pain Syndromes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic Regional Pain Syndromes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic Inflammatory Syndromes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chronic Overlapping Pain Syndromes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chronic Overlapping Pain Syndromes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic Fatigue Syndromes: While fatigue is a prominent feature in fibromyalgia, the presence of widespread pain and other symptoms differentiates it from chronic fatigue syndrome, which primarily focuses on debilitating fatigue.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chronic Fatigue Syndromes:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic Regional Pain Syndromes: These syndromes involve pain localized to a specific region of the body, unlike the widespread pain seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic Regional Pain Syndromes:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic Inflammatory Syndromes: Although inflammation might play a role in some COPS conditions, it&#x27;s not the defining characteristic. Fibromyalgia, for example, is not primarily an inflammatory disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic Inflammatory Syndromes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the concept of COPS is important for understanding the complex interplay of various chronic pain conditions and their potential shared pathophysiological mechanisms. This can help guide a more holistic approach to diagnosis and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of rheumatoid arthritis presents with proteinuria and peripheral edema. Renal biopsy reveals amyloid deposits. Which type of amyloidosis is most likely in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AA Amyloidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AL Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AÎ² Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ATTR Amyloidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. AA Amyloidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) AA Amyloidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. AL Amyloidosis : Associated with plasma cell dyscrasias.&lt;/li&gt;&lt;li&gt;â€¢ Option B. AL Amyloidosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. AÎ² Amyloidosis : Associated with Alzheimer&#x27;s disease and deposits in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. AÎ² Amyloidosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. ATTR Amyloidosis : Primarily affects the heart and nerves.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ATTR Amyloidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the association between chronic inflammatory diseases and AA amyloidosis is crucial for early diagnosis and intervention to prevent irreversible organ damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with long-standing multiple myeloma presents with nephrotic syndrome and macroglossia (enlarged tongue). Which of the following types of amyloidosis is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AA Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AL Amyloidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AÎ² Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ATTR Amyloidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AL Amyloidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) AL Amyloidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. AA Amyloidosis: This type is associated with chronic inflammatory conditions (like rheumatoid arthritis or Crohn&#x27;s disease) and typically affects the kidneys, liver, and spleen. While it can cause nephrotic syndrome, macroglossia is less common.&lt;/li&gt;&lt;li&gt;â€¢ Option A. AA Amyloidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. AÎ² Amyloidosis: This type is associated with Alzheimer&#x27;s disease and predominantly affects the brain. It does not typically cause systemic manifestations like nephrotic syndrome or macroglossia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. AÎ² Amyloidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ATTR Amyloidosis: This type can be hereditary or wild-type (age-related) and primarily affects the heart and nerves. It can also affect the kidneys and gastrointestinal tract, but macroglossia is not a typical feature.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ATTR Amyloidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Identifying AL amyloidosis as a potential complication of multiple myeloma is essential for prompt diagnosis and treatment to prevent organ damage and improve patient outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which diagnostic test is considered the gold standard for confirming the presence of amyloid deposits in tissues?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum protein electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congo red staining of biopsy tissue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Congo red staining of biopsy tissue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Congo red staining of biopsy tissue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum protein electrophoresis (SPEP): SPEP can detect abnormal proteins in the blood, which may suggest amyloidosis. However, it does not directly visualize or confirm the presence of amyloid deposits in tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum protein electrophoresis (SPEP):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone marrow biopsy: Bone marrow biopsy is helpful in diagnosing AL amyloidosis, where amyloid deposits originate from light chains produced by plasma cells. However, it&#x27;s not the gold standard for all types of amyloidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone marrow biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiogram: While an echocardiogram can reveal structural and functional abnormalities in the heart suggestive of amyloidosis (especially ATTR amyloidosis), it does not directly confirm the presence of amyloid deposits. A biopsy is still needed for definitive diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Echocardiogram:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Understanding the role of Congo red staining in the diagnosis of amyloidosis is crucial for accurate identification and classification of this disease. It allows for confirmation of amyloid deposits in various tissues and helps distinguish different types of amyloidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with ATTR amyloid cardiomyopathy and New York Heart Association (NYHA) class III heart failure is started on tafamidis. Which of the following is the most realistic expectation of treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete reversal of heart failure symptoms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Regression of cardiac hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stabilization of disease progression and improved quality of life&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cure of the underlying amyloidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stabilization of disease progression and improved quality of life&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Stabilization of disease progression and improved quality of life&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete reversal of heart failure symptoms: Unlikely due to existing heart damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete reversal of heart failure symptoms:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Regression of cardiac hypertrophy: Tafamidis doesn&#x27;t reverse thickening.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Regression of cardiac hypertrophy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Regression of cardiac hypertrophy: Tafamidis doesn&#x27;t reverse thickening.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Regression of cardiac hypertrophy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Tafamidis is a valuable therapeutic option for ATTR amyloid cardiomyopathy, but it&#x27;s important to understand its limitations. It&#x27;s not a cure but can offer significant benefits in terms of slowing disease progression and improving quality of life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 130 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

</body>
</html>
